data_2l59_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l59 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 pt -79.22 166.97 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.284 0.634 . . . . 0.0 111.268 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -126.5 141.68 51.79 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.157 1.783 . . . . 0.0 109.516 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.42 155.36 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.785 1.234 . . . . 0.0 111.954 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.3 p -137.85 159.91 40.72 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.064 1.746 . . . . 0.0 111.206 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.69 -28.25 68.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.02 -17.69 54.9 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -122.18 -17.77 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.169 1.388 . . . . 0.0 114.368 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -50.85 -41.43 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.979 1.712 . . . . 0.0 112.957 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 -31.43 71.96 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -35.02 33.95 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 111.627 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.95 -45.6 16.43 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.74 -54.44 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 111.173 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -80.92 -13.35 58.98 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -168.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 t -95.72 -6.35 40.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.569 1.148 . . . . 0.0 112.979 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -69.32 144.33 53.55 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.163 -0.96 . . . . 0.0 112.814 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -82.62 -5.42 58.8 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.939 1.296 . . . . 0.0 113.429 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -102.87 169.33 7.61 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 126.132 1.773 . . . . 0.0 112.367 -164.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -62.04 125.62 16.88 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.152 1.235 . . . . 0.0 109.147 147.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.99 116.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 109.938 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 tt -94.02 125.59 38.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.743 1.617 . . . . 0.0 108.39 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.85 128.27 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.441 -0.787 . . . . 0.0 110.582 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -106.04 113.08 26.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.218 1.007 . . . . 0.0 111.773 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -89.91 111.39 22.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.616 1.567 . . . . 0.0 108.913 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.8 172.8 15.04 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -163.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.82 142.74 51.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.387 1.075 . . . . 0.0 110.286 165.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -17.55 63.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -91.01 -11.86 37.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.535 1.534 . . . . 0.0 114.131 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 130.95 37.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.967 0.907 . . . . 0.0 111.873 -172.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.51 -60.27 9.12 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.691 1.139 . . . . 0.0 114.732 -175.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 -19.21 52.22 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.291 1.994 . . . . 0.0 113.236 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.4 m -71.18 -46.54 61.13 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.97 0.908 . . . . 0.0 111.059 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.99 -32.32 73.83 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.196 -0.94 . . . . 0.0 112.143 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.0 ttt -61.23 -34.97 75.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.671 0.788 . . . . 0.0 113.067 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.56 -11.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.11 -50.93 72.47 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-N 120.116 1.326 . . . . 0.0 114.385 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.92 -34.3 30.25 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.499 1.466 . . . . 0.0 112.222 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -67.47 -49.27 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.256 -0.902 . . . . 0.0 111.303 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.84 -42.24 95.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.448 0.699 . . . . 0.0 111.054 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.77 -45.48 92.14 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.596 0.634 . . . . 0.0 111.876 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.71 -49.45 53.19 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.461 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.49 -42.46 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.761 1.164 . . . . 0.0 110.564 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.24 -31.33 68.69 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -74.09 -37.42 64.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.86 0.464 . . . . 0.0 110.334 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.76 -35.14 24.58 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -116.2 24.47 11.38 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.63 1.572 . . . . 0.0 113.537 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.43 -26.23 29.57 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.3 p -80.17 -18.16 50.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.446 1.499 . . . . 0.0 113.999 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -100.14 -40.94 7.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.264 1.425 . . . . 0.0 112.551 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.07 159.92 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.539 1.136 . . . . 0.0 113.49 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.0 m -107.21 141.49 38.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 110.233 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -117.87 133.75 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.173 0.589 . . . . 0.0 110.479 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.05 162.6 26.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.837 2.055 . . . . 0.0 111.235 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -133.07 142.89 48.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -116.98 123.72 47.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.7 2.0 . . . . 0.0 109.083 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -92.44 91.59 7.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 110.378 -172.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 m -66.25 -19.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.301 -0.874 . . . . 0.0 112.92 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.69 -26.34 68.33 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -122.11 -22.93 5.49 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.619 1.168 . . . . 0.0 113.579 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -120.55 88.61 43.24 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.323 1.449 . . . . 0.0 111.227 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.2 -13.56 18.95 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.836 2.357 . . . . 0.0 113.081 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -77.06 -39.98 47.88 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.839 -1.163 . . . . 0.0 112.2 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -27.5 55.51 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.663 -0.648 . . . . 0.0 111.822 168.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.53 96.92 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.251 -0.905 . . . . 0.0 112.255 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -72.24 -26.71 62.11 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.262 -0.899 . . . . 0.0 113.059 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.76 -40.79 89.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.118 0.967 . . . . 0.0 112.476 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -107.52 14.69 25.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.567 1.547 . . . . 0.0 113.819 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 53.26 57.11 6.57 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.316 1.846 . . . . 0.0 113.611 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.55 134.72 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.144 168.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.86 -40.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.568 1.147 . . . . 0.0 111.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.2 m -122.1 157.09 32.22 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.642 1.577 . . . . 0.0 110.215 163.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.2 pt -126.58 149.92 69.38 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.987 1.315 . . . . 0.0 111.782 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.33 140.26 65.18 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 CA-C-N 119.106 0.716 . . . . 0.0 112.391 -2.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -102.15 114.84 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.195 . . . . 0.0 107.931 168.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.73 127.96 52.68 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.147 0.979 . . . . 0.0 109.196 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.1 127.52 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.831 0.853 . . . . 0.0 109.705 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.9 tp -104.85 120.63 41.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.597 1.159 . . . . 0.0 110.751 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.27 157.35 16.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.084 1.753 . . . . 0.0 110.616 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -135.38 128.81 32.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.905 1.682 . . . . 0.0 109.109 165.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.0 t70 53.88 32.73 15.71 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.163 0.985 . . . . 0.0 113.248 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.72 9.46 84.91 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.467 1.508 . . . . 0.0 115.563 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -112.58 134.98 21.51 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 118.952 1.376 . . . . 0.0 110.888 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.01 140.18 41.14 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.881 2.388 . . . . 0.0 112.27 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.64 -46.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.73 1.212 . . . . 0.0 111.848 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -158.91 153.19 23.91 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.555 1.142 . . . . 0.0 113.302 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -128.62 139.03 52.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.488 1.915 . . . . 0.0 111.031 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.5 mm -129.69 147.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.092 1.757 . . . . 0.0 109.426 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.9 136.66 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 110.139 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.67 171.15 31.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.1 1.333 . . . . 0.0 113.174 -168.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 156.98 35.99 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -171.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -124.44 161.79 25.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.529 2.332 . . . . 0.0 111.842 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.51 161.8 13.18 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.8 1.19 . . . . 0.0 110.76 156.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -52.72 -39.78 62.39 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.331 1.052 . . . . 0.0 112.95 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.67 79.36 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.461 0.705 . . . . 0.0 112.029 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.61 72.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.362 0.665 . . . . 0.0 111.991 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.31 -47.99 83.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.928 0.891 . . . . 0.0 111.07 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.46 -31.5 68.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.626 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 ttp-105 -67.55 -46.26 73.26 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.422 1.465 . . . . 0.0 111.975 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -70.02 -21.5 63.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.09 -40.07 68.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.392 1.077 . . . . 0.0 112.96 163.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.7 m -66.28 -22.03 66.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.021 1.328 . . . . 0.0 112.198 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.33 -20.74 66.53 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 126.101 1.76 . . . . 0.0 112.157 -170.807 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.7 165.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.995 1.718 . . . . 0.0 111.115 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 143.44 50.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.91 1.284 . . . . 0.0 111.991 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -131.74 156.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.839 1.255 . . . . 0.0 112.939 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.6 p -137.24 168.32 19.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.933 2.493 . . . . 0.0 109.762 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.91 -27.91 65.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.89 -18.12 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.3 p -110.5 -25.11 10.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.729 1.611 . . . . 0.0 113.995 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -48.86 -41.54 33.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.581 1.952 . . . . 0.0 112.579 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.75 72.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -84.73 -33.04 23.18 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.28 -0.888 . . . . 0.0 111.947 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -84.77 -40.3 17.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 t -98.94 -52.71 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.38 1.472 . . . . 0.0 111.347 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.3 mt -83.12 -18.31 39.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.5 m -104.77 20.69 18.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.703 1.601 . . . . 0.0 113.538 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.9 p -58.74 -38.45 78.42 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.22 25.72 1.91 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.116 1.367 . . . . 0.0 113.633 -163.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.46 165.97 16.77 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 125.49 1.516 . . . . 0.0 112.31 168.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -45.24 133.61 11.86 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.72 2.28 . . . . 0.0 112.692 154.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -142.84 124.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.779 0.832 . . . . 0.0 111.215 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.7 tp -90.57 133.06 35.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.379 1.472 . . . . 0.0 107.558 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.92 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.819 1.19 . . . . 0.0 109.871 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -108.47 120.68 43.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.649 1.18 . . . . 0.0 111.704 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -98.55 112.71 24.66 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.021 2.128 . . . . 0.0 108.537 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.57 -179.0 7.03 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.13 137.33 52.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.848 0.459 . . . . 0.0 109.958 156.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.0 p -61.94 -23.21 66.23 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -85.78 -12.23 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.303 1.441 . . . . 0.0 114.47 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 143.9 38.95 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.285 0.948 . . . . 0.0 112.924 -170.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.11 -63.72 5.06 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.452 1.025 . . . . 0.0 114.27 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.91 -24.55 67.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.963 1.775 . . . . 0.0 112.625 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.6 m -62.92 -47.87 81.39 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.045 0.938 . . . . 0.0 110.953 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -64.3 -32.85 74.61 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.072 0.949 . . . . 0.0 112.792 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.95 -32.75 73.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 p -91.17 -13.54 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.436 1.016 . . . . 0.0 113.608 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.99 -50.4 62.9 Favored Pre-proline 0 CA--C 1.555 1.171 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.67 -30.63 34.37 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.627 1.552 . . . . 0.0 112.577 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.87 -49.63 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.05 0.94 . . . . 0.0 111.597 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.45 -34.81 77.94 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 111.618 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.7 -41.72 92.01 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.435 1.016 . . . . 0.0 112.5 170.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.73 -44.11 78.36 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.024 -1.048 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -58.15 -44.11 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.957 1.253 . . . . 0.0 111.266 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.44 78.12 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.036 0.534 . . . . 0.0 112.126 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -77.17 -41.36 41.94 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.53 -0.731 . . . . 0.0 111.357 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -83.67 -28.95 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -111.01 20.3 17.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.968 1.307 . . . . 0.0 113.128 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.15 -33.1 17.86 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -74.59 -23.38 58.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.136 1.375 . . . . 0.0 112.845 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -105.52 -33.79 7.99 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.579 1.952 . . . . 0.0 112.993 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -151.7 139.32 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.577 1.551 . . . . 0.0 110.517 -156.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.7 m -115.84 140.49 49.17 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.309 1.443 . . . . 0.0 109.614 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.68 128.25 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.935 0.894 . . . . 0.0 109.725 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.61 143.66 45.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.139 1.776 . . . . 0.0 111.918 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -110.6 127.86 55.42 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.198 1.399 . . . . 0.0 111.974 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.33 123.98 41.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.059 1.343 . . . . 0.0 109.786 167.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.91 118.0 34.69 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.535 0.734 . . . . 0.0 110.18 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -71.31 -16.44 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.52 -38.97 11.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.64 1.176 . . . . 0.0 112.714 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.7 p -87.49 -21.88 25.22 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.75 80.61 55.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.034 0.933 . . . . 0.0 111.891 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.55 -20.34 70.39 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.152 2.568 . . . . 0.0 113.706 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.93 -44.41 92.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 112.74 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 m -73.17 -33.09 65.25 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.195 0.907 . . . . 0.0 111.452 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.47 92.95 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.463 -0.773 . . . . 0.0 111.933 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.99 -25.82 53.16 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.86 -45.94 88.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.189 0.904 . . . . 0.0 111.397 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.07 10.33 41.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 113.933 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 45.42 50.59 10.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.798 2.039 . . . . 0.0 113.674 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 p -75.23 138.04 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.294 -0.879 . . . . 0.0 111.529 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -123.56 -15.81 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.3 m -133.68 150.88 51.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.828 1.651 . . . . 0.0 110.898 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.79 140.58 37.98 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.814 0.846 . . . . 0.0 111.873 174.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.72 152.73 94.98 Favored 'Cis proline' 0 CA--C 1.543 0.935 0 CA-C-N 118.973 0.669 . . . . 0.0 111.177 -11.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.9 m -133.87 124.88 27.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.767 1.227 . . . . 0.0 109.421 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.74 147.15 28.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.853 1.261 . . . . 0.0 110.867 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 tt -131.7 144.55 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.384 1.474 . . . . 0.0 109.633 169.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 tp -107.21 130.63 54.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.228 1.011 . . . . 0.0 110.307 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.68 147.16 29.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.84 1.256 . . . . 0.0 109.568 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -108.65 116.44 31.99 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.537 1.535 . . . . 0.0 108.365 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 51.33 34.27 11.44 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.812 1.245 . . . . 0.0 113.669 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.22 17.29 67.26 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -125.42 136.6 28.48 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 119.501 1.651 . . . . 0.0 110.865 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.22 139.81 39.48 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.773 2.316 . . . . 0.0 112.243 -172.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.57 -36.04 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -162.06 149.64 14.32 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.593 1.088 . . . . 0.0 113.302 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -129.07 141.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.891 1.676 . . . . 0.0 111.597 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 123.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.237 1.815 . . . . 0.0 111.44 -175.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.04 150.73 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.333 1.053 . . . . 0.0 111.822 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.76 -179.98 53.24 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.051 1.31 . . . . 0.0 113.437 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.95 157.51 28.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -129.49 152.23 49.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.034 1.734 . . . . 0.0 111.091 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.49 154.31 20.98 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 163.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -57.7 -33.03 67.95 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.12 82.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.149 0.58 . . . . 0.0 111.786 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.12 66.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.442 0.697 . . . . 0.0 111.457 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.64 -43.46 98.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.919 0.887 . . . . 0.0 111.343 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.1 tp -67.66 -34.74 77.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.774 0.829 . . . . 0.0 113.014 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -66.81 -45.14 79.29 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.361 1.437 . . . . 0.0 111.51 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.34 -34.67 70.89 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.35 -44.0 30.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 p -72.05 -15.06 62.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.755 1.222 . . . . 0.0 113.095 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -14.19 48.03 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 126.673 1.989 . . . . 0.0 110.431 -177.618 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 pt -121.52 134.74 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 112.816 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -82.6 127.44 33.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.411 1.484 . . . . 0.0 108.932 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.04 156.85 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.349 1.059 . . . . 0.0 112.282 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -134.39 172.0 13.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.455 2.302 . . . . 0.0 111.052 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.3 -26.67 63.3 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.062 -1.024 . . . . 0.0 113.659 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.63 -35.0 24.95 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.9 p -100.05 -24.14 14.69 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -53.01 -40.83 64.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.056 1.342 . . . . 0.0 112.597 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.34 -31.57 72.44 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.081 -1.012 . . . . 0.0 113.39 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.7 m -81.6 -33.83 31.31 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.796 0.838 . . . . 0.0 111.993 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -92.83 -25.73 17.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.23 -53.87 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.37 -19.93 55.51 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -77.2 -23.81 51.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -81.39 122.34 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.044 -164.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -72.45 -29.26 63.52 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.276 1.03 . . . . 0.0 111.629 166.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -72.18 158.94 86.69 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.373 1.069 . . . . 0.0 110.962 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.47 139.9 73.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.504 2.136 . . . . 0.0 110.974 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 t -128.85 117.54 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.689 0.796 . . . . 0.0 110.388 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.65 128.27 36.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.587 1.155 . . . . 0.0 108.678 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.38 127.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.85 0.86 . . . . 0.0 109.87 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -97.5 112.6 24.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.199 0.6 . . . . 0.0 111.179 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.22 109.54 18.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.192 1.397 . . . . 0.0 107.65 170.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.42 178.51 8.37 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -165.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.96 47.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.834 0.454 . . . . 0.0 109.944 157.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -62.33 -20.71 64.65 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -85.42 -16.55 39.39 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.151 1.38 . . . . 0.0 114.461 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 144.71 38.54 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.23 0.923 . . . . 0.0 113.398 -167.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.35 -63.9 4.88 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.634 1.111 . . . . 0.0 114.405 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.79 -21.33 51.17 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 119.616 1.708 . . . . 0.0 112.932 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.9 m -63.14 -47.48 82.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.487 1.039 . . . . 0.0 110.683 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.16 -32.3 73.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.903 0.881 . . . . 0.0 112.647 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.9 ttt -63.77 -36.43 83.85 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.45 -11.37 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -54.67 39.53 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 119.948 1.249 . . . . 0.0 113.915 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.3 -33.43 59.27 Favored 'Trans proline' 0 C--N 1.355 0.893 0 CA-C-N 121.143 1.444 . . . . 0.0 111.685 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.24 -51.27 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.609 0.764 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.48 -37.96 83.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.684 0.675 . . . . 0.0 111.086 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.64 -42.6 98.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.499 0.591 . . . . 0.0 112.218 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.98 -48.04 69.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.049 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.1 mm -57.94 -42.88 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.839 1.654 . . . . 0.0 110.821 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.52 91.82 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.138 0.426 . . . . 0.0 111.685 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -79.43 -31.36 42.6 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.297 1.039 . . . . 0.0 112.459 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -87.03 -31.12 20.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -126.49 27.02 6.23 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.8 -28.93 17.17 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -76.63 -20.32 56.83 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.755 1.622 . . . . 0.0 114.257 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.57 -37.15 8.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.821 1.249 . . . . 0.0 112.709 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.59 174.0 12.17 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.383 1.473 . . . . 0.0 113.088 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.3 m -117.96 146.34 44.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.199 1.399 . . . . 0.0 109.783 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.23 138.12 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.765 0.826 . . . . 0.0 109.995 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.05 161.26 35.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.289 1.835 . . . . 0.0 112.101 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -131.55 138.08 48.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.544 1.138 . . . . 0.0 112.713 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 tt -128.14 111.91 13.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.294 2.238 . . . . 0.0 107.966 -172.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -86.45 112.52 21.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.379 0.609 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -71.42 -17.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -88.11 -40.69 13.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.285 1.034 . . . . 0.0 112.555 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -90.71 -23.32 20.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -130.56 68.25 81.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.144 1.377 . . . . 0.0 110.445 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.41 -16.65 39.17 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.241 2.627 . . . . 0.0 113.839 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.52 -37.67 87.44 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.32 -0.862 . . . . 0.0 112.727 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.7 p -77.18 -35.29 55.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.48 0.712 . . . . 0.0 112.387 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.04 98.59 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 112.357 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -76.91 -23.29 52.53 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -58.75 -42.32 88.59 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.301 0.955 . . . . 0.0 111.635 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -97.98 5.66 48.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.197 1.399 . . . . 0.0 113.589 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 52.46 41.05 30.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.516 1.927 . . . . 0.0 114.176 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -78.65 128.81 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.992 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -126.27 -6.94 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.626 1.57 . . . . 0.0 114.025 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.7 m -122.24 150.76 41.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.226 1.81 . . . . 0.0 110.876 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.8 pt -137.86 144.88 45.96 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.086 0.955 . . . . 0.0 112.08 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.27 144.91 74.59 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 CA-C-N 119.498 0.857 . . . . 0.0 111.084 -13.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -122.66 114.73 20.98 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.494 1.118 . . . . 0.0 108.881 172.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.6 mt -98.69 123.87 43.17 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.011 1.324 . . . . 0.0 109.433 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.96 139.78 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.384 1.074 . . . . 0.0 110.397 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 tp -106.17 126.65 52.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.857 1.263 . . . . 0.0 111.502 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -107.59 152.75 23.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.607 1.963 . . . . 0.0 111.607 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -144.91 131.44 19.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 0.0 109.883 172.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.18 33.28 12.05 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -171.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.51 42.14 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.859 1.695 . . . . 0.0 114.94 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -95.59 139.04 21.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 118.711 1.255 . . . . 0.0 110.538 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.88 135.98 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.48 2.12 . . . . 0.0 110.841 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.75 -48.9 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.852 0.861 . . . . 0.0 112.237 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -154.21 148.64 26.14 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.628 1.171 . . . . 0.0 112.125 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -132.83 139.89 47.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.161 1.384 . . . . 0.0 111.596 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.72 129.01 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 110.754 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.39 36.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.289 1.435 . . . . 0.0 113.603 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.41 174.25 38.79 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.347 0.975 . . . . 0.0 114.297 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.31 154.34 42.01 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.715 1.206 . . . . 0.0 113.878 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.03 153.49 51.34 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.006 1.723 . . . . 0.0 111.595 165.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.26 167.42 43.3 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.215 0.912 . . . . 0.0 110.961 164.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -58.69 -34.64 71.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.36 66.99 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.824 0.45 . . . . 0.0 111.385 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.23 83.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.656 0.782 . . . . 0.0 111.771 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 tp -68.53 -38.21 80.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.381 -0.824 . . . . 0.0 112.21 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -68.09 -33.45 74.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.161 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 tpt85 -68.5 -38.82 81.29 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.313 1.415 . . . . 0.0 112.65 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -62.24 -36.32 81.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.456 1.102 . . . . 0.0 111.347 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mt -68.56 -43.6 76.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 113.404 169.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.2 m -68.15 -17.96 64.49 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.113 1.365 . . . . 0.0 112.186 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.53 -12.37 43.97 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.54 1.136 . . . . 0.0 113.57 167.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 126.231 1.813 . . . . 0.0 112.023 -176.263 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 pt -140.79 168.58 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.312 1.845 . . . . 0.0 111.825 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -115.5 143.47 45.26 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.832 1.253 . . . . 0.0 110.422 163.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.35 167.13 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.428 1.491 . . . . 0.0 112.425 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.5 p -127.93 172.04 11.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.317 2.647 . . . . 0.0 109.36 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.89 -33.12 64.31 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.043 -1.036 . . . . 0.0 113.181 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.22 -38.14 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.679 0.791 . . . . 0.0 113.04 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -80.61 -24.68 38.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.316 1.046 . . . . 0.0 113.54 -176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -53.43 -41.84 66.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.898 1.279 . . . . 0.0 112.639 -173.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.37 69.87 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 m -87.33 -23.25 24.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.726 1.21 . . . . 0.0 113.081 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -107.34 -31.57 8.13 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.73 -56.44 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.221 1.009 . . . . 0.0 111.487 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.1 -12.43 60.9 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -76.19 -21.29 56.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.809 1.644 . . . . 0.0 114.104 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 t -96.27 128.19 42.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -73.33 -24.55 60.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.533 1.533 . . . . 0.0 112.449 166.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -74.17 149.42 87.11 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.281 1.432 . . . . 0.0 109.817 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.13 129.35 34.79 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.384 2.056 . . . . 0.0 111.904 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -128.71 120.07 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.641 1.176 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 29.8 tp -91.23 133.6 35.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.743 1.217 . . . . 0.0 108.87 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.78 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.494 1.043 . . . . 0.0 110.952 169.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -107.79 127.19 53.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.498 1.519 . . . . 0.0 111.57 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -100.34 117.53 34.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.894 1.678 . . . . 0.0 110.064 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.31 168.65 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -169.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 -176.93 3.65 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.817 1.647 . . . . 0.0 111.726 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.7 p -74.66 -23.72 58.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.167 1.387 . . . . 0.0 114.52 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -114.56 -13.49 12.16 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -161.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.59 120.55 24.09 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -164.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.91 -59.07 8.45 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.612 1.101 . . . . 0.0 114.413 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.5 -24.14 36.59 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.007 1.903 . . . . 0.0 113.386 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -76.31 -32.29 58.66 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.327 0.967 . . . . 0.0 111.965 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -75.36 -32.58 60.89 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.624 -0.673 . . . . 0.0 112.052 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.58 -33.47 75.03 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.17 0.988 . . . . 0.0 113.57 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.76 -20.43 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.404 1.002 . . . . 0.0 113.592 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.66 -40.72 85.42 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.536 1.517 . . . . 0.0 115.083 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.19 -37.81 80.71 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.632 2.221 . . . . 0.0 113.047 171.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.89 -39.53 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.804 0.842 . . . . 0.0 110.806 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.79 -49.54 57.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.7 1.2 . . . . 0.0 110.683 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.61 -37.99 71.44 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.476 . . . . 0.0 110.538 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -77.18 -49.25 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.159 -0.448 . . . . 0.0 112.143 -172.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.8 mm -65.01 -36.4 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.356 0.98 . . . . 0.0 111.042 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.712 . . . . 0.0 112.822 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -75.48 -43.85 47.09 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.675 1.125 . . . . 0.0 110.956 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.69 -33.14 47.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -121.33 30.82 6.6 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.171 1.788 . . . . 0.0 112.374 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.57 -28.79 22.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.474 1.51 . . . . 0.0 114.335 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 m -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.775 1.23 . . . . 0.0 112.242 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -90.76 -37.88 13.38 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.768 1.227 . . . . 0.0 113.027 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 166.82 23.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.6 m -125.9 142.5 51.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.086 1.754 . . . . 0.0 108.51 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.16 138.18 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.489 0.716 . . . . 0.0 110.782 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.12 152.36 46.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.303 1.441 . . . . 0.0 112.639 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -106.85 135.05 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.552 1.541 . . . . 0.0 110.498 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.42 121.34 43.26 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -94.61 114.54 26.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.6 m -69.52 -16.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.46 -24.14 39.74 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.831 0.852 . . . . 0.0 112.726 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 p -86.9 -30.96 20.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -148.18 106.4 3.61 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.683 1.193 . . . . 0.0 110.987 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.2 -10.95 29.37 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 121.775 1.65 . . . . 0.0 112.465 161.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.77 -51.45 69.27 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.335 1.454 . . . . 0.0 112.194 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.56 -30.46 64.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.509 0.724 . . . . 0.0 112.05 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -43.43 98.86 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.499 -0.751 . . . . 0.0 111.944 173.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -77.26 -24.62 51.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -59.86 -44.59 94.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.289 0.95 . . . . 0.0 112.092 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.51 15.05 24.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 113.704 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 50.99 46.15 26.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.223 2.209 . . . . 0.0 113.836 173.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.96 121.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.357 1.063 . . . . 0.0 109.54 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.22 -29.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.054 1.342 . . . . 0.0 112.907 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.5 m -125.7 155.9 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.215 1.806 . . . . 0.0 110.201 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.31 123.08 27.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.82 159.01 98.22 Favored 'Cis proline' 0 CA--C 1.542 0.876 0 CA-C-N 120.015 1.041 . . . . 0.0 113.321 0.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.2 m -127.07 129.98 49.03 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.492 1.117 . . . . 0.0 108.874 161.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.76 144.26 38.42 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.057 1.343 . . . . 0.0 110.367 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 tp -140.72 126.78 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.005 1.322 . . . . 0.0 109.508 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.76 133.19 38.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.789 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -118.95 149.65 41.25 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.84 1.656 . . . . 0.0 111.633 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -146.49 136.44 23.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.596 1.159 . . . . 0.0 110.75 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.33 30.02 14.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.324 1.05 . . . . 0.0 112.665 -171.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.58 5.12 49.15 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.613 2.054 . . . . 0.0 114.895 -172.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -95.26 131.75 29.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 118.527 1.163 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.66 132.49 23.59 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.55 2.167 . . . . 0.0 110.812 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.2 t -106.72 -47.47 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.547 1.139 . . . . 0.0 111.832 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -158.45 131.83 7.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.682 1.193 . . . . 0.0 111.254 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -112.28 136.55 51.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.379 1.471 . . . . 0.0 110.73 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.42 122.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.893 1.277 . . . . 0.0 109.524 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.09 41.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.014 1.325 . . . . 0.0 112.883 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.76 -178.77 41.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.154 0.883 . . . . 0.0 114.067 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.18 157.23 34.23 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.684 1.193 . . . . 0.0 113.871 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -129.98 160.7 32.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.6 1.96 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.35 164.02 12.12 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.3 1.428 . . . . 0.0 110.85 159.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -52.57 -40.8 62.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.546 1.139 . . . . 0.0 113.253 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.45 -44.96 77.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.17 0.588 . . . . 0.0 111.794 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -40.32 68.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.524 0.73 . . . . 0.0 112.242 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.3 tp -62.29 -44.67 95.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.921 0.888 . . . . 0.0 111.452 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.0 tp -68.12 -30.04 69.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.459 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -60.57 -47.69 85.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.604 1.093 . . . . 0.0 110.933 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.61 -40.5 87.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.475 1.034 . . . . 0.0 111.815 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.48 -30.52 69.39 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -75.63 -26.19 57.56 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.656 1.183 . . . . 0.0 112.386 171.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -85.7 11.15 11.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.342 1.857 . . . . 0.0 113.498 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.468 0.454 0 O-C-N 120.881 -1.137 . . . . 0.0 113.319 -171.244 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 pt -137.34 167.58 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.766 1.626 . . . . 0.0 111.132 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -127.71 148.41 50.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.704 0.802 . . . . 0.0 112.203 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.14 159.58 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.677 1.591 . . . . 0.0 112.446 -170.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.9 p -142.6 168.42 19.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.829 2.452 . . . . 0.0 110.501 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -56.03 -25.97 46.99 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.26 -16.68 39.37 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.1 p -119.64 -25.28 5.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.676 1.591 . . . . 0.0 114.71 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.53 -39.44 48.93 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.36 1.864 . . . . 0.0 112.932 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.35 71.85 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.2 m -87.33 -30.77 20.57 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.448 -0.782 . . . . 0.0 112.043 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -87.31 -43.92 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.0 t -98.62 -52.87 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.89 1.276 . . . . 0.0 111.344 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -79.81 -13.77 59.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -110.4 18.18 20.08 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 0.0 113.343 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.0 p -62.25 -36.89 83.43 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -167.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.295 0.5 OUTLIER 48.01 21.6 0.33 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.916 1.687 . . . . 0.0 115.185 -161.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.22 168.1 11.85 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 126.177 1.791 . . . . 0.0 111.928 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.75 139.31 74.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.708 2.272 . . . . 0.0 112.901 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.74 124.77 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.69 1.196 . . . . 0.0 111.388 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.5 99.01 10.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.702 1.601 . . . . 0.0 109.171 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -99.28 121.05 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.282 -0.887 . . . . 0.0 110.655 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -102.34 118.4 36.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.6 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -91.97 112.82 24.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.614 1.566 . . . . 0.0 108.552 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 172.62 13.98 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.378 1.071 . . . . 0.0 113.02 -169.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.54 175.08 5.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.591 1.156 . . . . 0.0 111.09 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.5 p -74.93 -18.54 60.38 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.0 -1.062 . . . . 0.0 113.726 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -116.95 -5.25 11.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -163.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.75 134.39 39.18 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.457 1.026 . . . . 0.0 113.699 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -62.99 5.54 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.454 1.026 . . . . 0.0 114.094 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.17 -25.01 65.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.335 2.023 . . . . 0.0 113.363 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -74.55 -33.42 62.71 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.091 0.859 . . . . 0.0 112.088 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -64.01 -40.75 97.03 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.453 -0.779 . . . . 0.0 112.023 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.43 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.16 99.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 120.343 1.429 . . . . 0.0 113.517 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.82 -41.69 36.33 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.869 1.713 . . . . 0.0 112.163 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.14 -47.04 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.57 1.148 . . . . 0.0 111.77 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.74 -38.21 76.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.112 0.965 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 -41.05 82.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.612 1.096 . . . . 0.0 112.314 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.03 -47.97 69.76 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.013 -1.054 . . . . 0.0 111.614 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 mm -59.14 -40.5 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.286 1.403 . . . . 0.0 111.233 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.73 75.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.714 0.688 . . . . 0.0 112.564 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.4 m -78.19 -40.42 37.7 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.284 -0.885 . . . . 0.0 111.463 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.17 -21.7 29.09 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -128.66 25.67 5.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.146 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -34.11 21.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.499 1.52 . . . . 0.0 114.459 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -78.17 -18.56 55.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.465 1.506 . . . . 0.0 113.701 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -97.61 -38.25 9.61 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.135 1.374 . . . . 0.0 112.49 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 160.42 43.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -109.08 138.01 46.09 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.099 1.359 . . . . 0.0 109.508 166.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.74 133.5 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.33 147.34 49.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.209 1.404 . . . . 0.0 111.873 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.55 135.19 53.56 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.533 1.133 . . . . 0.0 111.705 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.31 124.93 52.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.039 1.336 . . . . 0.0 109.26 164.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.29 96.61 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.928 0.891 . . . . 0.0 109.926 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -65.73 -22.72 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.044 -1.035 . . . . 0.0 112.493 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.31 -27.48 63.42 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.527 1.531 . . . . 0.0 113.015 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.1 p -123.51 -21.24 5.33 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.069 1.348 . . . . 0.0 114.254 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -128.73 63.84 67.1 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.385 1.474 . . . . 0.0 111.929 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.25 -13.26 38.89 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.322 2.681 . . . . 0.0 113.784 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -61.9 -37.36 84.3 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.218 -0.926 . . . . 0.0 112.199 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -77.5 -32.29 54.07 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.648 -0.657 . . . . 0.0 112.096 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.24 95.92 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.059 -1.025 . . . . 0.0 111.657 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -75.7 -25.55 56.78 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.34 -42.74 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.224 0.92 . . . . 0.0 111.977 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -104.52 9.87 35.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.431 1.492 . . . . 0.0 113.795 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 49.55 48.55 21.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 113.675 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.1 130.69 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.617 1.167 . . . . 0.0 110.297 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.04 -17.01 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 68.9 m -128.66 158.81 37.49 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.66 1.584 . . . . 0.0 111.079 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.4 pt -135.54 142.54 41.5 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.189 0.996 . . . . 0.0 112.07 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.39 139.55 57.12 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 CA-C-N 119.495 0.855 . . . . 0.0 111.501 -8.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.0 m -122.46 118.18 27.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.857 0.863 . . . . 0.0 108.858 168.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.05 141.62 32.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.333 1.053 . . . . 0.0 109.822 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 tp -137.77 121.47 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.065 1.346 . . . . 0.0 108.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -95.88 114.99 26.77 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.237 1.415 . . . . 0.0 109.706 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -95.55 148.74 22.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.207 1.403 . . . . 0.0 110.44 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -129.73 119.16 23.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.38 1.472 . . . . 0.0 108.877 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 49.87 35.22 8.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.684 1.194 . . . . 0.0 113.814 -174.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.5 76.85 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -122.23 141.55 34.79 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.465 1.632 . . . . 0.0 111.843 165.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.07 142.56 38.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.31 2.673 . . . . 0.0 112.277 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -120.85 -43.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.384 1.074 . . . . 0.0 113.118 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.62 133.16 19.77 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.492 1.117 . . . . 0.0 112.144 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -111.59 141.3 45.36 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.394 1.477 . . . . 0.0 111.668 171.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.6 147.46 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.301 2.24 . . . . 0.0 110.665 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.28 141.85 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 0.0 111.035 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.82 171.03 44.61 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.193 1.377 . . . . 0.0 113.597 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.44 39.34 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -138.97 158.95 43.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.905 2.082 . . . . 0.0 111.044 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.42 169.35 32.92 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.519 1.057 . . . . 0.0 111.863 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -57.58 -38.05 74.19 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.099 -0.648 . . . . 0.0 112.568 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.84 81.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.333 0.653 . . . . 0.0 111.677 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.25 77.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.37 0.668 . . . . 0.0 111.594 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.65 -40.17 96.18 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.107 0.963 . . . . 0.0 112.103 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.07 -33.15 74.88 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.846 0.858 . . . . 0.0 112.401 172.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -68.21 -38.93 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.49 1.041 . . . . 0.0 112.403 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -61.49 -38.71 88.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 0.826 . . . . 0.0 111.537 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.2 tp -67.2 -43.56 81.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.72 0.408 . . . . 0.0 111.814 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.2 p -71.82 -15.37 62.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.37 -16.99 64.56 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 126.562 1.945 . . . . 0.0 111.873 -173.291 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 121.328 0.585 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 pt -112.47 163.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.448 1.099 . . . . 0.0 111.227 160.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -126.46 130.72 51.23 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.683 1.593 . . . . 0.0 109.611 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.31 156.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.09 0.956 . . . . 0.0 113.368 -168.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.3 p -138.96 163.47 32.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.44 2.296 . . . . 0.0 110.406 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.04 -32.66 72.28 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -166.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.28 -20.59 57.21 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -109.38 -18.87 13.46 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.561 1.545 . . . . 0.0 113.88 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -52.93 -41.39 64.42 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.8 1.64 . . . . 0.0 112.927 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.44 72.18 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 m -85.52 -22.14 28.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 112.57 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -96.45 -42.38 8.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 -54.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.871 1.268 . . . . 0.0 111.623 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.66 -11.73 60.06 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.3 p -78.35 -14.34 59.45 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.311 1.844 . . . . 0.0 114.098 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.9 t -69.31 148.92 49.07 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -161.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -107.01 21.37 17.67 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.9 2.08 . . . . 0.0 112.386 167.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -138.76 156.23 72.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 128.31 2.644 . . . . 0.0 108.977 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.31 141.35 88.91 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.711 1.607 . . . . 0.0 112.559 160.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 123.09 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.418 1.087 . . . . 0.0 110.55 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.46 131.25 34.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.492 1.117 . . . . 0.0 108.531 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.63 127.9 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 119.089 0.859 . . . . 0.0 109.837 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -102.13 125.12 48.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.617 0.767 . . . . 0.0 111.172 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.16 112.24 24.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.412 1.485 . . . . 0.0 109.115 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.88 171.68 16.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -166.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 174.72 7.74 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.168 1.387 . . . . 0.0 111.954 174.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.6 p -75.11 -18.73 60.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -115.11 -7.0 12.49 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -165.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.05 128.02 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.37 -60.69 8.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.467 1.032 . . . . 0.0 114.102 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.42 -27.1 54.91 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.192 1.928 . . . . 0.0 113.501 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.61 -33.18 64.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.048 0.84 . . . . 0.0 112.015 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.82 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.172 -0.955 . . . . 0.0 112.722 167.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.89 -30.34 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.835 1.198 . . . . 0.0 113.79 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.64 -6.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.94 -53.89 53.05 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.469 1.031 . . . . 0.0 113.496 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.0 -33.85 91.6 Favored 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 121.646 1.624 . . . . 0.0 112.409 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.91 -50.02 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.988 0.915 . . . . 0.0 112.08 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.78 -37.68 82.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.36 0.664 . . . . 0.0 111.31 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.1 -37.37 78.36 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.143 0.577 . . . . 0.0 112.338 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.39 -48.59 66.93 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.781 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mm -59.67 -38.84 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 120.734 1.606 . . . . 0.0 111.185 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.66 90.51 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.802 0.728 . . . . 0.0 112.884 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.3 m -74.52 -39.5 62.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.041 0.536 . . . . 0.0 111.909 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.27 -34.67 14.85 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -167.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -117.01 20.48 13.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.216 1.406 . . . . 0.0 113.619 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.8 -27.8 19.71 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -81.16 -18.79 45.1 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.48 1.512 . . . . 0.0 113.936 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -94.56 -42.59 8.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.829 1.252 . . . . 0.0 112.068 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.62 155.94 38.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.007 1.323 . . . . 0.0 112.64 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.82 137.85 37.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.159 171.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.11 133.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.829 0.741 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.63 153.87 44.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.625 1.97 . . . . 0.0 111.705 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -123.12 131.48 53.71 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 0.0 112.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.91 121.96 45.55 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.384 1.474 . . . . 0.0 108.729 170.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.22 95.05 7.14 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.184 0.994 . . . . 0.0 109.772 -171.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.5 -20.73 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.327 1.051 . . . . 0.0 113.323 -170.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.44 -33.12 62.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.876 1.27 . . . . 0.0 112.827 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 p -107.35 -20.83 13.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.343 1.457 . . . . 0.0 113.349 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.05 81.91 69.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.734 2.013 . . . . 0.0 109.449 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -74.99 -11.22 21.49 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.202 2.601 . . . . 0.0 114.356 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.8 -40.28 61.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.161 0.984 . . . . 0.0 112.772 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -73.74 -29.59 62.32 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.025 -1.047 . . . . 0.0 112.472 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.14 94.18 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.371 0.669 . . . . 0.0 111.97 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -81.66 -23.24 37.02 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -59.42 -44.79 92.8 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.692 1.197 . . . . 0.0 111.575 171.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.43 4.77 50.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.144 1.378 . . . . 0.0 114.49 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 48.73 61.15 3.23 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.667 1.587 . . . . 0.0 112.763 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.25 134.17 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.604 1.562 . . . . 0.0 110.767 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.19 -14.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 t -146.71 167.55 23.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.025 1.33 . . . . 0.0 111.95 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.28 121.91 16.84 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.709 1.204 . . . . 0.0 108.36 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.65 157.32 94.66 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.882 0.994 . . . . 0.0 112.59 -5.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.9 m -130.33 120.81 24.92 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.216 1.006 . . . . 0.0 109.559 165.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.4 126.99 50.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.644 1.577 . . . . 0.0 109.006 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.39 133.27 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.287 1.035 . . . . 0.0 110.501 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -104.18 118.39 36.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 110.539 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.86 151.34 19.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.602 1.561 . . . . 0.0 110.43 167.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -124.7 124.39 42.06 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 108.834 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.26 36.25 12.27 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.458 1.103 . . . . 0.0 113.5 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.97 18.26 78.94 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.073 1.321 . . . . 0.0 116.094 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -126.3 140.29 36.76 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.565 1.682 . . . . 0.0 111.469 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.05 140.06 33.9 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.128 2.552 . . . . 0.0 112.53 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 t -114.53 -48.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.713 1.205 . . . . 0.0 112.605 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -153.92 141.14 19.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 111.269 -167.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -129.36 136.34 49.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.91 1.284 . . . . 0.0 112.416 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.7 mm -129.83 142.62 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.964 2.106 . . . . 0.0 109.868 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -113.42 148.99 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.332 1.453 . . . . 0.0 112.363 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.31 175.41 42.78 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.158 0.885 . . . . 0.0 114.239 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.74 148.42 38.56 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -154.19 163.87 39.44 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.601 1.961 . . . . 0.0 112.092 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.48 166.79 32.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.688 1.137 . . . . 0.0 112.642 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -60.88 -32.09 71.55 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.637 1.175 . . . . 0.0 114.131 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.6 91.83 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.225 0.61 . . . . 0.0 111.691 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.23 60.78 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.082 0.953 . . . . 0.0 112.773 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.58 -44.0 65.29 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.266 -0.896 . . . . 0.0 111.295 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.38 -30.32 70.07 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.398 -0.813 . . . . 0.0 112.127 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -68.46 -42.81 78.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.585 1.084 . . . . 0.0 112.505 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.04 -29.45 69.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.445 1.02 . . . . 0.0 112.186 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.77 -44.21 81.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.228 0.467 . . . . 0.0 111.87 168.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.1 m -66.25 -18.96 65.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.819 1.248 . . . . 0.0 112.641 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.06 -18.82 65.62 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 124.87 1.268 . . . . 0.0 110.888 175.505 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.34 141.96 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.65 1.58 . . . . 0.0 111.431 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -97.95 134.76 40.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.553 1.141 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.21 162.25 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.735 1.214 . . . . 0.0 112.833 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.2 p -123.03 169.77 10.84 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.478 1.911 . . . . 0.0 111.238 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.65 -25.86 60.79 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.096 -1.003 . . . . 0.0 113.264 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.44 -50.67 7.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.54 1.136 . . . . 0.0 113.574 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -80.33 -16.1 55.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -49.28 -42.96 42.62 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.815 1.246 . . . . 0.0 111.632 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.2 94.46 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.507 -0.746 . . . . 0.0 112.281 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 m -72.32 -30.21 64.55 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -94.93 -34.14 12.51 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.93 -49.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.667 1.187 . . . . 0.0 111.562 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.1 mt -88.91 -34.83 16.8 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 m -83.94 3.54 33.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.556 1.142 . . . . 0.0 113.866 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -62.03 151.71 34.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.355 1.062 . . . . 0.0 113.139 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -81.21 -7.31 59.54 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.179 1.392 . . . . 0.0 114.022 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -142.76 167.08 17.17 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.402 1.881 . . . . 0.0 110.64 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -60.98 149.75 87.39 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.69 2.26 . . . . 0.0 112.207 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.1 t -129.66 130.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.723 0.809 . . . . 0.0 112.062 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 132.34 36.84 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.385 1.474 . . . . 0.0 108.627 168.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 129.92 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.15 0.886 . . . . 0.0 110.345 169.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -105.71 114.17 28.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.934 0.894 . . . . 0.0 111.128 171.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -91.9 117.2 29.58 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.529 1.531 . . . . 0.0 109.135 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.39 168.52 23.18 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -168.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.99 51.7 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 155.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.4 p -65.69 -12.29 52.34 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -167.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -105.41 -10.69 16.81 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.487 1.915 . . . . 0.0 114.452 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 145.11 45.76 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.311 0.96 . . . . 0.0 112.294 -173.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.52 -64.33 4.42 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.306 -0.872 . . . . 0.0 113.873 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.21 -28.2 87.08 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.15 2.566 . . . . 0.0 114.05 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.1 m -63.7 -49.67 72.19 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.537 0.735 . . . . 0.0 110.461 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.27 67.51 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.054 -1.029 . . . . 0.0 112.202 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.0 tpp -62.15 -31.71 72.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.27 -12.97 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.371 0.987 . . . . 0.0 113.647 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.5 -50.09 73.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 120.415 1.461 . . . . 0.0 114.176 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.72 -26.55 38.97 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.453 2.102 . . . . 0.0 113.493 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.2 t -69.35 -40.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 120.907 -1.121 . . . . 0.0 110.829 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.54 -40.41 35.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.0 1.32 . . . . 0.0 111.096 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.59 -43.16 46.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.535 1.134 . . . . 0.0 111.481 162.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.05 -51.71 10.6 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.984 -0.447 . . . . 0.0 111.442 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mm -62.0 -38.2 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.542 -0.723 . . . . 0.0 111.111 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.79 85.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.391 0.996 . . . . 0.0 112.43 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -75.53 -36.43 60.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.693 0.678 . . . . 0.0 111.689 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.95 -34.2 11.88 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -114.28 22.51 13.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.533 1.533 . . . . 0.0 113.444 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.37 -26.55 41.87 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -78.97 -22.76 45.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.443 1.097 . . . . 0.0 113.012 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -90.63 -46.76 8.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.264 1.426 . . . . 0.0 111.872 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.84 156.72 38.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.326 1.451 . . . . 0.0 112.272 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.6 m -106.0 143.5 34.05 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.618 1.167 . . . . 0.0 109.794 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.81 128.6 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 110.587 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.29 160.36 25.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.496 1.918 . . . . 0.0 112.297 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -124.75 137.37 54.33 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.94 1.696 . . . . 0.0 111.458 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -125.77 122.64 36.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.977 0.911 . . . . 0.0 110.351 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -93.47 111.82 23.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 110.55 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.09 -16.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.91 -42.85 23.29 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.061 0.944 . . . . 0.0 112.764 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -87.38 -25.5 23.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.02 0.928 . . . . 0.0 113.342 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -127.96 60.5 46.37 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.147 1.379 . . . . 0.0 112.222 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -65.43 -17.35 57.46 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.746 2.297 . . . . 0.0 112.553 172.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.44 -46.29 90.58 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.416 1.086 . . . . 0.0 111.533 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -29.94 67.44 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.198 -1.564 . . . . 0.0 111.714 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.72 78.36 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.255 -0.903 . . . . 0.0 112.752 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -26.11 54.22 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.806 1.184 . . . . 0.0 113.273 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -57.28 -44.86 84.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.906 0.882 . . . . 0.0 111.441 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -107.35 9.05 29.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 47.44 60.04 3.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.943 1.697 . . . . 0.0 112.003 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.5 t -84.5 117.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.045 1.338 . . . . 0.0 110.741 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -147.99 129.46 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.978 2.111 . . . . 0.0 107.114 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -121.98 157.37 31.44 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.881 3.272 . . . . 0.0 110.826 -9.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.8 pt -69.28 145.66 96.08 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -171.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.46 138.96 56.12 Favored 'Cis proline' 0 CA--C 1.538 0.713 0 CA-C-N 118.756 0.592 . . . . 0.0 110.937 -11.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.5 m -112.35 113.87 26.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.955 0.902 . . . . 0.0 108.957 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.23 124.78 46.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.987 1.315 . . . . 0.0 108.457 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -128.76 138.82 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.088 0.955 . . . . 0.0 111.367 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.57 129.89 52.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.099 1.36 . . . . 0.0 111.983 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -109.87 139.67 44.68 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.816 2.047 . . . . 0.0 111.114 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -124.02 122.31 37.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.365 1.866 . . . . 0.0 108.982 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 49.01 32.65 4.03 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.128 1.371 . . . . 0.0 114.38 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.79 18.87 69.22 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.61 147.06 59.12 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-N 119.519 1.659 . . . . 0.0 112.385 161.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.68 146.49 48.94 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.331 2.687 . . . . 0.0 112.016 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.97 -45.42 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.63 133.85 19.45 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -117.8 131.94 56.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.255 2.222 . . . . 0.0 110.002 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.57 140.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.268 1.827 . . . . 0.0 109.603 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.27 146.92 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.929 1.292 . . . . 0.0 112.012 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.83 172.2 45.51 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.247 0.927 . . . . 0.0 113.712 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.09 143.88 47.23 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.46 156.64 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.86 2.064 . . . . 0.0 111.321 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.95 174.92 39.54 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.257 1.408 . . . . 0.0 112.932 -174.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -58.76 -39.97 82.55 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.29 78.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.476 0.711 . . . . 0.0 111.321 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -40.42 74.85 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.778 0.831 . . . . 0.0 112.049 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.66 -42.94 81.41 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.353 -0.842 . . . . 0.0 111.895 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.73 -31.28 71.82 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.676 -0.64 . . . . 0.0 111.928 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -44.78 96.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.127 -0.939 . . . . 0.0 111.685 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.58 -38.05 83.34 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.005 1.275 . . . . 0.0 111.862 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.37 -46.85 78.51 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.491 0.316 . . . . 0.0 111.54 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.3 m -67.71 -24.34 65.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.204 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.99 -10.59 59.99 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.6 t . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 126.012 1.725 . . . . 0.0 112.102 -167.204 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.746 0.308 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.7 pt -126.84 171.58 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.135 1.374 . . . . 0.0 112.414 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -125.95 145.42 50.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.493 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.24 159.41 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.537 1.535 . . . . 0.0 112.272 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.7 p -140.19 166.97 23.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.257 2.623 . . . . 0.0 109.935 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.16 -28.06 64.38 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.623 -1.298 . . . . 0.0 114.392 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.08 -24.28 35.3 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -102.51 -27.08 12.99 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 0.0 114.172 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.07 -40.72 58.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.682 1.993 . . . . 0.0 112.457 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.33 -31.4 71.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -83.07 -34.94 26.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.777 0.831 . . . . 0.0 111.798 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.74 -32.94 20.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -109.9 -52.92 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.288 1.435 . . . . 0.0 111.366 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -82.37 -13.38 56.95 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -89.1 1.69 55.22 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.575 1.15 . . . . 0.0 113.009 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -67.15 154.01 42.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.458 1.503 . . . . 0.0 114.946 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -121.06 22.59 10.94 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 126.718 2.007 . . . . 0.0 111.9 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -146.13 168.72 11.03 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 127.956 2.503 . . . . 0.0 111.14 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.19 137.63 52.76 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.71 116.42 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.118 1.367 . . . . 0.0 110.219 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.03 133.81 35.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.754 1.222 . . . . 0.0 109.072 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.9 129.5 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.503 1.047 . . . . 0.0 110.763 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -103.69 128.09 51.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.9 1.28 . . . . 0.0 111.706 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -99.53 116.66 32.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.235 1.414 . . . . 0.0 108.894 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -144.4 167.94 21.28 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.7 176.76 6.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 111.519 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.3 p -68.19 -24.71 64.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -112.88 -13.33 13.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 p -78.19 124.62 28.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -164.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.72 -59.59 10.52 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.795 1.188 . . . . 0.0 114.085 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.27 -27.0 41.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.128 1.964 . . . . 0.0 113.225 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.1 p -72.03 -39.58 69.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.305 0.957 . . . . 0.0 111.686 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -68.93 -29.34 67.56 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.293 -0.879 . . . . 0.0 112.434 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.5 ttp -68.66 -35.93 77.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.703 0.801 . . . . 0.0 113.156 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.73 -24.32 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.566 1.075 . . . . 0.0 113.511 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -45.94 -47.66 41.59 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -64.17 -27.62 64.72 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.96 1.773 . . . . 0.0 113.039 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 t -68.24 -35.87 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.889 1.222 . . . . 0.0 111.229 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 mt -67.98 -48.99 64.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.24 1.016 . . . . 0.0 110.341 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.65 -40.61 72.43 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.661 0.784 . . . . 0.0 110.866 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.16 -51.97 12.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.645 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.5 -39.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.972 1.26 . . . . 0.0 111.361 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.45 96.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.745 0.702 . . . . 0.0 111.604 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.5 m -76.79 -32.48 57.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.06 -22.83 28.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -130.18 27.24 5.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.983 1.313 . . . . 0.0 113.504 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.61 29.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.424 1.49 . . . . 0.0 114.517 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 p -78.11 -18.29 55.86 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.14 1.376 . . . . 0.0 113.737 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -102.01 -40.55 6.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.858 1.263 . . . . 0.0 112.687 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 172.79 12.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.635 1.174 . . . . 0.0 113.674 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -126.19 143.89 50.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.438 1.495 . . . . 0.0 109.779 170.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.8 127.83 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.568 0.699 . . . . 0.0 110.408 168.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.74 164.51 16.47 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.74 2.416 . . . . 0.0 111.722 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 137.96 47.57 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.498 1.119 . . . . 0.0 111.909 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.17 122.34 40.76 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.24 1.416 . . . . 0.0 110.175 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.84 108.63 19.63 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.803 0.841 . . . . 0.0 110.507 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -72.09 -16.65 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.3 -41.14 11.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.541 1.137 . . . . 0.0 112.522 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.7 p -89.43 -22.25 22.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -131.26 72.5 81.15 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.782 1.233 . . . . 0.0 111.793 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -14.59 45.64 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.891 2.394 . . . . 0.0 113.141 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -62.56 -42.87 99.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 112.546 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.0 m -74.18 -31.71 62.79 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.34 0.973 . . . . 0.0 111.711 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.29 94.38 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.658 0.783 . . . . 0.0 111.856 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -77.53 -24.51 49.95 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 168.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -61.28 -46.47 90.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.175 0.898 . . . . 0.0 111.474 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.11 4.25 41.98 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 48.85 62.78 2.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.768 1.627 . . . . 0.0 112.59 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.6 141.92 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 110.652 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.48 -45.03 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.599 1.16 . . . . 0.0 111.951 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -121.67 158.04 29.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.577 1.551 . . . . 0.0 111.287 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.58 130.46 23.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.998 0.919 . . . . 0.0 110.079 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.09 150.5 95.79 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.944 1.016 . . . . 0.0 113.317 -5.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 m -121.1 134.98 55.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.127 1.371 . . . . 0.0 109.12 164.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.73 139.75 45.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.156 1.782 . . . . 0.0 110.145 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 tp -135.03 126.2 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.71 1.204 . . . . 0.0 108.235 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.7 tp -107.06 126.4 52.3 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.978 1.311 . . . . 0.0 109.681 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -107.85 152.37 24.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.969 1.708 . . . . 0.0 110.275 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.202 1.801 . . . . 0.0 108.07 172.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 52.43 32.08 10.72 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 16.83 79.55 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.524 1.535 . . . . 0.0 116.841 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.62 144.14 43.59 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 119.543 1.671 . . . . 0.0 111.776 166.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.45 140.29 39.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.839 2.359 . . . . 0.0 112.2 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.0 m -117.15 -31.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.124 1.37 . . . . 0.0 114.226 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -158.17 142.12 15.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.183 0.993 . . . . 0.0 112.257 -170.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -125.76 136.68 53.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.106 1.763 . . . . 0.0 110.73 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.47 151.89 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.021 1.728 . . . . 0.0 110.295 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.56 147.14 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.492 1.117 . . . . 0.0 111.693 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.07 171.96 48.42 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.478 1.037 . . . . 0.0 113.753 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.8 38.52 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -139.47 152.0 46.65 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.718 2.007 . . . . 0.0 111.341 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.39 169.16 32.76 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.419 1.009 . . . . 0.0 112.022 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.43 -34.46 72.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.93 -42.76 84.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.14 0.576 . . . . 0.0 111.388 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.83 -44.83 72.64 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.582 0.753 . . . . 0.0 111.853 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.36 -43.48 97.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.731 0.813 . . . . 0.0 111.62 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -63.37 -35.75 81.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.406 0.682 . . . . 0.0 111.955 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.2 tpt85 -68.32 -38.25 81.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.201 0.909 . . . . 0.0 112.774 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.83 -39.48 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.444 1.02 . . . . 0.0 111.467 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -42.92 78.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.948 0.499 . . . . 0.0 111.867 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m -66.16 -20.16 66.05 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.061 1.344 . . . . 0.0 112.631 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.78 -19.83 66.03 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.469 0.524 0 C-N-CA 125.099 1.359 . . . . 0.0 110.359 176.08 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 121.218 0.532 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.4 pt -130.75 157.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.2 1.4 . . . . 0.0 111.703 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -103.09 141.74 35.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.85 1.26 . . . . 0.0 110.605 168.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.88 159.44 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.734 1.613 . . . . 0.0 111.359 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.5 p -141.39 168.28 20.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.927 2.491 . . . . 0.0 109.787 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.23 -27.4 34.36 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 120.636 -1.29 . . . . 0.0 113.933 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.76 57.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 p -126.72 -22.1 3.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -172.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -51.18 -41.55 60.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.134 1.773 . . . . 0.0 112.625 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.26 -31.38 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 m -86.07 -29.52 23.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.826 0.85 . . . . 0.0 112.15 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.84 -35.48 14.05 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.77 -55.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.823 1.249 . . . . 0.0 111.282 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.1 mt -80.01 -20.84 44.45 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -92.96 0.78 57.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.735 1.214 . . . . 0.0 113.318 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 t -65.82 143.72 57.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.863 0.865 . . . . 0.0 112.697 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -91.6 3.63 54.56 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.293 1.437 . . . . 0.0 113.044 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -141.62 168.85 12.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.642 1.977 . . . . 0.0 111.294 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.55 144.52 62.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.749 2.299 . . . . 0.0 114.092 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.43 129.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.704 1.202 . . . . 0.0 109.956 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.81 135.66 34.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 164.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.3 t -119.88 125.13 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 118.542 0.61 . . . . 0.0 110.078 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -107.34 113.73 27.3 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.535 1.134 . . . . 0.0 112.245 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -86.21 115.04 23.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.798 2.039 . . . . 0.0 109.102 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.54 172.03 15.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -167.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.75 146.39 50.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.611 1.165 . . . . 0.0 110.438 159.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.0 p -72.38 -14.96 61.84 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -93.66 -9.63 37.25 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.909 1.684 . . . . 0.0 114.032 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 135.22 36.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.373 1.069 . . . . 0.0 111.504 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.23 -65.24 3.66 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.831 1.205 . . . . 0.0 114.643 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.06 -25.87 65.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.376 2.05 . . . . 0.0 112.634 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.6 m -63.36 -45.7 89.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.833 0.853 . . . . 0.0 111.672 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -69.06 -32.83 72.58 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -66.65 -35.19 79.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.345 1.058 . . . . 0.0 113.561 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 m -77.84 -25.19 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.646 1.112 . . . . 0.0 113.684 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.92 -43.48 75.4 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.24 -36.48 87.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.541 2.161 . . . . 0.0 112.954 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.64 -37.03 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.137 0.975 . . . . 0.0 110.926 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.67 -49.69 51.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.521 1.128 . . . . 0.0 110.278 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.88 -40.8 76.89 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.36 0.664 . . . . 0.0 110.859 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -76.42 -48.82 18.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.074 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.49 -39.82 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 110.825 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.07 96.62 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 0.994 . . . . 0.0 111.628 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 m -77.82 -33.63 52.31 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.29 -30.51 23.69 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.235 -0.915 . . . . 0.0 113.054 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -118.45 26.52 9.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.248 1.819 . . . . 0.0 112.174 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.68 33.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.352 1.461 . . . . 0.0 114.195 -176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 p -76.89 -18.18 58.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.235 1.414 . . . . 0.0 113.671 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -101.4 -39.54 7.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.477 1.511 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.03 167.24 29.07 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -120.03 138.87 53.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.313 1.445 . . . . 0.0 109.737 166.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.43 127.6 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.177 0.591 . . . . 0.0 109.768 169.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.93 158.76 22.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.482 1.913 . . . . 0.0 111.585 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.21 131.41 54.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.196 1.398 . . . . 0.0 110.599 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.7 120.63 42.68 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.261 0.553 . . . . 0.0 109.582 164.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -94.67 97.25 9.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.091 0.957 . . . . 0.0 109.619 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.55 -19.41 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.186 -0.946 . . . . 0.0 112.37 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.93 -23.26 60.66 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.262 1.425 . . . . 0.0 114.056 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.0 p -127.2 -22.92 3.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -144.66 76.23 14.29 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.897 1.279 . . . . 0.0 111.134 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.6 -3.81 13.33 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.401 2.734 . . . . 0.0 113.9 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.25 -42.58 95.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.426 1.09 . . . . 0.0 113.051 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -27.17 52.7 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.9 94.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 111.796 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -76.75 -28.59 55.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -58.43 -44.29 89.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 112.069 172.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.68 7.36 46.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.939 1.296 . . . . 0.0 113.718 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 50.9 49.02 21.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.087 1.755 . . . . 0.0 113.246 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.04 123.32 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.504 1.121 . . . . 0.0 109.985 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.64 -23.92 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 t -135.5 165.69 24.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.256 1.422 . . . . 0.0 111.877 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.65 143.5 46.8 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.968 1.307 . . . . 0.0 111.745 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.7 147.37 86.49 Favored 'Cis proline' 0 CA--C 1.54 0.806 0 CA-C-N 119.431 0.833 . . . . 0.0 111.523 -8.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.2 m -133.04 122.22 23.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.216 1.006 . . . . 0.0 109.842 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.71 137.42 44.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.934 1.294 . . . . 0.0 109.75 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.34 132.83 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.114 0.966 . . . . 0.0 109.767 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -114.09 119.79 38.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.105 1.362 . . . . 0.0 111.307 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -101.55 146.68 27.35 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.874 2.07 . . . . 0.0 110.357 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -98.99 -41.17 7.69 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.696 0.798 . . . . 0.0 113.094 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -149.92 53.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.272 1.429 . . . . 0.0 110.422 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.96 15.96 63.38 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.491 1.043 . . . . 0.0 113.667 -168.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.68 126.81 22.8 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.969 2.108 . . . . 0.0 109.161 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.74 143.64 27.02 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.567 2.844 . . . . 0.0 112.754 -170.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.35 -46.6 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.45 1.1 . . . . 0.0 112.418 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -151.05 156.29 40.79 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -121.71 137.55 54.71 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.741 2.016 . . . . 0.0 110.126 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 127.85 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.352 1.461 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.2 157.71 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.525 1.13 . . . . 0.0 112.126 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.15 177.72 40.68 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.655 1.121 . . . . 0.0 113.818 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.33 155.71 38.25 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.24 151.85 50.12 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.606 1.962 . . . . 0.0 111.288 167.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.52 170.98 37.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.7 1.143 . . . . 0.0 111.332 161.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -55.28 -39.13 69.48 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.841 . . . . 0.0 113.028 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.65 85.01 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.398 0.679 . . . . 0.0 112.09 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.82 78.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.353 0.661 . . . . 0.0 111.696 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.2 -39.07 89.39 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.201 -0.937 . . . . 0.0 111.782 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.02 -30.63 69.05 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.328 1.051 . . . . 0.0 112.657 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -62.06 -47.6 83.98 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.691 1.132 . . . . 0.0 111.143 168.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -59.17 -41.58 88.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.121 0.873 . . . . 0.0 111.903 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.0 -41.95 97.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.137 0.575 . . . . 0.0 112.471 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.2 m -67.4 -25.1 65.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 112.465 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -75.96 0.05 19.8 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.15 0.98 . . . . 0.0 113.392 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 N--CA 1.475 0.793 0 C-N-CA 125.92 1.688 . . . . 0.0 112.523 -178.034 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.73 164.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.197 1.399 . . . . 0.0 110.941 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.95 143.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.753 1.221 . . . . 0.0 110.923 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.51 156.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.661 1.584 . . . . 0.0 112.283 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.3 p -117.72 174.33 6.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.333 2.253 . . . . 0.0 110.332 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.07 -29.77 45.62 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.94 -47.45 11.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.036 0.934 . . . . 0.0 113.262 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.79 -12.35 55.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.99 -46.24 43.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.714 1.205 . . . . 0.0 112.666 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.47 -31.32 69.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.3 m -89.31 -19.94 24.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.88 1.272 . . . . 0.0 113.223 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -122.01 -21.92 5.84 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.92 -37.23 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.511 1.505 . . . . 0.0 114.406 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.33 -11.42 60.05 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.059 1.3 . . . . 0.0 113.389 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.9 p -76.9 -7.56 55.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.453 1.501 . . . . 0.0 114.111 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 84.1 p -67.69 160.13 28.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.721 . . . . 0.0 114.883 -171.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.12 16.03 5.11 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.117 1.767 . . . . 0.0 112.536 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -142.43 173.03 5.03 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 128.282 2.633 . . . . 0.0 109.533 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -61.06 140.12 88.02 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.141 1.894 . . . . 0.0 113.383 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.02 114.93 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.078 1.351 . . . . 0.0 110.75 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.84 117.01 23.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -105.76 124.01 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.849 0.75 . . . . 0.0 109.873 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -101.64 117.06 34.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.869 1.268 . . . . 0.0 110.531 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.19 115.0 26.74 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.099 1.759 . . . . 0.0 109.351 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -148.1 168.04 23.44 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.6 170.41 7.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.183 0.993 . . . . 0.0 111.107 166.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -76.64 -6.17 50.93 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -129.41 -2.72 4.93 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -165.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 p -80.5 136.6 36.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.709 1.141 . . . . 0.0 113.981 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -62.93 5.32 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.805 1.193 . . . . 0.0 114.458 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.71 -23.18 42.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.37 2.046 . . . . 0.0 112.873 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.43 -40.06 58.13 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -68.29 -32.58 72.83 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.093 -1.004 . . . . 0.0 112.05 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.7 -32.3 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.791 0.836 . . . . 0.0 113.025 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.37 -5.5 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -53.52 52.3 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 120.269 1.395 . . . . 0.0 113.461 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 -33.48 48.56 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.627 1.551 . . . . 0.0 112.31 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.38 -52.01 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.1 0.864 . . . . 0.0 111.317 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -67.81 -36.7 80.88 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.902 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.8 -34.19 71.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.61 -46.02 77.23 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.261 -0.9 . . . . 0.0 111.321 171.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -56.7 -43.73 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.674 1.579 . . . . 0.0 110.973 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.58 85.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.729 0.412 . . . . 0.0 111.761 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.6 m -79.08 -29.85 43.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.389 1.076 . . . . 0.0 112.262 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -87.2 -23.05 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -129.4 24.96 5.48 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.34 -30.63 29.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.254 1.422 . . . . 0.0 114.712 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -77.5 -18.45 57.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.245 1.418 . . . . 0.0 113.933 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -104.3 -37.88 7.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.144 1.378 . . . . 0.0 112.726 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.61 173.79 12.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.092 1.357 . . . . 0.0 113.017 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.8 m -122.21 153.78 38.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.43 1.492 . . . . 0.0 109.939 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -124.19 138.03 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.68 0.792 . . . . 0.0 109.58 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.38 160.36 38.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.097 1.759 . . . . 0.0 112.007 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -125.83 138.26 53.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.218 1.007 . . . . 0.0 112.697 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -119.39 125.59 49.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.934 1.694 . . . . 0.0 109.37 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.14 93.17 7.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.024 0.93 . . . . 0.0 110.519 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.02 -23.34 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.364 1.065 . . . . 0.0 113.152 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.09 -27.89 69.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.806 1.242 . . . . 0.0 112.368 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.7 p -119.46 -11.17 9.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.836 1.654 . . . . 0.0 113.844 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -127.07 56.82 19.59 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.839 1.656 . . . . 0.0 112.594 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.39 -13.37 33.02 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.178 2.586 . . . . 0.0 113.874 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.31 -30.7 60.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.378 1.071 . . . . 0.0 112.437 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -33.94 58.07 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.189 0.996 . . . . 0.0 112.559 165.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.07 95.89 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.838 0.744 . . . . 0.0 112.324 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -76.31 -23.43 54.31 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.3 -43.06 98.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.537 0.735 . . . . 0.0 111.851 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.41 11.98 35.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.479 1.512 . . . . 0.0 114.061 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 52.54 60.23 3.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.235 1.814 . . . . 0.0 113.056 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.5 t -66.11 126.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.915 0.886 . . . . 0.0 109.373 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.9 m -129.21 -30.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.002 1.321 . . . . 0.0 112.704 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -131.23 147.72 52.62 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.474 1.91 . . . . 0.0 109.358 167.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 pt -111.73 129.88 23.73 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.301 1.04 . . . . 0.0 110.145 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.63 143.39 77.38 Favored 'Cis proline' 0 CA--C 1.54 0.805 0 CA-C-N 119.649 0.91 . . . . 0.0 112.711 1.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.58 133.23 46.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.556 1.142 . . . . 0.0 108.036 161.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.39 126.15 51.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.7 1.2 . . . . 0.0 108.621 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.68 126.86 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 121.478 -0.764 . . . . 0.0 109.954 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.24 117.55 35.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.923 1.289 . . . . 0.0 110.399 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -94.14 158.33 15.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.868 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -142.54 135.39 28.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.749 1.619 . . . . 0.0 108.63 158.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.56 37.48 23.25 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.803 0.841 . . . . 0.0 113.093 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.19 16.65 67.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.508 2.004 . . . . 0.0 115.223 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -123.52 138.22 29.84 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.947 1.299 . . . . 0.0 110.973 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.42 139.85 32.39 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.914 2.409 . . . . 0.0 112.62 -173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -116.07 -42.83 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.664 1.586 . . . . 0.0 112.304 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -150.76 147.23 27.06 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.777 1.231 . . . . 0.0 112.597 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -125.21 137.11 54.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.854 2.062 . . . . 0.0 111.092 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.64 159.78 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 127.103 2.161 . . . . 0.0 110.874 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.6 153.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 111.527 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.45 169.36 25.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.637 1.113 . . . . 0.0 113.414 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 154.92 38.26 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.57 156.39 48.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.665 1.986 . . . . 0.0 110.923 168.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.99 162.63 42.85 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -57.33 -34.41 68.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.248 1.019 . . . . 0.0 113.645 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.36 77.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.856 0.463 . . . . 0.0 111.584 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.44 -50.09 64.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.685 0.794 . . . . 0.0 111.736 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.3 tp -61.61 -40.64 95.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.689 -0.632 . . . . 0.0 111.673 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.19 -40.22 95.34 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.106 0.866 . . . . 0.0 111.871 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -49.85 76.0 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.359 0.982 . . . . 0.0 110.662 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -63.19 -30.05 71.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -39.73 26.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 112.13 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.1 m -67.52 -18.11 64.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.8 1.64 . . . . 0.0 112.835 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.89 -16.02 15.49 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.09 1.356 . . . . 0.0 113.57 167.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 127.004 2.122 . . . . 0.0 109.913 178.057 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.36 170.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.398 1.479 . . . . 0.0 112.08 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -128.69 149.6 50.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.21 1.004 . . . . 0.0 112.274 165.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.33 156.56 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.5 p -139.07 159.56 41.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.644 1.978 . . . . 0.0 110.166 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.9 -27.94 68.53 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -164.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.98 -23.08 60.6 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.8 m -111.46 -19.87 12.42 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 0.0 113.46 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -49.36 -39.46 31.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 112.966 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.09 71.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.5 m -84.7 -33.87 23.06 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.613 -0.679 . . . . 0.0 111.751 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -80.85 -42.37 21.67 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.63 -52.48 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.538 1.535 . . . . 0.0 110.956 -174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -80.3 -12.37 59.61 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 t -98.81 5.2 47.59 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.605 1.162 . . . . 0.0 113.353 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -67.11 152.11 46.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.497 1.519 . . . . 0.0 114.598 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.83 28.5 8.74 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.993 1.717 . . . . 0.0 111.022 171.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -153.06 169.33 9.88 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 128.267 2.627 . . . . 0.0 110.236 -175.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.23 144.84 87.66 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.073 1.848 . . . . 0.0 111.484 161.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.8 118.66 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.029 . . . . 0.0 109.597 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.25 112.72 25.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.948 1.299 . . . . 0.0 108.753 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.1 124.24 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.377 0.99 . . . . 0.0 110.667 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -97.54 112.7 24.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 111.429 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -85.55 111.14 19.75 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.747 1.619 . . . . 0.0 108.188 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.85 178.92 8.46 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -162.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.13 144.47 45.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.525 0.73 . . . . 0.0 110.364 159.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.9 p -67.37 -23.26 65.57 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -85.23 -9.58 57.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.361 1.464 . . . . 0.0 114.245 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 135.38 36.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.011 0.924 . . . . 0.0 111.48 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -62.95 5.63 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.742 1.163 . . . . 0.0 114.546 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.4 -21.02 61.3 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.342 2.028 . . . . 0.0 113.149 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.4 m -68.03 -49.63 60.25 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.937 0.789 . . . . 0.0 110.991 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.85 -32.97 74.66 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.108 -0.995 . . . . 0.0 112.03 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.51 -35.22 73.74 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.212 1.005 . . . . 0.0 113.108 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.63 -7.54 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.76 63.22 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 120.406 1.457 . . . . 0.0 114.15 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.23 -35.81 30.96 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.496 1.464 . . . . 0.0 112.012 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.83 -48.94 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.917 0.887 . . . . 0.0 111.469 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.17 -39.11 82.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.344 0.657 . . . . 0.0 110.756 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.8 -45.38 94.09 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.399 0.545 . . . . 0.0 112.075 173.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.92 -47.53 68.5 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.345 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -62.05 -35.21 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.999 1.727 . . . . 0.0 111.949 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.15 -43.95 92.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.547 1.067 . . . . 0.0 111.606 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.0 m -81.1 -30.09 34.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.889 0.876 . . . . 0.0 112.604 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -79.75 -15.57 57.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.365 1.066 . . . . 0.0 113.733 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.64 24.22 3.14 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.359 1.464 . . . . 0.0 114.122 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.41 -29.57 49.47 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -17.99 43.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.289 1.436 . . . . 0.0 113.688 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -101.66 -41.41 6.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.081 1.352 . . . . 0.0 112.698 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 176.46 10.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.911 1.684 . . . . 0.0 112.864 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -129.36 142.64 50.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 110.407 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.16 132.27 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.533 0.733 . . . . 0.0 109.84 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.05 162.65 30.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.204 2.202 . . . . 0.0 112.214 -164.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -127.59 139.65 52.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.234 1.413 . . . . 0.0 112.676 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.55 124.27 39.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.616 1.566 . . . . 0.0 109.766 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -89.62 97.46 11.21 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.157 0.983 . . . . 0.0 110.149 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.5 -25.15 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.984 -1.073 . . . . 0.0 112.559 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.18 -21.09 43.4 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.707 1.603 . . . . 0.0 113.845 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.0 p -125.89 -17.08 5.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -131.01 79.0 72.34 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.226 1.01 . . . . 0.0 111.542 163.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.27 -13.47 36.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.436 2.757 . . . . 0.0 114.496 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -58.09 -40.57 81.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.77 1.228 . . . . 0.0 112.821 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -81.52 -30.66 33.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.85 -1.156 . . . . 0.0 112.07 172.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.0 87.57 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.361 -0.837 . . . . 0.0 111.958 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 54.99 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.055 0.942 . . . . 0.0 113.5 169.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -64.36 -44.57 91.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.982 0.81 . . . . 0.0 111.084 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.78 4.27 37.73 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.973 1.309 . . . . 0.0 114.481 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 50.59 49.54 20.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.97 1.708 . . . . 0.0 113.093 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.72 134.63 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.807 0.843 . . . . 0.0 111.598 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.09 -40.04 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.353 1.061 . . . . 0.0 112.768 -170.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -142.27 168.39 19.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.227 1.411 . . . . 0.0 111.717 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.0 pt -130.76 146.18 60.85 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.822 1.249 . . . . 0.0 112.697 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.18 143.03 75.88 Favored 'Cis proline' 0 CA--C 1.54 0.79 0 CA-C-N 118.976 0.67 . . . . 0.0 111.423 -8.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.1 m -121.99 118.26 28.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.203 1.001 . . . . 0.0 108.665 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -105.65 129.5 53.88 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.142 0.977 . . . . 0.0 109.53 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.59 126.7 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.547 1.139 . . . . 0.0 109.833 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -105.19 119.75 39.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.127 1.371 . . . . 0.0 111.042 -173.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -97.08 154.73 17.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.158 1.783 . . . . 0.0 110.927 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -130.89 109.16 10.35 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.333 1.853 . . . . 0.0 109.386 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 52.97 37.74 25.36 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.211 1.004 . . . . 0.0 112.906 -174.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.06 11.65 82.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.307 1.432 . . . . 0.0 116.5 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -113.7 138.09 22.51 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 119.601 1.701 . . . . 0.0 111.507 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.57 139.55 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.74 -43.13 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.403 1.081 . . . . 0.0 112.661 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -149.46 141.12 23.51 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.835 1.254 . . . . 0.0 111.463 -165.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -129.17 138.28 51.65 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.284 1.434 . . . . 0.0 111.662 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.4 151.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 111.665 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.4 147.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.049 1.339 . . . . 0.0 111.225 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.23 168.11 42.65 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.819 1.676 . . . . 0.0 113.389 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.52 156.39 35.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.97 158.07 45.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.724 2.01 . . . . 0.0 111.197 169.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.82 170.27 41.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.026 0.822 . . . . 0.0 111.179 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.77 -39.81 71.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.55 -46.75 78.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.09 0.556 . . . . 0.0 111.575 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.31 76.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.324 0.65 . . . . 0.0 111.818 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.92 -40.04 95.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.203 0.601 . . . . 0.0 112.113 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.97 -30.12 68.48 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.64 -0.663 . . . . 0.0 112.269 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -36.8 70.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.864 1.211 . . . . 0.0 112.47 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.9 -35.89 79.69 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.508 -0.745 . . . . 0.0 111.847 168.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.59 -38.2 83.67 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -68.31 -21.11 64.79 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.412 1.085 . . . . 0.0 112.572 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -68.51 -10.66 57.05 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 125.93 1.692 . . . . 0.0 112.704 -174.573 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 pt -119.45 173.44 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.942 1.297 . . . . 0.0 111.46 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -127.81 139.4 52.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.771 1.628 . . . . 0.0 109.654 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.88 160.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.787 1.235 . . . . 0.0 112.795 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.8 p -124.47 166.61 15.72 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.296 2.638 . . . . 0.0 110.136 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -25.83 63.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.15 17.74 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.572 1.149 . . . . 0.0 113.07 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -80.34 -18.35 49.35 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.92 -41.72 25.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.917 2.087 . . . . 0.0 112.98 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.25 71.35 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.057 -1.027 . . . . 0.0 113.626 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -92.47 -19.0 22.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.378 1.471 . . . . 0.0 113.071 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -116.13 -25.47 7.61 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.11 -54.93 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.511 1.124 . . . . 0.0 111.422 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.8 mt -71.66 -16.94 62.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.4 p -75.33 -16.91 60.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.763 1.625 . . . . 0.0 114.505 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -72.0 149.14 45.24 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -165.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.62 -0.03 57.25 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.508 1.523 . . . . 0.0 113.796 172.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.94 167.25 20.91 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.019 2.127 . . . . 0.0 110.978 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.06 147.12 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.802 2.334 . . . . 0.0 114.311 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.3 t -133.5 125.58 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.797 0.839 . . . . 0.0 111.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.46 129.09 35.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.054 . . . . 0.0 108.802 172.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.49 127.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.321 1.048 . . . . 0.0 109.287 166.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -104.23 123.86 48.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.379 0.672 . . . . 0.0 111.409 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -87.1 112.81 22.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.258 1.023 . . . . 0.0 109.317 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.34 174.12 12.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -168.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.77 174.72 8.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.396 1.478 . . . . 0.0 111.206 171.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.1 p -75.93 -10.49 59.46 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -124.39 -5.05 7.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -164.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.55 132.39 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.597 1.089 . . . . 0.0 113.886 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -58.99 11.32 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.719 1.152 . . . . 0.0 114.284 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.87 -23.89 40.75 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 119.982 1.891 . . . . 0.0 113.041 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.9 -34.71 59.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.024 -1.047 . . . . 0.0 111.788 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -67.12 -32.32 73.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.821 0.848 . . . . 0.0 112.131 166.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.0 ttt -64.42 -35.37 80.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 174.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.42 -11.45 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.65 85.4 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.14 -30.99 37.35 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.467 1.56 . . . . 0.0 112.643 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.6 -47.82 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.253 0.933 . . . . 0.0 111.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.14 -35.27 73.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.258 1.023 . . . . 0.0 111.47 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.87 -45.26 90.23 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.061 0.846 . . . . 0.0 112.324 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.14 -45.87 79.52 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.933 -0.479 . . . . 0.0 110.756 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mm -61.28 -38.38 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.659 1.118 . . . . 0.0 111.881 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.63 92.89 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.619 1.1 . . . . 0.0 112.264 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.5 m -79.02 -33.27 45.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.859 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.92 -33.42 15.61 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -113.27 26.4 10.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.622 1.569 . . . . 0.0 113.101 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -25.88 53.67 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -73.2 -29.9 63.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.593 1.157 . . . . 0.0 112.153 173.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -90.71 -38.22 13.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.271 1.428 . . . . 0.0 113.008 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.11 173.05 13.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -110.9 146.87 35.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.782 1.633 . . . . 0.0 109.363 157.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.58 129.57 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.387 -0.821 . . . . 0.0 110.251 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.84 161.14 29.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.261 2.225 . . . . 0.0 111.295 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -131.76 142.95 49.9 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.433 0.693 . . . . 0.0 111.614 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.21 127.52 56.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.297 1.839 . . . . 0.0 109.599 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -96.04 97.25 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.485 1.114 . . . . 0.0 111.825 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.94 -16.0 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.2 -25.2 61.57 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.623 0.769 . . . . 0.0 112.538 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.8 p -126.67 -23.16 3.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -146.74 67.58 11.37 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.035 1.334 . . . . 0.0 111.977 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.34 2.86 5.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.014 3.143 . . . . 0.0 114.75 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -61.79 -39.73 92.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.842 -1.161 . . . . 0.0 113.59 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.34 -28.66 53.14 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 113.863 170.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.64 88.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.873 1.215 . . . . 0.0 112.117 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -75.51 -27.26 58.69 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.097 -1.002 . . . . 0.0 113.328 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -59.73 -41.82 91.75 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.21 0.914 . . . . 0.0 111.938 171.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -96.65 19.17 12.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.506 1.522 . . . . 0.0 113.597 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 52.59 42.52 31.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.451 2.301 . . . . 0.0 114.637 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.85 124.07 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.668 1.187 . . . . 0.0 110.59 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.88 -40.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.072 0.949 . . . . 0.0 111.418 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -147.88 161.74 40.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.615 1.566 . . . . 0.0 111.026 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.5 pt -109.01 142.39 25.42 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.746 1.218 . . . . 0.0 111.688 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.87 154.03 99.42 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.545 0.873 . . . . 0.0 112.535 -0.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -133.88 120.92 21.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.868 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.12 134.16 38.15 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.963 1.305 . . . . 0.0 109.0 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.6 131.19 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.411 1.084 . . . . 0.0 109.111 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.7 tp -108.18 116.4 31.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.845 1.258 . . . . 0.0 110.476 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.87 157.37 16.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.233 1.813 . . . . 0.0 111.514 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -144.75 131.56 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.493 1.917 . . . . 0.0 109.45 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.6 t70 50.0 32.99 6.19 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.27 16.21 80.73 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.876 1.227 . . . . 0.0 115.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -117.1 152.22 48.61 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.209 1.504 . . . . 0.0 111.638 164.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.1 150.43 77.31 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.293 1.996 . . . . 0.0 111.301 168.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.02 -42.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.258 1.023 . . . . 0.0 112.37 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -142.19 146.08 34.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.808 1.243 . . . . 0.0 112.32 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -129.44 130.35 45.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.533 1.533 . . . . 0.0 110.557 166.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -129.81 123.88 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.83 1.652 . . . . 0.0 109.777 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 148.06 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.687 1.195 . . . . 0.0 111.873 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.92 172.62 39.53 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.495 1.045 . . . . 0.0 114.333 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 149.8 42.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -151.48 162.02 41.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.308 1.843 . . . . 0.0 112.513 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.94 166.67 31.32 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.797 1.189 . . . . 0.0 112.547 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -59.89 -31.64 69.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.9 97.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.216 0.606 . . . . 0.0 111.868 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.65 -30.72 56.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.954 0.902 . . . . 0.0 113.199 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.65 -42.88 73.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.33 -0.856 . . . . 0.0 110.793 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.1 tp -67.88 -33.47 74.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.473 -0.767 . . . . 0.0 112.391 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.57 -50.11 70.75 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.566 1.075 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -64.28 -29.34 70.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.164 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.9 tp -67.74 -47.18 70.02 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.764 0.826 . . . . 0.0 113.194 171.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 m -68.89 -20.43 64.25 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.446 0.698 . . . . 0.0 112.385 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.75 -9.19 58.32 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 125.588 1.555 . . . . 0.0 112.79 -166.593 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -132.3 166.85 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.027 1.731 . . . . 0.0 111.905 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -116.42 139.36 50.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.795 1.638 . . . . 0.0 109.837 168.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.64 158.54 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.559 1.544 . . . . 0.0 112.041 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.2 p -143.53 162.71 35.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.028 1.731 . . . . 0.0 111.748 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.14 -28.15 62.49 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.59 -18.15 49.15 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.401 1.08 . . . . 0.0 113.835 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -124.06 -10.0 7.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 114.351 -171.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -53.16 -41.07 64.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.714 1.606 . . . . 0.0 112.959 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.47 72.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -84.58 -26.67 27.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.136 1.375 . . . . 0.0 112.437 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -92.86 -44.78 8.3 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -98.96 -55.18 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.009 1.324 . . . . 0.0 111.083 -175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.2 mt -78.14 -11.99 59.96 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.9 p -71.56 -17.24 62.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.23 1.412 . . . . 0.0 113.627 172.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -83.08 123.29 29.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.565 1.546 . . . . 0.0 111.833 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -78.7 -24.43 45.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.231 1.012 . . . . 0.0 112.701 171.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -82.51 166.73 34.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.589 1.556 . . . . 0.0 110.479 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.87 144.94 99.38 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.297 1.998 . . . . 0.0 112.722 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.6 t -132.17 124.99 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.074 0.949 . . . . 0.0 110.412 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 132.03 36.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 169.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.1 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 0.854 . . . . 0.0 110.418 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.73 118.34 36.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.031 1.333 . . . . 0.0 111.559 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.2 112.56 24.26 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.631 1.573 . . . . 0.0 109.203 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 170.19 19.02 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -163.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.88 -167.54 1.82 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.907 1.683 . . . . 0.0 109.672 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -98.83 -20.16 17.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -86.44 -22.36 26.56 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.98 132.81 35.41 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.247 1.019 . . . . 0.0 113.018 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.16 -59.02 11.4 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.39 0.995 . . . . 0.0 114.213 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.33 -25.06 36.58 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.269 1.979 . . . . 0.0 113.406 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.51 -32.91 54.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.359 -0.838 . . . . 0.0 112.088 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -70.51 -36.57 73.85 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 111.589 169.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.1 ttt -60.49 -31.94 70.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.671 1.188 . . . . 0.0 113.762 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.91 -5.91 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -52.73 70.28 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.811 1.187 . . . . 0.0 113.963 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.02 -33.32 74.49 Favored 'Trans proline' 0 C--N 1.353 0.805 0 CA-C-N 121.421 1.543 . . . . 0.0 112.423 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.31 -49.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.811 0.844 . . . . 0.0 111.792 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.51 -37.03 84.17 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.386 0.539 . . . . 0.0 111.176 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.92 -38.53 83.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.028 0.831 . . . . 0.0 112.25 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.05 -48.03 69.52 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.295 -0.878 . . . . 0.0 111.819 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mm -59.49 -41.6 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.545 1.52 . . . . 0.0 111.001 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.52 71.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.356 0.662 . . . . 0.0 112.684 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.3 m -76.73 -42.95 39.33 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.088 -1.007 . . . . 0.0 111.2 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.43 -36.06 17.93 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -166.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -114.75 21.64 14.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.926 1.29 . . . . 0.0 113.601 -171.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.2 41.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.353 1.461 . . . . 0.0 114.589 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 p -80.95 -18.28 47.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.479 1.512 . . . . 0.0 113.657 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -101.75 -39.54 7.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.071 1.348 . . . . 0.0 112.784 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.9 169.21 21.68 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.891 1.276 . . . . 0.0 113.676 -176.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -110.54 142.26 42.58 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.465 1.506 . . . . 0.0 110.09 171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.28 119.31 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.531 169.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.77 163.33 16.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.838 2.055 . . . . 0.0 111.535 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.75 137.92 47.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.594 0.758 . . . . 0.0 112.049 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.61 123.44 46.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.845 1.258 . . . . 0.0 109.443 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -91.49 108.74 20.1 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.998 0.919 . . . . 0.0 109.447 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 m -70.86 -16.23 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -87.95 -41.24 13.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.271 1.028 . . . . 0.0 112.671 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -87.35 -22.29 25.17 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -139.99 69.6 35.58 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.568 1.147 . . . . 0.0 112.644 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.43 -14.83 46.96 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.249 2.632 . . . . 0.0 113.829 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -64.98 -34.9 79.55 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.059 -1.026 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -80.2 -30.31 38.69 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.476 -0.765 . . . . 0.0 112.051 169.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.51 80.91 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.627 -1.296 . . . . 0.0 112.308 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -76.75 -23.2 53.01 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 168.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -60.6 -43.5 97.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 0.0 111.683 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -102.43 7.76 40.26 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.18 1.392 . . . . 0.0 114.039 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 48.67 67.05 0.92 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.762 1.625 . . . . 0.0 112.331 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.03 81.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 123.055 1.407 . . . . 0.0 110.249 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.8 m -87.43 -22.97 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.306 1.842 . . . . 0.0 112.868 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -122.07 133.14 54.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.221 1.808 . . . . 0.0 109.73 173.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 tt -118.23 135.08 23.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.384 1.074 . . . . 0.0 111.517 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.82 157.23 92.44 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 118.847 0.624 . . . . 0.0 112.7 -9.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -107.42 124.21 49.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.673 1.189 . . . . 0.0 108.39 163.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.13 122.78 48.77 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.283 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 tp -130.37 129.83 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.486 1.114 . . . . 0.0 109.986 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.2 tp -100.14 132.34 45.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.151 1.38 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -118.36 151.76 37.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.875 1.67 . . . . 0.0 111.576 175.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -143.59 130.0 19.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.14 1.776 . . . . 0.0 109.832 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 t70 49.63 35.91 9.6 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.952 1.301 . . . . 0.0 114.381 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 16.41 80.8 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.847 1.213 . . . . 0.0 116.012 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -125.21 144.35 47.15 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 118.745 1.273 . . . . 0.0 111.494 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.46 144.96 51.77 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.009 2.473 . . . . 0.0 111.673 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.13 -54.7 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.832 1.253 . . . . 0.0 112.17 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -156.05 152.72 28.4 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -117.97 141.6 48.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.587 1.955 . . . . 0.0 111.571 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.79 146.71 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.952 . . . . 0.0 109.706 171.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.05 151.61 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.719 1.207 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.16 -171.15 55.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.748 0.689 . . . . 0.0 111.959 -170.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.08 155.79 23.67 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -135.17 149.92 50.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.214 2.205 . . . . 0.0 110.139 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.46 160.62 29.33 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 162.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -58.03 -34.53 70.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.75 73.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.313 0.645 . . . . 0.0 111.655 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.36 73.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.565 0.746 . . . . 0.0 111.598 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.62 -40.58 97.43 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.764 -0.585 . . . . 0.0 111.565 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.32 -33.4 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -61.58 -48.68 79.84 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.625 1.102 . . . . 0.0 110.555 170.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.66 -33.97 74.91 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 mt -71.2 -35.33 71.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.268 1.027 . . . . 0.0 113.623 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 t -69.69 -26.41 64.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.634 1.174 . . . . 0.0 112.008 172.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -76.38 5.44 7.16 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.412 1.485 . . . . 0.0 114.451 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.47 0.562 0 C-N-CA 125.005 1.322 . . . . 0.0 112.984 179.56 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.352 0.12 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 pt -108.3 134.4 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.813 0.845 . . . . 0.0 112.752 -170.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.08 129.51 35.03 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.255 . . . . 0.0 109.415 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.48 155.72 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.568 1.147 . . . . 0.0 111.544 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.7 p -121.47 172.7 7.88 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.385 1.874 . . . . 0.0 110.891 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.09 -24.78 42.32 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 -51.14 7.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.23 1.012 . . . . 0.0 113.167 172.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -80.65 -23.23 39.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -50.76 -41.63 56.95 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.087 1.355 . . . . 0.0 112.018 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.48 72.11 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.765 -1.209 . . . . 0.0 113.654 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -84.44 -30.63 25.14 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.365 -0.834 . . . . 0.0 112.421 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -92.56 -30.02 15.87 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.21 -54.39 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.216 1.406 . . . . 0.0 111.288 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.25 -22.46 35.81 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -172.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -88.31 3.75 48.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.348 1.059 . . . . 0.0 113.201 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -68.29 154.79 41.05 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.563 1.545 . . . . 0.0 114.237 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -112.91 9.45 18.85 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.562 1.945 . . . . 0.0 113.315 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -138.49 170.4 10.4 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 127.631 2.372 . . . . 0.0 111.288 -173.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -66.88 138.97 50.18 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.104 1.869 . . . . 0.0 112.379 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.46 113.46 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 110.323 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -86.64 128.71 35.01 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.375 1.07 . . . . 0.0 108.181 170.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -120.06 124.48 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 110.028 169.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.53 124.11 41.65 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.04 0.936 . . . . 0.0 111.119 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -95.01 118.36 31.69 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.421 1.488 . . . . 0.0 109.325 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -145.03 165.32 28.54 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -171.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.17 177.62 4.66 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.261 1.824 . . . . 0.0 111.748 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.1 p -68.52 -23.43 64.54 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -117.71 -13.95 10.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -161.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -74.98 129.06 37.0 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -165.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.74 -62.98 5.51 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.198 0.904 . . . . 0.0 112.897 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -60.33 -30.44 91.03 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.415 2.077 . . . . 0.0 113.952 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.06 -33.56 70.38 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.931 0.787 . . . . 0.0 112.161 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -73.11 -32.24 64.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.912 0.885 . . . . 0.0 112.597 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -68.64 -31.01 69.85 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -83.17 -17.61 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.715 1.143 . . . . 0.0 113.161 174.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.51 -50.24 67.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 120.255 1.389 . . . . 0.0 114.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.1 -33.23 51.0 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.021 1.814 . . . . 0.0 113.092 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.61 -42.88 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.261 1.391 . . . . 0.0 111.06 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.72 -48.2 55.79 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.304 1.442 . . . . 0.0 111.01 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.04 -37.31 66.52 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.386 1.074 . . . . 0.0 111.648 169.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.98 -43.8 23.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.788 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.3 mm -65.53 -34.31 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.463 1.029 . . . . 0.0 111.543 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.64 86.9 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 0.597 . . . . 0.0 112.022 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.6 m -76.16 -34.33 59.37 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.241 0.473 . . . . 0.0 111.741 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -79.83 -35.99 37.52 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.2 30.53 4.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.257 1.023 . . . . 0.0 113.444 -173.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.14 -34.04 20.95 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.624 1.57 . . . . 0.0 114.562 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -76.33 -18.2 59.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.001 1.32 . . . . 0.0 114.069 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -105.8 -37.96 6.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.681 1.193 . . . . 0.0 112.848 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.31 165.2 29.11 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -121.49 144.38 48.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.886 1.675 . . . . 0.0 110.719 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.95 139.02 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.034 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.67 164.45 30.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.937 1.695 . . . . 0.0 114.113 -167.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -118.44 132.23 56.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.846 2.058 . . . . 0.0 111.806 174.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -114.36 125.25 53.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.893 1.277 . . . . 0.0 109.477 164.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.59 113.12 25.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.279 0.631 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.98 -20.53 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -171.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.69 -38.27 33.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 111.963 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 t -95.9 -8.64 33.42 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -128.37 61.5 54.13 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.995 1.318 . . . . 0.0 113.358 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.22 -29.61 88.14 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.183 1.922 . . . . 0.0 113.486 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -66.07 -38.49 88.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.986 0.914 . . . . 0.0 112.428 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -35.2 57.71 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.603 -0.685 . . . . 0.0 111.31 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.55 93.17 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.585 -0.697 . . . . 0.0 111.667 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -71.93 -23.84 61.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.08 -39.17 77.9 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.951 0.9 . . . . 0.0 112.161 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -110.01 21.5 16.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.854 1.662 . . . . 0.0 113.366 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 52.98 35.8 20.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.743 2.017 . . . . 0.0 114.241 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.72 125.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.253 1.021 . . . . 0.0 110.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.21 -48.49 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.328 1.451 . . . . 0.0 110.099 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.5 m -85.94 143.8 27.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.481 1.112 . . . . 0.0 110.752 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.05 145.7 58.91 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.906 1.282 . . . . 0.0 111.147 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.16 146.51 85.17 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.715 0.934 . . . . 0.0 113.103 0.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.1 m -129.73 120.84 25.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.82 0.848 . . . . 0.0 109.258 165.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.48 132.59 38.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.29 1.436 . . . . 0.0 108.566 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 tp -127.2 126.4 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.841 1.256 . . . . 0.0 107.972 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 tp -108.22 128.44 54.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.638 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -110.0 151.93 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.942 1.697 . . . . 0.0 110.156 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -123.06 117.34 25.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.604 1.561 . . . . 0.0 108.021 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.309 4.0 p30 48.57 38.84 11.96 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 4.39 90.24 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.981 1.753 . . . . 0.0 116.124 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.96 133.6 20.21 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 119.236 1.518 . . . . 0.0 110.635 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.66 138.55 41.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.426 2.084 . . . . 0.0 111.656 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.22 -31.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.271 . . . . 0.0 114.205 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -159.52 141.55 13.39 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.485 1.038 . . . . 0.0 112.493 -172.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -133.79 130.93 38.69 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.596 1.559 . . . . 0.0 111.533 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 mm -129.6 123.7 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.463 1.505 . . . . 0.0 110.075 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.93 36.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 125.142 1.377 . . . . 0.0 113.572 -172.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.06 -172.74 35.37 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.319 -0.863 . . . . 0.0 114.257 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.96 154.14 41.86 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.331 1.052 . . . . 0.0 113.545 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -136.22 153.52 51.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.427 1.891 . . . . 0.0 110.773 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.35 163.54 14.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.61 1.1 . . . . 0.0 110.792 165.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -52.31 -43.04 64.31 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.444 1.122 . . . . 0.0 113.205 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.88 72.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.131 0.572 . . . . 0.0 111.7 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.06 63.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.132 0.973 . . . . 0.0 111.969 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.0 tp -63.98 -46.0 86.56 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.399 -0.813 . . . . 0.0 111.34 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.3 tp -71.59 -24.67 61.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.328 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -60.6 -47.2 87.26 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.322 1.419 . . . . 0.0 111.388 162.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.78 -36.08 75.95 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.086 0.857 . . . . 0.0 112.339 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.57 -36.38 68.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.918 0.887 . . . . 0.0 113.103 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -69.82 -22.76 63.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.376 1.07 . . . . 0.0 112.329 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -73.0 -10.43 59.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.75 1.22 . . . . 0.0 113.275 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 126.423 1.889 . . . . 0.0 112.558 -173.065 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 121.194 0.521 . . . . 0.0 111.542 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.44 166.77 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.357 1.463 . . . . 0.0 111.403 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -124.7 143.45 50.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.529 1.132 . . . . 0.0 111.9 173.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.56 165.92 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.242 1.417 . . . . 0.0 112.658 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.9 p -132.17 175.41 9.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.351 2.66 . . . . 0.0 110.755 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.48 -29.46 61.78 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.89 -1.131 . . . . 0.0 113.08 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.96 -49.56 8.85 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.98 0.912 . . . . 0.0 112.849 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -80.14 -20.84 44.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -51.02 -41.23 59.68 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.144 1.378 . . . . 0.0 112.805 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -31.43 71.91 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.099 -1.001 . . . . 0.0 113.516 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -89.28 -19.35 25.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.703 1.601 . . . . 0.0 113.198 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -112.98 -27.05 8.21 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.36 -54.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.539 1.136 . . . . 0.0 111.631 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.0 mt -73.53 -12.34 60.74 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.5 p -76.83 -14.04 59.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.889 1.676 . . . . 0.0 113.97 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -69.98 155.83 40.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -165.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -114.25 17.49 17.58 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.787 2.035 . . . . 0.0 112.595 172.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -142.62 169.44 10.83 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 127.58 2.352 . . . . 0.0 111.297 -170.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.67 135.32 69.84 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.03 2.487 . . . . 0.0 112.644 159.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -137.6 123.49 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.511 1.124 . . . . 0.0 110.963 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -93.92 133.69 37.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.313 1.445 . . . . 0.0 109.637 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 t -123.12 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.155 0.889 . . . . 0.0 110.295 172.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -107.01 122.49 46.56 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.509 1.524 . . . . 0.0 111.626 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.11 116.57 27.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 110.687 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -147.11 169.77 18.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 0.0 113.613 -172.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.19 39.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.128 1.371 . . . . 0.0 111.21 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -58.09 -28.4 64.55 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.978 1.311 . . . . 0.0 113.117 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -88.9 -2.78 58.76 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.585 1.554 . . . . 0.0 114.515 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.4 t -84.43 105.19 15.06 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.905 -1.122 . . . . 0.0 112.859 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.45 -56.78 22.73 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.38 1.467 . . . . 0.0 114.79 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.51 -29.36 44.72 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 120.613 2.207 . . . . 0.0 112.509 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.36 -47.41 79.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.162 0.892 . . . . 0.0 111.467 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.69 -32.44 73.92 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -66.0 -42.71 89.42 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.736 0.814 . . . . 0.0 112.31 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 m -84.08 -17.78 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -42.02 -48.94 11.3 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -64.4 -27.29 62.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.66 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.4 -38.74 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.092 1.315 . . . . 0.0 111.084 173.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 mt -69.26 -48.72 60.98 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.751 1.22 . . . . 0.0 109.777 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.75 -40.56 72.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.18 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.74 -50.08 33.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.539 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.3 mm -58.15 -41.7 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.82 1.191 . . . . 0.0 111.436 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.35 97.24 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.818 0.735 . . . . 0.0 111.762 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.2 m -76.77 -31.67 57.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.519 0.727 . . . . 0.0 112.198 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -85.04 -31.65 23.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -122.34 30.33 6.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.414 1.485 . . . . 0.0 113.372 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.8 29.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.937 1.295 . . . . 0.0 114.356 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -72.82 -27.43 61.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.946 1.299 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.66 -33.93 10.41 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.207 1.403 . . . . 0.0 113.451 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 176.95 9.81 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.9 m -129.57 149.26 51.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.984 1.714 . . . . 0.0 108.784 162.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.65 135.12 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.902 0.774 . . . . 0.0 110.721 171.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.0 152.25 44.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.749 1.62 . . . . 0.0 112.859 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.454 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 4.8 mmmm -107.45 134.03 51.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.14 1.376 . . . . 0.0 111.302 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.76 110.83 11.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.5 1.12 . . . . 0.0 109.962 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.65 111.78 20.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.727 -0.608 . . . . 0.0 111.955 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.89 -20.41 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.13 -31.37 39.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.251 1.02 . . . . 0.0 112.124 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 t -104.71 -22.82 13.16 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.062 0.945 . . . . 0.0 113.233 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -128.9 67.54 78.03 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.7 1.6 . . . . 0.0 110.781 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.15 -15.5 31.96 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.337 2.692 . . . . 0.0 113.958 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.22 -35.06 79.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.223 -0.923 . . . . 0.0 112.527 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.7 p -77.18 -33.29 56.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 112.699 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.58 91.49 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.497 0.719 . . . . 0.0 111.845 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -76.77 -25.7 53.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -65.01 -44.57 88.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.958 0.799 . . . . 0.0 112.027 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.25 10.18 41.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.299 1.439 . . . . 0.0 114.071 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 51.22 58.11 5.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.242 1.817 . . . . 0.0 113.124 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.81 121.55 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.207 1.003 . . . . 0.0 109.256 173.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.19 -29.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.207 1.403 . . . . 0.0 112.724 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.8 p -121.21 152.59 38.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.468 1.907 . . . . 0.0 109.359 161.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.2 135.45 24.2 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.534 0.734 . . . . 0.0 111.941 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.14 147.42 66.22 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.15 0.732 . . . . 0.0 113.76 -6.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -99.89 136.89 39.13 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 154.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 mt -110.93 140.48 45.39 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.586 1.555 . . . . 0.0 108.994 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 tp -130.63 131.61 64.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.31 125.56 51.27 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.226 1.01 . . . . 0.0 109.489 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -108.96 158.17 17.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.858 2.063 . . . . 0.0 110.242 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -138.93 134.14 32.78 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.781 1.232 . . . . 0.0 108.995 160.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 54.08 39.82 31.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.019 0.927 . . . . 0.0 112.858 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.68 17.53 69.16 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.115 1.817 . . . . 0.0 114.982 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -125.9 134.11 25.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.835 1.254 . . . . 0.0 110.854 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.27 139.67 39.0 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.712 2.275 . . . . 0.0 111.764 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.51 -36.63 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -154.29 149.52 27.03 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.856 1.207 . . . . 0.0 113.672 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -101.59 145.6 28.83 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.154 1.782 . . . . 0.0 110.25 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.86 147.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.512 1.525 . . . . 0.0 109.623 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.31 147.98 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.386 1.074 . . . . 0.0 111.594 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.74 175.07 43.23 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 122.182 0.879 . . . . 0.0 113.592 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 149.84 44.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 145.83 46.26 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.282 1.833 . . . . 0.0 111.542 168.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.01 173.72 48.97 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.624 1.107 . . . . 0.0 111.167 166.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -59.52 -35.12 73.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.0 -43.54 74.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.946 0.498 . . . . 0.0 111.523 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.45 71.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.483 0.713 . . . . 0.0 111.921 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.8 tp -63.39 -40.75 98.09 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.996 0.918 . . . . 0.0 111.39 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.14 -30.74 71.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.354 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -68.34 -42.15 79.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.127 1.331 . . . . 0.0 112.551 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -56.25 -41.73 76.22 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.776 0.716 . . . . 0.0 110.565 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.5 -39.33 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -70.16 -20.25 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 112.394 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -69.72 -11.13 60.61 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 125.83 1.652 . . . . 0.0 113.702 -169.018 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -133.39 161.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.916 1.686 . . . . 0.0 111.467 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -106.42 143.31 34.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 110.738 164.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.89 160.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.7 1.6 . . . . 0.0 111.625 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.6 p -136.24 170.01 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.663 1.985 . . . . 0.0 109.706 173.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.93 -27.49 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.76 -1.213 . . . . 0.0 113.912 173.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.04 -20.08 53.09 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.8 p -121.0 -16.02 8.14 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -53.4 -41.3 65.82 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 112.933 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.63 70.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.7 m -81.26 -31.66 33.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 112.194 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.56 -39.91 7.68 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.83 -54.3 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.309 1.044 . . . . 0.0 111.53 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.3 mt -77.57 -15.07 59.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.5 t -66.61 -37.87 85.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.905 0.882 . . . . 0.0 112.209 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.299 3.5 t 52.89 -138.9 1.07 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.537 1.535 . . . . 0.0 111.249 168.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -84.31 -8.31 59.05 Favored 'General case' 0 CA--C 1.548 0.903 3 C-N-CA 133.582 4.753 . . . . 0.0 113.999 -1.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.14 156.49 76.6 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.078 0.951 . . . . 0.0 110.995 170.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -57.5 146.03 85.74 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.877 1.718 . . . . 0.0 114.634 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.12 124.24 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.131 0.972 . . . . 0.0 109.719 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.53 130.43 44.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 108.837 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 131.51 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.788 0.835 . . . . 0.0 110.619 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -98.42 119.62 37.44 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.74 0.816 . . . . 0.0 111.384 167.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -90.41 112.09 23.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.399 172.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.54 174.4 13.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -160.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.96 47.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.839 1.256 . . . . 0.0 111.174 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.5 p -74.03 -27.51 60.98 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -84.23 -8.93 58.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.426 1.49 . . . . 0.0 113.894 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 t -80.41 122.09 26.54 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 111.97 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.49 -57.34 20.31 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.065 1.317 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.53 -22.65 44.4 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 120.238 2.019 . . . . 0.0 112.959 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -67.69 -42.4 82.1 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.235 -0.916 . . . . 0.0 111.331 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -66.67 -32.36 73.63 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.781 0.832 . . . . 0.0 112.562 170.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -64.24 -38.0 89.48 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.978 0.808 . . . . 0.0 112.987 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -83.93 -10.95 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.96 99.92 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 119.791 1.178 . . . . 0.0 113.717 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.11 -38.2 47.1 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.247 1.965 . . . . 0.0 112.461 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.7 t -64.91 -49.18 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.693 0.797 . . . . 0.0 111.258 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.83 -37.13 81.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.168 0.587 . . . . 0.0 112.124 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.11 -41.85 97.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.951 0.796 . . . . 0.0 112.203 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.74 -43.55 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.733 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mm -61.44 -40.87 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.654 1.115 . . . . 0.0 110.909 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.41 92.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 100.0 m -70.3 -38.16 74.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.404 0.682 . . . . 0.0 111.32 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.2 -32.33 26.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -172.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -122.94 27.41 7.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -172.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.58 10.47 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -75.59 -33.52 60.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.89 1.276 . . . . 0.0 113.486 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -90.51 -38.2 13.37 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.28 0.945 . . . . 0.0 112.888 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.07 167.93 22.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -172.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -114.18 145.21 41.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.98 1.712 . . . . 0.0 109.705 168.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.69 135.67 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.418 0.687 . . . . 0.0 110.595 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 165.5 24.67 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.535 1.934 . . . . 0.0 111.825 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -127.69 147.97 50.39 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.29 124.61 52.43 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.695 1.598 . . . . 0.0 109.205 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.08 97.91 11.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.131 . . . . 0.0 109.927 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.56 -20.95 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.292 -0.88 . . . . 0.0 112.455 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.29 -25.88 63.54 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.439 1.496 . . . . 0.0 113.292 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.7 p -125.57 -22.81 4.19 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -142.17 72.57 22.33 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 111.961 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.25 -0.95 9.39 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.605 2.87 . . . . 0.0 114.505 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -63.33 -40.35 97.08 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.742 -1.224 . . . . 0.0 113.269 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.46 -27.72 52.17 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.208 -0.932 . . . . 0.0 113.411 168.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.04 94.47 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 112.006 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -75.5 -27.44 58.79 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -61.32 -42.16 98.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.153 0.888 . . . . 0.0 112.076 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -96.6 14.68 23.98 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.218 1.407 . . . . 0.0 113.478 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 50.55 41.18 25.11 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.474 2.31 . . . . 0.0 114.025 173.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.73 121.8 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.639 1.175 . . . . 0.0 110.421 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -101.78 -27.63 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.838 1.255 . . . . 0.0 113.571 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.9 m -133.85 160.4 37.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.987 1.715 . . . . 0.0 111.41 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.3 pt -127.97 144.34 51.12 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 0.0 111.7 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.14 153.67 88.18 Favored 'Cis proline' 0 CA--C 1.537 0.659 0 CA-C-N 119.462 0.843 . . . . 0.0 111.773 -6.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.3 m -133.34 119.62 19.94 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.972 0.909 . . . . 0.0 109.27 168.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.0 mt -103.13 119.77 39.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 109.193 -174.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.35 135.09 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.615 1.166 . . . . 0.0 110.372 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 tp -118.73 123.72 45.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.114 0.965 . . . . 0.0 111.722 -170.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -104.55 152.44 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.305 1.842 . . . . 0.0 111.315 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -142.51 135.28 28.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.15 1.78 . . . . 0.0 109.754 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t70 52.01 31.6 8.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.667 1.187 . . . . 0.0 113.329 -168.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.46 7.41 60.71 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.06 1.791 . . . . 0.0 114.662 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -100.56 129.89 26.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 118.771 1.285 . . . . 0.0 110.096 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.95 135.93 33.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.352 2.034 . . . . 0.0 110.789 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.38 -44.88 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.953 0.901 . . . . 0.0 112.214 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -153.37 150.55 28.98 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.609 1.164 . . . . 0.0 113.087 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.81 127.87 46.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.512 2.325 . . . . 0.0 109.879 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.9 mm -122.59 126.06 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.807 1.243 . . . . 0.0 109.985 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.06 147.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.371 1.069 . . . . 0.0 111.345 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.04 173.44 49.66 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.42 1.009 . . . . 0.0 114.19 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.27 151.56 38.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -138.44 155.11 48.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.519 1.928 . . . . 0.0 111.731 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.38 167.5 27.53 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.642 1.115 . . . . 0.0 111.942 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -56.29 -37.48 69.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 112.789 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.96 78.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.23 0.612 . . . . 0.0 111.724 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.08 78.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.402 0.681 . . . . 0.0 111.957 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.1 tp -67.98 -39.99 83.2 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.417 -0.802 . . . . 0.0 111.875 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.47 -28.5 66.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.256 0.622 . . . . 0.0 112.264 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -61.95 -48.57 79.8 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.615 1.098 . . . . 0.0 110.875 167.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.45 -38.08 76.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.293 0.951 . . . . 0.0 111.875 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.0 mt -66.51 -43.47 85.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.6 m -70.0 -23.57 63.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.007 0.923 . . . . 0.0 112.458 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.9 -10.53 59.5 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.112 1.365 . . . . 0.0 112.667 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 126.117 1.767 . . . . 0.0 112.8 -176.464 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 pt -136.5 165.63 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.674 1.59 . . . . 0.0 111.189 171.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -126.23 138.84 53.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.011 1.324 . . . . 0.0 110.707 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.06 156.08 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.521 1.129 . . . . 0.0 112.918 -172.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.3 p -142.39 161.82 37.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.007 2.123 . . . . 0.0 110.107 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -55.1 -35.61 64.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -166.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.08 59.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.5 m -113.27 -21.59 10.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.504 1.522 . . . . 0.0 113.79 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -44.83 -41.98 7.51 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.888 2.475 . . . . 0.0 113.114 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.61 71.5 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.1 m -89.93 -25.96 20.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.856 1.262 . . . . 0.0 112.096 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -84.37 -50.01 8.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.931 0.892 . . . . 0.0 113.295 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.53 -33.65 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -77.73 -11.68 59.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 120.052 1.296 . . . . 0.0 113.585 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.0 m -88.96 -0.87 57.78 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -66.24 153.03 43.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.824 1.25 . . . . 0.0 113.653 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -121.53 28.02 7.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.37 1.468 . . . . 0.0 112.173 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.77 171.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 128.459 2.703 . . . . 0.0 109.823 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.76 139.51 80.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.853 1.702 . . . . 0.0 111.572 161.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.62 123.97 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.589 0.756 . . . . 0.0 111.928 170.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.49 125.5 31.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.313 1.445 . . . . 0.0 107.875 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -113.75 121.06 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 169.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -107.36 115.98 31.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.264 1.026 . . . . 0.0 111.634 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -92.35 123.91 36.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.969 1.708 . . . . 0.0 109.288 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.466 ' CE2' ' HE2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -149.82 168.1 24.67 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -176.315 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.03 174.75 5.75 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.998 1.319 . . . . 0.0 111.951 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.6 p -71.66 -22.66 61.64 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -116.06 -12.75 11.26 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -163.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.94 130.15 38.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.17 -59.57 10.61 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.82 1.2 . . . . 0.0 114.179 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.75 -23.73 48.16 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.36 2.04 . . . . 0.0 113.301 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.3 p -77.76 -35.08 52.08 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.344 -0.848 . . . . 0.0 112.405 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -75.41 -27.88 59.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.934 -1.104 . . . . 0.0 112.359 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttt -58.91 -31.34 68.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.245 1.018 . . . . 0.0 113.262 171.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.62 -5.85 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.6 95.84 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-N 119.983 1.265 . . . . 0.0 114.39 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.01 -32.09 45.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.383 1.53 . . . . 0.0 112.589 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.52 -48.15 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.352 -0.843 . . . . 0.0 111.664 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.0 -37.38 84.09 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.977 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.01 -45.81 90.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.684 0.675 . . . . 0.0 111.97 172.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.51 -46.15 77.18 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.575 -0.703 . . . . 0.0 111.465 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.98 -42.79 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.025 1.284 . . . . 0.0 111.249 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -31.62 72.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.4 0.545 . . . . 0.0 112.359 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.4 m -78.6 -40.07 35.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.413 0.685 . . . . 0.0 111.745 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.84 -22.11 22.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -168.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -128.36 22.93 6.0 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.794 1.238 . . . . 0.0 113.877 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.37 -28.63 44.53 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.351 1.461 . . . . 0.0 114.682 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -80.17 -18.34 49.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.394 1.478 . . . . 0.0 113.643 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -101.7 -38.22 7.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.101 1.361 . . . . 0.0 112.88 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.58 177.76 9.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.264 1.426 . . . . 0.0 112.873 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.99 153.95 40.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.781 1.632 . . . . 0.0 109.326 167.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.08 136.14 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.605 0.762 . . . . 0.0 110.361 172.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.84 152.79 49.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.416 1.887 . . . . 0.0 112.092 -170.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HE2' ' CE2' ' A' ' 33' ' ' TRP . 17.2 mmmt -115.98 135.26 54.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.935 1.294 . . . . 0.0 112.61 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.78 127.09 50.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.618 1.167 . . . . 0.0 110.484 167.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.37 104.29 16.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 110.054 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -69.88 -20.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.294 -0.879 . . . . 0.0 112.973 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.62 -33.39 47.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.468 1.107 . . . . 0.0 112.952 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -106.83 -22.47 12.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.539 1.136 . . . . 0.0 113.601 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -131.59 68.07 80.58 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.923 1.289 . . . . 0.0 111.743 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.52 -14.64 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.094 2.529 . . . . 0.0 113.058 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.31 -41.12 83.78 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.467 1.107 . . . . 0.0 112.605 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -75.63 -32.9 60.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.083 0.856 . . . . 0.0 111.71 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.66 92.04 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.149 -0.969 . . . . 0.0 111.81 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.98 -23.15 52.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 169.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.03 -47.72 85.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.799 0.84 . . . . 0.0 111.234 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.51 6.53 44.31 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 50.9 53.83 12.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 112.795 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -88.16 121.52 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.649 1.18 . . . . 0.0 109.443 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -110.71 -29.44 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.511 1.124 . . . . 0.0 112.701 -171.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -121.8 160.75 23.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.518 1.527 . . . . 0.0 111.686 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.68 147.02 64.36 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.679 1.192 . . . . 0.0 112.888 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.35 154.29 89.01 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.126 0.723 . . . . 0.0 111.829 -11.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.6 m -130.94 120.54 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.726 0.811 . . . . 0.0 109.638 168.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.49 122.82 37.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.85 126.83 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.316 1.047 . . . . 0.0 108.9 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.4 tp -112.12 128.3 56.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.623 1.569 . . . . 0.0 110.034 -166.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -108.24 157.35 18.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.686 1.594 . . . . 0.0 110.159 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.1 127.51 26.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.167 1.787 . . . . 0.0 108.528 167.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.01 40.36 28.15 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.763 0.792 . . . . 0.0 112.727 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.23 17.35 72.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.03 1.776 . . . . 0.0 115.409 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -124.08 133.04 24.37 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.71 1.204 . . . . 0.0 110.843 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.48 139.15 37.11 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.831 2.354 . . . . 0.0 112.073 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.5 -26.35 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.17 149.61 32.29 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.056 1.298 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -143.68 127.87 17.66 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.702 1.201 . . . . 0.0 111.098 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mm -132.09 137.59 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.392 1.077 . . . . 0.0 110.618 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.93 157.51 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.079 1.352 . . . . 0.0 112.401 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 173.81 36.35 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.745 1.164 . . . . 0.0 113.913 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 156.63 34.04 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.53 152.41 50.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.351 1.86 . . . . 0.0 111.732 171.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 166.92 44.71 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 159.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -57.25 -34.43 68.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.41 82.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.582 0.753 . . . . 0.0 112.372 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.29 -39.83 65.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.91 -48.11 80.39 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.079 -0.388 . . . . 0.0 110.203 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.477 -0.764 . . . . 0.0 112.37 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -69.24 -43.17 74.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.078 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.98 -27.3 65.58 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.253 1.388 . . . . 0.0 112.505 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.27 -41.36 81.19 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.453 0.701 . . . . 0.0 111.871 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -65.71 -25.74 67.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.545 1.138 . . . . 0.0 111.705 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.97 1.09 6.07 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 170.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.475 0.786 0 C-N-CA 126.777 2.031 . . . . 0.0 111.714 178.581 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.1 p . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.1 165.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.019 1.728 . . . . 0.0 111.695 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -109.89 143.23 40.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.176 1.79 . . . . 0.0 110.376 170.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.73 156.21 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.801 1.241 . . . . 0.0 111.697 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.1 p -114.7 168.81 9.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.15 2.18 . . . . 0.0 110.532 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.85 -27.84 67.0 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.819 -1.176 . . . . 0.0 113.221 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.34 -47.3 14.69 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.193 0.997 . . . . 0.0 112.894 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 p -77.79 -26.56 49.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -49.76 -39.89 39.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.2 1.8 . . . . 0.0 112.605 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.16 70.51 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -95.33 -20.66 18.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.694 1.198 . . . . 0.0 112.531 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -91.39 -58.29 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.417 1.087 . . . . 0.0 112.347 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -88.09 -51.88 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.213 1.405 . . . . 0.0 111.349 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.15 -15.01 62.47 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -77.43 -18.05 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 m -85.89 118.72 25.55 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -166.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 p-10 -75.42 -24.51 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.718 1.207 . . . . 0.0 112.113 160.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -65.26 146.35 98.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 127.17 2.188 . . . . 0.0 110.087 167.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.02 140.12 82.67 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.062 1.841 . . . . 0.0 111.4 170.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.62 130.97 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.984 0.914 . . . . 0.0 110.554 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.6 mp -104.5 124.66 49.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 108.769 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -120.1 117.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 110.311 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -98.45 117.58 33.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.606 0.763 . . . . 0.0 112.638 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.19 112.68 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.854 1.661 . . . . 0.0 108.442 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.26 170.28 19.88 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -164.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.69 155.78 48.74 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.989 1.316 . . . . 0.0 111.881 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -78.61 -19.52 52.52 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -86.05 -5.45 59.21 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.707 1.203 . . . . 0.0 113.822 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.48 120.11 31.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.184 1.394 . . . . 0.0 112.215 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -55.17 31.64 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.018 1.294 . . . . 0.0 114.726 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.03 -23.93 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 120.201 2.0 . . . . 0.0 112.638 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.3 m -67.16 -39.19 86.45 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.065 -1.022 . . . . 0.0 111.588 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.9 -31.89 71.99 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.438 -0.789 . . . . 0.0 112.711 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -65.34 -34.7 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.0 -12.15 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.341 0.973 . . . . 0.0 113.589 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.76 -49.14 85.03 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -29.27 49.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.763 1.642 . . . . 0.0 112.718 173.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.5 -48.06 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.147 -0.97 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.6 -36.79 79.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.297 0.639 . . . . 0.0 112.021 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.33 -46.91 87.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.777 0.717 . . . . 0.0 111.424 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -69.05 -47.77 64.51 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.715 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.2 mm -59.44 -40.8 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 121.061 1.755 . . . . 0.0 110.95 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.54 90.41 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.093 0.86 . . . . 0.0 112.546 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.1 m -77.09 -36.12 55.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.651 0.78 . . . . 0.0 111.325 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -92.64 -34.66 13.89 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -116.82 13.74 15.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.932 1.293 . . . . 0.0 113.583 -163.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.14 -31.03 29.26 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -69.72 -29.94 67.44 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.27 -0.894 . . . . 0.0 112.671 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -90.53 -41.12 11.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.772 1.229 . . . . 0.0 112.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.3 162.52 41.03 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.0 m -106.48 136.36 46.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.734 1.214 . . . . 0.0 110.482 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 t -110.91 122.15 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.083 0.953 . . . . 0.0 110.47 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.5 164.38 18.2 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.637 1.975 . . . . 0.0 111.739 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -129.75 143.52 50.86 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.42 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -126.43 120.91 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.362 1.465 . . . . 0.0 109.721 170.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -96.29 85.22 3.91 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.228 1.811 . . . . 0.0 111.153 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -60.81 -22.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -166.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.04 -28.32 61.36 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.217 1.407 . . . . 0.0 113.459 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -127.17 -9.88 5.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.949 1.7 . . . . 0.0 114.585 -171.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -142.51 59.51 8.74 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.897 2.079 . . . . 0.0 110.318 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.85 -6.17 14.13 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.534 2.822 . . . . 0.0 114.565 -167.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.2 -39.18 92.49 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.119 -0.988 . . . . 0.0 112.374 -174.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -30.4 54.77 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.391 -0.818 . . . . 0.0 112.065 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.34 99.04 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.313 -0.867 . . . . 0.0 111.65 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -74.16 -23.25 59.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -61.75 -44.03 97.7 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.882 0.873 . . . . 0.0 111.282 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.55 5.57 50.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.142 1.377 . . . . 0.0 114.162 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 50.51 41.23 24.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.408 1.883 . . . . 0.0 113.666 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.59 128.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.94 1.296 . . . . 0.0 110.128 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.94 -45.66 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.869 1.268 . . . . 0.0 111.348 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 p -86.26 152.4 22.81 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.717 1.207 . . . . 0.0 111.674 170.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 pt -145.43 155.54 53.62 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.834 1.654 . . . . 0.0 111.098 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.35 138.67 57.02 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 119.795 0.963 . . . . 0.0 111.6 -4.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 m -125.29 108.08 11.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.624 0.77 . . . . 0.0 109.9 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.29 126.1 43.65 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.754 1.222 . . . . 0.0 110.136 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 tt -120.9 132.85 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 122.199 1.0 . . . . 0.0 110.634 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.89 130.67 44.15 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 109.565 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -120.07 148.5 43.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.287 1.835 . . . . 0.0 111.319 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -144.81 135.13 24.24 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.971 1.708 . . . . 0.0 109.701 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 t70 51.34 33.68 10.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.63 19.92 71.53 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.335 1.445 . . . . 0.0 115.401 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -126.15 150.25 69.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 118.8 1.3 . . . . 0.0 112.104 169.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.37 145.93 44.01 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.905 2.403 . . . . 0.0 112.399 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.45 -46.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.97 1.308 . . . . 0.0 111.678 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -159.54 146.38 16.62 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.887 1.275 . . . . 0.0 111.94 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -129.0 137.21 51.21 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.159 1.384 . . . . 0.0 112.156 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.8 116.55 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.234 1.814 . . . . 0.0 110.224 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -100.17 159.4 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.054 1.742 . . . . 0.0 112.407 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.1 -171.69 50.67 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.067 0.841 . . . . 0.0 111.958 -174.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.18 147.02 45.14 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.153 -1.204 . . . . 0.0 112.93 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.69 153.15 47.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.077 1.751 . . . . 0.0 111.707 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.37 163.9 24.23 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.565 1.079 . . . . 0.0 112.092 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -59.88 -33.97 72.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.244 1.018 . . . . 0.0 113.53 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.37 80.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.968 0.507 . . . . 0.0 111.522 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.72 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.311 0.645 . . . . 0.0 111.214 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.2 tp -62.53 -40.32 96.41 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.219 -0.926 . . . . 0.0 112.344 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.4 tp -70.17 -30.81 68.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.844 0.858 . . . . 0.0 112.686 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -62.6 -44.93 95.06 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.729 1.149 . . . . 0.0 111.413 167.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.1 -36.03 80.47 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.32 0.964 . . . . 0.0 111.789 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.58 -39.2 81.07 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -65.34 -26.06 67.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.468 1.107 . . . . 0.0 112.211 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -75.95 -5.08 44.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.9 1.28 . . . . 0.0 114.089 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 125.055 1.342 . . . . 0.0 111.755 172.705 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.2 pt -117.93 157.47 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.466 1.506 . . . . 0.0 111.192 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -109.25 137.59 46.89 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.886 1.674 . . . . 0.0 110.007 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.35 156.34 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.821 1.248 . . . . 0.0 112.475 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.2 p -143.29 161.55 38.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.548 1.939 . . . . 0.0 110.793 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.83 -35.62 61.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -168.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.95 -18.87 60.32 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 m -119.26 -11.6 9.54 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.703 1.601 . . . . 0.0 113.646 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -51.9 -40.09 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 113.08 -175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.5 72.04 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -83.2 -32.25 26.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.158 0.983 . . . . 0.0 111.953 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.56 -37.81 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.42 -54.48 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.155 1.382 . . . . 0.0 110.986 -174.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.95 -12.03 59.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 m -78.74 -11.5 59.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.5 m -80.73 121.31 25.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.273 1.429 . . . . 0.0 112.641 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.35 -26.98 60.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.006 0.523 . . . . 0.0 111.857 164.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -69.75 153.54 95.49 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.253 1.021 . . . . 0.0 110.701 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.06 145.75 85.69 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.755 1.637 . . . . 0.0 111.675 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.0 132.3 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.145 . . . . 0.0 111.915 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.5 134.22 35.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.769 1.628 . . . . 0.0 109.169 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.27 129.8 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.316 0.647 . . . . 0.0 110.457 167.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -103.52 136.73 42.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.406 1.482 . . . . 0.0 113.076 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.26 120.17 39.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.126 1.37 . . . . 0.0 111.097 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -75.03 168.1 20.64 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.261 1.024 . . . . 0.0 113.344 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.69 144.79 32.86 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.244 142.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.9 p -67.94 -31.42 71.16 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -165.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -96.33 -8.28 33.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.644 1.978 . . . . 0.0 113.777 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.5 t -82.41 110.44 17.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.52 1.128 . . . . 0.0 113.24 -160.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.57 -57.07 12.87 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.277 1.418 . . . . 0.0 114.364 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.17 -24.42 65.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 120.481 2.14 . . . . 0.0 113.349 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.84 -42.03 82.05 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.213 0.915 . . . . 0.0 111.217 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -66.3 -32.23 73.51 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.463 -0.773 . . . . 0.0 112.462 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.55 -31.93 71.49 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.65 -14.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.781 1.173 . . . . 0.0 113.691 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.37 46.1 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.21 -32.0 52.72 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.674 1.583 . . . . 0.0 112.327 176.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.43 -51.22 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.352 0.978 . . . . 0.0 111.734 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.06 -35.28 74.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 111.298 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -71.43 -34.9 70.69 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -66.18 -47.6 73.45 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.806 -1.184 . . . . 0.0 111.222 171.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.38 -40.75 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.609 1.549 . . . . 0.0 111.08 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.19 -38.02 85.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.9 0.773 . . . . 0.0 112.581 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -77.19 -34.92 56.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.663 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -88.52 -39.58 14.07 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -113.64 17.25 18.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.231 1.412 . . . . 0.0 113.457 -162.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.89 34.62 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.328 1.451 . . . . 0.0 114.626 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -78.23 -18.52 55.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.216 1.407 . . . . 0.0 113.825 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -98.18 -41.41 7.91 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.838 1.255 . . . . 0.0 112.48 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.32 164.08 35.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.598 1.159 . . . . 0.0 113.3 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.6 m -107.15 144.45 33.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.883 1.273 . . . . 0.0 110.359 171.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -118.84 128.76 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.422 0.689 . . . . 0.0 110.286 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.49 162.31 23.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.644 1.978 . . . . 0.0 111.429 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -136.28 144.75 44.92 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.91 122.69 46.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.765 1.626 . . . . 0.0 110.448 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -87.15 84.08 7.33 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.823 1.249 . . . . 0.0 110.797 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 p -62.92 -24.06 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.66 -26.57 61.69 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.08 0.952 . . . . 0.0 113.383 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.1 p -110.06 -22.66 11.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.416 1.086 . . . . 0.0 113.479 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.03 77.39 26.0 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.464 1.506 . . . . 0.0 111.548 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.67 -15.21 37.3 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.718 2.278 . . . . 0.0 112.851 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.81 -38.24 75.21 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.666 1.187 . . . . 0.0 112.966 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -34.0 68.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.119 0.872 . . . . 0.0 112.331 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.0 73.41 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.906 -1.122 . . . . 0.0 111.454 173.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -74.99 -39.52 61.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.284 1.033 . . . . 0.0 111.768 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.84 -45.41 67.34 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.993 1.317 . . . . 0.0 111.622 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -98.18 15.72 23.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.305 1.442 . . . . 0.0 114.512 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.272 7.6 pt20 47.46 42.53 14.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.773 2.029 . . . . 0.0 115.13 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.95 126.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.454 1.502 . . . . 0.0 110.429 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.1 m -130.91 -9.84 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.431 1.492 . . . . 0.0 113.799 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 151.19 41.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.37 1.868 . . . . 0.0 110.197 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.23 141.48 29.54 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.879 0.872 . . . . 0.0 112.579 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.17 154.49 88.45 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.261 0.772 . . . . 0.0 111.951 -7.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -132.55 135.56 46.02 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.831 1.252 . . . . 0.0 108.73 171.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 142.83 46.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.318 1.047 . . . . 0.0 110.386 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.5 tp -122.34 137.6 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.827 1.651 . . . . 0.0 109.117 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.8 tp -108.8 125.57 52.1 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.612 1.565 . . . . 0.0 109.694 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -116.08 155.6 27.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.574 1.149 . . . . 0.0 111.391 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.54 136.12 27.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.66 1.584 . . . . 0.0 109.646 164.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.78 32.2 14.44 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.11 1.364 . . . . 0.0 114.256 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.59 17.31 80.18 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.853 1.216 . . . . 0.0 115.63 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -126.09 143.62 46.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 118.776 1.288 . . . . 0.0 111.503 172.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 144.09 42.13 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.893 2.395 . . . . 0.0 111.628 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.34 -45.18 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.12 1.368 . . . . 0.0 111.388 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -158.37 146.15 18.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.443 1.097 . . . . 0.0 111.529 -163.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.34 142.14 51.67 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.38 1.472 . . . . 0.0 110.826 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 132.4 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.998 1.719 . . . . 0.0 110.098 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.81 143.89 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.403 1.481 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.29 176.02 46.07 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.708 0.671 . . . . 0.0 112.719 -168.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.23 152.06 44.65 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -128.33 149.17 50.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.097 2.159 . . . . 0.0 109.851 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.24 166.42 32.1 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 161.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.53 -38.99 75.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.073 0.949 . . . . 0.0 113.183 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.42 77.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.404 0.681 . . . . 0.0 111.593 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -45.56 64.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 111.82 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.349 0.977 . . . . 0.0 111.355 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.54 -37.58 87.84 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.762 -0.586 . . . . 0.0 111.926 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -61.76 -43.03 99.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.771 -1.206 . . . . 0.0 112.29 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.88 -31.96 73.32 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.937 0.789 . . . . 0.0 112.372 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.7 -40.27 76.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.668 0.387 . . . . 0.0 111.815 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.5 m -64.78 -25.48 67.94 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.234 -0.916 . . . . 0.0 112.695 170.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.56 -10.78 57.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.168 1.387 . . . . 0.0 114.41 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.131 1.373 . . . . 0.0 114.162 -173.366 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.76 164.08 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.711 1.204 . . . . 0.0 112.7 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -109.46 142.73 40.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.882 1.673 . . . . 0.0 110.141 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.81 154.01 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.439 1.096 . . . . 0.0 112.638 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.2 p -145.45 160.93 40.84 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.973 2.109 . . . . 0.0 110.159 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.81 -34.53 40.55 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -171.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.99 -20.48 62.41 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -120.88 -14.2 8.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.59 1.556 . . . . 0.0 113.693 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -51.17 -41.65 60.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.397 1.879 . . . . 0.0 113.34 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.25 71.72 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.5 m -82.19 -33.71 29.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.593 0.757 . . . . 0.0 111.793 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.08 -43.25 19.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.97 -54.42 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 111.194 -173.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.06 -17.07 53.67 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.6 m -101.45 7.27 42.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.843 1.257 . . . . 0.0 113.119 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -66.01 144.63 56.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.979 0.912 . . . . 0.0 112.994 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.23 1.68 43.47 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.988 1.315 . . . . 0.0 113.213 174.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -142.73 166.69 19.27 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 126.825 2.05 . . . . 0.0 111.651 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.45 147.12 6.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.024 3.149 . . . . 0.0 114.822 163.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.1 130.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.477 1.111 . . . . 0.0 110.789 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.4 129.04 39.68 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.909 1.284 . . . . 0.0 107.931 169.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.2 t -112.37 123.89 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.445 1.021 . . . . 0.0 109.801 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -113.08 121.9 45.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.403 1.081 . . . . 0.0 112.458 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -93.69 120.11 33.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.354 1.862 . . . . 0.0 110.598 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.72 171.17 16.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.97 176.92 4.9 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.86 1.664 . . . . 0.0 111.541 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -71.43 -29.58 65.05 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.841 -1.162 . . . . 0.0 113.118 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -100.23 -14.86 18.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -163.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -76.47 127.67 33.29 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -163.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.23 -63.54 5.22 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.739 1.162 . . . . 0.0 113.948 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.0 -24.42 60.17 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.43 2.086 . . . . 0.0 113.149 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -74.89 -36.33 62.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.93 0.786 . . . . 0.0 111.789 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -75.48 -28.01 59.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.987 -1.071 . . . . 0.0 112.629 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.3 mmm -63.93 -29.71 70.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.1 m -83.48 -8.57 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 119.664 1.12 . . . . 0.0 113.928 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.4 -50.69 83.66 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 120.708 1.595 . . . . 0.0 113.905 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.24 -37.05 33.39 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.538 1.492 . . . . 0.0 112.359 174.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.3 t -62.91 -49.23 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.374 1.069 . . . . 0.0 111.694 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 pp -70.36 -39.87 74.36 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.614 1.166 . . . . 0.0 110.858 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -62.03 -44.16 97.3 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.75 0.705 . . . . 0.0 111.962 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -64.61 -54.29 34.28 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.449 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -65.48 -33.9 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.742 1.155 . . . . 0.0 111.502 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.17 89.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.482 1.037 . . . . 0.0 111.364 172.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 m -82.38 -30.82 30.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.415 0.686 . . . . 0.0 112.74 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -80.1 -28.32 39.06 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.044 -1.035 . . . . 0.0 113.203 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -120.27 29.42 7.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.798 1.639 . . . . 0.0 112.621 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -25.84 33.29 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.842 1.257 . . . . 0.0 114.293 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -80.71 -18.5 47.65 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.433 1.493 . . . . 0.0 113.884 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -103.5 -36.49 7.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.404 1.482 . . . . 0.0 112.945 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 160.28 43.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.8 m -111.03 139.62 46.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.297 1.439 . . . . 0.0 109.872 166.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.03 127.93 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.57 0.7 . . . . 0.0 110.153 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.68 145.55 42.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.541 2.337 . . . . 0.0 110.608 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.5 137.94 54.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.5 129.23 54.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.798 1.639 . . . . 0.0 109.637 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -99.35 105.65 17.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.392 1.077 . . . . 0.0 109.433 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.97 -22.1 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -164.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.52 -29.91 41.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.551 1.141 . . . . 0.0 113.233 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.1 p -106.08 -19.18 13.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.451 1.1 . . . . 0.0 113.81 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -133.03 78.68 64.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.687 0.795 . . . . 0.0 112.068 164.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.25 -22.57 75.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.125 2.55 . . . . 0.0 114.11 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.834 0.854 . . . . 0.0 113.096 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -76.93 -30.49 56.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.137 0.88 . . . . 0.0 111.679 172.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.58 98.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.969 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -76.68 -24.47 53.19 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -56.8 -40.01 75.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.37 0.986 . . . . 0.0 112.125 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.65 13.65 26.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 113.807 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 51.45 53.25 13.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.591 1.956 . . . . 0.0 114.141 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.54 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.219 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.55 -61.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.353 1.061 . . . . 0.0 109.788 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.8 m -86.86 151.33 23.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.237 1.015 . . . . 0.0 110.621 166.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.5 133.62 25.29 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.364 1.065 . . . . 0.0 109.515 -171.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.74 159.94 96.57 Favored 'Cis proline' 0 C--N 1.351 0.676 0 CA-C-N 120.365 1.166 . . . . 0.0 113.246 -0.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -126.98 136.11 51.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.426 1.09 . . . . 0.0 109.197 163.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.26 141.87 44.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 109.128 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.72 129.38 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.901 0.88 . . . . 0.0 108.954 166.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.44 125.21 52.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.892 1.277 . . . . 0.0 110.821 -173.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -104.83 148.45 26.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.249 1.819 . . . . 0.0 111.196 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -112.71 116.92 30.89 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.859 1.664 . . . . 0.0 108.264 164.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 51.16 37.37 18.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.644 1.178 . . . . 0.0 113.934 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 9.83 85.68 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.19 1.376 . . . . 0.0 115.944 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -113.93 131.39 23.16 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 119.27 1.535 . . . . 0.0 110.665 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.75 139.93 37.86 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.79 2.327 . . . . 0.0 112.526 -173.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.61 -48.66 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.966 1.306 . . . . 0.0 112.02 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -157.6 158.5 35.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.312 1.045 . . . . 0.0 113.436 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -118.51 140.36 50.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.021 1.728 . . . . 0.0 110.532 168.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.6 139.09 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.772 1.629 . . . . 0.0 109.522 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.48 142.89 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.657 1.183 . . . . 0.0 111.059 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.82 175.86 51.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.213 0.911 . . . . 0.0 113.228 -170.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 156.68 38.38 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -118.16 158.02 25.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.131 2.172 . . . . 0.0 110.086 172.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.5 166.65 25.48 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 155.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -51.17 -45.68 61.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.972 0.886 . . . . 0.0 112.169 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.67 84.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.298 1.039 . . . . 0.0 112.651 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.2 -42.92 62.14 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 111.864 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -63.32 -40.13 96.47 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.366 -0.834 . . . . 0.0 111.364 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.02 -30.87 71.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.695 1.198 . . . . 0.0 112.854 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -64.7 -42.64 95.15 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.342 0.974 . . . . 0.0 111.47 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.44 -39.2 92.56 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.537 1.062 . . . . 0.0 111.776 173.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.3 -40.73 96.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.167 0.587 . . . . 0.0 112.104 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -65.92 -28.3 68.83 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.336 -0.852 . . . . 0.0 111.899 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.6 -18.79 50.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 113.339 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.477 0.905 0 C-N-CA 125.491 1.516 . . . . 0.0 112.228 170.036 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.5 p -144.53 -166.85 2.49 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.821 2.048 . . . . 0.0 110.403 -173.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.68 -27.24 62.91 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.305 -1.497 . . . . 0.0 113.267 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.8 p -91.93 -41.39 10.61 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.517 1.127 . . . . 0.0 112.316 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.62 63.54 7.61 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.803 1.641 . . . . 0.0 109.008 167.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -50.65 128.73 21.22 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.001 1.72 . . . . 0.0 113.24 -164.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.0 m -61.04 145.09 52.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.995 1.318 . . . . 0.0 113.221 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 152.56 40.29 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.065 0.946 . . . . 0.0 113.249 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -95.06 159.29 15.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 129.532 3.133 . . . . 0.0 112.68 -4.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 pt -79.22 166.97 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.284 0.634 . . . . 0.0 111.268 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -126.5 141.68 51.79 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.157 1.783 . . . . 0.0 109.516 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.42 155.36 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.785 1.234 . . . . 0.0 111.954 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.3 p -137.85 159.91 40.72 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.064 1.746 . . . . 0.0 111.206 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.69 -28.25 68.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.02 -17.69 54.9 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -122.18 -17.77 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.169 1.388 . . . . 0.0 114.368 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -50.85 -41.43 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.979 1.712 . . . . 0.0 112.957 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 -31.43 71.96 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -35.02 33.95 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 111.627 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.95 -45.6 16.43 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.74 -54.44 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 111.173 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -80.92 -13.35 58.98 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -168.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 t -95.72 -6.35 40.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.569 1.148 . . . . 0.0 112.979 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -69.32 144.33 53.55 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.163 -0.96 . . . . 0.0 112.814 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -82.62 -5.42 58.8 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.939 1.296 . . . . 0.0 113.429 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -102.87 169.33 7.61 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 126.132 1.773 . . . . 0.0 112.367 -164.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -62.04 125.62 16.88 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.152 1.235 . . . . 0.0 109.147 147.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.99 116.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 109.938 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 tt -94.02 125.59 38.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.743 1.617 . . . . 0.0 108.39 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.85 128.27 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.441 -0.787 . . . . 0.0 110.582 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -106.04 113.08 26.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.218 1.007 . . . . 0.0 111.773 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -89.91 111.39 22.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.616 1.567 . . . . 0.0 108.913 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.8 172.8 15.04 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -163.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.82 142.74 51.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.387 1.075 . . . . 0.0 110.286 165.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -17.55 63.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -91.01 -11.86 37.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.535 1.534 . . . . 0.0 114.131 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 130.95 37.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.967 0.907 . . . . 0.0 111.873 -172.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.51 -60.27 9.12 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.691 1.139 . . . . 0.0 114.732 -175.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 -19.21 52.22 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.291 1.994 . . . . 0.0 113.236 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.4 m -71.18 -46.54 61.13 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.97 0.908 . . . . 0.0 111.059 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.99 -32.32 73.83 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.196 -0.94 . . . . 0.0 112.143 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.0 ttt -61.23 -34.97 75.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.671 0.788 . . . . 0.0 113.067 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -88.56 -11.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.11 -50.93 72.47 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-N 120.116 1.326 . . . . 0.0 114.385 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.92 -34.3 30.25 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.499 1.466 . . . . 0.0 112.222 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -67.47 -49.27 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.256 -0.902 . . . . 0.0 111.303 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.84 -42.24 95.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.448 0.699 . . . . 0.0 111.054 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.77 -45.48 92.14 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.596 0.634 . . . . 0.0 111.876 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.71 -49.45 53.19 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.461 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.49 -42.46 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.761 1.164 . . . . 0.0 110.564 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.24 -31.33 68.69 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -74.09 -37.42 64.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.86 0.464 . . . . 0.0 110.334 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.76 -35.14 24.58 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -116.2 24.47 11.38 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.63 1.572 . . . . 0.0 113.537 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.43 -26.23 29.57 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.3 p -80.17 -18.16 50.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.446 1.499 . . . . 0.0 113.999 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -100.14 -40.94 7.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.264 1.425 . . . . 0.0 112.551 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.07 159.92 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.539 1.136 . . . . 0.0 113.49 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.0 m -107.21 141.49 38.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 110.233 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -117.87 133.75 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.173 0.589 . . . . 0.0 110.479 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.05 162.6 26.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.837 2.055 . . . . 0.0 111.235 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -133.07 142.89 48.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -116.98 123.72 47.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.7 2.0 . . . . 0.0 109.083 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -92.44 91.59 7.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 110.378 -172.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 m -66.25 -19.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.301 -0.874 . . . . 0.0 112.92 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.69 -26.34 68.33 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -122.11 -22.93 5.49 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.619 1.168 . . . . 0.0 113.579 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -120.55 88.61 43.24 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.323 1.449 . . . . 0.0 111.227 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.2 -13.56 18.95 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.836 2.357 . . . . 0.0 113.081 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -77.06 -39.98 47.88 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.839 -1.163 . . . . 0.0 112.2 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -27.5 55.51 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.663 -0.648 . . . . 0.0 111.822 168.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.53 96.92 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.251 -0.905 . . . . 0.0 112.255 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -72.24 -26.71 62.11 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.262 -0.899 . . . . 0.0 113.059 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.76 -40.79 89.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.118 0.967 . . . . 0.0 112.476 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -107.52 14.69 25.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.567 1.547 . . . . 0.0 113.819 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 53.26 57.11 6.57 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.316 1.846 . . . . 0.0 113.611 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.55 134.72 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.144 168.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.86 -40.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.568 1.147 . . . . 0.0 111.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.2 m -122.1 157.09 32.22 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.642 1.577 . . . . 0.0 110.215 163.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.2 pt -126.58 149.92 69.38 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.987 1.315 . . . . 0.0 111.782 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.33 140.26 65.18 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 CA-C-N 119.106 0.716 . . . . 0.0 112.391 -2.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -102.15 114.84 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.195 . . . . 0.0 107.931 168.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.73 127.96 52.68 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.147 0.979 . . . . 0.0 109.196 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.1 127.52 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.831 0.853 . . . . 0.0 109.705 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.9 tp -104.85 120.63 41.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.597 1.159 . . . . 0.0 110.751 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.27 157.35 16.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.084 1.753 . . . . 0.0 110.616 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -135.38 128.81 32.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.905 1.682 . . . . 0.0 109.109 165.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.0 t70 53.88 32.73 15.71 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.163 0.985 . . . . 0.0 113.248 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.72 9.46 84.91 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.467 1.508 . . . . 0.0 115.563 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -112.58 134.98 21.51 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 118.952 1.376 . . . . 0.0 110.888 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.01 140.18 41.14 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.881 2.388 . . . . 0.0 112.27 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.64 -46.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.73 1.212 . . . . 0.0 111.848 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -158.91 153.19 23.91 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.555 1.142 . . . . 0.0 113.302 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -128.62 139.03 52.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.488 1.915 . . . . 0.0 111.031 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.5 mm -129.69 147.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.092 1.757 . . . . 0.0 109.426 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.9 136.66 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 110.139 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.67 171.15 31.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.1 1.333 . . . . 0.0 113.174 -168.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 156.98 35.99 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -171.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -124.44 161.79 25.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.529 2.332 . . . . 0.0 111.842 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.51 161.8 13.18 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.8 1.19 . . . . 0.0 110.76 156.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -52.72 -39.78 62.39 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.331 1.052 . . . . 0.0 112.95 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.67 79.36 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.461 0.705 . . . . 0.0 112.029 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.61 72.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.362 0.665 . . . . 0.0 111.991 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.31 -47.99 83.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.928 0.891 . . . . 0.0 111.07 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.46 -31.5 68.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.626 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 ttp-105 -67.55 -46.26 73.26 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.422 1.465 . . . . 0.0 111.975 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -70.02 -21.5 63.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.09 -40.07 68.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.392 1.077 . . . . 0.0 112.96 163.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.7 m -66.28 -22.03 66.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.021 1.328 . . . . 0.0 112.198 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.33 -20.74 66.53 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.56 -33.01 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.101 1.76 . . . . 0.0 112.157 -170.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.95 147.98 61.18 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 125.176 1.39 . . . . 0.0 112.198 169.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.26 135.26 69.2 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.124 2.549 . . . . 0.0 113.954 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -161.65 -57.17 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.936 1.295 . . . . 0.0 112.268 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.55 51.8 2.33 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.284 1.434 . . . . 0.0 111.863 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.061 1.745 . . . . 0.0 112.518 -170.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.535 0.207 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.3 p -102.08 -10.49 19.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.076 1.35 . . . . 0.0 113.708 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -95.88 124.36 39.86 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.493 1.517 . . . . 0.0 111.794 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.2 p -99.5 5.39 46.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.082 1.753 . . . . 0.0 114.589 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -94.48 -44.88 7.67 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.643 1.577 . . . . 0.0 110.966 171.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -87.41 -16.76 33.98 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.24 1.816 . . . . 0.0 113.128 -173.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.3 t -126.76 133.83 50.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.678 1.991 . . . . 0.0 109.289 164.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.51 64.16 7.74 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p -110.48 139.78 45.38 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.862 1.265 . . . . 0.0 112.601 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.7 165.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.995 1.718 . . . . 0.0 111.115 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 143.44 50.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.91 1.284 . . . . 0.0 111.991 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -131.74 156.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.839 1.255 . . . . 0.0 112.939 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.6 p -137.24 168.32 19.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.933 2.493 . . . . 0.0 109.762 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.91 -27.91 65.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.89 -18.12 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.3 p -110.5 -25.11 10.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.729 1.611 . . . . 0.0 113.995 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -48.86 -41.54 33.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.581 1.952 . . . . 0.0 112.579 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.75 72.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -84.73 -33.04 23.18 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.28 -0.888 . . . . 0.0 111.947 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -84.77 -40.3 17.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 t -98.94 -52.71 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.38 1.472 . . . . 0.0 111.347 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.3 mt -83.12 -18.31 39.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.5 m -104.77 20.69 18.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.703 1.601 . . . . 0.0 113.538 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.9 p -58.74 -38.45 78.42 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.22 25.72 1.91 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.116 1.367 . . . . 0.0 113.633 -163.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.46 165.97 16.77 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 125.49 1.516 . . . . 0.0 112.31 168.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -45.24 133.61 11.86 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.72 2.28 . . . . 0.0 112.692 154.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -142.84 124.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.779 0.832 . . . . 0.0 111.215 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.7 tp -90.57 133.06 35.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.379 1.472 . . . . 0.0 107.558 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.92 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.819 1.19 . . . . 0.0 109.871 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -108.47 120.68 43.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.649 1.18 . . . . 0.0 111.704 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -98.55 112.71 24.66 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.021 2.128 . . . . 0.0 108.537 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.57 -179.0 7.03 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.13 137.33 52.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.848 0.459 . . . . 0.0 109.958 156.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.0 p -61.94 -23.21 66.23 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -85.78 -12.23 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.303 1.441 . . . . 0.0 114.47 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 143.9 38.95 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.285 0.948 . . . . 0.0 112.924 -170.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.11 -63.72 5.06 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.452 1.025 . . . . 0.0 114.27 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.91 -24.55 67.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.963 1.775 . . . . 0.0 112.625 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.6 m -62.92 -47.87 81.39 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.045 0.938 . . . . 0.0 110.953 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -64.3 -32.85 74.61 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.072 0.949 . . . . 0.0 112.792 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.95 -32.75 73.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 p -91.17 -13.54 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.436 1.016 . . . . 0.0 113.608 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.99 -50.4 62.9 Favored Pre-proline 0 CA--C 1.555 1.171 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.67 -30.63 34.37 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.627 1.552 . . . . 0.0 112.577 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.87 -49.63 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.05 0.94 . . . . 0.0 111.597 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.45 -34.81 77.94 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 111.618 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.7 -41.72 92.01 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.435 1.016 . . . . 0.0 112.5 170.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.73 -44.11 78.36 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.024 -1.048 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -58.15 -44.11 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.957 1.253 . . . . 0.0 111.266 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.44 78.12 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.036 0.534 . . . . 0.0 112.126 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -77.17 -41.36 41.94 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.53 -0.731 . . . . 0.0 111.357 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -83.67 -28.95 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -111.01 20.3 17.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.968 1.307 . . . . 0.0 113.128 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.15 -33.1 17.86 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -74.59 -23.38 58.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.136 1.375 . . . . 0.0 112.845 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -105.52 -33.79 7.99 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.579 1.952 . . . . 0.0 112.993 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -151.7 139.32 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.577 1.551 . . . . 0.0 110.517 -156.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.7 m -115.84 140.49 49.17 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.309 1.443 . . . . 0.0 109.614 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.68 128.25 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.935 0.894 . . . . 0.0 109.725 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.61 143.66 45.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.139 1.776 . . . . 0.0 111.918 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -110.6 127.86 55.42 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.198 1.399 . . . . 0.0 111.974 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.33 123.98 41.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.059 1.343 . . . . 0.0 109.786 167.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.91 118.0 34.69 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.535 0.734 . . . . 0.0 110.18 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -71.31 -16.44 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.52 -38.97 11.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.64 1.176 . . . . 0.0 112.714 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.7 p -87.49 -21.88 25.22 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.75 80.61 55.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.034 0.933 . . . . 0.0 111.891 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.55 -20.34 70.39 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.152 2.568 . . . . 0.0 113.706 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.93 -44.41 92.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 112.74 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 m -73.17 -33.09 65.25 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.195 0.907 . . . . 0.0 111.452 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.47 92.95 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.463 -0.773 . . . . 0.0 111.933 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.99 -25.82 53.16 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.86 -45.94 88.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.189 0.904 . . . . 0.0 111.397 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.07 10.33 41.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 113.933 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 45.42 50.59 10.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.798 2.039 . . . . 0.0 113.674 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 p -75.23 138.04 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.294 -0.879 . . . . 0.0 111.529 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -123.56 -15.81 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.3 m -133.68 150.88 51.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.828 1.651 . . . . 0.0 110.898 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.79 140.58 37.98 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.814 0.846 . . . . 0.0 111.873 174.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.72 152.73 94.98 Favored 'Cis proline' 0 CA--C 1.543 0.935 0 CA-C-N 118.973 0.669 . . . . 0.0 111.177 -11.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.9 m -133.87 124.88 27.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.767 1.227 . . . . 0.0 109.421 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.74 147.15 28.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.853 1.261 . . . . 0.0 110.867 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 tt -131.7 144.55 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.384 1.474 . . . . 0.0 109.633 169.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 tp -107.21 130.63 54.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.228 1.011 . . . . 0.0 110.307 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.68 147.16 29.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.84 1.256 . . . . 0.0 109.568 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -108.65 116.44 31.99 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.537 1.535 . . . . 0.0 108.365 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 51.33 34.27 11.44 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.812 1.245 . . . . 0.0 113.669 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.22 17.29 67.26 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -125.42 136.6 28.48 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 119.501 1.651 . . . . 0.0 110.865 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.22 139.81 39.48 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.773 2.316 . . . . 0.0 112.243 -172.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.57 -36.04 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -162.06 149.64 14.32 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.593 1.088 . . . . 0.0 113.302 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -129.07 141.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.891 1.676 . . . . 0.0 111.597 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 123.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.237 1.815 . . . . 0.0 111.44 -175.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.04 150.73 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.333 1.053 . . . . 0.0 111.822 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.76 -179.98 53.24 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.051 1.31 . . . . 0.0 113.437 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.95 157.51 28.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -129.49 152.23 49.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.034 1.734 . . . . 0.0 111.091 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.49 154.31 20.98 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 163.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -57.7 -33.03 67.95 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.12 82.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.149 0.58 . . . . 0.0 111.786 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.12 66.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.442 0.697 . . . . 0.0 111.457 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.9 tp -61.64 -43.46 98.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.919 0.887 . . . . 0.0 111.343 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.1 tp -67.66 -34.74 77.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.774 0.829 . . . . 0.0 113.014 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -66.81 -45.14 79.29 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.361 1.437 . . . . 0.0 111.51 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.34 -34.67 70.89 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.35 -44.0 30.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 p -72.05 -15.06 62.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.755 1.222 . . . . 0.0 113.095 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -14.19 48.03 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.42 149.36 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.673 1.989 . . . . 0.0 110.431 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.7 t -93.16 135.03 26.18 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.891 1.276 . . . . 0.0 110.891 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -69.44 166.36 27.47 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.339 2.693 . . . . 0.0 112.922 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -66.26 -43.76 85.58 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -170.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.5 tp -144.46 -7.72 0.68 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -172.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.824 1.25 . . . . 0.0 113.326 -170.846 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.7 p -86.69 142.26 28.32 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.187 0.995 . . . . 0.0 112.579 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.0 134.41 38.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.394 2.278 . . . . 0.0 111.336 -8.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.1 p -67.82 -14.59 63.08 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -172.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.45 -3.5 36.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.498 1.119 . . . . 0.0 113.614 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -99.41 -21.48 15.97 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -70.56 125.37 26.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.109 0.964 . . . . 0.0 110.91 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.47 16.82 15.98 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -169.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t -80.37 153.97 28.01 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.035 -1.041 . . . . 0.0 111.548 174.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 pt -121.52 134.74 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 112.816 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -82.6 127.44 33.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.411 1.484 . . . . 0.0 108.932 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.04 156.85 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.349 1.059 . . . . 0.0 112.282 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -134.39 172.0 13.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.455 2.302 . . . . 0.0 111.052 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.3 -26.67 63.3 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.062 -1.024 . . . . 0.0 113.659 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.63 -35.0 24.95 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.9 p -100.05 -24.14 14.69 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -53.01 -40.83 64.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.056 1.342 . . . . 0.0 112.597 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.34 -31.57 72.44 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.081 -1.012 . . . . 0.0 113.39 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.7 m -81.6 -33.83 31.31 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.796 0.838 . . . . 0.0 111.993 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -92.83 -25.73 17.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.23 -53.87 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.37 -19.93 55.51 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -77.2 -23.81 51.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -81.39 122.34 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.044 -164.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -72.45 -29.26 63.52 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.276 1.03 . . . . 0.0 111.629 166.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -72.18 158.94 86.69 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.373 1.069 . . . . 0.0 110.962 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.47 139.9 73.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.504 2.136 . . . . 0.0 110.974 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 t -128.85 117.54 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.689 0.796 . . . . 0.0 110.388 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.65 128.27 36.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.587 1.155 . . . . 0.0 108.678 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.38 127.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.85 0.86 . . . . 0.0 109.87 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -97.5 112.6 24.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.199 0.6 . . . . 0.0 111.179 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -85.22 109.54 18.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.192 1.397 . . . . 0.0 107.65 170.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.42 178.51 8.37 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -165.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.96 47.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.834 0.454 . . . . 0.0 109.944 157.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -62.33 -20.71 64.65 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -85.42 -16.55 39.39 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.151 1.38 . . . . 0.0 114.461 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 144.71 38.54 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.23 0.923 . . . . 0.0 113.398 -167.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.35 -63.9 4.88 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.634 1.111 . . . . 0.0 114.405 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.79 -21.33 51.17 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 119.616 1.708 . . . . 0.0 112.932 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.9 m -63.14 -47.48 82.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.487 1.039 . . . . 0.0 110.683 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.16 -32.3 73.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.903 0.881 . . . . 0.0 112.647 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.9 ttt -63.77 -36.43 83.85 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.45 -11.37 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -54.67 39.53 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 119.948 1.249 . . . . 0.0 113.915 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.3 -33.43 59.27 Favored 'Trans proline' 0 C--N 1.355 0.893 0 CA-C-N 121.143 1.444 . . . . 0.0 111.685 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.24 -51.27 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.609 0.764 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.48 -37.96 83.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.684 0.675 . . . . 0.0 111.086 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.64 -42.6 98.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.499 0.591 . . . . 0.0 112.218 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.98 -48.04 69.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.049 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.1 mm -57.94 -42.88 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.839 1.654 . . . . 0.0 110.821 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.52 91.82 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.138 0.426 . . . . 0.0 111.685 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -79.43 -31.36 42.6 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.297 1.039 . . . . 0.0 112.459 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -87.03 -31.12 20.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -126.49 27.02 6.23 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.8 -28.93 17.17 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -76.63 -20.32 56.83 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.755 1.622 . . . . 0.0 114.257 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.57 -37.15 8.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.821 1.249 . . . . 0.0 112.709 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.59 174.0 12.17 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.383 1.473 . . . . 0.0 113.088 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.3 m -117.96 146.34 44.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.199 1.399 . . . . 0.0 109.783 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.23 138.12 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.765 0.826 . . . . 0.0 109.995 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.05 161.26 35.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.289 1.835 . . . . 0.0 112.101 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -131.55 138.08 48.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.544 1.138 . . . . 0.0 112.713 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 tt -128.14 111.91 13.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.294 2.238 . . . . 0.0 107.966 -172.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -86.45 112.52 21.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.379 0.609 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -71.42 -17.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -88.11 -40.69 13.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.285 1.034 . . . . 0.0 112.555 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -90.71 -23.32 20.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -130.56 68.25 81.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.144 1.377 . . . . 0.0 110.445 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.41 -16.65 39.17 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.241 2.627 . . . . 0.0 113.839 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.52 -37.67 87.44 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.32 -0.862 . . . . 0.0 112.727 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.7 p -77.18 -35.29 55.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.48 0.712 . . . . 0.0 112.387 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.04 98.59 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 112.357 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -76.91 -23.29 52.53 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -58.75 -42.32 88.59 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.301 0.955 . . . . 0.0 111.635 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -97.98 5.66 48.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.197 1.399 . . . . 0.0 113.589 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 52.46 41.05 30.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.516 1.927 . . . . 0.0 114.176 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -78.65 128.81 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.992 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -126.27 -6.94 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.626 1.57 . . . . 0.0 114.025 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.7 m -122.24 150.76 41.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.226 1.81 . . . . 0.0 110.876 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.8 pt -137.86 144.88 45.96 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.086 0.955 . . . . 0.0 112.08 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.27 144.91 74.59 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 CA-C-N 119.498 0.857 . . . . 0.0 111.084 -13.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -122.66 114.73 20.98 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.494 1.118 . . . . 0.0 108.881 172.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.6 mt -98.69 123.87 43.17 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.011 1.324 . . . . 0.0 109.433 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.96 139.78 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.384 1.074 . . . . 0.0 110.397 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 tp -106.17 126.65 52.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.857 1.263 . . . . 0.0 111.502 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -107.59 152.75 23.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.607 1.963 . . . . 0.0 111.607 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -144.91 131.44 19.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 0.0 109.883 172.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.18 33.28 12.05 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -171.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.51 42.14 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.859 1.695 . . . . 0.0 114.94 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -95.59 139.04 21.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 118.711 1.255 . . . . 0.0 110.538 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.88 135.98 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.48 2.12 . . . . 0.0 110.841 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.75 -48.9 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.852 0.861 . . . . 0.0 112.237 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -154.21 148.64 26.14 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.628 1.171 . . . . 0.0 112.125 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -132.83 139.89 47.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.161 1.384 . . . . 0.0 111.596 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.72 129.01 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 110.754 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.39 36.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.289 1.435 . . . . 0.0 113.603 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.41 174.25 38.79 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.347 0.975 . . . . 0.0 114.297 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.31 154.34 42.01 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.715 1.206 . . . . 0.0 113.878 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.03 153.49 51.34 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.006 1.723 . . . . 0.0 111.595 165.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.26 167.42 43.3 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.215 0.912 . . . . 0.0 110.961 164.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -58.69 -34.64 71.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.36 66.99 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.824 0.45 . . . . 0.0 111.385 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.23 83.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.656 0.782 . . . . 0.0 111.771 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 tp -68.53 -38.21 80.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.381 -0.824 . . . . 0.0 112.21 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -68.09 -33.45 74.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.161 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 tpt85 -68.5 -38.82 81.29 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.313 1.415 . . . . 0.0 112.65 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -62.24 -36.32 81.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.456 1.102 . . . . 0.0 111.347 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mt -68.56 -43.6 76.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 113.404 169.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.2 m -68.15 -17.96 64.49 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.113 1.365 . . . . 0.0 112.186 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.53 -12.37 43.97 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.54 1.136 . . . . 0.0 113.57 167.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.6 t -125.85 -44.47 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.231 1.813 . . . . 0.0 112.023 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -99.26 138.53 20.56 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 124.344 1.058 . . . . 0.0 111.904 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -58.76 126.45 21.23 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.641 2.228 . . . . 0.0 112.001 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -156.82 152.07 26.42 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.23 1.412 . . . . 0.0 110.514 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -71.76 -28.53 63.71 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.802 1.241 . . . . 0.0 112.314 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.792 2.437 . . . . 0.0 113.514 -178.078 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.356 0.122 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m -67.04 138.08 56.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.462 1.105 . . . . 0.0 111.561 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.96 35.68 0.59 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.397 1.079 . . . . 0.0 113.127 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.9 t -153.46 156.83 38.92 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.94 1.696 . . . . 0.0 111.437 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 60.43 -62.0 0.07 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.668 2.787 . . . . 0.0 115.132 -173.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 57.79 -2.85 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.871 2.868 . . . . 0.0 117.47 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 p -78.69 139.75 38.45 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.543 1.537 . . . . 0.0 112.942 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.38 58.5 2.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.035 0.934 . . . . 0.0 111.678 173.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 p -115.6 142.39 46.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.316 1.446 . . . . 0.0 113.797 -170.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 pt -140.79 168.58 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.312 1.845 . . . . 0.0 111.825 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -115.5 143.47 45.26 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.832 1.253 . . . . 0.0 110.422 163.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.35 167.13 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.428 1.491 . . . . 0.0 112.425 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.5 p -127.93 172.04 11.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.317 2.647 . . . . 0.0 109.36 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.89 -33.12 64.31 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.043 -1.036 . . . . 0.0 113.181 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.22 -38.14 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.679 0.791 . . . . 0.0 113.04 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -80.61 -24.68 38.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.316 1.046 . . . . 0.0 113.54 -176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -53.43 -41.84 66.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.898 1.279 . . . . 0.0 112.639 -173.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.37 69.87 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 m -87.33 -23.25 24.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.726 1.21 . . . . 0.0 113.081 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -107.34 -31.57 8.13 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.73 -56.44 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.221 1.009 . . . . 0.0 111.487 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.1 -12.43 60.9 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -76.19 -21.29 56.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.809 1.644 . . . . 0.0 114.104 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 t -96.27 128.19 42.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -73.33 -24.55 60.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.533 1.533 . . . . 0.0 112.449 166.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -74.17 149.42 87.11 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.281 1.432 . . . . 0.0 109.817 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.13 129.35 34.79 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.384 2.056 . . . . 0.0 111.904 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -128.71 120.07 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.641 1.176 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 29.8 tp -91.23 133.6 35.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.743 1.217 . . . . 0.0 108.87 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.78 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.494 1.043 . . . . 0.0 110.952 169.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -107.79 127.19 53.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.498 1.519 . . . . 0.0 111.57 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -100.34 117.53 34.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.894 1.678 . . . . 0.0 110.064 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.31 168.65 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -169.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 -176.93 3.65 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.817 1.647 . . . . 0.0 111.726 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.7 p -74.66 -23.72 58.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.167 1.387 . . . . 0.0 114.52 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -114.56 -13.49 12.16 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -161.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.59 120.55 24.09 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -164.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.91 -59.07 8.45 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.612 1.101 . . . . 0.0 114.413 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.5 -24.14 36.59 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.007 1.903 . . . . 0.0 113.386 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -76.31 -32.29 58.66 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.327 0.967 . . . . 0.0 111.965 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -75.36 -32.58 60.89 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.624 -0.673 . . . . 0.0 112.052 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.58 -33.47 75.03 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.17 0.988 . . . . 0.0 113.57 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.76 -20.43 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.404 1.002 . . . . 0.0 113.592 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.66 -40.72 85.42 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.536 1.517 . . . . 0.0 115.083 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.19 -37.81 80.71 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.632 2.221 . . . . 0.0 113.047 171.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.89 -39.53 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.804 0.842 . . . . 0.0 110.806 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.79 -49.54 57.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.7 1.2 . . . . 0.0 110.683 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.61 -37.99 71.44 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.476 . . . . 0.0 110.538 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -77.18 -49.25 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.159 -0.448 . . . . 0.0 112.143 -172.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.8 mm -65.01 -36.4 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.356 0.98 . . . . 0.0 111.042 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.712 . . . . 0.0 112.822 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -75.48 -43.85 47.09 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.675 1.125 . . . . 0.0 110.956 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.69 -33.14 47.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -121.33 30.82 6.6 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.171 1.788 . . . . 0.0 112.374 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.57 -28.79 22.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.474 1.51 . . . . 0.0 114.335 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 m -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.775 1.23 . . . . 0.0 112.242 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -90.76 -37.88 13.38 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.768 1.227 . . . . 0.0 113.027 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 166.82 23.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.6 m -125.9 142.5 51.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.086 1.754 . . . . 0.0 108.51 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.16 138.18 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.489 0.716 . . . . 0.0 110.782 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.12 152.36 46.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.303 1.441 . . . . 0.0 112.639 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -106.85 135.05 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.552 1.541 . . . . 0.0 110.498 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.42 121.34 43.26 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -94.61 114.54 26.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.6 m -69.52 -16.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.46 -24.14 39.74 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.831 0.852 . . . . 0.0 112.726 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 p -86.9 -30.96 20.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -148.18 106.4 3.61 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.683 1.193 . . . . 0.0 110.987 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.2 -10.95 29.37 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 121.775 1.65 . . . . 0.0 112.465 161.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.77 -51.45 69.27 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.335 1.454 . . . . 0.0 112.194 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.56 -30.46 64.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.509 0.724 . . . . 0.0 112.05 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -43.43 98.86 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.499 -0.751 . . . . 0.0 111.944 173.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -77.26 -24.62 51.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -59.86 -44.59 94.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.289 0.95 . . . . 0.0 112.092 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.51 15.05 24.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 113.704 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 50.99 46.15 26.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.223 2.209 . . . . 0.0 113.836 173.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.96 121.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.357 1.063 . . . . 0.0 109.54 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.22 -29.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.054 1.342 . . . . 0.0 112.907 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.5 m -125.7 155.9 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.215 1.806 . . . . 0.0 110.201 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.31 123.08 27.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.82 159.01 98.22 Favored 'Cis proline' 0 CA--C 1.542 0.876 0 CA-C-N 120.015 1.041 . . . . 0.0 113.321 0.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.2 m -127.07 129.98 49.03 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.492 1.117 . . . . 0.0 108.874 161.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.76 144.26 38.42 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.057 1.343 . . . . 0.0 110.367 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 tp -140.72 126.78 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.005 1.322 . . . . 0.0 109.508 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.76 133.19 38.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.789 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -118.95 149.65 41.25 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.84 1.656 . . . . 0.0 111.633 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -146.49 136.44 23.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.596 1.159 . . . . 0.0 110.75 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.33 30.02 14.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.324 1.05 . . . . 0.0 112.665 -171.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.58 5.12 49.15 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.613 2.054 . . . . 0.0 114.895 -172.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -95.26 131.75 29.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 118.527 1.163 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.66 132.49 23.59 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.55 2.167 . . . . 0.0 110.812 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.2 t -106.72 -47.47 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.547 1.139 . . . . 0.0 111.832 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -158.45 131.83 7.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.682 1.193 . . . . 0.0 111.254 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -112.28 136.55 51.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.379 1.471 . . . . 0.0 110.73 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.42 122.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.893 1.277 . . . . 0.0 109.524 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.09 41.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.014 1.325 . . . . 0.0 112.883 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.76 -178.77 41.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.154 0.883 . . . . 0.0 114.067 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.18 157.23 34.23 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.684 1.193 . . . . 0.0 113.871 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -129.98 160.7 32.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.6 1.96 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.35 164.02 12.12 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.3 1.428 . . . . 0.0 110.85 159.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -52.57 -40.8 62.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.546 1.139 . . . . 0.0 113.253 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.45 -44.96 77.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.17 0.588 . . . . 0.0 111.794 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -40.32 68.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.524 0.73 . . . . 0.0 112.242 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.3 tp -62.29 -44.67 95.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.921 0.888 . . . . 0.0 111.452 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.0 tp -68.12 -30.04 69.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.459 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -60.57 -47.69 85.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.604 1.093 . . . . 0.0 110.933 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.61 -40.5 87.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.475 1.034 . . . . 0.0 111.815 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.48 -30.52 69.39 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -75.63 -26.19 57.56 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.656 1.183 . . . . 0.0 112.386 171.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -85.7 11.15 11.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.342 1.857 . . . . 0.0 113.498 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.45 147.27 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.881 -1.137 . . . . 0.0 113.319 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.8 142.23 10.86 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 126.513 1.925 . . . . 0.0 109.893 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.43 107.72 2.05 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.987 1.791 . . . . 0.0 109.772 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.97 -17.24 64.54 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -165.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.4 tp -73.02 -21.49 60.81 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.676 1.19 . . . . 0.0 113.383 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.9 m120 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.295 1.438 . . . . 0.0 113.11 -177.674 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 ttp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 t -98.55 163.29 12.73 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.163 0.985 . . . . 0.0 112.802 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.96 -24.74 67.84 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.73 1.212 . . . . 0.0 113.976 -171.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 m -91.79 -0.19 57.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.154 1.382 . . . . 0.0 114.049 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -92.33 -14.21 29.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.983 1.313 . . . . 0.0 113.589 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.67 178.69 4.21 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.829 2.052 . . . . 0.0 111.932 174.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 m -60.94 119.24 7.89 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.459 1.104 . . . . 0.0 112.323 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.77 61.94 4.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.792 0.837 . . . . 0.0 111.392 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -111.08 139.46 46.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.043 1.337 . . . . 0.0 112.708 -174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 pt -137.34 167.58 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.766 1.626 . . . . 0.0 111.132 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -127.71 148.41 50.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.704 0.802 . . . . 0.0 112.203 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.14 159.58 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.677 1.591 . . . . 0.0 112.446 -170.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.9 p -142.6 168.42 19.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.829 2.452 . . . . 0.0 110.501 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -56.03 -25.97 46.99 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.26 -16.68 39.37 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.1 p -119.64 -25.28 5.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.676 1.591 . . . . 0.0 114.71 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.53 -39.44 48.93 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.36 1.864 . . . . 0.0 112.932 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.35 71.85 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.2 m -87.33 -30.77 20.57 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.448 -0.782 . . . . 0.0 112.043 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -87.31 -43.92 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.0 t -98.62 -52.87 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.89 1.276 . . . . 0.0 111.344 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -79.81 -13.77 59.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -110.4 18.18 20.08 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 0.0 113.343 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.0 p -62.25 -36.89 83.43 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -167.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.295 0.5 OUTLIER 48.01 21.6 0.33 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.916 1.687 . . . . 0.0 115.185 -161.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.22 168.1 11.85 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 126.177 1.791 . . . . 0.0 111.928 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.75 139.31 74.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.708 2.272 . . . . 0.0 112.901 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.74 124.77 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.69 1.196 . . . . 0.0 111.388 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.5 99.01 10.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.702 1.601 . . . . 0.0 109.171 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -99.28 121.05 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.282 -0.887 . . . . 0.0 110.655 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -102.34 118.4 36.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.6 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -91.97 112.82 24.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.614 1.566 . . . . 0.0 108.552 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 172.62 13.98 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.378 1.071 . . . . 0.0 113.02 -169.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.54 175.08 5.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.591 1.156 . . . . 0.0 111.09 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.5 p -74.93 -18.54 60.38 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.0 -1.062 . . . . 0.0 113.726 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -116.95 -5.25 11.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -163.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.75 134.39 39.18 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.457 1.026 . . . . 0.0 113.699 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -62.99 5.54 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.454 1.026 . . . . 0.0 114.094 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.17 -25.01 65.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.335 2.023 . . . . 0.0 113.363 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -74.55 -33.42 62.71 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.091 0.859 . . . . 0.0 112.088 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -64.01 -40.75 97.03 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.453 -0.779 . . . . 0.0 112.023 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.43 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.16 99.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 120.343 1.429 . . . . 0.0 113.517 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.82 -41.69 36.33 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.869 1.713 . . . . 0.0 112.163 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.14 -47.04 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.57 1.148 . . . . 0.0 111.77 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.74 -38.21 76.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.112 0.965 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 -41.05 82.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.612 1.096 . . . . 0.0 112.314 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.03 -47.97 69.76 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.013 -1.054 . . . . 0.0 111.614 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 mm -59.14 -40.5 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.286 1.403 . . . . 0.0 111.233 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.73 75.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.714 0.688 . . . . 0.0 112.564 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.4 m -78.19 -40.42 37.7 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.284 -0.885 . . . . 0.0 111.463 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.17 -21.7 29.09 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -128.66 25.67 5.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.146 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -34.11 21.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.499 1.52 . . . . 0.0 114.459 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -78.17 -18.56 55.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.465 1.506 . . . . 0.0 113.701 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -97.61 -38.25 9.61 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.135 1.374 . . . . 0.0 112.49 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 160.42 43.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -109.08 138.01 46.09 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.099 1.359 . . . . 0.0 109.508 166.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.74 133.5 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.33 147.34 49.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.209 1.404 . . . . 0.0 111.873 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.55 135.19 53.56 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.533 1.133 . . . . 0.0 111.705 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.31 124.93 52.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.039 1.336 . . . . 0.0 109.26 164.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.29 96.61 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.928 0.891 . . . . 0.0 109.926 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -65.73 -22.72 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.044 -1.035 . . . . 0.0 112.493 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.31 -27.48 63.42 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.527 1.531 . . . . 0.0 113.015 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.1 p -123.51 -21.24 5.33 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.069 1.348 . . . . 0.0 114.254 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -128.73 63.84 67.1 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.385 1.474 . . . . 0.0 111.929 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.25 -13.26 38.89 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.322 2.681 . . . . 0.0 113.784 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -61.9 -37.36 84.3 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.218 -0.926 . . . . 0.0 112.199 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -77.5 -32.29 54.07 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.648 -0.657 . . . . 0.0 112.096 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.24 95.92 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.059 -1.025 . . . . 0.0 111.657 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -75.7 -25.55 56.78 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.34 -42.74 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.224 0.92 . . . . 0.0 111.977 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -104.52 9.87 35.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.431 1.492 . . . . 0.0 113.795 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 49.55 48.55 21.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 113.675 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.1 130.69 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.617 1.167 . . . . 0.0 110.297 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.04 -17.01 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 68.9 m -128.66 158.81 37.49 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.66 1.584 . . . . 0.0 111.079 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.4 pt -135.54 142.54 41.5 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.189 0.996 . . . . 0.0 112.07 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.39 139.55 57.12 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 CA-C-N 119.495 0.855 . . . . 0.0 111.501 -8.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.0 m -122.46 118.18 27.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.857 0.863 . . . . 0.0 108.858 168.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.05 141.62 32.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.333 1.053 . . . . 0.0 109.822 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 tp -137.77 121.47 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.065 1.346 . . . . 0.0 108.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -95.88 114.99 26.77 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.237 1.415 . . . . 0.0 109.706 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -95.55 148.74 22.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.207 1.403 . . . . 0.0 110.44 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -129.73 119.16 23.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.38 1.472 . . . . 0.0 108.877 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 49.87 35.22 8.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.684 1.194 . . . . 0.0 113.814 -174.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.5 76.85 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -122.23 141.55 34.79 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.465 1.632 . . . . 0.0 111.843 165.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.07 142.56 38.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.31 2.673 . . . . 0.0 112.277 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -120.85 -43.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.384 1.074 . . . . 0.0 113.118 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.62 133.16 19.77 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.492 1.117 . . . . 0.0 112.144 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -111.59 141.3 45.36 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.394 1.477 . . . . 0.0 111.668 171.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.6 147.46 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.301 2.24 . . . . 0.0 110.665 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.28 141.85 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 0.0 111.035 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.82 171.03 44.61 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.193 1.377 . . . . 0.0 113.597 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.44 39.34 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -138.97 158.95 43.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.905 2.082 . . . . 0.0 111.044 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.42 169.35 32.92 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.519 1.057 . . . . 0.0 111.863 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -57.58 -38.05 74.19 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.099 -0.648 . . . . 0.0 112.568 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.84 81.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.333 0.653 . . . . 0.0 111.677 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.25 77.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.37 0.668 . . . . 0.0 111.594 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.65 -40.17 96.18 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.107 0.963 . . . . 0.0 112.103 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.07 -33.15 74.88 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.846 0.858 . . . . 0.0 112.401 172.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -68.21 -38.93 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.49 1.041 . . . . 0.0 112.403 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -61.49 -38.71 88.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 0.826 . . . . 0.0 111.537 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.2 tp -67.2 -43.56 81.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.72 0.408 . . . . 0.0 111.814 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.2 p -71.82 -15.37 62.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.37 -16.99 64.56 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.8 t -122.55 -27.17 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.562 1.945 . . . . 0.0 111.873 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.3 t -125.98 86.93 56.94 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.174 1.79 . . . . 0.0 109.738 -174.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.3 161.05 88.24 Favored 'Cis proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.513 0.862 . . . . 0.0 113.056 -7.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -85.86 -17.38 35.78 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 tt 63.06 -41.33 0.19 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.951 2.9 . . . . 0.0 115.828 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 127.204 2.202 . . . . 0.0 111.96 178.574 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 p -145.59 178.64 7.98 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.682 1.993 . . . . 0.0 109.783 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.1 -9.86 8.62 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m -133.33 25.55 4.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.997 1.719 . . . . 0.0 113.097 171.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -139.7 84.26 1.97 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.619 1.568 . . . . 0.0 107.943 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? 52.45 86.86 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.24 1.816 . . . . 0.0 110.859 -153.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.1 p -66.08 162.04 20.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 130.278 3.431 . . . . 0.0 117.937 17.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.18 27.8 0.66 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.672 1.189 . . . . 0.0 113.543 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -76.8 174.02 11.0 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.138 -0.976 . . . . 0.0 111.742 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 pt -112.47 163.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.448 1.099 . . . . 0.0 111.227 160.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -126.46 130.72 51.23 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.683 1.593 . . . . 0.0 109.611 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.31 156.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.09 0.956 . . . . 0.0 113.368 -168.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.3 p -138.96 163.47 32.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.44 2.296 . . . . 0.0 110.406 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.04 -32.66 72.28 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -166.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.28 -20.59 57.21 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -109.38 -18.87 13.46 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.561 1.545 . . . . 0.0 113.88 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -52.93 -41.39 64.42 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.8 1.64 . . . . 0.0 112.927 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.44 72.18 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 m -85.52 -22.14 28.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 112.57 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -96.45 -42.38 8.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 -54.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.871 1.268 . . . . 0.0 111.623 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.66 -11.73 60.06 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.3 p -78.35 -14.34 59.45 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.311 1.844 . . . . 0.0 114.098 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.9 t -69.31 148.92 49.07 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -161.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -107.01 21.37 17.67 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.9 2.08 . . . . 0.0 112.386 167.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -138.76 156.23 72.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 128.31 2.644 . . . . 0.0 108.977 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.31 141.35 88.91 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.711 1.607 . . . . 0.0 112.559 160.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 123.09 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.418 1.087 . . . . 0.0 110.55 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.46 131.25 34.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.492 1.117 . . . . 0.0 108.531 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.63 127.9 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 119.089 0.859 . . . . 0.0 109.837 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -102.13 125.12 48.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.617 0.767 . . . . 0.0 111.172 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.16 112.24 24.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.412 1.485 . . . . 0.0 109.115 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.88 171.68 16.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -166.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 174.72 7.74 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.168 1.387 . . . . 0.0 111.954 174.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.6 p -75.11 -18.73 60.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -115.11 -7.0 12.49 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -165.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.05 128.02 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.37 -60.69 8.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.467 1.032 . . . . 0.0 114.102 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.42 -27.1 54.91 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.192 1.928 . . . . 0.0 113.501 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.61 -33.18 64.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.048 0.84 . . . . 0.0 112.015 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.82 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.172 -0.955 . . . . 0.0 112.722 167.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.89 -30.34 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.835 1.198 . . . . 0.0 113.79 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.64 -6.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.94 -53.89 53.05 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.469 1.031 . . . . 0.0 113.496 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.0 -33.85 91.6 Favored 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 121.646 1.624 . . . . 0.0 112.409 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.91 -50.02 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.988 0.915 . . . . 0.0 112.08 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.78 -37.68 82.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.36 0.664 . . . . 0.0 111.31 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.1 -37.37 78.36 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.143 0.577 . . . . 0.0 112.338 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.39 -48.59 66.93 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.781 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mm -59.67 -38.84 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 120.734 1.606 . . . . 0.0 111.185 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.66 90.51 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.802 0.728 . . . . 0.0 112.884 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.3 m -74.52 -39.5 62.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.041 0.536 . . . . 0.0 111.909 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.27 -34.67 14.85 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -167.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -117.01 20.48 13.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.216 1.406 . . . . 0.0 113.619 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.8 -27.8 19.71 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -81.16 -18.79 45.1 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.48 1.512 . . . . 0.0 113.936 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -94.56 -42.59 8.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.829 1.252 . . . . 0.0 112.068 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.62 155.94 38.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.007 1.323 . . . . 0.0 112.64 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.82 137.85 37.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.159 171.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.11 133.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.829 0.741 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.63 153.87 44.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.625 1.97 . . . . 0.0 111.705 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -123.12 131.48 53.71 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 0.0 112.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.91 121.96 45.55 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.384 1.474 . . . . 0.0 108.729 170.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.22 95.05 7.14 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.184 0.994 . . . . 0.0 109.772 -171.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.5 -20.73 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.327 1.051 . . . . 0.0 113.323 -170.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.44 -33.12 62.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.876 1.27 . . . . 0.0 112.827 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 p -107.35 -20.83 13.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.343 1.457 . . . . 0.0 113.349 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.05 81.91 69.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.734 2.013 . . . . 0.0 109.449 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -74.99 -11.22 21.49 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.202 2.601 . . . . 0.0 114.356 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.8 -40.28 61.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.161 0.984 . . . . 0.0 112.772 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -73.74 -29.59 62.32 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.025 -1.047 . . . . 0.0 112.472 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.14 94.18 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.371 0.669 . . . . 0.0 111.97 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -81.66 -23.24 37.02 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -59.42 -44.79 92.8 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.692 1.197 . . . . 0.0 111.575 171.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.43 4.77 50.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.144 1.378 . . . . 0.0 114.49 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 48.73 61.15 3.23 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.667 1.587 . . . . 0.0 112.763 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.25 134.17 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.604 1.562 . . . . 0.0 110.767 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.19 -14.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 t -146.71 167.55 23.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.025 1.33 . . . . 0.0 111.95 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.28 121.91 16.84 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.709 1.204 . . . . 0.0 108.36 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.65 157.32 94.66 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.882 0.994 . . . . 0.0 112.59 -5.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.9 m -130.33 120.81 24.92 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.216 1.006 . . . . 0.0 109.559 165.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.4 126.99 50.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.644 1.577 . . . . 0.0 109.006 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.39 133.27 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.287 1.035 . . . . 0.0 110.501 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -104.18 118.39 36.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 110.539 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.86 151.34 19.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.602 1.561 . . . . 0.0 110.43 167.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -124.7 124.39 42.06 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 108.834 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.26 36.25 12.27 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.458 1.103 . . . . 0.0 113.5 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.97 18.26 78.94 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.073 1.321 . . . . 0.0 116.094 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -126.3 140.29 36.76 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.565 1.682 . . . . 0.0 111.469 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.05 140.06 33.9 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.128 2.552 . . . . 0.0 112.53 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 t -114.53 -48.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.713 1.205 . . . . 0.0 112.605 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -153.92 141.14 19.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 111.269 -167.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -129.36 136.34 49.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.91 1.284 . . . . 0.0 112.416 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.7 mm -129.83 142.62 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.964 2.106 . . . . 0.0 109.868 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -113.42 148.99 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.332 1.453 . . . . 0.0 112.363 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.31 175.41 42.78 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.158 0.885 . . . . 0.0 114.239 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.74 148.42 38.56 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -154.19 163.87 39.44 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.601 1.961 . . . . 0.0 112.092 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.48 166.79 32.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.688 1.137 . . . . 0.0 112.642 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -60.88 -32.09 71.55 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.637 1.175 . . . . 0.0 114.131 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.6 91.83 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.225 0.61 . . . . 0.0 111.691 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.23 60.78 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.082 0.953 . . . . 0.0 112.773 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.58 -44.0 65.29 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.266 -0.896 . . . . 0.0 111.295 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.38 -30.32 70.07 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.398 -0.813 . . . . 0.0 112.127 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -68.46 -42.81 78.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.585 1.084 . . . . 0.0 112.505 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.04 -29.45 69.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.445 1.02 . . . . 0.0 112.186 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.77 -44.21 81.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.228 0.467 . . . . 0.0 111.87 168.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.1 m -66.25 -18.96 65.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.819 1.248 . . . . 0.0 112.641 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.06 -18.82 65.62 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.47 148.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.87 1.268 . . . . 0.0 110.888 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.5 t -128.66 133.81 25.59 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.712 1.605 . . . . 0.0 110.14 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.95 165.85 30.48 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.528 2.819 . . . . 0.0 113.009 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -146.31 158.44 43.89 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.45 1.5 . . . . 0.0 110.681 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -73.77 -10.42 59.66 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.735 1.384 . . . . 0.0 114.735 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.361 2.264 . . . . 0.0 110.486 176.7 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tmm? . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.2 p -72.07 -30.6 65.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.448 1.099 . . . . 0.0 113.938 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 60.76 16.45 6.75 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.372 1.869 . . . . 0.0 113.934 -161.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.5 m -79.06 -31.35 44.44 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.013 -1.055 . . . . 0.0 112.707 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -126.85 103.25 7.41 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.078 0.942 . . . . 0.0 110.863 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.72 -173.34 4.49 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.805 2.842 . . . . 0.0 108.435 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.6 m -60.79 113.61 2.58 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.237 1.38 . . . . 0.0 111.443 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -125.5 50.45 1.81 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 130.308 3.443 . . . . 0.0 111.404 -13.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -94.88 152.47 18.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.566 1.546 . . . . 0.0 112.973 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.34 141.96 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.65 1.58 . . . . 0.0 111.431 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -97.95 134.76 40.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.553 1.141 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.21 162.25 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.735 1.214 . . . . 0.0 112.833 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.2 p -123.03 169.77 10.84 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.478 1.911 . . . . 0.0 111.238 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.65 -25.86 60.79 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.096 -1.003 . . . . 0.0 113.264 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.44 -50.67 7.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.54 1.136 . . . . 0.0 113.574 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -80.33 -16.1 55.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -49.28 -42.96 42.62 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.815 1.246 . . . . 0.0 111.632 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.2 94.46 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.507 -0.746 . . . . 0.0 112.281 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 m -72.32 -30.21 64.55 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -94.93 -34.14 12.51 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.93 -49.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.667 1.187 . . . . 0.0 111.562 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.1 mt -88.91 -34.83 16.8 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 m -83.94 3.54 33.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.556 1.142 . . . . 0.0 113.866 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -62.03 151.71 34.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.355 1.062 . . . . 0.0 113.139 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -81.21 -7.31 59.54 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.179 1.392 . . . . 0.0 114.022 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -142.76 167.08 17.17 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.402 1.881 . . . . 0.0 110.64 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -60.98 149.75 87.39 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.69 2.26 . . . . 0.0 112.207 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.1 t -129.66 130.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.723 0.809 . . . . 0.0 112.062 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 132.34 36.84 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.385 1.474 . . . . 0.0 108.627 168.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 129.92 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.15 0.886 . . . . 0.0 110.345 169.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -105.71 114.17 28.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.934 0.894 . . . . 0.0 111.128 171.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -91.9 117.2 29.58 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.529 1.531 . . . . 0.0 109.135 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.39 168.52 23.18 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -168.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.99 51.7 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 155.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.4 p -65.69 -12.29 52.34 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -167.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -105.41 -10.69 16.81 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.487 1.915 . . . . 0.0 114.452 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 145.11 45.76 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.311 0.96 . . . . 0.0 112.294 -173.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.52 -64.33 4.42 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.306 -0.872 . . . . 0.0 113.873 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.21 -28.2 87.08 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.15 2.566 . . . . 0.0 114.05 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.1 m -63.7 -49.67 72.19 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.537 0.735 . . . . 0.0 110.461 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.27 67.51 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.054 -1.029 . . . . 0.0 112.202 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.0 tpp -62.15 -31.71 72.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.27 -12.97 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.371 0.987 . . . . 0.0 113.647 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.5 -50.09 73.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 120.415 1.461 . . . . 0.0 114.176 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.72 -26.55 38.97 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.453 2.102 . . . . 0.0 113.493 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.2 t -69.35 -40.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 120.907 -1.121 . . . . 0.0 110.829 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.54 -40.41 35.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.0 1.32 . . . . 0.0 111.096 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.59 -43.16 46.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.535 1.134 . . . . 0.0 111.481 162.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.05 -51.71 10.6 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.984 -0.447 . . . . 0.0 111.442 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mm -62.0 -38.2 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.542 -0.723 . . . . 0.0 111.111 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.79 85.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.391 0.996 . . . . 0.0 112.43 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -75.53 -36.43 60.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.693 0.678 . . . . 0.0 111.689 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.95 -34.2 11.88 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -114.28 22.51 13.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.533 1.533 . . . . 0.0 113.444 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.37 -26.55 41.87 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -78.97 -22.76 45.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.443 1.097 . . . . 0.0 113.012 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -90.63 -46.76 8.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.264 1.426 . . . . 0.0 111.872 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.84 156.72 38.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.326 1.451 . . . . 0.0 112.272 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.6 m -106.0 143.5 34.05 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.618 1.167 . . . . 0.0 109.794 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.81 128.6 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 110.587 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.29 160.36 25.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.496 1.918 . . . . 0.0 112.297 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -124.75 137.37 54.33 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.94 1.696 . . . . 0.0 111.458 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -125.77 122.64 36.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.977 0.911 . . . . 0.0 110.351 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -93.47 111.82 23.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 110.55 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.09 -16.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.91 -42.85 23.29 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.061 0.944 . . . . 0.0 112.764 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -87.38 -25.5 23.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.02 0.928 . . . . 0.0 113.342 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -127.96 60.5 46.37 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.147 1.379 . . . . 0.0 112.222 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -65.43 -17.35 57.46 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.746 2.297 . . . . 0.0 112.553 172.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.44 -46.29 90.58 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.416 1.086 . . . . 0.0 111.533 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -29.94 67.44 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.198 -1.564 . . . . 0.0 111.714 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.72 78.36 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.255 -0.903 . . . . 0.0 112.752 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -26.11 54.22 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.806 1.184 . . . . 0.0 113.273 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -57.28 -44.86 84.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.906 0.882 . . . . 0.0 111.441 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -107.35 9.05 29.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 47.44 60.04 3.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.943 1.697 . . . . 0.0 112.003 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.5 t -84.5 117.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.045 1.338 . . . . 0.0 110.741 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -147.99 129.46 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.978 2.111 . . . . 0.0 107.114 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -121.98 157.37 31.44 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.881 3.272 . . . . 0.0 110.826 -9.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.8 pt -69.28 145.66 96.08 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -171.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.46 138.96 56.12 Favored 'Cis proline' 0 CA--C 1.538 0.713 0 CA-C-N 118.756 0.592 . . . . 0.0 110.937 -11.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.5 m -112.35 113.87 26.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.955 0.902 . . . . 0.0 108.957 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.23 124.78 46.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.987 1.315 . . . . 0.0 108.457 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -128.76 138.82 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.088 0.955 . . . . 0.0 111.367 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.57 129.89 52.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.099 1.36 . . . . 0.0 111.983 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -109.87 139.67 44.68 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.816 2.047 . . . . 0.0 111.114 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -124.02 122.31 37.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.365 1.866 . . . . 0.0 108.982 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 49.01 32.65 4.03 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.128 1.371 . . . . 0.0 114.38 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.79 18.87 69.22 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.61 147.06 59.12 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-N 119.519 1.659 . . . . 0.0 112.385 161.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.68 146.49 48.94 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.331 2.687 . . . . 0.0 112.016 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.97 -45.42 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.63 133.85 19.45 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -117.8 131.94 56.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.255 2.222 . . . . 0.0 110.002 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.57 140.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.268 1.827 . . . . 0.0 109.603 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.27 146.92 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.929 1.292 . . . . 0.0 112.012 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.83 172.2 45.51 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.247 0.927 . . . . 0.0 113.712 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.09 143.88 47.23 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.46 156.64 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.86 2.064 . . . . 0.0 111.321 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.95 174.92 39.54 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.257 1.408 . . . . 0.0 112.932 -174.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -58.76 -39.97 82.55 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.29 78.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.476 0.711 . . . . 0.0 111.321 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -40.42 74.85 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.778 0.831 . . . . 0.0 112.049 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.66 -42.94 81.41 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.353 -0.842 . . . . 0.0 111.895 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.73 -31.28 71.82 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.676 -0.64 . . . . 0.0 111.928 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -44.78 96.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.127 -0.939 . . . . 0.0 111.685 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.58 -38.05 83.34 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.005 1.275 . . . . 0.0 111.862 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.37 -46.85 78.51 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.491 0.316 . . . . 0.0 111.54 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.3 m -67.71 -24.34 65.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.204 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.99 -10.59 59.99 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.6 t -124.82 -40.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.012 1.725 . . . . 0.0 112.102 -167.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.65 131.16 7.42 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.841 0.856 . . . . 0.0 111.887 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.56 144.56 97.83 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.023 2.482 . . . . 0.0 112.597 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -146.22 177.94 8.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.546 1.139 . . . . 0.0 111.566 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.4 mt -81.73 48.72 1.23 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.114 1.766 . . . . 0.0 111.42 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 125.83 1.652 . . . . 0.0 114.529 -158.151 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.479 0.18 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.3 p -79.72 -17.37 53.72 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.651 1.18 . . . . 0.0 113.967 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -145.63 165.84 27.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.105 1.762 . . . . 0.0 111.012 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.3 p -140.52 -172.26 3.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.818 1.647 . . . . 0.0 112.613 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.5 -10.33 24.9 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.284 1.434 . . . . 0.0 113.991 170.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mttm 62.79 169.57 0.14 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.131 2.573 . . . . 0.0 114.747 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 m -67.16 152.05 46.46 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.922 1.289 . . . . 0.0 112.365 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.37 14.48 29.56 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -168.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -82.22 151.86 26.66 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.085 -1.01 . . . . 0.0 111.319 173.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.7 pt -126.84 171.58 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.135 1.374 . . . . 0.0 112.414 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -125.95 145.42 50.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.493 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.24 159.41 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.537 1.535 . . . . 0.0 112.272 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.7 p -140.19 166.97 23.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.257 2.623 . . . . 0.0 109.935 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.16 -28.06 64.38 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.623 -1.298 . . . . 0.0 114.392 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.08 -24.28 35.3 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -102.51 -27.08 12.99 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 0.0 114.172 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.07 -40.72 58.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.682 1.993 . . . . 0.0 112.457 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.33 -31.4 71.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -83.07 -34.94 26.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.777 0.831 . . . . 0.0 111.798 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.74 -32.94 20.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -109.9 -52.92 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.288 1.435 . . . . 0.0 111.366 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -82.37 -13.38 56.95 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -89.1 1.69 55.22 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.575 1.15 . . . . 0.0 113.009 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -67.15 154.01 42.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.458 1.503 . . . . 0.0 114.946 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -121.06 22.59 10.94 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 126.718 2.007 . . . . 0.0 111.9 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -146.13 168.72 11.03 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 127.956 2.503 . . . . 0.0 111.14 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.19 137.63 52.76 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.71 116.42 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.118 1.367 . . . . 0.0 110.219 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.03 133.81 35.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.754 1.222 . . . . 0.0 109.072 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.9 129.5 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.503 1.047 . . . . 0.0 110.763 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -103.69 128.09 51.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.9 1.28 . . . . 0.0 111.706 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -99.53 116.66 32.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.235 1.414 . . . . 0.0 108.894 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -144.4 167.94 21.28 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.7 176.76 6.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 111.519 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.3 p -68.19 -24.71 64.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -112.88 -13.33 13.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 p -78.19 124.62 28.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -164.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.72 -59.59 10.52 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.795 1.188 . . . . 0.0 114.085 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.27 -27.0 41.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.128 1.964 . . . . 0.0 113.225 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.1 p -72.03 -39.58 69.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.305 0.957 . . . . 0.0 111.686 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -68.93 -29.34 67.56 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.293 -0.879 . . . . 0.0 112.434 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.5 ttp -68.66 -35.93 77.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.703 0.801 . . . . 0.0 113.156 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.73 -24.32 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.566 1.075 . . . . 0.0 113.511 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -45.94 -47.66 41.59 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -64.17 -27.62 64.72 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.96 1.773 . . . . 0.0 113.039 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 t -68.24 -35.87 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.889 1.222 . . . . 0.0 111.229 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 mt -67.98 -48.99 64.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.24 1.016 . . . . 0.0 110.341 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.65 -40.61 72.43 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.661 0.784 . . . . 0.0 110.866 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.16 -51.97 12.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.645 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.5 -39.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.972 1.26 . . . . 0.0 111.361 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.45 96.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.745 0.702 . . . . 0.0 111.604 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.5 m -76.79 -32.48 57.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.06 -22.83 28.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -130.18 27.24 5.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.983 1.313 . . . . 0.0 113.504 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.61 29.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.424 1.49 . . . . 0.0 114.517 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 p -78.11 -18.29 55.86 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.14 1.376 . . . . 0.0 113.737 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -102.01 -40.55 6.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.858 1.263 . . . . 0.0 112.687 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 172.79 12.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.635 1.174 . . . . 0.0 113.674 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -126.19 143.89 50.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.438 1.495 . . . . 0.0 109.779 170.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.8 127.83 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.568 0.699 . . . . 0.0 110.408 168.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.74 164.51 16.47 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.74 2.416 . . . . 0.0 111.722 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 137.96 47.57 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.498 1.119 . . . . 0.0 111.909 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.17 122.34 40.76 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.24 1.416 . . . . 0.0 110.175 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.84 108.63 19.63 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.803 0.841 . . . . 0.0 110.507 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -72.09 -16.65 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.3 -41.14 11.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.541 1.137 . . . . 0.0 112.522 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.7 p -89.43 -22.25 22.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -131.26 72.5 81.15 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.782 1.233 . . . . 0.0 111.793 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -14.59 45.64 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.891 2.394 . . . . 0.0 113.141 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -62.56 -42.87 99.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 112.546 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.0 m -74.18 -31.71 62.79 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.34 0.973 . . . . 0.0 111.711 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.29 94.38 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.658 0.783 . . . . 0.0 111.856 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -77.53 -24.51 49.95 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 168.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -61.28 -46.47 90.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.175 0.898 . . . . 0.0 111.474 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.11 4.25 41.98 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 48.85 62.78 2.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.768 1.627 . . . . 0.0 112.59 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.6 141.92 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 110.652 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.48 -45.03 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.599 1.16 . . . . 0.0 111.951 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -121.67 158.04 29.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.577 1.551 . . . . 0.0 111.287 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.58 130.46 23.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.998 0.919 . . . . 0.0 110.079 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.09 150.5 95.79 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.944 1.016 . . . . 0.0 113.317 -5.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 m -121.1 134.98 55.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.127 1.371 . . . . 0.0 109.12 164.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.73 139.75 45.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.156 1.782 . . . . 0.0 110.145 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 tp -135.03 126.2 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.71 1.204 . . . . 0.0 108.235 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.7 tp -107.06 126.4 52.3 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.978 1.311 . . . . 0.0 109.681 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -107.85 152.37 24.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.969 1.708 . . . . 0.0 110.275 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.202 1.801 . . . . 0.0 108.07 172.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 52.43 32.08 10.72 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 16.83 79.55 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.524 1.535 . . . . 0.0 116.841 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.62 144.14 43.59 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 119.543 1.671 . . . . 0.0 111.776 166.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.45 140.29 39.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.839 2.359 . . . . 0.0 112.2 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.0 m -117.15 -31.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.124 1.37 . . . . 0.0 114.226 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -158.17 142.12 15.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.183 0.993 . . . . 0.0 112.257 -170.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -125.76 136.68 53.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.106 1.763 . . . . 0.0 110.73 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.47 151.89 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.021 1.728 . . . . 0.0 110.295 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.56 147.14 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.492 1.117 . . . . 0.0 111.693 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.07 171.96 48.42 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.478 1.037 . . . . 0.0 113.753 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.8 38.52 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -139.47 152.0 46.65 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.718 2.007 . . . . 0.0 111.341 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.39 169.16 32.76 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.419 1.009 . . . . 0.0 112.022 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.43 -34.46 72.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.93 -42.76 84.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.14 0.576 . . . . 0.0 111.388 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.83 -44.83 72.64 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.582 0.753 . . . . 0.0 111.853 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.36 -43.48 97.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.731 0.813 . . . . 0.0 111.62 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -63.37 -35.75 81.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.406 0.682 . . . . 0.0 111.955 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.2 tpt85 -68.32 -38.25 81.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.201 0.909 . . . . 0.0 112.774 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.83 -39.48 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.444 1.02 . . . . 0.0 111.467 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -42.92 78.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.948 0.499 . . . . 0.0 111.867 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m -66.16 -20.16 66.05 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.061 1.344 . . . . 0.0 112.631 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.78 -19.83 66.03 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.31 146.28 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.099 1.359 . . . . 0.0 110.359 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.15 146.5 51.65 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 126.194 1.798 . . . . 0.0 109.794 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.3 -27.6 63.71 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.8 2.333 . . . . 0.0 114.187 -166.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -88.0 -6.62 57.89 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.417 1.487 . . . . 0.0 114.551 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 tp 52.61 34.97 16.9 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.496 1.918 . . . . 0.0 113.564 -170.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.329 0 C-N-CA 127.702 2.401 . . . . 0.0 113.869 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.4 m -73.65 -33.05 64.32 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.108 0.963 . . . . 0.0 112.706 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -143.9 147.99 34.79 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.22 1.808 . . . . 0.0 109.946 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -59.05 120.85 9.9 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.344 1.058 . . . . 0.0 113.559 -168.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -141.11 33.66 1.73 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.548 1.539 . . . . 0.0 111.404 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -69.5 -20.32 63.72 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.2 m -127.99 140.78 51.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.502 1.921 . . . . 0.0 110.481 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.56 22.11 3.64 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -82.58 155.42 24.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.005 1.322 . . . . 0.0 112.415 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.4 pt -130.75 157.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.2 1.4 . . . . 0.0 111.703 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -103.09 141.74 35.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.85 1.26 . . . . 0.0 110.605 168.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.88 159.44 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.734 1.613 . . . . 0.0 111.359 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.5 p -141.39 168.28 20.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.927 2.491 . . . . 0.0 109.787 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.23 -27.4 34.36 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 120.636 -1.29 . . . . 0.0 113.933 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.76 57.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 p -126.72 -22.1 3.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -172.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -51.18 -41.55 60.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.134 1.773 . . . . 0.0 112.625 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.26 -31.38 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 m -86.07 -29.52 23.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.826 0.85 . . . . 0.0 112.15 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.84 -35.48 14.05 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.77 -55.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.823 1.249 . . . . 0.0 111.282 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.1 mt -80.01 -20.84 44.45 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -92.96 0.78 57.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.735 1.214 . . . . 0.0 113.318 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 t -65.82 143.72 57.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.863 0.865 . . . . 0.0 112.697 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -91.6 3.63 54.56 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.293 1.437 . . . . 0.0 113.044 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -141.62 168.85 12.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.642 1.977 . . . . 0.0 111.294 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.55 144.52 62.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.749 2.299 . . . . 0.0 114.092 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.43 129.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.704 1.202 . . . . 0.0 109.956 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.81 135.66 34.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 164.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.3 t -119.88 125.13 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 118.542 0.61 . . . . 0.0 110.078 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -107.34 113.73 27.3 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.535 1.134 . . . . 0.0 112.245 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -86.21 115.04 23.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.798 2.039 . . . . 0.0 109.102 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.54 172.03 15.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -167.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.75 146.39 50.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.611 1.165 . . . . 0.0 110.438 159.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.0 p -72.38 -14.96 61.84 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -93.66 -9.63 37.25 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.909 1.684 . . . . 0.0 114.032 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 135.22 36.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.373 1.069 . . . . 0.0 111.504 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.23 -65.24 3.66 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.831 1.205 . . . . 0.0 114.643 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.06 -25.87 65.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.376 2.05 . . . . 0.0 112.634 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.6 m -63.36 -45.7 89.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.833 0.853 . . . . 0.0 111.672 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -69.06 -32.83 72.58 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -66.65 -35.19 79.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.345 1.058 . . . . 0.0 113.561 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 m -77.84 -25.19 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.646 1.112 . . . . 0.0 113.684 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.92 -43.48 75.4 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.24 -36.48 87.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.541 2.161 . . . . 0.0 112.954 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.64 -37.03 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.137 0.975 . . . . 0.0 110.926 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.67 -49.69 51.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.521 1.128 . . . . 0.0 110.278 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.88 -40.8 76.89 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.36 0.664 . . . . 0.0 110.859 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -76.42 -48.82 18.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.074 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.49 -39.82 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 110.825 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.07 96.62 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 0.994 . . . . 0.0 111.628 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 m -77.82 -33.63 52.31 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.29 -30.51 23.69 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.235 -0.915 . . . . 0.0 113.054 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -118.45 26.52 9.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.248 1.819 . . . . 0.0 112.174 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.68 33.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.352 1.461 . . . . 0.0 114.195 -176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 p -76.89 -18.18 58.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.235 1.414 . . . . 0.0 113.671 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -101.4 -39.54 7.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.477 1.511 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.03 167.24 29.07 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -120.03 138.87 53.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.313 1.445 . . . . 0.0 109.737 166.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.43 127.6 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.177 0.591 . . . . 0.0 109.768 169.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.93 158.76 22.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.482 1.913 . . . . 0.0 111.585 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.21 131.41 54.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.196 1.398 . . . . 0.0 110.599 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.7 120.63 42.68 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.261 0.553 . . . . 0.0 109.582 164.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -94.67 97.25 9.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.091 0.957 . . . . 0.0 109.619 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.55 -19.41 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.186 -0.946 . . . . 0.0 112.37 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.93 -23.26 60.66 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.262 1.425 . . . . 0.0 114.056 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.0 p -127.2 -22.92 3.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -144.66 76.23 14.29 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.897 1.279 . . . . 0.0 111.134 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.6 -3.81 13.33 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.401 2.734 . . . . 0.0 113.9 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.25 -42.58 95.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.426 1.09 . . . . 0.0 113.051 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -27.17 52.7 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.9 94.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 111.796 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -76.75 -28.59 55.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -58.43 -44.29 89.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 112.069 172.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.68 7.36 46.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.939 1.296 . . . . 0.0 113.718 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 50.9 49.02 21.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.087 1.755 . . . . 0.0 113.246 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.04 123.32 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.504 1.121 . . . . 0.0 109.985 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.64 -23.92 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 t -135.5 165.69 24.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.256 1.422 . . . . 0.0 111.877 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.65 143.5 46.8 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.968 1.307 . . . . 0.0 111.745 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.7 147.37 86.49 Favored 'Cis proline' 0 CA--C 1.54 0.806 0 CA-C-N 119.431 0.833 . . . . 0.0 111.523 -8.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.2 m -133.04 122.22 23.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.216 1.006 . . . . 0.0 109.842 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.71 137.42 44.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.934 1.294 . . . . 0.0 109.75 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.34 132.83 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.114 0.966 . . . . 0.0 109.767 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -114.09 119.79 38.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.105 1.362 . . . . 0.0 111.307 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -101.55 146.68 27.35 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.874 2.07 . . . . 0.0 110.357 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -98.99 -41.17 7.69 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.696 0.798 . . . . 0.0 113.094 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -149.92 53.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.272 1.429 . . . . 0.0 110.422 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.96 15.96 63.38 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.491 1.043 . . . . 0.0 113.667 -168.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.68 126.81 22.8 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.969 2.108 . . . . 0.0 109.161 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.74 143.64 27.02 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.567 2.844 . . . . 0.0 112.754 -170.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.35 -46.6 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.45 1.1 . . . . 0.0 112.418 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -151.05 156.29 40.79 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -121.71 137.55 54.71 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.741 2.016 . . . . 0.0 110.126 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 127.85 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.352 1.461 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.2 157.71 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.525 1.13 . . . . 0.0 112.126 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.15 177.72 40.68 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.655 1.121 . . . . 0.0 113.818 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.33 155.71 38.25 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.24 151.85 50.12 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.606 1.962 . . . . 0.0 111.288 167.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.52 170.98 37.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.7 1.143 . . . . 0.0 111.332 161.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -55.28 -39.13 69.48 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.841 . . . . 0.0 113.028 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.65 85.01 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.398 0.679 . . . . 0.0 112.09 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.82 78.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.353 0.661 . . . . 0.0 111.696 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.2 -39.07 89.39 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.201 -0.937 . . . . 0.0 111.782 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.02 -30.63 69.05 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.328 1.051 . . . . 0.0 112.657 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -62.06 -47.6 83.98 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.691 1.132 . . . . 0.0 111.143 168.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -59.17 -41.58 88.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.121 0.873 . . . . 0.0 111.903 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.0 -41.95 97.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.137 0.575 . . . . 0.0 112.471 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.2 m -67.4 -25.1 65.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 112.465 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -75.96 0.05 19.8 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.15 0.98 . . . . 0.0 113.392 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t -125.59 -39.42 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.92 1.688 . . . . 0.0 112.523 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.9 140.78 38.73 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 124.733 1.213 . . . . 0.0 111.707 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.71 158.05 84.71 Favored 'Cis proline' 0 CA--C 1.541 0.831 0 CA-C-N 120.188 1.103 . . . . 0.0 113.823 0.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.85 -16.74 64.23 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -161.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -76.82 -4.6 44.39 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.3 1.44 . . . . 0.0 111.705 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.4 m -63.89 142.06 58.54 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.407 1.083 . . . . 0.0 111.578 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.39 144.58 46.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.304 1.041 . . . . 0.0 112.942 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.1 p 53.92 19.72 2.09 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.387 1.875 . . . . 0.0 115.506 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 56.27 27.59 12.03 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.872 1.669 . . . . 0.0 113.752 -171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -65.64 156.53 32.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.289 1.436 . . . . 0.0 111.562 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.6 m -59.96 145.05 47.49 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.649 0.779 . . . . 0.0 110.862 165.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.06 29.89 0.27 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -172.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p -94.15 159.12 15.29 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 0.0 112.862 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.73 164.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.197 1.399 . . . . 0.0 110.941 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.95 143.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.753 1.221 . . . . 0.0 110.923 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.51 156.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.661 1.584 . . . . 0.0 112.283 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.3 p -117.72 174.33 6.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.333 2.253 . . . . 0.0 110.332 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.07 -29.77 45.62 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.94 -47.45 11.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.036 0.934 . . . . 0.0 113.262 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.79 -12.35 55.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.99 -46.24 43.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.714 1.205 . . . . 0.0 112.666 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.47 -31.32 69.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.3 m -89.31 -19.94 24.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.88 1.272 . . . . 0.0 113.223 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -122.01 -21.92 5.84 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.92 -37.23 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.511 1.505 . . . . 0.0 114.406 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.33 -11.42 60.05 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.059 1.3 . . . . 0.0 113.389 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.9 p -76.9 -7.56 55.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.453 1.501 . . . . 0.0 114.111 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 84.1 p -67.69 160.13 28.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.721 . . . . 0.0 114.883 -171.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.12 16.03 5.11 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.117 1.767 . . . . 0.0 112.536 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -142.43 173.03 5.03 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 128.282 2.633 . . . . 0.0 109.533 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -61.06 140.12 88.02 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.141 1.894 . . . . 0.0 113.383 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.02 114.93 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.078 1.351 . . . . 0.0 110.75 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.84 117.01 23.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -105.76 124.01 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.849 0.75 . . . . 0.0 109.873 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -101.64 117.06 34.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.869 1.268 . . . . 0.0 110.531 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.19 115.0 26.74 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.099 1.759 . . . . 0.0 109.351 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -148.1 168.04 23.44 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.6 170.41 7.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.183 0.993 . . . . 0.0 111.107 166.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -76.64 -6.17 50.93 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -129.41 -2.72 4.93 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -165.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 p -80.5 136.6 36.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.709 1.141 . . . . 0.0 113.981 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -62.93 5.32 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.805 1.193 . . . . 0.0 114.458 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.71 -23.18 42.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.37 2.046 . . . . 0.0 112.873 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.43 -40.06 58.13 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -68.29 -32.58 72.83 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.093 -1.004 . . . . 0.0 112.05 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.7 -32.3 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.791 0.836 . . . . 0.0 113.025 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.37 -5.5 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -53.52 52.3 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 120.269 1.395 . . . . 0.0 113.461 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 -33.48 48.56 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.627 1.551 . . . . 0.0 112.31 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.38 -52.01 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.1 0.864 . . . . 0.0 111.317 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -67.81 -36.7 80.88 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.902 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.8 -34.19 71.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.61 -46.02 77.23 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.261 -0.9 . . . . 0.0 111.321 171.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -56.7 -43.73 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.674 1.579 . . . . 0.0 110.973 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.81 -45.58 85.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.729 0.412 . . . . 0.0 111.761 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.6 m -79.08 -29.85 43.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.389 1.076 . . . . 0.0 112.262 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -87.2 -23.05 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -129.4 24.96 5.48 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.34 -30.63 29.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.254 1.422 . . . . 0.0 114.712 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -77.5 -18.45 57.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.245 1.418 . . . . 0.0 113.933 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -104.3 -37.88 7.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.144 1.378 . . . . 0.0 112.726 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.61 173.79 12.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.092 1.357 . . . . 0.0 113.017 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.8 m -122.21 153.78 38.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.43 1.492 . . . . 0.0 109.939 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -124.19 138.03 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.68 0.792 . . . . 0.0 109.58 168.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.38 160.36 38.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.097 1.759 . . . . 0.0 112.007 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -125.83 138.26 53.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.218 1.007 . . . . 0.0 112.697 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -119.39 125.59 49.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.934 1.694 . . . . 0.0 109.37 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.14 93.17 7.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.024 0.93 . . . . 0.0 110.519 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.02 -23.34 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.364 1.065 . . . . 0.0 113.152 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.09 -27.89 69.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.806 1.242 . . . . 0.0 112.368 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.7 p -119.46 -11.17 9.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.836 1.654 . . . . 0.0 113.844 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -127.07 56.82 19.59 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.839 1.656 . . . . 0.0 112.594 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.39 -13.37 33.02 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.178 2.586 . . . . 0.0 113.874 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.31 -30.7 60.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.378 1.071 . . . . 0.0 112.437 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -33.94 58.07 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.189 0.996 . . . . 0.0 112.559 165.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.07 95.89 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.838 0.744 . . . . 0.0 112.324 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -76.31 -23.43 54.31 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.3 -43.06 98.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.537 0.735 . . . . 0.0 111.851 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.41 11.98 35.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.479 1.512 . . . . 0.0 114.061 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 52.54 60.23 3.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.235 1.814 . . . . 0.0 113.056 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.5 t -66.11 126.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.915 0.886 . . . . 0.0 109.373 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.9 m -129.21 -30.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.002 1.321 . . . . 0.0 112.704 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -131.23 147.72 52.62 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.474 1.91 . . . . 0.0 109.358 167.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 pt -111.73 129.88 23.73 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.301 1.04 . . . . 0.0 110.145 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.63 143.39 77.38 Favored 'Cis proline' 0 CA--C 1.54 0.805 0 CA-C-N 119.649 0.91 . . . . 0.0 112.711 1.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.58 133.23 46.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.556 1.142 . . . . 0.0 108.036 161.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.39 126.15 51.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.7 1.2 . . . . 0.0 108.621 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.68 126.86 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 121.478 -0.764 . . . . 0.0 109.954 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.24 117.55 35.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.923 1.289 . . . . 0.0 110.399 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -94.14 158.33 15.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.868 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -142.54 135.39 28.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.749 1.619 . . . . 0.0 108.63 158.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.56 37.48 23.25 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.803 0.841 . . . . 0.0 113.093 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.19 16.65 67.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.508 2.004 . . . . 0.0 115.223 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -123.52 138.22 29.84 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.947 1.299 . . . . 0.0 110.973 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.42 139.85 32.39 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.914 2.409 . . . . 0.0 112.62 -173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -116.07 -42.83 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.664 1.586 . . . . 0.0 112.304 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -150.76 147.23 27.06 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.777 1.231 . . . . 0.0 112.597 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -125.21 137.11 54.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.854 2.062 . . . . 0.0 111.092 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.64 159.78 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 127.103 2.161 . . . . 0.0 110.874 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.6 153.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 111.527 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.45 169.36 25.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.637 1.113 . . . . 0.0 113.414 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 154.92 38.26 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.57 156.39 48.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.665 1.986 . . . . 0.0 110.923 168.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.99 162.63 42.85 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -57.33 -34.41 68.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.248 1.019 . . . . 0.0 113.645 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.36 77.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.856 0.463 . . . . 0.0 111.584 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.44 -50.09 64.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.685 0.794 . . . . 0.0 111.736 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.3 tp -61.61 -40.64 95.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.689 -0.632 . . . . 0.0 111.673 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.19 -40.22 95.34 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.106 0.866 . . . . 0.0 111.871 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -49.85 76.0 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.359 0.982 . . . . 0.0 110.662 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -63.19 -30.05 71.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -39.73 26.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 112.13 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.1 m -67.52 -18.11 64.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.8 1.64 . . . . 0.0 112.835 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.89 -16.02 15.49 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.09 1.356 . . . . 0.0 113.57 167.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 t -117.83 147.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 127.004 2.122 . . . . 0.0 109.913 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.66 148.1 85.01 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.321 1.048 . . . . 0.0 112.227 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.96 142.04 65.88 Favored 'Cis proline' 0 CA--C 1.541 0.84 0 CA-C-N 120.171 1.097 . . . . 0.0 113.468 0.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -151.67 139.0 19.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.896 1.679 . . . . 0.0 109.492 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 tp -81.01 -24.63 37.81 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.029 1.332 . . . . 0.0 113.568 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.646 1.179 . . . . 0.0 113.454 -174.111 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.575 0.226 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.6 p -76.27 158.45 31.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.659 1.184 . . . . 0.0 112.6 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -145.9 139.42 26.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.141 1.376 . . . . 0.0 111.369 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.0 p -158.28 -47.12 0.06 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.732 1.213 . . . . 0.0 112.742 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -144.81 143.79 30.81 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.777 2.031 . . . . 0.0 110.097 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.66 156.64 17.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.724 1.609 . . . . 0.0 111.918 177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.5 p -71.77 159.64 33.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.797 1.239 . . . . 0.0 112.586 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.4 19.71 20.12 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -171.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -87.71 151.96 22.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.107 0.963 . . . . 0.0 111.83 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.36 170.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.398 1.479 . . . . 0.0 112.08 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -128.69 149.6 50.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.21 1.004 . . . . 0.0 112.274 165.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.33 156.56 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.5 p -139.07 159.56 41.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.644 1.978 . . . . 0.0 110.166 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.9 -27.94 68.53 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -164.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.98 -23.08 60.6 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.8 m -111.46 -19.87 12.42 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 0.0 113.46 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -49.36 -39.46 31.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 112.966 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.09 71.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.5 m -84.7 -33.87 23.06 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.613 -0.679 . . . . 0.0 111.751 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -80.85 -42.37 21.67 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.63 -52.48 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.538 1.535 . . . . 0.0 110.956 -174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -80.3 -12.37 59.61 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 t -98.81 5.2 47.59 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.605 1.162 . . . . 0.0 113.353 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -67.11 152.11 46.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.497 1.519 . . . . 0.0 114.598 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.83 28.5 8.74 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.993 1.717 . . . . 0.0 111.022 171.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -153.06 169.33 9.88 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 128.267 2.627 . . . . 0.0 110.236 -175.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.23 144.84 87.66 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.073 1.848 . . . . 0.0 111.484 161.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.8 118.66 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.029 . . . . 0.0 109.597 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.25 112.72 25.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.948 1.299 . . . . 0.0 108.753 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.1 124.24 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.377 0.99 . . . . 0.0 110.667 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -97.54 112.7 24.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 111.429 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -85.55 111.14 19.75 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.747 1.619 . . . . 0.0 108.188 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.85 178.92 8.46 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -162.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.13 144.47 45.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.525 0.73 . . . . 0.0 110.364 159.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.9 p -67.37 -23.26 65.57 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -85.23 -9.58 57.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.361 1.464 . . . . 0.0 114.245 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 135.38 36.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.011 0.924 . . . . 0.0 111.48 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -62.95 5.63 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.742 1.163 . . . . 0.0 114.546 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.4 -21.02 61.3 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.342 2.028 . . . . 0.0 113.149 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.4 m -68.03 -49.63 60.25 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.937 0.789 . . . . 0.0 110.991 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.85 -32.97 74.66 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.108 -0.995 . . . . 0.0 112.03 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.51 -35.22 73.74 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.212 1.005 . . . . 0.0 113.108 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.63 -7.54 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.76 63.22 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 120.406 1.457 . . . . 0.0 114.15 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.23 -35.81 30.96 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.496 1.464 . . . . 0.0 112.012 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.83 -48.94 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.917 0.887 . . . . 0.0 111.469 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.17 -39.11 82.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.344 0.657 . . . . 0.0 110.756 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.8 -45.38 94.09 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.399 0.545 . . . . 0.0 112.075 173.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.92 -47.53 68.5 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.345 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -62.05 -35.21 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.999 1.727 . . . . 0.0 111.949 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.15 -43.95 92.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.547 1.067 . . . . 0.0 111.606 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.0 m -81.1 -30.09 34.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.889 0.876 . . . . 0.0 112.604 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -79.75 -15.57 57.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.365 1.066 . . . . 0.0 113.733 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.64 24.22 3.14 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.359 1.464 . . . . 0.0 114.122 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.41 -29.57 49.47 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -17.99 43.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.289 1.436 . . . . 0.0 113.688 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -101.66 -41.41 6.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.081 1.352 . . . . 0.0 112.698 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 176.46 10.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.911 1.684 . . . . 0.0 112.864 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -129.36 142.64 50.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 110.407 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.16 132.27 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.533 0.733 . . . . 0.0 109.84 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.05 162.65 30.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.204 2.202 . . . . 0.0 112.214 -164.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -127.59 139.65 52.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.234 1.413 . . . . 0.0 112.676 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.55 124.27 39.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.616 1.566 . . . . 0.0 109.766 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -89.62 97.46 11.21 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.157 0.983 . . . . 0.0 110.149 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.5 -25.15 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.984 -1.073 . . . . 0.0 112.559 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.18 -21.09 43.4 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.707 1.603 . . . . 0.0 113.845 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.0 p -125.89 -17.08 5.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -131.01 79.0 72.34 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.226 1.01 . . . . 0.0 111.542 163.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.27 -13.47 36.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.436 2.757 . . . . 0.0 114.496 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -58.09 -40.57 81.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.77 1.228 . . . . 0.0 112.821 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -81.52 -30.66 33.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.85 -1.156 . . . . 0.0 112.07 172.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.0 87.57 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.361 -0.837 . . . . 0.0 111.958 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 54.99 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.055 0.942 . . . . 0.0 113.5 169.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -64.36 -44.57 91.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.982 0.81 . . . . 0.0 111.084 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.78 4.27 37.73 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.973 1.309 . . . . 0.0 114.481 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 50.59 49.54 20.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.97 1.708 . . . . 0.0 113.093 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.72 134.63 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.807 0.843 . . . . 0.0 111.598 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.09 -40.04 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.353 1.061 . . . . 0.0 112.768 -170.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -142.27 168.39 19.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.227 1.411 . . . . 0.0 111.717 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.0 pt -130.76 146.18 60.85 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.822 1.249 . . . . 0.0 112.697 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.18 143.03 75.88 Favored 'Cis proline' 0 CA--C 1.54 0.79 0 CA-C-N 118.976 0.67 . . . . 0.0 111.423 -8.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.1 m -121.99 118.26 28.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.203 1.001 . . . . 0.0 108.665 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -105.65 129.5 53.88 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.142 0.977 . . . . 0.0 109.53 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.59 126.7 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.547 1.139 . . . . 0.0 109.833 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -105.19 119.75 39.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.127 1.371 . . . . 0.0 111.042 -173.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -97.08 154.73 17.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.158 1.783 . . . . 0.0 110.927 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -130.89 109.16 10.35 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.333 1.853 . . . . 0.0 109.386 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 52.97 37.74 25.36 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.211 1.004 . . . . 0.0 112.906 -174.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.06 11.65 82.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.307 1.432 . . . . 0.0 116.5 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -113.7 138.09 22.51 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 119.601 1.701 . . . . 0.0 111.507 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.57 139.55 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.74 -43.13 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.403 1.081 . . . . 0.0 112.661 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -149.46 141.12 23.51 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.835 1.254 . . . . 0.0 111.463 -165.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -129.17 138.28 51.65 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.284 1.434 . . . . 0.0 111.662 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.4 151.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 111.665 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.4 147.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.049 1.339 . . . . 0.0 111.225 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.23 168.11 42.65 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.819 1.676 . . . . 0.0 113.389 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.52 156.39 35.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.97 158.07 45.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.724 2.01 . . . . 0.0 111.197 169.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.82 170.27 41.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.026 0.822 . . . . 0.0 111.179 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.77 -39.81 71.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.55 -46.75 78.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.09 0.556 . . . . 0.0 111.575 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.31 76.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.324 0.65 . . . . 0.0 111.818 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.92 -40.04 95.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.203 0.601 . . . . 0.0 112.113 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.97 -30.12 68.48 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.64 -0.663 . . . . 0.0 112.269 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -36.8 70.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.864 1.211 . . . . 0.0 112.47 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.9 -35.89 79.69 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.508 -0.745 . . . . 0.0 111.847 168.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.59 -38.2 83.67 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -68.31 -21.11 64.79 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.412 1.085 . . . . 0.0 112.572 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -68.51 -10.66 57.05 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.74 -38.09 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.93 1.692 . . . . 0.0 112.704 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.02 152.15 75.23 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 125.866 1.666 . . . . 0.0 112.417 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.76 39.96 0.81 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 124.086 3.191 . . . . 0.0 115.166 -169.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -56.21 -32.26 64.25 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.512 -1.367 . . . . 0.0 112.823 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -77.43 -2.89 37.51 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.676 1.59 . . . . 0.0 111.772 -176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttm . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 p -74.19 156.79 36.93 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.676 1.19 . . . . 0.0 113.01 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -74.04 153.87 39.49 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.255 1.022 . . . . 0.0 112.605 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.1 p -149.13 170.02 19.36 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.02 1.328 . . . . 0.0 112.446 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.43 5.03 28.86 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.66 1.184 . . . . 0.0 113.571 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -69.8 148.37 49.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.978 1.311 . . . . 0.0 112.451 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.8 m -66.39 146.17 54.87 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.665 1.186 . . . . 0.0 112.7 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.14 22.05 14.73 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 p -94.22 160.84 14.51 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.204 -0.935 . . . . 0.0 112.143 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 pt -119.45 173.44 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.942 1.297 . . . . 0.0 111.46 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -127.81 139.4 52.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.771 1.628 . . . . 0.0 109.654 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.88 160.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.787 1.235 . . . . 0.0 112.795 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.8 p -124.47 166.61 15.72 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.296 2.638 . . . . 0.0 110.136 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -25.83 63.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.15 17.74 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.572 1.149 . . . . 0.0 113.07 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -80.34 -18.35 49.35 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.92 -41.72 25.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.917 2.087 . . . . 0.0 112.98 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.25 71.35 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.057 -1.027 . . . . 0.0 113.626 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -92.47 -19.0 22.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.378 1.471 . . . . 0.0 113.071 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -116.13 -25.47 7.61 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.11 -54.93 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.511 1.124 . . . . 0.0 111.422 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.8 mt -71.66 -16.94 62.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.4 p -75.33 -16.91 60.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.763 1.625 . . . . 0.0 114.505 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -72.0 149.14 45.24 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -165.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.62 -0.03 57.25 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.508 1.523 . . . . 0.0 113.796 172.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.94 167.25 20.91 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.019 2.127 . . . . 0.0 110.978 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.06 147.12 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.802 2.334 . . . . 0.0 114.311 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.3 t -133.5 125.58 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.797 0.839 . . . . 0.0 111.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.46 129.09 35.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.054 . . . . 0.0 108.802 172.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.49 127.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.321 1.048 . . . . 0.0 109.287 166.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -104.23 123.86 48.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.379 0.672 . . . . 0.0 111.409 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -87.1 112.81 22.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.258 1.023 . . . . 0.0 109.317 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.34 174.12 12.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -168.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.77 174.72 8.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.396 1.478 . . . . 0.0 111.206 171.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.1 p -75.93 -10.49 59.46 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -124.39 -5.05 7.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -164.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.55 132.39 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.597 1.089 . . . . 0.0 113.886 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -58.99 11.32 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.719 1.152 . . . . 0.0 114.284 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.87 -23.89 40.75 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 119.982 1.891 . . . . 0.0 113.041 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.9 -34.71 59.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.024 -1.047 . . . . 0.0 111.788 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -67.12 -32.32 73.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.821 0.848 . . . . 0.0 112.131 166.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.0 ttt -64.42 -35.37 80.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 174.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.42 -11.45 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.65 85.4 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.14 -30.99 37.35 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.467 1.56 . . . . 0.0 112.643 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.6 -47.82 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.253 0.933 . . . . 0.0 111.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.14 -35.27 73.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.258 1.023 . . . . 0.0 111.47 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.87 -45.26 90.23 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.061 0.846 . . . . 0.0 112.324 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.14 -45.87 79.52 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.933 -0.479 . . . . 0.0 110.756 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mm -61.28 -38.38 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.659 1.118 . . . . 0.0 111.881 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.63 92.89 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.619 1.1 . . . . 0.0 112.264 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.5 m -79.02 -33.27 45.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.859 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.92 -33.42 15.61 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -113.27 26.4 10.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.622 1.569 . . . . 0.0 113.101 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -25.88 53.67 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -73.2 -29.9 63.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.593 1.157 . . . . 0.0 112.153 173.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -90.71 -38.22 13.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.271 1.428 . . . . 0.0 113.008 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.11 173.05 13.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -110.9 146.87 35.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.782 1.633 . . . . 0.0 109.363 157.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.58 129.57 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.387 -0.821 . . . . 0.0 110.251 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.84 161.14 29.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.261 2.225 . . . . 0.0 111.295 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -131.76 142.95 49.9 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.433 0.693 . . . . 0.0 111.614 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.21 127.52 56.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.297 1.839 . . . . 0.0 109.599 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -96.04 97.25 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.485 1.114 . . . . 0.0 111.825 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.94 -16.0 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.2 -25.2 61.57 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.623 0.769 . . . . 0.0 112.538 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.8 p -126.67 -23.16 3.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -146.74 67.58 11.37 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.035 1.334 . . . . 0.0 111.977 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.34 2.86 5.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.014 3.143 . . . . 0.0 114.75 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -61.79 -39.73 92.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.842 -1.161 . . . . 0.0 113.59 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.34 -28.66 53.14 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 113.863 170.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.64 88.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.873 1.215 . . . . 0.0 112.117 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -75.51 -27.26 58.69 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.097 -1.002 . . . . 0.0 113.328 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -59.73 -41.82 91.75 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.21 0.914 . . . . 0.0 111.938 171.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -96.65 19.17 12.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.506 1.522 . . . . 0.0 113.597 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 52.59 42.52 31.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.451 2.301 . . . . 0.0 114.637 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.85 124.07 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.668 1.187 . . . . 0.0 110.59 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.88 -40.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.072 0.949 . . . . 0.0 111.418 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -147.88 161.74 40.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.615 1.566 . . . . 0.0 111.026 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.5 pt -109.01 142.39 25.42 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.746 1.218 . . . . 0.0 111.688 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.87 154.03 99.42 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.545 0.873 . . . . 0.0 112.535 -0.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -133.88 120.92 21.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.868 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.12 134.16 38.15 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.963 1.305 . . . . 0.0 109.0 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.6 131.19 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.411 1.084 . . . . 0.0 109.111 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.7 tp -108.18 116.4 31.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.845 1.258 . . . . 0.0 110.476 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.87 157.37 16.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.233 1.813 . . . . 0.0 111.514 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -144.75 131.56 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.493 1.917 . . . . 0.0 109.45 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.6 t70 50.0 32.99 6.19 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.27 16.21 80.73 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.876 1.227 . . . . 0.0 115.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -117.1 152.22 48.61 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.209 1.504 . . . . 0.0 111.638 164.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.1 150.43 77.31 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.293 1.996 . . . . 0.0 111.301 168.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.02 -42.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.258 1.023 . . . . 0.0 112.37 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -142.19 146.08 34.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.808 1.243 . . . . 0.0 112.32 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -129.44 130.35 45.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.533 1.533 . . . . 0.0 110.557 166.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -129.81 123.88 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.83 1.652 . . . . 0.0 109.777 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 148.06 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.687 1.195 . . . . 0.0 111.873 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.92 172.62 39.53 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.495 1.045 . . . . 0.0 114.333 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 149.8 42.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -151.48 162.02 41.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.308 1.843 . . . . 0.0 112.513 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.94 166.67 31.32 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.797 1.189 . . . . 0.0 112.547 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -59.89 -31.64 69.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.9 97.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.216 0.606 . . . . 0.0 111.868 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.65 -30.72 56.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.954 0.902 . . . . 0.0 113.199 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.65 -42.88 73.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.33 -0.856 . . . . 0.0 110.793 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.1 tp -67.88 -33.47 74.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.473 -0.767 . . . . 0.0 112.391 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.57 -50.11 70.75 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.566 1.075 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -64.28 -29.34 70.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.164 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.9 tp -67.74 -47.18 70.02 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.764 0.826 . . . . 0.0 113.194 171.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 m -68.89 -20.43 64.25 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.446 0.698 . . . . 0.0 112.385 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.75 -9.19 58.32 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.6 -42.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.588 1.555 . . . . 0.0 112.79 -166.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.33 142.07 97.58 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 118.99 0.814 . . . . 0.0 112.517 -175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.26 155.81 43.92 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.12 2.547 . . . . 0.0 114.04 175.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -144.6 136.14 25.57 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.465 1.506 . . . . 0.0 110.488 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.3 tp -86.67 -19.34 29.38 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.26 1.424 . . . . 0.0 113.354 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.403 0 C-N-CA 125.655 1.582 . . . . 0.0 112.016 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 111.409 0.152 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 p -78.66 -22.56 46.62 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.8 t70 52.09 -102.31 0.13 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.77 2.028 . . . . 0.0 113.963 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.1 t -154.02 166.44 33.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.652 1.581 . . . . 0.0 111.615 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -78.84 69.55 5.03 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.481 1.512 . . . . 0.0 111.679 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -73.8 162.48 29.08 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.636 1.574 . . . . 0.0 112.805 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 p -68.79 134.66 50.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.361 1.464 . . . . 0.0 112.674 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.45 69.38 8.96 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.914 0.886 . . . . 0.0 111.148 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -124.87 152.33 44.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.202 1.401 . . . . 0.0 112.585 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -132.3 166.85 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.027 1.731 . . . . 0.0 111.905 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -116.42 139.36 50.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.795 1.638 . . . . 0.0 109.837 168.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.64 158.54 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.559 1.544 . . . . 0.0 112.041 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.2 p -143.53 162.71 35.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.028 1.731 . . . . 0.0 111.748 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.14 -28.15 62.49 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.59 -18.15 49.15 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.401 1.08 . . . . 0.0 113.835 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -124.06 -10.0 7.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 114.351 -171.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -53.16 -41.07 64.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.714 1.606 . . . . 0.0 112.959 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.47 72.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -84.58 -26.67 27.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.136 1.375 . . . . 0.0 112.437 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -92.86 -44.78 8.3 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -98.96 -55.18 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.009 1.324 . . . . 0.0 111.083 -175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.2 mt -78.14 -11.99 59.96 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.9 p -71.56 -17.24 62.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.23 1.412 . . . . 0.0 113.627 172.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -83.08 123.29 29.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.565 1.546 . . . . 0.0 111.833 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -78.7 -24.43 45.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.231 1.012 . . . . 0.0 112.701 171.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -82.51 166.73 34.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.589 1.556 . . . . 0.0 110.479 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.87 144.94 99.38 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.297 1.998 . . . . 0.0 112.722 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.6 t -132.17 124.99 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.074 0.949 . . . . 0.0 110.412 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 132.03 36.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 169.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.1 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 0.854 . . . . 0.0 110.418 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.73 118.34 36.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.031 1.333 . . . . 0.0 111.559 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.2 112.56 24.26 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.631 1.573 . . . . 0.0 109.203 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 170.19 19.02 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -163.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.88 -167.54 1.82 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.907 1.683 . . . . 0.0 109.672 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -98.83 -20.16 17.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -86.44 -22.36 26.56 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.98 132.81 35.41 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.247 1.019 . . . . 0.0 113.018 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.16 -59.02 11.4 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.39 0.995 . . . . 0.0 114.213 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.33 -25.06 36.58 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.269 1.979 . . . . 0.0 113.406 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.51 -32.91 54.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.359 -0.838 . . . . 0.0 112.088 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -70.51 -36.57 73.85 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 111.589 169.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.1 ttt -60.49 -31.94 70.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.671 1.188 . . . . 0.0 113.762 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.91 -5.91 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -52.73 70.28 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.811 1.187 . . . . 0.0 113.963 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.02 -33.32 74.49 Favored 'Trans proline' 0 C--N 1.353 0.805 0 CA-C-N 121.421 1.543 . . . . 0.0 112.423 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.31 -49.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.811 0.844 . . . . 0.0 111.792 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.51 -37.03 84.17 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.386 0.539 . . . . 0.0 111.176 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.92 -38.53 83.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.028 0.831 . . . . 0.0 112.25 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.05 -48.03 69.52 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.295 -0.878 . . . . 0.0 111.819 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mm -59.49 -41.6 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.545 1.52 . . . . 0.0 111.001 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.52 71.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.356 0.662 . . . . 0.0 112.684 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.3 m -76.73 -42.95 39.33 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.088 -1.007 . . . . 0.0 111.2 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.43 -36.06 17.93 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -166.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -114.75 21.64 14.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.926 1.29 . . . . 0.0 113.601 -171.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.2 41.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.353 1.461 . . . . 0.0 114.589 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 p -80.95 -18.28 47.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.479 1.512 . . . . 0.0 113.657 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -101.75 -39.54 7.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.071 1.348 . . . . 0.0 112.784 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.9 169.21 21.68 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.891 1.276 . . . . 0.0 113.676 -176.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -110.54 142.26 42.58 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.465 1.506 . . . . 0.0 110.09 171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.28 119.31 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.531 169.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.77 163.33 16.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.838 2.055 . . . . 0.0 111.535 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.75 137.92 47.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.594 0.758 . . . . 0.0 112.049 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.61 123.44 46.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.845 1.258 . . . . 0.0 109.443 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -91.49 108.74 20.1 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.998 0.919 . . . . 0.0 109.447 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 m -70.86 -16.23 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -87.95 -41.24 13.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.271 1.028 . . . . 0.0 112.671 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -87.35 -22.29 25.17 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -139.99 69.6 35.58 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.568 1.147 . . . . 0.0 112.644 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.43 -14.83 46.96 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.249 2.632 . . . . 0.0 113.829 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -64.98 -34.9 79.55 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.059 -1.026 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -80.2 -30.31 38.69 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.476 -0.765 . . . . 0.0 112.051 169.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.51 80.91 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.627 -1.296 . . . . 0.0 112.308 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -76.75 -23.2 53.01 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 168.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -60.6 -43.5 97.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 0.0 111.683 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -102.43 7.76 40.26 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.18 1.392 . . . . 0.0 114.039 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 48.67 67.05 0.92 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.762 1.625 . . . . 0.0 112.331 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.03 81.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 123.055 1.407 . . . . 0.0 110.249 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.8 m -87.43 -22.97 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.306 1.842 . . . . 0.0 112.868 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -122.07 133.14 54.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.221 1.808 . . . . 0.0 109.73 173.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 tt -118.23 135.08 23.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.384 1.074 . . . . 0.0 111.517 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.82 157.23 92.44 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 118.847 0.624 . . . . 0.0 112.7 -9.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -107.42 124.21 49.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.673 1.189 . . . . 0.0 108.39 163.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.13 122.78 48.77 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.283 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 tp -130.37 129.83 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.486 1.114 . . . . 0.0 109.986 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.2 tp -100.14 132.34 45.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.151 1.38 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -118.36 151.76 37.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.875 1.67 . . . . 0.0 111.576 175.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -143.59 130.0 19.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.14 1.776 . . . . 0.0 109.832 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 t70 49.63 35.91 9.6 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.952 1.301 . . . . 0.0 114.381 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 16.41 80.8 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.847 1.213 . . . . 0.0 116.012 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -125.21 144.35 47.15 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 118.745 1.273 . . . . 0.0 111.494 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.46 144.96 51.77 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.009 2.473 . . . . 0.0 111.673 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.13 -54.7 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.832 1.253 . . . . 0.0 112.17 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -156.05 152.72 28.4 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -117.97 141.6 48.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.587 1.955 . . . . 0.0 111.571 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.79 146.71 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.952 . . . . 0.0 109.706 171.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.05 151.61 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.719 1.207 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.16 -171.15 55.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.748 0.689 . . . . 0.0 111.959 -170.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.08 155.79 23.67 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -135.17 149.92 50.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.214 2.205 . . . . 0.0 110.139 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.46 160.62 29.33 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 162.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -58.03 -34.53 70.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.75 73.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.313 0.645 . . . . 0.0 111.655 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.36 73.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.565 0.746 . . . . 0.0 111.598 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.62 -40.58 97.43 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.764 -0.585 . . . . 0.0 111.565 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.32 -33.4 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -61.58 -48.68 79.84 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.625 1.102 . . . . 0.0 110.555 170.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.66 -33.97 74.91 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 mt -71.2 -35.33 71.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.268 1.027 . . . . 0.0 113.623 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 t -69.69 -26.41 64.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.634 1.174 . . . . 0.0 112.008 172.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -76.38 5.44 7.16 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.412 1.485 . . . . 0.0 114.451 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 p -64.59 162.98 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.005 1.322 . . . . 0.0 112.984 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.83 128.94 89.6 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 123.958 0.903 . . . . 0.0 109.899 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.53 148.31 87.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.998 2.465 . . . . 0.0 113.369 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -71.55 -12.36 61.33 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -172.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.37 9.18 23.52 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.241 1.816 . . . . 0.0 113.289 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.273 0 C-N-CA 125.536 1.534 . . . . 0.0 111.82 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.584 0.231 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.4 p -76.38 157.33 32.45 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.769 1.228 . . . . 0.0 112.484 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -121.23 168.31 11.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.482 3.113 . . . . 0.0 112.86 0.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 m -78.29 44.72 0.51 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.903 1.681 . . . . 0.0 113.652 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 54.18 52.75 12.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.758 2.023 . . . . 0.0 113.236 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -65.5 -23.39 66.88 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.6 m -82.66 124.95 30.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.085 1.354 . . . . 0.0 112.127 -161.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.04 12.75 1.26 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 128.378 2.671 . . . . 0.0 115.023 -11.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -77.33 143.95 38.41 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.776 -1.203 . . . . 0.0 110.901 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 pt -108.3 134.4 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.813 0.845 . . . . 0.0 112.752 -170.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.08 129.51 35.03 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.255 . . . . 0.0 109.415 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.48 155.72 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.568 1.147 . . . . 0.0 111.544 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.7 p -121.47 172.7 7.88 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.385 1.874 . . . . 0.0 110.891 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.09 -24.78 42.32 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 -51.14 7.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.23 1.012 . . . . 0.0 113.167 172.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -80.65 -23.23 39.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -50.76 -41.63 56.95 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.087 1.355 . . . . 0.0 112.018 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.48 72.11 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.765 -1.209 . . . . 0.0 113.654 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -84.44 -30.63 25.14 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.365 -0.834 . . . . 0.0 112.421 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -92.56 -30.02 15.87 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.21 -54.39 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.216 1.406 . . . . 0.0 111.288 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.25 -22.46 35.81 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -172.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -88.31 3.75 48.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.348 1.059 . . . . 0.0 113.201 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -68.29 154.79 41.05 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.563 1.545 . . . . 0.0 114.237 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -112.91 9.45 18.85 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.562 1.945 . . . . 0.0 113.315 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -138.49 170.4 10.4 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 127.631 2.372 . . . . 0.0 111.288 -173.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -66.88 138.97 50.18 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.104 1.869 . . . . 0.0 112.379 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.46 113.46 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 110.323 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -86.64 128.71 35.01 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.375 1.07 . . . . 0.0 108.181 170.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -120.06 124.48 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 110.028 169.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.53 124.11 41.65 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.04 0.936 . . . . 0.0 111.119 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -95.01 118.36 31.69 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.421 1.488 . . . . 0.0 109.325 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -145.03 165.32 28.54 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -171.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.17 177.62 4.66 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.261 1.824 . . . . 0.0 111.748 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.1 p -68.52 -23.43 64.54 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -117.71 -13.95 10.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -161.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -74.98 129.06 37.0 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -165.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.74 -62.98 5.51 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.198 0.904 . . . . 0.0 112.897 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -60.33 -30.44 91.03 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.415 2.077 . . . . 0.0 113.952 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.06 -33.56 70.38 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.931 0.787 . . . . 0.0 112.161 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -73.11 -32.24 64.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.912 0.885 . . . . 0.0 112.597 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -68.64 -31.01 69.85 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -83.17 -17.61 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.715 1.143 . . . . 0.0 113.161 174.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.51 -50.24 67.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 120.255 1.389 . . . . 0.0 114.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.1 -33.23 51.0 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.021 1.814 . . . . 0.0 113.092 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.61 -42.88 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.261 1.391 . . . . 0.0 111.06 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.72 -48.2 55.79 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.304 1.442 . . . . 0.0 111.01 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.04 -37.31 66.52 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.386 1.074 . . . . 0.0 111.648 169.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.98 -43.8 23.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.788 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.3 mm -65.53 -34.31 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.463 1.029 . . . . 0.0 111.543 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.64 86.9 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 0.597 . . . . 0.0 112.022 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.6 m -76.16 -34.33 59.37 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.241 0.473 . . . . 0.0 111.741 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -79.83 -35.99 37.52 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.2 30.53 4.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.257 1.023 . . . . 0.0 113.444 -173.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.14 -34.04 20.95 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.624 1.57 . . . . 0.0 114.562 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -76.33 -18.2 59.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.001 1.32 . . . . 0.0 114.069 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -105.8 -37.96 6.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.681 1.193 . . . . 0.0 112.848 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.31 165.2 29.11 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -121.49 144.38 48.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.886 1.675 . . . . 0.0 110.719 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.95 139.02 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.034 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.67 164.45 30.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.937 1.695 . . . . 0.0 114.113 -167.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -118.44 132.23 56.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.846 2.058 . . . . 0.0 111.806 174.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -114.36 125.25 53.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.893 1.277 . . . . 0.0 109.477 164.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.59 113.12 25.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.279 0.631 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.98 -20.53 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -171.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.69 -38.27 33.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 111.963 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 t -95.9 -8.64 33.42 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -128.37 61.5 54.13 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.995 1.318 . . . . 0.0 113.358 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.22 -29.61 88.14 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.183 1.922 . . . . 0.0 113.486 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -66.07 -38.49 88.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.986 0.914 . . . . 0.0 112.428 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -35.2 57.71 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.603 -0.685 . . . . 0.0 111.31 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.55 93.17 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.585 -0.697 . . . . 0.0 111.667 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -71.93 -23.84 61.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.08 -39.17 77.9 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.951 0.9 . . . . 0.0 112.161 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -110.01 21.5 16.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.854 1.662 . . . . 0.0 113.366 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 52.98 35.8 20.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.743 2.017 . . . . 0.0 114.241 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.72 125.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.253 1.021 . . . . 0.0 110.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.21 -48.49 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.328 1.451 . . . . 0.0 110.099 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.5 m -85.94 143.8 27.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.481 1.112 . . . . 0.0 110.752 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.05 145.7 58.91 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.906 1.282 . . . . 0.0 111.147 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.16 146.51 85.17 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.715 0.934 . . . . 0.0 113.103 0.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.1 m -129.73 120.84 25.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.82 0.848 . . . . 0.0 109.258 165.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.48 132.59 38.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.29 1.436 . . . . 0.0 108.566 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 tp -127.2 126.4 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.841 1.256 . . . . 0.0 107.972 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 tp -108.22 128.44 54.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.638 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -110.0 151.93 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.942 1.697 . . . . 0.0 110.156 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -123.06 117.34 25.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.604 1.561 . . . . 0.0 108.021 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.309 4.0 p30 48.57 38.84 11.96 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 4.39 90.24 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.981 1.753 . . . . 0.0 116.124 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.96 133.6 20.21 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 119.236 1.518 . . . . 0.0 110.635 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.66 138.55 41.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.426 2.084 . . . . 0.0 111.656 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.22 -31.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.271 . . . . 0.0 114.205 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -159.52 141.55 13.39 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.485 1.038 . . . . 0.0 112.493 -172.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -133.79 130.93 38.69 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.596 1.559 . . . . 0.0 111.533 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 mm -129.6 123.7 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.463 1.505 . . . . 0.0 110.075 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.93 36.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 125.142 1.377 . . . . 0.0 113.572 -172.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.06 -172.74 35.37 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.319 -0.863 . . . . 0.0 114.257 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.96 154.14 41.86 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.331 1.052 . . . . 0.0 113.545 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -136.22 153.52 51.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.427 1.891 . . . . 0.0 110.773 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.35 163.54 14.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.61 1.1 . . . . 0.0 110.792 165.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -52.31 -43.04 64.31 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.444 1.122 . . . . 0.0 113.205 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.88 72.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.131 0.572 . . . . 0.0 111.7 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.06 63.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.132 0.973 . . . . 0.0 111.969 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.0 tp -63.98 -46.0 86.56 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.399 -0.813 . . . . 0.0 111.34 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.3 tp -71.59 -24.67 61.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.328 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -60.6 -47.2 87.26 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.322 1.419 . . . . 0.0 111.388 162.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.78 -36.08 75.95 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.086 0.857 . . . . 0.0 112.339 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.57 -36.38 68.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.918 0.887 . . . . 0.0 113.103 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -69.82 -22.76 63.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.376 1.07 . . . . 0.0 112.329 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -73.0 -10.43 59.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.75 1.22 . . . . 0.0 113.275 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.59 -30.75 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.423 1.889 . . . . 0.0 112.558 -173.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.2 140.71 31.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.332 1.453 . . . . 0.0 110.52 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -56.85 117.78 4.52 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.619 2.213 . . . . 0.0 112.179 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -156.94 153.19 27.69 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.532 1.533 . . . . 0.0 110.755 -171.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.83 -4.67 59.22 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -172.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.149 2.18 . . . . 0.0 112.954 -166.989 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 119.461 -0.304 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.6 p -74.2 159.33 32.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.476 1.11 . . . . 0.0 112.623 175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -145.5 148.1 32.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.334 1.454 . . . . 0.0 111.654 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -105.55 16.77 24.93 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.339 1.456 . . . . 0.0 113.967 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 61.22 8.54 2.09 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.151 2.181 . . . . 0.0 115.553 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 52.77 26.44 4.53 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.512 2.325 . . . . 0.0 115.677 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 p -75.7 152.91 37.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.18 0.992 . . . . 0.0 112.998 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.96 12.55 28.6 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -163.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.38 151.85 41.05 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 120.828 -1.17 . . . . 0.0 111.542 169.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.44 166.77 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.357 1.463 . . . . 0.0 111.403 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -124.7 143.45 50.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.529 1.132 . . . . 0.0 111.9 173.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.56 165.92 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.242 1.417 . . . . 0.0 112.658 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.9 p -132.17 175.41 9.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.351 2.66 . . . . 0.0 110.755 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.48 -29.46 61.78 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.89 -1.131 . . . . 0.0 113.08 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.96 -49.56 8.85 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.98 0.912 . . . . 0.0 112.849 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -80.14 -20.84 44.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -51.02 -41.23 59.68 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.144 1.378 . . . . 0.0 112.805 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -31.43 71.91 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.099 -1.001 . . . . 0.0 113.516 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -89.28 -19.35 25.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.703 1.601 . . . . 0.0 113.198 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -112.98 -27.05 8.21 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.36 -54.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.539 1.136 . . . . 0.0 111.631 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.0 mt -73.53 -12.34 60.74 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.5 p -76.83 -14.04 59.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.889 1.676 . . . . 0.0 113.97 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -69.98 155.83 40.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -165.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -114.25 17.49 17.58 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.787 2.035 . . . . 0.0 112.595 172.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -142.62 169.44 10.83 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 127.58 2.352 . . . . 0.0 111.297 -170.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.67 135.32 69.84 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.03 2.487 . . . . 0.0 112.644 159.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -137.6 123.49 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.511 1.124 . . . . 0.0 110.963 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -93.92 133.69 37.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.313 1.445 . . . . 0.0 109.637 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 t -123.12 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.155 0.889 . . . . 0.0 110.295 172.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -107.01 122.49 46.56 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.509 1.524 . . . . 0.0 111.626 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.11 116.57 27.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 110.687 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -147.11 169.77 18.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 0.0 113.613 -172.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.19 39.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.128 1.371 . . . . 0.0 111.21 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -58.09 -28.4 64.55 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.978 1.311 . . . . 0.0 113.117 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -88.9 -2.78 58.76 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.585 1.554 . . . . 0.0 114.515 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.4 t -84.43 105.19 15.06 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.905 -1.122 . . . . 0.0 112.859 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.45 -56.78 22.73 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.38 1.467 . . . . 0.0 114.79 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.51 -29.36 44.72 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 120.613 2.207 . . . . 0.0 112.509 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.36 -47.41 79.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.162 0.892 . . . . 0.0 111.467 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.69 -32.44 73.92 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -66.0 -42.71 89.42 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.736 0.814 . . . . 0.0 112.31 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 m -84.08 -17.78 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -42.02 -48.94 11.3 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -64.4 -27.29 62.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.66 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.4 -38.74 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.092 1.315 . . . . 0.0 111.084 173.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 mt -69.26 -48.72 60.98 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.751 1.22 . . . . 0.0 109.777 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.75 -40.56 72.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.18 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.74 -50.08 33.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.539 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.3 mm -58.15 -41.7 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.82 1.191 . . . . 0.0 111.436 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.35 97.24 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.818 0.735 . . . . 0.0 111.762 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.2 m -76.77 -31.67 57.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.519 0.727 . . . . 0.0 112.198 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -85.04 -31.65 23.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -122.34 30.33 6.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.414 1.485 . . . . 0.0 113.372 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.8 29.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.937 1.295 . . . . 0.0 114.356 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -72.82 -27.43 61.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.946 1.299 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.66 -33.93 10.41 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.207 1.403 . . . . 0.0 113.451 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 176.95 9.81 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.9 m -129.57 149.26 51.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.984 1.714 . . . . 0.0 108.784 162.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.65 135.12 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.902 0.774 . . . . 0.0 110.721 171.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.0 152.25 44.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.749 1.62 . . . . 0.0 112.859 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.454 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 4.8 mmmm -107.45 134.03 51.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.14 1.376 . . . . 0.0 111.302 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.76 110.83 11.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.5 1.12 . . . . 0.0 109.962 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.65 111.78 20.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.727 -0.608 . . . . 0.0 111.955 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.89 -20.41 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.13 -31.37 39.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.251 1.02 . . . . 0.0 112.124 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 t -104.71 -22.82 13.16 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.062 0.945 . . . . 0.0 113.233 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -128.9 67.54 78.03 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.7 1.6 . . . . 0.0 110.781 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.15 -15.5 31.96 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.337 2.692 . . . . 0.0 113.958 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.22 -35.06 79.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.223 -0.923 . . . . 0.0 112.527 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.7 p -77.18 -33.29 56.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 112.699 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.58 91.49 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.497 0.719 . . . . 0.0 111.845 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -76.77 -25.7 53.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -65.01 -44.57 88.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.958 0.799 . . . . 0.0 112.027 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.25 10.18 41.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.299 1.439 . . . . 0.0 114.071 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 51.22 58.11 5.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.242 1.817 . . . . 0.0 113.124 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.81 121.55 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.207 1.003 . . . . 0.0 109.256 173.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.19 -29.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.207 1.403 . . . . 0.0 112.724 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.8 p -121.21 152.59 38.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.468 1.907 . . . . 0.0 109.359 161.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.2 135.45 24.2 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.534 0.734 . . . . 0.0 111.941 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.14 147.42 66.22 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.15 0.732 . . . . 0.0 113.76 -6.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -99.89 136.89 39.13 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 154.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 mt -110.93 140.48 45.39 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.586 1.555 . . . . 0.0 108.994 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 tp -130.63 131.61 64.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.31 125.56 51.27 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.226 1.01 . . . . 0.0 109.489 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -108.96 158.17 17.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.858 2.063 . . . . 0.0 110.242 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -138.93 134.14 32.78 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.781 1.232 . . . . 0.0 108.995 160.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 54.08 39.82 31.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.019 0.927 . . . . 0.0 112.858 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.68 17.53 69.16 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.115 1.817 . . . . 0.0 114.982 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -125.9 134.11 25.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.835 1.254 . . . . 0.0 110.854 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.27 139.67 39.0 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.712 2.275 . . . . 0.0 111.764 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.51 -36.63 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -154.29 149.52 27.03 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.856 1.207 . . . . 0.0 113.672 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -101.59 145.6 28.83 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.154 1.782 . . . . 0.0 110.25 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.86 147.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.512 1.525 . . . . 0.0 109.623 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.31 147.98 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.386 1.074 . . . . 0.0 111.594 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.74 175.07 43.23 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 122.182 0.879 . . . . 0.0 113.592 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 149.84 44.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 145.83 46.26 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.282 1.833 . . . . 0.0 111.542 168.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.01 173.72 48.97 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.624 1.107 . . . . 0.0 111.167 166.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -59.52 -35.12 73.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.0 -43.54 74.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.946 0.498 . . . . 0.0 111.523 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.45 71.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.483 0.713 . . . . 0.0 111.921 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.8 tp -63.39 -40.75 98.09 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.996 0.918 . . . . 0.0 111.39 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.14 -30.74 71.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.354 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -68.34 -42.15 79.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.127 1.331 . . . . 0.0 112.551 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -56.25 -41.73 76.22 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.776 0.716 . . . . 0.0 110.565 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.5 -39.33 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -70.16 -20.25 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 112.394 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -69.72 -11.13 60.61 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.61 -40.92 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.83 1.652 . . . . 0.0 113.702 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.16 -38.72 49.59 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.79 1.636 . . . . 0.0 114.68 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -60.48 156.69 40.17 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.988 2.458 . . . . 0.0 114.901 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -147.47 162.54 38.83 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.67 1.588 . . . . 0.0 110.795 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.1 -21.87 65.84 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.941 1.296 . . . . 0.0 113.416 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.141 0 C-N-CA 127.051 2.14 . . . . 0.0 110.575 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mmt . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.3 p -136.5 158.08 45.28 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.615 1.566 . . . . 0.0 111.97 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.9 t0 53.6 37.4 25.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.593 1.557 . . . . 0.0 114.05 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.7 p -143.52 166.47 24.72 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.952 1.701 . . . . 0.0 112.502 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -77.42 98.05 5.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.098 0.959 . . . . 0.0 110.804 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -69.67 168.03 15.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.958 1.303 . . . . 0.0 113.319 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m 53.22 50.51 17.51 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.184 1.794 . . . . 0.0 112.627 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.58 55.46 1.99 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.269 1.428 . . . . 0.0 114.001 -166.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.5 p -117.47 161.61 19.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.666 1.186 . . . . 0.0 113.515 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -133.39 161.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.916 1.686 . . . . 0.0 111.467 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -106.42 143.31 34.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 110.738 164.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.89 160.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.7 1.6 . . . . 0.0 111.625 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.6 p -136.24 170.01 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.663 1.985 . . . . 0.0 109.706 173.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.93 -27.49 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.76 -1.213 . . . . 0.0 113.912 173.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.04 -20.08 53.09 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.8 p -121.0 -16.02 8.14 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -53.4 -41.3 65.82 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 112.933 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.63 70.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.7 m -81.26 -31.66 33.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 112.194 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.56 -39.91 7.68 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.83 -54.3 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.309 1.044 . . . . 0.0 111.53 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.3 mt -77.57 -15.07 59.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.5 t -66.61 -37.87 85.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.905 0.882 . . . . 0.0 112.209 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.299 3.5 t 52.89 -138.9 1.07 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.537 1.535 . . . . 0.0 111.249 168.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -84.31 -8.31 59.05 Favored 'General case' 0 CA--C 1.548 0.903 3 C-N-CA 133.582 4.753 . . . . 0.0 113.999 -1.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.14 156.49 76.6 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.078 0.951 . . . . 0.0 110.995 170.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -57.5 146.03 85.74 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.877 1.718 . . . . 0.0 114.634 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.12 124.24 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.131 0.972 . . . . 0.0 109.719 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.53 130.43 44.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 108.837 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 131.51 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.788 0.835 . . . . 0.0 110.619 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -98.42 119.62 37.44 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.74 0.816 . . . . 0.0 111.384 167.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -90.41 112.09 23.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.399 172.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.54 174.4 13.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -160.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.96 47.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.839 1.256 . . . . 0.0 111.174 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.5 p -74.03 -27.51 60.98 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -84.23 -8.93 58.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.426 1.49 . . . . 0.0 113.894 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 t -80.41 122.09 26.54 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 111.97 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.49 -57.34 20.31 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.065 1.317 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.53 -22.65 44.4 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 120.238 2.019 . . . . 0.0 112.959 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -67.69 -42.4 82.1 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.235 -0.916 . . . . 0.0 111.331 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -66.67 -32.36 73.63 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.781 0.832 . . . . 0.0 112.562 170.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -64.24 -38.0 89.48 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.978 0.808 . . . . 0.0 112.987 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -83.93 -10.95 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.96 99.92 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 119.791 1.178 . . . . 0.0 113.717 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.11 -38.2 47.1 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.247 1.965 . . . . 0.0 112.461 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.7 t -64.91 -49.18 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.693 0.797 . . . . 0.0 111.258 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.83 -37.13 81.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.168 0.587 . . . . 0.0 112.124 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.11 -41.85 97.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.951 0.796 . . . . 0.0 112.203 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.74 -43.55 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.733 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mm -61.44 -40.87 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.654 1.115 . . . . 0.0 110.909 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.41 92.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 100.0 m -70.3 -38.16 74.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.404 0.682 . . . . 0.0 111.32 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.2 -32.33 26.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -172.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -122.94 27.41 7.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -172.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.58 10.47 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -75.59 -33.52 60.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.89 1.276 . . . . 0.0 113.486 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -90.51 -38.2 13.37 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.28 0.945 . . . . 0.0 112.888 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.07 167.93 22.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -172.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -114.18 145.21 41.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.98 1.712 . . . . 0.0 109.705 168.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.69 135.67 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.418 0.687 . . . . 0.0 110.595 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 165.5 24.67 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.535 1.934 . . . . 0.0 111.825 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -127.69 147.97 50.39 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.29 124.61 52.43 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.695 1.598 . . . . 0.0 109.205 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.08 97.91 11.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.131 . . . . 0.0 109.927 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.56 -20.95 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.292 -0.88 . . . . 0.0 112.455 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.29 -25.88 63.54 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.439 1.496 . . . . 0.0 113.292 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.7 p -125.57 -22.81 4.19 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -142.17 72.57 22.33 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 111.961 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.25 -0.95 9.39 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.605 2.87 . . . . 0.0 114.505 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -63.33 -40.35 97.08 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.742 -1.224 . . . . 0.0 113.269 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.46 -27.72 52.17 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.208 -0.932 . . . . 0.0 113.411 168.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.04 94.47 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 112.006 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -75.5 -27.44 58.79 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -61.32 -42.16 98.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.153 0.888 . . . . 0.0 112.076 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -96.6 14.68 23.98 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.218 1.407 . . . . 0.0 113.478 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 50.55 41.18 25.11 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.474 2.31 . . . . 0.0 114.025 173.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.73 121.8 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.639 1.175 . . . . 0.0 110.421 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -101.78 -27.63 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.838 1.255 . . . . 0.0 113.571 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.9 m -133.85 160.4 37.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.987 1.715 . . . . 0.0 111.41 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.3 pt -127.97 144.34 51.12 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 0.0 111.7 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.14 153.67 88.18 Favored 'Cis proline' 0 CA--C 1.537 0.659 0 CA-C-N 119.462 0.843 . . . . 0.0 111.773 -6.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.3 m -133.34 119.62 19.94 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.972 0.909 . . . . 0.0 109.27 168.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.0 mt -103.13 119.77 39.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 109.193 -174.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.35 135.09 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.615 1.166 . . . . 0.0 110.372 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 tp -118.73 123.72 45.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.114 0.965 . . . . 0.0 111.722 -170.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -104.55 152.44 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.305 1.842 . . . . 0.0 111.315 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -142.51 135.28 28.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.15 1.78 . . . . 0.0 109.754 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t70 52.01 31.6 8.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.667 1.187 . . . . 0.0 113.329 -168.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.46 7.41 60.71 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.06 1.791 . . . . 0.0 114.662 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -100.56 129.89 26.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 118.771 1.285 . . . . 0.0 110.096 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.95 135.93 33.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.352 2.034 . . . . 0.0 110.789 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.38 -44.88 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.953 0.901 . . . . 0.0 112.214 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -153.37 150.55 28.98 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.609 1.164 . . . . 0.0 113.087 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.81 127.87 46.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.512 2.325 . . . . 0.0 109.879 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.9 mm -122.59 126.06 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.807 1.243 . . . . 0.0 109.985 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.06 147.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.371 1.069 . . . . 0.0 111.345 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.04 173.44 49.66 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.42 1.009 . . . . 0.0 114.19 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.27 151.56 38.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -138.44 155.11 48.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.519 1.928 . . . . 0.0 111.731 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.38 167.5 27.53 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.642 1.115 . . . . 0.0 111.942 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -56.29 -37.48 69.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 112.789 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.96 78.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.23 0.612 . . . . 0.0 111.724 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.08 78.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.402 0.681 . . . . 0.0 111.957 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.1 tp -67.98 -39.99 83.2 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.417 -0.802 . . . . 0.0 111.875 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.47 -28.5 66.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.256 0.622 . . . . 0.0 112.264 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -61.95 -48.57 79.8 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.615 1.098 . . . . 0.0 110.875 167.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.45 -38.08 76.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.293 0.951 . . . . 0.0 111.875 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.0 mt -66.51 -43.47 85.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.6 m -70.0 -23.57 63.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.007 0.923 . . . . 0.0 112.458 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.9 -10.53 59.5 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.112 1.365 . . . . 0.0 112.667 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t -113.93 -42.03 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.117 1.767 . . . . 0.0 112.8 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.1 p -134.76 142.69 43.36 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.628 1.171 . . . . 0.0 111.897 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.1 164.9 20.85 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.811 2.341 . . . . 0.0 113.306 169.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -138.53 136.24 35.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.423 1.489 . . . . 0.0 110.162 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 tp -135.27 22.65 3.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.588 1.555 . . . . 0.0 111.252 175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.727 1.611 . . . . 0.0 112.447 -172.949 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 t -148.62 169.1 21.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.805 1.242 . . . . 0.0 112.17 173.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -79.38 156.75 27.82 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.13 1.372 . . . . 0.0 113.679 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -59.21 -21.96 60.3 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.425 1.49 . . . . 0.0 114.093 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -90.92 88.53 7.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 157.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.61 11.06 9.14 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 129.933 3.293 . . . . 0.0 115.126 19.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.9 t -62.34 104.79 0.53 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.797 1.18 . . . . 0.0 112.588 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.24 55.65 2.9 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.155 0.982 . . . . 0.0 112.719 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -94.45 151.21 19.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.945 0.898 . . . . 0.0 112.558 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 pt -136.5 165.63 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.674 1.59 . . . . 0.0 111.189 171.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -126.23 138.84 53.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.011 1.324 . . . . 0.0 110.707 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.06 156.08 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.521 1.129 . . . . 0.0 112.918 -172.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.3 p -142.39 161.82 37.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.007 2.123 . . . . 0.0 110.107 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -55.1 -35.61 64.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -166.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.08 59.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.5 m -113.27 -21.59 10.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.504 1.522 . . . . 0.0 113.79 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -44.83 -41.98 7.51 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.888 2.475 . . . . 0.0 113.114 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.61 71.5 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.1 m -89.93 -25.96 20.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.856 1.262 . . . . 0.0 112.096 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -84.37 -50.01 8.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.931 0.892 . . . . 0.0 113.295 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.53 -33.65 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -77.73 -11.68 59.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 120.052 1.296 . . . . 0.0 113.585 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.0 m -88.96 -0.87 57.78 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -66.24 153.03 43.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.824 1.25 . . . . 0.0 113.653 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -121.53 28.02 7.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.37 1.468 . . . . 0.0 112.173 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.77 171.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 128.459 2.703 . . . . 0.0 109.823 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.76 139.51 80.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.853 1.702 . . . . 0.0 111.572 161.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.62 123.97 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.589 0.756 . . . . 0.0 111.928 170.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.49 125.5 31.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.313 1.445 . . . . 0.0 107.875 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -113.75 121.06 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 169.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -107.36 115.98 31.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.264 1.026 . . . . 0.0 111.634 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -92.35 123.91 36.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.969 1.708 . . . . 0.0 109.288 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.466 ' CE2' ' HE2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -149.82 168.1 24.67 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -176.315 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.03 174.75 5.75 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.998 1.319 . . . . 0.0 111.951 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.6 p -71.66 -22.66 61.64 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -116.06 -12.75 11.26 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -163.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.94 130.15 38.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.17 -59.57 10.61 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.82 1.2 . . . . 0.0 114.179 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.75 -23.73 48.16 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.36 2.04 . . . . 0.0 113.301 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.3 p -77.76 -35.08 52.08 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.344 -0.848 . . . . 0.0 112.405 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -75.41 -27.88 59.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.934 -1.104 . . . . 0.0 112.359 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttt -58.91 -31.34 68.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.245 1.018 . . . . 0.0 113.262 171.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.62 -5.85 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.6 95.84 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-N 119.983 1.265 . . . . 0.0 114.39 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.01 -32.09 45.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.383 1.53 . . . . 0.0 112.589 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.52 -48.15 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.352 -0.843 . . . . 0.0 111.664 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.0 -37.38 84.09 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.977 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.01 -45.81 90.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.684 0.675 . . . . 0.0 111.97 172.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.51 -46.15 77.18 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.575 -0.703 . . . . 0.0 111.465 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.98 -42.79 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.025 1.284 . . . . 0.0 111.249 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -31.62 72.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.4 0.545 . . . . 0.0 112.359 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.4 m -78.6 -40.07 35.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.413 0.685 . . . . 0.0 111.745 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.84 -22.11 22.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -168.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -128.36 22.93 6.0 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.794 1.238 . . . . 0.0 113.877 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.37 -28.63 44.53 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.351 1.461 . . . . 0.0 114.682 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -80.17 -18.34 49.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.394 1.478 . . . . 0.0 113.643 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -101.7 -38.22 7.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.101 1.361 . . . . 0.0 112.88 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.58 177.76 9.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.264 1.426 . . . . 0.0 112.873 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.99 153.95 40.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.781 1.632 . . . . 0.0 109.326 167.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.08 136.14 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.605 0.762 . . . . 0.0 110.361 172.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.84 152.79 49.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.416 1.887 . . . . 0.0 112.092 -170.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HE2' ' CE2' ' A' ' 33' ' ' TRP . 17.2 mmmt -115.98 135.26 54.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.935 1.294 . . . . 0.0 112.61 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -121.78 127.09 50.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.618 1.167 . . . . 0.0 110.484 167.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.37 104.29 16.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 110.054 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -69.88 -20.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.294 -0.879 . . . . 0.0 112.973 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.62 -33.39 47.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.468 1.107 . . . . 0.0 112.952 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -106.83 -22.47 12.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.539 1.136 . . . . 0.0 113.601 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -131.59 68.07 80.58 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.923 1.289 . . . . 0.0 111.743 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.52 -14.64 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.094 2.529 . . . . 0.0 113.058 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.31 -41.12 83.78 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.467 1.107 . . . . 0.0 112.605 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -75.63 -32.9 60.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.083 0.856 . . . . 0.0 111.71 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.66 92.04 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.149 -0.969 . . . . 0.0 111.81 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.98 -23.15 52.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 169.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.03 -47.72 85.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.799 0.84 . . . . 0.0 111.234 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.51 6.53 44.31 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 50.9 53.83 12.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 112.795 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -88.16 121.52 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.649 1.18 . . . . 0.0 109.443 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -110.71 -29.44 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.511 1.124 . . . . 0.0 112.701 -171.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -121.8 160.75 23.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.518 1.527 . . . . 0.0 111.686 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.68 147.02 64.36 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.679 1.192 . . . . 0.0 112.888 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.35 154.29 89.01 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.126 0.723 . . . . 0.0 111.829 -11.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.6 m -130.94 120.54 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.726 0.811 . . . . 0.0 109.638 168.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.49 122.82 37.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.85 126.83 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.316 1.047 . . . . 0.0 108.9 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.4 tp -112.12 128.3 56.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.623 1.569 . . . . 0.0 110.034 -166.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -108.24 157.35 18.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.686 1.594 . . . . 0.0 110.159 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.1 127.51 26.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.167 1.787 . . . . 0.0 108.528 167.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.01 40.36 28.15 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.763 0.792 . . . . 0.0 112.727 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.23 17.35 72.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.03 1.776 . . . . 0.0 115.409 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -124.08 133.04 24.37 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.71 1.204 . . . . 0.0 110.843 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.48 139.15 37.11 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.831 2.354 . . . . 0.0 112.073 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.5 -26.35 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.17 149.61 32.29 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.056 1.298 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -143.68 127.87 17.66 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.702 1.201 . . . . 0.0 111.098 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mm -132.09 137.59 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.392 1.077 . . . . 0.0 110.618 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.93 157.51 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.079 1.352 . . . . 0.0 112.401 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 173.81 36.35 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.745 1.164 . . . . 0.0 113.913 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 156.63 34.04 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.53 152.41 50.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.351 1.86 . . . . 0.0 111.732 171.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 166.92 44.71 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 159.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -57.25 -34.43 68.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.41 82.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.582 0.753 . . . . 0.0 112.372 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.29 -39.83 65.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.91 -48.11 80.39 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.079 -0.388 . . . . 0.0 110.203 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.477 -0.764 . . . . 0.0 112.37 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -69.24 -43.17 74.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.078 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.98 -27.3 65.58 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.253 1.388 . . . . 0.0 112.505 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.27 -41.36 81.19 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.453 0.701 . . . . 0.0 111.871 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -65.71 -25.74 67.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.545 1.138 . . . . 0.0 111.705 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.97 1.09 6.07 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 170.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.26 -35.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.777 2.031 . . . . 0.0 111.714 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.8 76.4 75.13 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.961 1.705 . . . . 0.0 111.119 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.49 169.52 17.01 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.55 2.833 . . . . 0.0 112.43 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -62.0 -22.74 65.93 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -95.36 6.33 49.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.503 1.521 . . . . 0.0 115.015 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.609 1.563 . . . . 0.0 112.279 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m 51.6 38.72 23.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.108 1.763 . . . . 0.0 113.672 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -81.77 60.16 4.56 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.644 -1.285 . . . . 0.0 110.777 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m 57.71 16.04 3.26 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.018 1.727 . . . . 0.0 114.35 -159.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.94 -12.8 61.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.232 1.413 . . . . 0.0 114.36 -173.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -87.47 -7.28 57.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.484 1.514 . . . . 0.0 113.934 173.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 t -75.3 145.46 41.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.28 1.032 . . . . 0.0 112.397 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.91 12.38 30.49 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.846 1.259 . . . . 0.0 113.257 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.1 p -80.73 157.44 25.85 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.076 0.951 . . . . 0.0 113.21 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.1 165.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.019 1.728 . . . . 0.0 111.695 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -109.89 143.23 40.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.176 1.79 . . . . 0.0 110.376 170.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.73 156.21 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.801 1.241 . . . . 0.0 111.697 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.1 p -114.7 168.81 9.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.15 2.18 . . . . 0.0 110.532 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.85 -27.84 67.0 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.819 -1.176 . . . . 0.0 113.221 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.34 -47.3 14.69 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.193 0.997 . . . . 0.0 112.894 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 p -77.79 -26.56 49.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -49.76 -39.89 39.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.2 1.8 . . . . 0.0 112.605 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.16 70.51 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -95.33 -20.66 18.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.694 1.198 . . . . 0.0 112.531 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -91.39 -58.29 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.417 1.087 . . . . 0.0 112.347 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -88.09 -51.88 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.213 1.405 . . . . 0.0 111.349 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.15 -15.01 62.47 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -77.43 -18.05 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 m -85.89 118.72 25.55 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -166.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 p-10 -75.42 -24.51 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.718 1.207 . . . . 0.0 112.113 160.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -65.26 146.35 98.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 127.17 2.188 . . . . 0.0 110.087 167.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.02 140.12 82.67 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.062 1.841 . . . . 0.0 111.4 170.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.62 130.97 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.984 0.914 . . . . 0.0 110.554 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.6 mp -104.5 124.66 49.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 108.769 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -120.1 117.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 110.311 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -98.45 117.58 33.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.606 0.763 . . . . 0.0 112.638 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.19 112.68 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.854 1.661 . . . . 0.0 108.442 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.26 170.28 19.88 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -164.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.69 155.78 48.74 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.989 1.316 . . . . 0.0 111.881 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -78.61 -19.52 52.52 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -86.05 -5.45 59.21 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.707 1.203 . . . . 0.0 113.822 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.48 120.11 31.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.184 1.394 . . . . 0.0 112.215 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -55.17 31.64 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.018 1.294 . . . . 0.0 114.726 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.03 -23.93 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 120.201 2.0 . . . . 0.0 112.638 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.3 m -67.16 -39.19 86.45 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.065 -1.022 . . . . 0.0 111.588 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.9 -31.89 71.99 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.438 -0.789 . . . . 0.0 112.711 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -65.34 -34.7 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.0 -12.15 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.341 0.973 . . . . 0.0 113.589 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.76 -49.14 85.03 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -29.27 49.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.763 1.642 . . . . 0.0 112.718 173.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.5 -48.06 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.147 -0.97 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.6 -36.79 79.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.297 0.639 . . . . 0.0 112.021 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.33 -46.91 87.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.777 0.717 . . . . 0.0 111.424 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -69.05 -47.77 64.51 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.715 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.2 mm -59.44 -40.8 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 121.061 1.755 . . . . 0.0 110.95 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.54 90.41 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.093 0.86 . . . . 0.0 112.546 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.1 m -77.09 -36.12 55.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.651 0.78 . . . . 0.0 111.325 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -92.64 -34.66 13.89 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -116.82 13.74 15.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.932 1.293 . . . . 0.0 113.583 -163.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.14 -31.03 29.26 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -69.72 -29.94 67.44 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.27 -0.894 . . . . 0.0 112.671 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -90.53 -41.12 11.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.772 1.229 . . . . 0.0 112.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.3 162.52 41.03 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.0 m -106.48 136.36 46.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.734 1.214 . . . . 0.0 110.482 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 t -110.91 122.15 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.083 0.953 . . . . 0.0 110.47 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.5 164.38 18.2 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.637 1.975 . . . . 0.0 111.739 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -129.75 143.52 50.86 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.42 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -126.43 120.91 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.362 1.465 . . . . 0.0 109.721 170.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -96.29 85.22 3.91 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.228 1.811 . . . . 0.0 111.153 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -60.81 -22.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -166.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.04 -28.32 61.36 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.217 1.407 . . . . 0.0 113.459 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -127.17 -9.88 5.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.949 1.7 . . . . 0.0 114.585 -171.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -142.51 59.51 8.74 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.897 2.079 . . . . 0.0 110.318 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.85 -6.17 14.13 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.534 2.822 . . . . 0.0 114.565 -167.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.2 -39.18 92.49 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.119 -0.988 . . . . 0.0 112.374 -174.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -30.4 54.77 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.391 -0.818 . . . . 0.0 112.065 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.34 99.04 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.313 -0.867 . . . . 0.0 111.65 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -74.16 -23.25 59.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -61.75 -44.03 97.7 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.882 0.873 . . . . 0.0 111.282 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.55 5.57 50.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.142 1.377 . . . . 0.0 114.162 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 50.51 41.23 24.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.408 1.883 . . . . 0.0 113.666 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.59 128.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.94 1.296 . . . . 0.0 110.128 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.94 -45.66 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.869 1.268 . . . . 0.0 111.348 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 p -86.26 152.4 22.81 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.717 1.207 . . . . 0.0 111.674 170.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 pt -145.43 155.54 53.62 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.834 1.654 . . . . 0.0 111.098 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.35 138.67 57.02 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 119.795 0.963 . . . . 0.0 111.6 -4.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 m -125.29 108.08 11.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.624 0.77 . . . . 0.0 109.9 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.29 126.1 43.65 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.754 1.222 . . . . 0.0 110.136 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 tt -120.9 132.85 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 122.199 1.0 . . . . 0.0 110.634 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.89 130.67 44.15 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 109.565 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -120.07 148.5 43.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.287 1.835 . . . . 0.0 111.319 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -144.81 135.13 24.24 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.971 1.708 . . . . 0.0 109.701 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 t70 51.34 33.68 10.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.63 19.92 71.53 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.335 1.445 . . . . 0.0 115.401 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -126.15 150.25 69.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 118.8 1.3 . . . . 0.0 112.104 169.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.37 145.93 44.01 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.905 2.403 . . . . 0.0 112.399 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.45 -46.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.97 1.308 . . . . 0.0 111.678 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -159.54 146.38 16.62 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.887 1.275 . . . . 0.0 111.94 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -129.0 137.21 51.21 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.159 1.384 . . . . 0.0 112.156 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.8 116.55 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.234 1.814 . . . . 0.0 110.224 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -100.17 159.4 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.054 1.742 . . . . 0.0 112.407 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.1 -171.69 50.67 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.067 0.841 . . . . 0.0 111.958 -174.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.18 147.02 45.14 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.153 -1.204 . . . . 0.0 112.93 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.69 153.15 47.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.077 1.751 . . . . 0.0 111.707 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.37 163.9 24.23 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.565 1.079 . . . . 0.0 112.092 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -59.88 -33.97 72.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.244 1.018 . . . . 0.0 113.53 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.37 80.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.968 0.507 . . . . 0.0 111.522 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.72 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.311 0.645 . . . . 0.0 111.214 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.2 tp -62.53 -40.32 96.41 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.219 -0.926 . . . . 0.0 112.344 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.4 tp -70.17 -30.81 68.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.844 0.858 . . . . 0.0 112.686 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -62.6 -44.93 95.06 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.729 1.149 . . . . 0.0 111.413 167.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.1 -36.03 80.47 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.32 0.964 . . . . 0.0 111.789 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.58 -39.2 81.07 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -65.34 -26.06 67.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.468 1.107 . . . . 0.0 112.211 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -75.95 -5.08 44.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.9 1.28 . . . . 0.0 114.089 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.22 151.37 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.055 1.342 . . . . 0.0 111.755 172.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -101.04 132.97 21.32 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.969 1.708 . . . . 0.0 109.891 171.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.6 -33.27 36.57 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.377 2.052 . . . . 0.0 113.899 -171.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -139.32 139.22 37.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.603 1.561 . . . . 0.0 111.519 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.43 -15.5 45.94 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.17 1.388 . . . . 0.0 113.149 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 t30 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 126.975 2.11 . . . . 0.0 110.889 -179.842 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.1 p -100.56 -35.22 9.6 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.556 1.143 . . . . 0.0 113.92 -174.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.7 -21.71 54.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.027 0.931 . . . . 0.0 113.353 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.9 m -154.22 154.38 33.38 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.949 2.1 . . . . 0.0 109.726 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.15 43.07 0.77 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.47 1.108 . . . . 0.0 113.397 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -80.77 -20.25 43.05 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.9 p -149.23 147.24 28.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.655 1.582 . . . . 0.0 111.877 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.11 39.79 3.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.959 1.303 . . . . 0.0 112.843 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p -94.83 163.81 13.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.957 1.303 . . . . 0.0 113.217 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.2 pt -117.93 157.47 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.466 1.506 . . . . 0.0 111.192 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -109.25 137.59 46.89 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.886 1.674 . . . . 0.0 110.007 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.35 156.34 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.821 1.248 . . . . 0.0 112.475 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.2 p -143.29 161.55 38.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.548 1.939 . . . . 0.0 110.793 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.83 -35.62 61.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -168.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.95 -18.87 60.32 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 m -119.26 -11.6 9.54 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.703 1.601 . . . . 0.0 113.646 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -51.9 -40.09 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 113.08 -175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.5 72.04 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -83.2 -32.25 26.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.158 0.983 . . . . 0.0 111.953 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.56 -37.81 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.42 -54.48 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.155 1.382 . . . . 0.0 110.986 -174.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.95 -12.03 59.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 m -78.74 -11.5 59.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.5 m -80.73 121.31 25.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.273 1.429 . . . . 0.0 112.641 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.35 -26.98 60.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.006 0.523 . . . . 0.0 111.857 164.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -69.75 153.54 95.49 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.253 1.021 . . . . 0.0 110.701 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.06 145.75 85.69 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.755 1.637 . . . . 0.0 111.675 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.0 132.3 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.145 . . . . 0.0 111.915 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.5 134.22 35.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.769 1.628 . . . . 0.0 109.169 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.27 129.8 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.316 0.647 . . . . 0.0 110.457 167.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -103.52 136.73 42.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.406 1.482 . . . . 0.0 113.076 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.26 120.17 39.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.126 1.37 . . . . 0.0 111.097 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -75.03 168.1 20.64 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.261 1.024 . . . . 0.0 113.344 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.69 144.79 32.86 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.244 142.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.9 p -67.94 -31.42 71.16 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -165.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -96.33 -8.28 33.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.644 1.978 . . . . 0.0 113.777 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.5 t -82.41 110.44 17.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.52 1.128 . . . . 0.0 113.24 -160.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.57 -57.07 12.87 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.277 1.418 . . . . 0.0 114.364 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.17 -24.42 65.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 120.481 2.14 . . . . 0.0 113.349 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.84 -42.03 82.05 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.213 0.915 . . . . 0.0 111.217 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -66.3 -32.23 73.51 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.463 -0.773 . . . . 0.0 112.462 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.55 -31.93 71.49 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.65 -14.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.781 1.173 . . . . 0.0 113.691 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.37 46.1 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.21 -32.0 52.72 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.674 1.583 . . . . 0.0 112.327 176.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.43 -51.22 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.352 0.978 . . . . 0.0 111.734 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.06 -35.28 74.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 111.298 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -71.43 -34.9 70.69 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -66.18 -47.6 73.45 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.806 -1.184 . . . . 0.0 111.222 171.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.38 -40.75 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.609 1.549 . . . . 0.0 111.08 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.19 -38.02 85.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.9 0.773 . . . . 0.0 112.581 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -77.19 -34.92 56.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.663 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -88.52 -39.58 14.07 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -113.64 17.25 18.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.231 1.412 . . . . 0.0 113.457 -162.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.89 34.62 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.328 1.451 . . . . 0.0 114.626 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -78.23 -18.52 55.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.216 1.407 . . . . 0.0 113.825 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -98.18 -41.41 7.91 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.838 1.255 . . . . 0.0 112.48 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.32 164.08 35.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.598 1.159 . . . . 0.0 113.3 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.6 m -107.15 144.45 33.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.883 1.273 . . . . 0.0 110.359 171.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -118.84 128.76 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.422 0.689 . . . . 0.0 110.286 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.49 162.31 23.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.644 1.978 . . . . 0.0 111.429 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -136.28 144.75 44.92 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.91 122.69 46.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.765 1.626 . . . . 0.0 110.448 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -87.15 84.08 7.33 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.823 1.249 . . . . 0.0 110.797 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 p -62.92 -24.06 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.66 -26.57 61.69 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.08 0.952 . . . . 0.0 113.383 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.1 p -110.06 -22.66 11.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.416 1.086 . . . . 0.0 113.479 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.03 77.39 26.0 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.464 1.506 . . . . 0.0 111.548 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.67 -15.21 37.3 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.718 2.278 . . . . 0.0 112.851 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.81 -38.24 75.21 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.666 1.187 . . . . 0.0 112.966 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -34.0 68.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.119 0.872 . . . . 0.0 112.331 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.0 73.41 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.906 -1.122 . . . . 0.0 111.454 173.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -74.99 -39.52 61.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.284 1.033 . . . . 0.0 111.768 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.84 -45.41 67.34 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.993 1.317 . . . . 0.0 111.622 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -98.18 15.72 23.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.305 1.442 . . . . 0.0 114.512 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.272 7.6 pt20 47.46 42.53 14.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.773 2.029 . . . . 0.0 115.13 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.95 126.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.454 1.502 . . . . 0.0 110.429 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.1 m -130.91 -9.84 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.431 1.492 . . . . 0.0 113.799 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 151.19 41.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.37 1.868 . . . . 0.0 110.197 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.23 141.48 29.54 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.879 0.872 . . . . 0.0 112.579 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.17 154.49 88.45 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.261 0.772 . . . . 0.0 111.951 -7.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -132.55 135.56 46.02 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.831 1.252 . . . . 0.0 108.73 171.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 142.83 46.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.318 1.047 . . . . 0.0 110.386 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.5 tp -122.34 137.6 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.827 1.651 . . . . 0.0 109.117 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.8 tp -108.8 125.57 52.1 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.612 1.565 . . . . 0.0 109.694 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -116.08 155.6 27.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.574 1.149 . . . . 0.0 111.391 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.54 136.12 27.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.66 1.584 . . . . 0.0 109.646 164.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.78 32.2 14.44 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.11 1.364 . . . . 0.0 114.256 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.59 17.31 80.18 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.853 1.216 . . . . 0.0 115.63 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -126.09 143.62 46.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 118.776 1.288 . . . . 0.0 111.503 172.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 144.09 42.13 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.893 2.395 . . . . 0.0 111.628 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.34 -45.18 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.12 1.368 . . . . 0.0 111.388 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -158.37 146.15 18.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.443 1.097 . . . . 0.0 111.529 -163.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.34 142.14 51.67 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.38 1.472 . . . . 0.0 110.826 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 132.4 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.998 1.719 . . . . 0.0 110.098 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.81 143.89 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.403 1.481 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.29 176.02 46.07 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.708 0.671 . . . . 0.0 112.719 -168.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.23 152.06 44.65 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -128.33 149.17 50.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.097 2.159 . . . . 0.0 109.851 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.24 166.42 32.1 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 161.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.53 -38.99 75.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.073 0.949 . . . . 0.0 113.183 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.42 77.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.404 0.681 . . . . 0.0 111.593 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -45.56 64.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 111.82 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.349 0.977 . . . . 0.0 111.355 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.54 -37.58 87.84 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.762 -0.586 . . . . 0.0 111.926 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -61.76 -43.03 99.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.771 -1.206 . . . . 0.0 112.29 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.88 -31.96 73.32 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.937 0.789 . . . . 0.0 112.372 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.7 -40.27 76.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.668 0.387 . . . . 0.0 111.815 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.5 m -64.78 -25.48 67.94 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.234 -0.916 . . . . 0.0 112.695 170.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.56 -10.78 57.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.168 1.387 . . . . 0.0 114.41 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.78 157.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.131 1.373 . . . . 0.0 114.162 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.3 t -80.9 142.29 52.05 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 125.677 1.591 . . . . 0.0 110.386 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -61.78 162.08 23.01 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.563 2.842 . . . . 0.0 114.964 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.9 -17.69 61.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.946 0.898 . . . . 0.0 113.016 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.7 tp 59.38 15.03 4.1 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.195 2.198 . . . . 0.0 114.654 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 127.418 2.287 . . . . 0.0 110.824 176.191 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.388 0.614 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.1 m -82.53 84.86 7.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.664 1.186 . . . . 0.0 110.12 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.4 t70 61.3 -53.13 0.11 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 128.65 2.78 . . . . 0.0 115.458 -170.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -154.92 129.54 9.21 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.486 1.515 . . . . 0.0 110.902 171.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -140.8 135.83 31.85 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.965 1.706 . . . . 0.0 109.646 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -106.29 152.02 24.08 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.522 1.529 . . . . 0.0 112.183 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.6 m -126.88 150.83 49.07 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.123 1.769 . . . . 0.0 110.708 172.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.86 36.83 0.77 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -99.09 153.59 18.77 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.733 1.613 . . . . 0.0 112.196 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.76 164.08 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.711 1.204 . . . . 0.0 112.7 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -109.46 142.73 40.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.882 1.673 . . . . 0.0 110.141 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.81 154.01 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.439 1.096 . . . . 0.0 112.638 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.2 p -145.45 160.93 40.84 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.973 2.109 . . . . 0.0 110.159 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.81 -34.53 40.55 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -171.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.99 -20.48 62.41 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -120.88 -14.2 8.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.59 1.556 . . . . 0.0 113.693 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -51.17 -41.65 60.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.397 1.879 . . . . 0.0 113.34 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.25 71.72 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.5 m -82.19 -33.71 29.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.593 0.757 . . . . 0.0 111.793 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.08 -43.25 19.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.97 -54.42 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 111.194 -173.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.06 -17.07 53.67 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.6 m -101.45 7.27 42.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.843 1.257 . . . . 0.0 113.119 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -66.01 144.63 56.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.979 0.912 . . . . 0.0 112.994 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.23 1.68 43.47 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.988 1.315 . . . . 0.0 113.213 174.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -142.73 166.69 19.27 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 126.825 2.05 . . . . 0.0 111.651 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.45 147.12 6.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.024 3.149 . . . . 0.0 114.822 163.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.1 130.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.477 1.111 . . . . 0.0 110.789 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.4 129.04 39.68 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.909 1.284 . . . . 0.0 107.931 169.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.2 t -112.37 123.89 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.445 1.021 . . . . 0.0 109.801 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -113.08 121.9 45.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.403 1.081 . . . . 0.0 112.458 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -93.69 120.11 33.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.354 1.862 . . . . 0.0 110.598 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.72 171.17 16.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.97 176.92 4.9 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.86 1.664 . . . . 0.0 111.541 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -71.43 -29.58 65.05 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.841 -1.162 . . . . 0.0 113.118 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -100.23 -14.86 18.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -163.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -76.47 127.67 33.29 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -163.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.23 -63.54 5.22 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.739 1.162 . . . . 0.0 113.948 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.0 -24.42 60.17 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.43 2.086 . . . . 0.0 113.149 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -74.89 -36.33 62.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.93 0.786 . . . . 0.0 111.789 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -75.48 -28.01 59.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.987 -1.071 . . . . 0.0 112.629 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.3 mmm -63.93 -29.71 70.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.1 m -83.48 -8.57 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 119.664 1.12 . . . . 0.0 113.928 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.4 -50.69 83.66 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 120.708 1.595 . . . . 0.0 113.905 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.24 -37.05 33.39 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.538 1.492 . . . . 0.0 112.359 174.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.3 t -62.91 -49.23 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.374 1.069 . . . . 0.0 111.694 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 pp -70.36 -39.87 74.36 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.614 1.166 . . . . 0.0 110.858 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -62.03 -44.16 97.3 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.75 0.705 . . . . 0.0 111.962 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -64.61 -54.29 34.28 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.449 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -65.48 -33.9 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.742 1.155 . . . . 0.0 111.502 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.17 89.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.482 1.037 . . . . 0.0 111.364 172.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 m -82.38 -30.82 30.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.415 0.686 . . . . 0.0 112.74 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -80.1 -28.32 39.06 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.044 -1.035 . . . . 0.0 113.203 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -120.27 29.42 7.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.798 1.639 . . . . 0.0 112.621 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -25.84 33.29 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.842 1.257 . . . . 0.0 114.293 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -80.71 -18.5 47.65 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.433 1.493 . . . . 0.0 113.884 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -103.5 -36.49 7.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.404 1.482 . . . . 0.0 112.945 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 160.28 43.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.8 m -111.03 139.62 46.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.297 1.439 . . . . 0.0 109.872 166.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.03 127.93 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.57 0.7 . . . . 0.0 110.153 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.68 145.55 42.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.541 2.337 . . . . 0.0 110.608 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.5 137.94 54.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.5 129.23 54.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.798 1.639 . . . . 0.0 109.637 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -99.35 105.65 17.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.392 1.077 . . . . 0.0 109.433 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.97 -22.1 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -164.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.52 -29.91 41.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.551 1.141 . . . . 0.0 113.233 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.1 p -106.08 -19.18 13.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.451 1.1 . . . . 0.0 113.81 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -133.03 78.68 64.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.687 0.795 . . . . 0.0 112.068 164.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.25 -22.57 75.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.125 2.55 . . . . 0.0 114.11 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.834 0.854 . . . . 0.0 113.096 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -76.93 -30.49 56.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.137 0.88 . . . . 0.0 111.679 172.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.58 98.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.969 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -76.68 -24.47 53.19 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -56.8 -40.01 75.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.37 0.986 . . . . 0.0 112.125 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.65 13.65 26.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 113.807 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 51.45 53.25 13.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.591 1.956 . . . . 0.0 114.141 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.54 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.219 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.55 -61.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.353 1.061 . . . . 0.0 109.788 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.8 m -86.86 151.33 23.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.237 1.015 . . . . 0.0 110.621 166.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.5 133.62 25.29 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.364 1.065 . . . . 0.0 109.515 -171.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.74 159.94 96.57 Favored 'Cis proline' 0 C--N 1.351 0.676 0 CA-C-N 120.365 1.166 . . . . 0.0 113.246 -0.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -126.98 136.11 51.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.426 1.09 . . . . 0.0 109.197 163.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.26 141.87 44.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 109.128 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.72 129.38 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.901 0.88 . . . . 0.0 108.954 166.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.44 125.21 52.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.892 1.277 . . . . 0.0 110.821 -173.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -104.83 148.45 26.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.249 1.819 . . . . 0.0 111.196 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -112.71 116.92 30.89 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.859 1.664 . . . . 0.0 108.264 164.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 51.16 37.37 18.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.644 1.178 . . . . 0.0 113.934 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 9.83 85.68 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.19 1.376 . . . . 0.0 115.944 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -113.93 131.39 23.16 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 119.27 1.535 . . . . 0.0 110.665 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.75 139.93 37.86 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.79 2.327 . . . . 0.0 112.526 -173.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.61 -48.66 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.966 1.306 . . . . 0.0 112.02 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -157.6 158.5 35.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.312 1.045 . . . . 0.0 113.436 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -118.51 140.36 50.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.021 1.728 . . . . 0.0 110.532 168.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.6 139.09 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.772 1.629 . . . . 0.0 109.522 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.48 142.89 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.657 1.183 . . . . 0.0 111.059 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.82 175.86 51.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.213 0.911 . . . . 0.0 113.228 -170.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 156.68 38.38 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -118.16 158.02 25.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.131 2.172 . . . . 0.0 110.086 172.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.5 166.65 25.48 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 155.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -51.17 -45.68 61.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.972 0.886 . . . . 0.0 112.169 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.67 84.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.298 1.039 . . . . 0.0 112.651 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.2 -42.92 62.14 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 111.864 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -63.32 -40.13 96.47 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.366 -0.834 . . . . 0.0 111.364 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.02 -30.87 71.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.695 1.198 . . . . 0.0 112.854 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -64.7 -42.64 95.15 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.342 0.974 . . . . 0.0 111.47 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.44 -39.2 92.56 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.537 1.062 . . . . 0.0 111.776 173.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.3 -40.73 96.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.167 0.587 . . . . 0.0 112.104 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -65.92 -28.3 68.83 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.336 -0.852 . . . . 0.0 111.899 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.6 -18.79 50.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 113.339 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.42 -23.89 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.491 1.516 . . . . 0.0 112.228 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.2 t 54.58 63.31 7.34 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.868 1.667 . . . . 0.0 111.734 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.49 -21.85 73.0 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.502 2.801 . . . . 0.0 113.578 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -76.18 -4.15 40.16 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.123 1.769 . . . . 0.0 114.738 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 tp -65.52 -25.97 67.69 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.885 1.274 . . . . 0.0 113.559 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.1 m120 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.67 1.588 . . . . 0.0 112.653 -171.922 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 pt -79.22 166.97 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.284 0.634 . . . . 0.0 111.268 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -126.5 141.68 51.79 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.157 1.783 . . . . 0.0 109.516 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.42 155.36 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.785 1.234 . . . . 0.0 111.954 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.3 p -137.85 159.91 40.72 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.064 1.746 . . . . 0.0 111.206 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.69 -28.25 68.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.02 -17.69 54.9 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -122.18 -17.77 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.169 1.388 . . . . 0.0 114.368 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -50.85 -41.43 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.979 1.712 . . . . 0.0 112.957 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 -31.43 71.96 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -35.02 33.95 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 111.627 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.95 -45.6 16.43 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.74 -54.44 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 111.173 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -80.92 -13.35 58.98 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -168.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 t -95.72 -6.35 40.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.569 1.148 . . . . 0.0 112.979 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -69.32 144.33 53.55 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.163 -0.96 . . . . 0.0 112.814 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -82.62 -5.42 58.8 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.939 1.296 . . . . 0.0 113.429 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -102.87 169.33 7.61 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 126.132 1.773 . . . . 0.0 112.367 -164.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -62.04 125.62 16.88 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.152 1.235 . . . . 0.0 109.147 147.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.99 116.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 109.938 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 tt -94.02 125.59 38.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.743 1.617 . . . . 0.0 108.39 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.85 128.27 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.441 -0.787 . . . . 0.0 110.582 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -106.04 113.08 26.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.218 1.007 . . . . 0.0 111.773 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -89.91 111.39 22.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.616 1.567 . . . . 0.0 108.913 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.8 172.8 15.04 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -163.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.82 142.74 51.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.387 1.075 . . . . 0.0 110.286 165.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -17.55 63.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -91.01 -11.86 37.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.535 1.534 . . . . 0.0 114.131 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 130.95 37.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.967 0.907 . . . . 0.0 111.873 -172.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.51 -60.27 9.12 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.691 1.139 . . . . 0.0 114.732 -175.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 -19.21 52.22 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.291 1.994 . . . . 0.0 113.236 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.4 m -71.18 -46.54 61.13 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.97 0.908 . . . . 0.0 111.059 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.99 -32.32 73.83 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.196 -0.94 . . . . 0.0 112.143 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.0 ttt -61.23 -34.97 75.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.671 0.788 . . . . 0.0 113.067 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.414 ' CG1' ' H ' ' A' ' 99' ' ' LYS . 27.6 m -88.56 -11.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.11 -50.93 72.47 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-N 120.116 1.326 . . . . 0.0 114.385 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.92 -34.3 30.25 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.499 1.466 . . . . 0.0 112.222 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -67.47 -49.27 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.256 -0.902 . . . . 0.0 111.303 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.84 -42.24 95.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.448 0.699 . . . . 0.0 111.054 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.77 -45.48 92.14 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.596 0.634 . . . . 0.0 111.876 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.71 -49.45 53.19 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.461 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.49 -42.46 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.761 1.164 . . . . 0.0 110.564 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.24 -31.33 68.69 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -74.09 -37.42 64.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.86 0.464 . . . . 0.0 110.334 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.76 -35.14 24.58 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -116.2 24.47 11.38 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.63 1.572 . . . . 0.0 113.537 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.43 -26.23 29.57 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.3 p -80.17 -18.16 50.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.446 1.499 . . . . 0.0 113.999 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -100.14 -40.94 7.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.264 1.425 . . . . 0.0 112.551 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.07 159.92 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.539 1.136 . . . . 0.0 113.49 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.0 m -107.21 141.49 38.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 110.233 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -117.87 133.75 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.173 0.589 . . . . 0.0 110.479 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.05 162.6 26.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.837 2.055 . . . . 0.0 111.235 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -133.07 142.89 48.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -116.98 123.72 47.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.7 2.0 . . . . 0.0 109.083 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -92.44 91.59 7.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 110.378 -172.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 m -66.25 -19.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.301 -0.874 . . . . 0.0 112.92 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.69 -26.34 68.33 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -122.11 -22.93 5.49 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.619 1.168 . . . . 0.0 113.579 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -120.55 88.61 43.24 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.323 1.449 . . . . 0.0 111.227 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.2 -13.56 18.95 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.836 2.357 . . . . 0.0 113.081 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -77.06 -39.98 47.88 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.839 -1.163 . . . . 0.0 112.2 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -27.5 55.51 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.663 -0.648 . . . . 0.0 111.822 168.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.53 96.92 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.251 -0.905 . . . . 0.0 112.255 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -72.24 -26.71 62.11 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.262 -0.899 . . . . 0.0 113.059 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.76 -40.79 89.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.118 0.967 . . . . 0.0 112.476 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -107.52 14.69 25.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.567 1.547 . . . . 0.0 113.819 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 53.26 57.11 6.57 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.316 1.846 . . . . 0.0 113.611 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.55 134.72 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.144 168.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.86 -40.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.568 1.147 . . . . 0.0 111.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.2 m -122.1 157.09 32.22 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.642 1.577 . . . . 0.0 110.215 163.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.2 pt -126.58 149.92 69.38 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.987 1.315 . . . . 0.0 111.782 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.33 140.26 65.18 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 CA-C-N 119.106 0.716 . . . . 0.0 112.391 -2.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -102.15 114.84 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.195 . . . . 0.0 107.931 168.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.73 127.96 52.68 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.147 0.979 . . . . 0.0 109.196 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.1 127.52 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.831 0.853 . . . . 0.0 109.705 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.9 tp -104.85 120.63 41.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.597 1.159 . . . . 0.0 110.751 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.27 157.35 16.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.084 1.753 . . . . 0.0 110.616 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -135.38 128.81 32.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.905 1.682 . . . . 0.0 109.109 165.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.0 t70 53.88 32.73 15.71 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.163 0.985 . . . . 0.0 113.248 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.72 9.46 84.91 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.467 1.508 . . . . 0.0 115.563 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -112.58 134.98 21.51 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 118.952 1.376 . . . . 0.0 110.888 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.01 140.18 41.14 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.881 2.388 . . . . 0.0 112.27 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.64 -46.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.73 1.212 . . . . 0.0 111.848 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -158.91 153.19 23.91 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.555 1.142 . . . . 0.0 113.302 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -128.62 139.03 52.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.488 1.915 . . . . 0.0 111.031 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.5 mm -129.69 147.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.092 1.757 . . . . 0.0 109.426 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.9 136.66 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 110.139 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.67 171.15 31.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.1 1.333 . . . . 0.0 113.174 -168.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 156.98 35.99 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -171.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.414 ' H ' ' CG1' ' A' ' 43' ' ' VAL . 3.5 mptp? -124.44 161.79 25.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.529 2.332 . . . . 0.0 111.842 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.51 161.8 13.18 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.8 1.19 . . . . 0.0 110.76 156.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -52.72 -39.78 62.39 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.331 1.052 . . . . 0.0 112.95 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.67 79.36 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.461 0.705 . . . . 0.0 112.029 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.61 72.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.362 0.665 . . . . 0.0 111.991 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.31 -47.99 83.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.928 0.891 . . . . 0.0 111.07 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.46 -31.5 68.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.626 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 ttp-105 -67.55 -46.26 73.26 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.422 1.465 . . . . 0.0 111.975 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -70.02 -21.5 63.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.09 -40.07 68.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.392 1.077 . . . . 0.0 112.96 163.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.7 m -66.28 -22.03 66.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.021 1.328 . . . . 0.0 112.198 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.33 -20.74 66.53 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 126.101 1.76 . . . . 0.0 112.157 -170.807 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.7 165.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.995 1.718 . . . . 0.0 111.115 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 143.44 50.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.91 1.284 . . . . 0.0 111.991 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -131.74 156.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.839 1.255 . . . . 0.0 112.939 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.6 p -137.24 168.32 19.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.933 2.493 . . . . 0.0 109.762 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.91 -27.91 65.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.89 -18.12 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.3 p -110.5 -25.11 10.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.729 1.611 . . . . 0.0 113.995 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -48.86 -41.54 33.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.581 1.952 . . . . 0.0 112.579 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.75 72.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -84.73 -33.04 23.18 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.28 -0.888 . . . . 0.0 111.947 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -84.77 -40.3 17.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 t -98.94 -52.71 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.38 1.472 . . . . 0.0 111.347 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.3 mt -83.12 -18.31 39.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.5 m -104.77 20.69 18.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.703 1.601 . . . . 0.0 113.538 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.9 p -58.74 -38.45 78.42 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.22 25.72 1.91 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.116 1.367 . . . . 0.0 113.633 -163.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.46 165.97 16.77 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 125.49 1.516 . . . . 0.0 112.31 168.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -45.24 133.61 11.86 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.72 2.28 . . . . 0.0 112.692 154.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -142.84 124.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.779 0.832 . . . . 0.0 111.215 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.7 tp -90.57 133.06 35.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.379 1.472 . . . . 0.0 107.558 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.92 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.819 1.19 . . . . 0.0 109.871 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -108.47 120.68 43.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.649 1.18 . . . . 0.0 111.704 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -98.55 112.71 24.66 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.021 2.128 . . . . 0.0 108.537 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.57 -179.0 7.03 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.13 137.33 52.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.848 0.459 . . . . 0.0 109.958 156.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.0 p -61.94 -23.21 66.23 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -85.78 -12.23 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.303 1.441 . . . . 0.0 114.47 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 143.9 38.95 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.285 0.948 . . . . 0.0 112.924 -170.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.11 -63.72 5.06 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.452 1.025 . . . . 0.0 114.27 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.91 -24.55 67.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.963 1.775 . . . . 0.0 112.625 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.6 m -62.92 -47.87 81.39 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.045 0.938 . . . . 0.0 110.953 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -64.3 -32.85 74.61 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.072 0.949 . . . . 0.0 112.792 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.95 -32.75 73.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 p -91.17 -13.54 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.436 1.016 . . . . 0.0 113.608 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.99 -50.4 62.9 Favored Pre-proline 0 CA--C 1.555 1.171 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.67 -30.63 34.37 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.627 1.552 . . . . 0.0 112.577 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.87 -49.63 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.05 0.94 . . . . 0.0 111.597 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.45 -34.81 77.94 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 111.618 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.7 -41.72 92.01 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.435 1.016 . . . . 0.0 112.5 170.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.73 -44.11 78.36 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.024 -1.048 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -58.15 -44.11 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.957 1.253 . . . . 0.0 111.266 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.44 78.12 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.036 0.534 . . . . 0.0 112.126 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -77.17 -41.36 41.94 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.53 -0.731 . . . . 0.0 111.357 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -83.67 -28.95 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -111.01 20.3 17.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.968 1.307 . . . . 0.0 113.128 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.15 -33.1 17.86 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -74.59 -23.38 58.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.136 1.375 . . . . 0.0 112.845 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -105.52 -33.79 7.99 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.579 1.952 . . . . 0.0 112.993 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -151.7 139.32 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.577 1.551 . . . . 0.0 110.517 -156.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.7 m -115.84 140.49 49.17 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.309 1.443 . . . . 0.0 109.614 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.68 128.25 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.935 0.894 . . . . 0.0 109.725 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.61 143.66 45.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.139 1.776 . . . . 0.0 111.918 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -110.6 127.86 55.42 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.198 1.399 . . . . 0.0 111.974 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.33 123.98 41.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.059 1.343 . . . . 0.0 109.786 167.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.91 118.0 34.69 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.535 0.734 . . . . 0.0 110.18 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -71.31 -16.44 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.52 -38.97 11.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.64 1.176 . . . . 0.0 112.714 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.7 p -87.49 -21.88 25.22 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.75 80.61 55.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.034 0.933 . . . . 0.0 111.891 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.55 -20.34 70.39 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.152 2.568 . . . . 0.0 113.706 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.93 -44.41 92.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 112.74 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 m -73.17 -33.09 65.25 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.195 0.907 . . . . 0.0 111.452 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.47 92.95 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.463 -0.773 . . . . 0.0 111.933 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.99 -25.82 53.16 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.86 -45.94 88.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.189 0.904 . . . . 0.0 111.397 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.07 10.33 41.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 113.933 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 45.42 50.59 10.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.798 2.039 . . . . 0.0 113.674 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 p -75.23 138.04 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.294 -0.879 . . . . 0.0 111.529 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -123.56 -15.81 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.3 m -133.68 150.88 51.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.828 1.651 . . . . 0.0 110.898 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.79 140.58 37.98 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.814 0.846 . . . . 0.0 111.873 174.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.72 152.73 94.98 Favored 'Cis proline' 0 CA--C 1.543 0.935 0 CA-C-N 118.973 0.669 . . . . 0.0 111.177 -11.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.9 m -133.87 124.88 27.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.767 1.227 . . . . 0.0 109.421 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.74 147.15 28.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.853 1.261 . . . . 0.0 110.867 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 tt -131.7 144.55 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.384 1.474 . . . . 0.0 109.633 169.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 tp -107.21 130.63 54.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.228 1.011 . . . . 0.0 110.307 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.68 147.16 29.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.84 1.256 . . . . 0.0 109.568 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -108.65 116.44 31.99 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.537 1.535 . . . . 0.0 108.365 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 51.33 34.27 11.44 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.812 1.245 . . . . 0.0 113.669 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.22 17.29 67.26 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -125.42 136.6 28.48 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 119.501 1.651 . . . . 0.0 110.865 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.22 139.81 39.48 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.773 2.316 . . . . 0.0 112.243 -172.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.57 -36.04 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -162.06 149.64 14.32 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.593 1.088 . . . . 0.0 113.302 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -129.07 141.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.891 1.676 . . . . 0.0 111.597 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 123.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.237 1.815 . . . . 0.0 111.44 -175.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.04 150.73 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.333 1.053 . . . . 0.0 111.822 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.76 -179.98 53.24 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.051 1.31 . . . . 0.0 113.437 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.95 157.51 28.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -129.49 152.23 49.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.034 1.734 . . . . 0.0 111.091 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.49 154.31 20.98 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 163.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -57.7 -33.03 67.95 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.12 82.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.149 0.58 . . . . 0.0 111.786 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.12 66.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.442 0.697 . . . . 0.0 111.457 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 104' ' ' LEU . 11.9 tp -61.64 -43.46 98.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.919 0.887 . . . . 0.0 111.343 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.1 tp -67.66 -34.74 77.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.774 0.829 . . . . 0.0 113.014 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -66.81 -45.14 79.29 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.361 1.437 . . . . 0.0 111.51 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.34 -34.67 70.89 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.35 -44.0 30.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 p -72.05 -15.06 62.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.755 1.222 . . . . 0.0 113.095 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -14.19 48.03 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 126.673 1.989 . . . . 0.0 110.431 -177.618 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 pt -121.52 134.74 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 112.816 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -82.6 127.44 33.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.411 1.484 . . . . 0.0 108.932 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.04 156.85 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.349 1.059 . . . . 0.0 112.282 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -134.39 172.0 13.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.455 2.302 . . . . 0.0 111.052 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.3 -26.67 63.3 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.062 -1.024 . . . . 0.0 113.659 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.63 -35.0 24.95 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.9 p -100.05 -24.14 14.69 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -53.01 -40.83 64.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.056 1.342 . . . . 0.0 112.597 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.34 -31.57 72.44 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.081 -1.012 . . . . 0.0 113.39 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.7 m -81.6 -33.83 31.31 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.796 0.838 . . . . 0.0 111.993 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -92.83 -25.73 17.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.23 -53.87 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.37 -19.93 55.51 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -77.2 -23.81 51.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -81.39 122.34 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.044 -164.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -72.45 -29.26 63.52 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.276 1.03 . . . . 0.0 111.629 166.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -72.18 158.94 86.69 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.373 1.069 . . . . 0.0 110.962 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.47 139.9 73.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.504 2.136 . . . . 0.0 110.974 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 t -128.85 117.54 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.689 0.796 . . . . 0.0 110.388 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.65 128.27 36.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.587 1.155 . . . . 0.0 108.678 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.38 127.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.85 0.86 . . . . 0.0 109.87 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -97.5 112.6 24.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.199 0.6 . . . . 0.0 111.179 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 11.1 m-85 -85.22 109.54 18.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.192 1.397 . . . . 0.0 107.65 170.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.42 178.51 8.37 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -165.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.96 47.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.834 0.454 . . . . 0.0 109.944 157.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -62.33 -20.71 64.65 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -85.42 -16.55 39.39 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.151 1.38 . . . . 0.0 114.461 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 144.71 38.54 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.23 0.923 . . . . 0.0 113.398 -167.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.35 -63.9 4.88 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.634 1.111 . . . . 0.0 114.405 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.79 -21.33 51.17 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 119.616 1.708 . . . . 0.0 112.932 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.9 m -63.14 -47.48 82.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.487 1.039 . . . . 0.0 110.683 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.16 -32.3 73.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.903 0.881 . . . . 0.0 112.647 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.9 ttt -63.77 -36.43 83.85 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.45 -11.37 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -54.67 39.53 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 119.948 1.249 . . . . 0.0 113.915 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.3 -33.43 59.27 Favored 'Trans proline' 0 C--N 1.355 0.893 0 CA-C-N 121.143 1.444 . . . . 0.0 111.685 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.24 -51.27 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.609 0.764 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.48 -37.96 83.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.684 0.675 . . . . 0.0 111.086 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.64 -42.6 98.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.499 0.591 . . . . 0.0 112.218 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.98 -48.04 69.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.049 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.1 mm -57.94 -42.88 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.839 1.654 . . . . 0.0 110.821 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.52 91.82 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.138 0.426 . . . . 0.0 111.685 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -79.43 -31.36 42.6 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.297 1.039 . . . . 0.0 112.459 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -87.03 -31.12 20.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -126.49 27.02 6.23 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.8 -28.93 17.17 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -76.63 -20.32 56.83 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.755 1.622 . . . . 0.0 114.257 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.57 -37.15 8.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.821 1.249 . . . . 0.0 112.709 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.59 174.0 12.17 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.383 1.473 . . . . 0.0 113.088 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.3 m -117.96 146.34 44.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.199 1.399 . . . . 0.0 109.783 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.23 138.12 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.765 0.826 . . . . 0.0 109.995 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.05 161.26 35.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.289 1.835 . . . . 0.0 112.101 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -131.55 138.08 48.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.544 1.138 . . . . 0.0 112.713 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.435 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 5.1 tt -128.14 111.91 13.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.294 2.238 . . . . 0.0 107.966 -172.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -86.45 112.52 21.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.379 0.609 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -71.42 -17.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -88.11 -40.69 13.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.285 1.034 . . . . 0.0 112.555 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -90.71 -23.32 20.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -130.56 68.25 81.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.144 1.377 . . . . 0.0 110.445 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.41 -16.65 39.17 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.241 2.627 . . . . 0.0 113.839 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.52 -37.67 87.44 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.32 -0.862 . . . . 0.0 112.727 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.7 p -77.18 -35.29 55.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.48 0.712 . . . . 0.0 112.387 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.04 98.59 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 112.357 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -76.91 -23.29 52.53 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -58.75 -42.32 88.59 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.301 0.955 . . . . 0.0 111.635 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -97.98 5.66 48.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.197 1.399 . . . . 0.0 113.589 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 52.46 41.05 30.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.516 1.927 . . . . 0.0 114.176 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -78.65 128.81 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.992 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -126.27 -6.94 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.626 1.57 . . . . 0.0 114.025 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.7 m -122.24 150.76 41.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.226 1.81 . . . . 0.0 110.876 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.8 pt -137.86 144.88 45.96 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.086 0.955 . . . . 0.0 112.08 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.27 144.91 74.59 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 CA-C-N 119.498 0.857 . . . . 0.0 111.084 -13.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -122.66 114.73 20.98 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.494 1.118 . . . . 0.0 108.881 172.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.6 mt -98.69 123.87 43.17 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.011 1.324 . . . . 0.0 109.433 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.96 139.78 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.384 1.074 . . . . 0.0 110.397 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 tp -106.17 126.65 52.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.857 1.263 . . . . 0.0 111.502 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -107.59 152.75 23.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.607 1.963 . . . . 0.0 111.607 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -144.91 131.44 19.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 0.0 109.883 172.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.18 33.28 12.05 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -171.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.51 42.14 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.859 1.695 . . . . 0.0 114.94 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -95.59 139.04 21.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 118.711 1.255 . . . . 0.0 110.538 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.88 135.98 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.48 2.12 . . . . 0.0 110.841 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.75 -48.9 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.852 0.861 . . . . 0.0 112.237 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -154.21 148.64 26.14 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.628 1.171 . . . . 0.0 112.125 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -132.83 139.89 47.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.161 1.384 . . . . 0.0 111.596 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.72 129.01 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 110.754 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.39 36.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.289 1.435 . . . . 0.0 113.603 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.41 174.25 38.79 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.347 0.975 . . . . 0.0 114.297 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.31 154.34 42.01 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.715 1.206 . . . . 0.0 113.878 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.03 153.49 51.34 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.006 1.723 . . . . 0.0 111.595 165.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.26 167.42 43.3 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.215 0.912 . . . . 0.0 110.961 164.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -58.69 -34.64 71.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.36 66.99 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.824 0.45 . . . . 0.0 111.385 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.23 83.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.656 0.782 . . . . 0.0 111.771 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 tp -68.53 -38.21 80.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.381 -0.824 . . . . 0.0 112.21 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -68.09 -33.45 74.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.161 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 tpt85 -68.5 -38.82 81.29 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.313 1.415 . . . . 0.0 112.65 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -62.24 -36.32 81.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.456 1.102 . . . . 0.0 111.347 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mt -68.56 -43.6 76.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 113.404 169.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.2 m -68.15 -17.96 64.49 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.113 1.365 . . . . 0.0 112.186 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.53 -12.37 43.97 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.54 1.136 . . . . 0.0 113.57 167.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 126.231 1.813 . . . . 0.0 112.023 -176.263 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 pt -140.79 168.58 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.312 1.845 . . . . 0.0 111.825 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -115.5 143.47 45.26 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.832 1.253 . . . . 0.0 110.422 163.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.35 167.13 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.428 1.491 . . . . 0.0 112.425 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.412 ' H ' ' HB2' ' A' ' 16' ' ' SER . 76.5 p -127.93 172.04 11.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.317 2.647 . . . . 0.0 109.36 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.89 -33.12 64.31 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.043 -1.036 . . . . 0.0 113.181 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.22 -38.14 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.679 0.791 . . . . 0.0 113.04 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 13' ' ' THR . 14.7 m -80.61 -24.68 38.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.316 1.046 . . . . 0.0 113.54 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -53.43 -41.84 66.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.898 1.279 . . . . 0.0 112.639 -173.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.37 69.87 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 m -87.33 -23.25 24.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.726 1.21 . . . . 0.0 113.081 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -107.34 -31.57 8.13 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.73 -56.44 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.221 1.009 . . . . 0.0 111.487 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.1 -12.43 60.9 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -76.19 -21.29 56.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.809 1.644 . . . . 0.0 114.104 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 t -96.27 128.19 42.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -73.33 -24.55 60.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.533 1.533 . . . . 0.0 112.449 166.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -74.17 149.42 87.11 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.281 1.432 . . . . 0.0 109.817 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.13 129.35 34.79 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.384 2.056 . . . . 0.0 111.904 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -128.71 120.07 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.641 1.176 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.445 HD21 HD11 ' A' ' 104' ' ' LEU . 29.8 tp -91.23 133.6 35.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.743 1.217 . . . . 0.0 108.87 174.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.78 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.494 1.043 . . . . 0.0 110.952 169.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -107.79 127.19 53.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.498 1.519 . . . . 0.0 111.57 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -100.34 117.53 34.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.894 1.678 . . . . 0.0 110.064 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.31 168.65 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -169.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 -176.93 3.65 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.817 1.647 . . . . 0.0 111.726 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.7 p -74.66 -23.72 58.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.167 1.387 . . . . 0.0 114.52 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -114.56 -13.49 12.16 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -161.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.59 120.55 24.09 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -164.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.91 -59.07 8.45 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.612 1.101 . . . . 0.0 114.413 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.5 -24.14 36.59 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.007 1.903 . . . . 0.0 113.386 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -76.31 -32.29 58.66 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.327 0.967 . . . . 0.0 111.965 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -75.36 -32.58 60.89 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.624 -0.673 . . . . 0.0 112.052 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.58 -33.47 75.03 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.17 0.988 . . . . 0.0 113.57 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.76 -20.43 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.404 1.002 . . . . 0.0 113.592 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.66 -40.72 85.42 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.536 1.517 . . . . 0.0 115.083 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.19 -37.81 80.71 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.632 2.221 . . . . 0.0 113.047 171.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.89 -39.53 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.804 0.842 . . . . 0.0 110.806 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.79 -49.54 57.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.7 1.2 . . . . 0.0 110.683 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.61 -37.99 71.44 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.476 . . . . 0.0 110.538 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -77.18 -49.25 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.159 -0.448 . . . . 0.0 112.143 -172.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.8 mm -65.01 -36.4 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.356 0.98 . . . . 0.0 111.042 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.712 . . . . 0.0 112.822 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -75.48 -43.85 47.09 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.675 1.125 . . . . 0.0 110.956 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.69 -33.14 47.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -121.33 30.82 6.6 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.171 1.788 . . . . 0.0 112.374 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.57 -28.79 22.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.474 1.51 . . . . 0.0 114.335 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 m -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.775 1.23 . . . . 0.0 112.242 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -90.76 -37.88 13.38 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.768 1.227 . . . . 0.0 113.027 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 166.82 23.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.6 m -125.9 142.5 51.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.086 1.754 . . . . 0.0 108.51 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.16 138.18 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.489 0.716 . . . . 0.0 110.782 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.12 152.36 46.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.303 1.441 . . . . 0.0 112.639 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -106.85 135.05 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.552 1.541 . . . . 0.0 110.498 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.42 121.34 43.26 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -94.61 114.54 26.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.6 m -69.52 -16.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.46 -24.14 39.74 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.831 0.852 . . . . 0.0 112.726 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 p -86.9 -30.96 20.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -148.18 106.4 3.61 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.683 1.193 . . . . 0.0 110.987 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.2 -10.95 29.37 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 121.775 1.65 . . . . 0.0 112.465 161.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.77 -51.45 69.27 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.335 1.454 . . . . 0.0 112.194 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.56 -30.46 64.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.509 0.724 . . . . 0.0 112.05 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -43.43 98.86 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.499 -0.751 . . . . 0.0 111.944 173.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -77.26 -24.62 51.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -59.86 -44.59 94.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.289 0.95 . . . . 0.0 112.092 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.51 15.05 24.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 113.704 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 50.99 46.15 26.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.223 2.209 . . . . 0.0 113.836 173.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.96 121.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.357 1.063 . . . . 0.0 109.54 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.22 -29.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.054 1.342 . . . . 0.0 112.907 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.5 m -125.7 155.9 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.215 1.806 . . . . 0.0 110.201 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.31 123.08 27.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.82 159.01 98.22 Favored 'Cis proline' 0 CA--C 1.542 0.876 0 CA-C-N 120.015 1.041 . . . . 0.0 113.321 0.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.2 m -127.07 129.98 49.03 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.492 1.117 . . . . 0.0 108.874 161.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.76 144.26 38.42 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.057 1.343 . . . . 0.0 110.367 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 tp -140.72 126.78 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.005 1.322 . . . . 0.0 109.508 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.76 133.19 38.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.789 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -118.95 149.65 41.25 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.84 1.656 . . . . 0.0 111.633 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -146.49 136.44 23.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.596 1.159 . . . . 0.0 110.75 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.33 30.02 14.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.324 1.05 . . . . 0.0 112.665 -171.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.58 5.12 49.15 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.613 2.054 . . . . 0.0 114.895 -172.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -95.26 131.75 29.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 118.527 1.163 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.66 132.49 23.59 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.55 2.167 . . . . 0.0 110.812 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.2 t -106.72 -47.47 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.547 1.139 . . . . 0.0 111.832 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -158.45 131.83 7.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.682 1.193 . . . . 0.0 111.254 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -112.28 136.55 51.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.379 1.471 . . . . 0.0 110.73 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.42 122.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.893 1.277 . . . . 0.0 109.524 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.09 41.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.014 1.325 . . . . 0.0 112.883 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.76 -178.77 41.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.154 0.883 . . . . 0.0 114.067 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.18 157.23 34.23 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.684 1.193 . . . . 0.0 113.871 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -129.98 160.7 32.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.6 1.96 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.35 164.02 12.12 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.3 1.428 . . . . 0.0 110.85 159.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -52.57 -40.8 62.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.546 1.139 . . . . 0.0 113.253 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.45 -44.96 77.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.17 0.588 . . . . 0.0 111.794 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -40.32 68.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.524 0.73 . . . . 0.0 112.242 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.445 HD11 HD21 ' A' ' 29' ' ' LEU . 15.3 tp -62.29 -44.67 95.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.921 0.888 . . . . 0.0 111.452 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.0 tp -68.12 -30.04 69.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.459 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -60.57 -47.69 85.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.604 1.093 . . . . 0.0 110.933 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.61 -40.5 87.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.475 1.034 . . . . 0.0 111.815 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.48 -30.52 69.39 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -75.63 -26.19 57.56 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.656 1.183 . . . . 0.0 112.386 171.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -85.7 11.15 11.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.342 1.857 . . . . 0.0 113.498 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.468 0.454 0 O-C-N 120.881 -1.137 . . . . 0.0 113.319 -171.244 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 pt -137.34 167.58 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.766 1.626 . . . . 0.0 111.132 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -127.71 148.41 50.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.704 0.802 . . . . 0.0 112.203 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.14 159.58 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.677 1.591 . . . . 0.0 112.446 -170.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.9 p -142.6 168.42 19.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.829 2.452 . . . . 0.0 110.501 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -56.03 -25.97 46.99 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.26 -16.68 39.37 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.1 p -119.64 -25.28 5.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.676 1.591 . . . . 0.0 114.71 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.53 -39.44 48.93 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.36 1.864 . . . . 0.0 112.932 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.35 71.85 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.2 m -87.33 -30.77 20.57 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.448 -0.782 . . . . 0.0 112.043 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -87.31 -43.92 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.0 t -98.62 -52.87 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.89 1.276 . . . . 0.0 111.344 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -79.81 -13.77 59.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -110.4 18.18 20.08 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 0.0 113.343 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.0 p -62.25 -36.89 83.43 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -167.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.295 0.5 OUTLIER 48.01 21.6 0.33 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.916 1.687 . . . . 0.0 115.185 -161.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.22 168.1 11.85 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 126.177 1.791 . . . . 0.0 111.928 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.75 139.31 74.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.708 2.272 . . . . 0.0 112.901 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.74 124.77 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.69 1.196 . . . . 0.0 111.388 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.5 99.01 10.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.702 1.601 . . . . 0.0 109.171 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -99.28 121.05 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.282 -0.887 . . . . 0.0 110.655 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -102.34 118.4 36.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.6 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -91.97 112.82 24.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.614 1.566 . . . . 0.0 108.552 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 172.62 13.98 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.378 1.071 . . . . 0.0 113.02 -169.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.54 175.08 5.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.591 1.156 . . . . 0.0 111.09 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.5 p -74.93 -18.54 60.38 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.0 -1.062 . . . . 0.0 113.726 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -116.95 -5.25 11.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -163.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.75 134.39 39.18 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.457 1.026 . . . . 0.0 113.699 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -62.99 5.54 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.454 1.026 . . . . 0.0 114.094 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.17 -25.01 65.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.335 2.023 . . . . 0.0 113.363 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -74.55 -33.42 62.71 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.091 0.859 . . . . 0.0 112.088 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -64.01 -40.75 97.03 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.453 -0.779 . . . . 0.0 112.023 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.43 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.16 99.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 120.343 1.429 . . . . 0.0 113.517 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.82 -41.69 36.33 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.869 1.713 . . . . 0.0 112.163 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.14 -47.04 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.57 1.148 . . . . 0.0 111.77 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.74 -38.21 76.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.112 0.965 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 -41.05 82.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.612 1.096 . . . . 0.0 112.314 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.03 -47.97 69.76 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.013 -1.054 . . . . 0.0 111.614 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 mm -59.14 -40.5 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.286 1.403 . . . . 0.0 111.233 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.73 75.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.714 0.688 . . . . 0.0 112.564 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.4 m -78.19 -40.42 37.7 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.284 -0.885 . . . . 0.0 111.463 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.17 -21.7 29.09 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -128.66 25.67 5.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.146 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -34.11 21.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.499 1.52 . . . . 0.0 114.459 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -78.17 -18.56 55.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.465 1.506 . . . . 0.0 113.701 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -97.61 -38.25 9.61 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.135 1.374 . . . . 0.0 112.49 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 160.42 43.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -109.08 138.01 46.09 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.099 1.359 . . . . 0.0 109.508 166.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.74 133.5 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.33 147.34 49.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.209 1.404 . . . . 0.0 111.873 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.55 135.19 53.56 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.533 1.133 . . . . 0.0 111.705 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.31 124.93 52.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.039 1.336 . . . . 0.0 109.26 164.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.29 96.61 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.928 0.891 . . . . 0.0 109.926 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -65.73 -22.72 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.044 -1.035 . . . . 0.0 112.493 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.31 -27.48 63.42 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.527 1.531 . . . . 0.0 113.015 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.1 p -123.51 -21.24 5.33 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.069 1.348 . . . . 0.0 114.254 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -128.73 63.84 67.1 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.385 1.474 . . . . 0.0 111.929 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.25 -13.26 38.89 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.322 2.681 . . . . 0.0 113.784 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -61.9 -37.36 84.3 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.218 -0.926 . . . . 0.0 112.199 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -77.5 -32.29 54.07 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.648 -0.657 . . . . 0.0 112.096 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.24 95.92 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.059 -1.025 . . . . 0.0 111.657 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -75.7 -25.55 56.78 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.34 -42.74 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.224 0.92 . . . . 0.0 111.977 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -104.52 9.87 35.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.431 1.492 . . . . 0.0 113.795 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 49.55 48.55 21.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 113.675 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.1 130.69 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.617 1.167 . . . . 0.0 110.297 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.04 -17.01 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 68.9 m -128.66 158.81 37.49 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.66 1.584 . . . . 0.0 111.079 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.4 pt -135.54 142.54 41.5 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.189 0.996 . . . . 0.0 112.07 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.39 139.55 57.12 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 CA-C-N 119.495 0.855 . . . . 0.0 111.501 -8.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.0 m -122.46 118.18 27.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.857 0.863 . . . . 0.0 108.858 168.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.05 141.62 32.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.333 1.053 . . . . 0.0 109.822 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 tp -137.77 121.47 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.065 1.346 . . . . 0.0 108.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -95.88 114.99 26.77 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.237 1.415 . . . . 0.0 109.706 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -95.55 148.74 22.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.207 1.403 . . . . 0.0 110.44 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -129.73 119.16 23.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.38 1.472 . . . . 0.0 108.877 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 49.87 35.22 8.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.684 1.194 . . . . 0.0 113.814 -174.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.5 76.85 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -122.23 141.55 34.79 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.465 1.632 . . . . 0.0 111.843 165.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.07 142.56 38.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.31 2.673 . . . . 0.0 112.277 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -120.85 -43.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.384 1.074 . . . . 0.0 113.118 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.62 133.16 19.77 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.492 1.117 . . . . 0.0 112.144 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -111.59 141.3 45.36 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.394 1.477 . . . . 0.0 111.668 171.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.6 147.46 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.301 2.24 . . . . 0.0 110.665 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.28 141.85 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 0.0 111.035 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.82 171.03 44.61 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.193 1.377 . . . . 0.0 113.597 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.44 39.34 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -138.97 158.95 43.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.905 2.082 . . . . 0.0 111.044 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.42 169.35 32.92 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.519 1.057 . . . . 0.0 111.863 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -57.58 -38.05 74.19 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.099 -0.648 . . . . 0.0 112.568 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.84 81.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.333 0.653 . . . . 0.0 111.677 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.25 77.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.37 0.668 . . . . 0.0 111.594 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.65 -40.17 96.18 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.107 0.963 . . . . 0.0 112.103 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.07 -33.15 74.88 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.846 0.858 . . . . 0.0 112.401 172.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -68.21 -38.93 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.49 1.041 . . . . 0.0 112.403 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -61.49 -38.71 88.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 0.826 . . . . 0.0 111.537 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.2 tp -67.2 -43.56 81.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.72 0.408 . . . . 0.0 111.814 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.2 p -71.82 -15.37 62.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.37 -16.99 64.56 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 126.562 1.945 . . . . 0.0 111.873 -173.291 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 121.328 0.585 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 pt -112.47 163.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.448 1.099 . . . . 0.0 111.227 160.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -126.46 130.72 51.23 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.683 1.593 . . . . 0.0 109.611 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.31 156.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.09 0.956 . . . . 0.0 113.368 -168.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.3 p -138.96 163.47 32.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.44 2.296 . . . . 0.0 110.406 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.04 -32.66 72.28 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -166.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.28 -20.59 57.21 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -109.38 -18.87 13.46 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.561 1.545 . . . . 0.0 113.88 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -52.93 -41.39 64.42 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.8 1.64 . . . . 0.0 112.927 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.44 72.18 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 m -85.52 -22.14 28.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 112.57 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -96.45 -42.38 8.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 -54.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.871 1.268 . . . . 0.0 111.623 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.66 -11.73 60.06 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.3 p -78.35 -14.34 59.45 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.311 1.844 . . . . 0.0 114.098 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.9 t -69.31 148.92 49.07 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -161.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -107.01 21.37 17.67 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.9 2.08 . . . . 0.0 112.386 167.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -138.76 156.23 72.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 128.31 2.644 . . . . 0.0 108.977 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.31 141.35 88.91 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.711 1.607 . . . . 0.0 112.559 160.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 123.09 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.418 1.087 . . . . 0.0 110.55 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.46 131.25 34.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.492 1.117 . . . . 0.0 108.531 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.63 127.9 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 119.089 0.859 . . . . 0.0 109.837 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -102.13 125.12 48.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.617 0.767 . . . . 0.0 111.172 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.16 112.24 24.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.412 1.485 . . . . 0.0 109.115 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.88 171.68 16.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -166.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 174.72 7.74 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.168 1.387 . . . . 0.0 111.954 174.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.6 p -75.11 -18.73 60.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -115.11 -7.0 12.49 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -165.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.05 128.02 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.37 -60.69 8.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.467 1.032 . . . . 0.0 114.102 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.42 -27.1 54.91 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.192 1.928 . . . . 0.0 113.501 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.61 -33.18 64.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.048 0.84 . . . . 0.0 112.015 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.82 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.172 -0.955 . . . . 0.0 112.722 167.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.89 -30.34 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.835 1.198 . . . . 0.0 113.79 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.64 -6.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.94 -53.89 53.05 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.469 1.031 . . . . 0.0 113.496 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.0 -33.85 91.6 Favored 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 121.646 1.624 . . . . 0.0 112.409 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.91 -50.02 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.988 0.915 . . . . 0.0 112.08 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.78 -37.68 82.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.36 0.664 . . . . 0.0 111.31 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.1 -37.37 78.36 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.143 0.577 . . . . 0.0 112.338 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.39 -48.59 66.93 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.781 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mm -59.67 -38.84 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 120.734 1.606 . . . . 0.0 111.185 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.66 90.51 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.802 0.728 . . . . 0.0 112.884 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.3 m -74.52 -39.5 62.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.041 0.536 . . . . 0.0 111.909 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.27 -34.67 14.85 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -167.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -117.01 20.48 13.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.216 1.406 . . . . 0.0 113.619 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.8 -27.8 19.71 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -81.16 -18.79 45.1 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.48 1.512 . . . . 0.0 113.936 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -94.56 -42.59 8.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.829 1.252 . . . . 0.0 112.068 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.62 155.94 38.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.007 1.323 . . . . 0.0 112.64 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.82 137.85 37.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.159 171.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.11 133.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.829 0.741 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.63 153.87 44.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.625 1.97 . . . . 0.0 111.705 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -123.12 131.48 53.71 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 0.0 112.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.91 121.96 45.55 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.384 1.474 . . . . 0.0 108.729 170.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.22 95.05 7.14 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.184 0.994 . . . . 0.0 109.772 -171.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.5 -20.73 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.327 1.051 . . . . 0.0 113.323 -170.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.44 -33.12 62.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.876 1.27 . . . . 0.0 112.827 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 p -107.35 -20.83 13.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.343 1.457 . . . . 0.0 113.349 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.05 81.91 69.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.734 2.013 . . . . 0.0 109.449 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -74.99 -11.22 21.49 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.202 2.601 . . . . 0.0 114.356 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.8 -40.28 61.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.161 0.984 . . . . 0.0 112.772 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -73.74 -29.59 62.32 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.025 -1.047 . . . . 0.0 112.472 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.14 94.18 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.371 0.669 . . . . 0.0 111.97 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -81.66 -23.24 37.02 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -59.42 -44.79 92.8 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.692 1.197 . . . . 0.0 111.575 171.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.43 4.77 50.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.144 1.378 . . . . 0.0 114.49 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 48.73 61.15 3.23 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.667 1.587 . . . . 0.0 112.763 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.25 134.17 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.604 1.562 . . . . 0.0 110.767 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.19 -14.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 t -146.71 167.55 23.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.025 1.33 . . . . 0.0 111.95 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.28 121.91 16.84 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.709 1.204 . . . . 0.0 108.36 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.65 157.32 94.66 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.882 0.994 . . . . 0.0 112.59 -5.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.9 m -130.33 120.81 24.92 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.216 1.006 . . . . 0.0 109.559 165.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.4 126.99 50.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.644 1.577 . . . . 0.0 109.006 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.39 133.27 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.287 1.035 . . . . 0.0 110.501 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -104.18 118.39 36.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 110.539 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.86 151.34 19.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.602 1.561 . . . . 0.0 110.43 167.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -124.7 124.39 42.06 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 108.834 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.26 36.25 12.27 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.458 1.103 . . . . 0.0 113.5 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.97 18.26 78.94 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.073 1.321 . . . . 0.0 116.094 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -126.3 140.29 36.76 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.565 1.682 . . . . 0.0 111.469 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.05 140.06 33.9 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.128 2.552 . . . . 0.0 112.53 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 t -114.53 -48.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.713 1.205 . . . . 0.0 112.605 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -153.92 141.14 19.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 111.269 -167.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -129.36 136.34 49.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.91 1.284 . . . . 0.0 112.416 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.7 mm -129.83 142.62 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.964 2.106 . . . . 0.0 109.868 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -113.42 148.99 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.332 1.453 . . . . 0.0 112.363 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.31 175.41 42.78 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.158 0.885 . . . . 0.0 114.239 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.74 148.42 38.56 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -154.19 163.87 39.44 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.601 1.961 . . . . 0.0 112.092 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.48 166.79 32.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.688 1.137 . . . . 0.0 112.642 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -60.88 -32.09 71.55 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.637 1.175 . . . . 0.0 114.131 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.6 91.83 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.225 0.61 . . . . 0.0 111.691 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.23 60.78 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.082 0.953 . . . . 0.0 112.773 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.58 -44.0 65.29 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.266 -0.896 . . . . 0.0 111.295 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.38 -30.32 70.07 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.398 -0.813 . . . . 0.0 112.127 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -68.46 -42.81 78.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.585 1.084 . . . . 0.0 112.505 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.04 -29.45 69.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.445 1.02 . . . . 0.0 112.186 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.77 -44.21 81.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.228 0.467 . . . . 0.0 111.87 168.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.1 m -66.25 -18.96 65.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.819 1.248 . . . . 0.0 112.641 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.06 -18.82 65.62 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 124.87 1.268 . . . . 0.0 110.888 175.505 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.34 141.96 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.65 1.58 . . . . 0.0 111.431 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -97.95 134.76 40.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.553 1.141 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.21 162.25 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.735 1.214 . . . . 0.0 112.833 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.2 p -123.03 169.77 10.84 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.478 1.911 . . . . 0.0 111.238 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.65 -25.86 60.79 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.096 -1.003 . . . . 0.0 113.264 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.44 -50.67 7.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.54 1.136 . . . . 0.0 113.574 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -80.33 -16.1 55.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -49.28 -42.96 42.62 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.815 1.246 . . . . 0.0 111.632 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.2 94.46 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.507 -0.746 . . . . 0.0 112.281 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 m -72.32 -30.21 64.55 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -94.93 -34.14 12.51 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.93 -49.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.667 1.187 . . . . 0.0 111.562 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.1 mt -88.91 -34.83 16.8 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 m -83.94 3.54 33.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.556 1.142 . . . . 0.0 113.866 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -62.03 151.71 34.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.355 1.062 . . . . 0.0 113.139 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -81.21 -7.31 59.54 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.179 1.392 . . . . 0.0 114.022 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -142.76 167.08 17.17 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.402 1.881 . . . . 0.0 110.64 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -60.98 149.75 87.39 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.69 2.26 . . . . 0.0 112.207 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.1 t -129.66 130.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.723 0.809 . . . . 0.0 112.062 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 132.34 36.84 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.385 1.474 . . . . 0.0 108.627 168.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 129.92 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.15 0.886 . . . . 0.0 110.345 169.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -105.71 114.17 28.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.934 0.894 . . . . 0.0 111.128 171.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -91.9 117.2 29.58 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.529 1.531 . . . . 0.0 109.135 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.39 168.52 23.18 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -168.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.99 51.7 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 155.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.4 p -65.69 -12.29 52.34 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -167.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -105.41 -10.69 16.81 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.487 1.915 . . . . 0.0 114.452 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 145.11 45.76 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.311 0.96 . . . . 0.0 112.294 -173.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.52 -64.33 4.42 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.306 -0.872 . . . . 0.0 113.873 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.21 -28.2 87.08 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.15 2.566 . . . . 0.0 114.05 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.1 m -63.7 -49.67 72.19 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.537 0.735 . . . . 0.0 110.461 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.27 67.51 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.054 -1.029 . . . . 0.0 112.202 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.0 tpp -62.15 -31.71 72.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.27 -12.97 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.371 0.987 . . . . 0.0 113.647 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.5 -50.09 73.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 120.415 1.461 . . . . 0.0 114.176 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.72 -26.55 38.97 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.453 2.102 . . . . 0.0 113.493 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.2 t -69.35 -40.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 120.907 -1.121 . . . . 0.0 110.829 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.54 -40.41 35.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.0 1.32 . . . . 0.0 111.096 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.59 -43.16 46.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.535 1.134 . . . . 0.0 111.481 162.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.05 -51.71 10.6 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.984 -0.447 . . . . 0.0 111.442 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mm -62.0 -38.2 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.542 -0.723 . . . . 0.0 111.111 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.79 85.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.391 0.996 . . . . 0.0 112.43 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -75.53 -36.43 60.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.693 0.678 . . . . 0.0 111.689 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.95 -34.2 11.88 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -114.28 22.51 13.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.533 1.533 . . . . 0.0 113.444 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.37 -26.55 41.87 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -78.97 -22.76 45.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.443 1.097 . . . . 0.0 113.012 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -90.63 -46.76 8.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.264 1.426 . . . . 0.0 111.872 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.84 156.72 38.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.326 1.451 . . . . 0.0 112.272 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.6 m -106.0 143.5 34.05 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.618 1.167 . . . . 0.0 109.794 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.81 128.6 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 110.587 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.29 160.36 25.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.496 1.918 . . . . 0.0 112.297 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -124.75 137.37 54.33 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.94 1.696 . . . . 0.0 111.458 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -125.77 122.64 36.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.977 0.911 . . . . 0.0 110.351 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -93.47 111.82 23.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 110.55 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.09 -16.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.91 -42.85 23.29 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.061 0.944 . . . . 0.0 112.764 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -87.38 -25.5 23.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.02 0.928 . . . . 0.0 113.342 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -127.96 60.5 46.37 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.147 1.379 . . . . 0.0 112.222 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -65.43 -17.35 57.46 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.746 2.297 . . . . 0.0 112.553 172.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.44 -46.29 90.58 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.416 1.086 . . . . 0.0 111.533 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -29.94 67.44 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.198 -1.564 . . . . 0.0 111.714 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.72 78.36 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.255 -0.903 . . . . 0.0 112.752 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -26.11 54.22 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.806 1.184 . . . . 0.0 113.273 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -57.28 -44.86 84.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.906 0.882 . . . . 0.0 111.441 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -107.35 9.05 29.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 47.44 60.04 3.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.943 1.697 . . . . 0.0 112.003 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.5 t -84.5 117.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.045 1.338 . . . . 0.0 110.741 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.446 ' H ' ' NH2' ' A' ' 94' ' ' ARG . 51.6 t -147.99 129.46 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.978 2.111 . . . . 0.0 107.114 174.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -121.98 157.37 31.44 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.881 3.272 . . . . 0.0 110.826 -9.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.8 pt -69.28 145.66 96.08 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -171.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.46 138.96 56.12 Favored 'Cis proline' 0 CA--C 1.538 0.713 0 CA-C-N 118.756 0.592 . . . . 0.0 110.937 -11.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.5 m -112.35 113.87 26.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.955 0.902 . . . . 0.0 108.957 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.23 124.78 46.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.987 1.315 . . . . 0.0 108.457 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -128.76 138.82 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.088 0.955 . . . . 0.0 111.367 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.57 129.89 52.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.099 1.36 . . . . 0.0 111.983 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -109.87 139.67 44.68 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.816 2.047 . . . . 0.0 111.114 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -124.02 122.31 37.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.365 1.866 . . . . 0.0 108.982 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 49.01 32.65 4.03 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.128 1.371 . . . . 0.0 114.38 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.79 18.87 69.22 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.61 147.06 59.12 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-N 119.519 1.659 . . . . 0.0 112.385 161.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.68 146.49 48.94 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.331 2.687 . . . . 0.0 112.016 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.97 -45.42 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.63 133.85 19.45 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' NH2' ' H ' ' A' ' 78' ' ' VAL . 52.3 ttt180 -117.8 131.94 56.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.255 2.222 . . . . 0.0 110.002 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.57 140.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.268 1.827 . . . . 0.0 109.603 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.27 146.92 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.929 1.292 . . . . 0.0 112.012 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.83 172.2 45.51 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.247 0.927 . . . . 0.0 113.712 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.09 143.88 47.23 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.46 156.64 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.86 2.064 . . . . 0.0 111.321 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.95 174.92 39.54 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.257 1.408 . . . . 0.0 112.932 -174.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -58.76 -39.97 82.55 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.29 78.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.476 0.711 . . . . 0.0 111.321 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -40.42 74.85 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.778 0.831 . . . . 0.0 112.049 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.66 -42.94 81.41 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.353 -0.842 . . . . 0.0 111.895 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.73 -31.28 71.82 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.676 -0.64 . . . . 0.0 111.928 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -44.78 96.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.127 -0.939 . . . . 0.0 111.685 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.58 -38.05 83.34 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.005 1.275 . . . . 0.0 111.862 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.37 -46.85 78.51 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.491 0.316 . . . . 0.0 111.54 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.3 m -67.71 -24.34 65.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.204 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.99 -10.59 59.99 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.6 t . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 126.012 1.725 . . . . 0.0 112.102 -167.204 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.746 0.308 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.7 pt -126.84 171.58 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.135 1.374 . . . . 0.0 112.414 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -125.95 145.42 50.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.493 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.24 159.41 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.537 1.535 . . . . 0.0 112.272 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.7 p -140.19 166.97 23.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.257 2.623 . . . . 0.0 109.935 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.16 -28.06 64.38 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.623 -1.298 . . . . 0.0 114.392 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.08 -24.28 35.3 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -102.51 -27.08 12.99 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 0.0 114.172 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.07 -40.72 58.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.682 1.993 . . . . 0.0 112.457 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.33 -31.4 71.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -83.07 -34.94 26.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.777 0.831 . . . . 0.0 111.798 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.74 -32.94 20.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -109.9 -52.92 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.288 1.435 . . . . 0.0 111.366 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -82.37 -13.38 56.95 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -89.1 1.69 55.22 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.575 1.15 . . . . 0.0 113.009 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -67.15 154.01 42.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.458 1.503 . . . . 0.0 114.946 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -121.06 22.59 10.94 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 126.718 2.007 . . . . 0.0 111.9 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -146.13 168.72 11.03 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 127.956 2.503 . . . . 0.0 111.14 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.19 137.63 52.76 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.71 116.42 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.118 1.367 . . . . 0.0 110.219 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.03 133.81 35.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.754 1.222 . . . . 0.0 109.072 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.9 129.5 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.503 1.047 . . . . 0.0 110.763 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -103.69 128.09 51.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.9 1.28 . . . . 0.0 111.706 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -99.53 116.66 32.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.235 1.414 . . . . 0.0 108.894 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -144.4 167.94 21.28 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.7 176.76 6.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 111.519 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.3 p -68.19 -24.71 64.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -112.88 -13.33 13.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 p -78.19 124.62 28.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -164.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.72 -59.59 10.52 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.795 1.188 . . . . 0.0 114.085 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.27 -27.0 41.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.128 1.964 . . . . 0.0 113.225 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.1 p -72.03 -39.58 69.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.305 0.957 . . . . 0.0 111.686 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -68.93 -29.34 67.56 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.293 -0.879 . . . . 0.0 112.434 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.5 ttp -68.66 -35.93 77.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.703 0.801 . . . . 0.0 113.156 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.73 -24.32 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.566 1.075 . . . . 0.0 113.511 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -45.94 -47.66 41.59 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -64.17 -27.62 64.72 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.96 1.773 . . . . 0.0 113.039 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 t -68.24 -35.87 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.889 1.222 . . . . 0.0 111.229 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 mt -67.98 -48.99 64.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.24 1.016 . . . . 0.0 110.341 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.65 -40.61 72.43 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.661 0.784 . . . . 0.0 110.866 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.16 -51.97 12.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.645 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.5 -39.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.972 1.26 . . . . 0.0 111.361 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.45 96.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.745 0.702 . . . . 0.0 111.604 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.5 m -76.79 -32.48 57.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.06 -22.83 28.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -130.18 27.24 5.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.983 1.313 . . . . 0.0 113.504 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.61 29.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.424 1.49 . . . . 0.0 114.517 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 p -78.11 -18.29 55.86 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.14 1.376 . . . . 0.0 113.737 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -102.01 -40.55 6.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.858 1.263 . . . . 0.0 112.687 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 172.79 12.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.635 1.174 . . . . 0.0 113.674 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -126.19 143.89 50.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.438 1.495 . . . . 0.0 109.779 170.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.8 127.83 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.568 0.699 . . . . 0.0 110.408 168.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.74 164.51 16.47 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.74 2.416 . . . . 0.0 111.722 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 137.96 47.57 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.498 1.119 . . . . 0.0 111.909 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.17 122.34 40.76 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.24 1.416 . . . . 0.0 110.175 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.84 108.63 19.63 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.803 0.841 . . . . 0.0 110.507 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -72.09 -16.65 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.3 -41.14 11.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.541 1.137 . . . . 0.0 112.522 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.7 p -89.43 -22.25 22.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -131.26 72.5 81.15 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.782 1.233 . . . . 0.0 111.793 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -14.59 45.64 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.891 2.394 . . . . 0.0 113.141 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -62.56 -42.87 99.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 112.546 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.0 m -74.18 -31.71 62.79 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.34 0.973 . . . . 0.0 111.711 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.29 94.38 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.658 0.783 . . . . 0.0 111.856 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -77.53 -24.51 49.95 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 168.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -61.28 -46.47 90.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.175 0.898 . . . . 0.0 111.474 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.11 4.25 41.98 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 48.85 62.78 2.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.768 1.627 . . . . 0.0 112.59 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.6 141.92 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 110.652 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.48 -45.03 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.599 1.16 . . . . 0.0 111.951 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -121.67 158.04 29.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.577 1.551 . . . . 0.0 111.287 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.58 130.46 23.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.998 0.919 . . . . 0.0 110.079 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.09 150.5 95.79 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.944 1.016 . . . . 0.0 113.317 -5.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 m -121.1 134.98 55.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.127 1.371 . . . . 0.0 109.12 164.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.73 139.75 45.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.156 1.782 . . . . 0.0 110.145 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 tp -135.03 126.2 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.71 1.204 . . . . 0.0 108.235 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.7 tp -107.06 126.4 52.3 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.978 1.311 . . . . 0.0 109.681 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -107.85 152.37 24.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.969 1.708 . . . . 0.0 110.275 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.202 1.801 . . . . 0.0 108.07 172.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 52.43 32.08 10.72 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 16.83 79.55 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.524 1.535 . . . . 0.0 116.841 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.62 144.14 43.59 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 119.543 1.671 . . . . 0.0 111.776 166.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.45 140.29 39.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.839 2.359 . . . . 0.0 112.2 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.0 m -117.15 -31.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.124 1.37 . . . . 0.0 114.226 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -158.17 142.12 15.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.183 0.993 . . . . 0.0 112.257 -170.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -125.76 136.68 53.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.106 1.763 . . . . 0.0 110.73 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.47 151.89 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.021 1.728 . . . . 0.0 110.295 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.56 147.14 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.492 1.117 . . . . 0.0 111.693 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.07 171.96 48.42 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.478 1.037 . . . . 0.0 113.753 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.8 38.52 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -139.47 152.0 46.65 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.718 2.007 . . . . 0.0 111.341 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.39 169.16 32.76 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.419 1.009 . . . . 0.0 112.022 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.43 -34.46 72.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.93 -42.76 84.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.14 0.576 . . . . 0.0 111.388 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.83 -44.83 72.64 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.582 0.753 . . . . 0.0 111.853 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.36 -43.48 97.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.731 0.813 . . . . 0.0 111.62 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -63.37 -35.75 81.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.406 0.682 . . . . 0.0 111.955 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.2 tpt85 -68.32 -38.25 81.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.201 0.909 . . . . 0.0 112.774 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.83 -39.48 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.444 1.02 . . . . 0.0 111.467 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -42.92 78.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.948 0.499 . . . . 0.0 111.867 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m -66.16 -20.16 66.05 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.061 1.344 . . . . 0.0 112.631 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.78 -19.83 66.03 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.469 0.524 0 C-N-CA 125.099 1.359 . . . . 0.0 110.359 176.08 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 121.218 0.532 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.4 pt -130.75 157.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.2 1.4 . . . . 0.0 111.703 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -103.09 141.74 35.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.85 1.26 . . . . 0.0 110.605 168.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.88 159.44 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.734 1.613 . . . . 0.0 111.359 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.5 p -141.39 168.28 20.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.927 2.491 . . . . 0.0 109.787 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.23 -27.4 34.36 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 120.636 -1.29 . . . . 0.0 113.933 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.76 57.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 p -126.72 -22.1 3.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -172.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -51.18 -41.55 60.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.134 1.773 . . . . 0.0 112.625 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.26 -31.38 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 m -86.07 -29.52 23.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.826 0.85 . . . . 0.0 112.15 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.84 -35.48 14.05 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.77 -55.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.823 1.249 . . . . 0.0 111.282 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.1 mt -80.01 -20.84 44.45 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -92.96 0.78 57.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.735 1.214 . . . . 0.0 113.318 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 t -65.82 143.72 57.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.863 0.865 . . . . 0.0 112.697 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -91.6 3.63 54.56 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.293 1.437 . . . . 0.0 113.044 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -141.62 168.85 12.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.642 1.977 . . . . 0.0 111.294 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.55 144.52 62.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.749 2.299 . . . . 0.0 114.092 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.43 129.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.704 1.202 . . . . 0.0 109.956 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.81 135.66 34.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 164.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.3 t -119.88 125.13 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 118.542 0.61 . . . . 0.0 110.078 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -107.34 113.73 27.3 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.535 1.134 . . . . 0.0 112.245 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -86.21 115.04 23.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.798 2.039 . . . . 0.0 109.102 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.54 172.03 15.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -167.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.75 146.39 50.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.611 1.165 . . . . 0.0 110.438 159.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.0 p -72.38 -14.96 61.84 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -93.66 -9.63 37.25 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.909 1.684 . . . . 0.0 114.032 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 135.22 36.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.373 1.069 . . . . 0.0 111.504 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.23 -65.24 3.66 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.831 1.205 . . . . 0.0 114.643 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.06 -25.87 65.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.376 2.05 . . . . 0.0 112.634 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.6 m -63.36 -45.7 89.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.833 0.853 . . . . 0.0 111.672 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -69.06 -32.83 72.58 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -66.65 -35.19 79.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.345 1.058 . . . . 0.0 113.561 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 m -77.84 -25.19 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.646 1.112 . . . . 0.0 113.684 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.92 -43.48 75.4 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.24 -36.48 87.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.541 2.161 . . . . 0.0 112.954 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.64 -37.03 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.137 0.975 . . . . 0.0 110.926 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.67 -49.69 51.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.521 1.128 . . . . 0.0 110.278 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.88 -40.8 76.89 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.36 0.664 . . . . 0.0 110.859 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -76.42 -48.82 18.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.074 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.49 -39.82 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 110.825 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.07 96.62 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 0.994 . . . . 0.0 111.628 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 m -77.82 -33.63 52.31 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.29 -30.51 23.69 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.235 -0.915 . . . . 0.0 113.054 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -118.45 26.52 9.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.248 1.819 . . . . 0.0 112.174 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.68 33.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.352 1.461 . . . . 0.0 114.195 -176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 p -76.89 -18.18 58.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.235 1.414 . . . . 0.0 113.671 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -101.4 -39.54 7.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.477 1.511 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.03 167.24 29.07 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -120.03 138.87 53.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.313 1.445 . . . . 0.0 109.737 166.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.43 127.6 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.177 0.591 . . . . 0.0 109.768 169.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.93 158.76 22.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.482 1.913 . . . . 0.0 111.585 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.21 131.41 54.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.196 1.398 . . . . 0.0 110.599 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.7 120.63 42.68 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.261 0.553 . . . . 0.0 109.582 164.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -94.67 97.25 9.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.091 0.957 . . . . 0.0 109.619 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.55 -19.41 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.186 -0.946 . . . . 0.0 112.37 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.93 -23.26 60.66 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.262 1.425 . . . . 0.0 114.056 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.0 p -127.2 -22.92 3.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -144.66 76.23 14.29 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.897 1.279 . . . . 0.0 111.134 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.6 -3.81 13.33 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.401 2.734 . . . . 0.0 113.9 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.25 -42.58 95.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.426 1.09 . . . . 0.0 113.051 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -27.17 52.7 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.9 94.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 111.796 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -76.75 -28.59 55.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -58.43 -44.29 89.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 112.069 172.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.68 7.36 46.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.939 1.296 . . . . 0.0 113.718 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 50.9 49.02 21.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.087 1.755 . . . . 0.0 113.246 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.04 123.32 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.504 1.121 . . . . 0.0 109.985 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.64 -23.92 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 t -135.5 165.69 24.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.256 1.422 . . . . 0.0 111.877 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.65 143.5 46.8 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.968 1.307 . . . . 0.0 111.745 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.7 147.37 86.49 Favored 'Cis proline' 0 CA--C 1.54 0.806 0 CA-C-N 119.431 0.833 . . . . 0.0 111.523 -8.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.2 m -133.04 122.22 23.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.216 1.006 . . . . 0.0 109.842 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.71 137.42 44.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.934 1.294 . . . . 0.0 109.75 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.34 132.83 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.114 0.966 . . . . 0.0 109.767 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -114.09 119.79 38.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.105 1.362 . . . . 0.0 111.307 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -101.55 146.68 27.35 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.874 2.07 . . . . 0.0 110.357 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -98.99 -41.17 7.69 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.696 0.798 . . . . 0.0 113.094 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -149.92 53.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.272 1.429 . . . . 0.0 110.422 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.96 15.96 63.38 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.491 1.043 . . . . 0.0 113.667 -168.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.68 126.81 22.8 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.969 2.108 . . . . 0.0 109.161 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.74 143.64 27.02 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.567 2.844 . . . . 0.0 112.754 -170.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.35 -46.6 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.45 1.1 . . . . 0.0 112.418 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -151.05 156.29 40.79 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -121.71 137.55 54.71 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.741 2.016 . . . . 0.0 110.126 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 127.85 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.352 1.461 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.2 157.71 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.525 1.13 . . . . 0.0 112.126 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.15 177.72 40.68 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.655 1.121 . . . . 0.0 113.818 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.33 155.71 38.25 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.24 151.85 50.12 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.606 1.962 . . . . 0.0 111.288 167.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.52 170.98 37.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.7 1.143 . . . . 0.0 111.332 161.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -55.28 -39.13 69.48 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.841 . . . . 0.0 113.028 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.65 85.01 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.398 0.679 . . . . 0.0 112.09 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.82 78.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.353 0.661 . . . . 0.0 111.696 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 104' ' ' LEU . 14.0 tp -66.2 -39.07 89.39 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.201 -0.937 . . . . 0.0 111.782 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.02 -30.63 69.05 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.328 1.051 . . . . 0.0 112.657 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -62.06 -47.6 83.98 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.691 1.132 . . . . 0.0 111.143 168.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -59.17 -41.58 88.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.121 0.873 . . . . 0.0 111.903 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.0 -41.95 97.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.137 0.575 . . . . 0.0 112.471 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.2 m -67.4 -25.1 65.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 112.465 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -75.96 0.05 19.8 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.15 0.98 . . . . 0.0 113.392 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 N--CA 1.475 0.793 0 C-N-CA 125.92 1.688 . . . . 0.0 112.523 -178.034 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.73 164.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.197 1.399 . . . . 0.0 110.941 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.95 143.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.753 1.221 . . . . 0.0 110.923 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.51 156.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.661 1.584 . . . . 0.0 112.283 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.3 p -117.72 174.33 6.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.333 2.253 . . . . 0.0 110.332 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.07 -29.77 45.62 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.94 -47.45 11.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.036 0.934 . . . . 0.0 113.262 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.79 -12.35 55.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.99 -46.24 43.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.714 1.205 . . . . 0.0 112.666 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.47 -31.32 69.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.3 m -89.31 -19.94 24.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.88 1.272 . . . . 0.0 113.223 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -122.01 -21.92 5.84 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.92 -37.23 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.511 1.505 . . . . 0.0 114.406 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.33 -11.42 60.05 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.059 1.3 . . . . 0.0 113.389 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.9 p -76.9 -7.56 55.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.453 1.501 . . . . 0.0 114.111 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 84.1 p -67.69 160.13 28.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.721 . . . . 0.0 114.883 -171.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.12 16.03 5.11 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.117 1.767 . . . . 0.0 112.536 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -142.43 173.03 5.03 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 128.282 2.633 . . . . 0.0 109.533 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -61.06 140.12 88.02 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.141 1.894 . . . . 0.0 113.383 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.02 114.93 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.078 1.351 . . . . 0.0 110.75 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.84 117.01 23.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -105.76 124.01 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.849 0.75 . . . . 0.0 109.873 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -101.64 117.06 34.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.869 1.268 . . . . 0.0 110.531 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.19 115.0 26.74 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.099 1.759 . . . . 0.0 109.351 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -148.1 168.04 23.44 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.6 170.41 7.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.183 0.993 . . . . 0.0 111.107 166.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -76.64 -6.17 50.93 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -129.41 -2.72 4.93 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -165.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 p -80.5 136.6 36.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.709 1.141 . . . . 0.0 113.981 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -62.93 5.32 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.805 1.193 . . . . 0.0 114.458 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.71 -23.18 42.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.37 2.046 . . . . 0.0 112.873 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.43 -40.06 58.13 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -68.29 -32.58 72.83 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.093 -1.004 . . . . 0.0 112.05 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.7 -32.3 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.791 0.836 . . . . 0.0 113.025 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.37 -5.5 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -53.52 52.3 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 120.269 1.395 . . . . 0.0 113.461 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 -33.48 48.56 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.627 1.551 . . . . 0.0 112.31 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.38 -52.01 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.1 0.864 . . . . 0.0 111.317 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -67.81 -36.7 80.88 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.902 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.8 -34.19 71.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.61 -46.02 77.23 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.261 -0.9 . . . . 0.0 111.321 171.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -56.7 -43.73 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.674 1.579 . . . . 0.0 110.973 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 60' ' ' VAL . . . -57.81 -45.58 85.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.729 0.412 . . . . 0.0 111.761 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.6 m -79.08 -29.85 43.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.389 1.076 . . . . 0.0 112.262 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -87.2 -23.05 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -129.4 24.96 5.48 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.34 -30.63 29.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.254 1.422 . . . . 0.0 114.712 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -77.5 -18.45 57.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.245 1.418 . . . . 0.0 113.933 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -104.3 -37.88 7.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.144 1.378 . . . . 0.0 112.726 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.61 173.79 12.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.092 1.357 . . . . 0.0 113.017 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.8 m -122.21 153.78 38.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.43 1.492 . . . . 0.0 109.939 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 51' ' ' ALA . 59.1 t -124.19 138.03 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.68 0.792 . . . . 0.0 109.58 168.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.38 160.36 38.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.097 1.759 . . . . 0.0 112.007 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -125.83 138.26 53.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.218 1.007 . . . . 0.0 112.697 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -119.39 125.59 49.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.934 1.694 . . . . 0.0 109.37 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.14 93.17 7.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.024 0.93 . . . . 0.0 110.519 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.02 -23.34 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.364 1.065 . . . . 0.0 113.152 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.09 -27.89 69.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.806 1.242 . . . . 0.0 112.368 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.7 p -119.46 -11.17 9.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.836 1.654 . . . . 0.0 113.844 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -127.07 56.82 19.59 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.839 1.656 . . . . 0.0 112.594 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.39 -13.37 33.02 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.178 2.586 . . . . 0.0 113.874 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.31 -30.7 60.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.378 1.071 . . . . 0.0 112.437 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -33.94 58.07 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.189 0.996 . . . . 0.0 112.559 165.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.07 95.89 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.838 0.744 . . . . 0.0 112.324 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -76.31 -23.43 54.31 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.3 -43.06 98.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.537 0.735 . . . . 0.0 111.851 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.41 11.98 35.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.479 1.512 . . . . 0.0 114.061 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 52.54 60.23 3.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.235 1.814 . . . . 0.0 113.056 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.5 t -66.11 126.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.915 0.886 . . . . 0.0 109.373 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.9 m -129.21 -30.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.002 1.321 . . . . 0.0 112.704 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -131.23 147.72 52.62 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.474 1.91 . . . . 0.0 109.358 167.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 pt -111.73 129.88 23.73 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.301 1.04 . . . . 0.0 110.145 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.63 143.39 77.38 Favored 'Cis proline' 0 CA--C 1.54 0.805 0 CA-C-N 119.649 0.91 . . . . 0.0 112.711 1.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.58 133.23 46.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.556 1.142 . . . . 0.0 108.036 161.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.39 126.15 51.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.7 1.2 . . . . 0.0 108.621 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.68 126.86 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 121.478 -0.764 . . . . 0.0 109.954 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.24 117.55 35.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.923 1.289 . . . . 0.0 110.399 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -94.14 158.33 15.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.868 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -142.54 135.39 28.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.749 1.619 . . . . 0.0 108.63 158.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.56 37.48 23.25 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.803 0.841 . . . . 0.0 113.093 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.19 16.65 67.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.508 2.004 . . . . 0.0 115.223 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -123.52 138.22 29.84 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.947 1.299 . . . . 0.0 110.973 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.42 139.85 32.39 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.914 2.409 . . . . 0.0 112.62 -173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -116.07 -42.83 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.664 1.586 . . . . 0.0 112.304 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -150.76 147.23 27.06 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.777 1.231 . . . . 0.0 112.597 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -125.21 137.11 54.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.854 2.062 . . . . 0.0 111.092 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.64 159.78 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 127.103 2.161 . . . . 0.0 110.874 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.6 153.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 111.527 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.45 169.36 25.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.637 1.113 . . . . 0.0 113.414 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 154.92 38.26 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.57 156.39 48.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.665 1.986 . . . . 0.0 110.923 168.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.99 162.63 42.85 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -57.33 -34.41 68.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.248 1.019 . . . . 0.0 113.645 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.36 77.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.856 0.463 . . . . 0.0 111.584 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.44 -50.09 64.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.685 0.794 . . . . 0.0 111.736 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.3 tp -61.61 -40.64 95.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.689 -0.632 . . . . 0.0 111.673 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.19 -40.22 95.34 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.106 0.866 . . . . 0.0 111.871 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -49.85 76.0 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.359 0.982 . . . . 0.0 110.662 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -63.19 -30.05 71.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -39.73 26.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 112.13 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.1 m -67.52 -18.11 64.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.8 1.64 . . . . 0.0 112.835 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.89 -16.02 15.49 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.09 1.356 . . . . 0.0 113.57 167.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 127.004 2.122 . . . . 0.0 109.913 178.057 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.36 170.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.398 1.479 . . . . 0.0 112.08 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -128.69 149.6 50.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.21 1.004 . . . . 0.0 112.274 165.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.33 156.56 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.5 p -139.07 159.56 41.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.644 1.978 . . . . 0.0 110.166 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.9 -27.94 68.53 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -164.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.98 -23.08 60.6 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.8 m -111.46 -19.87 12.42 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 0.0 113.46 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -49.36 -39.46 31.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 112.966 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.09 71.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.5 m -84.7 -33.87 23.06 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.613 -0.679 . . . . 0.0 111.751 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -80.85 -42.37 21.67 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.63 -52.48 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.538 1.535 . . . . 0.0 110.956 -174.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -80.3 -12.37 59.61 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 t -98.81 5.2 47.59 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.605 1.162 . . . . 0.0 113.353 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -67.11 152.11 46.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.497 1.519 . . . . 0.0 114.598 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.83 28.5 8.74 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.993 1.717 . . . . 0.0 111.022 171.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -153.06 169.33 9.88 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 128.267 2.627 . . . . 0.0 110.236 -175.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.23 144.84 87.66 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.073 1.848 . . . . 0.0 111.484 161.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.8 118.66 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.029 . . . . 0.0 109.597 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.25 112.72 25.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.948 1.299 . . . . 0.0 108.753 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.1 124.24 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.377 0.99 . . . . 0.0 110.667 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -97.54 112.7 24.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 111.429 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -85.55 111.14 19.75 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.747 1.619 . . . . 0.0 108.188 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.85 178.92 8.46 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -162.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.13 144.47 45.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.525 0.73 . . . . 0.0 110.364 159.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.9 p -67.37 -23.26 65.57 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -85.23 -9.58 57.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.361 1.464 . . . . 0.0 114.245 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 135.38 36.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.011 0.924 . . . . 0.0 111.48 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -62.95 5.63 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.742 1.163 . . . . 0.0 114.546 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.4 -21.02 61.3 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.342 2.028 . . . . 0.0 113.149 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.4 m -68.03 -49.63 60.25 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.937 0.789 . . . . 0.0 110.991 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.85 -32.97 74.66 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.108 -0.995 . . . . 0.0 112.03 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.51 -35.22 73.74 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.212 1.005 . . . . 0.0 113.108 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.63 -7.54 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.76 63.22 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 120.406 1.457 . . . . 0.0 114.15 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.23 -35.81 30.96 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.496 1.464 . . . . 0.0 112.012 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.83 -48.94 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.917 0.887 . . . . 0.0 111.469 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.17 -39.11 82.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.344 0.657 . . . . 0.0 110.756 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.8 -45.38 94.09 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.399 0.545 . . . . 0.0 112.075 173.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.92 -47.53 68.5 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.345 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -62.05 -35.21 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.999 1.727 . . . . 0.0 111.949 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.15 -43.95 92.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.547 1.067 . . . . 0.0 111.606 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.0 m -81.1 -30.09 34.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.889 0.876 . . . . 0.0 112.604 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -79.75 -15.57 57.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.365 1.066 . . . . 0.0 113.733 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.64 24.22 3.14 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.359 1.464 . . . . 0.0 114.122 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.41 -29.57 49.47 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -17.99 43.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.289 1.436 . . . . 0.0 113.688 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -101.66 -41.41 6.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.081 1.352 . . . . 0.0 112.698 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 176.46 10.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.911 1.684 . . . . 0.0 112.864 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -129.36 142.64 50.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 110.407 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.16 132.27 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.533 0.733 . . . . 0.0 109.84 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.05 162.65 30.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.204 2.202 . . . . 0.0 112.214 -164.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -127.59 139.65 52.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.234 1.413 . . . . 0.0 112.676 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.55 124.27 39.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.616 1.566 . . . . 0.0 109.766 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -89.62 97.46 11.21 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.157 0.983 . . . . 0.0 110.149 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.5 -25.15 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.984 -1.073 . . . . 0.0 112.559 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.18 -21.09 43.4 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.707 1.603 . . . . 0.0 113.845 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.0 p -125.89 -17.08 5.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -131.01 79.0 72.34 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.226 1.01 . . . . 0.0 111.542 163.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.27 -13.47 36.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.436 2.757 . . . . 0.0 114.496 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -58.09 -40.57 81.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.77 1.228 . . . . 0.0 112.821 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -81.52 -30.66 33.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.85 -1.156 . . . . 0.0 112.07 172.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.0 87.57 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.361 -0.837 . . . . 0.0 111.958 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 54.99 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.055 0.942 . . . . 0.0 113.5 169.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -64.36 -44.57 91.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.982 0.81 . . . . 0.0 111.084 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.78 4.27 37.73 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.973 1.309 . . . . 0.0 114.481 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 50.59 49.54 20.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.97 1.708 . . . . 0.0 113.093 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.72 134.63 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.807 0.843 . . . . 0.0 111.598 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.09 -40.04 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.353 1.061 . . . . 0.0 112.768 -170.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -142.27 168.39 19.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.227 1.411 . . . . 0.0 111.717 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.0 pt -130.76 146.18 60.85 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.822 1.249 . . . . 0.0 112.697 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.18 143.03 75.88 Favored 'Cis proline' 0 CA--C 1.54 0.79 0 CA-C-N 118.976 0.67 . . . . 0.0 111.423 -8.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.1 m -121.99 118.26 28.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.203 1.001 . . . . 0.0 108.665 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -105.65 129.5 53.88 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.142 0.977 . . . . 0.0 109.53 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.59 126.7 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.547 1.139 . . . . 0.0 109.833 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -105.19 119.75 39.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.127 1.371 . . . . 0.0 111.042 -173.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -97.08 154.73 17.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.158 1.783 . . . . 0.0 110.927 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -130.89 109.16 10.35 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.333 1.853 . . . . 0.0 109.386 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 52.97 37.74 25.36 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.211 1.004 . . . . 0.0 112.906 -174.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.06 11.65 82.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.307 1.432 . . . . 0.0 116.5 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -113.7 138.09 22.51 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 119.601 1.701 . . . . 0.0 111.507 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.57 139.55 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.74 -43.13 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.403 1.081 . . . . 0.0 112.661 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -149.46 141.12 23.51 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.835 1.254 . . . . 0.0 111.463 -165.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -129.17 138.28 51.65 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.284 1.434 . . . . 0.0 111.662 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.4 151.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 111.665 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.4 147.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.049 1.339 . . . . 0.0 111.225 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.23 168.11 42.65 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.819 1.676 . . . . 0.0 113.389 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.52 156.39 35.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.97 158.07 45.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.724 2.01 . . . . 0.0 111.197 169.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.82 170.27 41.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.026 0.822 . . . . 0.0 111.179 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.77 -39.81 71.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.55 -46.75 78.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.09 0.556 . . . . 0.0 111.575 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.31 76.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.324 0.65 . . . . 0.0 111.818 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.92 -40.04 95.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.203 0.601 . . . . 0.0 112.113 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.97 -30.12 68.48 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.64 -0.663 . . . . 0.0 112.269 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -36.8 70.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.864 1.211 . . . . 0.0 112.47 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.9 -35.89 79.69 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.508 -0.745 . . . . 0.0 111.847 168.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.59 -38.2 83.67 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -68.31 -21.11 64.79 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.412 1.085 . . . . 0.0 112.572 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -68.51 -10.66 57.05 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 125.93 1.692 . . . . 0.0 112.704 -174.573 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 pt -119.45 173.44 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.942 1.297 . . . . 0.0 111.46 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -127.81 139.4 52.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.771 1.628 . . . . 0.0 109.654 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.88 160.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.787 1.235 . . . . 0.0 112.795 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.8 p -124.47 166.61 15.72 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.296 2.638 . . . . 0.0 110.136 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -25.83 63.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.15 17.74 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.572 1.149 . . . . 0.0 113.07 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -80.34 -18.35 49.35 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.92 -41.72 25.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.917 2.087 . . . . 0.0 112.98 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.25 71.35 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.057 -1.027 . . . . 0.0 113.626 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -92.47 -19.0 22.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.378 1.471 . . . . 0.0 113.071 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -116.13 -25.47 7.61 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.11 -54.93 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.511 1.124 . . . . 0.0 111.422 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.8 mt -71.66 -16.94 62.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.4 p -75.33 -16.91 60.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.763 1.625 . . . . 0.0 114.505 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -72.0 149.14 45.24 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -165.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.62 -0.03 57.25 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.508 1.523 . . . . 0.0 113.796 172.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.94 167.25 20.91 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.019 2.127 . . . . 0.0 110.978 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.06 147.12 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.802 2.334 . . . . 0.0 114.311 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.3 t -133.5 125.58 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.797 0.839 . . . . 0.0 111.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.46 129.09 35.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.054 . . . . 0.0 108.802 172.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.49 127.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.321 1.048 . . . . 0.0 109.287 166.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -104.23 123.86 48.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.379 0.672 . . . . 0.0 111.409 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -87.1 112.81 22.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.258 1.023 . . . . 0.0 109.317 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.34 174.12 12.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -168.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.77 174.72 8.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.396 1.478 . . . . 0.0 111.206 171.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.1 p -75.93 -10.49 59.46 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -124.39 -5.05 7.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -164.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.55 132.39 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.597 1.089 . . . . 0.0 113.886 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -58.99 11.32 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.719 1.152 . . . . 0.0 114.284 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.87 -23.89 40.75 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 119.982 1.891 . . . . 0.0 113.041 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.9 -34.71 59.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.024 -1.047 . . . . 0.0 111.788 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -67.12 -32.32 73.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.821 0.848 . . . . 0.0 112.131 166.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.0 ttt -64.42 -35.37 80.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 174.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.42 -11.45 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.65 85.4 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.14 -30.99 37.35 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.467 1.56 . . . . 0.0 112.643 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.6 -47.82 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.253 0.933 . . . . 0.0 111.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.14 -35.27 73.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.258 1.023 . . . . 0.0 111.47 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.87 -45.26 90.23 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.061 0.846 . . . . 0.0 112.324 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.14 -45.87 79.52 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.933 -0.479 . . . . 0.0 110.756 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mm -61.28 -38.38 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.659 1.118 . . . . 0.0 111.881 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.63 92.89 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.619 1.1 . . . . 0.0 112.264 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.5 m -79.02 -33.27 45.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.859 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.92 -33.42 15.61 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -113.27 26.4 10.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.622 1.569 . . . . 0.0 113.101 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -25.88 53.67 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -73.2 -29.9 63.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.593 1.157 . . . . 0.0 112.153 173.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -90.71 -38.22 13.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.271 1.428 . . . . 0.0 113.008 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.11 173.05 13.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -110.9 146.87 35.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.782 1.633 . . . . 0.0 109.363 157.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.58 129.57 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.387 -0.821 . . . . 0.0 110.251 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.84 161.14 29.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.261 2.225 . . . . 0.0 111.295 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -131.76 142.95 49.9 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.433 0.693 . . . . 0.0 111.614 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.21 127.52 56.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.297 1.839 . . . . 0.0 109.599 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -96.04 97.25 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.485 1.114 . . . . 0.0 111.825 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.94 -16.0 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.2 -25.2 61.57 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.623 0.769 . . . . 0.0 112.538 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.8 p -126.67 -23.16 3.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -146.74 67.58 11.37 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.035 1.334 . . . . 0.0 111.977 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.34 2.86 5.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.014 3.143 . . . . 0.0 114.75 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -61.79 -39.73 92.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.842 -1.161 . . . . 0.0 113.59 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.34 -28.66 53.14 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 113.863 170.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.64 88.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.873 1.215 . . . . 0.0 112.117 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -75.51 -27.26 58.69 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.097 -1.002 . . . . 0.0 113.328 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -59.73 -41.82 91.75 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.21 0.914 . . . . 0.0 111.938 171.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -96.65 19.17 12.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.506 1.522 . . . . 0.0 113.597 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 52.59 42.52 31.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.451 2.301 . . . . 0.0 114.637 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.85 124.07 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.668 1.187 . . . . 0.0 110.59 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.88 -40.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.072 0.949 . . . . 0.0 111.418 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -147.88 161.74 40.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.615 1.566 . . . . 0.0 111.026 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.5 pt -109.01 142.39 25.42 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.746 1.218 . . . . 0.0 111.688 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.87 154.03 99.42 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.545 0.873 . . . . 0.0 112.535 -0.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -133.88 120.92 21.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.868 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.12 134.16 38.15 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.963 1.305 . . . . 0.0 109.0 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.6 131.19 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.411 1.084 . . . . 0.0 109.111 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.7 tp -108.18 116.4 31.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.845 1.258 . . . . 0.0 110.476 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.87 157.37 16.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.233 1.813 . . . . 0.0 111.514 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -144.75 131.56 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.493 1.917 . . . . 0.0 109.45 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.6 t70 50.0 32.99 6.19 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.27 16.21 80.73 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.876 1.227 . . . . 0.0 115.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -117.1 152.22 48.61 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.209 1.504 . . . . 0.0 111.638 164.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.1 150.43 77.31 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.293 1.996 . . . . 0.0 111.301 168.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.02 -42.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.258 1.023 . . . . 0.0 112.37 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -142.19 146.08 34.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.808 1.243 . . . . 0.0 112.32 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -129.44 130.35 45.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.533 1.533 . . . . 0.0 110.557 166.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -129.81 123.88 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.83 1.652 . . . . 0.0 109.777 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 148.06 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.687 1.195 . . . . 0.0 111.873 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.92 172.62 39.53 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.495 1.045 . . . . 0.0 114.333 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 149.8 42.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -151.48 162.02 41.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.308 1.843 . . . . 0.0 112.513 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.94 166.67 31.32 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.797 1.189 . . . . 0.0 112.547 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -59.89 -31.64 69.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.9 97.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.216 0.606 . . . . 0.0 111.868 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.65 -30.72 56.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.954 0.902 . . . . 0.0 113.199 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.65 -42.88 73.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.33 -0.856 . . . . 0.0 110.793 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.1 tp -67.88 -33.47 74.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.473 -0.767 . . . . 0.0 112.391 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.57 -50.11 70.75 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.566 1.075 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -64.28 -29.34 70.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.164 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.9 tp -67.74 -47.18 70.02 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.764 0.826 . . . . 0.0 113.194 171.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 m -68.89 -20.43 64.25 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.446 0.698 . . . . 0.0 112.385 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.75 -9.19 58.32 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 125.588 1.555 . . . . 0.0 112.79 -166.593 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -132.3 166.85 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.027 1.731 . . . . 0.0 111.905 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -116.42 139.36 50.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.795 1.638 . . . . 0.0 109.837 168.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.64 158.54 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.559 1.544 . . . . 0.0 112.041 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.2 p -143.53 162.71 35.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.028 1.731 . . . . 0.0 111.748 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.14 -28.15 62.49 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.59 -18.15 49.15 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.401 1.08 . . . . 0.0 113.835 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -124.06 -10.0 7.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 114.351 -171.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -53.16 -41.07 64.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.714 1.606 . . . . 0.0 112.959 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.47 72.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -84.58 -26.67 27.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.136 1.375 . . . . 0.0 112.437 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -92.86 -44.78 8.3 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -98.96 -55.18 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.009 1.324 . . . . 0.0 111.083 -175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.2 mt -78.14 -11.99 59.96 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.9 p -71.56 -17.24 62.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.23 1.412 . . . . 0.0 113.627 172.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -83.08 123.29 29.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.565 1.546 . . . . 0.0 111.833 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -78.7 -24.43 45.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.231 1.012 . . . . 0.0 112.701 171.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -82.51 166.73 34.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.589 1.556 . . . . 0.0 110.479 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.87 144.94 99.38 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.297 1.998 . . . . 0.0 112.722 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.6 t -132.17 124.99 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.074 0.949 . . . . 0.0 110.412 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 132.03 36.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 169.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.1 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 0.854 . . . . 0.0 110.418 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.73 118.34 36.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.031 1.333 . . . . 0.0 111.559 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.2 112.56 24.26 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.631 1.573 . . . . 0.0 109.203 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 170.19 19.02 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -163.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.88 -167.54 1.82 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.907 1.683 . . . . 0.0 109.672 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -98.83 -20.16 17.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -86.44 -22.36 26.56 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.98 132.81 35.41 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.247 1.019 . . . . 0.0 113.018 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.16 -59.02 11.4 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.39 0.995 . . . . 0.0 114.213 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.33 -25.06 36.58 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.269 1.979 . . . . 0.0 113.406 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.51 -32.91 54.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.359 -0.838 . . . . 0.0 112.088 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -70.51 -36.57 73.85 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 111.589 169.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.1 ttt -60.49 -31.94 70.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.671 1.188 . . . . 0.0 113.762 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.91 -5.91 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -52.73 70.28 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.811 1.187 . . . . 0.0 113.963 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.02 -33.32 74.49 Favored 'Trans proline' 0 C--N 1.353 0.805 0 CA-C-N 121.421 1.543 . . . . 0.0 112.423 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.31 -49.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.811 0.844 . . . . 0.0 111.792 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.51 -37.03 84.17 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.386 0.539 . . . . 0.0 111.176 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.92 -38.53 83.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.028 0.831 . . . . 0.0 112.25 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.05 -48.03 69.52 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.295 -0.878 . . . . 0.0 111.819 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mm -59.49 -41.6 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.545 1.52 . . . . 0.0 111.001 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.52 71.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.356 0.662 . . . . 0.0 112.684 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.3 m -76.73 -42.95 39.33 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.088 -1.007 . . . . 0.0 111.2 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.43 -36.06 17.93 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -166.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -114.75 21.64 14.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.926 1.29 . . . . 0.0 113.601 -171.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.2 41.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.353 1.461 . . . . 0.0 114.589 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 p -80.95 -18.28 47.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.479 1.512 . . . . 0.0 113.657 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -101.75 -39.54 7.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.071 1.348 . . . . 0.0 112.784 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.9 169.21 21.68 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.891 1.276 . . . . 0.0 113.676 -176.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -110.54 142.26 42.58 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.465 1.506 . . . . 0.0 110.09 171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.28 119.31 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.531 169.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.77 163.33 16.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.838 2.055 . . . . 0.0 111.535 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.75 137.92 47.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.594 0.758 . . . . 0.0 112.049 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.61 123.44 46.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.845 1.258 . . . . 0.0 109.443 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -91.49 108.74 20.1 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.998 0.919 . . . . 0.0 109.447 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 m -70.86 -16.23 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -87.95 -41.24 13.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.271 1.028 . . . . 0.0 112.671 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -87.35 -22.29 25.17 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -139.99 69.6 35.58 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.568 1.147 . . . . 0.0 112.644 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.43 -14.83 46.96 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.249 2.632 . . . . 0.0 113.829 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -64.98 -34.9 79.55 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.059 -1.026 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -80.2 -30.31 38.69 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.476 -0.765 . . . . 0.0 112.051 169.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.51 80.91 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.627 -1.296 . . . . 0.0 112.308 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -76.75 -23.2 53.01 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 168.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -60.6 -43.5 97.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 0.0 111.683 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -102.43 7.76 40.26 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.18 1.392 . . . . 0.0 114.039 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 48.67 67.05 0.92 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.762 1.625 . . . . 0.0 112.331 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.03 81.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 123.055 1.407 . . . . 0.0 110.249 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.8 m -87.43 -22.97 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.306 1.842 . . . . 0.0 112.868 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -122.07 133.14 54.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.221 1.808 . . . . 0.0 109.73 173.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 tt -118.23 135.08 23.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.384 1.074 . . . . 0.0 111.517 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.82 157.23 92.44 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 118.847 0.624 . . . . 0.0 112.7 -9.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -107.42 124.21 49.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.673 1.189 . . . . 0.0 108.39 163.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.13 122.78 48.77 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.283 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 tp -130.37 129.83 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.486 1.114 . . . . 0.0 109.986 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.2 tp -100.14 132.34 45.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.151 1.38 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -118.36 151.76 37.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.875 1.67 . . . . 0.0 111.576 175.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -143.59 130.0 19.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.14 1.776 . . . . 0.0 109.832 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 t70 49.63 35.91 9.6 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.952 1.301 . . . . 0.0 114.381 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 16.41 80.8 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.847 1.213 . . . . 0.0 116.012 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -125.21 144.35 47.15 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 118.745 1.273 . . . . 0.0 111.494 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.46 144.96 51.77 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.009 2.473 . . . . 0.0 111.673 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.13 -54.7 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.832 1.253 . . . . 0.0 112.17 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -156.05 152.72 28.4 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -117.97 141.6 48.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.587 1.955 . . . . 0.0 111.571 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.79 146.71 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.952 . . . . 0.0 109.706 171.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.05 151.61 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.719 1.207 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.16 -171.15 55.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.748 0.689 . . . . 0.0 111.959 -170.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.08 155.79 23.67 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -135.17 149.92 50.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.214 2.205 . . . . 0.0 110.139 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.46 160.62 29.33 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 162.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -58.03 -34.53 70.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.75 73.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.313 0.645 . . . . 0.0 111.655 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.36 73.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.565 0.746 . . . . 0.0 111.598 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.62 -40.58 97.43 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.764 -0.585 . . . . 0.0 111.565 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.32 -33.4 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -61.58 -48.68 79.84 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.625 1.102 . . . . 0.0 110.555 170.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.66 -33.97 74.91 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 mt -71.2 -35.33 71.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.268 1.027 . . . . 0.0 113.623 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 t -69.69 -26.41 64.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.634 1.174 . . . . 0.0 112.008 172.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -76.38 5.44 7.16 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.412 1.485 . . . . 0.0 114.451 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.47 0.562 0 C-N-CA 125.005 1.322 . . . . 0.0 112.984 179.56 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.352 0.12 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 pt -108.3 134.4 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.813 0.845 . . . . 0.0 112.752 -170.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.08 129.51 35.03 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.255 . . . . 0.0 109.415 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.48 155.72 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.568 1.147 . . . . 0.0 111.544 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.7 p -121.47 172.7 7.88 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.385 1.874 . . . . 0.0 110.891 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.09 -24.78 42.32 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 -51.14 7.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.23 1.012 . . . . 0.0 113.167 172.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -80.65 -23.23 39.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -50.76 -41.63 56.95 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.087 1.355 . . . . 0.0 112.018 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.48 72.11 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.765 -1.209 . . . . 0.0 113.654 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -84.44 -30.63 25.14 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.365 -0.834 . . . . 0.0 112.421 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -92.56 -30.02 15.87 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.21 -54.39 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.216 1.406 . . . . 0.0 111.288 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.25 -22.46 35.81 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -172.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -88.31 3.75 48.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.348 1.059 . . . . 0.0 113.201 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -68.29 154.79 41.05 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.563 1.545 . . . . 0.0 114.237 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -112.91 9.45 18.85 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.562 1.945 . . . . 0.0 113.315 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -138.49 170.4 10.4 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 127.631 2.372 . . . . 0.0 111.288 -173.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -66.88 138.97 50.18 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.104 1.869 . . . . 0.0 112.379 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.46 113.46 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 110.323 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -86.64 128.71 35.01 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.375 1.07 . . . . 0.0 108.181 170.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -120.06 124.48 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 110.028 169.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.53 124.11 41.65 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.04 0.936 . . . . 0.0 111.119 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD2' HD12 ' A' ' 63' ' ' LEU . 9.8 m-85 -95.01 118.36 31.69 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.421 1.488 . . . . 0.0 109.325 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -145.03 165.32 28.54 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -171.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.17 177.62 4.66 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.261 1.824 . . . . 0.0 111.748 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.1 p -68.52 -23.43 64.54 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -117.71 -13.95 10.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -161.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -74.98 129.06 37.0 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -165.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.74 -62.98 5.51 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.198 0.904 . . . . 0.0 112.897 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -60.33 -30.44 91.03 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.415 2.077 . . . . 0.0 113.952 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.06 -33.56 70.38 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.931 0.787 . . . . 0.0 112.161 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -73.11 -32.24 64.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.912 0.885 . . . . 0.0 112.597 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -68.64 -31.01 69.85 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -83.17 -17.61 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.715 1.143 . . . . 0.0 113.161 174.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.51 -50.24 67.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 120.255 1.389 . . . . 0.0 114.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.1 -33.23 51.0 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.021 1.814 . . . . 0.0 113.092 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.61 -42.88 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.261 1.391 . . . . 0.0 111.06 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.72 -48.2 55.79 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.304 1.442 . . . . 0.0 111.01 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.04 -37.31 66.52 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.386 1.074 . . . . 0.0 111.648 169.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.98 -43.8 23.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.788 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.3 mm -65.53 -34.31 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.463 1.029 . . . . 0.0 111.543 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.64 86.9 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 0.597 . . . . 0.0 112.022 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.6 m -76.16 -34.33 59.37 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.241 0.473 . . . . 0.0 111.741 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -79.83 -35.99 37.52 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.2 30.53 4.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.257 1.023 . . . . 0.0 113.444 -173.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.14 -34.04 20.95 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.624 1.57 . . . . 0.0 114.562 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -76.33 -18.2 59.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.001 1.32 . . . . 0.0 114.069 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -105.8 -37.96 6.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.681 1.193 . . . . 0.0 112.848 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.31 165.2 29.11 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -121.49 144.38 48.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.886 1.675 . . . . 0.0 110.719 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.95 139.02 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.034 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.67 164.45 30.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.937 1.695 . . . . 0.0 114.113 -167.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -118.44 132.23 56.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.846 2.058 . . . . 0.0 111.806 174.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 32' ' ' PHE . 3.0 tm? -114.36 125.25 53.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.893 1.277 . . . . 0.0 109.477 164.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.59 113.12 25.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.279 0.631 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.98 -20.53 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -171.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.69 -38.27 33.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 111.963 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 t -95.9 -8.64 33.42 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -128.37 61.5 54.13 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.995 1.318 . . . . 0.0 113.358 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.22 -29.61 88.14 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.183 1.922 . . . . 0.0 113.486 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -66.07 -38.49 88.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.986 0.914 . . . . 0.0 112.428 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -35.2 57.71 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.603 -0.685 . . . . 0.0 111.31 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.55 93.17 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.585 -0.697 . . . . 0.0 111.667 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -71.93 -23.84 61.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.08 -39.17 77.9 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.951 0.9 . . . . 0.0 112.161 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -110.01 21.5 16.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.854 1.662 . . . . 0.0 113.366 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 52.98 35.8 20.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.743 2.017 . . . . 0.0 114.241 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.72 125.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.253 1.021 . . . . 0.0 110.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.21 -48.49 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.328 1.451 . . . . 0.0 110.099 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.5 m -85.94 143.8 27.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.481 1.112 . . . . 0.0 110.752 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.05 145.7 58.91 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.906 1.282 . . . . 0.0 111.147 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.16 146.51 85.17 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.715 0.934 . . . . 0.0 113.103 0.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.1 m -129.73 120.84 25.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.82 0.848 . . . . 0.0 109.258 165.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.48 132.59 38.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.29 1.436 . . . . 0.0 108.566 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 tp -127.2 126.4 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.841 1.256 . . . . 0.0 107.972 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 tp -108.22 128.44 54.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.638 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -110.0 151.93 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.942 1.697 . . . . 0.0 110.156 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -123.06 117.34 25.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.604 1.561 . . . . 0.0 108.021 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.309 4.0 p30 48.57 38.84 11.96 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 4.39 90.24 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.981 1.753 . . . . 0.0 116.124 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.96 133.6 20.21 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 119.236 1.518 . . . . 0.0 110.635 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.66 138.55 41.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.426 2.084 . . . . 0.0 111.656 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.22 -31.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.271 . . . . 0.0 114.205 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -159.52 141.55 13.39 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.485 1.038 . . . . 0.0 112.493 -172.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -133.79 130.93 38.69 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.596 1.559 . . . . 0.0 111.533 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 mm -129.6 123.7 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.463 1.505 . . . . 0.0 110.075 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.93 36.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 125.142 1.377 . . . . 0.0 113.572 -172.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.06 -172.74 35.37 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.319 -0.863 . . . . 0.0 114.257 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.96 154.14 41.86 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.331 1.052 . . . . 0.0 113.545 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -136.22 153.52 51.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.427 1.891 . . . . 0.0 110.773 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.35 163.54 14.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.61 1.1 . . . . 0.0 110.792 165.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -52.31 -43.04 64.31 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.444 1.122 . . . . 0.0 113.205 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.88 72.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.131 0.572 . . . . 0.0 111.7 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.06 63.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.132 0.973 . . . . 0.0 111.969 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.0 tp -63.98 -46.0 86.56 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.399 -0.813 . . . . 0.0 111.34 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.3 tp -71.59 -24.67 61.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.328 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -60.6 -47.2 87.26 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.322 1.419 . . . . 0.0 111.388 162.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.78 -36.08 75.95 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.086 0.857 . . . . 0.0 112.339 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.57 -36.38 68.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.918 0.887 . . . . 0.0 113.103 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -69.82 -22.76 63.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.376 1.07 . . . . 0.0 112.329 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -73.0 -10.43 59.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.75 1.22 . . . . 0.0 113.275 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 126.423 1.889 . . . . 0.0 112.558 -173.065 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 121.194 0.521 . . . . 0.0 111.542 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.44 166.77 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.357 1.463 . . . . 0.0 111.403 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -124.7 143.45 50.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.529 1.132 . . . . 0.0 111.9 173.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.56 165.92 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.242 1.417 . . . . 0.0 112.658 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.9 p -132.17 175.41 9.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.351 2.66 . . . . 0.0 110.755 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.48 -29.46 61.78 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.89 -1.131 . . . . 0.0 113.08 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.96 -49.56 8.85 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.98 0.912 . . . . 0.0 112.849 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -80.14 -20.84 44.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -51.02 -41.23 59.68 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.144 1.378 . . . . 0.0 112.805 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -31.43 71.91 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.099 -1.001 . . . . 0.0 113.516 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -89.28 -19.35 25.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.703 1.601 . . . . 0.0 113.198 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -112.98 -27.05 8.21 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.36 -54.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.539 1.136 . . . . 0.0 111.631 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.0 mt -73.53 -12.34 60.74 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.5 p -76.83 -14.04 59.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.889 1.676 . . . . 0.0 113.97 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -69.98 155.83 40.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -165.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -114.25 17.49 17.58 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.787 2.035 . . . . 0.0 112.595 172.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -142.62 169.44 10.83 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 127.58 2.352 . . . . 0.0 111.297 -170.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.67 135.32 69.84 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.03 2.487 . . . . 0.0 112.644 159.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -137.6 123.49 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.511 1.124 . . . . 0.0 110.963 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -93.92 133.69 37.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.313 1.445 . . . . 0.0 109.637 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 t -123.12 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.155 0.889 . . . . 0.0 110.295 172.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -107.01 122.49 46.56 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.509 1.524 . . . . 0.0 111.626 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.11 116.57 27.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 110.687 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -147.11 169.77 18.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 0.0 113.613 -172.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.19 39.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.128 1.371 . . . . 0.0 111.21 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -58.09 -28.4 64.55 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.978 1.311 . . . . 0.0 113.117 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -88.9 -2.78 58.76 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.585 1.554 . . . . 0.0 114.515 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.4 t -84.43 105.19 15.06 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.905 -1.122 . . . . 0.0 112.859 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.45 -56.78 22.73 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.38 1.467 . . . . 0.0 114.79 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.51 -29.36 44.72 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 120.613 2.207 . . . . 0.0 112.509 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.36 -47.41 79.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.162 0.892 . . . . 0.0 111.467 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.69 -32.44 73.92 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -66.0 -42.71 89.42 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.736 0.814 . . . . 0.0 112.31 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 m -84.08 -17.78 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -42.02 -48.94 11.3 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -64.4 -27.29 62.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.66 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.4 -38.74 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.092 1.315 . . . . 0.0 111.084 173.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 47' ' ' LEU . 2.9 mt -69.26 -48.72 60.98 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.751 1.22 . . . . 0.0 109.777 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.75 -40.56 72.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.18 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.74 -50.08 33.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.539 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.3 mm -58.15 -41.7 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.82 1.191 . . . . 0.0 111.436 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.35 97.24 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.818 0.735 . . . . 0.0 111.762 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.2 m -76.77 -31.67 57.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.519 0.727 . . . . 0.0 112.198 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -85.04 -31.65 23.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -122.34 30.33 6.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.414 1.485 . . . . 0.0 113.372 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.8 29.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.937 1.295 . . . . 0.0 114.356 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -72.82 -27.43 61.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.946 1.299 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.66 -33.93 10.41 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.207 1.403 . . . . 0.0 113.451 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 176.95 9.81 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.9 m -129.57 149.26 51.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.984 1.714 . . . . 0.0 108.784 162.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.65 135.12 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.902 0.774 . . . . 0.0 110.721 171.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.0 152.25 44.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.749 1.62 . . . . 0.0 112.859 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 4.8 mmmm -107.45 134.03 51.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.14 1.376 . . . . 0.0 111.302 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.76 110.83 11.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.5 1.12 . . . . 0.0 109.962 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.65 111.78 20.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.727 -0.608 . . . . 0.0 111.955 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.89 -20.41 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.13 -31.37 39.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.251 1.02 . . . . 0.0 112.124 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 t -104.71 -22.82 13.16 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.062 0.945 . . . . 0.0 113.233 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -128.9 67.54 78.03 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.7 1.6 . . . . 0.0 110.781 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.15 -15.5 31.96 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.337 2.692 . . . . 0.0 113.958 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.22 -35.06 79.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.223 -0.923 . . . . 0.0 112.527 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.7 p -77.18 -33.29 56.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 112.699 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.58 91.49 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.497 0.719 . . . . 0.0 111.845 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -76.77 -25.7 53.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -65.01 -44.57 88.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.958 0.799 . . . . 0.0 112.027 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.25 10.18 41.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.299 1.439 . . . . 0.0 114.071 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 51.22 58.11 5.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.242 1.817 . . . . 0.0 113.124 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.81 121.55 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.207 1.003 . . . . 0.0 109.256 173.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.19 -29.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.207 1.403 . . . . 0.0 112.724 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.8 p -121.21 152.59 38.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.468 1.907 . . . . 0.0 109.359 161.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.2 135.45 24.2 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.534 0.734 . . . . 0.0 111.941 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.14 147.42 66.22 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.15 0.732 . . . . 0.0 113.76 -6.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -99.89 136.89 39.13 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 154.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 mt -110.93 140.48 45.39 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.586 1.555 . . . . 0.0 108.994 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 tp -130.63 131.61 64.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.31 125.56 51.27 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.226 1.01 . . . . 0.0 109.489 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -108.96 158.17 17.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.858 2.063 . . . . 0.0 110.242 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -138.93 134.14 32.78 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.781 1.232 . . . . 0.0 108.995 160.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 54.08 39.82 31.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.019 0.927 . . . . 0.0 112.858 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.68 17.53 69.16 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.115 1.817 . . . . 0.0 114.982 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -125.9 134.11 25.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.835 1.254 . . . . 0.0 110.854 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.27 139.67 39.0 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.712 2.275 . . . . 0.0 111.764 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.51 -36.63 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -154.29 149.52 27.03 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.856 1.207 . . . . 0.0 113.672 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -101.59 145.6 28.83 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.154 1.782 . . . . 0.0 110.25 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.86 147.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.512 1.525 . . . . 0.0 109.623 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.31 147.98 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.386 1.074 . . . . 0.0 111.594 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.74 175.07 43.23 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 122.182 0.879 . . . . 0.0 113.592 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 149.84 44.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 145.83 46.26 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.282 1.833 . . . . 0.0 111.542 168.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.01 173.72 48.97 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.624 1.107 . . . . 0.0 111.167 166.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -59.52 -35.12 73.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.0 -43.54 74.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.946 0.498 . . . . 0.0 111.523 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.45 71.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.483 0.713 . . . . 0.0 111.921 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.8 tp -63.39 -40.75 98.09 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.996 0.918 . . . . 0.0 111.39 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.14 -30.74 71.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.354 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -68.34 -42.15 79.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.127 1.331 . . . . 0.0 112.551 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -56.25 -41.73 76.22 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.776 0.716 . . . . 0.0 110.565 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.5 -39.33 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -70.16 -20.25 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 112.394 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -69.72 -11.13 60.61 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 125.83 1.652 . . . . 0.0 113.702 -169.018 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -133.39 161.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.916 1.686 . . . . 0.0 111.467 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -106.42 143.31 34.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 110.738 164.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.89 160.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.7 1.6 . . . . 0.0 111.625 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.6 p -136.24 170.01 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.663 1.985 . . . . 0.0 109.706 173.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.93 -27.49 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.76 -1.213 . . . . 0.0 113.912 173.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.04 -20.08 53.09 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.8 p -121.0 -16.02 8.14 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -53.4 -41.3 65.82 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 112.933 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.63 70.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.7 m -81.26 -31.66 33.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 112.194 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.56 -39.91 7.68 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.83 -54.3 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.309 1.044 . . . . 0.0 111.53 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.3 mt -77.57 -15.07 59.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.5 t -66.61 -37.87 85.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.905 0.882 . . . . 0.0 112.209 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.402 ' CB ' ' HA ' ' A' ' 25' ' ' ASN 0.299 3.5 t 52.89 -138.9 1.07 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.537 1.535 . . . . 0.0 111.249 168.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HA ' ' CB ' ' A' ' 24' ' ' SER . 51.1 p-10 -84.31 -8.31 59.05 Favored 'General case' 0 CA--C 1.548 0.903 3 C-N-CA 133.582 4.753 . . . . 0.0 113.999 -1.704 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.14 156.49 76.6 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.078 0.951 . . . . 0.0 110.995 170.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -57.5 146.03 85.74 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.877 1.718 . . . . 0.0 114.634 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.12 124.24 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.131 0.972 . . . . 0.0 109.719 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.53 130.43 44.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 108.837 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 131.51 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.788 0.835 . . . . 0.0 110.619 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -98.42 119.62 37.44 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.74 0.816 . . . . 0.0 111.384 167.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -90.41 112.09 23.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.399 172.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.54 174.4 13.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -160.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.96 47.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.839 1.256 . . . . 0.0 111.174 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.5 p -74.03 -27.51 60.98 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -84.23 -8.93 58.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.426 1.49 . . . . 0.0 113.894 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 t -80.41 122.09 26.54 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 111.97 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.49 -57.34 20.31 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.065 1.317 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.53 -22.65 44.4 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 120.238 2.019 . . . . 0.0 112.959 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -67.69 -42.4 82.1 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.235 -0.916 . . . . 0.0 111.331 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -66.67 -32.36 73.63 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.781 0.832 . . . . 0.0 112.562 170.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -64.24 -38.0 89.48 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.978 0.808 . . . . 0.0 112.987 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -83.93 -10.95 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 176.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.96 99.92 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 119.791 1.178 . . . . 0.0 113.717 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.11 -38.2 47.1 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.247 1.965 . . . . 0.0 112.461 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.7 t -64.91 -49.18 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.693 0.797 . . . . 0.0 111.258 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.83 -37.13 81.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.168 0.587 . . . . 0.0 112.124 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.11 -41.85 97.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.951 0.796 . . . . 0.0 112.203 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.74 -43.55 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.733 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mm -61.44 -40.87 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.654 1.115 . . . . 0.0 110.909 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.41 92.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 100.0 m -70.3 -38.16 74.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.404 0.682 . . . . 0.0 111.32 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.2 -32.33 26.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -172.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -122.94 27.41 7.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -172.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.58 10.47 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -75.59 -33.52 60.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.89 1.276 . . . . 0.0 113.486 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -90.51 -38.2 13.37 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.28 0.945 . . . . 0.0 112.888 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.07 167.93 22.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -172.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -114.18 145.21 41.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.98 1.712 . . . . 0.0 109.705 168.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.69 135.67 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.418 0.687 . . . . 0.0 110.595 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 165.5 24.67 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.535 1.934 . . . . 0.0 111.825 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -127.69 147.97 50.39 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.29 124.61 52.43 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.695 1.598 . . . . 0.0 109.205 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.08 97.91 11.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.131 . . . . 0.0 109.927 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.56 -20.95 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.292 -0.88 . . . . 0.0 112.455 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.29 -25.88 63.54 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.439 1.496 . . . . 0.0 113.292 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.7 p -125.57 -22.81 4.19 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -142.17 72.57 22.33 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 111.961 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.25 -0.95 9.39 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.605 2.87 . . . . 0.0 114.505 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -63.33 -40.35 97.08 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.742 -1.224 . . . . 0.0 113.269 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.46 -27.72 52.17 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.208 -0.932 . . . . 0.0 113.411 168.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.04 94.47 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 112.006 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -75.5 -27.44 58.79 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -61.32 -42.16 98.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.153 0.888 . . . . 0.0 112.076 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -96.6 14.68 23.98 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.218 1.407 . . . . 0.0 113.478 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 50.55 41.18 25.11 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.474 2.31 . . . . 0.0 114.025 173.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.73 121.8 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.639 1.175 . . . . 0.0 110.421 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -101.78 -27.63 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.838 1.255 . . . . 0.0 113.571 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.9 m -133.85 160.4 37.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.987 1.715 . . . . 0.0 111.41 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.3 pt -127.97 144.34 51.12 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 0.0 111.7 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.14 153.67 88.18 Favored 'Cis proline' 0 CA--C 1.537 0.659 0 CA-C-N 119.462 0.843 . . . . 0.0 111.773 -6.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.3 m -133.34 119.62 19.94 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.972 0.909 . . . . 0.0 109.27 168.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.0 mt -103.13 119.77 39.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 109.193 -174.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.35 135.09 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.615 1.166 . . . . 0.0 110.372 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 tp -118.73 123.72 45.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.114 0.965 . . . . 0.0 111.722 -170.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -104.55 152.44 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.305 1.842 . . . . 0.0 111.315 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -142.51 135.28 28.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.15 1.78 . . . . 0.0 109.754 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t70 52.01 31.6 8.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.667 1.187 . . . . 0.0 113.329 -168.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.46 7.41 60.71 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.06 1.791 . . . . 0.0 114.662 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -100.56 129.89 26.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 118.771 1.285 . . . . 0.0 110.096 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.95 135.93 33.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.352 2.034 . . . . 0.0 110.789 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.38 -44.88 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.953 0.901 . . . . 0.0 112.214 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -153.37 150.55 28.98 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.609 1.164 . . . . 0.0 113.087 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.81 127.87 46.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.512 2.325 . . . . 0.0 109.879 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.9 mm -122.59 126.06 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.807 1.243 . . . . 0.0 109.985 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.06 147.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.371 1.069 . . . . 0.0 111.345 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.04 173.44 49.66 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.42 1.009 . . . . 0.0 114.19 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.27 151.56 38.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -138.44 155.11 48.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.519 1.928 . . . . 0.0 111.731 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.38 167.5 27.53 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.642 1.115 . . . . 0.0 111.942 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -56.29 -37.48 69.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 112.789 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.96 78.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.23 0.612 . . . . 0.0 111.724 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.08 78.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.402 0.681 . . . . 0.0 111.957 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.1 tp -67.98 -39.99 83.2 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.417 -0.802 . . . . 0.0 111.875 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.47 -28.5 66.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.256 0.622 . . . . 0.0 112.264 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -61.95 -48.57 79.8 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.615 1.098 . . . . 0.0 110.875 167.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.45 -38.08 76.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.293 0.951 . . . . 0.0 111.875 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.0 mt -66.51 -43.47 85.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.6 m -70.0 -23.57 63.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.007 0.923 . . . . 0.0 112.458 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.9 -10.53 59.5 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.112 1.365 . . . . 0.0 112.667 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 126.117 1.767 . . . . 0.0 112.8 -176.464 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 pt -136.5 165.63 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.674 1.59 . . . . 0.0 111.189 171.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -126.23 138.84 53.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.011 1.324 . . . . 0.0 110.707 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.06 156.08 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.521 1.129 . . . . 0.0 112.918 -172.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.3 p -142.39 161.82 37.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.007 2.123 . . . . 0.0 110.107 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -55.1 -35.61 64.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -166.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.08 59.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.5 m -113.27 -21.59 10.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.504 1.522 . . . . 0.0 113.79 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -44.83 -41.98 7.51 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.888 2.475 . . . . 0.0 113.114 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.61 71.5 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.1 m -89.93 -25.96 20.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.856 1.262 . . . . 0.0 112.096 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -84.37 -50.01 8.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.931 0.892 . . . . 0.0 113.295 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.53 -33.65 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -77.73 -11.68 59.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 120.052 1.296 . . . . 0.0 113.585 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.0 m -88.96 -0.87 57.78 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -66.24 153.03 43.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.824 1.25 . . . . 0.0 113.653 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -121.53 28.02 7.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.37 1.468 . . . . 0.0 112.173 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.77 171.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 128.459 2.703 . . . . 0.0 109.823 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.76 139.51 80.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.853 1.702 . . . . 0.0 111.572 161.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.62 123.97 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.589 0.756 . . . . 0.0 111.928 170.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.49 125.5 31.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.313 1.445 . . . . 0.0 107.875 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -113.75 121.06 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 169.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -107.36 115.98 31.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.264 1.026 . . . . 0.0 111.634 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD2' HD12 ' A' ' 63' ' ' LEU . 8.5 m-85 -92.35 123.91 36.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.969 1.708 . . . . 0.0 109.288 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.476 ' CE2' ' HE2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -149.82 168.1 24.67 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -176.315 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.03 174.75 5.75 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.998 1.319 . . . . 0.0 111.951 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.6 p -71.66 -22.66 61.64 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -116.06 -12.75 11.26 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -163.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.94 130.15 38.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.17 -59.57 10.61 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.82 1.2 . . . . 0.0 114.179 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.75 -23.73 48.16 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.36 2.04 . . . . 0.0 113.301 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.3 p -77.76 -35.08 52.08 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.344 -0.848 . . . . 0.0 112.405 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -75.41 -27.88 59.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.934 -1.104 . . . . 0.0 112.359 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttt -58.91 -31.34 68.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.245 1.018 . . . . 0.0 113.262 171.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.62 -5.85 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.6 95.84 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-N 119.983 1.265 . . . . 0.0 114.39 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.01 -32.09 45.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.383 1.53 . . . . 0.0 112.589 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.52 -48.15 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.352 -0.843 . . . . 0.0 111.664 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.0 -37.38 84.09 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.977 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.01 -45.81 90.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.684 0.675 . . . . 0.0 111.97 172.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.51 -46.15 77.18 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.575 -0.703 . . . . 0.0 111.465 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.98 -42.79 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.025 1.284 . . . . 0.0 111.249 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -31.62 72.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.4 0.545 . . . . 0.0 112.359 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.4 m -78.6 -40.07 35.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.413 0.685 . . . . 0.0 111.745 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.84 -22.11 22.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -168.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -128.36 22.93 6.0 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.794 1.238 . . . . 0.0 113.877 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.37 -28.63 44.53 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.351 1.461 . . . . 0.0 114.682 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -80.17 -18.34 49.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.394 1.478 . . . . 0.0 113.643 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -101.7 -38.22 7.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.101 1.361 . . . . 0.0 112.88 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.58 177.76 9.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.264 1.426 . . . . 0.0 112.873 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.99 153.95 40.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.781 1.632 . . . . 0.0 109.326 167.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.08 136.14 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.605 0.762 . . . . 0.0 110.361 172.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.84 152.79 49.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.416 1.887 . . . . 0.0 112.092 -170.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.476 ' HE2' ' CE2' ' A' ' 33' ' ' TRP . 17.2 mmmt -115.98 135.26 54.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.935 1.294 . . . . 0.0 112.61 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.436 HD12 ' CD2' ' A' ' 32' ' ' PHE . 3.4 tm? -121.78 127.09 50.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.618 1.167 . . . . 0.0 110.484 167.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.37 104.29 16.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 110.054 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -69.88 -20.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.294 -0.879 . . . . 0.0 112.973 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.62 -33.39 47.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.468 1.107 . . . . 0.0 112.952 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -106.83 -22.47 12.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.539 1.136 . . . . 0.0 113.601 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -131.59 68.07 80.58 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.923 1.289 . . . . 0.0 111.743 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.52 -14.64 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.094 2.529 . . . . 0.0 113.058 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.31 -41.12 83.78 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.467 1.107 . . . . 0.0 112.605 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -75.63 -32.9 60.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.083 0.856 . . . . 0.0 111.71 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.66 92.04 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.149 -0.969 . . . . 0.0 111.81 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.98 -23.15 52.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 169.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.03 -47.72 85.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.799 0.84 . . . . 0.0 111.234 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.51 6.53 44.31 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 50.9 53.83 12.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 112.795 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -88.16 121.52 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.649 1.18 . . . . 0.0 109.443 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -110.71 -29.44 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.511 1.124 . . . . 0.0 112.701 -171.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -121.8 160.75 23.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.518 1.527 . . . . 0.0 111.686 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.68 147.02 64.36 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.679 1.192 . . . . 0.0 112.888 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.35 154.29 89.01 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.126 0.723 . . . . 0.0 111.829 -11.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.6 m -130.94 120.54 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.726 0.811 . . . . 0.0 109.638 168.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.49 122.82 37.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.85 126.83 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.316 1.047 . . . . 0.0 108.9 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.4 tp -112.12 128.3 56.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.623 1.569 . . . . 0.0 110.034 -166.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -108.24 157.35 18.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.686 1.594 . . . . 0.0 110.159 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.1 127.51 26.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.167 1.787 . . . . 0.0 108.528 167.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.01 40.36 28.15 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.763 0.792 . . . . 0.0 112.727 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.23 17.35 72.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.03 1.776 . . . . 0.0 115.409 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -124.08 133.04 24.37 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.71 1.204 . . . . 0.0 110.843 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.48 139.15 37.11 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.831 2.354 . . . . 0.0 112.073 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.5 -26.35 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.17 149.61 32.29 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.056 1.298 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -143.68 127.87 17.66 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.702 1.201 . . . . 0.0 111.098 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mm -132.09 137.59 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.392 1.077 . . . . 0.0 110.618 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.93 157.51 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.079 1.352 . . . . 0.0 112.401 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 173.81 36.35 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.745 1.164 . . . . 0.0 113.913 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 156.63 34.04 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.53 152.41 50.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.351 1.86 . . . . 0.0 111.732 171.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 166.92 44.71 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 159.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -57.25 -34.43 68.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.41 82.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.582 0.753 . . . . 0.0 112.372 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.29 -39.83 65.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.91 -48.11 80.39 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.079 -0.388 . . . . 0.0 110.203 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.477 -0.764 . . . . 0.0 112.37 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -69.24 -43.17 74.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.078 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.98 -27.3 65.58 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.253 1.388 . . . . 0.0 112.505 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.27 -41.36 81.19 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.453 0.701 . . . . 0.0 111.871 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -65.71 -25.74 67.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.545 1.138 . . . . 0.0 111.705 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.97 1.09 6.07 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 170.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.475 0.786 0 C-N-CA 126.777 2.031 . . . . 0.0 111.714 178.581 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.1 p . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.1 165.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.019 1.728 . . . . 0.0 111.695 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -109.89 143.23 40.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.176 1.79 . . . . 0.0 110.376 170.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.73 156.21 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.801 1.241 . . . . 0.0 111.697 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.1 p -114.7 168.81 9.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.15 2.18 . . . . 0.0 110.532 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.85 -27.84 67.0 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.819 -1.176 . . . . 0.0 113.221 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.34 -47.3 14.69 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.193 0.997 . . . . 0.0 112.894 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 p -77.79 -26.56 49.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -49.76 -39.89 39.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.2 1.8 . . . . 0.0 112.605 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.16 70.51 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -95.33 -20.66 18.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.694 1.198 . . . . 0.0 112.531 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -91.39 -58.29 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.417 1.087 . . . . 0.0 112.347 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -88.09 -51.88 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.213 1.405 . . . . 0.0 111.349 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.15 -15.01 62.47 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -77.43 -18.05 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 m -85.89 118.72 25.55 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -166.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 p-10 -75.42 -24.51 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.718 1.207 . . . . 0.0 112.113 160.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -65.26 146.35 98.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 127.17 2.188 . . . . 0.0 110.087 167.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.02 140.12 82.67 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.062 1.841 . . . . 0.0 111.4 170.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.62 130.97 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.984 0.914 . . . . 0.0 110.554 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.6 mp -104.5 124.66 49.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 108.769 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -120.1 117.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 110.311 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -98.45 117.58 33.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.606 0.763 . . . . 0.0 112.638 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.19 112.68 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.854 1.661 . . . . 0.0 108.442 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.26 170.28 19.88 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -164.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.69 155.78 48.74 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.989 1.316 . . . . 0.0 111.881 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -78.61 -19.52 52.52 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -86.05 -5.45 59.21 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.707 1.203 . . . . 0.0 113.822 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.48 120.11 31.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.184 1.394 . . . . 0.0 112.215 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -55.17 31.64 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.018 1.294 . . . . 0.0 114.726 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.03 -23.93 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 120.201 2.0 . . . . 0.0 112.638 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.3 m -67.16 -39.19 86.45 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.065 -1.022 . . . . 0.0 111.588 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.9 -31.89 71.99 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.438 -0.789 . . . . 0.0 112.711 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -65.34 -34.7 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.0 -12.15 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.341 0.973 . . . . 0.0 113.589 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.76 -49.14 85.03 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -29.27 49.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.763 1.642 . . . . 0.0 112.718 173.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.5 -48.06 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.147 -0.97 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.6 -36.79 79.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.297 0.639 . . . . 0.0 112.021 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.33 -46.91 87.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.777 0.717 . . . . 0.0 111.424 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -69.05 -47.77 64.51 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.715 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.2 mm -59.44 -40.8 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 121.061 1.755 . . . . 0.0 110.95 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.54 90.41 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.093 0.86 . . . . 0.0 112.546 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.1 m -77.09 -36.12 55.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.651 0.78 . . . . 0.0 111.325 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -92.64 -34.66 13.89 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -116.82 13.74 15.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.932 1.293 . . . . 0.0 113.583 -163.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.14 -31.03 29.26 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -69.72 -29.94 67.44 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.27 -0.894 . . . . 0.0 112.671 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -90.53 -41.12 11.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.772 1.229 . . . . 0.0 112.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.3 162.52 41.03 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.0 m -106.48 136.36 46.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.734 1.214 . . . . 0.0 110.482 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 t -110.91 122.15 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.083 0.953 . . . . 0.0 110.47 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.5 164.38 18.2 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.637 1.975 . . . . 0.0 111.739 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -129.75 143.52 50.86 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.42 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -126.43 120.91 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.362 1.465 . . . . 0.0 109.721 170.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -96.29 85.22 3.91 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.228 1.811 . . . . 0.0 111.153 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -60.81 -22.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -166.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.04 -28.32 61.36 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.217 1.407 . . . . 0.0 113.459 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -127.17 -9.88 5.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.949 1.7 . . . . 0.0 114.585 -171.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -142.51 59.51 8.74 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.897 2.079 . . . . 0.0 110.318 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.85 -6.17 14.13 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.534 2.822 . . . . 0.0 114.565 -167.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.2 -39.18 92.49 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.119 -0.988 . . . . 0.0 112.374 -174.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -30.4 54.77 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.391 -0.818 . . . . 0.0 112.065 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.34 99.04 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.313 -0.867 . . . . 0.0 111.65 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -74.16 -23.25 59.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -61.75 -44.03 97.7 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.882 0.873 . . . . 0.0 111.282 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.55 5.57 50.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.142 1.377 . . . . 0.0 114.162 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 50.51 41.23 24.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.408 1.883 . . . . 0.0 113.666 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.59 128.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.94 1.296 . . . . 0.0 110.128 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.94 -45.66 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.869 1.268 . . . . 0.0 111.348 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 p -86.26 152.4 22.81 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.717 1.207 . . . . 0.0 111.674 170.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 pt -145.43 155.54 53.62 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.834 1.654 . . . . 0.0 111.098 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.35 138.67 57.02 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 119.795 0.963 . . . . 0.0 111.6 -4.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 m -125.29 108.08 11.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.624 0.77 . . . . 0.0 109.9 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.29 126.1 43.65 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.754 1.222 . . . . 0.0 110.136 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 tt -120.9 132.85 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 122.199 1.0 . . . . 0.0 110.634 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.89 130.67 44.15 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 109.565 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -120.07 148.5 43.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.287 1.835 . . . . 0.0 111.319 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -144.81 135.13 24.24 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.971 1.708 . . . . 0.0 109.701 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 t70 51.34 33.68 10.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.63 19.92 71.53 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.335 1.445 . . . . 0.0 115.401 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -126.15 150.25 69.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 118.8 1.3 . . . . 0.0 112.104 169.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.37 145.93 44.01 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.905 2.403 . . . . 0.0 112.399 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.45 -46.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.97 1.308 . . . . 0.0 111.678 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -159.54 146.38 16.62 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.887 1.275 . . . . 0.0 111.94 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -129.0 137.21 51.21 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.159 1.384 . . . . 0.0 112.156 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.8 116.55 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.234 1.814 . . . . 0.0 110.224 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -100.17 159.4 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.054 1.742 . . . . 0.0 112.407 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.1 -171.69 50.67 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.067 0.841 . . . . 0.0 111.958 -174.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.18 147.02 45.14 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.153 -1.204 . . . . 0.0 112.93 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.69 153.15 47.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.077 1.751 . . . . 0.0 111.707 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.37 163.9 24.23 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.565 1.079 . . . . 0.0 112.092 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -59.88 -33.97 72.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.244 1.018 . . . . 0.0 113.53 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.37 80.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.968 0.507 . . . . 0.0 111.522 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.72 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.311 0.645 . . . . 0.0 111.214 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.2 tp -62.53 -40.32 96.41 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.219 -0.926 . . . . 0.0 112.344 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.4 tp -70.17 -30.81 68.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.844 0.858 . . . . 0.0 112.686 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -62.6 -44.93 95.06 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.729 1.149 . . . . 0.0 111.413 167.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.1 -36.03 80.47 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.32 0.964 . . . . 0.0 111.789 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.58 -39.2 81.07 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -65.34 -26.06 67.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.468 1.107 . . . . 0.0 112.211 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -75.95 -5.08 44.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.9 1.28 . . . . 0.0 114.089 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 125.055 1.342 . . . . 0.0 111.755 172.705 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.2 pt -117.93 157.47 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.466 1.506 . . . . 0.0 111.192 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -109.25 137.59 46.89 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.886 1.674 . . . . 0.0 110.007 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.35 156.34 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.821 1.248 . . . . 0.0 112.475 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.2 p -143.29 161.55 38.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.548 1.939 . . . . 0.0 110.793 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.83 -35.62 61.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -168.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.95 -18.87 60.32 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 m -119.26 -11.6 9.54 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.703 1.601 . . . . 0.0 113.646 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -51.9 -40.09 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 113.08 -175.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.5 72.04 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -83.2 -32.25 26.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.158 0.983 . . . . 0.0 111.953 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.56 -37.81 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.42 -54.48 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.155 1.382 . . . . 0.0 110.986 -174.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.95 -12.03 59.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 m -78.74 -11.5 59.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.5 m -80.73 121.31 25.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.273 1.429 . . . . 0.0 112.641 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.35 -26.98 60.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.006 0.523 . . . . 0.0 111.857 164.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -69.75 153.54 95.49 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.253 1.021 . . . . 0.0 110.701 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.06 145.75 85.69 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.755 1.637 . . . . 0.0 111.675 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.0 132.3 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.145 . . . . 0.0 111.915 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.5 134.22 35.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.769 1.628 . . . . 0.0 109.169 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.27 129.8 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.316 0.647 . . . . 0.0 110.457 167.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -103.52 136.73 42.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.406 1.482 . . . . 0.0 113.076 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.26 120.17 39.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.126 1.37 . . . . 0.0 111.097 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -75.03 168.1 20.64 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.261 1.024 . . . . 0.0 113.344 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.69 144.79 32.86 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.244 142.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.9 p -67.94 -31.42 71.16 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -165.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -96.33 -8.28 33.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.644 1.978 . . . . 0.0 113.777 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.5 t -82.41 110.44 17.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.52 1.128 . . . . 0.0 113.24 -160.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.57 -57.07 12.87 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.277 1.418 . . . . 0.0 114.364 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.17 -24.42 65.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 120.481 2.14 . . . . 0.0 113.349 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.84 -42.03 82.05 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.213 0.915 . . . . 0.0 111.217 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -66.3 -32.23 73.51 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.463 -0.773 . . . . 0.0 112.462 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.55 -31.93 71.49 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.65 -14.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.781 1.173 . . . . 0.0 113.691 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.37 46.1 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.21 -32.0 52.72 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.674 1.583 . . . . 0.0 112.327 176.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.43 -51.22 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.352 0.978 . . . . 0.0 111.734 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.06 -35.28 74.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 111.298 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -71.43 -34.9 70.69 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -66.18 -47.6 73.45 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.806 -1.184 . . . . 0.0 111.222 171.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.38 -40.75 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.609 1.549 . . . . 0.0 111.08 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.19 -38.02 85.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.9 0.773 . . . . 0.0 112.581 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -77.19 -34.92 56.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.663 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -88.52 -39.58 14.07 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -113.64 17.25 18.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.231 1.412 . . . . 0.0 113.457 -162.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.89 34.62 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.328 1.451 . . . . 0.0 114.626 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -78.23 -18.52 55.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.216 1.407 . . . . 0.0 113.825 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -98.18 -41.41 7.91 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.838 1.255 . . . . 0.0 112.48 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.32 164.08 35.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.598 1.159 . . . . 0.0 113.3 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.6 m -107.15 144.45 33.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.883 1.273 . . . . 0.0 110.359 171.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -118.84 128.76 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.422 0.689 . . . . 0.0 110.286 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.49 162.31 23.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.644 1.978 . . . . 0.0 111.429 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -136.28 144.75 44.92 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.91 122.69 46.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.765 1.626 . . . . 0.0 110.448 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -87.15 84.08 7.33 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.823 1.249 . . . . 0.0 110.797 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 p -62.92 -24.06 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.66 -26.57 61.69 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.08 0.952 . . . . 0.0 113.383 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.1 p -110.06 -22.66 11.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.416 1.086 . . . . 0.0 113.479 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.03 77.39 26.0 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.464 1.506 . . . . 0.0 111.548 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.67 -15.21 37.3 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.718 2.278 . . . . 0.0 112.851 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.81 -38.24 75.21 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.666 1.187 . . . . 0.0 112.966 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -34.0 68.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.119 0.872 . . . . 0.0 112.331 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.0 73.41 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.906 -1.122 . . . . 0.0 111.454 173.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -74.99 -39.52 61.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.284 1.033 . . . . 0.0 111.768 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.84 -45.41 67.34 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.993 1.317 . . . . 0.0 111.622 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -98.18 15.72 23.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.305 1.442 . . . . 0.0 114.512 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.272 7.6 pt20 47.46 42.53 14.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.773 2.029 . . . . 0.0 115.13 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.95 126.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.454 1.502 . . . . 0.0 110.429 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.1 m -130.91 -9.84 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.431 1.492 . . . . 0.0 113.799 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 151.19 41.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.37 1.868 . . . . 0.0 110.197 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.23 141.48 29.54 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.879 0.872 . . . . 0.0 112.579 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.17 154.49 88.45 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.261 0.772 . . . . 0.0 111.951 -7.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -132.55 135.56 46.02 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.831 1.252 . . . . 0.0 108.73 171.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 142.83 46.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.318 1.047 . . . . 0.0 110.386 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.5 tp -122.34 137.6 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.827 1.651 . . . . 0.0 109.117 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.8 tp -108.8 125.57 52.1 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.612 1.565 . . . . 0.0 109.694 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -116.08 155.6 27.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.574 1.149 . . . . 0.0 111.391 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.54 136.12 27.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.66 1.584 . . . . 0.0 109.646 164.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.78 32.2 14.44 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.11 1.364 . . . . 0.0 114.256 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.59 17.31 80.18 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.853 1.216 . . . . 0.0 115.63 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -126.09 143.62 46.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 118.776 1.288 . . . . 0.0 111.503 172.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 144.09 42.13 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.893 2.395 . . . . 0.0 111.628 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.34 -45.18 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.12 1.368 . . . . 0.0 111.388 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -158.37 146.15 18.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.443 1.097 . . . . 0.0 111.529 -163.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.34 142.14 51.67 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.38 1.472 . . . . 0.0 110.826 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 132.4 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.998 1.719 . . . . 0.0 110.098 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.81 143.89 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.403 1.481 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.29 176.02 46.07 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.708 0.671 . . . . 0.0 112.719 -168.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.23 152.06 44.65 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -128.33 149.17 50.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.097 2.159 . . . . 0.0 109.851 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.24 166.42 32.1 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 161.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.53 -38.99 75.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.073 0.949 . . . . 0.0 113.183 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.42 77.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.404 0.681 . . . . 0.0 111.593 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -45.56 64.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 111.82 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.349 0.977 . . . . 0.0 111.355 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.54 -37.58 87.84 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.762 -0.586 . . . . 0.0 111.926 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -61.76 -43.03 99.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.771 -1.206 . . . . 0.0 112.29 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.88 -31.96 73.32 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.937 0.789 . . . . 0.0 112.372 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.7 -40.27 76.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.668 0.387 . . . . 0.0 111.815 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.5 m -64.78 -25.48 67.94 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.234 -0.916 . . . . 0.0 112.695 170.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.56 -10.78 57.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.168 1.387 . . . . 0.0 114.41 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.131 1.373 . . . . 0.0 114.162 -173.366 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.76 164.08 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.711 1.204 . . . . 0.0 112.7 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -109.46 142.73 40.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.882 1.673 . . . . 0.0 110.141 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.81 154.01 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.439 1.096 . . . . 0.0 112.638 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.2 p -145.45 160.93 40.84 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.973 2.109 . . . . 0.0 110.159 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.81 -34.53 40.55 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -171.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.99 -20.48 62.41 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -120.88 -14.2 8.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.59 1.556 . . . . 0.0 113.693 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -51.17 -41.65 60.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.397 1.879 . . . . 0.0 113.34 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.25 71.72 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.5 m -82.19 -33.71 29.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.593 0.757 . . . . 0.0 111.793 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.08 -43.25 19.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.97 -54.42 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 111.194 -173.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.06 -17.07 53.67 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.6 m -101.45 7.27 42.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.843 1.257 . . . . 0.0 113.119 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -66.01 144.63 56.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.979 0.912 . . . . 0.0 112.994 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.23 1.68 43.47 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.988 1.315 . . . . 0.0 113.213 174.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -142.73 166.69 19.27 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 126.825 2.05 . . . . 0.0 111.651 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.45 147.12 6.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.024 3.149 . . . . 0.0 114.822 163.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.1 130.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.477 1.111 . . . . 0.0 110.789 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.4 129.04 39.68 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.909 1.284 . . . . 0.0 107.931 169.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.2 t -112.37 123.89 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.445 1.021 . . . . 0.0 109.801 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -113.08 121.9 45.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.403 1.081 . . . . 0.0 112.458 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -93.69 120.11 33.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.354 1.862 . . . . 0.0 110.598 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.72 171.17 16.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.97 176.92 4.9 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.86 1.664 . . . . 0.0 111.541 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -71.43 -29.58 65.05 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.841 -1.162 . . . . 0.0 113.118 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -100.23 -14.86 18.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -163.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -76.47 127.67 33.29 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -163.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.23 -63.54 5.22 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.739 1.162 . . . . 0.0 113.948 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.0 -24.42 60.17 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.43 2.086 . . . . 0.0 113.149 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -74.89 -36.33 62.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.93 0.786 . . . . 0.0 111.789 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -75.48 -28.01 59.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.987 -1.071 . . . . 0.0 112.629 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.3 mmm -63.93 -29.71 70.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.1 m -83.48 -8.57 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 119.664 1.12 . . . . 0.0 113.928 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.4 -50.69 83.66 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 120.708 1.595 . . . . 0.0 113.905 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.24 -37.05 33.39 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.538 1.492 . . . . 0.0 112.359 174.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.3 t -62.91 -49.23 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.374 1.069 . . . . 0.0 111.694 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 pp -70.36 -39.87 74.36 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.614 1.166 . . . . 0.0 110.858 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -62.03 -44.16 97.3 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.75 0.705 . . . . 0.0 111.962 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -64.61 -54.29 34.28 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.449 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -65.48 -33.9 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.742 1.155 . . . . 0.0 111.502 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.17 89.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.482 1.037 . . . . 0.0 111.364 172.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 m -82.38 -30.82 30.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.415 0.686 . . . . 0.0 112.74 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -80.1 -28.32 39.06 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.044 -1.035 . . . . 0.0 113.203 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -120.27 29.42 7.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.798 1.639 . . . . 0.0 112.621 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -25.84 33.29 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.842 1.257 . . . . 0.0 114.293 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -80.71 -18.5 47.65 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.433 1.493 . . . . 0.0 113.884 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -103.5 -36.49 7.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.404 1.482 . . . . 0.0 112.945 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 160.28 43.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.8 m -111.03 139.62 46.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.297 1.439 . . . . 0.0 109.872 166.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.03 127.93 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.57 0.7 . . . . 0.0 110.153 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.68 145.55 42.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.541 2.337 . . . . 0.0 110.608 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.5 137.94 54.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.5 129.23 54.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.798 1.639 . . . . 0.0 109.637 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -99.35 105.65 17.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.392 1.077 . . . . 0.0 109.433 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.97 -22.1 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -164.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.52 -29.91 41.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.551 1.141 . . . . 0.0 113.233 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.1 p -106.08 -19.18 13.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.451 1.1 . . . . 0.0 113.81 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -133.03 78.68 64.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.687 0.795 . . . . 0.0 112.068 164.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.25 -22.57 75.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.125 2.55 . . . . 0.0 114.11 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.834 0.854 . . . . 0.0 113.096 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -76.93 -30.49 56.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.137 0.88 . . . . 0.0 111.679 172.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.58 98.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.969 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -76.68 -24.47 53.19 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -56.8 -40.01 75.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.37 0.986 . . . . 0.0 112.125 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.65 13.65 26.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 113.807 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 51.45 53.25 13.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.591 1.956 . . . . 0.0 114.141 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.54 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.219 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.55 -61.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.353 1.061 . . . . 0.0 109.788 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.8 m -86.86 151.33 23.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.237 1.015 . . . . 0.0 110.621 166.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.5 133.62 25.29 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.364 1.065 . . . . 0.0 109.515 -171.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.74 159.94 96.57 Favored 'Cis proline' 0 C--N 1.351 0.676 0 CA-C-N 120.365 1.166 . . . . 0.0 113.246 -0.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -126.98 136.11 51.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.426 1.09 . . . . 0.0 109.197 163.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.26 141.87 44.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 109.128 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.72 129.38 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.901 0.88 . . . . 0.0 108.954 166.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.44 125.21 52.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.892 1.277 . . . . 0.0 110.821 -173.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -104.83 148.45 26.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.249 1.819 . . . . 0.0 111.196 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -112.71 116.92 30.89 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.859 1.664 . . . . 0.0 108.264 164.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 51.16 37.37 18.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.644 1.178 . . . . 0.0 113.934 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 9.83 85.68 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.19 1.376 . . . . 0.0 115.944 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -113.93 131.39 23.16 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 119.27 1.535 . . . . 0.0 110.665 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.75 139.93 37.86 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.79 2.327 . . . . 0.0 112.526 -173.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.61 -48.66 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.966 1.306 . . . . 0.0 112.02 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -157.6 158.5 35.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.312 1.045 . . . . 0.0 113.436 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -118.51 140.36 50.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.021 1.728 . . . . 0.0 110.532 168.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.6 139.09 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.772 1.629 . . . . 0.0 109.522 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.48 142.89 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.657 1.183 . . . . 0.0 111.059 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.82 175.86 51.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.213 0.911 . . . . 0.0 113.228 -170.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 156.68 38.38 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -118.16 158.02 25.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.131 2.172 . . . . 0.0 110.086 172.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.5 166.65 25.48 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 155.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -51.17 -45.68 61.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.972 0.886 . . . . 0.0 112.169 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.67 84.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.298 1.039 . . . . 0.0 112.651 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.2 -42.92 62.14 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 111.864 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -63.32 -40.13 96.47 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.366 -0.834 . . . . 0.0 111.364 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.02 -30.87 71.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.695 1.198 . . . . 0.0 112.854 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -64.7 -42.64 95.15 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.342 0.974 . . . . 0.0 111.47 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.44 -39.2 92.56 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.537 1.062 . . . . 0.0 111.776 173.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.3 -40.73 96.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.167 0.587 . . . . 0.0 112.104 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -65.92 -28.3 68.83 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.336 -0.852 . . . . 0.0 111.899 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.6 -18.79 50.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 113.339 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.477 0.905 0 C-N-CA 125.491 1.516 . . . . 0.0 112.228 170.036 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.5 p -144.53 -166.85 2.49 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.821 2.048 . . . . 0.0 110.403 -173.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.68 -27.24 62.91 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.305 -1.497 . . . . 0.0 113.267 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.8 p -91.93 -41.39 10.61 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.517 1.127 . . . . 0.0 112.316 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.62 63.54 7.61 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.803 1.641 . . . . 0.0 109.008 167.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -50.65 128.73 21.22 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.001 1.72 . . . . 0.0 113.24 -164.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.0 m -61.04 145.09 52.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.995 1.318 . . . . 0.0 113.221 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 152.56 40.29 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.065 0.946 . . . . 0.0 113.249 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -95.06 159.29 15.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 129.532 3.133 . . . . 0.0 112.68 -4.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 pt -79.22 166.97 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.284 0.634 . . . . 0.0 111.268 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -126.5 141.68 51.79 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.157 1.783 . . . . 0.0 109.516 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.42 155.36 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.785 1.234 . . . . 0.0 111.954 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.3 p -137.85 159.91 40.72 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.064 1.746 . . . . 0.0 111.206 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.69 -28.25 68.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.02 -17.69 54.9 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -122.18 -17.77 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.169 1.388 . . . . 0.0 114.368 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -50.85 -41.43 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.979 1.712 . . . . 0.0 112.957 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 -31.43 71.96 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -35.02 33.95 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 111.627 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.95 -45.6 16.43 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.74 -54.44 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 111.173 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -80.92 -13.35 58.98 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -168.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 t -95.72 -6.35 40.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.569 1.148 . . . . 0.0 112.979 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -69.32 144.33 53.55 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.163 -0.96 . . . . 0.0 112.814 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -82.62 -5.42 58.8 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.939 1.296 . . . . 0.0 113.429 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -102.87 169.33 7.61 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 126.132 1.773 . . . . 0.0 112.367 -164.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -62.04 125.62 16.88 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.152 1.235 . . . . 0.0 109.147 147.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.99 116.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 109.938 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 tt -94.02 125.59 38.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.743 1.617 . . . . 0.0 108.39 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.85 128.27 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.441 -0.787 . . . . 0.0 110.582 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -106.04 113.08 26.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.218 1.007 . . . . 0.0 111.773 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -89.91 111.39 22.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.616 1.567 . . . . 0.0 108.913 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.8 172.8 15.04 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -163.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.82 142.74 51.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.387 1.075 . . . . 0.0 110.286 165.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -17.55 63.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -91.01 -11.86 37.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.535 1.534 . . . . 0.0 114.131 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 130.95 37.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.967 0.907 . . . . 0.0 111.873 -172.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.51 -60.27 9.12 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.691 1.139 . . . . 0.0 114.732 -175.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 -19.21 52.22 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.291 1.994 . . . . 0.0 113.236 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.4 m -71.18 -46.54 61.13 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.97 0.908 . . . . 0.0 111.059 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.99 -32.32 73.83 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.196 -0.94 . . . . 0.0 112.143 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.0 ttt -61.23 -34.97 75.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.671 0.788 . . . . 0.0 113.067 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.414 ' CG1' ' H ' ' A' ' 99' ' ' LYS . 27.6 m -88.56 -11.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.11 -50.93 72.47 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-N 120.116 1.326 . . . . 0.0 114.385 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.92 -34.3 30.25 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.499 1.466 . . . . 0.0 112.222 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -67.47 -49.27 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.256 -0.902 . . . . 0.0 111.303 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.84 -42.24 95.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.448 0.699 . . . . 0.0 111.054 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.77 -45.48 92.14 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.596 0.634 . . . . 0.0 111.876 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.71 -49.45 53.19 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.461 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.49 -42.46 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.761 1.164 . . . . 0.0 110.564 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.24 -31.33 68.69 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -74.09 -37.42 64.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.86 0.464 . . . . 0.0 110.334 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.76 -35.14 24.58 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -116.2 24.47 11.38 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.63 1.572 . . . . 0.0 113.537 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.43 -26.23 29.57 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.3 p -80.17 -18.16 50.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.446 1.499 . . . . 0.0 113.999 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -100.14 -40.94 7.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.264 1.425 . . . . 0.0 112.551 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.07 159.92 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.539 1.136 . . . . 0.0 113.49 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.0 m -107.21 141.49 38.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 110.233 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -117.87 133.75 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.173 0.589 . . . . 0.0 110.479 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.05 162.6 26.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.837 2.055 . . . . 0.0 111.235 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -133.07 142.89 48.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -116.98 123.72 47.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.7 2.0 . . . . 0.0 109.083 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -92.44 91.59 7.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 110.378 -172.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 m -66.25 -19.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.301 -0.874 . . . . 0.0 112.92 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.69 -26.34 68.33 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -122.11 -22.93 5.49 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.619 1.168 . . . . 0.0 113.579 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -120.55 88.61 43.24 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.323 1.449 . . . . 0.0 111.227 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.2 -13.56 18.95 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.836 2.357 . . . . 0.0 113.081 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -77.06 -39.98 47.88 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.839 -1.163 . . . . 0.0 112.2 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -27.5 55.51 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.663 -0.648 . . . . 0.0 111.822 168.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.53 96.92 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.251 -0.905 . . . . 0.0 112.255 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -72.24 -26.71 62.11 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.262 -0.899 . . . . 0.0 113.059 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.76 -40.79 89.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.118 0.967 . . . . 0.0 112.476 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -107.52 14.69 25.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.567 1.547 . . . . 0.0 113.819 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 53.26 57.11 6.57 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.316 1.846 . . . . 0.0 113.611 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.55 134.72 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.144 168.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.86 -40.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.568 1.147 . . . . 0.0 111.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.2 m -122.1 157.09 32.22 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.642 1.577 . . . . 0.0 110.215 163.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.2 pt -126.58 149.92 69.38 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.987 1.315 . . . . 0.0 111.782 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.33 140.26 65.18 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 CA-C-N 119.106 0.716 . . . . 0.0 112.391 -2.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -102.15 114.84 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.195 . . . . 0.0 107.931 168.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.73 127.96 52.68 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.147 0.979 . . . . 0.0 109.196 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.1 127.52 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.831 0.853 . . . . 0.0 109.705 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.9 tp -104.85 120.63 41.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.597 1.159 . . . . 0.0 110.751 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.27 157.35 16.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.084 1.753 . . . . 0.0 110.616 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -135.38 128.81 32.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.905 1.682 . . . . 0.0 109.109 165.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.0 t70 53.88 32.73 15.71 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.163 0.985 . . . . 0.0 113.248 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.72 9.46 84.91 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.467 1.508 . . . . 0.0 115.563 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -112.58 134.98 21.51 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 118.952 1.376 . . . . 0.0 110.888 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.01 140.18 41.14 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.881 2.388 . . . . 0.0 112.27 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.64 -46.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.73 1.212 . . . . 0.0 111.848 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -158.91 153.19 23.91 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.555 1.142 . . . . 0.0 113.302 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -128.62 139.03 52.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.488 1.915 . . . . 0.0 111.031 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.5 mm -129.69 147.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.092 1.757 . . . . 0.0 109.426 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.9 136.66 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 110.139 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.67 171.15 31.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.1 1.333 . . . . 0.0 113.174 -168.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 156.98 35.99 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -171.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' H ' ' CG1' ' A' ' 43' ' ' VAL . 3.5 mptp? -124.44 161.79 25.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.529 2.332 . . . . 0.0 111.842 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.51 161.8 13.18 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.8 1.19 . . . . 0.0 110.76 156.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -52.72 -39.78 62.39 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.331 1.052 . . . . 0.0 112.95 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.67 79.36 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.461 0.705 . . . . 0.0 112.029 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.61 72.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.362 0.665 . . . . 0.0 111.991 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.31 -47.99 83.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.928 0.891 . . . . 0.0 111.07 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.46 -31.5 68.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.626 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 ttp-105 -67.55 -46.26 73.26 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.422 1.465 . . . . 0.0 111.975 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -70.02 -21.5 63.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.09 -40.07 68.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.392 1.077 . . . . 0.0 112.96 163.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.7 m -66.28 -22.03 66.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.021 1.328 . . . . 0.0 112.198 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.33 -20.74 66.53 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.56 -33.01 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.101 1.76 . . . . 0.0 112.157 -170.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.95 147.98 61.18 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 125.176 1.39 . . . . 0.0 112.198 169.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.26 135.26 69.2 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.124 2.549 . . . . 0.0 113.954 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -161.65 -57.17 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.936 1.295 . . . . 0.0 112.268 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.55 51.8 2.33 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.284 1.434 . . . . 0.0 111.863 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.061 1.745 . . . . 0.0 112.518 -170.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.535 0.207 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.3 p -102.08 -10.49 19.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.076 1.35 . . . . 0.0 113.708 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -95.88 124.36 39.86 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.493 1.517 . . . . 0.0 111.794 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.2 p -99.5 5.39 46.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.082 1.753 . . . . 0.0 114.589 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -94.48 -44.88 7.67 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.643 1.577 . . . . 0.0 110.966 171.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -87.41 -16.76 33.98 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.24 1.816 . . . . 0.0 113.128 -173.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.3 t -126.76 133.83 50.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.678 1.991 . . . . 0.0 109.289 164.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.51 64.16 7.74 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p -110.48 139.78 45.38 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.862 1.265 . . . . 0.0 112.601 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.7 165.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.995 1.718 . . . . 0.0 111.115 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 143.44 50.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.91 1.284 . . . . 0.0 111.991 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -131.74 156.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.839 1.255 . . . . 0.0 112.939 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.6 p -137.24 168.32 19.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.933 2.493 . . . . 0.0 109.762 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.91 -27.91 65.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.89 -18.12 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.3 p -110.5 -25.11 10.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.729 1.611 . . . . 0.0 113.995 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -48.86 -41.54 33.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.581 1.952 . . . . 0.0 112.579 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.75 72.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -84.73 -33.04 23.18 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.28 -0.888 . . . . 0.0 111.947 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -84.77 -40.3 17.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 t -98.94 -52.71 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.38 1.472 . . . . 0.0 111.347 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.3 mt -83.12 -18.31 39.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.5 m -104.77 20.69 18.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.703 1.601 . . . . 0.0 113.538 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.9 p -58.74 -38.45 78.42 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.22 25.72 1.91 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.116 1.367 . . . . 0.0 113.633 -163.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.46 165.97 16.77 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 125.49 1.516 . . . . 0.0 112.31 168.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -45.24 133.61 11.86 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.72 2.28 . . . . 0.0 112.692 154.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -142.84 124.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.779 0.832 . . . . 0.0 111.215 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.7 tp -90.57 133.06 35.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.379 1.472 . . . . 0.0 107.558 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.92 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.819 1.19 . . . . 0.0 109.871 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -108.47 120.68 43.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.649 1.18 . . . . 0.0 111.704 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -98.55 112.71 24.66 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.021 2.128 . . . . 0.0 108.537 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.57 -179.0 7.03 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.13 137.33 52.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.848 0.459 . . . . 0.0 109.958 156.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.0 p -61.94 -23.21 66.23 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -85.78 -12.23 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.303 1.441 . . . . 0.0 114.47 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 143.9 38.95 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.285 0.948 . . . . 0.0 112.924 -170.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.11 -63.72 5.06 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.452 1.025 . . . . 0.0 114.27 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.91 -24.55 67.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.963 1.775 . . . . 0.0 112.625 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.6 m -62.92 -47.87 81.39 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.045 0.938 . . . . 0.0 110.953 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -64.3 -32.85 74.61 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.072 0.949 . . . . 0.0 112.792 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.95 -32.75 73.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 p -91.17 -13.54 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.436 1.016 . . . . 0.0 113.608 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.99 -50.4 62.9 Favored Pre-proline 0 CA--C 1.555 1.171 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.67 -30.63 34.37 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.627 1.552 . . . . 0.0 112.577 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.87 -49.63 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.05 0.94 . . . . 0.0 111.597 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.45 -34.81 77.94 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 111.618 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.7 -41.72 92.01 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.435 1.016 . . . . 0.0 112.5 170.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.73 -44.11 78.36 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.024 -1.048 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -58.15 -44.11 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.957 1.253 . . . . 0.0 111.266 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.44 78.12 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.036 0.534 . . . . 0.0 112.126 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -77.17 -41.36 41.94 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.53 -0.731 . . . . 0.0 111.357 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -83.67 -28.95 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -111.01 20.3 17.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.968 1.307 . . . . 0.0 113.128 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.15 -33.1 17.86 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -74.59 -23.38 58.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.136 1.375 . . . . 0.0 112.845 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -105.52 -33.79 7.99 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.579 1.952 . . . . 0.0 112.993 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -151.7 139.32 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.577 1.551 . . . . 0.0 110.517 -156.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.7 m -115.84 140.49 49.17 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.309 1.443 . . . . 0.0 109.614 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.68 128.25 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.935 0.894 . . . . 0.0 109.725 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.61 143.66 45.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.139 1.776 . . . . 0.0 111.918 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -110.6 127.86 55.42 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.198 1.399 . . . . 0.0 111.974 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.33 123.98 41.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.059 1.343 . . . . 0.0 109.786 167.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.91 118.0 34.69 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.535 0.734 . . . . 0.0 110.18 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -71.31 -16.44 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.52 -38.97 11.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.64 1.176 . . . . 0.0 112.714 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.7 p -87.49 -21.88 25.22 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.75 80.61 55.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.034 0.933 . . . . 0.0 111.891 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.55 -20.34 70.39 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.152 2.568 . . . . 0.0 113.706 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.93 -44.41 92.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 112.74 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 m -73.17 -33.09 65.25 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.195 0.907 . . . . 0.0 111.452 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.47 92.95 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.463 -0.773 . . . . 0.0 111.933 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.99 -25.82 53.16 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.86 -45.94 88.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.189 0.904 . . . . 0.0 111.397 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.07 10.33 41.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 113.933 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 45.42 50.59 10.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.798 2.039 . . . . 0.0 113.674 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 p -75.23 138.04 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.294 -0.879 . . . . 0.0 111.529 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -123.56 -15.81 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.3 m -133.68 150.88 51.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.828 1.651 . . . . 0.0 110.898 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.79 140.58 37.98 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.814 0.846 . . . . 0.0 111.873 174.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.72 152.73 94.98 Favored 'Cis proline' 0 CA--C 1.543 0.935 0 CA-C-N 118.973 0.669 . . . . 0.0 111.177 -11.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.9 m -133.87 124.88 27.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.767 1.227 . . . . 0.0 109.421 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.74 147.15 28.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.853 1.261 . . . . 0.0 110.867 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 tt -131.7 144.55 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.384 1.474 . . . . 0.0 109.633 169.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 tp -107.21 130.63 54.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.228 1.011 . . . . 0.0 110.307 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.68 147.16 29.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.84 1.256 . . . . 0.0 109.568 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -108.65 116.44 31.99 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.537 1.535 . . . . 0.0 108.365 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 51.33 34.27 11.44 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.812 1.245 . . . . 0.0 113.669 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.22 17.29 67.26 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -125.42 136.6 28.48 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 119.501 1.651 . . . . 0.0 110.865 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.22 139.81 39.48 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.773 2.316 . . . . 0.0 112.243 -172.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.57 -36.04 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -162.06 149.64 14.32 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.593 1.088 . . . . 0.0 113.302 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -129.07 141.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.891 1.676 . . . . 0.0 111.597 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 123.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.237 1.815 . . . . 0.0 111.44 -175.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.04 150.73 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.333 1.053 . . . . 0.0 111.822 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.76 -179.98 53.24 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.051 1.31 . . . . 0.0 113.437 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.95 157.51 28.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -129.49 152.23 49.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.034 1.734 . . . . 0.0 111.091 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.49 154.31 20.98 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 163.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -57.7 -33.03 67.95 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.12 82.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.149 0.58 . . . . 0.0 111.786 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.12 66.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.442 0.697 . . . . 0.0 111.457 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 104' ' ' LEU . 11.9 tp -61.64 -43.46 98.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.919 0.887 . . . . 0.0 111.343 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.1 tp -67.66 -34.74 77.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.774 0.829 . . . . 0.0 113.014 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -66.81 -45.14 79.29 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.361 1.437 . . . . 0.0 111.51 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.34 -34.67 70.89 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.35 -44.0 30.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 p -72.05 -15.06 62.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.755 1.222 . . . . 0.0 113.095 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -14.19 48.03 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.42 149.36 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.673 1.989 . . . . 0.0 110.431 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.7 t -93.16 135.03 26.18 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.891 1.276 . . . . 0.0 110.891 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -69.44 166.36 27.47 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.339 2.693 . . . . 0.0 112.922 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -66.26 -43.76 85.58 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -170.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.5 tp -144.46 -7.72 0.68 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -172.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.824 1.25 . . . . 0.0 113.326 -170.846 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.7 p -86.69 142.26 28.32 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.187 0.995 . . . . 0.0 112.579 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.0 134.41 38.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.394 2.278 . . . . 0.0 111.336 -8.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.1 p -67.82 -14.59 63.08 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -172.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.45 -3.5 36.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.498 1.119 . . . . 0.0 113.614 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -99.41 -21.48 15.97 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -70.56 125.37 26.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.109 0.964 . . . . 0.0 110.91 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.47 16.82 15.98 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -169.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t -80.37 153.97 28.01 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.035 -1.041 . . . . 0.0 111.548 174.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 pt -121.52 134.74 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 112.816 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -82.6 127.44 33.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.411 1.484 . . . . 0.0 108.932 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.04 156.85 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.349 1.059 . . . . 0.0 112.282 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -134.39 172.0 13.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.455 2.302 . . . . 0.0 111.052 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.3 -26.67 63.3 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.062 -1.024 . . . . 0.0 113.659 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.63 -35.0 24.95 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.9 p -100.05 -24.14 14.69 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -53.01 -40.83 64.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.056 1.342 . . . . 0.0 112.597 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.34 -31.57 72.44 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.081 -1.012 . . . . 0.0 113.39 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.7 m -81.6 -33.83 31.31 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.796 0.838 . . . . 0.0 111.993 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -92.83 -25.73 17.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.23 -53.87 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.37 -19.93 55.51 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -77.2 -23.81 51.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -81.39 122.34 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.044 -164.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -72.45 -29.26 63.52 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.276 1.03 . . . . 0.0 111.629 166.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -72.18 158.94 86.69 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.373 1.069 . . . . 0.0 110.962 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.47 139.9 73.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.504 2.136 . . . . 0.0 110.974 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 t -128.85 117.54 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.689 0.796 . . . . 0.0 110.388 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.65 128.27 36.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.587 1.155 . . . . 0.0 108.678 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.38 127.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.85 0.86 . . . . 0.0 109.87 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -97.5 112.6 24.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.199 0.6 . . . . 0.0 111.179 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 11.1 m-85 -85.22 109.54 18.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.192 1.397 . . . . 0.0 107.65 170.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.42 178.51 8.37 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -165.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.96 47.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.834 0.454 . . . . 0.0 109.944 157.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -62.33 -20.71 64.65 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -85.42 -16.55 39.39 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.151 1.38 . . . . 0.0 114.461 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 144.71 38.54 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.23 0.923 . . . . 0.0 113.398 -167.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.35 -63.9 4.88 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.634 1.111 . . . . 0.0 114.405 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.79 -21.33 51.17 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 119.616 1.708 . . . . 0.0 112.932 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.9 m -63.14 -47.48 82.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.487 1.039 . . . . 0.0 110.683 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.16 -32.3 73.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.903 0.881 . . . . 0.0 112.647 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.9 ttt -63.77 -36.43 83.85 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.45 -11.37 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -54.67 39.53 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 119.948 1.249 . . . . 0.0 113.915 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.3 -33.43 59.27 Favored 'Trans proline' 0 C--N 1.355 0.893 0 CA-C-N 121.143 1.444 . . . . 0.0 111.685 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.24 -51.27 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.609 0.764 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.48 -37.96 83.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.684 0.675 . . . . 0.0 111.086 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.64 -42.6 98.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.499 0.591 . . . . 0.0 112.218 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.98 -48.04 69.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.049 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.1 mm -57.94 -42.88 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.839 1.654 . . . . 0.0 110.821 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.52 91.82 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.138 0.426 . . . . 0.0 111.685 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -79.43 -31.36 42.6 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.297 1.039 . . . . 0.0 112.459 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -87.03 -31.12 20.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -126.49 27.02 6.23 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.8 -28.93 17.17 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -76.63 -20.32 56.83 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.755 1.622 . . . . 0.0 114.257 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.57 -37.15 8.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.821 1.249 . . . . 0.0 112.709 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.59 174.0 12.17 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.383 1.473 . . . . 0.0 113.088 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.3 m -117.96 146.34 44.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.199 1.399 . . . . 0.0 109.783 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.23 138.12 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.765 0.826 . . . . 0.0 109.995 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.05 161.26 35.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.289 1.835 . . . . 0.0 112.101 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -131.55 138.08 48.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.544 1.138 . . . . 0.0 112.713 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.435 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 5.1 tt -128.14 111.91 13.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.294 2.238 . . . . 0.0 107.966 -172.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -86.45 112.52 21.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.379 0.609 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -71.42 -17.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -88.11 -40.69 13.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.285 1.034 . . . . 0.0 112.555 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -90.71 -23.32 20.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -130.56 68.25 81.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.144 1.377 . . . . 0.0 110.445 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.41 -16.65 39.17 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.241 2.627 . . . . 0.0 113.839 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.52 -37.67 87.44 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.32 -0.862 . . . . 0.0 112.727 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.7 p -77.18 -35.29 55.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.48 0.712 . . . . 0.0 112.387 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.04 98.59 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 112.357 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -76.91 -23.29 52.53 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -58.75 -42.32 88.59 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.301 0.955 . . . . 0.0 111.635 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -97.98 5.66 48.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.197 1.399 . . . . 0.0 113.589 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 52.46 41.05 30.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.516 1.927 . . . . 0.0 114.176 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -78.65 128.81 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.992 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -126.27 -6.94 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.626 1.57 . . . . 0.0 114.025 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.7 m -122.24 150.76 41.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.226 1.81 . . . . 0.0 110.876 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.8 pt -137.86 144.88 45.96 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.086 0.955 . . . . 0.0 112.08 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.27 144.91 74.59 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 CA-C-N 119.498 0.857 . . . . 0.0 111.084 -13.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -122.66 114.73 20.98 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.494 1.118 . . . . 0.0 108.881 172.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.6 mt -98.69 123.87 43.17 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.011 1.324 . . . . 0.0 109.433 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.96 139.78 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.384 1.074 . . . . 0.0 110.397 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 tp -106.17 126.65 52.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.857 1.263 . . . . 0.0 111.502 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -107.59 152.75 23.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.607 1.963 . . . . 0.0 111.607 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -144.91 131.44 19.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 0.0 109.883 172.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.18 33.28 12.05 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -171.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.51 42.14 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.859 1.695 . . . . 0.0 114.94 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -95.59 139.04 21.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 118.711 1.255 . . . . 0.0 110.538 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.88 135.98 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.48 2.12 . . . . 0.0 110.841 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.75 -48.9 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.852 0.861 . . . . 0.0 112.237 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -154.21 148.64 26.14 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.628 1.171 . . . . 0.0 112.125 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -132.83 139.89 47.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.161 1.384 . . . . 0.0 111.596 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.72 129.01 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 110.754 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.39 36.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.289 1.435 . . . . 0.0 113.603 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.41 174.25 38.79 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.347 0.975 . . . . 0.0 114.297 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.31 154.34 42.01 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.715 1.206 . . . . 0.0 113.878 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.03 153.49 51.34 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.006 1.723 . . . . 0.0 111.595 165.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.26 167.42 43.3 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.215 0.912 . . . . 0.0 110.961 164.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -58.69 -34.64 71.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.36 66.99 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.824 0.45 . . . . 0.0 111.385 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.23 83.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.656 0.782 . . . . 0.0 111.771 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 tp -68.53 -38.21 80.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.381 -0.824 . . . . 0.0 112.21 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -68.09 -33.45 74.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.161 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 tpt85 -68.5 -38.82 81.29 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.313 1.415 . . . . 0.0 112.65 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -62.24 -36.32 81.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.456 1.102 . . . . 0.0 111.347 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mt -68.56 -43.6 76.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 113.404 169.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.2 m -68.15 -17.96 64.49 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.113 1.365 . . . . 0.0 112.186 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.53 -12.37 43.97 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.54 1.136 . . . . 0.0 113.57 167.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.6 t -125.85 -44.47 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.231 1.813 . . . . 0.0 112.023 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -99.26 138.53 20.56 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 124.344 1.058 . . . . 0.0 111.904 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -58.76 126.45 21.23 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.641 2.228 . . . . 0.0 112.001 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -156.82 152.07 26.42 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.23 1.412 . . . . 0.0 110.514 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -71.76 -28.53 63.71 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.802 1.241 . . . . 0.0 112.314 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.792 2.437 . . . . 0.0 113.514 -178.078 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.356 0.122 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m -67.04 138.08 56.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.462 1.105 . . . . 0.0 111.561 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.96 35.68 0.59 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.397 1.079 . . . . 0.0 113.127 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.9 t -153.46 156.83 38.92 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.94 1.696 . . . . 0.0 111.437 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 60.43 -62.0 0.07 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.668 2.787 . . . . 0.0 115.132 -173.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 57.79 -2.85 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.871 2.868 . . . . 0.0 117.47 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 p -78.69 139.75 38.45 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.543 1.537 . . . . 0.0 112.942 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.38 58.5 2.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.035 0.934 . . . . 0.0 111.678 173.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 p -115.6 142.39 46.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.316 1.446 . . . . 0.0 113.797 -170.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 pt -140.79 168.58 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.312 1.845 . . . . 0.0 111.825 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -115.5 143.47 45.26 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.832 1.253 . . . . 0.0 110.422 163.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.35 167.13 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.428 1.491 . . . . 0.0 112.425 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.412 ' H ' ' HB2' ' A' ' 16' ' ' SER . 76.5 p -127.93 172.04 11.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.317 2.647 . . . . 0.0 109.36 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.89 -33.12 64.31 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.043 -1.036 . . . . 0.0 113.181 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.22 -38.14 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.679 0.791 . . . . 0.0 113.04 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 13' ' ' THR . 14.7 m -80.61 -24.68 38.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.316 1.046 . . . . 0.0 113.54 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -53.43 -41.84 66.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.898 1.279 . . . . 0.0 112.639 -173.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.37 69.87 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 m -87.33 -23.25 24.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.726 1.21 . . . . 0.0 113.081 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -107.34 -31.57 8.13 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.73 -56.44 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.221 1.009 . . . . 0.0 111.487 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.1 -12.43 60.9 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -76.19 -21.29 56.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.809 1.644 . . . . 0.0 114.104 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 t -96.27 128.19 42.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -73.33 -24.55 60.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.533 1.533 . . . . 0.0 112.449 166.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -74.17 149.42 87.11 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.281 1.432 . . . . 0.0 109.817 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.13 129.35 34.79 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.384 2.056 . . . . 0.0 111.904 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -128.71 120.07 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.641 1.176 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.445 HD21 HD11 ' A' ' 104' ' ' LEU . 29.8 tp -91.23 133.6 35.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.743 1.217 . . . . 0.0 108.87 174.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.78 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.494 1.043 . . . . 0.0 110.952 169.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -107.79 127.19 53.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.498 1.519 . . . . 0.0 111.57 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -100.34 117.53 34.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.894 1.678 . . . . 0.0 110.064 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.31 168.65 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -169.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 -176.93 3.65 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.817 1.647 . . . . 0.0 111.726 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.7 p -74.66 -23.72 58.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.167 1.387 . . . . 0.0 114.52 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -114.56 -13.49 12.16 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -161.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.59 120.55 24.09 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -164.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.91 -59.07 8.45 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.612 1.101 . . . . 0.0 114.413 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.5 -24.14 36.59 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.007 1.903 . . . . 0.0 113.386 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -76.31 -32.29 58.66 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.327 0.967 . . . . 0.0 111.965 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -75.36 -32.58 60.89 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.624 -0.673 . . . . 0.0 112.052 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.58 -33.47 75.03 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.17 0.988 . . . . 0.0 113.57 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.76 -20.43 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.404 1.002 . . . . 0.0 113.592 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.66 -40.72 85.42 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.536 1.517 . . . . 0.0 115.083 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.19 -37.81 80.71 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.632 2.221 . . . . 0.0 113.047 171.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.89 -39.53 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.804 0.842 . . . . 0.0 110.806 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.79 -49.54 57.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.7 1.2 . . . . 0.0 110.683 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.61 -37.99 71.44 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.476 . . . . 0.0 110.538 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -77.18 -49.25 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.159 -0.448 . . . . 0.0 112.143 -172.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.8 mm -65.01 -36.4 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.356 0.98 . . . . 0.0 111.042 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.712 . . . . 0.0 112.822 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -75.48 -43.85 47.09 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.675 1.125 . . . . 0.0 110.956 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.69 -33.14 47.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -121.33 30.82 6.6 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.171 1.788 . . . . 0.0 112.374 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.57 -28.79 22.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.474 1.51 . . . . 0.0 114.335 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 m -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.775 1.23 . . . . 0.0 112.242 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -90.76 -37.88 13.38 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.768 1.227 . . . . 0.0 113.027 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 166.82 23.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.6 m -125.9 142.5 51.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.086 1.754 . . . . 0.0 108.51 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.16 138.18 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.489 0.716 . . . . 0.0 110.782 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.12 152.36 46.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.303 1.441 . . . . 0.0 112.639 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -106.85 135.05 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.552 1.541 . . . . 0.0 110.498 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.42 121.34 43.26 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -94.61 114.54 26.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.6 m -69.52 -16.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.46 -24.14 39.74 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.831 0.852 . . . . 0.0 112.726 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 p -86.9 -30.96 20.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -148.18 106.4 3.61 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.683 1.193 . . . . 0.0 110.987 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.2 -10.95 29.37 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 121.775 1.65 . . . . 0.0 112.465 161.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.77 -51.45 69.27 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.335 1.454 . . . . 0.0 112.194 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.56 -30.46 64.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.509 0.724 . . . . 0.0 112.05 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -43.43 98.86 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.499 -0.751 . . . . 0.0 111.944 173.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -77.26 -24.62 51.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -59.86 -44.59 94.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.289 0.95 . . . . 0.0 112.092 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.51 15.05 24.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 113.704 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 50.99 46.15 26.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.223 2.209 . . . . 0.0 113.836 173.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.96 121.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.357 1.063 . . . . 0.0 109.54 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.22 -29.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.054 1.342 . . . . 0.0 112.907 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.5 m -125.7 155.9 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.215 1.806 . . . . 0.0 110.201 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.31 123.08 27.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.82 159.01 98.22 Favored 'Cis proline' 0 CA--C 1.542 0.876 0 CA-C-N 120.015 1.041 . . . . 0.0 113.321 0.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.2 m -127.07 129.98 49.03 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.492 1.117 . . . . 0.0 108.874 161.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.76 144.26 38.42 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.057 1.343 . . . . 0.0 110.367 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 tp -140.72 126.78 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.005 1.322 . . . . 0.0 109.508 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.76 133.19 38.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.789 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -118.95 149.65 41.25 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.84 1.656 . . . . 0.0 111.633 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -146.49 136.44 23.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.596 1.159 . . . . 0.0 110.75 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.33 30.02 14.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.324 1.05 . . . . 0.0 112.665 -171.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.58 5.12 49.15 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.613 2.054 . . . . 0.0 114.895 -172.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -95.26 131.75 29.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 118.527 1.163 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.66 132.49 23.59 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.55 2.167 . . . . 0.0 110.812 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.2 t -106.72 -47.47 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.547 1.139 . . . . 0.0 111.832 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -158.45 131.83 7.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.682 1.193 . . . . 0.0 111.254 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -112.28 136.55 51.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.379 1.471 . . . . 0.0 110.73 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.42 122.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.893 1.277 . . . . 0.0 109.524 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.09 41.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.014 1.325 . . . . 0.0 112.883 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.76 -178.77 41.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.154 0.883 . . . . 0.0 114.067 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.18 157.23 34.23 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.684 1.193 . . . . 0.0 113.871 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -129.98 160.7 32.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.6 1.96 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.35 164.02 12.12 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.3 1.428 . . . . 0.0 110.85 159.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -52.57 -40.8 62.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.546 1.139 . . . . 0.0 113.253 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.45 -44.96 77.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.17 0.588 . . . . 0.0 111.794 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -40.32 68.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.524 0.73 . . . . 0.0 112.242 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.445 HD11 HD21 ' A' ' 29' ' ' LEU . 15.3 tp -62.29 -44.67 95.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.921 0.888 . . . . 0.0 111.452 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.0 tp -68.12 -30.04 69.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.459 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -60.57 -47.69 85.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.604 1.093 . . . . 0.0 110.933 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.61 -40.5 87.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.475 1.034 . . . . 0.0 111.815 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.48 -30.52 69.39 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -75.63 -26.19 57.56 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.656 1.183 . . . . 0.0 112.386 171.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -85.7 11.15 11.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.342 1.857 . . . . 0.0 113.498 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.45 147.27 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.881 -1.137 . . . . 0.0 113.319 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.8 142.23 10.86 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 126.513 1.925 . . . . 0.0 109.893 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.43 107.72 2.05 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.987 1.791 . . . . 0.0 109.772 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.97 -17.24 64.54 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -165.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.4 tp -73.02 -21.49 60.81 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.676 1.19 . . . . 0.0 113.383 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.9 m120 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.295 1.438 . . . . 0.0 113.11 -177.674 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 ttp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 t -98.55 163.29 12.73 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.163 0.985 . . . . 0.0 112.802 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.96 -24.74 67.84 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.73 1.212 . . . . 0.0 113.976 -171.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 m -91.79 -0.19 57.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.154 1.382 . . . . 0.0 114.049 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -92.33 -14.21 29.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.983 1.313 . . . . 0.0 113.589 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.67 178.69 4.21 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.829 2.052 . . . . 0.0 111.932 174.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 m -60.94 119.24 7.89 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.459 1.104 . . . . 0.0 112.323 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.77 61.94 4.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.792 0.837 . . . . 0.0 111.392 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -111.08 139.46 46.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.043 1.337 . . . . 0.0 112.708 -174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 pt -137.34 167.58 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.766 1.626 . . . . 0.0 111.132 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -127.71 148.41 50.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.704 0.802 . . . . 0.0 112.203 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.14 159.58 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.677 1.591 . . . . 0.0 112.446 -170.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.9 p -142.6 168.42 19.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.829 2.452 . . . . 0.0 110.501 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -56.03 -25.97 46.99 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.26 -16.68 39.37 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.1 p -119.64 -25.28 5.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.676 1.591 . . . . 0.0 114.71 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.53 -39.44 48.93 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.36 1.864 . . . . 0.0 112.932 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.35 71.85 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.2 m -87.33 -30.77 20.57 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.448 -0.782 . . . . 0.0 112.043 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -87.31 -43.92 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.0 t -98.62 -52.87 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.89 1.276 . . . . 0.0 111.344 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -79.81 -13.77 59.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -110.4 18.18 20.08 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 0.0 113.343 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.0 p -62.25 -36.89 83.43 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -167.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.295 0.5 OUTLIER 48.01 21.6 0.33 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.916 1.687 . . . . 0.0 115.185 -161.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.22 168.1 11.85 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 126.177 1.791 . . . . 0.0 111.928 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.75 139.31 74.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.708 2.272 . . . . 0.0 112.901 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.74 124.77 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.69 1.196 . . . . 0.0 111.388 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.5 99.01 10.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.702 1.601 . . . . 0.0 109.171 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -99.28 121.05 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.282 -0.887 . . . . 0.0 110.655 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -102.34 118.4 36.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.6 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -91.97 112.82 24.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.614 1.566 . . . . 0.0 108.552 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 172.62 13.98 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.378 1.071 . . . . 0.0 113.02 -169.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.54 175.08 5.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.591 1.156 . . . . 0.0 111.09 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.5 p -74.93 -18.54 60.38 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.0 -1.062 . . . . 0.0 113.726 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -116.95 -5.25 11.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -163.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.75 134.39 39.18 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.457 1.026 . . . . 0.0 113.699 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -62.99 5.54 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.454 1.026 . . . . 0.0 114.094 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.17 -25.01 65.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.335 2.023 . . . . 0.0 113.363 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -74.55 -33.42 62.71 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.091 0.859 . . . . 0.0 112.088 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -64.01 -40.75 97.03 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.453 -0.779 . . . . 0.0 112.023 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.43 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.16 99.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 120.343 1.429 . . . . 0.0 113.517 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.82 -41.69 36.33 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.869 1.713 . . . . 0.0 112.163 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.14 -47.04 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.57 1.148 . . . . 0.0 111.77 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.74 -38.21 76.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.112 0.965 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 -41.05 82.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.612 1.096 . . . . 0.0 112.314 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.03 -47.97 69.76 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.013 -1.054 . . . . 0.0 111.614 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 mm -59.14 -40.5 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.286 1.403 . . . . 0.0 111.233 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.73 75.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.714 0.688 . . . . 0.0 112.564 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.4 m -78.19 -40.42 37.7 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.284 -0.885 . . . . 0.0 111.463 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.17 -21.7 29.09 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -128.66 25.67 5.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.146 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -34.11 21.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.499 1.52 . . . . 0.0 114.459 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -78.17 -18.56 55.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.465 1.506 . . . . 0.0 113.701 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -97.61 -38.25 9.61 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.135 1.374 . . . . 0.0 112.49 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 160.42 43.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -109.08 138.01 46.09 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.099 1.359 . . . . 0.0 109.508 166.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.74 133.5 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.33 147.34 49.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.209 1.404 . . . . 0.0 111.873 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.55 135.19 53.56 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.533 1.133 . . . . 0.0 111.705 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.31 124.93 52.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.039 1.336 . . . . 0.0 109.26 164.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.29 96.61 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.928 0.891 . . . . 0.0 109.926 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -65.73 -22.72 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.044 -1.035 . . . . 0.0 112.493 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.31 -27.48 63.42 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.527 1.531 . . . . 0.0 113.015 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.1 p -123.51 -21.24 5.33 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.069 1.348 . . . . 0.0 114.254 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -128.73 63.84 67.1 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.385 1.474 . . . . 0.0 111.929 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.25 -13.26 38.89 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.322 2.681 . . . . 0.0 113.784 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -61.9 -37.36 84.3 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.218 -0.926 . . . . 0.0 112.199 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -77.5 -32.29 54.07 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.648 -0.657 . . . . 0.0 112.096 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.24 95.92 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.059 -1.025 . . . . 0.0 111.657 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -75.7 -25.55 56.78 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.34 -42.74 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.224 0.92 . . . . 0.0 111.977 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -104.52 9.87 35.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.431 1.492 . . . . 0.0 113.795 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 49.55 48.55 21.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 113.675 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.1 130.69 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.617 1.167 . . . . 0.0 110.297 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.04 -17.01 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 68.9 m -128.66 158.81 37.49 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.66 1.584 . . . . 0.0 111.079 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.4 pt -135.54 142.54 41.5 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.189 0.996 . . . . 0.0 112.07 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.39 139.55 57.12 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 CA-C-N 119.495 0.855 . . . . 0.0 111.501 -8.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.0 m -122.46 118.18 27.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.857 0.863 . . . . 0.0 108.858 168.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.05 141.62 32.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.333 1.053 . . . . 0.0 109.822 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 tp -137.77 121.47 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.065 1.346 . . . . 0.0 108.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -95.88 114.99 26.77 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.237 1.415 . . . . 0.0 109.706 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -95.55 148.74 22.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.207 1.403 . . . . 0.0 110.44 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -129.73 119.16 23.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.38 1.472 . . . . 0.0 108.877 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 49.87 35.22 8.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.684 1.194 . . . . 0.0 113.814 -174.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.5 76.85 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -122.23 141.55 34.79 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.465 1.632 . . . . 0.0 111.843 165.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.07 142.56 38.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.31 2.673 . . . . 0.0 112.277 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -120.85 -43.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.384 1.074 . . . . 0.0 113.118 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.62 133.16 19.77 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.492 1.117 . . . . 0.0 112.144 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -111.59 141.3 45.36 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.394 1.477 . . . . 0.0 111.668 171.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.6 147.46 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.301 2.24 . . . . 0.0 110.665 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.28 141.85 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 0.0 111.035 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.82 171.03 44.61 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.193 1.377 . . . . 0.0 113.597 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.44 39.34 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -138.97 158.95 43.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.905 2.082 . . . . 0.0 111.044 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.42 169.35 32.92 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.519 1.057 . . . . 0.0 111.863 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -57.58 -38.05 74.19 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.099 -0.648 . . . . 0.0 112.568 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.84 81.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.333 0.653 . . . . 0.0 111.677 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.25 77.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.37 0.668 . . . . 0.0 111.594 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.65 -40.17 96.18 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.107 0.963 . . . . 0.0 112.103 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.07 -33.15 74.88 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.846 0.858 . . . . 0.0 112.401 172.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -68.21 -38.93 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.49 1.041 . . . . 0.0 112.403 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -61.49 -38.71 88.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 0.826 . . . . 0.0 111.537 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.2 tp -67.2 -43.56 81.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.72 0.408 . . . . 0.0 111.814 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.2 p -71.82 -15.37 62.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.37 -16.99 64.56 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.8 t -122.55 -27.17 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.562 1.945 . . . . 0.0 111.873 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.3 t -125.98 86.93 56.94 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.174 1.79 . . . . 0.0 109.738 -174.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.3 161.05 88.24 Favored 'Cis proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.513 0.862 . . . . 0.0 113.056 -7.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -85.86 -17.38 35.78 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 tt 63.06 -41.33 0.19 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.951 2.9 . . . . 0.0 115.828 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 127.204 2.202 . . . . 0.0 111.96 178.574 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 p -145.59 178.64 7.98 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.682 1.993 . . . . 0.0 109.783 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.1 -9.86 8.62 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m -133.33 25.55 4.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.997 1.719 . . . . 0.0 113.097 171.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -139.7 84.26 1.97 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.619 1.568 . . . . 0.0 107.943 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? 52.45 86.86 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.24 1.816 . . . . 0.0 110.859 -153.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.1 p -66.08 162.04 20.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 130.278 3.431 . . . . 0.0 117.937 17.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.18 27.8 0.66 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.672 1.189 . . . . 0.0 113.543 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -76.8 174.02 11.0 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.138 -0.976 . . . . 0.0 111.742 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 pt -112.47 163.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.448 1.099 . . . . 0.0 111.227 160.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -126.46 130.72 51.23 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.683 1.593 . . . . 0.0 109.611 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.31 156.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.09 0.956 . . . . 0.0 113.368 -168.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.3 p -138.96 163.47 32.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.44 2.296 . . . . 0.0 110.406 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.04 -32.66 72.28 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -166.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.28 -20.59 57.21 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -109.38 -18.87 13.46 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.561 1.545 . . . . 0.0 113.88 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -52.93 -41.39 64.42 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.8 1.64 . . . . 0.0 112.927 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.44 72.18 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 m -85.52 -22.14 28.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 112.57 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -96.45 -42.38 8.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 -54.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.871 1.268 . . . . 0.0 111.623 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.66 -11.73 60.06 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.3 p -78.35 -14.34 59.45 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.311 1.844 . . . . 0.0 114.098 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.9 t -69.31 148.92 49.07 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -161.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -107.01 21.37 17.67 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.9 2.08 . . . . 0.0 112.386 167.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -138.76 156.23 72.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 128.31 2.644 . . . . 0.0 108.977 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.31 141.35 88.91 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.711 1.607 . . . . 0.0 112.559 160.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 123.09 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.418 1.087 . . . . 0.0 110.55 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.46 131.25 34.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.492 1.117 . . . . 0.0 108.531 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.63 127.9 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 119.089 0.859 . . . . 0.0 109.837 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -102.13 125.12 48.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.617 0.767 . . . . 0.0 111.172 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.16 112.24 24.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.412 1.485 . . . . 0.0 109.115 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.88 171.68 16.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -166.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 174.72 7.74 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.168 1.387 . . . . 0.0 111.954 174.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.6 p -75.11 -18.73 60.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -115.11 -7.0 12.49 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -165.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.05 128.02 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.37 -60.69 8.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.467 1.032 . . . . 0.0 114.102 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.42 -27.1 54.91 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.192 1.928 . . . . 0.0 113.501 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.61 -33.18 64.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.048 0.84 . . . . 0.0 112.015 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.82 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.172 -0.955 . . . . 0.0 112.722 167.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.89 -30.34 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.835 1.198 . . . . 0.0 113.79 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.64 -6.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.94 -53.89 53.05 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.469 1.031 . . . . 0.0 113.496 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.0 -33.85 91.6 Favored 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 121.646 1.624 . . . . 0.0 112.409 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.91 -50.02 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.988 0.915 . . . . 0.0 112.08 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.78 -37.68 82.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.36 0.664 . . . . 0.0 111.31 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.1 -37.37 78.36 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.143 0.577 . . . . 0.0 112.338 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.39 -48.59 66.93 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.781 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mm -59.67 -38.84 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 120.734 1.606 . . . . 0.0 111.185 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.66 90.51 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.802 0.728 . . . . 0.0 112.884 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.3 m -74.52 -39.5 62.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.041 0.536 . . . . 0.0 111.909 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.27 -34.67 14.85 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -167.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -117.01 20.48 13.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.216 1.406 . . . . 0.0 113.619 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.8 -27.8 19.71 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -81.16 -18.79 45.1 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.48 1.512 . . . . 0.0 113.936 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -94.56 -42.59 8.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.829 1.252 . . . . 0.0 112.068 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.62 155.94 38.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.007 1.323 . . . . 0.0 112.64 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.82 137.85 37.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.159 171.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.11 133.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.829 0.741 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.63 153.87 44.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.625 1.97 . . . . 0.0 111.705 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -123.12 131.48 53.71 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 0.0 112.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.91 121.96 45.55 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.384 1.474 . . . . 0.0 108.729 170.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.22 95.05 7.14 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.184 0.994 . . . . 0.0 109.772 -171.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.5 -20.73 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.327 1.051 . . . . 0.0 113.323 -170.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.44 -33.12 62.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.876 1.27 . . . . 0.0 112.827 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 p -107.35 -20.83 13.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.343 1.457 . . . . 0.0 113.349 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.05 81.91 69.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.734 2.013 . . . . 0.0 109.449 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -74.99 -11.22 21.49 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.202 2.601 . . . . 0.0 114.356 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.8 -40.28 61.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.161 0.984 . . . . 0.0 112.772 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -73.74 -29.59 62.32 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.025 -1.047 . . . . 0.0 112.472 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.14 94.18 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.371 0.669 . . . . 0.0 111.97 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -81.66 -23.24 37.02 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -59.42 -44.79 92.8 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.692 1.197 . . . . 0.0 111.575 171.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.43 4.77 50.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.144 1.378 . . . . 0.0 114.49 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 48.73 61.15 3.23 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.667 1.587 . . . . 0.0 112.763 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.25 134.17 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.604 1.562 . . . . 0.0 110.767 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.19 -14.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 t -146.71 167.55 23.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.025 1.33 . . . . 0.0 111.95 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.28 121.91 16.84 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.709 1.204 . . . . 0.0 108.36 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.65 157.32 94.66 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.882 0.994 . . . . 0.0 112.59 -5.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.9 m -130.33 120.81 24.92 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.216 1.006 . . . . 0.0 109.559 165.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.4 126.99 50.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.644 1.577 . . . . 0.0 109.006 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.39 133.27 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.287 1.035 . . . . 0.0 110.501 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -104.18 118.39 36.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 110.539 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.86 151.34 19.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.602 1.561 . . . . 0.0 110.43 167.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -124.7 124.39 42.06 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 108.834 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.26 36.25 12.27 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.458 1.103 . . . . 0.0 113.5 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.97 18.26 78.94 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.073 1.321 . . . . 0.0 116.094 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -126.3 140.29 36.76 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.565 1.682 . . . . 0.0 111.469 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.05 140.06 33.9 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.128 2.552 . . . . 0.0 112.53 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 t -114.53 -48.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.713 1.205 . . . . 0.0 112.605 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -153.92 141.14 19.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 111.269 -167.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -129.36 136.34 49.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.91 1.284 . . . . 0.0 112.416 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.7 mm -129.83 142.62 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.964 2.106 . . . . 0.0 109.868 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -113.42 148.99 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.332 1.453 . . . . 0.0 112.363 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.31 175.41 42.78 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.158 0.885 . . . . 0.0 114.239 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.74 148.42 38.56 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -154.19 163.87 39.44 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.601 1.961 . . . . 0.0 112.092 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.48 166.79 32.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.688 1.137 . . . . 0.0 112.642 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -60.88 -32.09 71.55 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.637 1.175 . . . . 0.0 114.131 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.6 91.83 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.225 0.61 . . . . 0.0 111.691 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.23 60.78 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.082 0.953 . . . . 0.0 112.773 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.58 -44.0 65.29 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.266 -0.896 . . . . 0.0 111.295 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.38 -30.32 70.07 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.398 -0.813 . . . . 0.0 112.127 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -68.46 -42.81 78.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.585 1.084 . . . . 0.0 112.505 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.04 -29.45 69.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.445 1.02 . . . . 0.0 112.186 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.77 -44.21 81.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.228 0.467 . . . . 0.0 111.87 168.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.1 m -66.25 -18.96 65.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.819 1.248 . . . . 0.0 112.641 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.06 -18.82 65.62 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.47 148.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.87 1.268 . . . . 0.0 110.888 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.5 t -128.66 133.81 25.59 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.712 1.605 . . . . 0.0 110.14 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.95 165.85 30.48 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.528 2.819 . . . . 0.0 113.009 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -146.31 158.44 43.89 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.45 1.5 . . . . 0.0 110.681 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -73.77 -10.42 59.66 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.735 1.384 . . . . 0.0 114.735 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.361 2.264 . . . . 0.0 110.486 176.7 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tmm? . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.2 p -72.07 -30.6 65.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.448 1.099 . . . . 0.0 113.938 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 60.76 16.45 6.75 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.372 1.869 . . . . 0.0 113.934 -161.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.5 m -79.06 -31.35 44.44 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.013 -1.055 . . . . 0.0 112.707 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -126.85 103.25 7.41 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.078 0.942 . . . . 0.0 110.863 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.72 -173.34 4.49 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.805 2.842 . . . . 0.0 108.435 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.6 m -60.79 113.61 2.58 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.237 1.38 . . . . 0.0 111.443 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -125.5 50.45 1.81 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 130.308 3.443 . . . . 0.0 111.404 -13.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -94.88 152.47 18.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.566 1.546 . . . . 0.0 112.973 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.34 141.96 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.65 1.58 . . . . 0.0 111.431 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -97.95 134.76 40.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.553 1.141 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.21 162.25 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.735 1.214 . . . . 0.0 112.833 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.2 p -123.03 169.77 10.84 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.478 1.911 . . . . 0.0 111.238 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.65 -25.86 60.79 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.096 -1.003 . . . . 0.0 113.264 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.44 -50.67 7.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.54 1.136 . . . . 0.0 113.574 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -80.33 -16.1 55.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -49.28 -42.96 42.62 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.815 1.246 . . . . 0.0 111.632 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.2 94.46 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.507 -0.746 . . . . 0.0 112.281 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 m -72.32 -30.21 64.55 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -94.93 -34.14 12.51 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.93 -49.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.667 1.187 . . . . 0.0 111.562 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.1 mt -88.91 -34.83 16.8 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 m -83.94 3.54 33.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.556 1.142 . . . . 0.0 113.866 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -62.03 151.71 34.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.355 1.062 . . . . 0.0 113.139 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -81.21 -7.31 59.54 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.179 1.392 . . . . 0.0 114.022 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -142.76 167.08 17.17 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.402 1.881 . . . . 0.0 110.64 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -60.98 149.75 87.39 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.69 2.26 . . . . 0.0 112.207 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.1 t -129.66 130.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.723 0.809 . . . . 0.0 112.062 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 132.34 36.84 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.385 1.474 . . . . 0.0 108.627 168.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 129.92 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.15 0.886 . . . . 0.0 110.345 169.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -105.71 114.17 28.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.934 0.894 . . . . 0.0 111.128 171.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -91.9 117.2 29.58 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.529 1.531 . . . . 0.0 109.135 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.39 168.52 23.18 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -168.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.99 51.7 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 155.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.4 p -65.69 -12.29 52.34 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -167.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -105.41 -10.69 16.81 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.487 1.915 . . . . 0.0 114.452 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 145.11 45.76 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.311 0.96 . . . . 0.0 112.294 -173.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.52 -64.33 4.42 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.306 -0.872 . . . . 0.0 113.873 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.21 -28.2 87.08 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.15 2.566 . . . . 0.0 114.05 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.1 m -63.7 -49.67 72.19 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.537 0.735 . . . . 0.0 110.461 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.27 67.51 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.054 -1.029 . . . . 0.0 112.202 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.0 tpp -62.15 -31.71 72.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.27 -12.97 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.371 0.987 . . . . 0.0 113.647 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.5 -50.09 73.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 120.415 1.461 . . . . 0.0 114.176 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.72 -26.55 38.97 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.453 2.102 . . . . 0.0 113.493 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.2 t -69.35 -40.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 120.907 -1.121 . . . . 0.0 110.829 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.54 -40.41 35.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.0 1.32 . . . . 0.0 111.096 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.59 -43.16 46.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.535 1.134 . . . . 0.0 111.481 162.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.05 -51.71 10.6 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.984 -0.447 . . . . 0.0 111.442 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mm -62.0 -38.2 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.542 -0.723 . . . . 0.0 111.111 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.79 85.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.391 0.996 . . . . 0.0 112.43 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -75.53 -36.43 60.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.693 0.678 . . . . 0.0 111.689 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.95 -34.2 11.88 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -114.28 22.51 13.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.533 1.533 . . . . 0.0 113.444 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.37 -26.55 41.87 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -78.97 -22.76 45.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.443 1.097 . . . . 0.0 113.012 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -90.63 -46.76 8.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.264 1.426 . . . . 0.0 111.872 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.84 156.72 38.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.326 1.451 . . . . 0.0 112.272 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.6 m -106.0 143.5 34.05 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.618 1.167 . . . . 0.0 109.794 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.81 128.6 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 110.587 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.29 160.36 25.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.496 1.918 . . . . 0.0 112.297 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -124.75 137.37 54.33 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.94 1.696 . . . . 0.0 111.458 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -125.77 122.64 36.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.977 0.911 . . . . 0.0 110.351 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -93.47 111.82 23.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 110.55 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.09 -16.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.91 -42.85 23.29 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.061 0.944 . . . . 0.0 112.764 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -87.38 -25.5 23.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.02 0.928 . . . . 0.0 113.342 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -127.96 60.5 46.37 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.147 1.379 . . . . 0.0 112.222 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -65.43 -17.35 57.46 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.746 2.297 . . . . 0.0 112.553 172.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.44 -46.29 90.58 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.416 1.086 . . . . 0.0 111.533 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -29.94 67.44 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.198 -1.564 . . . . 0.0 111.714 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.72 78.36 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.255 -0.903 . . . . 0.0 112.752 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -26.11 54.22 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.806 1.184 . . . . 0.0 113.273 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -57.28 -44.86 84.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.906 0.882 . . . . 0.0 111.441 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -107.35 9.05 29.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 47.44 60.04 3.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.943 1.697 . . . . 0.0 112.003 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.5 t -84.5 117.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.045 1.338 . . . . 0.0 110.741 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.446 ' H ' ' NH2' ' A' ' 94' ' ' ARG . 51.6 t -147.99 129.46 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.978 2.111 . . . . 0.0 107.114 174.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -121.98 157.37 31.44 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.881 3.272 . . . . 0.0 110.826 -9.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.8 pt -69.28 145.66 96.08 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -171.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.46 138.96 56.12 Favored 'Cis proline' 0 CA--C 1.538 0.713 0 CA-C-N 118.756 0.592 . . . . 0.0 110.937 -11.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.5 m -112.35 113.87 26.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.955 0.902 . . . . 0.0 108.957 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.23 124.78 46.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.987 1.315 . . . . 0.0 108.457 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -128.76 138.82 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.088 0.955 . . . . 0.0 111.367 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.57 129.89 52.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.099 1.36 . . . . 0.0 111.983 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -109.87 139.67 44.68 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.816 2.047 . . . . 0.0 111.114 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -124.02 122.31 37.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.365 1.866 . . . . 0.0 108.982 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 49.01 32.65 4.03 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.128 1.371 . . . . 0.0 114.38 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.79 18.87 69.22 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.61 147.06 59.12 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-N 119.519 1.659 . . . . 0.0 112.385 161.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.68 146.49 48.94 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.331 2.687 . . . . 0.0 112.016 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.97 -45.42 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.63 133.85 19.45 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' NH2' ' H ' ' A' ' 78' ' ' VAL . 52.3 ttt180 -117.8 131.94 56.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.255 2.222 . . . . 0.0 110.002 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.57 140.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.268 1.827 . . . . 0.0 109.603 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.27 146.92 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.929 1.292 . . . . 0.0 112.012 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.83 172.2 45.51 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.247 0.927 . . . . 0.0 113.712 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.09 143.88 47.23 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.46 156.64 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.86 2.064 . . . . 0.0 111.321 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.95 174.92 39.54 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.257 1.408 . . . . 0.0 112.932 -174.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -58.76 -39.97 82.55 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.29 78.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.476 0.711 . . . . 0.0 111.321 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -40.42 74.85 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.778 0.831 . . . . 0.0 112.049 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.66 -42.94 81.41 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.353 -0.842 . . . . 0.0 111.895 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.73 -31.28 71.82 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.676 -0.64 . . . . 0.0 111.928 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -44.78 96.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.127 -0.939 . . . . 0.0 111.685 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.58 -38.05 83.34 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.005 1.275 . . . . 0.0 111.862 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.37 -46.85 78.51 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.491 0.316 . . . . 0.0 111.54 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.3 m -67.71 -24.34 65.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.204 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.99 -10.59 59.99 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.6 t -124.82 -40.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.012 1.725 . . . . 0.0 112.102 -167.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.65 131.16 7.42 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.841 0.856 . . . . 0.0 111.887 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.56 144.56 97.83 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.023 2.482 . . . . 0.0 112.597 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -146.22 177.94 8.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.546 1.139 . . . . 0.0 111.566 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.4 mt -81.73 48.72 1.23 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.114 1.766 . . . . 0.0 111.42 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 125.83 1.652 . . . . 0.0 114.529 -158.151 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.479 0.18 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.3 p -79.72 -17.37 53.72 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.651 1.18 . . . . 0.0 113.967 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -145.63 165.84 27.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.105 1.762 . . . . 0.0 111.012 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.3 p -140.52 -172.26 3.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.818 1.647 . . . . 0.0 112.613 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.5 -10.33 24.9 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.284 1.434 . . . . 0.0 113.991 170.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mttm 62.79 169.57 0.14 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.131 2.573 . . . . 0.0 114.747 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 m -67.16 152.05 46.46 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.922 1.289 . . . . 0.0 112.365 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.37 14.48 29.56 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -168.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -82.22 151.86 26.66 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.085 -1.01 . . . . 0.0 111.319 173.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.7 pt -126.84 171.58 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.135 1.374 . . . . 0.0 112.414 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -125.95 145.42 50.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.493 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.24 159.41 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.537 1.535 . . . . 0.0 112.272 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.7 p -140.19 166.97 23.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.257 2.623 . . . . 0.0 109.935 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.16 -28.06 64.38 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.623 -1.298 . . . . 0.0 114.392 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.08 -24.28 35.3 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -102.51 -27.08 12.99 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 0.0 114.172 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.07 -40.72 58.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.682 1.993 . . . . 0.0 112.457 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.33 -31.4 71.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -83.07 -34.94 26.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.777 0.831 . . . . 0.0 111.798 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.74 -32.94 20.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -109.9 -52.92 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.288 1.435 . . . . 0.0 111.366 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -82.37 -13.38 56.95 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -89.1 1.69 55.22 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.575 1.15 . . . . 0.0 113.009 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -67.15 154.01 42.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.458 1.503 . . . . 0.0 114.946 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -121.06 22.59 10.94 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 126.718 2.007 . . . . 0.0 111.9 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -146.13 168.72 11.03 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 127.956 2.503 . . . . 0.0 111.14 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.19 137.63 52.76 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.71 116.42 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.118 1.367 . . . . 0.0 110.219 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.03 133.81 35.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.754 1.222 . . . . 0.0 109.072 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.9 129.5 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.503 1.047 . . . . 0.0 110.763 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -103.69 128.09 51.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.9 1.28 . . . . 0.0 111.706 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -99.53 116.66 32.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.235 1.414 . . . . 0.0 108.894 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -144.4 167.94 21.28 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.7 176.76 6.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 111.519 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.3 p -68.19 -24.71 64.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -112.88 -13.33 13.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 p -78.19 124.62 28.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -164.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.72 -59.59 10.52 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.795 1.188 . . . . 0.0 114.085 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.27 -27.0 41.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.128 1.964 . . . . 0.0 113.225 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.1 p -72.03 -39.58 69.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.305 0.957 . . . . 0.0 111.686 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -68.93 -29.34 67.56 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.293 -0.879 . . . . 0.0 112.434 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.5 ttp -68.66 -35.93 77.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.703 0.801 . . . . 0.0 113.156 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.73 -24.32 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.566 1.075 . . . . 0.0 113.511 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -45.94 -47.66 41.59 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -64.17 -27.62 64.72 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.96 1.773 . . . . 0.0 113.039 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 t -68.24 -35.87 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.889 1.222 . . . . 0.0 111.229 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 mt -67.98 -48.99 64.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.24 1.016 . . . . 0.0 110.341 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.65 -40.61 72.43 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.661 0.784 . . . . 0.0 110.866 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.16 -51.97 12.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.645 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.5 -39.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.972 1.26 . . . . 0.0 111.361 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.45 96.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.745 0.702 . . . . 0.0 111.604 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.5 m -76.79 -32.48 57.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.06 -22.83 28.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -130.18 27.24 5.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.983 1.313 . . . . 0.0 113.504 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.61 29.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.424 1.49 . . . . 0.0 114.517 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 p -78.11 -18.29 55.86 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.14 1.376 . . . . 0.0 113.737 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -102.01 -40.55 6.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.858 1.263 . . . . 0.0 112.687 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 172.79 12.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.635 1.174 . . . . 0.0 113.674 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -126.19 143.89 50.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.438 1.495 . . . . 0.0 109.779 170.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.8 127.83 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.568 0.699 . . . . 0.0 110.408 168.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.74 164.51 16.47 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.74 2.416 . . . . 0.0 111.722 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 137.96 47.57 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.498 1.119 . . . . 0.0 111.909 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.17 122.34 40.76 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.24 1.416 . . . . 0.0 110.175 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.84 108.63 19.63 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.803 0.841 . . . . 0.0 110.507 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -72.09 -16.65 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.3 -41.14 11.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.541 1.137 . . . . 0.0 112.522 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.7 p -89.43 -22.25 22.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -131.26 72.5 81.15 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.782 1.233 . . . . 0.0 111.793 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -14.59 45.64 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.891 2.394 . . . . 0.0 113.141 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -62.56 -42.87 99.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 112.546 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.0 m -74.18 -31.71 62.79 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.34 0.973 . . . . 0.0 111.711 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.29 94.38 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.658 0.783 . . . . 0.0 111.856 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -77.53 -24.51 49.95 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 168.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -61.28 -46.47 90.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.175 0.898 . . . . 0.0 111.474 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.11 4.25 41.98 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 48.85 62.78 2.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.768 1.627 . . . . 0.0 112.59 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.6 141.92 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 110.652 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.48 -45.03 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.599 1.16 . . . . 0.0 111.951 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -121.67 158.04 29.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.577 1.551 . . . . 0.0 111.287 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.58 130.46 23.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.998 0.919 . . . . 0.0 110.079 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.09 150.5 95.79 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.944 1.016 . . . . 0.0 113.317 -5.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 m -121.1 134.98 55.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.127 1.371 . . . . 0.0 109.12 164.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.73 139.75 45.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.156 1.782 . . . . 0.0 110.145 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 tp -135.03 126.2 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.71 1.204 . . . . 0.0 108.235 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.7 tp -107.06 126.4 52.3 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.978 1.311 . . . . 0.0 109.681 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -107.85 152.37 24.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.969 1.708 . . . . 0.0 110.275 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.202 1.801 . . . . 0.0 108.07 172.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 52.43 32.08 10.72 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 16.83 79.55 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.524 1.535 . . . . 0.0 116.841 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.62 144.14 43.59 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 119.543 1.671 . . . . 0.0 111.776 166.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.45 140.29 39.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.839 2.359 . . . . 0.0 112.2 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.0 m -117.15 -31.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.124 1.37 . . . . 0.0 114.226 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -158.17 142.12 15.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.183 0.993 . . . . 0.0 112.257 -170.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -125.76 136.68 53.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.106 1.763 . . . . 0.0 110.73 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.47 151.89 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.021 1.728 . . . . 0.0 110.295 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.56 147.14 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.492 1.117 . . . . 0.0 111.693 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.07 171.96 48.42 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.478 1.037 . . . . 0.0 113.753 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.8 38.52 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -139.47 152.0 46.65 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.718 2.007 . . . . 0.0 111.341 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.39 169.16 32.76 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.419 1.009 . . . . 0.0 112.022 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.43 -34.46 72.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.93 -42.76 84.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.14 0.576 . . . . 0.0 111.388 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.83 -44.83 72.64 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.582 0.753 . . . . 0.0 111.853 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.36 -43.48 97.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.731 0.813 . . . . 0.0 111.62 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -63.37 -35.75 81.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.406 0.682 . . . . 0.0 111.955 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.2 tpt85 -68.32 -38.25 81.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.201 0.909 . . . . 0.0 112.774 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.83 -39.48 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.444 1.02 . . . . 0.0 111.467 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -42.92 78.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.948 0.499 . . . . 0.0 111.867 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m -66.16 -20.16 66.05 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.061 1.344 . . . . 0.0 112.631 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.78 -19.83 66.03 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.31 146.28 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.099 1.359 . . . . 0.0 110.359 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.15 146.5 51.65 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 126.194 1.798 . . . . 0.0 109.794 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.3 -27.6 63.71 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.8 2.333 . . . . 0.0 114.187 -166.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -88.0 -6.62 57.89 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.417 1.487 . . . . 0.0 114.551 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 tp 52.61 34.97 16.9 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.496 1.918 . . . . 0.0 113.564 -170.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.329 0 C-N-CA 127.702 2.401 . . . . 0.0 113.869 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.4 m -73.65 -33.05 64.32 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.108 0.963 . . . . 0.0 112.706 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -143.9 147.99 34.79 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.22 1.808 . . . . 0.0 109.946 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -59.05 120.85 9.9 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.344 1.058 . . . . 0.0 113.559 -168.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -141.11 33.66 1.73 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.548 1.539 . . . . 0.0 111.404 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -69.5 -20.32 63.72 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.2 m -127.99 140.78 51.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.502 1.921 . . . . 0.0 110.481 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.56 22.11 3.64 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -82.58 155.42 24.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.005 1.322 . . . . 0.0 112.415 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.4 pt -130.75 157.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.2 1.4 . . . . 0.0 111.703 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -103.09 141.74 35.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.85 1.26 . . . . 0.0 110.605 168.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.88 159.44 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.734 1.613 . . . . 0.0 111.359 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.5 p -141.39 168.28 20.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.927 2.491 . . . . 0.0 109.787 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.23 -27.4 34.36 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 120.636 -1.29 . . . . 0.0 113.933 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.76 57.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 p -126.72 -22.1 3.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -172.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -51.18 -41.55 60.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.134 1.773 . . . . 0.0 112.625 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.26 -31.38 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 m -86.07 -29.52 23.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.826 0.85 . . . . 0.0 112.15 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.84 -35.48 14.05 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.77 -55.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.823 1.249 . . . . 0.0 111.282 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.1 mt -80.01 -20.84 44.45 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -92.96 0.78 57.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.735 1.214 . . . . 0.0 113.318 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 t -65.82 143.72 57.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.863 0.865 . . . . 0.0 112.697 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -91.6 3.63 54.56 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.293 1.437 . . . . 0.0 113.044 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -141.62 168.85 12.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.642 1.977 . . . . 0.0 111.294 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.55 144.52 62.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.749 2.299 . . . . 0.0 114.092 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.43 129.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.704 1.202 . . . . 0.0 109.956 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.81 135.66 34.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 164.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.3 t -119.88 125.13 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 118.542 0.61 . . . . 0.0 110.078 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -107.34 113.73 27.3 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.535 1.134 . . . . 0.0 112.245 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -86.21 115.04 23.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.798 2.039 . . . . 0.0 109.102 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.54 172.03 15.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -167.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.75 146.39 50.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.611 1.165 . . . . 0.0 110.438 159.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.0 p -72.38 -14.96 61.84 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -93.66 -9.63 37.25 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.909 1.684 . . . . 0.0 114.032 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 135.22 36.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.373 1.069 . . . . 0.0 111.504 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.23 -65.24 3.66 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.831 1.205 . . . . 0.0 114.643 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.06 -25.87 65.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.376 2.05 . . . . 0.0 112.634 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.6 m -63.36 -45.7 89.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.833 0.853 . . . . 0.0 111.672 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -69.06 -32.83 72.58 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -66.65 -35.19 79.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.345 1.058 . . . . 0.0 113.561 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 m -77.84 -25.19 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.646 1.112 . . . . 0.0 113.684 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.92 -43.48 75.4 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.24 -36.48 87.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.541 2.161 . . . . 0.0 112.954 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.64 -37.03 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.137 0.975 . . . . 0.0 110.926 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.67 -49.69 51.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.521 1.128 . . . . 0.0 110.278 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.88 -40.8 76.89 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.36 0.664 . . . . 0.0 110.859 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -76.42 -48.82 18.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.074 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.49 -39.82 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 110.825 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.07 96.62 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 0.994 . . . . 0.0 111.628 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 m -77.82 -33.63 52.31 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.29 -30.51 23.69 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.235 -0.915 . . . . 0.0 113.054 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -118.45 26.52 9.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.248 1.819 . . . . 0.0 112.174 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.68 33.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.352 1.461 . . . . 0.0 114.195 -176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 p -76.89 -18.18 58.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.235 1.414 . . . . 0.0 113.671 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -101.4 -39.54 7.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.477 1.511 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.03 167.24 29.07 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -120.03 138.87 53.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.313 1.445 . . . . 0.0 109.737 166.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.43 127.6 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.177 0.591 . . . . 0.0 109.768 169.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.93 158.76 22.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.482 1.913 . . . . 0.0 111.585 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.21 131.41 54.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.196 1.398 . . . . 0.0 110.599 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.7 120.63 42.68 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.261 0.553 . . . . 0.0 109.582 164.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -94.67 97.25 9.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.091 0.957 . . . . 0.0 109.619 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.55 -19.41 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.186 -0.946 . . . . 0.0 112.37 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.93 -23.26 60.66 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.262 1.425 . . . . 0.0 114.056 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.0 p -127.2 -22.92 3.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -144.66 76.23 14.29 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.897 1.279 . . . . 0.0 111.134 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.6 -3.81 13.33 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.401 2.734 . . . . 0.0 113.9 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.25 -42.58 95.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.426 1.09 . . . . 0.0 113.051 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -27.17 52.7 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.9 94.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 111.796 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -76.75 -28.59 55.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -58.43 -44.29 89.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 112.069 172.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.68 7.36 46.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.939 1.296 . . . . 0.0 113.718 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 50.9 49.02 21.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.087 1.755 . . . . 0.0 113.246 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.04 123.32 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.504 1.121 . . . . 0.0 109.985 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.64 -23.92 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 t -135.5 165.69 24.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.256 1.422 . . . . 0.0 111.877 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.65 143.5 46.8 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.968 1.307 . . . . 0.0 111.745 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.7 147.37 86.49 Favored 'Cis proline' 0 CA--C 1.54 0.806 0 CA-C-N 119.431 0.833 . . . . 0.0 111.523 -8.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.2 m -133.04 122.22 23.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.216 1.006 . . . . 0.0 109.842 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.71 137.42 44.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.934 1.294 . . . . 0.0 109.75 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.34 132.83 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.114 0.966 . . . . 0.0 109.767 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -114.09 119.79 38.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.105 1.362 . . . . 0.0 111.307 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -101.55 146.68 27.35 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.874 2.07 . . . . 0.0 110.357 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -98.99 -41.17 7.69 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.696 0.798 . . . . 0.0 113.094 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -149.92 53.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.272 1.429 . . . . 0.0 110.422 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.96 15.96 63.38 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.491 1.043 . . . . 0.0 113.667 -168.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.68 126.81 22.8 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.969 2.108 . . . . 0.0 109.161 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.74 143.64 27.02 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.567 2.844 . . . . 0.0 112.754 -170.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.35 -46.6 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.45 1.1 . . . . 0.0 112.418 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -151.05 156.29 40.79 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -121.71 137.55 54.71 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.741 2.016 . . . . 0.0 110.126 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 127.85 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.352 1.461 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.2 157.71 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.525 1.13 . . . . 0.0 112.126 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.15 177.72 40.68 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.655 1.121 . . . . 0.0 113.818 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.33 155.71 38.25 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.24 151.85 50.12 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.606 1.962 . . . . 0.0 111.288 167.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.52 170.98 37.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.7 1.143 . . . . 0.0 111.332 161.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -55.28 -39.13 69.48 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.841 . . . . 0.0 113.028 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.65 85.01 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.398 0.679 . . . . 0.0 112.09 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.82 78.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.353 0.661 . . . . 0.0 111.696 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 104' ' ' LEU . 14.0 tp -66.2 -39.07 89.39 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.201 -0.937 . . . . 0.0 111.782 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.02 -30.63 69.05 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.328 1.051 . . . . 0.0 112.657 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -62.06 -47.6 83.98 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.691 1.132 . . . . 0.0 111.143 168.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -59.17 -41.58 88.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.121 0.873 . . . . 0.0 111.903 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.0 -41.95 97.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.137 0.575 . . . . 0.0 112.471 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.2 m -67.4 -25.1 65.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 112.465 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -75.96 0.05 19.8 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.15 0.98 . . . . 0.0 113.392 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t -125.59 -39.42 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.92 1.688 . . . . 0.0 112.523 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.9 140.78 38.73 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 124.733 1.213 . . . . 0.0 111.707 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.71 158.05 84.71 Favored 'Cis proline' 0 CA--C 1.541 0.831 0 CA-C-N 120.188 1.103 . . . . 0.0 113.823 0.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.85 -16.74 64.23 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -161.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -76.82 -4.6 44.39 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.3 1.44 . . . . 0.0 111.705 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.4 m -63.89 142.06 58.54 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.407 1.083 . . . . 0.0 111.578 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.39 144.58 46.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.304 1.041 . . . . 0.0 112.942 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.1 p 53.92 19.72 2.09 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.387 1.875 . . . . 0.0 115.506 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 56.27 27.59 12.03 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.872 1.669 . . . . 0.0 113.752 -171.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -65.64 156.53 32.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.289 1.436 . . . . 0.0 111.562 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.6 m -59.96 145.05 47.49 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.649 0.779 . . . . 0.0 110.862 165.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.06 29.89 0.27 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -172.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p -94.15 159.12 15.29 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 0.0 112.862 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.73 164.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.197 1.399 . . . . 0.0 110.941 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.95 143.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.753 1.221 . . . . 0.0 110.923 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.51 156.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.661 1.584 . . . . 0.0 112.283 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.3 p -117.72 174.33 6.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.333 2.253 . . . . 0.0 110.332 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.07 -29.77 45.62 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.94 -47.45 11.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.036 0.934 . . . . 0.0 113.262 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.79 -12.35 55.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.99 -46.24 43.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.714 1.205 . . . . 0.0 112.666 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.47 -31.32 69.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.3 m -89.31 -19.94 24.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.88 1.272 . . . . 0.0 113.223 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -122.01 -21.92 5.84 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.92 -37.23 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.511 1.505 . . . . 0.0 114.406 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.33 -11.42 60.05 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.059 1.3 . . . . 0.0 113.389 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.9 p -76.9 -7.56 55.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.453 1.501 . . . . 0.0 114.111 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 84.1 p -67.69 160.13 28.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.721 . . . . 0.0 114.883 -171.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.12 16.03 5.11 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.117 1.767 . . . . 0.0 112.536 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -142.43 173.03 5.03 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 128.282 2.633 . . . . 0.0 109.533 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -61.06 140.12 88.02 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.141 1.894 . . . . 0.0 113.383 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.02 114.93 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.078 1.351 . . . . 0.0 110.75 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.84 117.01 23.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -105.76 124.01 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.849 0.75 . . . . 0.0 109.873 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -101.64 117.06 34.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.869 1.268 . . . . 0.0 110.531 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.19 115.0 26.74 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.099 1.759 . . . . 0.0 109.351 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -148.1 168.04 23.44 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.6 170.41 7.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.183 0.993 . . . . 0.0 111.107 166.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -76.64 -6.17 50.93 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -129.41 -2.72 4.93 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -165.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 p -80.5 136.6 36.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.709 1.141 . . . . 0.0 113.981 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -62.93 5.32 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.805 1.193 . . . . 0.0 114.458 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.71 -23.18 42.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.37 2.046 . . . . 0.0 112.873 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.43 -40.06 58.13 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -68.29 -32.58 72.83 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.093 -1.004 . . . . 0.0 112.05 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.7 -32.3 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.791 0.836 . . . . 0.0 113.025 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.37 -5.5 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -53.52 52.3 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 120.269 1.395 . . . . 0.0 113.461 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 -33.48 48.56 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.627 1.551 . . . . 0.0 112.31 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.38 -52.01 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.1 0.864 . . . . 0.0 111.317 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -67.81 -36.7 80.88 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.902 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.8 -34.19 71.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.61 -46.02 77.23 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.261 -0.9 . . . . 0.0 111.321 171.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -56.7 -43.73 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.674 1.579 . . . . 0.0 110.973 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 60' ' ' VAL . . . -57.81 -45.58 85.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.729 0.412 . . . . 0.0 111.761 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.6 m -79.08 -29.85 43.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.389 1.076 . . . . 0.0 112.262 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -87.2 -23.05 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -129.4 24.96 5.48 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.34 -30.63 29.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.254 1.422 . . . . 0.0 114.712 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -77.5 -18.45 57.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.245 1.418 . . . . 0.0 113.933 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -104.3 -37.88 7.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.144 1.378 . . . . 0.0 112.726 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.61 173.79 12.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.092 1.357 . . . . 0.0 113.017 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.8 m -122.21 153.78 38.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.43 1.492 . . . . 0.0 109.939 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 51' ' ' ALA . 59.1 t -124.19 138.03 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.68 0.792 . . . . 0.0 109.58 168.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.38 160.36 38.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.097 1.759 . . . . 0.0 112.007 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -125.83 138.26 53.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.218 1.007 . . . . 0.0 112.697 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -119.39 125.59 49.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.934 1.694 . . . . 0.0 109.37 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.14 93.17 7.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.024 0.93 . . . . 0.0 110.519 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.02 -23.34 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.364 1.065 . . . . 0.0 113.152 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.09 -27.89 69.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.806 1.242 . . . . 0.0 112.368 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.7 p -119.46 -11.17 9.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.836 1.654 . . . . 0.0 113.844 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -127.07 56.82 19.59 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.839 1.656 . . . . 0.0 112.594 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.39 -13.37 33.02 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.178 2.586 . . . . 0.0 113.874 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.31 -30.7 60.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.378 1.071 . . . . 0.0 112.437 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -33.94 58.07 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.189 0.996 . . . . 0.0 112.559 165.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.07 95.89 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.838 0.744 . . . . 0.0 112.324 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -76.31 -23.43 54.31 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.3 -43.06 98.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.537 0.735 . . . . 0.0 111.851 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.41 11.98 35.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.479 1.512 . . . . 0.0 114.061 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 52.54 60.23 3.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.235 1.814 . . . . 0.0 113.056 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.5 t -66.11 126.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.915 0.886 . . . . 0.0 109.373 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.9 m -129.21 -30.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.002 1.321 . . . . 0.0 112.704 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -131.23 147.72 52.62 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.474 1.91 . . . . 0.0 109.358 167.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 pt -111.73 129.88 23.73 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.301 1.04 . . . . 0.0 110.145 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.63 143.39 77.38 Favored 'Cis proline' 0 CA--C 1.54 0.805 0 CA-C-N 119.649 0.91 . . . . 0.0 112.711 1.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.58 133.23 46.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.556 1.142 . . . . 0.0 108.036 161.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.39 126.15 51.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.7 1.2 . . . . 0.0 108.621 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.68 126.86 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 121.478 -0.764 . . . . 0.0 109.954 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.24 117.55 35.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.923 1.289 . . . . 0.0 110.399 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -94.14 158.33 15.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.868 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -142.54 135.39 28.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.749 1.619 . . . . 0.0 108.63 158.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.56 37.48 23.25 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.803 0.841 . . . . 0.0 113.093 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.19 16.65 67.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.508 2.004 . . . . 0.0 115.223 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -123.52 138.22 29.84 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.947 1.299 . . . . 0.0 110.973 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.42 139.85 32.39 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.914 2.409 . . . . 0.0 112.62 -173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -116.07 -42.83 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.664 1.586 . . . . 0.0 112.304 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -150.76 147.23 27.06 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.777 1.231 . . . . 0.0 112.597 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -125.21 137.11 54.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.854 2.062 . . . . 0.0 111.092 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.64 159.78 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 127.103 2.161 . . . . 0.0 110.874 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.6 153.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 111.527 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.45 169.36 25.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.637 1.113 . . . . 0.0 113.414 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 154.92 38.26 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.57 156.39 48.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.665 1.986 . . . . 0.0 110.923 168.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.99 162.63 42.85 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -57.33 -34.41 68.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.248 1.019 . . . . 0.0 113.645 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.36 77.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.856 0.463 . . . . 0.0 111.584 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.44 -50.09 64.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.685 0.794 . . . . 0.0 111.736 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.3 tp -61.61 -40.64 95.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.689 -0.632 . . . . 0.0 111.673 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.19 -40.22 95.34 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.106 0.866 . . . . 0.0 111.871 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -49.85 76.0 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.359 0.982 . . . . 0.0 110.662 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -63.19 -30.05 71.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -39.73 26.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 112.13 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.1 m -67.52 -18.11 64.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.8 1.64 . . . . 0.0 112.835 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.89 -16.02 15.49 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.09 1.356 . . . . 0.0 113.57 167.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 t -117.83 147.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 127.004 2.122 . . . . 0.0 109.913 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.66 148.1 85.01 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.321 1.048 . . . . 0.0 112.227 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.96 142.04 65.88 Favored 'Cis proline' 0 CA--C 1.541 0.84 0 CA-C-N 120.171 1.097 . . . . 0.0 113.468 0.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -151.67 139.0 19.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.896 1.679 . . . . 0.0 109.492 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 tp -81.01 -24.63 37.81 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.029 1.332 . . . . 0.0 113.568 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.646 1.179 . . . . 0.0 113.454 -174.111 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.575 0.226 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.6 p -76.27 158.45 31.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.659 1.184 . . . . 0.0 112.6 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -145.9 139.42 26.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.141 1.376 . . . . 0.0 111.369 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.0 p -158.28 -47.12 0.06 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.732 1.213 . . . . 0.0 112.742 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -144.81 143.79 30.81 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.777 2.031 . . . . 0.0 110.097 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.66 156.64 17.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.724 1.609 . . . . 0.0 111.918 177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.5 p -71.77 159.64 33.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.797 1.239 . . . . 0.0 112.586 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.4 19.71 20.12 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -171.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -87.71 151.96 22.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.107 0.963 . . . . 0.0 111.83 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.36 170.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.398 1.479 . . . . 0.0 112.08 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -128.69 149.6 50.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.21 1.004 . . . . 0.0 112.274 165.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.33 156.56 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.5 p -139.07 159.56 41.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.644 1.978 . . . . 0.0 110.166 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.9 -27.94 68.53 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -164.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.98 -23.08 60.6 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.8 m -111.46 -19.87 12.42 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 0.0 113.46 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -49.36 -39.46 31.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 112.966 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.09 71.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.5 m -84.7 -33.87 23.06 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.613 -0.679 . . . . 0.0 111.751 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -80.85 -42.37 21.67 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.63 -52.48 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.538 1.535 . . . . 0.0 110.956 -174.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -80.3 -12.37 59.61 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 t -98.81 5.2 47.59 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.605 1.162 . . . . 0.0 113.353 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -67.11 152.11 46.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.497 1.519 . . . . 0.0 114.598 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.83 28.5 8.74 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.993 1.717 . . . . 0.0 111.022 171.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -153.06 169.33 9.88 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 128.267 2.627 . . . . 0.0 110.236 -175.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.23 144.84 87.66 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.073 1.848 . . . . 0.0 111.484 161.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.8 118.66 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.029 . . . . 0.0 109.597 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.25 112.72 25.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.948 1.299 . . . . 0.0 108.753 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.1 124.24 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.377 0.99 . . . . 0.0 110.667 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -97.54 112.7 24.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 111.429 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -85.55 111.14 19.75 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.747 1.619 . . . . 0.0 108.188 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.85 178.92 8.46 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -162.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.13 144.47 45.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.525 0.73 . . . . 0.0 110.364 159.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.9 p -67.37 -23.26 65.57 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -85.23 -9.58 57.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.361 1.464 . . . . 0.0 114.245 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 135.38 36.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.011 0.924 . . . . 0.0 111.48 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -62.95 5.63 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.742 1.163 . . . . 0.0 114.546 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.4 -21.02 61.3 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.342 2.028 . . . . 0.0 113.149 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.4 m -68.03 -49.63 60.25 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.937 0.789 . . . . 0.0 110.991 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.85 -32.97 74.66 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.108 -0.995 . . . . 0.0 112.03 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.51 -35.22 73.74 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.212 1.005 . . . . 0.0 113.108 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.63 -7.54 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.76 63.22 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 120.406 1.457 . . . . 0.0 114.15 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.23 -35.81 30.96 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.496 1.464 . . . . 0.0 112.012 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.83 -48.94 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.917 0.887 . . . . 0.0 111.469 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.17 -39.11 82.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.344 0.657 . . . . 0.0 110.756 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.8 -45.38 94.09 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.399 0.545 . . . . 0.0 112.075 173.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.92 -47.53 68.5 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.345 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -62.05 -35.21 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.999 1.727 . . . . 0.0 111.949 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.15 -43.95 92.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.547 1.067 . . . . 0.0 111.606 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.0 m -81.1 -30.09 34.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.889 0.876 . . . . 0.0 112.604 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -79.75 -15.57 57.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.365 1.066 . . . . 0.0 113.733 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.64 24.22 3.14 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.359 1.464 . . . . 0.0 114.122 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.41 -29.57 49.47 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -17.99 43.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.289 1.436 . . . . 0.0 113.688 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -101.66 -41.41 6.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.081 1.352 . . . . 0.0 112.698 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 176.46 10.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.911 1.684 . . . . 0.0 112.864 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -129.36 142.64 50.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 110.407 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.16 132.27 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.533 0.733 . . . . 0.0 109.84 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.05 162.65 30.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.204 2.202 . . . . 0.0 112.214 -164.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -127.59 139.65 52.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.234 1.413 . . . . 0.0 112.676 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.55 124.27 39.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.616 1.566 . . . . 0.0 109.766 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -89.62 97.46 11.21 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.157 0.983 . . . . 0.0 110.149 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.5 -25.15 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.984 -1.073 . . . . 0.0 112.559 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.18 -21.09 43.4 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.707 1.603 . . . . 0.0 113.845 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.0 p -125.89 -17.08 5.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -131.01 79.0 72.34 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.226 1.01 . . . . 0.0 111.542 163.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.27 -13.47 36.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.436 2.757 . . . . 0.0 114.496 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -58.09 -40.57 81.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.77 1.228 . . . . 0.0 112.821 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -81.52 -30.66 33.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.85 -1.156 . . . . 0.0 112.07 172.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.0 87.57 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.361 -0.837 . . . . 0.0 111.958 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 54.99 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.055 0.942 . . . . 0.0 113.5 169.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -64.36 -44.57 91.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.982 0.81 . . . . 0.0 111.084 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.78 4.27 37.73 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.973 1.309 . . . . 0.0 114.481 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 50.59 49.54 20.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.97 1.708 . . . . 0.0 113.093 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.72 134.63 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.807 0.843 . . . . 0.0 111.598 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.09 -40.04 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.353 1.061 . . . . 0.0 112.768 -170.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -142.27 168.39 19.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.227 1.411 . . . . 0.0 111.717 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.0 pt -130.76 146.18 60.85 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.822 1.249 . . . . 0.0 112.697 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.18 143.03 75.88 Favored 'Cis proline' 0 CA--C 1.54 0.79 0 CA-C-N 118.976 0.67 . . . . 0.0 111.423 -8.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.1 m -121.99 118.26 28.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.203 1.001 . . . . 0.0 108.665 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -105.65 129.5 53.88 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.142 0.977 . . . . 0.0 109.53 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.59 126.7 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.547 1.139 . . . . 0.0 109.833 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -105.19 119.75 39.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.127 1.371 . . . . 0.0 111.042 -173.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -97.08 154.73 17.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.158 1.783 . . . . 0.0 110.927 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -130.89 109.16 10.35 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.333 1.853 . . . . 0.0 109.386 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 52.97 37.74 25.36 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.211 1.004 . . . . 0.0 112.906 -174.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.06 11.65 82.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.307 1.432 . . . . 0.0 116.5 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -113.7 138.09 22.51 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 119.601 1.701 . . . . 0.0 111.507 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.57 139.55 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.74 -43.13 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.403 1.081 . . . . 0.0 112.661 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -149.46 141.12 23.51 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.835 1.254 . . . . 0.0 111.463 -165.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -129.17 138.28 51.65 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.284 1.434 . . . . 0.0 111.662 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.4 151.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 111.665 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.4 147.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.049 1.339 . . . . 0.0 111.225 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.23 168.11 42.65 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.819 1.676 . . . . 0.0 113.389 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.52 156.39 35.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.97 158.07 45.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.724 2.01 . . . . 0.0 111.197 169.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.82 170.27 41.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.026 0.822 . . . . 0.0 111.179 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.77 -39.81 71.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.55 -46.75 78.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.09 0.556 . . . . 0.0 111.575 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.31 76.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.324 0.65 . . . . 0.0 111.818 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.92 -40.04 95.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.203 0.601 . . . . 0.0 112.113 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.97 -30.12 68.48 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.64 -0.663 . . . . 0.0 112.269 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -36.8 70.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.864 1.211 . . . . 0.0 112.47 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.9 -35.89 79.69 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.508 -0.745 . . . . 0.0 111.847 168.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.59 -38.2 83.67 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -68.31 -21.11 64.79 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.412 1.085 . . . . 0.0 112.572 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -68.51 -10.66 57.05 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.74 -38.09 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.93 1.692 . . . . 0.0 112.704 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.02 152.15 75.23 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 125.866 1.666 . . . . 0.0 112.417 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.76 39.96 0.81 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 124.086 3.191 . . . . 0.0 115.166 -169.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -56.21 -32.26 64.25 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.512 -1.367 . . . . 0.0 112.823 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -77.43 -2.89 37.51 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.676 1.59 . . . . 0.0 111.772 -176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttm . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 p -74.19 156.79 36.93 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.676 1.19 . . . . 0.0 113.01 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -74.04 153.87 39.49 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.255 1.022 . . . . 0.0 112.605 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.1 p -149.13 170.02 19.36 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.02 1.328 . . . . 0.0 112.446 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.43 5.03 28.86 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.66 1.184 . . . . 0.0 113.571 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -69.8 148.37 49.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.978 1.311 . . . . 0.0 112.451 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.8 m -66.39 146.17 54.87 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.665 1.186 . . . . 0.0 112.7 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.14 22.05 14.73 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 p -94.22 160.84 14.51 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.204 -0.935 . . . . 0.0 112.143 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 pt -119.45 173.44 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.942 1.297 . . . . 0.0 111.46 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -127.81 139.4 52.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.771 1.628 . . . . 0.0 109.654 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.88 160.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.787 1.235 . . . . 0.0 112.795 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.8 p -124.47 166.61 15.72 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.296 2.638 . . . . 0.0 110.136 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -25.83 63.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.15 17.74 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.572 1.149 . . . . 0.0 113.07 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -80.34 -18.35 49.35 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.92 -41.72 25.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.917 2.087 . . . . 0.0 112.98 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.25 71.35 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.057 -1.027 . . . . 0.0 113.626 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -92.47 -19.0 22.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.378 1.471 . . . . 0.0 113.071 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -116.13 -25.47 7.61 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.11 -54.93 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.511 1.124 . . . . 0.0 111.422 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.8 mt -71.66 -16.94 62.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.4 p -75.33 -16.91 60.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.763 1.625 . . . . 0.0 114.505 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -72.0 149.14 45.24 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -165.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.62 -0.03 57.25 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.508 1.523 . . . . 0.0 113.796 172.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.94 167.25 20.91 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.019 2.127 . . . . 0.0 110.978 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.06 147.12 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.802 2.334 . . . . 0.0 114.311 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.3 t -133.5 125.58 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.797 0.839 . . . . 0.0 111.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.46 129.09 35.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.054 . . . . 0.0 108.802 172.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.49 127.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.321 1.048 . . . . 0.0 109.287 166.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -104.23 123.86 48.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.379 0.672 . . . . 0.0 111.409 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -87.1 112.81 22.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.258 1.023 . . . . 0.0 109.317 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.34 174.12 12.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -168.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.77 174.72 8.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.396 1.478 . . . . 0.0 111.206 171.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.1 p -75.93 -10.49 59.46 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -124.39 -5.05 7.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -164.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.55 132.39 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.597 1.089 . . . . 0.0 113.886 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -58.99 11.32 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.719 1.152 . . . . 0.0 114.284 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.87 -23.89 40.75 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 119.982 1.891 . . . . 0.0 113.041 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.9 -34.71 59.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.024 -1.047 . . . . 0.0 111.788 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -67.12 -32.32 73.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.821 0.848 . . . . 0.0 112.131 166.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.0 ttt -64.42 -35.37 80.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 174.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.42 -11.45 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.65 85.4 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.14 -30.99 37.35 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.467 1.56 . . . . 0.0 112.643 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.6 -47.82 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.253 0.933 . . . . 0.0 111.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.14 -35.27 73.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.258 1.023 . . . . 0.0 111.47 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.87 -45.26 90.23 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.061 0.846 . . . . 0.0 112.324 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.14 -45.87 79.52 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.933 -0.479 . . . . 0.0 110.756 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mm -61.28 -38.38 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.659 1.118 . . . . 0.0 111.881 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.63 92.89 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.619 1.1 . . . . 0.0 112.264 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.5 m -79.02 -33.27 45.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.859 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.92 -33.42 15.61 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -113.27 26.4 10.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.622 1.569 . . . . 0.0 113.101 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -25.88 53.67 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -73.2 -29.9 63.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.593 1.157 . . . . 0.0 112.153 173.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -90.71 -38.22 13.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.271 1.428 . . . . 0.0 113.008 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.11 173.05 13.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -110.9 146.87 35.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.782 1.633 . . . . 0.0 109.363 157.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.58 129.57 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.387 -0.821 . . . . 0.0 110.251 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.84 161.14 29.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.261 2.225 . . . . 0.0 111.295 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -131.76 142.95 49.9 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.433 0.693 . . . . 0.0 111.614 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.21 127.52 56.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.297 1.839 . . . . 0.0 109.599 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -96.04 97.25 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.485 1.114 . . . . 0.0 111.825 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.94 -16.0 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.2 -25.2 61.57 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.623 0.769 . . . . 0.0 112.538 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.8 p -126.67 -23.16 3.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -146.74 67.58 11.37 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.035 1.334 . . . . 0.0 111.977 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.34 2.86 5.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.014 3.143 . . . . 0.0 114.75 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -61.79 -39.73 92.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.842 -1.161 . . . . 0.0 113.59 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.34 -28.66 53.14 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 113.863 170.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.64 88.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.873 1.215 . . . . 0.0 112.117 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -75.51 -27.26 58.69 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.097 -1.002 . . . . 0.0 113.328 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -59.73 -41.82 91.75 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.21 0.914 . . . . 0.0 111.938 171.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -96.65 19.17 12.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.506 1.522 . . . . 0.0 113.597 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 52.59 42.52 31.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.451 2.301 . . . . 0.0 114.637 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.85 124.07 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.668 1.187 . . . . 0.0 110.59 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.88 -40.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.072 0.949 . . . . 0.0 111.418 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -147.88 161.74 40.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.615 1.566 . . . . 0.0 111.026 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.5 pt -109.01 142.39 25.42 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.746 1.218 . . . . 0.0 111.688 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.87 154.03 99.42 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.545 0.873 . . . . 0.0 112.535 -0.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -133.88 120.92 21.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.868 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.12 134.16 38.15 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.963 1.305 . . . . 0.0 109.0 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.6 131.19 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.411 1.084 . . . . 0.0 109.111 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.7 tp -108.18 116.4 31.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.845 1.258 . . . . 0.0 110.476 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.87 157.37 16.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.233 1.813 . . . . 0.0 111.514 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -144.75 131.56 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.493 1.917 . . . . 0.0 109.45 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.6 t70 50.0 32.99 6.19 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.27 16.21 80.73 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.876 1.227 . . . . 0.0 115.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -117.1 152.22 48.61 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.209 1.504 . . . . 0.0 111.638 164.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.1 150.43 77.31 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.293 1.996 . . . . 0.0 111.301 168.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.02 -42.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.258 1.023 . . . . 0.0 112.37 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -142.19 146.08 34.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.808 1.243 . . . . 0.0 112.32 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -129.44 130.35 45.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.533 1.533 . . . . 0.0 110.557 166.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -129.81 123.88 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.83 1.652 . . . . 0.0 109.777 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 148.06 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.687 1.195 . . . . 0.0 111.873 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.92 172.62 39.53 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.495 1.045 . . . . 0.0 114.333 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 149.8 42.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -151.48 162.02 41.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.308 1.843 . . . . 0.0 112.513 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.94 166.67 31.32 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.797 1.189 . . . . 0.0 112.547 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -59.89 -31.64 69.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.9 97.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.216 0.606 . . . . 0.0 111.868 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.65 -30.72 56.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.954 0.902 . . . . 0.0 113.199 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.65 -42.88 73.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.33 -0.856 . . . . 0.0 110.793 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.1 tp -67.88 -33.47 74.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.473 -0.767 . . . . 0.0 112.391 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.57 -50.11 70.75 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.566 1.075 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -64.28 -29.34 70.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.164 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.9 tp -67.74 -47.18 70.02 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.764 0.826 . . . . 0.0 113.194 171.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 m -68.89 -20.43 64.25 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.446 0.698 . . . . 0.0 112.385 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.75 -9.19 58.32 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.6 -42.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.588 1.555 . . . . 0.0 112.79 -166.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.33 142.07 97.58 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 118.99 0.814 . . . . 0.0 112.517 -175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.26 155.81 43.92 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.12 2.547 . . . . 0.0 114.04 175.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -144.6 136.14 25.57 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.465 1.506 . . . . 0.0 110.488 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.3 tp -86.67 -19.34 29.38 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.26 1.424 . . . . 0.0 113.354 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.403 0 C-N-CA 125.655 1.582 . . . . 0.0 112.016 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 111.409 0.152 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 p -78.66 -22.56 46.62 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.8 t70 52.09 -102.31 0.13 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.77 2.028 . . . . 0.0 113.963 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.1 t -154.02 166.44 33.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.652 1.581 . . . . 0.0 111.615 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -78.84 69.55 5.03 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.481 1.512 . . . . 0.0 111.679 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -73.8 162.48 29.08 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.636 1.574 . . . . 0.0 112.805 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 p -68.79 134.66 50.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.361 1.464 . . . . 0.0 112.674 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.45 69.38 8.96 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.914 0.886 . . . . 0.0 111.148 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -124.87 152.33 44.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.202 1.401 . . . . 0.0 112.585 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -132.3 166.85 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.027 1.731 . . . . 0.0 111.905 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -116.42 139.36 50.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.795 1.638 . . . . 0.0 109.837 168.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.64 158.54 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.559 1.544 . . . . 0.0 112.041 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.2 p -143.53 162.71 35.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.028 1.731 . . . . 0.0 111.748 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.14 -28.15 62.49 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.59 -18.15 49.15 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.401 1.08 . . . . 0.0 113.835 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -124.06 -10.0 7.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 114.351 -171.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -53.16 -41.07 64.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.714 1.606 . . . . 0.0 112.959 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.47 72.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -84.58 -26.67 27.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.136 1.375 . . . . 0.0 112.437 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -92.86 -44.78 8.3 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -98.96 -55.18 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.009 1.324 . . . . 0.0 111.083 -175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.2 mt -78.14 -11.99 59.96 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.9 p -71.56 -17.24 62.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.23 1.412 . . . . 0.0 113.627 172.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -83.08 123.29 29.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.565 1.546 . . . . 0.0 111.833 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -78.7 -24.43 45.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.231 1.012 . . . . 0.0 112.701 171.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -82.51 166.73 34.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.589 1.556 . . . . 0.0 110.479 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.87 144.94 99.38 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.297 1.998 . . . . 0.0 112.722 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.6 t -132.17 124.99 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.074 0.949 . . . . 0.0 110.412 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 132.03 36.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 169.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.1 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 0.854 . . . . 0.0 110.418 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.73 118.34 36.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.031 1.333 . . . . 0.0 111.559 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.2 112.56 24.26 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.631 1.573 . . . . 0.0 109.203 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 170.19 19.02 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -163.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.88 -167.54 1.82 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.907 1.683 . . . . 0.0 109.672 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -98.83 -20.16 17.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -86.44 -22.36 26.56 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.98 132.81 35.41 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.247 1.019 . . . . 0.0 113.018 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.16 -59.02 11.4 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.39 0.995 . . . . 0.0 114.213 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.33 -25.06 36.58 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.269 1.979 . . . . 0.0 113.406 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.51 -32.91 54.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.359 -0.838 . . . . 0.0 112.088 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -70.51 -36.57 73.85 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 111.589 169.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.1 ttt -60.49 -31.94 70.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.671 1.188 . . . . 0.0 113.762 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.91 -5.91 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -52.73 70.28 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.811 1.187 . . . . 0.0 113.963 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.02 -33.32 74.49 Favored 'Trans proline' 0 C--N 1.353 0.805 0 CA-C-N 121.421 1.543 . . . . 0.0 112.423 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.31 -49.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.811 0.844 . . . . 0.0 111.792 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.51 -37.03 84.17 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.386 0.539 . . . . 0.0 111.176 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.92 -38.53 83.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.028 0.831 . . . . 0.0 112.25 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.05 -48.03 69.52 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.295 -0.878 . . . . 0.0 111.819 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mm -59.49 -41.6 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.545 1.52 . . . . 0.0 111.001 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.52 71.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.356 0.662 . . . . 0.0 112.684 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.3 m -76.73 -42.95 39.33 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.088 -1.007 . . . . 0.0 111.2 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.43 -36.06 17.93 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -166.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -114.75 21.64 14.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.926 1.29 . . . . 0.0 113.601 -171.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.2 41.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.353 1.461 . . . . 0.0 114.589 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 p -80.95 -18.28 47.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.479 1.512 . . . . 0.0 113.657 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -101.75 -39.54 7.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.071 1.348 . . . . 0.0 112.784 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.9 169.21 21.68 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.891 1.276 . . . . 0.0 113.676 -176.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -110.54 142.26 42.58 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.465 1.506 . . . . 0.0 110.09 171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.28 119.31 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.531 169.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.77 163.33 16.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.838 2.055 . . . . 0.0 111.535 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.75 137.92 47.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.594 0.758 . . . . 0.0 112.049 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.61 123.44 46.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.845 1.258 . . . . 0.0 109.443 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -91.49 108.74 20.1 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.998 0.919 . . . . 0.0 109.447 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 m -70.86 -16.23 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -87.95 -41.24 13.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.271 1.028 . . . . 0.0 112.671 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -87.35 -22.29 25.17 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -139.99 69.6 35.58 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.568 1.147 . . . . 0.0 112.644 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.43 -14.83 46.96 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.249 2.632 . . . . 0.0 113.829 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -64.98 -34.9 79.55 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.059 -1.026 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -80.2 -30.31 38.69 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.476 -0.765 . . . . 0.0 112.051 169.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.51 80.91 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.627 -1.296 . . . . 0.0 112.308 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -76.75 -23.2 53.01 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 168.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -60.6 -43.5 97.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 0.0 111.683 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -102.43 7.76 40.26 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.18 1.392 . . . . 0.0 114.039 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 48.67 67.05 0.92 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.762 1.625 . . . . 0.0 112.331 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.03 81.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 123.055 1.407 . . . . 0.0 110.249 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.8 m -87.43 -22.97 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.306 1.842 . . . . 0.0 112.868 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -122.07 133.14 54.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.221 1.808 . . . . 0.0 109.73 173.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 tt -118.23 135.08 23.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.384 1.074 . . . . 0.0 111.517 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.82 157.23 92.44 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 118.847 0.624 . . . . 0.0 112.7 -9.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -107.42 124.21 49.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.673 1.189 . . . . 0.0 108.39 163.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.13 122.78 48.77 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.283 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 tp -130.37 129.83 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.486 1.114 . . . . 0.0 109.986 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.2 tp -100.14 132.34 45.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.151 1.38 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -118.36 151.76 37.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.875 1.67 . . . . 0.0 111.576 175.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -143.59 130.0 19.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.14 1.776 . . . . 0.0 109.832 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 t70 49.63 35.91 9.6 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.952 1.301 . . . . 0.0 114.381 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 16.41 80.8 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.847 1.213 . . . . 0.0 116.012 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -125.21 144.35 47.15 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 118.745 1.273 . . . . 0.0 111.494 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.46 144.96 51.77 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.009 2.473 . . . . 0.0 111.673 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.13 -54.7 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.832 1.253 . . . . 0.0 112.17 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -156.05 152.72 28.4 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -117.97 141.6 48.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.587 1.955 . . . . 0.0 111.571 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.79 146.71 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.952 . . . . 0.0 109.706 171.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.05 151.61 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.719 1.207 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.16 -171.15 55.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.748 0.689 . . . . 0.0 111.959 -170.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.08 155.79 23.67 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -135.17 149.92 50.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.214 2.205 . . . . 0.0 110.139 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.46 160.62 29.33 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 162.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -58.03 -34.53 70.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.75 73.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.313 0.645 . . . . 0.0 111.655 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.36 73.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.565 0.746 . . . . 0.0 111.598 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.62 -40.58 97.43 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.764 -0.585 . . . . 0.0 111.565 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.32 -33.4 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -61.58 -48.68 79.84 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.625 1.102 . . . . 0.0 110.555 170.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.66 -33.97 74.91 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 mt -71.2 -35.33 71.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.268 1.027 . . . . 0.0 113.623 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 t -69.69 -26.41 64.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.634 1.174 . . . . 0.0 112.008 172.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -76.38 5.44 7.16 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.412 1.485 . . . . 0.0 114.451 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 p -64.59 162.98 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.005 1.322 . . . . 0.0 112.984 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.83 128.94 89.6 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 123.958 0.903 . . . . 0.0 109.899 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.53 148.31 87.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.998 2.465 . . . . 0.0 113.369 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -71.55 -12.36 61.33 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -172.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.37 9.18 23.52 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.241 1.816 . . . . 0.0 113.289 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.273 0 C-N-CA 125.536 1.534 . . . . 0.0 111.82 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.584 0.231 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.4 p -76.38 157.33 32.45 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.769 1.228 . . . . 0.0 112.484 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -121.23 168.31 11.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.482 3.113 . . . . 0.0 112.86 0.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 m -78.29 44.72 0.51 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.903 1.681 . . . . 0.0 113.652 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 54.18 52.75 12.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.758 2.023 . . . . 0.0 113.236 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -65.5 -23.39 66.88 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.6 m -82.66 124.95 30.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.085 1.354 . . . . 0.0 112.127 -161.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.04 12.75 1.26 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 128.378 2.671 . . . . 0.0 115.023 -11.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -77.33 143.95 38.41 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.776 -1.203 . . . . 0.0 110.901 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 pt -108.3 134.4 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.813 0.845 . . . . 0.0 112.752 -170.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.08 129.51 35.03 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.255 . . . . 0.0 109.415 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.48 155.72 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.568 1.147 . . . . 0.0 111.544 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.7 p -121.47 172.7 7.88 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.385 1.874 . . . . 0.0 110.891 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.09 -24.78 42.32 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 -51.14 7.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.23 1.012 . . . . 0.0 113.167 172.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -80.65 -23.23 39.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -50.76 -41.63 56.95 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.087 1.355 . . . . 0.0 112.018 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.48 72.11 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.765 -1.209 . . . . 0.0 113.654 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -84.44 -30.63 25.14 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.365 -0.834 . . . . 0.0 112.421 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -92.56 -30.02 15.87 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.21 -54.39 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.216 1.406 . . . . 0.0 111.288 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.25 -22.46 35.81 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -172.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -88.31 3.75 48.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.348 1.059 . . . . 0.0 113.201 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -68.29 154.79 41.05 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.563 1.545 . . . . 0.0 114.237 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -112.91 9.45 18.85 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.562 1.945 . . . . 0.0 113.315 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -138.49 170.4 10.4 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 127.631 2.372 . . . . 0.0 111.288 -173.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -66.88 138.97 50.18 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.104 1.869 . . . . 0.0 112.379 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.46 113.46 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 110.323 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -86.64 128.71 35.01 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.375 1.07 . . . . 0.0 108.181 170.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -120.06 124.48 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 110.028 169.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.53 124.11 41.65 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.04 0.936 . . . . 0.0 111.119 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD2' HD12 ' A' ' 63' ' ' LEU . 9.8 m-85 -95.01 118.36 31.69 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.421 1.488 . . . . 0.0 109.325 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -145.03 165.32 28.54 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -171.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.17 177.62 4.66 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.261 1.824 . . . . 0.0 111.748 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.1 p -68.52 -23.43 64.54 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -117.71 -13.95 10.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -161.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -74.98 129.06 37.0 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -165.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.74 -62.98 5.51 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.198 0.904 . . . . 0.0 112.897 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -60.33 -30.44 91.03 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.415 2.077 . . . . 0.0 113.952 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.06 -33.56 70.38 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.931 0.787 . . . . 0.0 112.161 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -73.11 -32.24 64.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.912 0.885 . . . . 0.0 112.597 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -68.64 -31.01 69.85 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -83.17 -17.61 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.715 1.143 . . . . 0.0 113.161 174.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.51 -50.24 67.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 120.255 1.389 . . . . 0.0 114.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.1 -33.23 51.0 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.021 1.814 . . . . 0.0 113.092 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.61 -42.88 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.261 1.391 . . . . 0.0 111.06 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.72 -48.2 55.79 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.304 1.442 . . . . 0.0 111.01 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.04 -37.31 66.52 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.386 1.074 . . . . 0.0 111.648 169.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.98 -43.8 23.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.788 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.3 mm -65.53 -34.31 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.463 1.029 . . . . 0.0 111.543 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.64 86.9 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 0.597 . . . . 0.0 112.022 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.6 m -76.16 -34.33 59.37 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.241 0.473 . . . . 0.0 111.741 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -79.83 -35.99 37.52 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.2 30.53 4.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.257 1.023 . . . . 0.0 113.444 -173.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.14 -34.04 20.95 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.624 1.57 . . . . 0.0 114.562 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -76.33 -18.2 59.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.001 1.32 . . . . 0.0 114.069 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -105.8 -37.96 6.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.681 1.193 . . . . 0.0 112.848 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.31 165.2 29.11 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -121.49 144.38 48.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.886 1.675 . . . . 0.0 110.719 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.95 139.02 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.034 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.67 164.45 30.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.937 1.695 . . . . 0.0 114.113 -167.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -118.44 132.23 56.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.846 2.058 . . . . 0.0 111.806 174.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 32' ' ' PHE . 3.0 tm? -114.36 125.25 53.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.893 1.277 . . . . 0.0 109.477 164.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.59 113.12 25.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.279 0.631 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.98 -20.53 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -171.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.69 -38.27 33.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 111.963 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 t -95.9 -8.64 33.42 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -128.37 61.5 54.13 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.995 1.318 . . . . 0.0 113.358 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.22 -29.61 88.14 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.183 1.922 . . . . 0.0 113.486 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -66.07 -38.49 88.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.986 0.914 . . . . 0.0 112.428 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -35.2 57.71 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.603 -0.685 . . . . 0.0 111.31 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.55 93.17 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.585 -0.697 . . . . 0.0 111.667 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -71.93 -23.84 61.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.08 -39.17 77.9 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.951 0.9 . . . . 0.0 112.161 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -110.01 21.5 16.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.854 1.662 . . . . 0.0 113.366 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 52.98 35.8 20.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.743 2.017 . . . . 0.0 114.241 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.72 125.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.253 1.021 . . . . 0.0 110.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.21 -48.49 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.328 1.451 . . . . 0.0 110.099 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.5 m -85.94 143.8 27.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.481 1.112 . . . . 0.0 110.752 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.05 145.7 58.91 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.906 1.282 . . . . 0.0 111.147 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.16 146.51 85.17 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.715 0.934 . . . . 0.0 113.103 0.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.1 m -129.73 120.84 25.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.82 0.848 . . . . 0.0 109.258 165.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.48 132.59 38.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.29 1.436 . . . . 0.0 108.566 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 tp -127.2 126.4 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.841 1.256 . . . . 0.0 107.972 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 tp -108.22 128.44 54.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.638 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -110.0 151.93 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.942 1.697 . . . . 0.0 110.156 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -123.06 117.34 25.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.604 1.561 . . . . 0.0 108.021 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.309 4.0 p30 48.57 38.84 11.96 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 4.39 90.24 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.981 1.753 . . . . 0.0 116.124 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.96 133.6 20.21 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 119.236 1.518 . . . . 0.0 110.635 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.66 138.55 41.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.426 2.084 . . . . 0.0 111.656 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.22 -31.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.271 . . . . 0.0 114.205 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -159.52 141.55 13.39 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.485 1.038 . . . . 0.0 112.493 -172.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -133.79 130.93 38.69 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.596 1.559 . . . . 0.0 111.533 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 mm -129.6 123.7 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.463 1.505 . . . . 0.0 110.075 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.93 36.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 125.142 1.377 . . . . 0.0 113.572 -172.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.06 -172.74 35.37 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.319 -0.863 . . . . 0.0 114.257 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.96 154.14 41.86 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.331 1.052 . . . . 0.0 113.545 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -136.22 153.52 51.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.427 1.891 . . . . 0.0 110.773 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.35 163.54 14.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.61 1.1 . . . . 0.0 110.792 165.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -52.31 -43.04 64.31 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.444 1.122 . . . . 0.0 113.205 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.88 72.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.131 0.572 . . . . 0.0 111.7 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.06 63.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.132 0.973 . . . . 0.0 111.969 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.0 tp -63.98 -46.0 86.56 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.399 -0.813 . . . . 0.0 111.34 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.3 tp -71.59 -24.67 61.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.328 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -60.6 -47.2 87.26 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.322 1.419 . . . . 0.0 111.388 162.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.78 -36.08 75.95 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.086 0.857 . . . . 0.0 112.339 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.57 -36.38 68.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.918 0.887 . . . . 0.0 113.103 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -69.82 -22.76 63.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.376 1.07 . . . . 0.0 112.329 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -73.0 -10.43 59.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.75 1.22 . . . . 0.0 113.275 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.59 -30.75 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.423 1.889 . . . . 0.0 112.558 -173.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.2 140.71 31.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.332 1.453 . . . . 0.0 110.52 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -56.85 117.78 4.52 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.619 2.213 . . . . 0.0 112.179 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 116' ' ' ASN . 22.3 t30 -156.94 153.19 27.69 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.532 1.533 . . . . 0.0 110.755 -171.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.83 -4.67 59.22 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -172.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.408 ' H ' ' ND2' ' A' ' 114' ' ' ASN . 41.2 t-20 . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.149 2.18 . . . . 0.0 112.954 -166.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 119.461 -0.304 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.6 p -74.2 159.33 32.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.476 1.11 . . . . 0.0 112.623 175.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -145.5 148.1 32.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.334 1.454 . . . . 0.0 111.654 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -105.55 16.77 24.93 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.339 1.456 . . . . 0.0 113.967 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 61.22 8.54 2.09 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.151 2.181 . . . . 0.0 115.553 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 52.77 26.44 4.53 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.512 2.325 . . . . 0.0 115.677 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 p -75.7 152.91 37.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.18 0.992 . . . . 0.0 112.998 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.96 12.55 28.6 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -163.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.38 151.85 41.05 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 120.828 -1.17 . . . . 0.0 111.542 169.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.44 166.77 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.357 1.463 . . . . 0.0 111.403 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -124.7 143.45 50.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.529 1.132 . . . . 0.0 111.9 173.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.56 165.92 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.242 1.417 . . . . 0.0 112.658 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.9 p -132.17 175.41 9.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.351 2.66 . . . . 0.0 110.755 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.48 -29.46 61.78 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.89 -1.131 . . . . 0.0 113.08 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.96 -49.56 8.85 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.98 0.912 . . . . 0.0 112.849 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -80.14 -20.84 44.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -51.02 -41.23 59.68 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.144 1.378 . . . . 0.0 112.805 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -31.43 71.91 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.099 -1.001 . . . . 0.0 113.516 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -89.28 -19.35 25.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.703 1.601 . . . . 0.0 113.198 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -112.98 -27.05 8.21 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.36 -54.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.539 1.136 . . . . 0.0 111.631 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.0 mt -73.53 -12.34 60.74 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.5 p -76.83 -14.04 59.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.889 1.676 . . . . 0.0 113.97 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -69.98 155.83 40.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -165.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -114.25 17.49 17.58 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.787 2.035 . . . . 0.0 112.595 172.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -142.62 169.44 10.83 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 127.58 2.352 . . . . 0.0 111.297 -170.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.67 135.32 69.84 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.03 2.487 . . . . 0.0 112.644 159.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -137.6 123.49 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.511 1.124 . . . . 0.0 110.963 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -93.92 133.69 37.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.313 1.445 . . . . 0.0 109.637 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 t -123.12 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.155 0.889 . . . . 0.0 110.295 172.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -107.01 122.49 46.56 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.509 1.524 . . . . 0.0 111.626 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.11 116.57 27.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 110.687 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -147.11 169.77 18.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 0.0 113.613 -172.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.19 39.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.128 1.371 . . . . 0.0 111.21 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -58.09 -28.4 64.55 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.978 1.311 . . . . 0.0 113.117 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -88.9 -2.78 58.76 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.585 1.554 . . . . 0.0 114.515 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.4 t -84.43 105.19 15.06 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.905 -1.122 . . . . 0.0 112.859 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.45 -56.78 22.73 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.38 1.467 . . . . 0.0 114.79 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.51 -29.36 44.72 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 120.613 2.207 . . . . 0.0 112.509 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.36 -47.41 79.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.162 0.892 . . . . 0.0 111.467 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.69 -32.44 73.92 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -66.0 -42.71 89.42 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.736 0.814 . . . . 0.0 112.31 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 m -84.08 -17.78 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -42.02 -48.94 11.3 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -64.4 -27.29 62.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.66 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.4 -38.74 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.092 1.315 . . . . 0.0 111.084 173.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 47' ' ' LEU . 2.9 mt -69.26 -48.72 60.98 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.751 1.22 . . . . 0.0 109.777 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.75 -40.56 72.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.18 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.74 -50.08 33.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.539 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.3 mm -58.15 -41.7 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.82 1.191 . . . . 0.0 111.436 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.35 97.24 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.818 0.735 . . . . 0.0 111.762 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.2 m -76.77 -31.67 57.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.519 0.727 . . . . 0.0 112.198 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -85.04 -31.65 23.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -122.34 30.33 6.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.414 1.485 . . . . 0.0 113.372 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.8 29.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.937 1.295 . . . . 0.0 114.356 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -72.82 -27.43 61.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.946 1.299 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.66 -33.93 10.41 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.207 1.403 . . . . 0.0 113.451 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 176.95 9.81 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.9 m -129.57 149.26 51.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.984 1.714 . . . . 0.0 108.784 162.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.65 135.12 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.902 0.774 . . . . 0.0 110.721 171.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.0 152.25 44.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.749 1.62 . . . . 0.0 112.859 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 4.8 mmmm -107.45 134.03 51.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.14 1.376 . . . . 0.0 111.302 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.76 110.83 11.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.5 1.12 . . . . 0.0 109.962 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.65 111.78 20.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.727 -0.608 . . . . 0.0 111.955 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.89 -20.41 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.13 -31.37 39.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.251 1.02 . . . . 0.0 112.124 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 t -104.71 -22.82 13.16 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.062 0.945 . . . . 0.0 113.233 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -128.9 67.54 78.03 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.7 1.6 . . . . 0.0 110.781 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.15 -15.5 31.96 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.337 2.692 . . . . 0.0 113.958 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.22 -35.06 79.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.223 -0.923 . . . . 0.0 112.527 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.7 p -77.18 -33.29 56.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 112.699 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.58 91.49 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.497 0.719 . . . . 0.0 111.845 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -76.77 -25.7 53.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -65.01 -44.57 88.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.958 0.799 . . . . 0.0 112.027 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.25 10.18 41.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.299 1.439 . . . . 0.0 114.071 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 51.22 58.11 5.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.242 1.817 . . . . 0.0 113.124 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.81 121.55 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.207 1.003 . . . . 0.0 109.256 173.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.19 -29.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.207 1.403 . . . . 0.0 112.724 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.8 p -121.21 152.59 38.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.468 1.907 . . . . 0.0 109.359 161.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.2 135.45 24.2 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.534 0.734 . . . . 0.0 111.941 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.14 147.42 66.22 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.15 0.732 . . . . 0.0 113.76 -6.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -99.89 136.89 39.13 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 154.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 mt -110.93 140.48 45.39 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.586 1.555 . . . . 0.0 108.994 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 tp -130.63 131.61 64.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.31 125.56 51.27 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.226 1.01 . . . . 0.0 109.489 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -108.96 158.17 17.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.858 2.063 . . . . 0.0 110.242 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -138.93 134.14 32.78 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.781 1.232 . . . . 0.0 108.995 160.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 54.08 39.82 31.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.019 0.927 . . . . 0.0 112.858 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.68 17.53 69.16 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.115 1.817 . . . . 0.0 114.982 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -125.9 134.11 25.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.835 1.254 . . . . 0.0 110.854 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.27 139.67 39.0 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.712 2.275 . . . . 0.0 111.764 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.51 -36.63 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -154.29 149.52 27.03 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.856 1.207 . . . . 0.0 113.672 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -101.59 145.6 28.83 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.154 1.782 . . . . 0.0 110.25 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.86 147.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.512 1.525 . . . . 0.0 109.623 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.31 147.98 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.386 1.074 . . . . 0.0 111.594 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.74 175.07 43.23 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 122.182 0.879 . . . . 0.0 113.592 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 149.84 44.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 145.83 46.26 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.282 1.833 . . . . 0.0 111.542 168.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.01 173.72 48.97 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.624 1.107 . . . . 0.0 111.167 166.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -59.52 -35.12 73.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.0 -43.54 74.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.946 0.498 . . . . 0.0 111.523 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.45 71.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.483 0.713 . . . . 0.0 111.921 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.8 tp -63.39 -40.75 98.09 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.996 0.918 . . . . 0.0 111.39 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.14 -30.74 71.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.354 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -68.34 -42.15 79.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.127 1.331 . . . . 0.0 112.551 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -56.25 -41.73 76.22 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.776 0.716 . . . . 0.0 110.565 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.5 -39.33 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -70.16 -20.25 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 112.394 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -69.72 -11.13 60.61 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.61 -40.92 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.83 1.652 . . . . 0.0 113.702 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.16 -38.72 49.59 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.79 1.636 . . . . 0.0 114.68 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -60.48 156.69 40.17 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.988 2.458 . . . . 0.0 114.901 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -147.47 162.54 38.83 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.67 1.588 . . . . 0.0 110.795 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.1 -21.87 65.84 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.941 1.296 . . . . 0.0 113.416 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.141 0 C-N-CA 127.051 2.14 . . . . 0.0 110.575 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mmt . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.3 p -136.5 158.08 45.28 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.615 1.566 . . . . 0.0 111.97 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.9 t0 53.6 37.4 25.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.593 1.557 . . . . 0.0 114.05 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.7 p -143.52 166.47 24.72 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.952 1.701 . . . . 0.0 112.502 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -77.42 98.05 5.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.098 0.959 . . . . 0.0 110.804 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -69.67 168.03 15.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.958 1.303 . . . . 0.0 113.319 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m 53.22 50.51 17.51 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.184 1.794 . . . . 0.0 112.627 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.58 55.46 1.99 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.269 1.428 . . . . 0.0 114.001 -166.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.5 p -117.47 161.61 19.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.666 1.186 . . . . 0.0 113.515 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -133.39 161.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.916 1.686 . . . . 0.0 111.467 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -106.42 143.31 34.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 110.738 164.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.89 160.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.7 1.6 . . . . 0.0 111.625 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.6 p -136.24 170.01 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.663 1.985 . . . . 0.0 109.706 173.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.93 -27.49 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.76 -1.213 . . . . 0.0 113.912 173.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.04 -20.08 53.09 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.8 p -121.0 -16.02 8.14 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -53.4 -41.3 65.82 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 112.933 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.63 70.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.7 m -81.26 -31.66 33.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 112.194 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.56 -39.91 7.68 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.83 -54.3 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.309 1.044 . . . . 0.0 111.53 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.3 mt -77.57 -15.07 59.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.5 t -66.61 -37.87 85.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.905 0.882 . . . . 0.0 112.209 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.402 ' CB ' ' HA ' ' A' ' 25' ' ' ASN 0.299 3.5 t 52.89 -138.9 1.07 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.537 1.535 . . . . 0.0 111.249 168.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HA ' ' CB ' ' A' ' 24' ' ' SER . 51.1 p-10 -84.31 -8.31 59.05 Favored 'General case' 0 CA--C 1.548 0.903 3 C-N-CA 133.582 4.753 . . . . 0.0 113.999 -1.704 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.14 156.49 76.6 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.078 0.951 . . . . 0.0 110.995 170.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -57.5 146.03 85.74 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.877 1.718 . . . . 0.0 114.634 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.12 124.24 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.131 0.972 . . . . 0.0 109.719 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.53 130.43 44.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 108.837 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 131.51 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.788 0.835 . . . . 0.0 110.619 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -98.42 119.62 37.44 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.74 0.816 . . . . 0.0 111.384 167.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -90.41 112.09 23.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.399 172.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.54 174.4 13.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -160.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.96 47.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.839 1.256 . . . . 0.0 111.174 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.5 p -74.03 -27.51 60.98 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -84.23 -8.93 58.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.426 1.49 . . . . 0.0 113.894 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 t -80.41 122.09 26.54 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 111.97 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.49 -57.34 20.31 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.065 1.317 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.53 -22.65 44.4 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 120.238 2.019 . . . . 0.0 112.959 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -67.69 -42.4 82.1 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.235 -0.916 . . . . 0.0 111.331 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -66.67 -32.36 73.63 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.781 0.832 . . . . 0.0 112.562 170.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -64.24 -38.0 89.48 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.978 0.808 . . . . 0.0 112.987 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -83.93 -10.95 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 176.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.96 99.92 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 119.791 1.178 . . . . 0.0 113.717 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.11 -38.2 47.1 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.247 1.965 . . . . 0.0 112.461 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.7 t -64.91 -49.18 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.693 0.797 . . . . 0.0 111.258 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.83 -37.13 81.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.168 0.587 . . . . 0.0 112.124 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.11 -41.85 97.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.951 0.796 . . . . 0.0 112.203 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.74 -43.55 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.733 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mm -61.44 -40.87 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.654 1.115 . . . . 0.0 110.909 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.41 92.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 100.0 m -70.3 -38.16 74.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.404 0.682 . . . . 0.0 111.32 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.2 -32.33 26.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -172.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -122.94 27.41 7.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -172.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.58 10.47 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -75.59 -33.52 60.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.89 1.276 . . . . 0.0 113.486 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -90.51 -38.2 13.37 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.28 0.945 . . . . 0.0 112.888 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.07 167.93 22.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -172.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -114.18 145.21 41.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.98 1.712 . . . . 0.0 109.705 168.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.69 135.67 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.418 0.687 . . . . 0.0 110.595 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 165.5 24.67 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.535 1.934 . . . . 0.0 111.825 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -127.69 147.97 50.39 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.29 124.61 52.43 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.695 1.598 . . . . 0.0 109.205 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.08 97.91 11.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.131 . . . . 0.0 109.927 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.56 -20.95 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.292 -0.88 . . . . 0.0 112.455 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.29 -25.88 63.54 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.439 1.496 . . . . 0.0 113.292 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.7 p -125.57 -22.81 4.19 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -142.17 72.57 22.33 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 111.961 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.25 -0.95 9.39 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.605 2.87 . . . . 0.0 114.505 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -63.33 -40.35 97.08 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.742 -1.224 . . . . 0.0 113.269 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.46 -27.72 52.17 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.208 -0.932 . . . . 0.0 113.411 168.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.04 94.47 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 112.006 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -75.5 -27.44 58.79 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -61.32 -42.16 98.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.153 0.888 . . . . 0.0 112.076 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -96.6 14.68 23.98 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.218 1.407 . . . . 0.0 113.478 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 50.55 41.18 25.11 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.474 2.31 . . . . 0.0 114.025 173.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.73 121.8 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.639 1.175 . . . . 0.0 110.421 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -101.78 -27.63 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.838 1.255 . . . . 0.0 113.571 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.9 m -133.85 160.4 37.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.987 1.715 . . . . 0.0 111.41 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.3 pt -127.97 144.34 51.12 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 0.0 111.7 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.14 153.67 88.18 Favored 'Cis proline' 0 CA--C 1.537 0.659 0 CA-C-N 119.462 0.843 . . . . 0.0 111.773 -6.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.3 m -133.34 119.62 19.94 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.972 0.909 . . . . 0.0 109.27 168.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.0 mt -103.13 119.77 39.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 109.193 -174.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.35 135.09 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.615 1.166 . . . . 0.0 110.372 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 tp -118.73 123.72 45.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.114 0.965 . . . . 0.0 111.722 -170.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -104.55 152.44 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.305 1.842 . . . . 0.0 111.315 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -142.51 135.28 28.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.15 1.78 . . . . 0.0 109.754 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t70 52.01 31.6 8.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.667 1.187 . . . . 0.0 113.329 -168.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.46 7.41 60.71 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.06 1.791 . . . . 0.0 114.662 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -100.56 129.89 26.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 118.771 1.285 . . . . 0.0 110.096 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.95 135.93 33.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.352 2.034 . . . . 0.0 110.789 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.38 -44.88 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.953 0.901 . . . . 0.0 112.214 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -153.37 150.55 28.98 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.609 1.164 . . . . 0.0 113.087 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.81 127.87 46.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.512 2.325 . . . . 0.0 109.879 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.9 mm -122.59 126.06 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.807 1.243 . . . . 0.0 109.985 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.06 147.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.371 1.069 . . . . 0.0 111.345 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.04 173.44 49.66 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.42 1.009 . . . . 0.0 114.19 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.27 151.56 38.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -138.44 155.11 48.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.519 1.928 . . . . 0.0 111.731 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.38 167.5 27.53 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.642 1.115 . . . . 0.0 111.942 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -56.29 -37.48 69.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 112.789 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.96 78.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.23 0.612 . . . . 0.0 111.724 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.08 78.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.402 0.681 . . . . 0.0 111.957 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.1 tp -67.98 -39.99 83.2 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.417 -0.802 . . . . 0.0 111.875 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.47 -28.5 66.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.256 0.622 . . . . 0.0 112.264 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -61.95 -48.57 79.8 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.615 1.098 . . . . 0.0 110.875 167.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.45 -38.08 76.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.293 0.951 . . . . 0.0 111.875 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.0 mt -66.51 -43.47 85.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.6 m -70.0 -23.57 63.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.007 0.923 . . . . 0.0 112.458 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.9 -10.53 59.5 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.112 1.365 . . . . 0.0 112.667 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t -113.93 -42.03 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.117 1.767 . . . . 0.0 112.8 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.1 p -134.76 142.69 43.36 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.628 1.171 . . . . 0.0 111.897 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.1 164.9 20.85 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.811 2.341 . . . . 0.0 113.306 169.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -138.53 136.24 35.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.423 1.489 . . . . 0.0 110.162 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 tp -135.27 22.65 3.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.588 1.555 . . . . 0.0 111.252 175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.727 1.611 . . . . 0.0 112.447 -172.949 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 t -148.62 169.1 21.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.805 1.242 . . . . 0.0 112.17 173.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -79.38 156.75 27.82 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.13 1.372 . . . . 0.0 113.679 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -59.21 -21.96 60.3 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.425 1.49 . . . . 0.0 114.093 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 44.3 mt-10 -90.92 88.53 7.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 157.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 97.7 mttt -123.61 11.06 9.14 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 129.933 3.293 . . . . 0.0 115.126 19.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.9 t -62.34 104.79 0.53 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.797 1.18 . . . . 0.0 112.588 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.24 55.65 2.9 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.155 0.982 . . . . 0.0 112.719 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -94.45 151.21 19.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.945 0.898 . . . . 0.0 112.558 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 pt -136.5 165.63 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.674 1.59 . . . . 0.0 111.189 171.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -126.23 138.84 53.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.011 1.324 . . . . 0.0 110.707 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.06 156.08 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.521 1.129 . . . . 0.0 112.918 -172.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.3 p -142.39 161.82 37.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.007 2.123 . . . . 0.0 110.107 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -55.1 -35.61 64.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -166.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.08 59.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.5 m -113.27 -21.59 10.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.504 1.522 . . . . 0.0 113.79 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -44.83 -41.98 7.51 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.888 2.475 . . . . 0.0 113.114 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.61 71.5 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.1 m -89.93 -25.96 20.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.856 1.262 . . . . 0.0 112.096 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -84.37 -50.01 8.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.931 0.892 . . . . 0.0 113.295 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.53 -33.65 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -77.73 -11.68 59.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 120.052 1.296 . . . . 0.0 113.585 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.0 m -88.96 -0.87 57.78 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -66.24 153.03 43.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.824 1.25 . . . . 0.0 113.653 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -121.53 28.02 7.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.37 1.468 . . . . 0.0 112.173 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.77 171.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 128.459 2.703 . . . . 0.0 109.823 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.76 139.51 80.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.853 1.702 . . . . 0.0 111.572 161.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.62 123.97 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.589 0.756 . . . . 0.0 111.928 170.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.49 125.5 31.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.313 1.445 . . . . 0.0 107.875 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -113.75 121.06 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 169.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -107.36 115.98 31.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.264 1.026 . . . . 0.0 111.634 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD2' HD12 ' A' ' 63' ' ' LEU . 8.5 m-85 -92.35 123.91 36.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.969 1.708 . . . . 0.0 109.288 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.476 ' CE2' ' HE2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -149.82 168.1 24.67 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -176.315 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.03 174.75 5.75 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.998 1.319 . . . . 0.0 111.951 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.6 p -71.66 -22.66 61.64 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -116.06 -12.75 11.26 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -163.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.94 130.15 38.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.17 -59.57 10.61 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.82 1.2 . . . . 0.0 114.179 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.75 -23.73 48.16 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.36 2.04 . . . . 0.0 113.301 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.3 p -77.76 -35.08 52.08 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.344 -0.848 . . . . 0.0 112.405 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -75.41 -27.88 59.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.934 -1.104 . . . . 0.0 112.359 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttt -58.91 -31.34 68.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.245 1.018 . . . . 0.0 113.262 171.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.62 -5.85 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.6 95.84 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-N 119.983 1.265 . . . . 0.0 114.39 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.01 -32.09 45.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.383 1.53 . . . . 0.0 112.589 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.52 -48.15 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.352 -0.843 . . . . 0.0 111.664 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.0 -37.38 84.09 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.977 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.01 -45.81 90.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.684 0.675 . . . . 0.0 111.97 172.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.51 -46.15 77.18 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.575 -0.703 . . . . 0.0 111.465 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.98 -42.79 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.025 1.284 . . . . 0.0 111.249 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -31.62 72.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.4 0.545 . . . . 0.0 112.359 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.4 m -78.6 -40.07 35.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.413 0.685 . . . . 0.0 111.745 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.84 -22.11 22.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -168.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -128.36 22.93 6.0 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.794 1.238 . . . . 0.0 113.877 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.37 -28.63 44.53 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.351 1.461 . . . . 0.0 114.682 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -80.17 -18.34 49.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.394 1.478 . . . . 0.0 113.643 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -101.7 -38.22 7.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.101 1.361 . . . . 0.0 112.88 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.58 177.76 9.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.264 1.426 . . . . 0.0 112.873 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.99 153.95 40.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.781 1.632 . . . . 0.0 109.326 167.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.08 136.14 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.605 0.762 . . . . 0.0 110.361 172.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.84 152.79 49.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.416 1.887 . . . . 0.0 112.092 -170.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.476 ' HE2' ' CE2' ' A' ' 33' ' ' TRP . 17.2 mmmt -115.98 135.26 54.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.935 1.294 . . . . 0.0 112.61 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.436 HD12 ' CD2' ' A' ' 32' ' ' PHE . 3.4 tm? -121.78 127.09 50.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.618 1.167 . . . . 0.0 110.484 167.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.37 104.29 16.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 110.054 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -69.88 -20.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.294 -0.879 . . . . 0.0 112.973 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.62 -33.39 47.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.468 1.107 . . . . 0.0 112.952 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -106.83 -22.47 12.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.539 1.136 . . . . 0.0 113.601 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -131.59 68.07 80.58 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.923 1.289 . . . . 0.0 111.743 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.52 -14.64 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.094 2.529 . . . . 0.0 113.058 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.31 -41.12 83.78 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.467 1.107 . . . . 0.0 112.605 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -75.63 -32.9 60.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.083 0.856 . . . . 0.0 111.71 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.66 92.04 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.149 -0.969 . . . . 0.0 111.81 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.98 -23.15 52.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 169.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.03 -47.72 85.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.799 0.84 . . . . 0.0 111.234 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.51 6.53 44.31 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 50.9 53.83 12.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 112.795 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -88.16 121.52 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.649 1.18 . . . . 0.0 109.443 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -110.71 -29.44 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.511 1.124 . . . . 0.0 112.701 -171.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -121.8 160.75 23.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.518 1.527 . . . . 0.0 111.686 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.68 147.02 64.36 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.679 1.192 . . . . 0.0 112.888 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.35 154.29 89.01 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.126 0.723 . . . . 0.0 111.829 -11.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.6 m -130.94 120.54 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.726 0.811 . . . . 0.0 109.638 168.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.49 122.82 37.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.85 126.83 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.316 1.047 . . . . 0.0 108.9 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.4 tp -112.12 128.3 56.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.623 1.569 . . . . 0.0 110.034 -166.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -108.24 157.35 18.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.686 1.594 . . . . 0.0 110.159 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.1 127.51 26.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.167 1.787 . . . . 0.0 108.528 167.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.01 40.36 28.15 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.763 0.792 . . . . 0.0 112.727 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.23 17.35 72.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.03 1.776 . . . . 0.0 115.409 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -124.08 133.04 24.37 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.71 1.204 . . . . 0.0 110.843 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.48 139.15 37.11 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.831 2.354 . . . . 0.0 112.073 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.5 -26.35 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.17 149.61 32.29 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.056 1.298 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -143.68 127.87 17.66 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.702 1.201 . . . . 0.0 111.098 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mm -132.09 137.59 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.392 1.077 . . . . 0.0 110.618 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.93 157.51 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.079 1.352 . . . . 0.0 112.401 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 173.81 36.35 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.745 1.164 . . . . 0.0 113.913 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 156.63 34.04 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.53 152.41 50.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.351 1.86 . . . . 0.0 111.732 171.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 166.92 44.71 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 159.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -57.25 -34.43 68.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.41 82.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.582 0.753 . . . . 0.0 112.372 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.29 -39.83 65.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.91 -48.11 80.39 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.079 -0.388 . . . . 0.0 110.203 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.477 -0.764 . . . . 0.0 112.37 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -69.24 -43.17 74.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.078 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.98 -27.3 65.58 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.253 1.388 . . . . 0.0 112.505 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.27 -41.36 81.19 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.453 0.701 . . . . 0.0 111.871 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -65.71 -25.74 67.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.545 1.138 . . . . 0.0 111.705 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.97 1.09 6.07 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 170.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.26 -35.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.777 2.031 . . . . 0.0 111.714 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.8 76.4 75.13 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.961 1.705 . . . . 0.0 111.119 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.49 169.52 17.01 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.55 2.833 . . . . 0.0 112.43 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -62.0 -22.74 65.93 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -95.36 6.33 49.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.503 1.521 . . . . 0.0 115.015 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.609 1.563 . . . . 0.0 112.279 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m 51.6 38.72 23.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.108 1.763 . . . . 0.0 113.672 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -81.77 60.16 4.56 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.644 -1.285 . . . . 0.0 110.777 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m 57.71 16.04 3.26 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.018 1.727 . . . . 0.0 114.35 -159.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.94 -12.8 61.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.232 1.413 . . . . 0.0 114.36 -173.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -87.47 -7.28 57.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.484 1.514 . . . . 0.0 113.934 173.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 t -75.3 145.46 41.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.28 1.032 . . . . 0.0 112.397 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.91 12.38 30.49 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.846 1.259 . . . . 0.0 113.257 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.1 p -80.73 157.44 25.85 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.076 0.951 . . . . 0.0 113.21 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.1 165.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.019 1.728 . . . . 0.0 111.695 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -109.89 143.23 40.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.176 1.79 . . . . 0.0 110.376 170.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.73 156.21 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.801 1.241 . . . . 0.0 111.697 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.1 p -114.7 168.81 9.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.15 2.18 . . . . 0.0 110.532 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.85 -27.84 67.0 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.819 -1.176 . . . . 0.0 113.221 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.34 -47.3 14.69 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.193 0.997 . . . . 0.0 112.894 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 p -77.79 -26.56 49.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -49.76 -39.89 39.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.2 1.8 . . . . 0.0 112.605 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.16 70.51 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -95.33 -20.66 18.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.694 1.198 . . . . 0.0 112.531 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -91.39 -58.29 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.417 1.087 . . . . 0.0 112.347 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -88.09 -51.88 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.213 1.405 . . . . 0.0 111.349 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.15 -15.01 62.47 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -77.43 -18.05 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 m -85.89 118.72 25.55 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -166.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 p-10 -75.42 -24.51 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.718 1.207 . . . . 0.0 112.113 160.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -65.26 146.35 98.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 127.17 2.188 . . . . 0.0 110.087 167.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.02 140.12 82.67 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.062 1.841 . . . . 0.0 111.4 170.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.62 130.97 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.984 0.914 . . . . 0.0 110.554 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.6 mp -104.5 124.66 49.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 108.769 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -120.1 117.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 110.311 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -98.45 117.58 33.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.606 0.763 . . . . 0.0 112.638 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.19 112.68 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.854 1.661 . . . . 0.0 108.442 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.26 170.28 19.88 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -164.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.69 155.78 48.74 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.989 1.316 . . . . 0.0 111.881 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -78.61 -19.52 52.52 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -86.05 -5.45 59.21 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.707 1.203 . . . . 0.0 113.822 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.48 120.11 31.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.184 1.394 . . . . 0.0 112.215 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -55.17 31.64 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.018 1.294 . . . . 0.0 114.726 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.03 -23.93 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 120.201 2.0 . . . . 0.0 112.638 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.3 m -67.16 -39.19 86.45 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.065 -1.022 . . . . 0.0 111.588 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.9 -31.89 71.99 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.438 -0.789 . . . . 0.0 112.711 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -65.34 -34.7 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.0 -12.15 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.341 0.973 . . . . 0.0 113.589 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.76 -49.14 85.03 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -29.27 49.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.763 1.642 . . . . 0.0 112.718 173.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.5 -48.06 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.147 -0.97 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.6 -36.79 79.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.297 0.639 . . . . 0.0 112.021 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.33 -46.91 87.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.777 0.717 . . . . 0.0 111.424 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -69.05 -47.77 64.51 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.715 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.2 mm -59.44 -40.8 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 121.061 1.755 . . . . 0.0 110.95 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.54 90.41 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.093 0.86 . . . . 0.0 112.546 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.1 m -77.09 -36.12 55.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.651 0.78 . . . . 0.0 111.325 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -92.64 -34.66 13.89 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -116.82 13.74 15.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.932 1.293 . . . . 0.0 113.583 -163.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.14 -31.03 29.26 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -69.72 -29.94 67.44 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.27 -0.894 . . . . 0.0 112.671 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -90.53 -41.12 11.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.772 1.229 . . . . 0.0 112.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.3 162.52 41.03 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.0 m -106.48 136.36 46.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.734 1.214 . . . . 0.0 110.482 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 t -110.91 122.15 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.083 0.953 . . . . 0.0 110.47 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.5 164.38 18.2 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.637 1.975 . . . . 0.0 111.739 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -129.75 143.52 50.86 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.42 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -126.43 120.91 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.362 1.465 . . . . 0.0 109.721 170.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -96.29 85.22 3.91 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.228 1.811 . . . . 0.0 111.153 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -60.81 -22.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -166.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.04 -28.32 61.36 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.217 1.407 . . . . 0.0 113.459 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -127.17 -9.88 5.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.949 1.7 . . . . 0.0 114.585 -171.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -142.51 59.51 8.74 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.897 2.079 . . . . 0.0 110.318 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.85 -6.17 14.13 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.534 2.822 . . . . 0.0 114.565 -167.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.2 -39.18 92.49 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.119 -0.988 . . . . 0.0 112.374 -174.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -30.4 54.77 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.391 -0.818 . . . . 0.0 112.065 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.34 99.04 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.313 -0.867 . . . . 0.0 111.65 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -74.16 -23.25 59.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -61.75 -44.03 97.7 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.882 0.873 . . . . 0.0 111.282 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.55 5.57 50.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.142 1.377 . . . . 0.0 114.162 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 50.51 41.23 24.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.408 1.883 . . . . 0.0 113.666 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.59 128.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.94 1.296 . . . . 0.0 110.128 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.94 -45.66 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.869 1.268 . . . . 0.0 111.348 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 p -86.26 152.4 22.81 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.717 1.207 . . . . 0.0 111.674 170.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 pt -145.43 155.54 53.62 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.834 1.654 . . . . 0.0 111.098 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.35 138.67 57.02 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 119.795 0.963 . . . . 0.0 111.6 -4.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 m -125.29 108.08 11.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.624 0.77 . . . . 0.0 109.9 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.29 126.1 43.65 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.754 1.222 . . . . 0.0 110.136 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 tt -120.9 132.85 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 122.199 1.0 . . . . 0.0 110.634 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.89 130.67 44.15 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 109.565 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -120.07 148.5 43.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.287 1.835 . . . . 0.0 111.319 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -144.81 135.13 24.24 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.971 1.708 . . . . 0.0 109.701 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 t70 51.34 33.68 10.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.63 19.92 71.53 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.335 1.445 . . . . 0.0 115.401 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -126.15 150.25 69.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 118.8 1.3 . . . . 0.0 112.104 169.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.37 145.93 44.01 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.905 2.403 . . . . 0.0 112.399 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.45 -46.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.97 1.308 . . . . 0.0 111.678 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -159.54 146.38 16.62 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.887 1.275 . . . . 0.0 111.94 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -129.0 137.21 51.21 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.159 1.384 . . . . 0.0 112.156 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.8 116.55 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.234 1.814 . . . . 0.0 110.224 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -100.17 159.4 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.054 1.742 . . . . 0.0 112.407 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.1 -171.69 50.67 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.067 0.841 . . . . 0.0 111.958 -174.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.18 147.02 45.14 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.153 -1.204 . . . . 0.0 112.93 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.69 153.15 47.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.077 1.751 . . . . 0.0 111.707 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.37 163.9 24.23 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.565 1.079 . . . . 0.0 112.092 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -59.88 -33.97 72.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.244 1.018 . . . . 0.0 113.53 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.37 80.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.968 0.507 . . . . 0.0 111.522 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.72 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.311 0.645 . . . . 0.0 111.214 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.2 tp -62.53 -40.32 96.41 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.219 -0.926 . . . . 0.0 112.344 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.4 tp -70.17 -30.81 68.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.844 0.858 . . . . 0.0 112.686 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -62.6 -44.93 95.06 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.729 1.149 . . . . 0.0 111.413 167.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.1 -36.03 80.47 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.32 0.964 . . . . 0.0 111.789 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.58 -39.2 81.07 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -65.34 -26.06 67.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.468 1.107 . . . . 0.0 112.211 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -75.95 -5.08 44.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.9 1.28 . . . . 0.0 114.089 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.22 151.37 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.055 1.342 . . . . 0.0 111.755 172.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -101.04 132.97 21.32 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.969 1.708 . . . . 0.0 109.891 171.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.6 -33.27 36.57 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.377 2.052 . . . . 0.0 113.899 -171.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -139.32 139.22 37.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.603 1.561 . . . . 0.0 111.519 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.43 -15.5 45.94 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.17 1.388 . . . . 0.0 113.149 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 t30 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 126.975 2.11 . . . . 0.0 110.889 -179.842 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.1 p -100.56 -35.22 9.6 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.556 1.143 . . . . 0.0 113.92 -174.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.7 -21.71 54.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.027 0.931 . . . . 0.0 113.353 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.9 m -154.22 154.38 33.38 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.949 2.1 . . . . 0.0 109.726 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.15 43.07 0.77 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.47 1.108 . . . . 0.0 113.397 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -80.77 -20.25 43.05 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.9 p -149.23 147.24 28.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.655 1.582 . . . . 0.0 111.877 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.11 39.79 3.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.959 1.303 . . . . 0.0 112.843 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p -94.83 163.81 13.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.957 1.303 . . . . 0.0 113.217 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.2 pt -117.93 157.47 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.466 1.506 . . . . 0.0 111.192 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -109.25 137.59 46.89 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.886 1.674 . . . . 0.0 110.007 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.35 156.34 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.821 1.248 . . . . 0.0 112.475 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.2 p -143.29 161.55 38.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.548 1.939 . . . . 0.0 110.793 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.83 -35.62 61.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -168.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.95 -18.87 60.32 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 m -119.26 -11.6 9.54 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.703 1.601 . . . . 0.0 113.646 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -51.9 -40.09 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 113.08 -175.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.5 72.04 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -83.2 -32.25 26.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.158 0.983 . . . . 0.0 111.953 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.56 -37.81 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.42 -54.48 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.155 1.382 . . . . 0.0 110.986 -174.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.95 -12.03 59.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 m -78.74 -11.5 59.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.5 m -80.73 121.31 25.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.273 1.429 . . . . 0.0 112.641 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.35 -26.98 60.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.006 0.523 . . . . 0.0 111.857 164.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -69.75 153.54 95.49 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.253 1.021 . . . . 0.0 110.701 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.06 145.75 85.69 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.755 1.637 . . . . 0.0 111.675 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.0 132.3 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.145 . . . . 0.0 111.915 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.5 134.22 35.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.769 1.628 . . . . 0.0 109.169 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.27 129.8 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.316 0.647 . . . . 0.0 110.457 167.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -103.52 136.73 42.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.406 1.482 . . . . 0.0 113.076 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.26 120.17 39.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.126 1.37 . . . . 0.0 111.097 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -75.03 168.1 20.64 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.261 1.024 . . . . 0.0 113.344 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.69 144.79 32.86 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.244 142.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.9 p -67.94 -31.42 71.16 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -165.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -96.33 -8.28 33.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.644 1.978 . . . . 0.0 113.777 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.5 t -82.41 110.44 17.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.52 1.128 . . . . 0.0 113.24 -160.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.57 -57.07 12.87 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.277 1.418 . . . . 0.0 114.364 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.17 -24.42 65.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 120.481 2.14 . . . . 0.0 113.349 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.84 -42.03 82.05 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.213 0.915 . . . . 0.0 111.217 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -66.3 -32.23 73.51 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.463 -0.773 . . . . 0.0 112.462 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.55 -31.93 71.49 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.65 -14.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.781 1.173 . . . . 0.0 113.691 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.37 46.1 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.21 -32.0 52.72 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.674 1.583 . . . . 0.0 112.327 176.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.43 -51.22 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.352 0.978 . . . . 0.0 111.734 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.06 -35.28 74.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 111.298 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -71.43 -34.9 70.69 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -66.18 -47.6 73.45 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.806 -1.184 . . . . 0.0 111.222 171.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.38 -40.75 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.609 1.549 . . . . 0.0 111.08 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.19 -38.02 85.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.9 0.773 . . . . 0.0 112.581 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -77.19 -34.92 56.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.663 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -88.52 -39.58 14.07 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -113.64 17.25 18.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.231 1.412 . . . . 0.0 113.457 -162.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.89 34.62 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.328 1.451 . . . . 0.0 114.626 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -78.23 -18.52 55.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.216 1.407 . . . . 0.0 113.825 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -98.18 -41.41 7.91 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.838 1.255 . . . . 0.0 112.48 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.32 164.08 35.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.598 1.159 . . . . 0.0 113.3 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.6 m -107.15 144.45 33.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.883 1.273 . . . . 0.0 110.359 171.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -118.84 128.76 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.422 0.689 . . . . 0.0 110.286 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.49 162.31 23.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.644 1.978 . . . . 0.0 111.429 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -136.28 144.75 44.92 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.91 122.69 46.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.765 1.626 . . . . 0.0 110.448 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -87.15 84.08 7.33 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.823 1.249 . . . . 0.0 110.797 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 p -62.92 -24.06 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.66 -26.57 61.69 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.08 0.952 . . . . 0.0 113.383 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.1 p -110.06 -22.66 11.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.416 1.086 . . . . 0.0 113.479 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.03 77.39 26.0 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.464 1.506 . . . . 0.0 111.548 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.67 -15.21 37.3 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.718 2.278 . . . . 0.0 112.851 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.81 -38.24 75.21 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.666 1.187 . . . . 0.0 112.966 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -34.0 68.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.119 0.872 . . . . 0.0 112.331 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.0 73.41 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.906 -1.122 . . . . 0.0 111.454 173.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -74.99 -39.52 61.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.284 1.033 . . . . 0.0 111.768 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.84 -45.41 67.34 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.993 1.317 . . . . 0.0 111.622 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -98.18 15.72 23.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.305 1.442 . . . . 0.0 114.512 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.272 7.6 pt20 47.46 42.53 14.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.773 2.029 . . . . 0.0 115.13 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.95 126.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.454 1.502 . . . . 0.0 110.429 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.1 m -130.91 -9.84 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.431 1.492 . . . . 0.0 113.799 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 151.19 41.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.37 1.868 . . . . 0.0 110.197 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.23 141.48 29.54 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.879 0.872 . . . . 0.0 112.579 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.17 154.49 88.45 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.261 0.772 . . . . 0.0 111.951 -7.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -132.55 135.56 46.02 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.831 1.252 . . . . 0.0 108.73 171.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 142.83 46.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.318 1.047 . . . . 0.0 110.386 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.5 tp -122.34 137.6 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.827 1.651 . . . . 0.0 109.117 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.8 tp -108.8 125.57 52.1 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.612 1.565 . . . . 0.0 109.694 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -116.08 155.6 27.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.574 1.149 . . . . 0.0 111.391 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.54 136.12 27.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.66 1.584 . . . . 0.0 109.646 164.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.78 32.2 14.44 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.11 1.364 . . . . 0.0 114.256 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.59 17.31 80.18 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.853 1.216 . . . . 0.0 115.63 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -126.09 143.62 46.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 118.776 1.288 . . . . 0.0 111.503 172.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 144.09 42.13 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.893 2.395 . . . . 0.0 111.628 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.34 -45.18 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.12 1.368 . . . . 0.0 111.388 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -158.37 146.15 18.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.443 1.097 . . . . 0.0 111.529 -163.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.34 142.14 51.67 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.38 1.472 . . . . 0.0 110.826 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 132.4 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.998 1.719 . . . . 0.0 110.098 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.81 143.89 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.403 1.481 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.29 176.02 46.07 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.708 0.671 . . . . 0.0 112.719 -168.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.23 152.06 44.65 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -128.33 149.17 50.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.097 2.159 . . . . 0.0 109.851 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.24 166.42 32.1 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 161.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.53 -38.99 75.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.073 0.949 . . . . 0.0 113.183 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.42 77.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.404 0.681 . . . . 0.0 111.593 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -45.56 64.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 111.82 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.349 0.977 . . . . 0.0 111.355 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.54 -37.58 87.84 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.762 -0.586 . . . . 0.0 111.926 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -61.76 -43.03 99.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.771 -1.206 . . . . 0.0 112.29 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.88 -31.96 73.32 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.937 0.789 . . . . 0.0 112.372 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.7 -40.27 76.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.668 0.387 . . . . 0.0 111.815 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.5 m -64.78 -25.48 67.94 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.234 -0.916 . . . . 0.0 112.695 170.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.56 -10.78 57.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.168 1.387 . . . . 0.0 114.41 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.78 157.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.131 1.373 . . . . 0.0 114.162 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.3 t -80.9 142.29 52.05 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 125.677 1.591 . . . . 0.0 110.386 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -61.78 162.08 23.01 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.563 2.842 . . . . 0.0 114.964 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.9 -17.69 61.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.946 0.898 . . . . 0.0 113.016 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.7 tp 59.38 15.03 4.1 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.195 2.198 . . . . 0.0 114.654 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 127.418 2.287 . . . . 0.0 110.824 176.191 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.388 0.614 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.1 m -82.53 84.86 7.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.664 1.186 . . . . 0.0 110.12 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.4 t70 61.3 -53.13 0.11 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 128.65 2.78 . . . . 0.0 115.458 -170.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -154.92 129.54 9.21 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.486 1.515 . . . . 0.0 110.902 171.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -140.8 135.83 31.85 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.965 1.706 . . . . 0.0 109.646 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -106.29 152.02 24.08 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.522 1.529 . . . . 0.0 112.183 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.6 m -126.88 150.83 49.07 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.123 1.769 . . . . 0.0 110.708 172.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.86 36.83 0.77 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -99.09 153.59 18.77 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.733 1.613 . . . . 0.0 112.196 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.76 164.08 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.711 1.204 . . . . 0.0 112.7 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -109.46 142.73 40.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.882 1.673 . . . . 0.0 110.141 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.81 154.01 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.439 1.096 . . . . 0.0 112.638 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.2 p -145.45 160.93 40.84 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.973 2.109 . . . . 0.0 110.159 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.81 -34.53 40.55 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -171.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.99 -20.48 62.41 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -120.88 -14.2 8.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.59 1.556 . . . . 0.0 113.693 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -51.17 -41.65 60.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.397 1.879 . . . . 0.0 113.34 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.25 71.72 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.5 m -82.19 -33.71 29.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.593 0.757 . . . . 0.0 111.793 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.08 -43.25 19.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.97 -54.42 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 111.194 -173.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.06 -17.07 53.67 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.6 m -101.45 7.27 42.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.843 1.257 . . . . 0.0 113.119 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -66.01 144.63 56.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.979 0.912 . . . . 0.0 112.994 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.23 1.68 43.47 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.988 1.315 . . . . 0.0 113.213 174.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -142.73 166.69 19.27 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 126.825 2.05 . . . . 0.0 111.651 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.45 147.12 6.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.024 3.149 . . . . 0.0 114.822 163.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.1 130.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.477 1.111 . . . . 0.0 110.789 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.4 129.04 39.68 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.909 1.284 . . . . 0.0 107.931 169.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.2 t -112.37 123.89 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.445 1.021 . . . . 0.0 109.801 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -113.08 121.9 45.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.403 1.081 . . . . 0.0 112.458 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -93.69 120.11 33.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.354 1.862 . . . . 0.0 110.598 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.72 171.17 16.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.97 176.92 4.9 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.86 1.664 . . . . 0.0 111.541 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -71.43 -29.58 65.05 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.841 -1.162 . . . . 0.0 113.118 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -100.23 -14.86 18.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -163.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -76.47 127.67 33.29 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -163.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.23 -63.54 5.22 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.739 1.162 . . . . 0.0 113.948 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.0 -24.42 60.17 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.43 2.086 . . . . 0.0 113.149 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -74.89 -36.33 62.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.93 0.786 . . . . 0.0 111.789 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -75.48 -28.01 59.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.987 -1.071 . . . . 0.0 112.629 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.3 mmm -63.93 -29.71 70.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.1 m -83.48 -8.57 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 119.664 1.12 . . . . 0.0 113.928 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.4 -50.69 83.66 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 120.708 1.595 . . . . 0.0 113.905 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.24 -37.05 33.39 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.538 1.492 . . . . 0.0 112.359 174.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.3 t -62.91 -49.23 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.374 1.069 . . . . 0.0 111.694 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 pp -70.36 -39.87 74.36 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.614 1.166 . . . . 0.0 110.858 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -62.03 -44.16 97.3 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.75 0.705 . . . . 0.0 111.962 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -64.61 -54.29 34.28 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.449 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -65.48 -33.9 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.742 1.155 . . . . 0.0 111.502 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.17 89.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.482 1.037 . . . . 0.0 111.364 172.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 m -82.38 -30.82 30.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.415 0.686 . . . . 0.0 112.74 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -80.1 -28.32 39.06 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.044 -1.035 . . . . 0.0 113.203 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -120.27 29.42 7.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.798 1.639 . . . . 0.0 112.621 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -25.84 33.29 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.842 1.257 . . . . 0.0 114.293 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -80.71 -18.5 47.65 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.433 1.493 . . . . 0.0 113.884 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -103.5 -36.49 7.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.404 1.482 . . . . 0.0 112.945 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 160.28 43.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.8 m -111.03 139.62 46.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.297 1.439 . . . . 0.0 109.872 166.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.03 127.93 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.57 0.7 . . . . 0.0 110.153 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.68 145.55 42.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.541 2.337 . . . . 0.0 110.608 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.5 137.94 54.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.5 129.23 54.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.798 1.639 . . . . 0.0 109.637 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -99.35 105.65 17.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.392 1.077 . . . . 0.0 109.433 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.97 -22.1 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -164.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.52 -29.91 41.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.551 1.141 . . . . 0.0 113.233 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.1 p -106.08 -19.18 13.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.451 1.1 . . . . 0.0 113.81 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -133.03 78.68 64.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.687 0.795 . . . . 0.0 112.068 164.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.25 -22.57 75.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.125 2.55 . . . . 0.0 114.11 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.834 0.854 . . . . 0.0 113.096 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -76.93 -30.49 56.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.137 0.88 . . . . 0.0 111.679 172.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.58 98.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.969 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -76.68 -24.47 53.19 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -56.8 -40.01 75.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.37 0.986 . . . . 0.0 112.125 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.65 13.65 26.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 113.807 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 51.45 53.25 13.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.591 1.956 . . . . 0.0 114.141 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.54 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.219 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.55 -61.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.353 1.061 . . . . 0.0 109.788 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.8 m -86.86 151.33 23.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.237 1.015 . . . . 0.0 110.621 166.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.5 133.62 25.29 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.364 1.065 . . . . 0.0 109.515 -171.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.74 159.94 96.57 Favored 'Cis proline' 0 C--N 1.351 0.676 0 CA-C-N 120.365 1.166 . . . . 0.0 113.246 -0.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -126.98 136.11 51.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.426 1.09 . . . . 0.0 109.197 163.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.26 141.87 44.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 109.128 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.72 129.38 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.901 0.88 . . . . 0.0 108.954 166.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.44 125.21 52.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.892 1.277 . . . . 0.0 110.821 -173.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -104.83 148.45 26.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.249 1.819 . . . . 0.0 111.196 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -112.71 116.92 30.89 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.859 1.664 . . . . 0.0 108.264 164.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 51.16 37.37 18.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.644 1.178 . . . . 0.0 113.934 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 9.83 85.68 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.19 1.376 . . . . 0.0 115.944 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -113.93 131.39 23.16 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 119.27 1.535 . . . . 0.0 110.665 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.75 139.93 37.86 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.79 2.327 . . . . 0.0 112.526 -173.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.61 -48.66 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.966 1.306 . . . . 0.0 112.02 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -157.6 158.5 35.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.312 1.045 . . . . 0.0 113.436 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -118.51 140.36 50.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.021 1.728 . . . . 0.0 110.532 168.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.6 139.09 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.772 1.629 . . . . 0.0 109.522 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.48 142.89 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.657 1.183 . . . . 0.0 111.059 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.82 175.86 51.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.213 0.911 . . . . 0.0 113.228 -170.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 156.68 38.38 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -118.16 158.02 25.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.131 2.172 . . . . 0.0 110.086 172.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.5 166.65 25.48 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 155.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -51.17 -45.68 61.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.972 0.886 . . . . 0.0 112.169 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.67 84.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.298 1.039 . . . . 0.0 112.651 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.2 -42.92 62.14 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 111.864 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -63.32 -40.13 96.47 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.366 -0.834 . . . . 0.0 111.364 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.02 -30.87 71.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.695 1.198 . . . . 0.0 112.854 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -64.7 -42.64 95.15 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.342 0.974 . . . . 0.0 111.47 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.44 -39.2 92.56 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.537 1.062 . . . . 0.0 111.776 173.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.3 -40.73 96.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.167 0.587 . . . . 0.0 112.104 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -65.92 -28.3 68.83 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.336 -0.852 . . . . 0.0 111.899 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.6 -18.79 50.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 113.339 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.42 -23.89 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.491 1.516 . . . . 0.0 112.228 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.2 t 54.58 63.31 7.34 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.868 1.667 . . . . 0.0 111.734 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.49 -21.85 73.0 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.502 2.801 . . . . 0.0 113.578 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -76.18 -4.15 40.16 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.123 1.769 . . . . 0.0 114.738 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 tp -65.52 -25.97 67.69 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.885 1.274 . . . . 0.0 113.559 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.1 m120 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.67 1.588 . . . . 0.0 112.653 -171.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 pt -79.22 166.97 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.284 0.634 . . . . 0.0 111.268 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -126.5 141.68 51.79 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.157 1.783 . . . . 0.0 109.516 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.42 155.36 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.785 1.234 . . . . 0.0 111.954 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.3 p -137.85 159.91 40.72 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.064 1.746 . . . . 0.0 111.206 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.69 -28.25 68.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.02 -17.69 54.9 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -122.18 -17.77 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.169 1.388 . . . . 0.0 114.368 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -50.85 -41.43 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.979 1.712 . . . . 0.0 112.957 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 -31.43 71.96 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -35.02 33.95 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 111.627 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.95 -45.6 16.43 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.74 -54.44 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 111.173 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -80.92 -13.35 58.98 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -168.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 t -95.72 -6.35 40.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.569 1.148 . . . . 0.0 112.979 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -69.32 144.33 53.55 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.163 -0.96 . . . . 0.0 112.814 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -82.62 -5.42 58.8 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.939 1.296 . . . . 0.0 113.429 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -102.87 169.33 7.61 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 126.132 1.773 . . . . 0.0 112.367 -164.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -62.04 125.62 16.88 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.152 1.235 . . . . 0.0 109.147 147.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.99 116.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 109.938 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 tt -94.02 125.59 38.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.743 1.617 . . . . 0.0 108.39 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.85 128.27 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.441 -0.787 . . . . 0.0 110.582 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -106.04 113.08 26.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.218 1.007 . . . . 0.0 111.773 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -89.91 111.39 22.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.616 1.567 . . . . 0.0 108.913 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.8 172.8 15.04 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -163.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.82 142.74 51.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.387 1.075 . . . . 0.0 110.286 165.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -17.55 63.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -91.01 -11.86 37.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.535 1.534 . . . . 0.0 114.131 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 130.95 37.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.967 0.907 . . . . 0.0 111.873 -172.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.51 -60.27 9.12 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.691 1.139 . . . . 0.0 114.732 -175.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 -19.21 52.22 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.291 1.994 . . . . 0.0 113.236 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.4 m -71.18 -46.54 61.13 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.97 0.908 . . . . 0.0 111.059 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.99 -32.32 73.83 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.196 -0.94 . . . . 0.0 112.143 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.0 ttt -61.23 -34.97 75.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.671 0.788 . . . . 0.0 113.067 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.414 ' CG1' ' H ' ' A' ' 99' ' ' LYS . 27.6 m -88.56 -11.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.11 -50.93 72.47 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-N 120.116 1.326 . . . . 0.0 114.385 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.92 -34.3 30.25 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.499 1.466 . . . . 0.0 112.222 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -67.47 -49.27 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.256 -0.902 . . . . 0.0 111.303 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.84 -42.24 95.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.448 0.699 . . . . 0.0 111.054 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.77 -45.48 92.14 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.596 0.634 . . . . 0.0 111.876 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.71 -49.45 53.19 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.461 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.49 -42.46 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.761 1.164 . . . . 0.0 110.564 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.24 -31.33 68.69 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -74.09 -37.42 64.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.86 0.464 . . . . 0.0 110.334 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.76 -35.14 24.58 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -116.2 24.47 11.38 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.63 1.572 . . . . 0.0 113.537 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.43 -26.23 29.57 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.3 p -80.17 -18.16 50.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.446 1.499 . . . . 0.0 113.999 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -100.14 -40.94 7.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.264 1.425 . . . . 0.0 112.551 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.07 159.92 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.539 1.136 . . . . 0.0 113.49 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.0 m -107.21 141.49 38.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 110.233 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -117.87 133.75 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.173 0.589 . . . . 0.0 110.479 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.05 162.6 26.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.837 2.055 . . . . 0.0 111.235 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -133.07 142.89 48.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -116.98 123.72 47.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.7 2.0 . . . . 0.0 109.083 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -92.44 91.59 7.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 110.378 -172.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 m -66.25 -19.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.301 -0.874 . . . . 0.0 112.92 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.69 -26.34 68.33 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -122.11 -22.93 5.49 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.619 1.168 . . . . 0.0 113.579 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -120.55 88.61 43.24 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.323 1.449 . . . . 0.0 111.227 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.2 -13.56 18.95 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.836 2.357 . . . . 0.0 113.081 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -77.06 -39.98 47.88 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.839 -1.163 . . . . 0.0 112.2 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -27.5 55.51 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.663 -0.648 . . . . 0.0 111.822 168.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.53 96.92 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.251 -0.905 . . . . 0.0 112.255 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -72.24 -26.71 62.11 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.262 -0.899 . . . . 0.0 113.059 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.76 -40.79 89.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.118 0.967 . . . . 0.0 112.476 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -107.52 14.69 25.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.567 1.547 . . . . 0.0 113.819 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 53.26 57.11 6.57 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.316 1.846 . . . . 0.0 113.611 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.55 134.72 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.144 168.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.86 -40.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.568 1.147 . . . . 0.0 111.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.2 m -122.1 157.09 32.22 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.642 1.577 . . . . 0.0 110.215 163.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.2 pt -126.58 149.92 69.38 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.987 1.315 . . . . 0.0 111.782 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.33 140.26 65.18 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 CA-C-N 119.106 0.716 . . . . 0.0 112.391 -2.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -102.15 114.84 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.195 . . . . 0.0 107.931 168.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.73 127.96 52.68 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.147 0.979 . . . . 0.0 109.196 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.1 127.52 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.831 0.853 . . . . 0.0 109.705 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.9 tp -104.85 120.63 41.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.597 1.159 . . . . 0.0 110.751 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.27 157.35 16.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.084 1.753 . . . . 0.0 110.616 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -135.38 128.81 32.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.905 1.682 . . . . 0.0 109.109 165.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.0 t70 53.88 32.73 15.71 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.163 0.985 . . . . 0.0 113.248 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.72 9.46 84.91 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.467 1.508 . . . . 0.0 115.563 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -112.58 134.98 21.51 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 118.952 1.376 . . . . 0.0 110.888 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.01 140.18 41.14 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.881 2.388 . . . . 0.0 112.27 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.64 -46.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.73 1.212 . . . . 0.0 111.848 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -158.91 153.19 23.91 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.555 1.142 . . . . 0.0 113.302 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -128.62 139.03 52.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.488 1.915 . . . . 0.0 111.031 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.5 mm -129.69 147.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.092 1.757 . . . . 0.0 109.426 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.9 136.66 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 110.139 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.67 171.15 31.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.1 1.333 . . . . 0.0 113.174 -168.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 156.98 35.99 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -171.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.414 ' H ' ' CG1' ' A' ' 43' ' ' VAL . 3.5 mptp? -124.44 161.79 25.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.529 2.332 . . . . 0.0 111.842 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.51 161.8 13.18 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.8 1.19 . . . . 0.0 110.76 156.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -52.72 -39.78 62.39 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.331 1.052 . . . . 0.0 112.95 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.67 79.36 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.461 0.705 . . . . 0.0 112.029 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.61 72.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.362 0.665 . . . . 0.0 111.991 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.31 -47.99 83.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.928 0.891 . . . . 0.0 111.07 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.46 -31.5 68.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.626 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 ttp-105 -67.55 -46.26 73.26 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.422 1.465 . . . . 0.0 111.975 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -70.02 -21.5 63.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.09 -40.07 68.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.392 1.077 . . . . 0.0 112.96 163.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.7 m -66.28 -22.03 66.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.021 1.328 . . . . 0.0 112.198 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.33 -20.74 66.53 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 126.101 1.76 . . . . 0.0 112.157 -170.807 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.7 165.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.995 1.718 . . . . 0.0 111.115 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 143.44 50.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.91 1.284 . . . . 0.0 111.991 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -131.74 156.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.839 1.255 . . . . 0.0 112.939 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.6 p -137.24 168.32 19.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.933 2.493 . . . . 0.0 109.762 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.91 -27.91 65.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.89 -18.12 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.3 p -110.5 -25.11 10.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.729 1.611 . . . . 0.0 113.995 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -48.86 -41.54 33.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.581 1.952 . . . . 0.0 112.579 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.75 72.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -84.73 -33.04 23.18 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.28 -0.888 . . . . 0.0 111.947 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -84.77 -40.3 17.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 t -98.94 -52.71 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.38 1.472 . . . . 0.0 111.347 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.3 mt -83.12 -18.31 39.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.5 m -104.77 20.69 18.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.703 1.601 . . . . 0.0 113.538 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.9 p -58.74 -38.45 78.42 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.22 25.72 1.91 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.116 1.367 . . . . 0.0 113.633 -163.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.46 165.97 16.77 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 125.49 1.516 . . . . 0.0 112.31 168.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -45.24 133.61 11.86 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.72 2.28 . . . . 0.0 112.692 154.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -142.84 124.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.779 0.832 . . . . 0.0 111.215 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.7 tp -90.57 133.06 35.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.379 1.472 . . . . 0.0 107.558 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.92 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.819 1.19 . . . . 0.0 109.871 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -108.47 120.68 43.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.649 1.18 . . . . 0.0 111.704 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -98.55 112.71 24.66 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.021 2.128 . . . . 0.0 108.537 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.57 -179.0 7.03 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.13 137.33 52.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.848 0.459 . . . . 0.0 109.958 156.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.0 p -61.94 -23.21 66.23 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -85.78 -12.23 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.303 1.441 . . . . 0.0 114.47 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 143.9 38.95 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.285 0.948 . . . . 0.0 112.924 -170.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.11 -63.72 5.06 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.452 1.025 . . . . 0.0 114.27 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.91 -24.55 67.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.963 1.775 . . . . 0.0 112.625 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.6 m -62.92 -47.87 81.39 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.045 0.938 . . . . 0.0 110.953 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -64.3 -32.85 74.61 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.072 0.949 . . . . 0.0 112.792 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.95 -32.75 73.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 p -91.17 -13.54 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.436 1.016 . . . . 0.0 113.608 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.99 -50.4 62.9 Favored Pre-proline 0 CA--C 1.555 1.171 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.67 -30.63 34.37 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.627 1.552 . . . . 0.0 112.577 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.87 -49.63 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.05 0.94 . . . . 0.0 111.597 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.45 -34.81 77.94 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 111.618 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.7 -41.72 92.01 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.435 1.016 . . . . 0.0 112.5 170.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.73 -44.11 78.36 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.024 -1.048 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -58.15 -44.11 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.957 1.253 . . . . 0.0 111.266 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.44 78.12 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.036 0.534 . . . . 0.0 112.126 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -77.17 -41.36 41.94 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.53 -0.731 . . . . 0.0 111.357 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -83.67 -28.95 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -111.01 20.3 17.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.968 1.307 . . . . 0.0 113.128 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.15 -33.1 17.86 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -74.59 -23.38 58.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.136 1.375 . . . . 0.0 112.845 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -105.52 -33.79 7.99 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.579 1.952 . . . . 0.0 112.993 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -151.7 139.32 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.577 1.551 . . . . 0.0 110.517 -156.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.7 m -115.84 140.49 49.17 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.309 1.443 . . . . 0.0 109.614 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.68 128.25 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.935 0.894 . . . . 0.0 109.725 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.61 143.66 45.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.139 1.776 . . . . 0.0 111.918 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -110.6 127.86 55.42 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.198 1.399 . . . . 0.0 111.974 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.33 123.98 41.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.059 1.343 . . . . 0.0 109.786 167.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.91 118.0 34.69 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.535 0.734 . . . . 0.0 110.18 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -71.31 -16.44 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.52 -38.97 11.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.64 1.176 . . . . 0.0 112.714 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.7 p -87.49 -21.88 25.22 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.75 80.61 55.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.034 0.933 . . . . 0.0 111.891 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.55 -20.34 70.39 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.152 2.568 . . . . 0.0 113.706 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.93 -44.41 92.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 112.74 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 m -73.17 -33.09 65.25 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.195 0.907 . . . . 0.0 111.452 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.47 92.95 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.463 -0.773 . . . . 0.0 111.933 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.99 -25.82 53.16 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.86 -45.94 88.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.189 0.904 . . . . 0.0 111.397 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.07 10.33 41.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 113.933 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 45.42 50.59 10.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.798 2.039 . . . . 0.0 113.674 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 p -75.23 138.04 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.294 -0.879 . . . . 0.0 111.529 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -123.56 -15.81 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.3 m -133.68 150.88 51.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.828 1.651 . . . . 0.0 110.898 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.79 140.58 37.98 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.814 0.846 . . . . 0.0 111.873 174.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.72 152.73 94.98 Favored 'Cis proline' 0 CA--C 1.543 0.935 0 CA-C-N 118.973 0.669 . . . . 0.0 111.177 -11.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.9 m -133.87 124.88 27.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.767 1.227 . . . . 0.0 109.421 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.74 147.15 28.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.853 1.261 . . . . 0.0 110.867 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 tt -131.7 144.55 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.384 1.474 . . . . 0.0 109.633 169.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 tp -107.21 130.63 54.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.228 1.011 . . . . 0.0 110.307 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.68 147.16 29.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.84 1.256 . . . . 0.0 109.568 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -108.65 116.44 31.99 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.537 1.535 . . . . 0.0 108.365 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 51.33 34.27 11.44 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.812 1.245 . . . . 0.0 113.669 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.22 17.29 67.26 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -125.42 136.6 28.48 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 119.501 1.651 . . . . 0.0 110.865 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.22 139.81 39.48 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.773 2.316 . . . . 0.0 112.243 -172.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.57 -36.04 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -162.06 149.64 14.32 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.593 1.088 . . . . 0.0 113.302 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -129.07 141.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.891 1.676 . . . . 0.0 111.597 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 123.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.237 1.815 . . . . 0.0 111.44 -175.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.04 150.73 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.333 1.053 . . . . 0.0 111.822 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.76 -179.98 53.24 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.051 1.31 . . . . 0.0 113.437 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.95 157.51 28.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -129.49 152.23 49.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.034 1.734 . . . . 0.0 111.091 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.49 154.31 20.98 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 163.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -57.7 -33.03 67.95 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.12 82.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.149 0.58 . . . . 0.0 111.786 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.12 66.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.442 0.697 . . . . 0.0 111.457 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 104' ' ' LEU . 11.9 tp -61.64 -43.46 98.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.919 0.887 . . . . 0.0 111.343 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.1 tp -67.66 -34.74 77.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.774 0.829 . . . . 0.0 113.014 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -66.81 -45.14 79.29 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.361 1.437 . . . . 0.0 111.51 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.34 -34.67 70.89 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.35 -44.0 30.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 p -72.05 -15.06 62.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.755 1.222 . . . . 0.0 113.095 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -14.19 48.03 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 N--CA 1.472 0.664 0 C-N-CA 126.673 1.989 . . . . 0.0 110.431 -177.618 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 pt -121.52 134.74 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 112.816 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -82.6 127.44 33.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.411 1.484 . . . . 0.0 108.932 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.04 156.85 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.349 1.059 . . . . 0.0 112.282 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -134.39 172.0 13.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.455 2.302 . . . . 0.0 111.052 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.3 -26.67 63.3 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.062 -1.024 . . . . 0.0 113.659 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.63 -35.0 24.95 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.9 p -100.05 -24.14 14.69 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -53.01 -40.83 64.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.056 1.342 . . . . 0.0 112.597 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.34 -31.57 72.44 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.081 -1.012 . . . . 0.0 113.39 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.7 m -81.6 -33.83 31.31 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.796 0.838 . . . . 0.0 111.993 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -92.83 -25.73 17.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.23 -53.87 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.37 -19.93 55.51 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -77.2 -23.81 51.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -81.39 122.34 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.044 -164.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -72.45 -29.26 63.52 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.276 1.03 . . . . 0.0 111.629 166.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -72.18 158.94 86.69 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.373 1.069 . . . . 0.0 110.962 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.47 139.9 73.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.504 2.136 . . . . 0.0 110.974 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 t -128.85 117.54 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.689 0.796 . . . . 0.0 110.388 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.65 128.27 36.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.587 1.155 . . . . 0.0 108.678 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.38 127.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.85 0.86 . . . . 0.0 109.87 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -97.5 112.6 24.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.199 0.6 . . . . 0.0 111.179 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 11.1 m-85 -85.22 109.54 18.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.192 1.397 . . . . 0.0 107.65 170.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.42 178.51 8.37 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -165.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.96 47.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.834 0.454 . . . . 0.0 109.944 157.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -62.33 -20.71 64.65 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -85.42 -16.55 39.39 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.151 1.38 . . . . 0.0 114.461 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 144.71 38.54 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.23 0.923 . . . . 0.0 113.398 -167.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.35 -63.9 4.88 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.634 1.111 . . . . 0.0 114.405 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.79 -21.33 51.17 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 119.616 1.708 . . . . 0.0 112.932 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.9 m -63.14 -47.48 82.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.487 1.039 . . . . 0.0 110.683 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.16 -32.3 73.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.903 0.881 . . . . 0.0 112.647 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.9 ttt -63.77 -36.43 83.85 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.45 -11.37 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -54.67 39.53 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 119.948 1.249 . . . . 0.0 113.915 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.3 -33.43 59.27 Favored 'Trans proline' 0 C--N 1.355 0.893 0 CA-C-N 121.143 1.444 . . . . 0.0 111.685 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.24 -51.27 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.609 0.764 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.48 -37.96 83.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.684 0.675 . . . . 0.0 111.086 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.64 -42.6 98.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.499 0.591 . . . . 0.0 112.218 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.98 -48.04 69.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.049 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.1 mm -57.94 -42.88 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.839 1.654 . . . . 0.0 110.821 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.52 91.82 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.138 0.426 . . . . 0.0 111.685 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -79.43 -31.36 42.6 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.297 1.039 . . . . 0.0 112.459 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -87.03 -31.12 20.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -126.49 27.02 6.23 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.8 -28.93 17.17 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -76.63 -20.32 56.83 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.755 1.622 . . . . 0.0 114.257 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.57 -37.15 8.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.821 1.249 . . . . 0.0 112.709 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.59 174.0 12.17 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.383 1.473 . . . . 0.0 113.088 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.3 m -117.96 146.34 44.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.199 1.399 . . . . 0.0 109.783 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.23 138.12 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.765 0.826 . . . . 0.0 109.995 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.05 161.26 35.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.289 1.835 . . . . 0.0 112.101 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -131.55 138.08 48.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.544 1.138 . . . . 0.0 112.713 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.435 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 5.1 tt -128.14 111.91 13.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.294 2.238 . . . . 0.0 107.966 -172.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -86.45 112.52 21.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.379 0.609 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -71.42 -17.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -88.11 -40.69 13.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.285 1.034 . . . . 0.0 112.555 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -90.71 -23.32 20.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -130.56 68.25 81.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.144 1.377 . . . . 0.0 110.445 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.41 -16.65 39.17 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.241 2.627 . . . . 0.0 113.839 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.52 -37.67 87.44 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.32 -0.862 . . . . 0.0 112.727 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.7 p -77.18 -35.29 55.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.48 0.712 . . . . 0.0 112.387 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.04 98.59 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 112.357 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -76.91 -23.29 52.53 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -58.75 -42.32 88.59 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.301 0.955 . . . . 0.0 111.635 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -97.98 5.66 48.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.197 1.399 . . . . 0.0 113.589 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 52.46 41.05 30.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.516 1.927 . . . . 0.0 114.176 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -78.65 128.81 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.992 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -126.27 -6.94 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.626 1.57 . . . . 0.0 114.025 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.7 m -122.24 150.76 41.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.226 1.81 . . . . 0.0 110.876 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.8 pt -137.86 144.88 45.96 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.086 0.955 . . . . 0.0 112.08 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.27 144.91 74.59 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 CA-C-N 119.498 0.857 . . . . 0.0 111.084 -13.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -122.66 114.73 20.98 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.494 1.118 . . . . 0.0 108.881 172.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.6 mt -98.69 123.87 43.17 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.011 1.324 . . . . 0.0 109.433 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.96 139.78 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.384 1.074 . . . . 0.0 110.397 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 tp -106.17 126.65 52.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.857 1.263 . . . . 0.0 111.502 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -107.59 152.75 23.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.607 1.963 . . . . 0.0 111.607 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -144.91 131.44 19.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 0.0 109.883 172.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.18 33.28 12.05 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -171.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.51 42.14 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.859 1.695 . . . . 0.0 114.94 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -95.59 139.04 21.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 118.711 1.255 . . . . 0.0 110.538 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.88 135.98 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.48 2.12 . . . . 0.0 110.841 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.75 -48.9 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.852 0.861 . . . . 0.0 112.237 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -154.21 148.64 26.14 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.628 1.171 . . . . 0.0 112.125 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -132.83 139.89 47.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.161 1.384 . . . . 0.0 111.596 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.72 129.01 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 110.754 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.39 36.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.289 1.435 . . . . 0.0 113.603 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.41 174.25 38.79 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.347 0.975 . . . . 0.0 114.297 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.31 154.34 42.01 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.715 1.206 . . . . 0.0 113.878 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.03 153.49 51.34 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.006 1.723 . . . . 0.0 111.595 165.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.26 167.42 43.3 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.215 0.912 . . . . 0.0 110.961 164.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -58.69 -34.64 71.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.36 66.99 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.824 0.45 . . . . 0.0 111.385 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.23 83.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.656 0.782 . . . . 0.0 111.771 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 tp -68.53 -38.21 80.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.381 -0.824 . . . . 0.0 112.21 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -68.09 -33.45 74.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.161 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 tpt85 -68.5 -38.82 81.29 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.313 1.415 . . . . 0.0 112.65 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -62.24 -36.32 81.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.456 1.102 . . . . 0.0 111.347 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mt -68.56 -43.6 76.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 113.404 169.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.2 m -68.15 -17.96 64.49 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.113 1.365 . . . . 0.0 112.186 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.53 -12.37 43.97 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.54 1.136 . . . . 0.0 113.57 167.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.6 t . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 126.231 1.813 . . . . 0.0 112.023 -176.263 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 pt -140.79 168.58 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.312 1.845 . . . . 0.0 111.825 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -115.5 143.47 45.26 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.832 1.253 . . . . 0.0 110.422 163.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.35 167.13 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.428 1.491 . . . . 0.0 112.425 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.412 ' H ' ' HB2' ' A' ' 16' ' ' SER . 76.5 p -127.93 172.04 11.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.317 2.647 . . . . 0.0 109.36 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.89 -33.12 64.31 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.043 -1.036 . . . . 0.0 113.181 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.22 -38.14 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.679 0.791 . . . . 0.0 113.04 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 13' ' ' THR . 14.7 m -80.61 -24.68 38.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.316 1.046 . . . . 0.0 113.54 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -53.43 -41.84 66.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.898 1.279 . . . . 0.0 112.639 -173.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.37 69.87 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 m -87.33 -23.25 24.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.726 1.21 . . . . 0.0 113.081 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -107.34 -31.57 8.13 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.73 -56.44 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.221 1.009 . . . . 0.0 111.487 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.1 -12.43 60.9 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -76.19 -21.29 56.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.809 1.644 . . . . 0.0 114.104 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 t -96.27 128.19 42.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -73.33 -24.55 60.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.533 1.533 . . . . 0.0 112.449 166.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -74.17 149.42 87.11 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.281 1.432 . . . . 0.0 109.817 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.13 129.35 34.79 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.384 2.056 . . . . 0.0 111.904 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -128.71 120.07 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.641 1.176 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.445 HD21 HD11 ' A' ' 104' ' ' LEU . 29.8 tp -91.23 133.6 35.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.743 1.217 . . . . 0.0 108.87 174.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.78 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.494 1.043 . . . . 0.0 110.952 169.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -107.79 127.19 53.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.498 1.519 . . . . 0.0 111.57 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -100.34 117.53 34.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.894 1.678 . . . . 0.0 110.064 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.31 168.65 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -169.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 -176.93 3.65 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.817 1.647 . . . . 0.0 111.726 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.7 p -74.66 -23.72 58.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.167 1.387 . . . . 0.0 114.52 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -114.56 -13.49 12.16 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -161.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.59 120.55 24.09 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -164.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.91 -59.07 8.45 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.612 1.101 . . . . 0.0 114.413 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.5 -24.14 36.59 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.007 1.903 . . . . 0.0 113.386 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -76.31 -32.29 58.66 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.327 0.967 . . . . 0.0 111.965 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -75.36 -32.58 60.89 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.624 -0.673 . . . . 0.0 112.052 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.58 -33.47 75.03 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.17 0.988 . . . . 0.0 113.57 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.76 -20.43 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.404 1.002 . . . . 0.0 113.592 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.66 -40.72 85.42 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.536 1.517 . . . . 0.0 115.083 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.19 -37.81 80.71 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.632 2.221 . . . . 0.0 113.047 171.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.89 -39.53 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.804 0.842 . . . . 0.0 110.806 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.79 -49.54 57.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.7 1.2 . . . . 0.0 110.683 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.61 -37.99 71.44 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.476 . . . . 0.0 110.538 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -77.18 -49.25 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.159 -0.448 . . . . 0.0 112.143 -172.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.8 mm -65.01 -36.4 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.356 0.98 . . . . 0.0 111.042 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.712 . . . . 0.0 112.822 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -75.48 -43.85 47.09 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.675 1.125 . . . . 0.0 110.956 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.69 -33.14 47.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -121.33 30.82 6.6 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.171 1.788 . . . . 0.0 112.374 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.57 -28.79 22.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.474 1.51 . . . . 0.0 114.335 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 m -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.775 1.23 . . . . 0.0 112.242 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -90.76 -37.88 13.38 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.768 1.227 . . . . 0.0 113.027 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 166.82 23.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.6 m -125.9 142.5 51.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.086 1.754 . . . . 0.0 108.51 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.16 138.18 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.489 0.716 . . . . 0.0 110.782 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.12 152.36 46.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.303 1.441 . . . . 0.0 112.639 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -106.85 135.05 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.552 1.541 . . . . 0.0 110.498 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.42 121.34 43.26 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -94.61 114.54 26.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.6 m -69.52 -16.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.46 -24.14 39.74 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.831 0.852 . . . . 0.0 112.726 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 p -86.9 -30.96 20.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -148.18 106.4 3.61 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.683 1.193 . . . . 0.0 110.987 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.2 -10.95 29.37 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 121.775 1.65 . . . . 0.0 112.465 161.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.77 -51.45 69.27 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.335 1.454 . . . . 0.0 112.194 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.56 -30.46 64.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.509 0.724 . . . . 0.0 112.05 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -43.43 98.86 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.499 -0.751 . . . . 0.0 111.944 173.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -77.26 -24.62 51.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -59.86 -44.59 94.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.289 0.95 . . . . 0.0 112.092 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.51 15.05 24.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 113.704 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 50.99 46.15 26.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.223 2.209 . . . . 0.0 113.836 173.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.96 121.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.357 1.063 . . . . 0.0 109.54 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.22 -29.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.054 1.342 . . . . 0.0 112.907 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.5 m -125.7 155.9 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.215 1.806 . . . . 0.0 110.201 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.31 123.08 27.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.82 159.01 98.22 Favored 'Cis proline' 0 CA--C 1.542 0.876 0 CA-C-N 120.015 1.041 . . . . 0.0 113.321 0.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.2 m -127.07 129.98 49.03 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.492 1.117 . . . . 0.0 108.874 161.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.76 144.26 38.42 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.057 1.343 . . . . 0.0 110.367 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 tp -140.72 126.78 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.005 1.322 . . . . 0.0 109.508 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.76 133.19 38.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.789 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -118.95 149.65 41.25 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.84 1.656 . . . . 0.0 111.633 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -146.49 136.44 23.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.596 1.159 . . . . 0.0 110.75 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.33 30.02 14.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.324 1.05 . . . . 0.0 112.665 -171.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.58 5.12 49.15 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.613 2.054 . . . . 0.0 114.895 -172.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -95.26 131.75 29.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 118.527 1.163 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.66 132.49 23.59 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.55 2.167 . . . . 0.0 110.812 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.2 t -106.72 -47.47 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.547 1.139 . . . . 0.0 111.832 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -158.45 131.83 7.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.682 1.193 . . . . 0.0 111.254 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -112.28 136.55 51.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.379 1.471 . . . . 0.0 110.73 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.42 122.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.893 1.277 . . . . 0.0 109.524 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.09 41.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.014 1.325 . . . . 0.0 112.883 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.76 -178.77 41.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.154 0.883 . . . . 0.0 114.067 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.18 157.23 34.23 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.684 1.193 . . . . 0.0 113.871 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -129.98 160.7 32.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.6 1.96 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.35 164.02 12.12 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.3 1.428 . . . . 0.0 110.85 159.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -52.57 -40.8 62.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.546 1.139 . . . . 0.0 113.253 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.45 -44.96 77.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.17 0.588 . . . . 0.0 111.794 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -40.32 68.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.524 0.73 . . . . 0.0 112.242 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.445 HD11 HD21 ' A' ' 29' ' ' LEU . 15.3 tp -62.29 -44.67 95.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.921 0.888 . . . . 0.0 111.452 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.0 tp -68.12 -30.04 69.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.459 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -60.57 -47.69 85.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.604 1.093 . . . . 0.0 110.933 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.61 -40.5 87.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.475 1.034 . . . . 0.0 111.815 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.48 -30.52 69.39 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -75.63 -26.19 57.56 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.656 1.183 . . . . 0.0 112.386 171.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -85.7 11.15 11.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.342 1.857 . . . . 0.0 113.498 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.468 0.454 0 O-C-N 120.881 -1.137 . . . . 0.0 113.319 -171.244 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 pt -137.34 167.58 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.766 1.626 . . . . 0.0 111.132 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -127.71 148.41 50.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.704 0.802 . . . . 0.0 112.203 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.14 159.58 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.677 1.591 . . . . 0.0 112.446 -170.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.9 p -142.6 168.42 19.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.829 2.452 . . . . 0.0 110.501 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -56.03 -25.97 46.99 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.26 -16.68 39.37 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.1 p -119.64 -25.28 5.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.676 1.591 . . . . 0.0 114.71 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.53 -39.44 48.93 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.36 1.864 . . . . 0.0 112.932 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.35 71.85 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.2 m -87.33 -30.77 20.57 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.448 -0.782 . . . . 0.0 112.043 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -87.31 -43.92 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.0 t -98.62 -52.87 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.89 1.276 . . . . 0.0 111.344 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -79.81 -13.77 59.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -110.4 18.18 20.08 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 0.0 113.343 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.0 p -62.25 -36.89 83.43 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -167.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.295 0.5 OUTLIER 48.01 21.6 0.33 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.916 1.687 . . . . 0.0 115.185 -161.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.22 168.1 11.85 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 126.177 1.791 . . . . 0.0 111.928 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.75 139.31 74.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.708 2.272 . . . . 0.0 112.901 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.74 124.77 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.69 1.196 . . . . 0.0 111.388 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.5 99.01 10.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.702 1.601 . . . . 0.0 109.171 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -99.28 121.05 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.282 -0.887 . . . . 0.0 110.655 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -102.34 118.4 36.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.6 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -91.97 112.82 24.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.614 1.566 . . . . 0.0 108.552 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 172.62 13.98 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.378 1.071 . . . . 0.0 113.02 -169.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.54 175.08 5.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.591 1.156 . . . . 0.0 111.09 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.5 p -74.93 -18.54 60.38 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.0 -1.062 . . . . 0.0 113.726 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -116.95 -5.25 11.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -163.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.75 134.39 39.18 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.457 1.026 . . . . 0.0 113.699 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -62.99 5.54 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.454 1.026 . . . . 0.0 114.094 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.17 -25.01 65.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.335 2.023 . . . . 0.0 113.363 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -74.55 -33.42 62.71 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.091 0.859 . . . . 0.0 112.088 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -64.01 -40.75 97.03 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.453 -0.779 . . . . 0.0 112.023 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.43 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.16 99.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 120.343 1.429 . . . . 0.0 113.517 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.82 -41.69 36.33 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.869 1.713 . . . . 0.0 112.163 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.14 -47.04 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.57 1.148 . . . . 0.0 111.77 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.74 -38.21 76.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.112 0.965 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 -41.05 82.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.612 1.096 . . . . 0.0 112.314 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.03 -47.97 69.76 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.013 -1.054 . . . . 0.0 111.614 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 mm -59.14 -40.5 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.286 1.403 . . . . 0.0 111.233 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.73 75.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.714 0.688 . . . . 0.0 112.564 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.4 m -78.19 -40.42 37.7 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.284 -0.885 . . . . 0.0 111.463 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.17 -21.7 29.09 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -128.66 25.67 5.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.146 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -34.11 21.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.499 1.52 . . . . 0.0 114.459 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -78.17 -18.56 55.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.465 1.506 . . . . 0.0 113.701 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -97.61 -38.25 9.61 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.135 1.374 . . . . 0.0 112.49 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 160.42 43.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -109.08 138.01 46.09 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.099 1.359 . . . . 0.0 109.508 166.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.74 133.5 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.33 147.34 49.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.209 1.404 . . . . 0.0 111.873 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.55 135.19 53.56 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.533 1.133 . . . . 0.0 111.705 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.31 124.93 52.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.039 1.336 . . . . 0.0 109.26 164.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.29 96.61 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.928 0.891 . . . . 0.0 109.926 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -65.73 -22.72 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.044 -1.035 . . . . 0.0 112.493 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.31 -27.48 63.42 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.527 1.531 . . . . 0.0 113.015 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.1 p -123.51 -21.24 5.33 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.069 1.348 . . . . 0.0 114.254 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -128.73 63.84 67.1 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.385 1.474 . . . . 0.0 111.929 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.25 -13.26 38.89 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.322 2.681 . . . . 0.0 113.784 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -61.9 -37.36 84.3 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.218 -0.926 . . . . 0.0 112.199 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -77.5 -32.29 54.07 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.648 -0.657 . . . . 0.0 112.096 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.24 95.92 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.059 -1.025 . . . . 0.0 111.657 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -75.7 -25.55 56.78 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.34 -42.74 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.224 0.92 . . . . 0.0 111.977 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -104.52 9.87 35.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.431 1.492 . . . . 0.0 113.795 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 49.55 48.55 21.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 113.675 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.1 130.69 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.617 1.167 . . . . 0.0 110.297 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.04 -17.01 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 68.9 m -128.66 158.81 37.49 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.66 1.584 . . . . 0.0 111.079 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.4 pt -135.54 142.54 41.5 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.189 0.996 . . . . 0.0 112.07 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.39 139.55 57.12 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 CA-C-N 119.495 0.855 . . . . 0.0 111.501 -8.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.0 m -122.46 118.18 27.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.857 0.863 . . . . 0.0 108.858 168.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.05 141.62 32.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.333 1.053 . . . . 0.0 109.822 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 tp -137.77 121.47 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.065 1.346 . . . . 0.0 108.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -95.88 114.99 26.77 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.237 1.415 . . . . 0.0 109.706 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -95.55 148.74 22.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.207 1.403 . . . . 0.0 110.44 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -129.73 119.16 23.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.38 1.472 . . . . 0.0 108.877 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 49.87 35.22 8.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.684 1.194 . . . . 0.0 113.814 -174.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.5 76.85 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -122.23 141.55 34.79 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.465 1.632 . . . . 0.0 111.843 165.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.07 142.56 38.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.31 2.673 . . . . 0.0 112.277 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -120.85 -43.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.384 1.074 . . . . 0.0 113.118 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.62 133.16 19.77 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.492 1.117 . . . . 0.0 112.144 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -111.59 141.3 45.36 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.394 1.477 . . . . 0.0 111.668 171.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.6 147.46 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.301 2.24 . . . . 0.0 110.665 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.28 141.85 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 0.0 111.035 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.82 171.03 44.61 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.193 1.377 . . . . 0.0 113.597 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.44 39.34 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -138.97 158.95 43.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.905 2.082 . . . . 0.0 111.044 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.42 169.35 32.92 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.519 1.057 . . . . 0.0 111.863 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -57.58 -38.05 74.19 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.099 -0.648 . . . . 0.0 112.568 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.84 81.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.333 0.653 . . . . 0.0 111.677 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.25 77.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.37 0.668 . . . . 0.0 111.594 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.65 -40.17 96.18 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.107 0.963 . . . . 0.0 112.103 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.07 -33.15 74.88 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.846 0.858 . . . . 0.0 112.401 172.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -68.21 -38.93 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.49 1.041 . . . . 0.0 112.403 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -61.49 -38.71 88.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 0.826 . . . . 0.0 111.537 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.2 tp -67.2 -43.56 81.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.72 0.408 . . . . 0.0 111.814 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.2 p -71.82 -15.37 62.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.37 -16.99 64.56 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 126.562 1.945 . . . . 0.0 111.873 -173.291 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 121.328 0.585 . . . . 0.0 111.742 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 pt -112.47 163.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.448 1.099 . . . . 0.0 111.227 160.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -126.46 130.72 51.23 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.683 1.593 . . . . 0.0 109.611 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.31 156.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.09 0.956 . . . . 0.0 113.368 -168.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.3 p -138.96 163.47 32.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.44 2.296 . . . . 0.0 110.406 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.04 -32.66 72.28 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -166.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.28 -20.59 57.21 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -109.38 -18.87 13.46 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.561 1.545 . . . . 0.0 113.88 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -52.93 -41.39 64.42 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.8 1.64 . . . . 0.0 112.927 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.44 72.18 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 m -85.52 -22.14 28.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 112.57 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -96.45 -42.38 8.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 -54.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.871 1.268 . . . . 0.0 111.623 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.66 -11.73 60.06 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.3 p -78.35 -14.34 59.45 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.311 1.844 . . . . 0.0 114.098 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.9 t -69.31 148.92 49.07 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -161.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -107.01 21.37 17.67 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.9 2.08 . . . . 0.0 112.386 167.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -138.76 156.23 72.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 128.31 2.644 . . . . 0.0 108.977 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.31 141.35 88.91 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.711 1.607 . . . . 0.0 112.559 160.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 123.09 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.418 1.087 . . . . 0.0 110.55 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.46 131.25 34.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.492 1.117 . . . . 0.0 108.531 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.63 127.9 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 119.089 0.859 . . . . 0.0 109.837 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -102.13 125.12 48.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.617 0.767 . . . . 0.0 111.172 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.16 112.24 24.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.412 1.485 . . . . 0.0 109.115 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.88 171.68 16.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -166.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 174.72 7.74 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.168 1.387 . . . . 0.0 111.954 174.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.6 p -75.11 -18.73 60.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -115.11 -7.0 12.49 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -165.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.05 128.02 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.37 -60.69 8.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.467 1.032 . . . . 0.0 114.102 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.42 -27.1 54.91 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.192 1.928 . . . . 0.0 113.501 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.61 -33.18 64.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.048 0.84 . . . . 0.0 112.015 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.82 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.172 -0.955 . . . . 0.0 112.722 167.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.89 -30.34 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.835 1.198 . . . . 0.0 113.79 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.64 -6.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.94 -53.89 53.05 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.469 1.031 . . . . 0.0 113.496 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.0 -33.85 91.6 Favored 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 121.646 1.624 . . . . 0.0 112.409 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.91 -50.02 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.988 0.915 . . . . 0.0 112.08 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.78 -37.68 82.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.36 0.664 . . . . 0.0 111.31 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.1 -37.37 78.36 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.143 0.577 . . . . 0.0 112.338 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.39 -48.59 66.93 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.781 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mm -59.67 -38.84 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 120.734 1.606 . . . . 0.0 111.185 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.66 90.51 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.802 0.728 . . . . 0.0 112.884 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.3 m -74.52 -39.5 62.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.041 0.536 . . . . 0.0 111.909 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.27 -34.67 14.85 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -167.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -117.01 20.48 13.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.216 1.406 . . . . 0.0 113.619 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.8 -27.8 19.71 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -81.16 -18.79 45.1 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.48 1.512 . . . . 0.0 113.936 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -94.56 -42.59 8.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.829 1.252 . . . . 0.0 112.068 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.62 155.94 38.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.007 1.323 . . . . 0.0 112.64 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.82 137.85 37.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.159 171.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.11 133.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.829 0.741 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.63 153.87 44.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.625 1.97 . . . . 0.0 111.705 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -123.12 131.48 53.71 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 0.0 112.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.91 121.96 45.55 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.384 1.474 . . . . 0.0 108.729 170.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.22 95.05 7.14 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.184 0.994 . . . . 0.0 109.772 -171.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.5 -20.73 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.327 1.051 . . . . 0.0 113.323 -170.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.44 -33.12 62.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.876 1.27 . . . . 0.0 112.827 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 p -107.35 -20.83 13.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.343 1.457 . . . . 0.0 113.349 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.05 81.91 69.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.734 2.013 . . . . 0.0 109.449 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -74.99 -11.22 21.49 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.202 2.601 . . . . 0.0 114.356 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.8 -40.28 61.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.161 0.984 . . . . 0.0 112.772 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -73.74 -29.59 62.32 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.025 -1.047 . . . . 0.0 112.472 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.14 94.18 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.371 0.669 . . . . 0.0 111.97 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -81.66 -23.24 37.02 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -59.42 -44.79 92.8 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.692 1.197 . . . . 0.0 111.575 171.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.43 4.77 50.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.144 1.378 . . . . 0.0 114.49 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 48.73 61.15 3.23 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.667 1.587 . . . . 0.0 112.763 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.25 134.17 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.604 1.562 . . . . 0.0 110.767 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.19 -14.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 t -146.71 167.55 23.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.025 1.33 . . . . 0.0 111.95 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.28 121.91 16.84 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.709 1.204 . . . . 0.0 108.36 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.65 157.32 94.66 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.882 0.994 . . . . 0.0 112.59 -5.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.9 m -130.33 120.81 24.92 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.216 1.006 . . . . 0.0 109.559 165.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.4 126.99 50.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.644 1.577 . . . . 0.0 109.006 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.39 133.27 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.287 1.035 . . . . 0.0 110.501 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -104.18 118.39 36.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 110.539 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.86 151.34 19.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.602 1.561 . . . . 0.0 110.43 167.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -124.7 124.39 42.06 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 108.834 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.26 36.25 12.27 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.458 1.103 . . . . 0.0 113.5 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.97 18.26 78.94 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.073 1.321 . . . . 0.0 116.094 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -126.3 140.29 36.76 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.565 1.682 . . . . 0.0 111.469 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.05 140.06 33.9 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.128 2.552 . . . . 0.0 112.53 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 t -114.53 -48.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.713 1.205 . . . . 0.0 112.605 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -153.92 141.14 19.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 111.269 -167.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -129.36 136.34 49.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.91 1.284 . . . . 0.0 112.416 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.7 mm -129.83 142.62 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.964 2.106 . . . . 0.0 109.868 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -113.42 148.99 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.332 1.453 . . . . 0.0 112.363 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.31 175.41 42.78 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.158 0.885 . . . . 0.0 114.239 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.74 148.42 38.56 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -154.19 163.87 39.44 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.601 1.961 . . . . 0.0 112.092 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.48 166.79 32.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.688 1.137 . . . . 0.0 112.642 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -60.88 -32.09 71.55 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.637 1.175 . . . . 0.0 114.131 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.6 91.83 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.225 0.61 . . . . 0.0 111.691 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.23 60.78 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.082 0.953 . . . . 0.0 112.773 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.58 -44.0 65.29 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.266 -0.896 . . . . 0.0 111.295 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.38 -30.32 70.07 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.398 -0.813 . . . . 0.0 112.127 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -68.46 -42.81 78.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.585 1.084 . . . . 0.0 112.505 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.04 -29.45 69.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.445 1.02 . . . . 0.0 112.186 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.77 -44.21 81.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.228 0.467 . . . . 0.0 111.87 168.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.1 m -66.25 -18.96 65.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.819 1.248 . . . . 0.0 112.641 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.06 -18.82 65.62 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 124.87 1.268 . . . . 0.0 110.888 175.505 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.34 141.96 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.65 1.58 . . . . 0.0 111.431 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -97.95 134.76 40.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.553 1.141 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.21 162.25 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.735 1.214 . . . . 0.0 112.833 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.2 p -123.03 169.77 10.84 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.478 1.911 . . . . 0.0 111.238 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.65 -25.86 60.79 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.096 -1.003 . . . . 0.0 113.264 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.44 -50.67 7.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.54 1.136 . . . . 0.0 113.574 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -80.33 -16.1 55.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -49.28 -42.96 42.62 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.815 1.246 . . . . 0.0 111.632 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.2 94.46 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.507 -0.746 . . . . 0.0 112.281 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 m -72.32 -30.21 64.55 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -94.93 -34.14 12.51 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.93 -49.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.667 1.187 . . . . 0.0 111.562 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.1 mt -88.91 -34.83 16.8 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 m -83.94 3.54 33.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.556 1.142 . . . . 0.0 113.866 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -62.03 151.71 34.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.355 1.062 . . . . 0.0 113.139 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -81.21 -7.31 59.54 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.179 1.392 . . . . 0.0 114.022 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -142.76 167.08 17.17 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.402 1.881 . . . . 0.0 110.64 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -60.98 149.75 87.39 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.69 2.26 . . . . 0.0 112.207 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.1 t -129.66 130.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.723 0.809 . . . . 0.0 112.062 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 132.34 36.84 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.385 1.474 . . . . 0.0 108.627 168.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 129.92 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.15 0.886 . . . . 0.0 110.345 169.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -105.71 114.17 28.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.934 0.894 . . . . 0.0 111.128 171.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -91.9 117.2 29.58 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.529 1.531 . . . . 0.0 109.135 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.39 168.52 23.18 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -168.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.99 51.7 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 155.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.4 p -65.69 -12.29 52.34 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -167.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -105.41 -10.69 16.81 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.487 1.915 . . . . 0.0 114.452 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 145.11 45.76 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.311 0.96 . . . . 0.0 112.294 -173.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.52 -64.33 4.42 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.306 -0.872 . . . . 0.0 113.873 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.21 -28.2 87.08 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.15 2.566 . . . . 0.0 114.05 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.1 m -63.7 -49.67 72.19 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.537 0.735 . . . . 0.0 110.461 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.27 67.51 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.054 -1.029 . . . . 0.0 112.202 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.0 tpp -62.15 -31.71 72.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.27 -12.97 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.371 0.987 . . . . 0.0 113.647 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.5 -50.09 73.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 120.415 1.461 . . . . 0.0 114.176 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.72 -26.55 38.97 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.453 2.102 . . . . 0.0 113.493 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.2 t -69.35 -40.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 120.907 -1.121 . . . . 0.0 110.829 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.54 -40.41 35.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.0 1.32 . . . . 0.0 111.096 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.59 -43.16 46.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.535 1.134 . . . . 0.0 111.481 162.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.05 -51.71 10.6 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.984 -0.447 . . . . 0.0 111.442 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mm -62.0 -38.2 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.542 -0.723 . . . . 0.0 111.111 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.79 85.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.391 0.996 . . . . 0.0 112.43 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -75.53 -36.43 60.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.693 0.678 . . . . 0.0 111.689 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.95 -34.2 11.88 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -114.28 22.51 13.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.533 1.533 . . . . 0.0 113.444 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.37 -26.55 41.87 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -78.97 -22.76 45.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.443 1.097 . . . . 0.0 113.012 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -90.63 -46.76 8.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.264 1.426 . . . . 0.0 111.872 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.84 156.72 38.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.326 1.451 . . . . 0.0 112.272 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.6 m -106.0 143.5 34.05 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.618 1.167 . . . . 0.0 109.794 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.81 128.6 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 110.587 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.29 160.36 25.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.496 1.918 . . . . 0.0 112.297 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -124.75 137.37 54.33 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.94 1.696 . . . . 0.0 111.458 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -125.77 122.64 36.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.977 0.911 . . . . 0.0 110.351 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -93.47 111.82 23.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 110.55 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.09 -16.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.91 -42.85 23.29 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.061 0.944 . . . . 0.0 112.764 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -87.38 -25.5 23.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.02 0.928 . . . . 0.0 113.342 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -127.96 60.5 46.37 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.147 1.379 . . . . 0.0 112.222 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -65.43 -17.35 57.46 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.746 2.297 . . . . 0.0 112.553 172.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.44 -46.29 90.58 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.416 1.086 . . . . 0.0 111.533 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -29.94 67.44 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.198 -1.564 . . . . 0.0 111.714 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.72 78.36 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.255 -0.903 . . . . 0.0 112.752 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -26.11 54.22 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.806 1.184 . . . . 0.0 113.273 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -57.28 -44.86 84.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.906 0.882 . . . . 0.0 111.441 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -107.35 9.05 29.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 47.44 60.04 3.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.943 1.697 . . . . 0.0 112.003 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.5 t -84.5 117.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.045 1.338 . . . . 0.0 110.741 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.446 ' H ' ' NH2' ' A' ' 94' ' ' ARG . 51.6 t -147.99 129.46 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.978 2.111 . . . . 0.0 107.114 174.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -121.98 157.37 31.44 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.881 3.272 . . . . 0.0 110.826 -9.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.8 pt -69.28 145.66 96.08 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -171.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.46 138.96 56.12 Favored 'Cis proline' 0 CA--C 1.538 0.713 0 CA-C-N 118.756 0.592 . . . . 0.0 110.937 -11.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.5 m -112.35 113.87 26.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.955 0.902 . . . . 0.0 108.957 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.23 124.78 46.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.987 1.315 . . . . 0.0 108.457 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -128.76 138.82 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.088 0.955 . . . . 0.0 111.367 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.57 129.89 52.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.099 1.36 . . . . 0.0 111.983 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -109.87 139.67 44.68 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.816 2.047 . . . . 0.0 111.114 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -124.02 122.31 37.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.365 1.866 . . . . 0.0 108.982 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 49.01 32.65 4.03 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.128 1.371 . . . . 0.0 114.38 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.79 18.87 69.22 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.61 147.06 59.12 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-N 119.519 1.659 . . . . 0.0 112.385 161.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.68 146.49 48.94 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.331 2.687 . . . . 0.0 112.016 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.97 -45.42 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.63 133.85 19.45 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' NH2' ' H ' ' A' ' 78' ' ' VAL . 52.3 ttt180 -117.8 131.94 56.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.255 2.222 . . . . 0.0 110.002 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.57 140.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.268 1.827 . . . . 0.0 109.603 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.27 146.92 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.929 1.292 . . . . 0.0 112.012 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.83 172.2 45.51 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.247 0.927 . . . . 0.0 113.712 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.09 143.88 47.23 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.46 156.64 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.86 2.064 . . . . 0.0 111.321 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.95 174.92 39.54 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.257 1.408 . . . . 0.0 112.932 -174.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -58.76 -39.97 82.55 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.29 78.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.476 0.711 . . . . 0.0 111.321 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -40.42 74.85 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.778 0.831 . . . . 0.0 112.049 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.66 -42.94 81.41 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.353 -0.842 . . . . 0.0 111.895 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.73 -31.28 71.82 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.676 -0.64 . . . . 0.0 111.928 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -44.78 96.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.127 -0.939 . . . . 0.0 111.685 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.58 -38.05 83.34 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.005 1.275 . . . . 0.0 111.862 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.37 -46.85 78.51 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.491 0.316 . . . . 0.0 111.54 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.3 m -67.71 -24.34 65.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.204 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.99 -10.59 59.99 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.6 t . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 126.012 1.725 . . . . 0.0 112.102 -167.204 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.746 0.308 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.7 pt -126.84 171.58 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.135 1.374 . . . . 0.0 112.414 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -125.95 145.42 50.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.493 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.24 159.41 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.537 1.535 . . . . 0.0 112.272 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.7 p -140.19 166.97 23.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.257 2.623 . . . . 0.0 109.935 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.16 -28.06 64.38 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.623 -1.298 . . . . 0.0 114.392 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.08 -24.28 35.3 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -102.51 -27.08 12.99 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 0.0 114.172 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.07 -40.72 58.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.682 1.993 . . . . 0.0 112.457 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.33 -31.4 71.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -83.07 -34.94 26.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.777 0.831 . . . . 0.0 111.798 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.74 -32.94 20.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -109.9 -52.92 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.288 1.435 . . . . 0.0 111.366 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -82.37 -13.38 56.95 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -89.1 1.69 55.22 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.575 1.15 . . . . 0.0 113.009 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -67.15 154.01 42.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.458 1.503 . . . . 0.0 114.946 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -121.06 22.59 10.94 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 126.718 2.007 . . . . 0.0 111.9 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -146.13 168.72 11.03 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 127.956 2.503 . . . . 0.0 111.14 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.19 137.63 52.76 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.71 116.42 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.118 1.367 . . . . 0.0 110.219 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.03 133.81 35.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.754 1.222 . . . . 0.0 109.072 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.9 129.5 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.503 1.047 . . . . 0.0 110.763 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -103.69 128.09 51.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.9 1.28 . . . . 0.0 111.706 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -99.53 116.66 32.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.235 1.414 . . . . 0.0 108.894 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -144.4 167.94 21.28 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.7 176.76 6.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 111.519 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.3 p -68.19 -24.71 64.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -112.88 -13.33 13.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 p -78.19 124.62 28.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -164.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.72 -59.59 10.52 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.795 1.188 . . . . 0.0 114.085 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.27 -27.0 41.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.128 1.964 . . . . 0.0 113.225 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.1 p -72.03 -39.58 69.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.305 0.957 . . . . 0.0 111.686 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -68.93 -29.34 67.56 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.293 -0.879 . . . . 0.0 112.434 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.5 ttp -68.66 -35.93 77.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.703 0.801 . . . . 0.0 113.156 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.73 -24.32 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.566 1.075 . . . . 0.0 113.511 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -45.94 -47.66 41.59 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -64.17 -27.62 64.72 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.96 1.773 . . . . 0.0 113.039 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 t -68.24 -35.87 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.889 1.222 . . . . 0.0 111.229 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 mt -67.98 -48.99 64.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.24 1.016 . . . . 0.0 110.341 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.65 -40.61 72.43 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.661 0.784 . . . . 0.0 110.866 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.16 -51.97 12.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.645 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.5 -39.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.972 1.26 . . . . 0.0 111.361 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.45 96.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.745 0.702 . . . . 0.0 111.604 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.5 m -76.79 -32.48 57.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.06 -22.83 28.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -130.18 27.24 5.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.983 1.313 . . . . 0.0 113.504 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.61 29.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.424 1.49 . . . . 0.0 114.517 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 p -78.11 -18.29 55.86 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.14 1.376 . . . . 0.0 113.737 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -102.01 -40.55 6.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.858 1.263 . . . . 0.0 112.687 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 172.79 12.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.635 1.174 . . . . 0.0 113.674 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -126.19 143.89 50.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.438 1.495 . . . . 0.0 109.779 170.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.8 127.83 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.568 0.699 . . . . 0.0 110.408 168.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.74 164.51 16.47 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.74 2.416 . . . . 0.0 111.722 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 137.96 47.57 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.498 1.119 . . . . 0.0 111.909 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.17 122.34 40.76 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.24 1.416 . . . . 0.0 110.175 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.84 108.63 19.63 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.803 0.841 . . . . 0.0 110.507 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -72.09 -16.65 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.3 -41.14 11.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.541 1.137 . . . . 0.0 112.522 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.7 p -89.43 -22.25 22.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -131.26 72.5 81.15 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.782 1.233 . . . . 0.0 111.793 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -14.59 45.64 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.891 2.394 . . . . 0.0 113.141 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -62.56 -42.87 99.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 112.546 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.0 m -74.18 -31.71 62.79 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.34 0.973 . . . . 0.0 111.711 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.29 94.38 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.658 0.783 . . . . 0.0 111.856 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -77.53 -24.51 49.95 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 168.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -61.28 -46.47 90.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.175 0.898 . . . . 0.0 111.474 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.11 4.25 41.98 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 48.85 62.78 2.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.768 1.627 . . . . 0.0 112.59 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.6 141.92 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 110.652 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.48 -45.03 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.599 1.16 . . . . 0.0 111.951 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -121.67 158.04 29.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.577 1.551 . . . . 0.0 111.287 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.58 130.46 23.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.998 0.919 . . . . 0.0 110.079 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.09 150.5 95.79 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.944 1.016 . . . . 0.0 113.317 -5.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 m -121.1 134.98 55.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.127 1.371 . . . . 0.0 109.12 164.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.73 139.75 45.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.156 1.782 . . . . 0.0 110.145 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 tp -135.03 126.2 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.71 1.204 . . . . 0.0 108.235 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.7 tp -107.06 126.4 52.3 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.978 1.311 . . . . 0.0 109.681 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -107.85 152.37 24.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.969 1.708 . . . . 0.0 110.275 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.202 1.801 . . . . 0.0 108.07 172.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 52.43 32.08 10.72 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 16.83 79.55 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.524 1.535 . . . . 0.0 116.841 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.62 144.14 43.59 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 119.543 1.671 . . . . 0.0 111.776 166.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.45 140.29 39.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.839 2.359 . . . . 0.0 112.2 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.0 m -117.15 -31.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.124 1.37 . . . . 0.0 114.226 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -158.17 142.12 15.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.183 0.993 . . . . 0.0 112.257 -170.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -125.76 136.68 53.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.106 1.763 . . . . 0.0 110.73 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.47 151.89 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.021 1.728 . . . . 0.0 110.295 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.56 147.14 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.492 1.117 . . . . 0.0 111.693 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.07 171.96 48.42 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.478 1.037 . . . . 0.0 113.753 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.8 38.52 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -139.47 152.0 46.65 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.718 2.007 . . . . 0.0 111.341 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.39 169.16 32.76 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.419 1.009 . . . . 0.0 112.022 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.43 -34.46 72.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.93 -42.76 84.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.14 0.576 . . . . 0.0 111.388 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.83 -44.83 72.64 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.582 0.753 . . . . 0.0 111.853 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.36 -43.48 97.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.731 0.813 . . . . 0.0 111.62 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -63.37 -35.75 81.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.406 0.682 . . . . 0.0 111.955 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.2 tpt85 -68.32 -38.25 81.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.201 0.909 . . . . 0.0 112.774 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.83 -39.48 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.444 1.02 . . . . 0.0 111.467 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -42.92 78.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.948 0.499 . . . . 0.0 111.867 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m -66.16 -20.16 66.05 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.061 1.344 . . . . 0.0 112.631 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.78 -19.83 66.03 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.469 0.524 0 C-N-CA 125.099 1.359 . . . . 0.0 110.359 176.08 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 121.218 0.532 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.4 pt -130.75 157.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.2 1.4 . . . . 0.0 111.703 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -103.09 141.74 35.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.85 1.26 . . . . 0.0 110.605 168.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.88 159.44 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.734 1.613 . . . . 0.0 111.359 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.5 p -141.39 168.28 20.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.927 2.491 . . . . 0.0 109.787 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.23 -27.4 34.36 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 120.636 -1.29 . . . . 0.0 113.933 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.76 57.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 p -126.72 -22.1 3.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -172.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -51.18 -41.55 60.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.134 1.773 . . . . 0.0 112.625 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.26 -31.38 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 m -86.07 -29.52 23.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.826 0.85 . . . . 0.0 112.15 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.84 -35.48 14.05 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.77 -55.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.823 1.249 . . . . 0.0 111.282 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.1 mt -80.01 -20.84 44.45 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -92.96 0.78 57.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.735 1.214 . . . . 0.0 113.318 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 t -65.82 143.72 57.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.863 0.865 . . . . 0.0 112.697 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -91.6 3.63 54.56 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.293 1.437 . . . . 0.0 113.044 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -141.62 168.85 12.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.642 1.977 . . . . 0.0 111.294 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.55 144.52 62.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.749 2.299 . . . . 0.0 114.092 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.43 129.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.704 1.202 . . . . 0.0 109.956 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.81 135.66 34.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 164.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.3 t -119.88 125.13 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 118.542 0.61 . . . . 0.0 110.078 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -107.34 113.73 27.3 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.535 1.134 . . . . 0.0 112.245 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -86.21 115.04 23.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.798 2.039 . . . . 0.0 109.102 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.54 172.03 15.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -167.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.75 146.39 50.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.611 1.165 . . . . 0.0 110.438 159.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.0 p -72.38 -14.96 61.84 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -93.66 -9.63 37.25 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.909 1.684 . . . . 0.0 114.032 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 135.22 36.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.373 1.069 . . . . 0.0 111.504 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.23 -65.24 3.66 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.831 1.205 . . . . 0.0 114.643 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.06 -25.87 65.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.376 2.05 . . . . 0.0 112.634 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.6 m -63.36 -45.7 89.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.833 0.853 . . . . 0.0 111.672 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -69.06 -32.83 72.58 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -66.65 -35.19 79.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.345 1.058 . . . . 0.0 113.561 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 m -77.84 -25.19 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.646 1.112 . . . . 0.0 113.684 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.92 -43.48 75.4 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.24 -36.48 87.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.541 2.161 . . . . 0.0 112.954 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.64 -37.03 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.137 0.975 . . . . 0.0 110.926 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.67 -49.69 51.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.521 1.128 . . . . 0.0 110.278 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.88 -40.8 76.89 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.36 0.664 . . . . 0.0 110.859 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -76.42 -48.82 18.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.074 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.49 -39.82 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 110.825 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.07 96.62 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 0.994 . . . . 0.0 111.628 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 m -77.82 -33.63 52.31 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.29 -30.51 23.69 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.235 -0.915 . . . . 0.0 113.054 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -118.45 26.52 9.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.248 1.819 . . . . 0.0 112.174 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.68 33.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.352 1.461 . . . . 0.0 114.195 -176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 p -76.89 -18.18 58.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.235 1.414 . . . . 0.0 113.671 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -101.4 -39.54 7.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.477 1.511 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.03 167.24 29.07 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -120.03 138.87 53.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.313 1.445 . . . . 0.0 109.737 166.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.43 127.6 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.177 0.591 . . . . 0.0 109.768 169.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.93 158.76 22.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.482 1.913 . . . . 0.0 111.585 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.21 131.41 54.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.196 1.398 . . . . 0.0 110.599 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.7 120.63 42.68 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.261 0.553 . . . . 0.0 109.582 164.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -94.67 97.25 9.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.091 0.957 . . . . 0.0 109.619 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.55 -19.41 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.186 -0.946 . . . . 0.0 112.37 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.93 -23.26 60.66 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.262 1.425 . . . . 0.0 114.056 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.0 p -127.2 -22.92 3.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -144.66 76.23 14.29 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.897 1.279 . . . . 0.0 111.134 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.6 -3.81 13.33 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.401 2.734 . . . . 0.0 113.9 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.25 -42.58 95.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.426 1.09 . . . . 0.0 113.051 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -27.17 52.7 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.9 94.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 111.796 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -76.75 -28.59 55.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -58.43 -44.29 89.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 112.069 172.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.68 7.36 46.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.939 1.296 . . . . 0.0 113.718 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 50.9 49.02 21.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.087 1.755 . . . . 0.0 113.246 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.04 123.32 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.504 1.121 . . . . 0.0 109.985 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.64 -23.92 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 t -135.5 165.69 24.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.256 1.422 . . . . 0.0 111.877 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.65 143.5 46.8 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.968 1.307 . . . . 0.0 111.745 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.7 147.37 86.49 Favored 'Cis proline' 0 CA--C 1.54 0.806 0 CA-C-N 119.431 0.833 . . . . 0.0 111.523 -8.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.2 m -133.04 122.22 23.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.216 1.006 . . . . 0.0 109.842 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.71 137.42 44.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.934 1.294 . . . . 0.0 109.75 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.34 132.83 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.114 0.966 . . . . 0.0 109.767 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -114.09 119.79 38.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.105 1.362 . . . . 0.0 111.307 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -101.55 146.68 27.35 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.874 2.07 . . . . 0.0 110.357 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -98.99 -41.17 7.69 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.696 0.798 . . . . 0.0 113.094 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -149.92 53.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.272 1.429 . . . . 0.0 110.422 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.96 15.96 63.38 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.491 1.043 . . . . 0.0 113.667 -168.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.68 126.81 22.8 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.969 2.108 . . . . 0.0 109.161 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.74 143.64 27.02 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.567 2.844 . . . . 0.0 112.754 -170.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.35 -46.6 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.45 1.1 . . . . 0.0 112.418 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -151.05 156.29 40.79 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -121.71 137.55 54.71 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.741 2.016 . . . . 0.0 110.126 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 127.85 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.352 1.461 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.2 157.71 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.525 1.13 . . . . 0.0 112.126 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.15 177.72 40.68 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.655 1.121 . . . . 0.0 113.818 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.33 155.71 38.25 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.24 151.85 50.12 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.606 1.962 . . . . 0.0 111.288 167.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.52 170.98 37.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.7 1.143 . . . . 0.0 111.332 161.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -55.28 -39.13 69.48 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.841 . . . . 0.0 113.028 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.65 85.01 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.398 0.679 . . . . 0.0 112.09 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.82 78.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.353 0.661 . . . . 0.0 111.696 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 104' ' ' LEU . 14.0 tp -66.2 -39.07 89.39 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.201 -0.937 . . . . 0.0 111.782 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.02 -30.63 69.05 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.328 1.051 . . . . 0.0 112.657 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -62.06 -47.6 83.98 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.691 1.132 . . . . 0.0 111.143 168.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -59.17 -41.58 88.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.121 0.873 . . . . 0.0 111.903 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.0 -41.95 97.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.137 0.575 . . . . 0.0 112.471 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.2 m -67.4 -25.1 65.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 112.465 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -75.96 0.05 19.8 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.15 0.98 . . . . 0.0 113.392 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 N--CA 1.475 0.793 0 C-N-CA 125.92 1.688 . . . . 0.0 112.523 -178.034 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.73 164.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.197 1.399 . . . . 0.0 110.941 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.95 143.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.753 1.221 . . . . 0.0 110.923 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.51 156.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.661 1.584 . . . . 0.0 112.283 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.3 p -117.72 174.33 6.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.333 2.253 . . . . 0.0 110.332 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.07 -29.77 45.62 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.94 -47.45 11.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.036 0.934 . . . . 0.0 113.262 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.79 -12.35 55.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.99 -46.24 43.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.714 1.205 . . . . 0.0 112.666 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.47 -31.32 69.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.3 m -89.31 -19.94 24.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.88 1.272 . . . . 0.0 113.223 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -122.01 -21.92 5.84 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.92 -37.23 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.511 1.505 . . . . 0.0 114.406 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.33 -11.42 60.05 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.059 1.3 . . . . 0.0 113.389 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.9 p -76.9 -7.56 55.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.453 1.501 . . . . 0.0 114.111 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 84.1 p -67.69 160.13 28.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.721 . . . . 0.0 114.883 -171.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.12 16.03 5.11 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.117 1.767 . . . . 0.0 112.536 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -142.43 173.03 5.03 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 128.282 2.633 . . . . 0.0 109.533 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -61.06 140.12 88.02 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.141 1.894 . . . . 0.0 113.383 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.02 114.93 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.078 1.351 . . . . 0.0 110.75 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.84 117.01 23.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -105.76 124.01 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.849 0.75 . . . . 0.0 109.873 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -101.64 117.06 34.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.869 1.268 . . . . 0.0 110.531 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.19 115.0 26.74 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.099 1.759 . . . . 0.0 109.351 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -148.1 168.04 23.44 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.6 170.41 7.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.183 0.993 . . . . 0.0 111.107 166.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -76.64 -6.17 50.93 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -129.41 -2.72 4.93 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -165.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 p -80.5 136.6 36.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.709 1.141 . . . . 0.0 113.981 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -62.93 5.32 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.805 1.193 . . . . 0.0 114.458 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.71 -23.18 42.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.37 2.046 . . . . 0.0 112.873 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.43 -40.06 58.13 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -68.29 -32.58 72.83 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.093 -1.004 . . . . 0.0 112.05 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.7 -32.3 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.791 0.836 . . . . 0.0 113.025 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.37 -5.5 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -53.52 52.3 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 120.269 1.395 . . . . 0.0 113.461 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 -33.48 48.56 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.627 1.551 . . . . 0.0 112.31 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.38 -52.01 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.1 0.864 . . . . 0.0 111.317 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -67.81 -36.7 80.88 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.902 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.8 -34.19 71.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.61 -46.02 77.23 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.261 -0.9 . . . . 0.0 111.321 171.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -56.7 -43.73 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.674 1.579 . . . . 0.0 110.973 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 60' ' ' VAL . . . -57.81 -45.58 85.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.729 0.412 . . . . 0.0 111.761 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.6 m -79.08 -29.85 43.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.389 1.076 . . . . 0.0 112.262 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -87.2 -23.05 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -129.4 24.96 5.48 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.34 -30.63 29.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.254 1.422 . . . . 0.0 114.712 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -77.5 -18.45 57.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.245 1.418 . . . . 0.0 113.933 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -104.3 -37.88 7.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.144 1.378 . . . . 0.0 112.726 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.61 173.79 12.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.092 1.357 . . . . 0.0 113.017 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.8 m -122.21 153.78 38.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.43 1.492 . . . . 0.0 109.939 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 51' ' ' ALA . 59.1 t -124.19 138.03 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.68 0.792 . . . . 0.0 109.58 168.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.38 160.36 38.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.097 1.759 . . . . 0.0 112.007 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -125.83 138.26 53.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.218 1.007 . . . . 0.0 112.697 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -119.39 125.59 49.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.934 1.694 . . . . 0.0 109.37 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.14 93.17 7.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.024 0.93 . . . . 0.0 110.519 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.02 -23.34 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.364 1.065 . . . . 0.0 113.152 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.09 -27.89 69.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.806 1.242 . . . . 0.0 112.368 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.7 p -119.46 -11.17 9.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.836 1.654 . . . . 0.0 113.844 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -127.07 56.82 19.59 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.839 1.656 . . . . 0.0 112.594 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.39 -13.37 33.02 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.178 2.586 . . . . 0.0 113.874 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.31 -30.7 60.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.378 1.071 . . . . 0.0 112.437 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -33.94 58.07 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.189 0.996 . . . . 0.0 112.559 165.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.07 95.89 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.838 0.744 . . . . 0.0 112.324 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -76.31 -23.43 54.31 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.3 -43.06 98.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.537 0.735 . . . . 0.0 111.851 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.41 11.98 35.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.479 1.512 . . . . 0.0 114.061 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 52.54 60.23 3.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.235 1.814 . . . . 0.0 113.056 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.5 t -66.11 126.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.915 0.886 . . . . 0.0 109.373 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.9 m -129.21 -30.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.002 1.321 . . . . 0.0 112.704 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -131.23 147.72 52.62 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.474 1.91 . . . . 0.0 109.358 167.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 pt -111.73 129.88 23.73 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.301 1.04 . . . . 0.0 110.145 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.63 143.39 77.38 Favored 'Cis proline' 0 CA--C 1.54 0.805 0 CA-C-N 119.649 0.91 . . . . 0.0 112.711 1.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.58 133.23 46.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.556 1.142 . . . . 0.0 108.036 161.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.39 126.15 51.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.7 1.2 . . . . 0.0 108.621 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.68 126.86 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 121.478 -0.764 . . . . 0.0 109.954 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.24 117.55 35.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.923 1.289 . . . . 0.0 110.399 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -94.14 158.33 15.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.868 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -142.54 135.39 28.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.749 1.619 . . . . 0.0 108.63 158.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.56 37.48 23.25 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.803 0.841 . . . . 0.0 113.093 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.19 16.65 67.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.508 2.004 . . . . 0.0 115.223 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -123.52 138.22 29.84 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.947 1.299 . . . . 0.0 110.973 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.42 139.85 32.39 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.914 2.409 . . . . 0.0 112.62 -173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -116.07 -42.83 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.664 1.586 . . . . 0.0 112.304 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -150.76 147.23 27.06 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.777 1.231 . . . . 0.0 112.597 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -125.21 137.11 54.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.854 2.062 . . . . 0.0 111.092 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.64 159.78 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 127.103 2.161 . . . . 0.0 110.874 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.6 153.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 111.527 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.45 169.36 25.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.637 1.113 . . . . 0.0 113.414 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 154.92 38.26 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.57 156.39 48.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.665 1.986 . . . . 0.0 110.923 168.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.99 162.63 42.85 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -57.33 -34.41 68.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.248 1.019 . . . . 0.0 113.645 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.36 77.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.856 0.463 . . . . 0.0 111.584 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.44 -50.09 64.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.685 0.794 . . . . 0.0 111.736 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.3 tp -61.61 -40.64 95.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.689 -0.632 . . . . 0.0 111.673 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.19 -40.22 95.34 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.106 0.866 . . . . 0.0 111.871 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -49.85 76.0 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.359 0.982 . . . . 0.0 110.662 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -63.19 -30.05 71.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -39.73 26.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 112.13 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.1 m -67.52 -18.11 64.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.8 1.64 . . . . 0.0 112.835 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.89 -16.02 15.49 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.09 1.356 . . . . 0.0 113.57 167.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 127.004 2.122 . . . . 0.0 109.913 178.057 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.36 170.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.398 1.479 . . . . 0.0 112.08 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -128.69 149.6 50.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.21 1.004 . . . . 0.0 112.274 165.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.33 156.56 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.5 p -139.07 159.56 41.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.644 1.978 . . . . 0.0 110.166 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.9 -27.94 68.53 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -164.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.98 -23.08 60.6 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.8 m -111.46 -19.87 12.42 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 0.0 113.46 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -49.36 -39.46 31.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 112.966 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.09 71.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.5 m -84.7 -33.87 23.06 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.613 -0.679 . . . . 0.0 111.751 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -80.85 -42.37 21.67 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.63 -52.48 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.538 1.535 . . . . 0.0 110.956 -174.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -80.3 -12.37 59.61 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 t -98.81 5.2 47.59 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.605 1.162 . . . . 0.0 113.353 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -67.11 152.11 46.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.497 1.519 . . . . 0.0 114.598 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.83 28.5 8.74 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.993 1.717 . . . . 0.0 111.022 171.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -153.06 169.33 9.88 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 128.267 2.627 . . . . 0.0 110.236 -175.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.23 144.84 87.66 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.073 1.848 . . . . 0.0 111.484 161.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.8 118.66 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.029 . . . . 0.0 109.597 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.25 112.72 25.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.948 1.299 . . . . 0.0 108.753 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.1 124.24 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.377 0.99 . . . . 0.0 110.667 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -97.54 112.7 24.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 111.429 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -85.55 111.14 19.75 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.747 1.619 . . . . 0.0 108.188 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.85 178.92 8.46 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -162.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.13 144.47 45.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.525 0.73 . . . . 0.0 110.364 159.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.9 p -67.37 -23.26 65.57 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -85.23 -9.58 57.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.361 1.464 . . . . 0.0 114.245 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 135.38 36.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.011 0.924 . . . . 0.0 111.48 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -62.95 5.63 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.742 1.163 . . . . 0.0 114.546 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.4 -21.02 61.3 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.342 2.028 . . . . 0.0 113.149 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.4 m -68.03 -49.63 60.25 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.937 0.789 . . . . 0.0 110.991 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.85 -32.97 74.66 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.108 -0.995 . . . . 0.0 112.03 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.51 -35.22 73.74 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.212 1.005 . . . . 0.0 113.108 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.63 -7.54 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.76 63.22 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 120.406 1.457 . . . . 0.0 114.15 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.23 -35.81 30.96 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.496 1.464 . . . . 0.0 112.012 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.83 -48.94 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.917 0.887 . . . . 0.0 111.469 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.17 -39.11 82.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.344 0.657 . . . . 0.0 110.756 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.8 -45.38 94.09 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.399 0.545 . . . . 0.0 112.075 173.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.92 -47.53 68.5 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.345 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -62.05 -35.21 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.999 1.727 . . . . 0.0 111.949 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.15 -43.95 92.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.547 1.067 . . . . 0.0 111.606 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.0 m -81.1 -30.09 34.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.889 0.876 . . . . 0.0 112.604 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -79.75 -15.57 57.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.365 1.066 . . . . 0.0 113.733 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.64 24.22 3.14 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.359 1.464 . . . . 0.0 114.122 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.41 -29.57 49.47 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -17.99 43.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.289 1.436 . . . . 0.0 113.688 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -101.66 -41.41 6.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.081 1.352 . . . . 0.0 112.698 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 176.46 10.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.911 1.684 . . . . 0.0 112.864 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -129.36 142.64 50.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 110.407 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.16 132.27 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.533 0.733 . . . . 0.0 109.84 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.05 162.65 30.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.204 2.202 . . . . 0.0 112.214 -164.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -127.59 139.65 52.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.234 1.413 . . . . 0.0 112.676 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.55 124.27 39.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.616 1.566 . . . . 0.0 109.766 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -89.62 97.46 11.21 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.157 0.983 . . . . 0.0 110.149 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.5 -25.15 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.984 -1.073 . . . . 0.0 112.559 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.18 -21.09 43.4 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.707 1.603 . . . . 0.0 113.845 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.0 p -125.89 -17.08 5.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -131.01 79.0 72.34 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.226 1.01 . . . . 0.0 111.542 163.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.27 -13.47 36.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.436 2.757 . . . . 0.0 114.496 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -58.09 -40.57 81.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.77 1.228 . . . . 0.0 112.821 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -81.52 -30.66 33.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.85 -1.156 . . . . 0.0 112.07 172.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.0 87.57 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.361 -0.837 . . . . 0.0 111.958 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 54.99 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.055 0.942 . . . . 0.0 113.5 169.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -64.36 -44.57 91.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.982 0.81 . . . . 0.0 111.084 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.78 4.27 37.73 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.973 1.309 . . . . 0.0 114.481 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 50.59 49.54 20.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.97 1.708 . . . . 0.0 113.093 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.72 134.63 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.807 0.843 . . . . 0.0 111.598 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.09 -40.04 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.353 1.061 . . . . 0.0 112.768 -170.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -142.27 168.39 19.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.227 1.411 . . . . 0.0 111.717 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.0 pt -130.76 146.18 60.85 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.822 1.249 . . . . 0.0 112.697 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.18 143.03 75.88 Favored 'Cis proline' 0 CA--C 1.54 0.79 0 CA-C-N 118.976 0.67 . . . . 0.0 111.423 -8.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.1 m -121.99 118.26 28.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.203 1.001 . . . . 0.0 108.665 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -105.65 129.5 53.88 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.142 0.977 . . . . 0.0 109.53 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.59 126.7 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.547 1.139 . . . . 0.0 109.833 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -105.19 119.75 39.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.127 1.371 . . . . 0.0 111.042 -173.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -97.08 154.73 17.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.158 1.783 . . . . 0.0 110.927 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -130.89 109.16 10.35 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.333 1.853 . . . . 0.0 109.386 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 52.97 37.74 25.36 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.211 1.004 . . . . 0.0 112.906 -174.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.06 11.65 82.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.307 1.432 . . . . 0.0 116.5 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -113.7 138.09 22.51 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 119.601 1.701 . . . . 0.0 111.507 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.57 139.55 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.74 -43.13 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.403 1.081 . . . . 0.0 112.661 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -149.46 141.12 23.51 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.835 1.254 . . . . 0.0 111.463 -165.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -129.17 138.28 51.65 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.284 1.434 . . . . 0.0 111.662 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.4 151.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 111.665 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.4 147.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.049 1.339 . . . . 0.0 111.225 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.23 168.11 42.65 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.819 1.676 . . . . 0.0 113.389 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.52 156.39 35.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.97 158.07 45.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.724 2.01 . . . . 0.0 111.197 169.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.82 170.27 41.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.026 0.822 . . . . 0.0 111.179 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.77 -39.81 71.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.55 -46.75 78.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.09 0.556 . . . . 0.0 111.575 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.31 76.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.324 0.65 . . . . 0.0 111.818 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.92 -40.04 95.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.203 0.601 . . . . 0.0 112.113 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.97 -30.12 68.48 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.64 -0.663 . . . . 0.0 112.269 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -36.8 70.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.864 1.211 . . . . 0.0 112.47 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.9 -35.89 79.69 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.508 -0.745 . . . . 0.0 111.847 168.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.59 -38.2 83.67 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -68.31 -21.11 64.79 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.412 1.085 . . . . 0.0 112.572 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -68.51 -10.66 57.05 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 125.93 1.692 . . . . 0.0 112.704 -174.573 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 pt -119.45 173.44 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.942 1.297 . . . . 0.0 111.46 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -127.81 139.4 52.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.771 1.628 . . . . 0.0 109.654 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.88 160.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.787 1.235 . . . . 0.0 112.795 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.8 p -124.47 166.61 15.72 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.296 2.638 . . . . 0.0 110.136 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -25.83 63.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.15 17.74 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.572 1.149 . . . . 0.0 113.07 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -80.34 -18.35 49.35 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.92 -41.72 25.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.917 2.087 . . . . 0.0 112.98 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.25 71.35 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.057 -1.027 . . . . 0.0 113.626 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -92.47 -19.0 22.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.378 1.471 . . . . 0.0 113.071 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -116.13 -25.47 7.61 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.11 -54.93 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.511 1.124 . . . . 0.0 111.422 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.8 mt -71.66 -16.94 62.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.4 p -75.33 -16.91 60.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.763 1.625 . . . . 0.0 114.505 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -72.0 149.14 45.24 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -165.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.62 -0.03 57.25 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.508 1.523 . . . . 0.0 113.796 172.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.94 167.25 20.91 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.019 2.127 . . . . 0.0 110.978 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.06 147.12 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.802 2.334 . . . . 0.0 114.311 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.3 t -133.5 125.58 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.797 0.839 . . . . 0.0 111.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.46 129.09 35.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.054 . . . . 0.0 108.802 172.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.49 127.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.321 1.048 . . . . 0.0 109.287 166.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -104.23 123.86 48.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.379 0.672 . . . . 0.0 111.409 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -87.1 112.81 22.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.258 1.023 . . . . 0.0 109.317 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.34 174.12 12.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -168.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.77 174.72 8.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.396 1.478 . . . . 0.0 111.206 171.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.1 p -75.93 -10.49 59.46 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -124.39 -5.05 7.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -164.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.55 132.39 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.597 1.089 . . . . 0.0 113.886 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -58.99 11.32 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.719 1.152 . . . . 0.0 114.284 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.87 -23.89 40.75 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 119.982 1.891 . . . . 0.0 113.041 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.9 -34.71 59.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.024 -1.047 . . . . 0.0 111.788 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -67.12 -32.32 73.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.821 0.848 . . . . 0.0 112.131 166.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.0 ttt -64.42 -35.37 80.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 174.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.42 -11.45 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.65 85.4 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.14 -30.99 37.35 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.467 1.56 . . . . 0.0 112.643 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.6 -47.82 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.253 0.933 . . . . 0.0 111.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.14 -35.27 73.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.258 1.023 . . . . 0.0 111.47 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.87 -45.26 90.23 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.061 0.846 . . . . 0.0 112.324 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.14 -45.87 79.52 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.933 -0.479 . . . . 0.0 110.756 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mm -61.28 -38.38 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.659 1.118 . . . . 0.0 111.881 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.63 92.89 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.619 1.1 . . . . 0.0 112.264 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.5 m -79.02 -33.27 45.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.859 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.92 -33.42 15.61 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -113.27 26.4 10.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.622 1.569 . . . . 0.0 113.101 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -25.88 53.67 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -73.2 -29.9 63.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.593 1.157 . . . . 0.0 112.153 173.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -90.71 -38.22 13.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.271 1.428 . . . . 0.0 113.008 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.11 173.05 13.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -110.9 146.87 35.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.782 1.633 . . . . 0.0 109.363 157.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.58 129.57 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.387 -0.821 . . . . 0.0 110.251 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.84 161.14 29.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.261 2.225 . . . . 0.0 111.295 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -131.76 142.95 49.9 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.433 0.693 . . . . 0.0 111.614 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.21 127.52 56.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.297 1.839 . . . . 0.0 109.599 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -96.04 97.25 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.485 1.114 . . . . 0.0 111.825 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.94 -16.0 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.2 -25.2 61.57 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.623 0.769 . . . . 0.0 112.538 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.8 p -126.67 -23.16 3.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -146.74 67.58 11.37 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.035 1.334 . . . . 0.0 111.977 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.34 2.86 5.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.014 3.143 . . . . 0.0 114.75 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -61.79 -39.73 92.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.842 -1.161 . . . . 0.0 113.59 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.34 -28.66 53.14 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 113.863 170.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.64 88.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.873 1.215 . . . . 0.0 112.117 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -75.51 -27.26 58.69 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.097 -1.002 . . . . 0.0 113.328 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -59.73 -41.82 91.75 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.21 0.914 . . . . 0.0 111.938 171.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -96.65 19.17 12.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.506 1.522 . . . . 0.0 113.597 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 52.59 42.52 31.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.451 2.301 . . . . 0.0 114.637 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.85 124.07 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.668 1.187 . . . . 0.0 110.59 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.88 -40.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.072 0.949 . . . . 0.0 111.418 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -147.88 161.74 40.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.615 1.566 . . . . 0.0 111.026 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.5 pt -109.01 142.39 25.42 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.746 1.218 . . . . 0.0 111.688 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.87 154.03 99.42 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.545 0.873 . . . . 0.0 112.535 -0.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -133.88 120.92 21.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.868 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.12 134.16 38.15 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.963 1.305 . . . . 0.0 109.0 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.6 131.19 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.411 1.084 . . . . 0.0 109.111 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.7 tp -108.18 116.4 31.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.845 1.258 . . . . 0.0 110.476 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.87 157.37 16.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.233 1.813 . . . . 0.0 111.514 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -144.75 131.56 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.493 1.917 . . . . 0.0 109.45 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.6 t70 50.0 32.99 6.19 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.27 16.21 80.73 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.876 1.227 . . . . 0.0 115.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -117.1 152.22 48.61 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.209 1.504 . . . . 0.0 111.638 164.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.1 150.43 77.31 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.293 1.996 . . . . 0.0 111.301 168.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.02 -42.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.258 1.023 . . . . 0.0 112.37 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -142.19 146.08 34.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.808 1.243 . . . . 0.0 112.32 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -129.44 130.35 45.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.533 1.533 . . . . 0.0 110.557 166.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -129.81 123.88 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.83 1.652 . . . . 0.0 109.777 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 148.06 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.687 1.195 . . . . 0.0 111.873 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.92 172.62 39.53 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.495 1.045 . . . . 0.0 114.333 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 149.8 42.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -151.48 162.02 41.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.308 1.843 . . . . 0.0 112.513 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.94 166.67 31.32 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.797 1.189 . . . . 0.0 112.547 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -59.89 -31.64 69.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.9 97.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.216 0.606 . . . . 0.0 111.868 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.65 -30.72 56.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.954 0.902 . . . . 0.0 113.199 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.65 -42.88 73.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.33 -0.856 . . . . 0.0 110.793 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.1 tp -67.88 -33.47 74.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.473 -0.767 . . . . 0.0 112.391 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.57 -50.11 70.75 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.566 1.075 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -64.28 -29.34 70.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.164 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.9 tp -67.74 -47.18 70.02 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.764 0.826 . . . . 0.0 113.194 171.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 m -68.89 -20.43 64.25 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.446 0.698 . . . . 0.0 112.385 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.75 -9.19 58.32 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 125.588 1.555 . . . . 0.0 112.79 -166.593 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -132.3 166.85 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.027 1.731 . . . . 0.0 111.905 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -116.42 139.36 50.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.795 1.638 . . . . 0.0 109.837 168.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.64 158.54 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.559 1.544 . . . . 0.0 112.041 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.2 p -143.53 162.71 35.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.028 1.731 . . . . 0.0 111.748 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.14 -28.15 62.49 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.59 -18.15 49.15 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.401 1.08 . . . . 0.0 113.835 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -124.06 -10.0 7.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 114.351 -171.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -53.16 -41.07 64.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.714 1.606 . . . . 0.0 112.959 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.47 72.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -84.58 -26.67 27.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.136 1.375 . . . . 0.0 112.437 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -92.86 -44.78 8.3 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -98.96 -55.18 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.009 1.324 . . . . 0.0 111.083 -175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.2 mt -78.14 -11.99 59.96 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.9 p -71.56 -17.24 62.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.23 1.412 . . . . 0.0 113.627 172.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -83.08 123.29 29.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.565 1.546 . . . . 0.0 111.833 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -78.7 -24.43 45.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.231 1.012 . . . . 0.0 112.701 171.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -82.51 166.73 34.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.589 1.556 . . . . 0.0 110.479 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.87 144.94 99.38 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.297 1.998 . . . . 0.0 112.722 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.6 t -132.17 124.99 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.074 0.949 . . . . 0.0 110.412 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 132.03 36.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 169.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.1 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 0.854 . . . . 0.0 110.418 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.73 118.34 36.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.031 1.333 . . . . 0.0 111.559 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.2 112.56 24.26 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.631 1.573 . . . . 0.0 109.203 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 170.19 19.02 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -163.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.88 -167.54 1.82 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.907 1.683 . . . . 0.0 109.672 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -98.83 -20.16 17.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -86.44 -22.36 26.56 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.98 132.81 35.41 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.247 1.019 . . . . 0.0 113.018 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.16 -59.02 11.4 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.39 0.995 . . . . 0.0 114.213 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.33 -25.06 36.58 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.269 1.979 . . . . 0.0 113.406 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.51 -32.91 54.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.359 -0.838 . . . . 0.0 112.088 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -70.51 -36.57 73.85 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 111.589 169.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.1 ttt -60.49 -31.94 70.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.671 1.188 . . . . 0.0 113.762 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.91 -5.91 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -52.73 70.28 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.811 1.187 . . . . 0.0 113.963 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.02 -33.32 74.49 Favored 'Trans proline' 0 C--N 1.353 0.805 0 CA-C-N 121.421 1.543 . . . . 0.0 112.423 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.31 -49.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.811 0.844 . . . . 0.0 111.792 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.51 -37.03 84.17 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.386 0.539 . . . . 0.0 111.176 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.92 -38.53 83.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.028 0.831 . . . . 0.0 112.25 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.05 -48.03 69.52 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.295 -0.878 . . . . 0.0 111.819 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mm -59.49 -41.6 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.545 1.52 . . . . 0.0 111.001 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.52 71.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.356 0.662 . . . . 0.0 112.684 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.3 m -76.73 -42.95 39.33 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.088 -1.007 . . . . 0.0 111.2 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.43 -36.06 17.93 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -166.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -114.75 21.64 14.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.926 1.29 . . . . 0.0 113.601 -171.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.2 41.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.353 1.461 . . . . 0.0 114.589 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 p -80.95 -18.28 47.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.479 1.512 . . . . 0.0 113.657 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -101.75 -39.54 7.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.071 1.348 . . . . 0.0 112.784 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.9 169.21 21.68 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.891 1.276 . . . . 0.0 113.676 -176.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -110.54 142.26 42.58 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.465 1.506 . . . . 0.0 110.09 171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.28 119.31 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.531 169.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.77 163.33 16.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.838 2.055 . . . . 0.0 111.535 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.75 137.92 47.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.594 0.758 . . . . 0.0 112.049 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.61 123.44 46.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.845 1.258 . . . . 0.0 109.443 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -91.49 108.74 20.1 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.998 0.919 . . . . 0.0 109.447 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 m -70.86 -16.23 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -87.95 -41.24 13.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.271 1.028 . . . . 0.0 112.671 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -87.35 -22.29 25.17 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -139.99 69.6 35.58 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.568 1.147 . . . . 0.0 112.644 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.43 -14.83 46.96 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.249 2.632 . . . . 0.0 113.829 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -64.98 -34.9 79.55 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.059 -1.026 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -80.2 -30.31 38.69 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.476 -0.765 . . . . 0.0 112.051 169.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.51 80.91 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.627 -1.296 . . . . 0.0 112.308 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -76.75 -23.2 53.01 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 168.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -60.6 -43.5 97.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 0.0 111.683 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -102.43 7.76 40.26 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.18 1.392 . . . . 0.0 114.039 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 48.67 67.05 0.92 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.762 1.625 . . . . 0.0 112.331 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.03 81.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 123.055 1.407 . . . . 0.0 110.249 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.8 m -87.43 -22.97 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.306 1.842 . . . . 0.0 112.868 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -122.07 133.14 54.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.221 1.808 . . . . 0.0 109.73 173.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 tt -118.23 135.08 23.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.384 1.074 . . . . 0.0 111.517 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.82 157.23 92.44 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 118.847 0.624 . . . . 0.0 112.7 -9.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -107.42 124.21 49.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.673 1.189 . . . . 0.0 108.39 163.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.13 122.78 48.77 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.283 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 tp -130.37 129.83 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.486 1.114 . . . . 0.0 109.986 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.2 tp -100.14 132.34 45.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.151 1.38 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -118.36 151.76 37.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.875 1.67 . . . . 0.0 111.576 175.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -143.59 130.0 19.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.14 1.776 . . . . 0.0 109.832 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 t70 49.63 35.91 9.6 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.952 1.301 . . . . 0.0 114.381 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 16.41 80.8 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.847 1.213 . . . . 0.0 116.012 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -125.21 144.35 47.15 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 118.745 1.273 . . . . 0.0 111.494 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.46 144.96 51.77 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.009 2.473 . . . . 0.0 111.673 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.13 -54.7 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.832 1.253 . . . . 0.0 112.17 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -156.05 152.72 28.4 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -117.97 141.6 48.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.587 1.955 . . . . 0.0 111.571 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.79 146.71 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.952 . . . . 0.0 109.706 171.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.05 151.61 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.719 1.207 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.16 -171.15 55.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.748 0.689 . . . . 0.0 111.959 -170.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.08 155.79 23.67 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -135.17 149.92 50.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.214 2.205 . . . . 0.0 110.139 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.46 160.62 29.33 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 162.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -58.03 -34.53 70.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.75 73.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.313 0.645 . . . . 0.0 111.655 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.36 73.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.565 0.746 . . . . 0.0 111.598 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.62 -40.58 97.43 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.764 -0.585 . . . . 0.0 111.565 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.32 -33.4 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -61.58 -48.68 79.84 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.625 1.102 . . . . 0.0 110.555 170.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.66 -33.97 74.91 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 mt -71.2 -35.33 71.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.268 1.027 . . . . 0.0 113.623 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 t -69.69 -26.41 64.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.634 1.174 . . . . 0.0 112.008 172.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -76.38 5.44 7.16 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.412 1.485 . . . . 0.0 114.451 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.47 0.562 0 C-N-CA 125.005 1.322 . . . . 0.0 112.984 179.56 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.352 0.12 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 pt -108.3 134.4 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.813 0.845 . . . . 0.0 112.752 -170.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.08 129.51 35.03 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.255 . . . . 0.0 109.415 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.48 155.72 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.568 1.147 . . . . 0.0 111.544 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.7 p -121.47 172.7 7.88 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.385 1.874 . . . . 0.0 110.891 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.09 -24.78 42.32 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 -51.14 7.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.23 1.012 . . . . 0.0 113.167 172.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -80.65 -23.23 39.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -50.76 -41.63 56.95 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.087 1.355 . . . . 0.0 112.018 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.48 72.11 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.765 -1.209 . . . . 0.0 113.654 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -84.44 -30.63 25.14 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.365 -0.834 . . . . 0.0 112.421 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -92.56 -30.02 15.87 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.21 -54.39 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.216 1.406 . . . . 0.0 111.288 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.25 -22.46 35.81 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -172.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -88.31 3.75 48.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.348 1.059 . . . . 0.0 113.201 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -68.29 154.79 41.05 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.563 1.545 . . . . 0.0 114.237 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -112.91 9.45 18.85 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.562 1.945 . . . . 0.0 113.315 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -138.49 170.4 10.4 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 127.631 2.372 . . . . 0.0 111.288 -173.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -66.88 138.97 50.18 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.104 1.869 . . . . 0.0 112.379 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.46 113.46 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 110.323 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -86.64 128.71 35.01 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.375 1.07 . . . . 0.0 108.181 170.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -120.06 124.48 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 110.028 169.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.53 124.11 41.65 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.04 0.936 . . . . 0.0 111.119 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD2' HD12 ' A' ' 63' ' ' LEU . 9.8 m-85 -95.01 118.36 31.69 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.421 1.488 . . . . 0.0 109.325 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -145.03 165.32 28.54 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -171.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.17 177.62 4.66 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.261 1.824 . . . . 0.0 111.748 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.1 p -68.52 -23.43 64.54 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -117.71 -13.95 10.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -161.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -74.98 129.06 37.0 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -165.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.74 -62.98 5.51 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.198 0.904 . . . . 0.0 112.897 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -60.33 -30.44 91.03 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.415 2.077 . . . . 0.0 113.952 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.06 -33.56 70.38 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.931 0.787 . . . . 0.0 112.161 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -73.11 -32.24 64.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.912 0.885 . . . . 0.0 112.597 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -68.64 -31.01 69.85 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -83.17 -17.61 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.715 1.143 . . . . 0.0 113.161 174.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.51 -50.24 67.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 120.255 1.389 . . . . 0.0 114.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.1 -33.23 51.0 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.021 1.814 . . . . 0.0 113.092 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.61 -42.88 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.261 1.391 . . . . 0.0 111.06 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.72 -48.2 55.79 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.304 1.442 . . . . 0.0 111.01 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.04 -37.31 66.52 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.386 1.074 . . . . 0.0 111.648 169.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.98 -43.8 23.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.788 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.3 mm -65.53 -34.31 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.463 1.029 . . . . 0.0 111.543 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.64 86.9 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 0.597 . . . . 0.0 112.022 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.6 m -76.16 -34.33 59.37 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.241 0.473 . . . . 0.0 111.741 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -79.83 -35.99 37.52 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.2 30.53 4.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.257 1.023 . . . . 0.0 113.444 -173.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.14 -34.04 20.95 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.624 1.57 . . . . 0.0 114.562 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -76.33 -18.2 59.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.001 1.32 . . . . 0.0 114.069 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -105.8 -37.96 6.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.681 1.193 . . . . 0.0 112.848 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.31 165.2 29.11 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -121.49 144.38 48.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.886 1.675 . . . . 0.0 110.719 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.95 139.02 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.034 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.67 164.45 30.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.937 1.695 . . . . 0.0 114.113 -167.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -118.44 132.23 56.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.846 2.058 . . . . 0.0 111.806 174.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 32' ' ' PHE . 3.0 tm? -114.36 125.25 53.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.893 1.277 . . . . 0.0 109.477 164.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.59 113.12 25.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.279 0.631 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.98 -20.53 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -171.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.69 -38.27 33.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 111.963 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 t -95.9 -8.64 33.42 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -128.37 61.5 54.13 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.995 1.318 . . . . 0.0 113.358 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.22 -29.61 88.14 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.183 1.922 . . . . 0.0 113.486 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -66.07 -38.49 88.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.986 0.914 . . . . 0.0 112.428 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -35.2 57.71 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.603 -0.685 . . . . 0.0 111.31 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.55 93.17 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.585 -0.697 . . . . 0.0 111.667 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -71.93 -23.84 61.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.08 -39.17 77.9 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.951 0.9 . . . . 0.0 112.161 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -110.01 21.5 16.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.854 1.662 . . . . 0.0 113.366 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 52.98 35.8 20.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.743 2.017 . . . . 0.0 114.241 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.72 125.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.253 1.021 . . . . 0.0 110.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.21 -48.49 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.328 1.451 . . . . 0.0 110.099 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.5 m -85.94 143.8 27.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.481 1.112 . . . . 0.0 110.752 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.05 145.7 58.91 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.906 1.282 . . . . 0.0 111.147 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.16 146.51 85.17 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.715 0.934 . . . . 0.0 113.103 0.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.1 m -129.73 120.84 25.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.82 0.848 . . . . 0.0 109.258 165.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.48 132.59 38.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.29 1.436 . . . . 0.0 108.566 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 tp -127.2 126.4 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.841 1.256 . . . . 0.0 107.972 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 tp -108.22 128.44 54.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.638 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -110.0 151.93 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.942 1.697 . . . . 0.0 110.156 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -123.06 117.34 25.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.604 1.561 . . . . 0.0 108.021 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.309 4.0 p30 48.57 38.84 11.96 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 4.39 90.24 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.981 1.753 . . . . 0.0 116.124 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.96 133.6 20.21 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 119.236 1.518 . . . . 0.0 110.635 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.66 138.55 41.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.426 2.084 . . . . 0.0 111.656 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.22 -31.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.271 . . . . 0.0 114.205 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -159.52 141.55 13.39 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.485 1.038 . . . . 0.0 112.493 -172.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -133.79 130.93 38.69 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.596 1.559 . . . . 0.0 111.533 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 mm -129.6 123.7 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.463 1.505 . . . . 0.0 110.075 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.93 36.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 125.142 1.377 . . . . 0.0 113.572 -172.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.06 -172.74 35.37 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.319 -0.863 . . . . 0.0 114.257 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.96 154.14 41.86 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.331 1.052 . . . . 0.0 113.545 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -136.22 153.52 51.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.427 1.891 . . . . 0.0 110.773 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.35 163.54 14.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.61 1.1 . . . . 0.0 110.792 165.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -52.31 -43.04 64.31 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.444 1.122 . . . . 0.0 113.205 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.88 72.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.131 0.572 . . . . 0.0 111.7 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.06 63.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.132 0.973 . . . . 0.0 111.969 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.0 tp -63.98 -46.0 86.56 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.399 -0.813 . . . . 0.0 111.34 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.3 tp -71.59 -24.67 61.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.328 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -60.6 -47.2 87.26 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.322 1.419 . . . . 0.0 111.388 162.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.78 -36.08 75.95 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.086 0.857 . . . . 0.0 112.339 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.57 -36.38 68.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.918 0.887 . . . . 0.0 113.103 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -69.82 -22.76 63.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.376 1.07 . . . . 0.0 112.329 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -73.0 -10.43 59.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.75 1.22 . . . . 0.0 113.275 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 126.423 1.889 . . . . 0.0 112.558 -173.065 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 121.194 0.521 . . . . 0.0 111.542 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.44 166.77 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.357 1.463 . . . . 0.0 111.403 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -124.7 143.45 50.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.529 1.132 . . . . 0.0 111.9 173.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.56 165.92 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.242 1.417 . . . . 0.0 112.658 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.9 p -132.17 175.41 9.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.351 2.66 . . . . 0.0 110.755 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.48 -29.46 61.78 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.89 -1.131 . . . . 0.0 113.08 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.96 -49.56 8.85 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.98 0.912 . . . . 0.0 112.849 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -80.14 -20.84 44.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -51.02 -41.23 59.68 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.144 1.378 . . . . 0.0 112.805 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -31.43 71.91 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.099 -1.001 . . . . 0.0 113.516 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -89.28 -19.35 25.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.703 1.601 . . . . 0.0 113.198 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -112.98 -27.05 8.21 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.36 -54.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.539 1.136 . . . . 0.0 111.631 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.0 mt -73.53 -12.34 60.74 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.5 p -76.83 -14.04 59.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.889 1.676 . . . . 0.0 113.97 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -69.98 155.83 40.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -165.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -114.25 17.49 17.58 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.787 2.035 . . . . 0.0 112.595 172.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -142.62 169.44 10.83 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 127.58 2.352 . . . . 0.0 111.297 -170.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.67 135.32 69.84 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.03 2.487 . . . . 0.0 112.644 159.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -137.6 123.49 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.511 1.124 . . . . 0.0 110.963 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -93.92 133.69 37.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.313 1.445 . . . . 0.0 109.637 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 t -123.12 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.155 0.889 . . . . 0.0 110.295 172.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -107.01 122.49 46.56 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.509 1.524 . . . . 0.0 111.626 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.11 116.57 27.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 110.687 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -147.11 169.77 18.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 0.0 113.613 -172.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.19 39.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.128 1.371 . . . . 0.0 111.21 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -58.09 -28.4 64.55 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.978 1.311 . . . . 0.0 113.117 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -88.9 -2.78 58.76 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.585 1.554 . . . . 0.0 114.515 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.4 t -84.43 105.19 15.06 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.905 -1.122 . . . . 0.0 112.859 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.45 -56.78 22.73 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.38 1.467 . . . . 0.0 114.79 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.51 -29.36 44.72 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 120.613 2.207 . . . . 0.0 112.509 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.36 -47.41 79.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.162 0.892 . . . . 0.0 111.467 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.69 -32.44 73.92 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -66.0 -42.71 89.42 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.736 0.814 . . . . 0.0 112.31 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 m -84.08 -17.78 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -42.02 -48.94 11.3 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -64.4 -27.29 62.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.66 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.4 -38.74 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.092 1.315 . . . . 0.0 111.084 173.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 47' ' ' LEU . 2.9 mt -69.26 -48.72 60.98 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.751 1.22 . . . . 0.0 109.777 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.75 -40.56 72.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.18 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.74 -50.08 33.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.539 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.3 mm -58.15 -41.7 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.82 1.191 . . . . 0.0 111.436 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.35 97.24 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.818 0.735 . . . . 0.0 111.762 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.2 m -76.77 -31.67 57.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.519 0.727 . . . . 0.0 112.198 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -85.04 -31.65 23.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -122.34 30.33 6.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.414 1.485 . . . . 0.0 113.372 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.8 29.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.937 1.295 . . . . 0.0 114.356 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -72.82 -27.43 61.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.946 1.299 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.66 -33.93 10.41 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.207 1.403 . . . . 0.0 113.451 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 176.95 9.81 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.9 m -129.57 149.26 51.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.984 1.714 . . . . 0.0 108.784 162.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.65 135.12 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.902 0.774 . . . . 0.0 110.721 171.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.0 152.25 44.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.749 1.62 . . . . 0.0 112.859 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 4.8 mmmm -107.45 134.03 51.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.14 1.376 . . . . 0.0 111.302 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.76 110.83 11.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.5 1.12 . . . . 0.0 109.962 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.65 111.78 20.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.727 -0.608 . . . . 0.0 111.955 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.89 -20.41 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.13 -31.37 39.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.251 1.02 . . . . 0.0 112.124 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 t -104.71 -22.82 13.16 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.062 0.945 . . . . 0.0 113.233 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -128.9 67.54 78.03 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.7 1.6 . . . . 0.0 110.781 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.15 -15.5 31.96 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.337 2.692 . . . . 0.0 113.958 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.22 -35.06 79.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.223 -0.923 . . . . 0.0 112.527 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.7 p -77.18 -33.29 56.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 112.699 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.58 91.49 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.497 0.719 . . . . 0.0 111.845 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -76.77 -25.7 53.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -65.01 -44.57 88.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.958 0.799 . . . . 0.0 112.027 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.25 10.18 41.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.299 1.439 . . . . 0.0 114.071 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 51.22 58.11 5.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.242 1.817 . . . . 0.0 113.124 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.81 121.55 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.207 1.003 . . . . 0.0 109.256 173.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.19 -29.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.207 1.403 . . . . 0.0 112.724 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.8 p -121.21 152.59 38.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.468 1.907 . . . . 0.0 109.359 161.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.2 135.45 24.2 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.534 0.734 . . . . 0.0 111.941 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.14 147.42 66.22 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.15 0.732 . . . . 0.0 113.76 -6.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -99.89 136.89 39.13 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 154.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 mt -110.93 140.48 45.39 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.586 1.555 . . . . 0.0 108.994 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 tp -130.63 131.61 64.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.31 125.56 51.27 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.226 1.01 . . . . 0.0 109.489 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -108.96 158.17 17.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.858 2.063 . . . . 0.0 110.242 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -138.93 134.14 32.78 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.781 1.232 . . . . 0.0 108.995 160.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 54.08 39.82 31.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.019 0.927 . . . . 0.0 112.858 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.68 17.53 69.16 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.115 1.817 . . . . 0.0 114.982 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -125.9 134.11 25.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.835 1.254 . . . . 0.0 110.854 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.27 139.67 39.0 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.712 2.275 . . . . 0.0 111.764 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.51 -36.63 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -154.29 149.52 27.03 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.856 1.207 . . . . 0.0 113.672 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -101.59 145.6 28.83 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.154 1.782 . . . . 0.0 110.25 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.86 147.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.512 1.525 . . . . 0.0 109.623 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.31 147.98 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.386 1.074 . . . . 0.0 111.594 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.74 175.07 43.23 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 122.182 0.879 . . . . 0.0 113.592 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 149.84 44.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 145.83 46.26 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.282 1.833 . . . . 0.0 111.542 168.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.01 173.72 48.97 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.624 1.107 . . . . 0.0 111.167 166.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -59.52 -35.12 73.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.0 -43.54 74.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.946 0.498 . . . . 0.0 111.523 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.45 71.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.483 0.713 . . . . 0.0 111.921 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.8 tp -63.39 -40.75 98.09 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.996 0.918 . . . . 0.0 111.39 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.14 -30.74 71.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.354 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -68.34 -42.15 79.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.127 1.331 . . . . 0.0 112.551 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -56.25 -41.73 76.22 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.776 0.716 . . . . 0.0 110.565 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.5 -39.33 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -70.16 -20.25 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 112.394 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -69.72 -11.13 60.61 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 125.83 1.652 . . . . 0.0 113.702 -169.018 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.5 p . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -133.39 161.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.916 1.686 . . . . 0.0 111.467 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -106.42 143.31 34.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 110.738 164.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.89 160.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.7 1.6 . . . . 0.0 111.625 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.6 p -136.24 170.01 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.663 1.985 . . . . 0.0 109.706 173.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.93 -27.49 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.76 -1.213 . . . . 0.0 113.912 173.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.04 -20.08 53.09 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.8 p -121.0 -16.02 8.14 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -53.4 -41.3 65.82 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 112.933 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.63 70.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.7 m -81.26 -31.66 33.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 112.194 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.56 -39.91 7.68 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.83 -54.3 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.309 1.044 . . . . 0.0 111.53 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.3 mt -77.57 -15.07 59.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.5 t -66.61 -37.87 85.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.905 0.882 . . . . 0.0 112.209 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.402 ' CB ' ' HA ' ' A' ' 25' ' ' ASN 0.299 3.5 t 52.89 -138.9 1.07 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.537 1.535 . . . . 0.0 111.249 168.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HA ' ' CB ' ' A' ' 24' ' ' SER . 51.1 p-10 -84.31 -8.31 59.05 Favored 'General case' 0 CA--C 1.548 0.903 3 C-N-CA 133.582 4.753 . . . . 0.0 113.999 -1.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.14 156.49 76.6 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.078 0.951 . . . . 0.0 110.995 170.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -57.5 146.03 85.74 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.877 1.718 . . . . 0.0 114.634 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.12 124.24 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.131 0.972 . . . . 0.0 109.719 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.53 130.43 44.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 108.837 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 131.51 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.788 0.835 . . . . 0.0 110.619 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -98.42 119.62 37.44 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.74 0.816 . . . . 0.0 111.384 167.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -90.41 112.09 23.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.399 172.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.54 174.4 13.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -160.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.96 47.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.839 1.256 . . . . 0.0 111.174 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.5 p -74.03 -27.51 60.98 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -84.23 -8.93 58.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.426 1.49 . . . . 0.0 113.894 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 t -80.41 122.09 26.54 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 111.97 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.49 -57.34 20.31 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.065 1.317 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.53 -22.65 44.4 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 120.238 2.019 . . . . 0.0 112.959 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -67.69 -42.4 82.1 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.235 -0.916 . . . . 0.0 111.331 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -66.67 -32.36 73.63 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.781 0.832 . . . . 0.0 112.562 170.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -64.24 -38.0 89.48 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.978 0.808 . . . . 0.0 112.987 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -83.93 -10.95 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 176.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.96 99.92 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 119.791 1.178 . . . . 0.0 113.717 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.11 -38.2 47.1 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.247 1.965 . . . . 0.0 112.461 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.7 t -64.91 -49.18 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.693 0.797 . . . . 0.0 111.258 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.83 -37.13 81.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.168 0.587 . . . . 0.0 112.124 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.11 -41.85 97.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.951 0.796 . . . . 0.0 112.203 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.74 -43.55 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.733 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mm -61.44 -40.87 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.654 1.115 . . . . 0.0 110.909 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.41 92.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 100.0 m -70.3 -38.16 74.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.404 0.682 . . . . 0.0 111.32 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.2 -32.33 26.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -172.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -122.94 27.41 7.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -172.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.58 10.47 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -75.59 -33.52 60.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.89 1.276 . . . . 0.0 113.486 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -90.51 -38.2 13.37 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.28 0.945 . . . . 0.0 112.888 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.07 167.93 22.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -172.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -114.18 145.21 41.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.98 1.712 . . . . 0.0 109.705 168.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.69 135.67 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.418 0.687 . . . . 0.0 110.595 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 165.5 24.67 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.535 1.934 . . . . 0.0 111.825 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -127.69 147.97 50.39 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.29 124.61 52.43 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.695 1.598 . . . . 0.0 109.205 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.08 97.91 11.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.131 . . . . 0.0 109.927 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.56 -20.95 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.292 -0.88 . . . . 0.0 112.455 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.29 -25.88 63.54 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.439 1.496 . . . . 0.0 113.292 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.7 p -125.57 -22.81 4.19 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -142.17 72.57 22.33 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 111.961 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.25 -0.95 9.39 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.605 2.87 . . . . 0.0 114.505 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -63.33 -40.35 97.08 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.742 -1.224 . . . . 0.0 113.269 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.46 -27.72 52.17 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.208 -0.932 . . . . 0.0 113.411 168.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.04 94.47 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 112.006 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -75.5 -27.44 58.79 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -61.32 -42.16 98.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.153 0.888 . . . . 0.0 112.076 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -96.6 14.68 23.98 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.218 1.407 . . . . 0.0 113.478 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 50.55 41.18 25.11 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.474 2.31 . . . . 0.0 114.025 173.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.73 121.8 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.639 1.175 . . . . 0.0 110.421 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -101.78 -27.63 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.838 1.255 . . . . 0.0 113.571 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.9 m -133.85 160.4 37.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.987 1.715 . . . . 0.0 111.41 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.3 pt -127.97 144.34 51.12 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 0.0 111.7 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.14 153.67 88.18 Favored 'Cis proline' 0 CA--C 1.537 0.659 0 CA-C-N 119.462 0.843 . . . . 0.0 111.773 -6.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.3 m -133.34 119.62 19.94 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.972 0.909 . . . . 0.0 109.27 168.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.0 mt -103.13 119.77 39.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 109.193 -174.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.35 135.09 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.615 1.166 . . . . 0.0 110.372 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 tp -118.73 123.72 45.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.114 0.965 . . . . 0.0 111.722 -170.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -104.55 152.44 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.305 1.842 . . . . 0.0 111.315 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -142.51 135.28 28.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.15 1.78 . . . . 0.0 109.754 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t70 52.01 31.6 8.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.667 1.187 . . . . 0.0 113.329 -168.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.46 7.41 60.71 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.06 1.791 . . . . 0.0 114.662 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -100.56 129.89 26.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 118.771 1.285 . . . . 0.0 110.096 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.95 135.93 33.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.352 2.034 . . . . 0.0 110.789 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.38 -44.88 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.953 0.901 . . . . 0.0 112.214 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -153.37 150.55 28.98 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.609 1.164 . . . . 0.0 113.087 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.81 127.87 46.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.512 2.325 . . . . 0.0 109.879 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.9 mm -122.59 126.06 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.807 1.243 . . . . 0.0 109.985 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.06 147.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.371 1.069 . . . . 0.0 111.345 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.04 173.44 49.66 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.42 1.009 . . . . 0.0 114.19 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.27 151.56 38.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -138.44 155.11 48.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.519 1.928 . . . . 0.0 111.731 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.38 167.5 27.53 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.642 1.115 . . . . 0.0 111.942 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -56.29 -37.48 69.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 112.789 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.96 78.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.23 0.612 . . . . 0.0 111.724 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.08 78.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.402 0.681 . . . . 0.0 111.957 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.1 tp -67.98 -39.99 83.2 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.417 -0.802 . . . . 0.0 111.875 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.47 -28.5 66.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.256 0.622 . . . . 0.0 112.264 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -61.95 -48.57 79.8 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.615 1.098 . . . . 0.0 110.875 167.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.45 -38.08 76.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.293 0.951 . . . . 0.0 111.875 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.0 mt -66.51 -43.47 85.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.6 m -70.0 -23.57 63.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.007 0.923 . . . . 0.0 112.458 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.9 -10.53 59.5 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.112 1.365 . . . . 0.0 112.667 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 126.117 1.767 . . . . 0.0 112.8 -176.464 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 pt -136.5 165.63 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.674 1.59 . . . . 0.0 111.189 171.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -126.23 138.84 53.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.011 1.324 . . . . 0.0 110.707 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.06 156.08 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.521 1.129 . . . . 0.0 112.918 -172.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.3 p -142.39 161.82 37.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.007 2.123 . . . . 0.0 110.107 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -55.1 -35.61 64.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -166.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.08 59.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.5 m -113.27 -21.59 10.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.504 1.522 . . . . 0.0 113.79 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -44.83 -41.98 7.51 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.888 2.475 . . . . 0.0 113.114 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.61 71.5 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.1 m -89.93 -25.96 20.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.856 1.262 . . . . 0.0 112.096 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -84.37 -50.01 8.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.931 0.892 . . . . 0.0 113.295 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.53 -33.65 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -77.73 -11.68 59.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 120.052 1.296 . . . . 0.0 113.585 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.0 m -88.96 -0.87 57.78 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -66.24 153.03 43.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.824 1.25 . . . . 0.0 113.653 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -121.53 28.02 7.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.37 1.468 . . . . 0.0 112.173 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.77 171.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 128.459 2.703 . . . . 0.0 109.823 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.76 139.51 80.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.853 1.702 . . . . 0.0 111.572 161.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.62 123.97 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.589 0.756 . . . . 0.0 111.928 170.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.49 125.5 31.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.313 1.445 . . . . 0.0 107.875 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -113.75 121.06 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 169.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -107.36 115.98 31.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.264 1.026 . . . . 0.0 111.634 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD2' HD12 ' A' ' 63' ' ' LEU . 8.5 m-85 -92.35 123.91 36.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.969 1.708 . . . . 0.0 109.288 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.476 ' CE2' ' HE2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -149.82 168.1 24.67 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -176.315 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.03 174.75 5.75 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.998 1.319 . . . . 0.0 111.951 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.6 p -71.66 -22.66 61.64 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -116.06 -12.75 11.26 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -163.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.94 130.15 38.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.17 -59.57 10.61 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.82 1.2 . . . . 0.0 114.179 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.75 -23.73 48.16 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.36 2.04 . . . . 0.0 113.301 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.3 p -77.76 -35.08 52.08 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.344 -0.848 . . . . 0.0 112.405 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -75.41 -27.88 59.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.934 -1.104 . . . . 0.0 112.359 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttt -58.91 -31.34 68.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.245 1.018 . . . . 0.0 113.262 171.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.62 -5.85 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.6 95.84 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-N 119.983 1.265 . . . . 0.0 114.39 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.01 -32.09 45.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.383 1.53 . . . . 0.0 112.589 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.52 -48.15 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.352 -0.843 . . . . 0.0 111.664 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.0 -37.38 84.09 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.977 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.01 -45.81 90.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.684 0.675 . . . . 0.0 111.97 172.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.51 -46.15 77.18 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.575 -0.703 . . . . 0.0 111.465 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.98 -42.79 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.025 1.284 . . . . 0.0 111.249 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -31.62 72.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.4 0.545 . . . . 0.0 112.359 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.4 m -78.6 -40.07 35.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.413 0.685 . . . . 0.0 111.745 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.84 -22.11 22.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -168.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -128.36 22.93 6.0 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.794 1.238 . . . . 0.0 113.877 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.37 -28.63 44.53 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.351 1.461 . . . . 0.0 114.682 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -80.17 -18.34 49.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.394 1.478 . . . . 0.0 113.643 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -101.7 -38.22 7.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.101 1.361 . . . . 0.0 112.88 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.58 177.76 9.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.264 1.426 . . . . 0.0 112.873 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.99 153.95 40.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.781 1.632 . . . . 0.0 109.326 167.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.08 136.14 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.605 0.762 . . . . 0.0 110.361 172.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.84 152.79 49.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.416 1.887 . . . . 0.0 112.092 -170.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.476 ' HE2' ' CE2' ' A' ' 33' ' ' TRP . 17.2 mmmt -115.98 135.26 54.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.935 1.294 . . . . 0.0 112.61 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.436 HD12 ' CD2' ' A' ' 32' ' ' PHE . 3.4 tm? -121.78 127.09 50.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.618 1.167 . . . . 0.0 110.484 167.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.37 104.29 16.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 110.054 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -69.88 -20.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.294 -0.879 . . . . 0.0 112.973 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.62 -33.39 47.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.468 1.107 . . . . 0.0 112.952 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -106.83 -22.47 12.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.539 1.136 . . . . 0.0 113.601 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -131.59 68.07 80.58 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.923 1.289 . . . . 0.0 111.743 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.52 -14.64 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.094 2.529 . . . . 0.0 113.058 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.31 -41.12 83.78 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.467 1.107 . . . . 0.0 112.605 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -75.63 -32.9 60.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.083 0.856 . . . . 0.0 111.71 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.66 92.04 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.149 -0.969 . . . . 0.0 111.81 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.98 -23.15 52.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 169.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.03 -47.72 85.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.799 0.84 . . . . 0.0 111.234 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.51 6.53 44.31 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 50.9 53.83 12.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 112.795 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -88.16 121.52 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.649 1.18 . . . . 0.0 109.443 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -110.71 -29.44 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.511 1.124 . . . . 0.0 112.701 -171.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -121.8 160.75 23.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.518 1.527 . . . . 0.0 111.686 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.68 147.02 64.36 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.679 1.192 . . . . 0.0 112.888 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.35 154.29 89.01 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.126 0.723 . . . . 0.0 111.829 -11.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.6 m -130.94 120.54 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.726 0.811 . . . . 0.0 109.638 168.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.49 122.82 37.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.85 126.83 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.316 1.047 . . . . 0.0 108.9 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.4 tp -112.12 128.3 56.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.623 1.569 . . . . 0.0 110.034 -166.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -108.24 157.35 18.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.686 1.594 . . . . 0.0 110.159 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.1 127.51 26.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.167 1.787 . . . . 0.0 108.528 167.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.01 40.36 28.15 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.763 0.792 . . . . 0.0 112.727 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.23 17.35 72.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.03 1.776 . . . . 0.0 115.409 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -124.08 133.04 24.37 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.71 1.204 . . . . 0.0 110.843 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.48 139.15 37.11 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.831 2.354 . . . . 0.0 112.073 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.5 -26.35 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.17 149.61 32.29 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.056 1.298 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -143.68 127.87 17.66 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.702 1.201 . . . . 0.0 111.098 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mm -132.09 137.59 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.392 1.077 . . . . 0.0 110.618 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.93 157.51 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.079 1.352 . . . . 0.0 112.401 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 173.81 36.35 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.745 1.164 . . . . 0.0 113.913 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 156.63 34.04 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.53 152.41 50.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.351 1.86 . . . . 0.0 111.732 171.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 166.92 44.71 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 159.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -57.25 -34.43 68.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.41 82.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.582 0.753 . . . . 0.0 112.372 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.29 -39.83 65.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.91 -48.11 80.39 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.079 -0.388 . . . . 0.0 110.203 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.477 -0.764 . . . . 0.0 112.37 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -69.24 -43.17 74.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.078 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.98 -27.3 65.58 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.253 1.388 . . . . 0.0 112.505 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.27 -41.36 81.19 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.453 0.701 . . . . 0.0 111.871 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -65.71 -25.74 67.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.545 1.138 . . . . 0.0 111.705 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.97 1.09 6.07 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 170.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.475 0.786 0 C-N-CA 126.777 2.031 . . . . 0.0 111.714 178.581 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.1 p . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.1 165.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.019 1.728 . . . . 0.0 111.695 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -109.89 143.23 40.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.176 1.79 . . . . 0.0 110.376 170.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.73 156.21 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.801 1.241 . . . . 0.0 111.697 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.1 p -114.7 168.81 9.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.15 2.18 . . . . 0.0 110.532 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.85 -27.84 67.0 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.819 -1.176 . . . . 0.0 113.221 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.34 -47.3 14.69 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.193 0.997 . . . . 0.0 112.894 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 p -77.79 -26.56 49.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -49.76 -39.89 39.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.2 1.8 . . . . 0.0 112.605 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.16 70.51 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -95.33 -20.66 18.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.694 1.198 . . . . 0.0 112.531 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -91.39 -58.29 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.417 1.087 . . . . 0.0 112.347 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -88.09 -51.88 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.213 1.405 . . . . 0.0 111.349 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.15 -15.01 62.47 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -77.43 -18.05 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 m -85.89 118.72 25.55 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -166.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 p-10 -75.42 -24.51 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.718 1.207 . . . . 0.0 112.113 160.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -65.26 146.35 98.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 127.17 2.188 . . . . 0.0 110.087 167.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.02 140.12 82.67 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.062 1.841 . . . . 0.0 111.4 170.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.62 130.97 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.984 0.914 . . . . 0.0 110.554 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.6 mp -104.5 124.66 49.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 108.769 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -120.1 117.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 110.311 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -98.45 117.58 33.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.606 0.763 . . . . 0.0 112.638 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.19 112.68 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.854 1.661 . . . . 0.0 108.442 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.26 170.28 19.88 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -164.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.69 155.78 48.74 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.989 1.316 . . . . 0.0 111.881 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -78.61 -19.52 52.52 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -86.05 -5.45 59.21 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.707 1.203 . . . . 0.0 113.822 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.48 120.11 31.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.184 1.394 . . . . 0.0 112.215 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -55.17 31.64 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.018 1.294 . . . . 0.0 114.726 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.03 -23.93 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 120.201 2.0 . . . . 0.0 112.638 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.3 m -67.16 -39.19 86.45 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.065 -1.022 . . . . 0.0 111.588 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.9 -31.89 71.99 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.438 -0.789 . . . . 0.0 112.711 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -65.34 -34.7 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.0 -12.15 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.341 0.973 . . . . 0.0 113.589 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.76 -49.14 85.03 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -29.27 49.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.763 1.642 . . . . 0.0 112.718 173.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.5 -48.06 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.147 -0.97 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.6 -36.79 79.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.297 0.639 . . . . 0.0 112.021 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.33 -46.91 87.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.777 0.717 . . . . 0.0 111.424 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -69.05 -47.77 64.51 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.715 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.2 mm -59.44 -40.8 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 121.061 1.755 . . . . 0.0 110.95 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.54 90.41 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.093 0.86 . . . . 0.0 112.546 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.1 m -77.09 -36.12 55.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.651 0.78 . . . . 0.0 111.325 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -92.64 -34.66 13.89 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -116.82 13.74 15.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.932 1.293 . . . . 0.0 113.583 -163.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.14 -31.03 29.26 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -69.72 -29.94 67.44 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.27 -0.894 . . . . 0.0 112.671 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -90.53 -41.12 11.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.772 1.229 . . . . 0.0 112.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.3 162.52 41.03 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.0 m -106.48 136.36 46.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.734 1.214 . . . . 0.0 110.482 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 t -110.91 122.15 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.083 0.953 . . . . 0.0 110.47 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.5 164.38 18.2 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.637 1.975 . . . . 0.0 111.739 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -129.75 143.52 50.86 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.42 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -126.43 120.91 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.362 1.465 . . . . 0.0 109.721 170.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -96.29 85.22 3.91 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.228 1.811 . . . . 0.0 111.153 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -60.81 -22.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -166.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.04 -28.32 61.36 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.217 1.407 . . . . 0.0 113.459 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -127.17 -9.88 5.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.949 1.7 . . . . 0.0 114.585 -171.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -142.51 59.51 8.74 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.897 2.079 . . . . 0.0 110.318 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.85 -6.17 14.13 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.534 2.822 . . . . 0.0 114.565 -167.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.2 -39.18 92.49 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.119 -0.988 . . . . 0.0 112.374 -174.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -30.4 54.77 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.391 -0.818 . . . . 0.0 112.065 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.34 99.04 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.313 -0.867 . . . . 0.0 111.65 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -74.16 -23.25 59.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -61.75 -44.03 97.7 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.882 0.873 . . . . 0.0 111.282 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.55 5.57 50.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.142 1.377 . . . . 0.0 114.162 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 50.51 41.23 24.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.408 1.883 . . . . 0.0 113.666 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.59 128.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.94 1.296 . . . . 0.0 110.128 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.94 -45.66 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.869 1.268 . . . . 0.0 111.348 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 p -86.26 152.4 22.81 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.717 1.207 . . . . 0.0 111.674 170.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 pt -145.43 155.54 53.62 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.834 1.654 . . . . 0.0 111.098 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.35 138.67 57.02 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 119.795 0.963 . . . . 0.0 111.6 -4.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 m -125.29 108.08 11.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.624 0.77 . . . . 0.0 109.9 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.29 126.1 43.65 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.754 1.222 . . . . 0.0 110.136 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 tt -120.9 132.85 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 122.199 1.0 . . . . 0.0 110.634 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.89 130.67 44.15 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 109.565 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -120.07 148.5 43.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.287 1.835 . . . . 0.0 111.319 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -144.81 135.13 24.24 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.971 1.708 . . . . 0.0 109.701 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 t70 51.34 33.68 10.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.63 19.92 71.53 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.335 1.445 . . . . 0.0 115.401 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -126.15 150.25 69.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 118.8 1.3 . . . . 0.0 112.104 169.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.37 145.93 44.01 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.905 2.403 . . . . 0.0 112.399 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.45 -46.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.97 1.308 . . . . 0.0 111.678 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -159.54 146.38 16.62 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.887 1.275 . . . . 0.0 111.94 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -129.0 137.21 51.21 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.159 1.384 . . . . 0.0 112.156 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.8 116.55 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.234 1.814 . . . . 0.0 110.224 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -100.17 159.4 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.054 1.742 . . . . 0.0 112.407 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.1 -171.69 50.67 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.067 0.841 . . . . 0.0 111.958 -174.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.18 147.02 45.14 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.153 -1.204 . . . . 0.0 112.93 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.69 153.15 47.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.077 1.751 . . . . 0.0 111.707 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.37 163.9 24.23 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.565 1.079 . . . . 0.0 112.092 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -59.88 -33.97 72.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.244 1.018 . . . . 0.0 113.53 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.37 80.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.968 0.507 . . . . 0.0 111.522 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.72 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.311 0.645 . . . . 0.0 111.214 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.2 tp -62.53 -40.32 96.41 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.219 -0.926 . . . . 0.0 112.344 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.4 tp -70.17 -30.81 68.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.844 0.858 . . . . 0.0 112.686 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -62.6 -44.93 95.06 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.729 1.149 . . . . 0.0 111.413 167.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.1 -36.03 80.47 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.32 0.964 . . . . 0.0 111.789 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.58 -39.2 81.07 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -65.34 -26.06 67.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.468 1.107 . . . . 0.0 112.211 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -75.95 -5.08 44.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.9 1.28 . . . . 0.0 114.089 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 125.055 1.342 . . . . 0.0 111.755 172.705 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.2 pt -117.93 157.47 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.466 1.506 . . . . 0.0 111.192 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -109.25 137.59 46.89 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.886 1.674 . . . . 0.0 110.007 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.35 156.34 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.821 1.248 . . . . 0.0 112.475 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.2 p -143.29 161.55 38.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.548 1.939 . . . . 0.0 110.793 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.83 -35.62 61.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -168.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.95 -18.87 60.32 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 m -119.26 -11.6 9.54 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.703 1.601 . . . . 0.0 113.646 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -51.9 -40.09 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 113.08 -175.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.5 72.04 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -83.2 -32.25 26.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.158 0.983 . . . . 0.0 111.953 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.56 -37.81 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.42 -54.48 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.155 1.382 . . . . 0.0 110.986 -174.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.95 -12.03 59.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 m -78.74 -11.5 59.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.5 m -80.73 121.31 25.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.273 1.429 . . . . 0.0 112.641 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.35 -26.98 60.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.006 0.523 . . . . 0.0 111.857 164.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -69.75 153.54 95.49 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.253 1.021 . . . . 0.0 110.701 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.06 145.75 85.69 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.755 1.637 . . . . 0.0 111.675 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.0 132.3 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.145 . . . . 0.0 111.915 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.5 134.22 35.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.769 1.628 . . . . 0.0 109.169 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.27 129.8 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.316 0.647 . . . . 0.0 110.457 167.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -103.52 136.73 42.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.406 1.482 . . . . 0.0 113.076 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.26 120.17 39.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.126 1.37 . . . . 0.0 111.097 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -75.03 168.1 20.64 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.261 1.024 . . . . 0.0 113.344 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.69 144.79 32.86 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.244 142.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.9 p -67.94 -31.42 71.16 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -165.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -96.33 -8.28 33.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.644 1.978 . . . . 0.0 113.777 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.5 t -82.41 110.44 17.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.52 1.128 . . . . 0.0 113.24 -160.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.57 -57.07 12.87 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.277 1.418 . . . . 0.0 114.364 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.17 -24.42 65.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 120.481 2.14 . . . . 0.0 113.349 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.84 -42.03 82.05 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.213 0.915 . . . . 0.0 111.217 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -66.3 -32.23 73.51 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.463 -0.773 . . . . 0.0 112.462 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.55 -31.93 71.49 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.65 -14.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.781 1.173 . . . . 0.0 113.691 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.37 46.1 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.21 -32.0 52.72 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.674 1.583 . . . . 0.0 112.327 176.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.43 -51.22 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.352 0.978 . . . . 0.0 111.734 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.06 -35.28 74.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 111.298 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -71.43 -34.9 70.69 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -66.18 -47.6 73.45 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.806 -1.184 . . . . 0.0 111.222 171.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.38 -40.75 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.609 1.549 . . . . 0.0 111.08 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.19 -38.02 85.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.9 0.773 . . . . 0.0 112.581 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -77.19 -34.92 56.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.663 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -88.52 -39.58 14.07 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -113.64 17.25 18.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.231 1.412 . . . . 0.0 113.457 -162.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.89 34.62 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.328 1.451 . . . . 0.0 114.626 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -78.23 -18.52 55.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.216 1.407 . . . . 0.0 113.825 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -98.18 -41.41 7.91 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.838 1.255 . . . . 0.0 112.48 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.32 164.08 35.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.598 1.159 . . . . 0.0 113.3 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.6 m -107.15 144.45 33.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.883 1.273 . . . . 0.0 110.359 171.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -118.84 128.76 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.422 0.689 . . . . 0.0 110.286 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.49 162.31 23.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.644 1.978 . . . . 0.0 111.429 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -136.28 144.75 44.92 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.91 122.69 46.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.765 1.626 . . . . 0.0 110.448 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -87.15 84.08 7.33 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.823 1.249 . . . . 0.0 110.797 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 p -62.92 -24.06 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.66 -26.57 61.69 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.08 0.952 . . . . 0.0 113.383 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.1 p -110.06 -22.66 11.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.416 1.086 . . . . 0.0 113.479 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.03 77.39 26.0 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.464 1.506 . . . . 0.0 111.548 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.67 -15.21 37.3 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.718 2.278 . . . . 0.0 112.851 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.81 -38.24 75.21 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.666 1.187 . . . . 0.0 112.966 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -34.0 68.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.119 0.872 . . . . 0.0 112.331 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.0 73.41 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.906 -1.122 . . . . 0.0 111.454 173.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -74.99 -39.52 61.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.284 1.033 . . . . 0.0 111.768 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.84 -45.41 67.34 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.993 1.317 . . . . 0.0 111.622 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -98.18 15.72 23.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.305 1.442 . . . . 0.0 114.512 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.272 7.6 pt20 47.46 42.53 14.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.773 2.029 . . . . 0.0 115.13 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.95 126.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.454 1.502 . . . . 0.0 110.429 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.1 m -130.91 -9.84 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.431 1.492 . . . . 0.0 113.799 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 151.19 41.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.37 1.868 . . . . 0.0 110.197 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.23 141.48 29.54 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.879 0.872 . . . . 0.0 112.579 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.17 154.49 88.45 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.261 0.772 . . . . 0.0 111.951 -7.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -132.55 135.56 46.02 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.831 1.252 . . . . 0.0 108.73 171.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 142.83 46.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.318 1.047 . . . . 0.0 110.386 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.5 tp -122.34 137.6 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.827 1.651 . . . . 0.0 109.117 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.8 tp -108.8 125.57 52.1 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.612 1.565 . . . . 0.0 109.694 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -116.08 155.6 27.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.574 1.149 . . . . 0.0 111.391 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.54 136.12 27.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.66 1.584 . . . . 0.0 109.646 164.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.78 32.2 14.44 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.11 1.364 . . . . 0.0 114.256 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.59 17.31 80.18 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.853 1.216 . . . . 0.0 115.63 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -126.09 143.62 46.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 118.776 1.288 . . . . 0.0 111.503 172.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 144.09 42.13 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.893 2.395 . . . . 0.0 111.628 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.34 -45.18 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.12 1.368 . . . . 0.0 111.388 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -158.37 146.15 18.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.443 1.097 . . . . 0.0 111.529 -163.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.34 142.14 51.67 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.38 1.472 . . . . 0.0 110.826 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 132.4 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.998 1.719 . . . . 0.0 110.098 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.81 143.89 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.403 1.481 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.29 176.02 46.07 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.708 0.671 . . . . 0.0 112.719 -168.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.23 152.06 44.65 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -128.33 149.17 50.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.097 2.159 . . . . 0.0 109.851 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.24 166.42 32.1 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 161.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.53 -38.99 75.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.073 0.949 . . . . 0.0 113.183 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.42 77.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.404 0.681 . . . . 0.0 111.593 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -45.56 64.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 111.82 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.349 0.977 . . . . 0.0 111.355 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.54 -37.58 87.84 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.762 -0.586 . . . . 0.0 111.926 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -61.76 -43.03 99.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.771 -1.206 . . . . 0.0 112.29 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.88 -31.96 73.32 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.937 0.789 . . . . 0.0 112.372 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.7 -40.27 76.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.668 0.387 . . . . 0.0 111.815 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.5 m -64.78 -25.48 67.94 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.234 -0.916 . . . . 0.0 112.695 170.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.56 -10.78 57.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.168 1.387 . . . . 0.0 114.41 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.131 1.373 . . . . 0.0 114.162 -173.366 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.76 164.08 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.711 1.204 . . . . 0.0 112.7 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -109.46 142.73 40.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.882 1.673 . . . . 0.0 110.141 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.81 154.01 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.439 1.096 . . . . 0.0 112.638 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.2 p -145.45 160.93 40.84 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.973 2.109 . . . . 0.0 110.159 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.81 -34.53 40.55 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -171.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.99 -20.48 62.41 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -120.88 -14.2 8.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.59 1.556 . . . . 0.0 113.693 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -51.17 -41.65 60.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.397 1.879 . . . . 0.0 113.34 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.25 71.72 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.5 m -82.19 -33.71 29.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.593 0.757 . . . . 0.0 111.793 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.08 -43.25 19.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.97 -54.42 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 111.194 -173.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.06 -17.07 53.67 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.6 m -101.45 7.27 42.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.843 1.257 . . . . 0.0 113.119 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -66.01 144.63 56.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.979 0.912 . . . . 0.0 112.994 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.23 1.68 43.47 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.988 1.315 . . . . 0.0 113.213 174.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -142.73 166.69 19.27 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 126.825 2.05 . . . . 0.0 111.651 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.45 147.12 6.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.024 3.149 . . . . 0.0 114.822 163.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.1 130.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.477 1.111 . . . . 0.0 110.789 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.4 129.04 39.68 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.909 1.284 . . . . 0.0 107.931 169.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.2 t -112.37 123.89 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.445 1.021 . . . . 0.0 109.801 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -113.08 121.9 45.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.403 1.081 . . . . 0.0 112.458 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -93.69 120.11 33.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.354 1.862 . . . . 0.0 110.598 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.72 171.17 16.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.97 176.92 4.9 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.86 1.664 . . . . 0.0 111.541 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -71.43 -29.58 65.05 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.841 -1.162 . . . . 0.0 113.118 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -100.23 -14.86 18.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -163.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -76.47 127.67 33.29 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -163.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.23 -63.54 5.22 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.739 1.162 . . . . 0.0 113.948 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.0 -24.42 60.17 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.43 2.086 . . . . 0.0 113.149 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -74.89 -36.33 62.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.93 0.786 . . . . 0.0 111.789 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -75.48 -28.01 59.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.987 -1.071 . . . . 0.0 112.629 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.3 mmm -63.93 -29.71 70.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.1 m -83.48 -8.57 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 119.664 1.12 . . . . 0.0 113.928 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.4 -50.69 83.66 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 120.708 1.595 . . . . 0.0 113.905 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.24 -37.05 33.39 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.538 1.492 . . . . 0.0 112.359 174.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.3 t -62.91 -49.23 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.374 1.069 . . . . 0.0 111.694 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 pp -70.36 -39.87 74.36 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.614 1.166 . . . . 0.0 110.858 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -62.03 -44.16 97.3 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.75 0.705 . . . . 0.0 111.962 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -64.61 -54.29 34.28 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.449 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -65.48 -33.9 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.742 1.155 . . . . 0.0 111.502 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.17 89.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.482 1.037 . . . . 0.0 111.364 172.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 m -82.38 -30.82 30.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.415 0.686 . . . . 0.0 112.74 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -80.1 -28.32 39.06 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.044 -1.035 . . . . 0.0 113.203 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -120.27 29.42 7.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.798 1.639 . . . . 0.0 112.621 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -25.84 33.29 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.842 1.257 . . . . 0.0 114.293 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -80.71 -18.5 47.65 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.433 1.493 . . . . 0.0 113.884 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -103.5 -36.49 7.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.404 1.482 . . . . 0.0 112.945 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 160.28 43.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.8 m -111.03 139.62 46.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.297 1.439 . . . . 0.0 109.872 166.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.03 127.93 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.57 0.7 . . . . 0.0 110.153 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.68 145.55 42.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.541 2.337 . . . . 0.0 110.608 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.5 137.94 54.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.5 129.23 54.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.798 1.639 . . . . 0.0 109.637 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -99.35 105.65 17.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.392 1.077 . . . . 0.0 109.433 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.97 -22.1 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -164.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.52 -29.91 41.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.551 1.141 . . . . 0.0 113.233 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.1 p -106.08 -19.18 13.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.451 1.1 . . . . 0.0 113.81 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -133.03 78.68 64.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.687 0.795 . . . . 0.0 112.068 164.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.25 -22.57 75.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.125 2.55 . . . . 0.0 114.11 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.834 0.854 . . . . 0.0 113.096 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -76.93 -30.49 56.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.137 0.88 . . . . 0.0 111.679 172.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.58 98.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.969 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -76.68 -24.47 53.19 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -56.8 -40.01 75.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.37 0.986 . . . . 0.0 112.125 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.65 13.65 26.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 113.807 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 51.45 53.25 13.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.591 1.956 . . . . 0.0 114.141 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.54 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.219 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.55 -61.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.353 1.061 . . . . 0.0 109.788 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.8 m -86.86 151.33 23.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.237 1.015 . . . . 0.0 110.621 166.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.5 133.62 25.29 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.364 1.065 . . . . 0.0 109.515 -171.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.74 159.94 96.57 Favored 'Cis proline' 0 C--N 1.351 0.676 0 CA-C-N 120.365 1.166 . . . . 0.0 113.246 -0.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -126.98 136.11 51.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.426 1.09 . . . . 0.0 109.197 163.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.26 141.87 44.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 109.128 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.72 129.38 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.901 0.88 . . . . 0.0 108.954 166.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.44 125.21 52.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.892 1.277 . . . . 0.0 110.821 -173.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -104.83 148.45 26.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.249 1.819 . . . . 0.0 111.196 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -112.71 116.92 30.89 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.859 1.664 . . . . 0.0 108.264 164.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 51.16 37.37 18.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.644 1.178 . . . . 0.0 113.934 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 9.83 85.68 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.19 1.376 . . . . 0.0 115.944 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -113.93 131.39 23.16 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 119.27 1.535 . . . . 0.0 110.665 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.75 139.93 37.86 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.79 2.327 . . . . 0.0 112.526 -173.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.61 -48.66 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.966 1.306 . . . . 0.0 112.02 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -157.6 158.5 35.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.312 1.045 . . . . 0.0 113.436 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -118.51 140.36 50.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.021 1.728 . . . . 0.0 110.532 168.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.6 139.09 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.772 1.629 . . . . 0.0 109.522 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.48 142.89 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.657 1.183 . . . . 0.0 111.059 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.82 175.86 51.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.213 0.911 . . . . 0.0 113.228 -170.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 156.68 38.38 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -118.16 158.02 25.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.131 2.172 . . . . 0.0 110.086 172.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.5 166.65 25.48 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 155.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -51.17 -45.68 61.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.972 0.886 . . . . 0.0 112.169 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.67 84.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.298 1.039 . . . . 0.0 112.651 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.2 -42.92 62.14 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 111.864 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -63.32 -40.13 96.47 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.366 -0.834 . . . . 0.0 111.364 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.02 -30.87 71.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.695 1.198 . . . . 0.0 112.854 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -64.7 -42.64 95.15 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.342 0.974 . . . . 0.0 111.47 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.44 -39.2 92.56 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.537 1.062 . . . . 0.0 111.776 173.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.3 -40.73 96.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.167 0.587 . . . . 0.0 112.104 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -65.92 -28.3 68.83 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.336 -0.852 . . . . 0.0 111.899 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.6 -18.79 50.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 113.339 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.477 0.905 0 C-N-CA 125.491 1.516 . . . . 0.0 112.228 170.036 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 57.5 p -144.53 -166.85 2.49 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.821 2.048 . . . . 0.0 110.403 -173.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -71.68 -27.24 62.91 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 120.305 -1.497 . . . . 0.0 113.267 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.8 p -91.93 -41.39 10.61 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.517 1.127 . . . . 0.0 112.316 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.62 63.54 7.61 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.803 1.641 . . . . 0.0 109.008 167.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -50.65 128.73 21.22 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.001 1.72 . . . . 0.0 113.24 -164.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.0 m -61.04 145.09 52.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.995 1.318 . . . . 0.0 113.221 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 152.56 40.29 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.065 0.946 . . . . 0.0 113.249 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -95.06 159.29 15.09 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 129.532 3.133 . . . . 0.0 112.68 -4.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 pt -79.22 166.97 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.284 0.634 . . . . 0.0 111.268 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -126.5 141.68 51.79 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.157 1.783 . . . . 0.0 109.516 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.42 155.36 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.785 1.234 . . . . 0.0 111.954 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.3 p -137.85 159.91 40.72 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.064 1.746 . . . . 0.0 111.206 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.69 -28.25 68.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -169.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.02 -17.69 54.9 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.5 m -122.18 -17.77 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.169 1.388 . . . . 0.0 114.368 -170.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -50.85 -41.43 57.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.979 1.712 . . . . 0.0 112.957 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 -31.43 71.96 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.6 m -80.74 -35.02 33.95 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 111.627 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -80.95 -45.6 16.43 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.74 -54.44 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.02 1.328 . . . . 0.0 111.173 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -80.92 -13.35 58.98 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -168.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 t -95.72 -6.35 40.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.569 1.148 . . . . 0.0 112.979 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.7 t -69.32 144.33 53.55 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.163 -0.96 . . . . 0.0 112.814 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -82.62 -5.42 58.8 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.939 1.296 . . . . 0.0 113.429 172.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -102.87 169.33 7.61 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 126.132 1.773 . . . . 0.0 112.367 -164.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -62.04 125.62 16.88 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.152 1.235 . . . . 0.0 109.147 147.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.2 t -124.99 116.25 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.915 1.286 . . . . 0.0 109.938 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 tt -94.02 125.59 38.73 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.743 1.617 . . . . 0.0 108.39 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.7 t -119.85 128.27 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 121.441 -0.787 . . . . 0.0 110.582 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -106.04 113.08 26.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.218 1.007 . . . . 0.0 111.773 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -89.91 111.39 22.44 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.616 1.567 . . . . 0.0 108.913 172.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.8 172.8 15.04 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -163.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -126.82 142.74 51.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.387 1.075 . . . . 0.0 110.286 165.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.3 p -70.39 -17.55 63.03 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -91.01 -11.86 37.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.535 1.534 . . . . 0.0 114.131 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 130.95 37.68 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.967 0.907 . . . . 0.0 111.873 -172.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.51 -60.27 9.12 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.691 1.139 . . . . 0.0 114.732 -175.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.97 -19.21 52.22 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.291 1.994 . . . . 0.0 113.236 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.4 m -71.18 -46.54 61.13 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.97 0.908 . . . . 0.0 111.059 172.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -63.99 -32.32 73.83 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.196 -0.94 . . . . 0.0 112.143 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.0 ttt -61.23 -34.97 75.99 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.671 0.788 . . . . 0.0 113.067 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.414 ' CG1' ' H ' ' A' ' 99' ' ' LYS . 27.6 m -88.56 -11.64 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 176.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.11 -50.93 72.47 Favored Pre-proline 0 CA--C 1.555 1.136 0 CA-C-N 120.116 1.326 . . . . 0.0 114.385 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.92 -34.3 30.25 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.499 1.466 . . . . 0.0 112.222 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 73.2 t -67.47 -49.27 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 121.256 -0.902 . . . . 0.0 111.303 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.84 -42.24 95.09 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.448 0.699 . . . . 0.0 111.054 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.77 -45.48 92.14 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.596 0.634 . . . . 0.0 111.876 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.71 -49.45 53.19 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.461 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.1 mm -60.49 -42.46 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 119.761 1.164 . . . . 0.0 110.564 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.24 -31.33 68.69 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.2 m -74.09 -37.42 64.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.86 0.464 . . . . 0.0 110.334 174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -83.76 -35.14 24.58 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -172.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.0 mmm-85 -116.2 24.47 11.38 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.63 1.572 . . . . 0.0 113.537 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.43 -26.23 29.57 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.3 p -80.17 -18.16 50.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.446 1.499 . . . . 0.0 113.999 175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -100.14 -40.94 7.34 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.264 1.425 . . . . 0.0 112.551 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.07 159.92 44.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.539 1.136 . . . . 0.0 113.49 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 98.0 m -107.21 141.49 38.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.117 1.367 . . . . 0.0 110.233 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.0 t -117.87 133.75 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.173 0.589 . . . . 0.0 110.479 169.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.05 162.6 26.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.837 2.055 . . . . 0.0 111.235 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.0 pttm -133.07 142.89 48.99 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -116.98 123.72 47.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.7 2.0 . . . . 0.0 109.083 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -92.44 91.59 7.71 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 110.378 -172.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 m -66.25 -19.98 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.301 -0.874 . . . . 0.0 112.92 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.69 -26.34 68.33 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.815 1.646 . . . . 0.0 113.424 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -122.11 -22.93 5.49 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.619 1.168 . . . . 0.0 113.579 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -120.55 88.61 43.24 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.323 1.449 . . . . 0.0 111.227 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.2 -13.56 18.95 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.836 2.357 . . . . 0.0 113.081 172.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -77.06 -39.98 47.88 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.839 -1.163 . . . . 0.0 112.2 -169.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -27.5 55.51 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 121.663 -0.648 . . . . 0.0 111.822 168.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.53 96.92 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.251 -0.905 . . . . 0.0 112.255 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ptt-85 -72.24 -26.71 62.11 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.262 -0.899 . . . . 0.0 113.059 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -59.76 -40.79 89.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.118 0.967 . . . . 0.0 112.476 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -107.52 14.69 25.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.567 1.547 . . . . 0.0 113.819 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 53.26 57.11 6.57 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.316 1.846 . . . . 0.0 113.611 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.55 134.72 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 121.162 -0.961 . . . . 0.0 109.144 168.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.86 -40.44 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.568 1.147 . . . . 0.0 111.944 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.2 m -122.1 157.09 32.22 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.642 1.577 . . . . 0.0 110.215 163.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.2 pt -126.58 149.92 69.38 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.987 1.315 . . . . 0.0 111.782 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -72.33 140.26 65.18 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 CA-C-N 119.106 0.716 . . . . 0.0 112.391 -2.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -102.15 114.84 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.686 1.195 . . . . 0.0 107.931 168.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -104.73 127.96 52.68 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.147 0.979 . . . . 0.0 109.196 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.1 127.52 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 123.831 0.853 . . . . 0.0 109.705 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.9 tp -104.85 120.63 41.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.597 1.159 . . . . 0.0 110.751 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -98.27 157.35 16.23 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.084 1.753 . . . . 0.0 110.616 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -135.38 128.81 32.33 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.905 1.682 . . . . 0.0 109.109 165.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.0 t70 53.88 32.73 15.71 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.163 0.985 . . . . 0.0 113.248 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.72 9.46 84.91 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.467 1.508 . . . . 0.0 115.563 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -112.58 134.98 21.51 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-N 118.952 1.376 . . . . 0.0 110.888 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.01 140.18 41.14 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.881 2.388 . . . . 0.0 112.27 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.64 -46.41 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.73 1.212 . . . . 0.0 111.848 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -158.91 153.19 23.91 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.555 1.142 . . . . 0.0 113.302 -175.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -128.62 139.03 52.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.488 1.915 . . . . 0.0 111.031 173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 32.5 mm -129.69 147.3 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.092 1.757 . . . . 0.0 109.426 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.5 t -122.9 136.66 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.206 1.002 . . . . 0.0 110.139 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 98.67 171.15 31.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.1 1.333 . . . . 0.0 113.174 -168.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.9 156.98 35.99 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -171.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' H ' ' CG1' ' A' ' 43' ' ' VAL . 3.5 mptp? -124.44 161.79 25.28 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.529 2.332 . . . . 0.0 111.842 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.51 161.8 13.18 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.8 1.19 . . . . 0.0 110.76 156.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -52.72 -39.78 62.39 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.331 1.052 . . . . 0.0 112.95 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.11 -44.67 79.36 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.461 0.705 . . . . 0.0 112.029 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.51 -43.61 72.72 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.362 0.665 . . . . 0.0 111.991 178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.8 tp -61.31 -47.99 83.4 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.928 0.891 . . . . 0.0 111.07 177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.5 tp -70.46 -31.5 68.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.555 -0.736 . . . . 0.0 112.626 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.7 ttp-105 -67.55 -46.26 73.26 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.422 1.465 . . . . 0.0 111.975 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -70.02 -21.5 63.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 175.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.09 -40.07 68.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.392 1.077 . . . . 0.0 112.96 163.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.7 m -66.28 -22.03 66.29 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.021 1.328 . . . . 0.0 112.198 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.33 -20.74 66.53 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.56 -33.01 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.101 1.76 . . . . 0.0 112.157 -170.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.5 m -136.95 147.98 61.18 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 125.176 1.39 . . . . 0.0 112.198 169.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.26 135.26 69.2 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.124 2.549 . . . . 0.0 113.954 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -161.65 -57.17 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.936 1.295 . . . . 0.0 112.268 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.2 mt -86.55 51.8 2.33 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.284 1.434 . . . . 0.0 111.863 -175.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.225 0 C-N-CA 126.061 1.745 . . . . 0.0 112.518 -170.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.535 0.207 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.3 p -102.08 -10.49 19.64 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.076 1.35 . . . . 0.0 113.708 175.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -95.88 124.36 39.86 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.493 1.517 . . . . 0.0 111.794 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 64.2 p -99.5 5.39 46.15 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.082 1.753 . . . . 0.0 114.589 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -94.48 -44.88 7.67 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.643 1.577 . . . . 0.0 110.966 171.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -87.41 -16.76 33.98 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.24 1.816 . . . . 0.0 113.128 -173.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.3 t -126.76 133.83 50.75 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.678 1.991 . . . . 0.0 109.289 164.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.51 64.16 7.74 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.0 p -110.48 139.78 45.38 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.862 1.265 . . . . 0.0 112.601 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.3 pt -140.7 165.93 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.995 1.718 . . . . 0.0 111.115 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 143.44 50.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.91 1.284 . . . . 0.0 111.991 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.7 m -131.74 156.39 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.839 1.255 . . . . 0.0 112.939 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.6 p -137.24 168.32 19.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.933 2.493 . . . . 0.0 109.762 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.91 -27.91 65.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -172.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.89 -18.12 38.5 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.3 p -110.5 -25.11 10.2 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.729 1.611 . . . . 0.0 113.995 -176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -48.86 -41.54 33.52 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.581 1.952 . . . . 0.0 112.579 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.55 -31.75 72.66 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.3 m -84.73 -33.04 23.18 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.28 -0.888 . . . . 0.0 111.947 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -84.77 -40.3 17.41 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 20.5 t -98.94 -52.71 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.38 1.472 . . . . 0.0 111.347 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.3 mt -83.12 -18.31 39.98 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.5 m -104.77 20.69 18.25 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.703 1.601 . . . . 0.0 113.538 170.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.9 p -58.74 -38.45 78.42 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -173.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.1 t30 50.22 25.72 1.91 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.116 1.367 . . . . 0.0 113.633 -163.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -148.46 165.97 16.77 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 125.49 1.516 . . . . 0.0 112.31 168.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -45.24 133.61 11.86 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.72 2.28 . . . . 0.0 112.692 154.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -142.84 124.17 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.779 0.832 . . . . 0.0 111.215 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.7 tp -90.57 133.06 35.36 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.379 1.472 . . . . 0.0 107.558 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -123.92 126.6 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 119.819 1.19 . . . . 0.0 109.871 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -108.47 120.68 43.13 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.649 1.18 . . . . 0.0 111.704 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -98.55 112.71 24.66 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 127.021 2.128 . . . . 0.0 108.537 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.57 -179.0 7.03 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.13 137.33 52.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.848 0.459 . . . . 0.0 109.958 156.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 41.0 p -61.94 -23.21 66.23 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -170.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -85.78 -12.23 51.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.303 1.441 . . . . 0.0 114.47 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.06 143.9 38.95 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.285 0.948 . . . . 0.0 112.924 -170.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.11 -63.72 5.06 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 124.452 1.025 . . . . 0.0 114.27 -175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.91 -24.55 67.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 121.963 1.775 . . . . 0.0 112.625 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 45.6 m -62.92 -47.87 81.39 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.045 0.938 . . . . 0.0 110.953 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -64.3 -32.85 74.61 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.072 0.949 . . . . 0.0 112.792 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 99.1 mmm -67.95 -32.75 73.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 p -91.17 -13.54 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 119.436 1.016 . . . . 0.0 113.608 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.99 -50.4 62.9 Favored Pre-proline 0 CA--C 1.555 1.171 0 N-CA-C 114.808 1.41 . . . . 0.0 114.808 174.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.67 -30.63 34.37 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.627 1.552 . . . . 0.0 112.577 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.87 -49.63 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.05 0.94 . . . . 0.0 111.597 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.45 -34.81 77.94 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.379 1.072 . . . . 0.0 111.618 176.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -65.7 -41.72 92.01 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.435 1.016 . . . . 0.0 112.5 170.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.73 -44.11 78.36 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.024 -1.048 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -58.15 -44.11 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 119.957 1.253 . . . . 0.0 111.266 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.4 -36.44 78.12 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.036 0.534 . . . . 0.0 112.126 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -77.17 -41.36 41.94 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.53 -0.731 . . . . 0.0 111.357 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -83.67 -28.95 28.0 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -111.01 20.3 17.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.968 1.307 . . . . 0.0 113.128 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.15 -33.1 17.86 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -74.59 -23.38 58.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.136 1.375 . . . . 0.0 112.845 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -105.52 -33.79 7.99 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.579 1.952 . . . . 0.0 112.993 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -151.7 139.32 19.67 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.577 1.551 . . . . 0.0 110.517 -156.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.7 m -115.84 140.49 49.17 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.309 1.443 . . . . 0.0 109.614 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.6 t -103.68 128.25 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.935 0.894 . . . . 0.0 109.725 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.61 143.66 45.03 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.139 1.776 . . . . 0.0 111.918 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -110.6 127.86 55.42 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.198 1.399 . . . . 0.0 111.974 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -124.33 123.98 41.38 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.059 1.343 . . . . 0.0 109.786 167.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.91 118.0 34.69 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.535 0.734 . . . . 0.0 110.18 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -71.31 -16.44 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 113.842 1.052 . . . . 0.0 113.842 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -93.52 -38.97 11.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.64 1.176 . . . . 0.0 112.714 177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.7 p -87.49 -21.88 25.22 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -133.75 80.61 55.35 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 124.034 0.933 . . . . 0.0 111.891 164.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -62.55 -20.34 70.39 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.152 2.568 . . . . 0.0 113.706 173.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.93 -44.41 92.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.064 0.946 . . . . 0.0 112.74 -175.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 m -73.17 -33.09 65.25 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 119.195 0.907 . . . . 0.0 111.452 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.47 92.95 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.463 -0.773 . . . . 0.0 111.933 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.99 -25.82 53.16 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 169.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.86 -45.94 88.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.189 0.904 . . . . 0.0 111.397 174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.07 10.33 41.69 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.302 1.441 . . . . 0.0 113.933 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 45.42 50.59 10.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.798 2.039 . . . . 0.0 113.674 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 p -75.23 138.04 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 121.294 -0.879 . . . . 0.0 111.529 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -123.56 -15.81 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -173.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.3 m -133.68 150.88 51.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.828 1.651 . . . . 0.0 110.898 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.4 pt -126.79 140.58 37.98 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.814 0.846 . . . . 0.0 111.873 174.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -70.72 152.73 94.98 Favored 'Cis proline' 0 CA--C 1.543 0.935 0 CA-C-N 118.973 0.669 . . . . 0.0 111.177 -11.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.9 m -133.87 124.88 27.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.767 1.227 . . . . 0.0 109.421 169.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.74 147.15 28.9 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.853 1.261 . . . . 0.0 110.867 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 tt -131.7 144.55 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.384 1.474 . . . . 0.0 109.633 169.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 67.1 tp -107.21 130.63 54.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.228 1.011 . . . . 0.0 110.307 167.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -106.68 147.16 29.9 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.84 1.256 . . . . 0.0 109.568 163.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -108.65 116.44 31.99 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.537 1.535 . . . . 0.0 108.365 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 51.33 34.27 11.44 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.812 1.245 . . . . 0.0 113.669 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.22 17.29 67.26 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -125.42 136.6 28.48 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-N 119.501 1.651 . . . . 0.0 110.865 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.22 139.81 39.48 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.773 2.316 . . . . 0.0 112.243 -172.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.1 m -120.57 -36.04 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -162.06 149.64 14.32 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 119.593 1.088 . . . . 0.0 113.302 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -129.07 141.46 51.21 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.891 1.676 . . . . 0.0 111.597 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 123.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.237 1.815 . . . . 0.0 111.44 -175.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.04 150.73 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.333 1.053 . . . . 0.0 111.822 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.76 -179.98 53.24 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.051 1.31 . . . . 0.0 113.437 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.95 157.51 28.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -129.49 152.23 49.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.034 1.734 . . . . 0.0 111.091 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.49 154.31 20.98 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 163.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -57.7 -33.03 67.95 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.12 82.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.149 0.58 . . . . 0.0 111.786 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.99 -48.12 66.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.442 0.697 . . . . 0.0 111.457 176.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 104' ' ' LEU . 11.9 tp -61.64 -43.46 98.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.919 0.887 . . . . 0.0 111.343 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.1 tp -67.66 -34.74 77.53 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.774 0.829 . . . . 0.0 113.014 174.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -66.81 -45.14 79.29 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.361 1.437 . . . . 0.0 111.51 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -58.34 -34.67 70.89 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 173.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -77.35 -44.0 30.96 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 p -72.05 -15.06 62.02 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.755 1.222 . . . . 0.0 113.095 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -63.44 -14.19 48.03 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.5 t -117.42 149.36 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 126.673 1.989 . . . . 0.0 110.431 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 20.7 t -93.16 135.03 26.18 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.891 1.276 . . . . 0.0 110.891 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -69.44 166.36 27.47 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.339 2.693 . . . . 0.0 112.922 174.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -66.26 -43.76 85.58 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -170.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.5 tp -144.46 -7.72 0.68 Allowed 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -172.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.824 1.25 . . . . 0.0 113.326 -170.846 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.7 p -86.69 142.26 28.32 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.187 0.995 . . . . 0.0 112.579 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.0 134.41 38.84 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.394 2.278 . . . . 0.0 111.336 -8.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.1 p -67.82 -14.59 63.08 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -172.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.45 -3.5 36.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.498 1.119 . . . . 0.0 113.614 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -99.41 -21.48 15.97 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.322 1.231 . . . . 0.0 114.322 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.5 m -70.56 125.37 26.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.109 0.964 . . . . 0.0 110.91 172.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.47 16.82 15.98 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -169.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.2 t -80.37 153.97 28.01 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.035 -1.041 . . . . 0.0 111.548 174.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.2 pt -121.52 134.74 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.472 1.109 . . . . 0.0 112.816 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -82.6 127.44 33.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.411 1.484 . . . . 0.0 108.932 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -115.04 156.85 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.349 1.059 . . . . 0.0 112.282 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -134.39 172.0 13.51 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 127.455 2.302 . . . . 0.0 111.052 -174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -58.3 -26.67 63.3 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.062 -1.024 . . . . 0.0 113.659 172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.63 -35.0 24.95 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.9 p -100.05 -24.14 14.69 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -171.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -53.01 -40.83 64.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.056 1.342 . . . . 0.0 112.597 -177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.34 -31.57 72.44 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.081 -1.012 . . . . 0.0 113.39 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.7 m -81.6 -33.83 31.31 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.796 0.838 . . . . 0.0 111.993 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -92.83 -25.73 17.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.23 -53.87 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.4 mt -77.37 -19.93 55.51 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.5 t -77.2 -23.81 51.4 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -81.39 122.34 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.341 1.456 . . . . 0.0 114.044 -164.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -72.45 -29.26 63.52 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.276 1.03 . . . . 0.0 111.629 166.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -72.18 158.94 86.69 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.373 1.069 . . . . 0.0 110.962 172.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.47 139.9 73.09 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.504 2.136 . . . . 0.0 110.974 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 t -128.85 117.54 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.689 0.796 . . . . 0.0 110.388 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.3 tp -90.65 128.27 36.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.587 1.155 . . . . 0.0 108.678 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t -120.38 127.67 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 123.85 0.86 . . . . 0.0 109.87 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -97.5 112.6 24.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.199 0.6 . . . . 0.0 111.179 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 11.1 m-85 -85.22 109.54 18.39 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.192 1.397 . . . . 0.0 107.65 170.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.42 178.51 8.37 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -165.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.82 138.96 47.27 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.834 0.454 . . . . 0.0 109.944 157.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 39.7 p -62.33 -20.71 64.65 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -168.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.1 p-90 -85.42 -16.55 39.39 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.151 1.38 . . . . 0.0 114.461 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 144.71 38.54 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.23 0.923 . . . . 0.0 113.398 -167.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.35 -63.9 4.88 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.634 1.111 . . . . 0.0 114.405 -174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.79 -21.33 51.17 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 CA-C-N 119.616 1.708 . . . . 0.0 112.932 175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.9 m -63.14 -47.48 82.56 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.487 1.039 . . . . 0.0 110.683 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.16 -32.3 73.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.903 0.881 . . . . 0.0 112.647 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.9 ttt -63.77 -36.43 83.85 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 172.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.45 -11.37 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -54.67 39.53 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 119.948 1.249 . . . . 0.0 113.915 175.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.3 -33.43 59.27 Favored 'Trans proline' 0 C--N 1.355 0.893 0 CA-C-N 121.143 1.444 . . . . 0.0 111.685 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.24 -51.27 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.609 0.764 . . . . 0.0 111.426 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.6 pp -67.48 -37.96 83.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.684 0.675 . . . . 0.0 111.086 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.64 -42.6 98.13 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.499 0.591 . . . . 0.0 112.218 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -66.98 -48.04 69.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.241 -0.885 . . . . 0.0 112.049 177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.1 mm -57.94 -42.88 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-N 120.839 1.654 . . . . 0.0 110.821 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.52 91.82 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.138 0.426 . . . . 0.0 111.685 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.1 m -79.43 -31.36 42.6 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.297 1.039 . . . . 0.0 112.459 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -87.03 -31.12 20.71 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -126.49 27.02 6.23 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.8 -28.93 17.17 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -76.63 -20.32 56.83 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.755 1.622 . . . . 0.0 114.257 177.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -102.57 -37.15 8.09 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.821 1.249 . . . . 0.0 112.709 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.59 174.0 12.17 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.383 1.473 . . . . 0.0 113.088 -176.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 95.3 m -117.96 146.34 44.05 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.199 1.399 . . . . 0.0 109.783 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.1 t -123.23 138.12 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.765 0.826 . . . . 0.0 109.995 170.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.05 161.26 35.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.289 1.835 . . . . 0.0 112.101 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -131.55 138.08 48.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.544 1.138 . . . . 0.0 112.713 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.435 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 5.1 tt -128.14 111.91 13.98 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.294 2.238 . . . . 0.0 107.966 -172.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -86.45 112.52 21.58 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.379 0.609 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -71.42 -17.4 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -88.11 -40.69 13.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.285 1.034 . . . . 0.0 112.555 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -90.71 -23.32 20.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -130.56 68.25 81.27 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 125.144 1.377 . . . . 0.0 110.445 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.41 -16.65 39.17 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.241 2.627 . . . . 0.0 113.839 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -65.52 -37.67 87.44 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.32 -0.862 . . . . 0.0 112.727 -175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.7 p -77.18 -35.29 55.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.48 0.712 . . . . 0.0 112.387 171.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.04 98.59 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.56 -0.712 . . . . 0.0 112.357 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -76.91 -23.29 52.53 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -58.75 -42.32 88.59 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.301 0.955 . . . . 0.0 111.635 173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -97.98 5.66 48.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.197 1.399 . . . . 0.0 113.589 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 52.46 41.05 30.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.516 1.927 . . . . 0.0 114.176 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 99.8 t -78.65 128.81 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.992 178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -126.27 -6.94 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.626 1.57 . . . . 0.0 114.025 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.7 m -122.24 150.76 41.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.226 1.81 . . . . 0.0 110.876 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.8 pt -137.86 144.88 45.96 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.086 0.955 . . . . 0.0 112.08 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.27 144.91 74.59 Favored 'Cis proline' 0 CA--C 1.538 0.708 0 CA-C-N 119.498 0.857 . . . . 0.0 111.084 -13.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -122.66 114.73 20.98 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.494 1.118 . . . . 0.0 108.881 172.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.6 mt -98.69 123.87 43.17 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.011 1.324 . . . . 0.0 109.433 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.6 tt -122.96 139.78 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.384 1.074 . . . . 0.0 110.397 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.6 tp -106.17 126.65 52.47 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.857 1.263 . . . . 0.0 111.502 171.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -107.59 152.75 23.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.607 1.963 . . . . 0.0 111.607 171.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -144.91 131.44 19.83 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.13 1.772 . . . . 0.0 109.883 172.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t0 52.18 33.28 12.05 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -171.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.82 0.51 42.14 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.859 1.695 . . . . 0.0 114.94 -174.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -95.59 139.04 21.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 118.711 1.255 . . . . 0.0 110.538 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.88 135.98 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.48 2.12 . . . . 0.0 110.841 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.75 -48.9 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.852 0.861 . . . . 0.0 112.237 -176.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -154.21 148.64 26.14 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.628 1.171 . . . . 0.0 112.125 173.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -132.83 139.89 47.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.161 1.384 . . . . 0.0 111.596 174.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.72 129.01 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.095 1.358 . . . . 0.0 110.754 174.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.39 36.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.289 1.435 . . . . 0.0 113.603 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.41 174.25 38.79 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.347 0.975 . . . . 0.0 114.297 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.31 154.34 42.01 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.715 1.206 . . . . 0.0 113.878 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.03 153.49 51.34 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.006 1.723 . . . . 0.0 111.595 165.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.26 167.42 43.3 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.215 0.912 . . . . 0.0 110.961 164.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -58.69 -34.64 71.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.42 -46.36 66.99 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.824 0.45 . . . . 0.0 111.385 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.49 -44.23 83.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.656 0.782 . . . . 0.0 111.771 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 tp -68.53 -38.21 80.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.381 -0.824 . . . . 0.0 112.21 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -68.09 -33.45 74.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.161 170.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.1 tpt85 -68.5 -38.82 81.29 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 120.313 1.415 . . . . 0.0 112.65 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -62.24 -36.32 81.64 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.456 1.102 . . . . 0.0 111.347 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mt -68.56 -43.6 76.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.719 1.208 . . . . 0.0 113.404 169.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.2 m -68.15 -17.96 64.49 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.113 1.365 . . . . 0.0 112.186 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.53 -12.37 43.97 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.54 1.136 . . . . 0.0 113.57 167.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.6 t -125.85 -44.47 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 126.231 1.813 . . . . 0.0 112.023 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 p -99.26 138.53 20.56 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 124.344 1.058 . . . . 0.0 111.904 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -58.76 126.45 21.23 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.641 2.228 . . . . 0.0 112.001 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -156.82 152.07 26.42 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.23 1.412 . . . . 0.0 110.514 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -71.76 -28.53 63.71 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.802 1.241 . . . . 0.0 112.314 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 127.792 2.437 . . . . 0.0 113.514 -178.078 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.356 0.122 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.7 m -67.04 138.08 56.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.462 1.105 . . . . 0.0 111.561 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -84.96 35.68 0.59 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.397 1.079 . . . . 0.0 113.127 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.9 t -153.46 156.83 38.92 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.94 1.696 . . . . 0.0 111.437 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 60.43 -62.0 0.07 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.668 2.787 . . . . 0.0 115.132 -173.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 57.79 -2.85 0.06 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 128.871 2.868 . . . . 0.0 117.47 174.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 p -78.69 139.75 38.45 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.543 1.537 . . . . 0.0 112.942 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.38 58.5 2.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.035 0.934 . . . . 0.0 111.678 173.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 p -115.6 142.39 46.8 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.316 1.446 . . . . 0.0 113.797 -170.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.9 pt -140.79 168.58 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.312 1.845 . . . . 0.0 111.825 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -115.5 143.47 45.26 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.832 1.253 . . . . 0.0 110.422 163.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.35 167.13 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.428 1.491 . . . . 0.0 112.425 173.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.412 ' H ' ' HB2' ' A' ' 16' ' ' SER . 76.5 p -127.93 172.04 11.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.317 2.647 . . . . 0.0 109.36 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -55.89 -33.12 64.31 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.043 -1.036 . . . . 0.0 113.181 174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.22 -38.14 43.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.679 0.791 . . . . 0.0 113.04 175.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.412 ' HB2' ' H ' ' A' ' 13' ' ' THR . 14.7 m -80.61 -24.68 38.93 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.316 1.046 . . . . 0.0 113.54 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -53.43 -41.84 66.48 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.898 1.279 . . . . 0.0 112.639 -173.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.25 -31.37 69.87 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.2 m -87.33 -23.25 24.68 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.726 1.21 . . . . 0.0 113.081 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -107.34 -31.57 8.13 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.73 -56.44 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.221 1.009 . . . . 0.0 111.487 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.6 mt -73.1 -12.43 60.9 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.2 p -76.19 -21.29 56.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.809 1.644 . . . . 0.0 114.104 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.4 t -96.27 128.19 42.96 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -73.33 -24.55 60.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.533 1.533 . . . . 0.0 112.449 166.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -74.17 149.42 87.11 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.281 1.432 . . . . 0.0 109.817 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.13 129.35 34.79 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.384 2.056 . . . . 0.0 111.904 165.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -128.71 120.07 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.641 1.176 . . . . 0.0 109.965 177.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.445 HD21 HD11 ' A' ' 104' ' ' LEU . 29.8 tp -91.23 133.6 35.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.743 1.217 . . . . 0.0 108.87 174.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -121.78 131.24 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 119.494 1.043 . . . . 0.0 110.952 169.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -107.79 127.19 53.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.498 1.519 . . . . 0.0 111.57 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -100.34 117.53 34.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.894 1.678 . . . . 0.0 110.064 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.31 168.65 22.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -169.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.56 -176.93 3.65 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.817 1.647 . . . . 0.0 111.726 176.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.7 p -74.66 -23.72 58.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.167 1.387 . . . . 0.0 114.52 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.7 p-90 -114.56 -13.49 12.16 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -161.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -79.59 120.55 24.09 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -164.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.91 -59.07 8.45 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.612 1.101 . . . . 0.0 114.413 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.5 -24.14 36.59 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 120.007 1.903 . . . . 0.0 113.386 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -76.31 -32.29 58.66 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 119.327 0.967 . . . . 0.0 111.965 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -75.36 -32.58 60.89 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.624 -0.673 . . . . 0.0 112.052 167.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.58 -33.47 75.03 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.17 0.988 . . . . 0.0 113.57 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.8 m -79.76 -20.43 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.404 1.002 . . . . 0.0 113.592 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.66 -40.72 85.42 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 120.536 1.517 . . . . 0.0 115.083 -172.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -60.19 -37.81 80.71 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.632 2.221 . . . . 0.0 113.047 171.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.5 t -63.89 -39.53 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.804 0.842 . . . . 0.0 110.806 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.79 -49.54 57.78 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.7 1.2 . . . . 0.0 110.683 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -56.61 -37.99 71.44 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 122.889 0.476 . . . . 0.0 110.538 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -77.18 -49.25 15.58 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.159 -0.448 . . . . 0.0 112.143 -172.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.8 mm -65.01 -36.4 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 119.356 0.98 . . . . 0.0 111.042 175.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.562 -0.712 . . . . 0.0 112.822 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.7 m -75.48 -43.85 47.09 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 119.675 1.125 . . . . 0.0 110.956 172.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -78.69 -33.14 47.14 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.0 mmm-85 -121.33 30.82 6.6 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.171 1.788 . . . . 0.0 112.374 -174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.57 -28.79 22.47 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.474 1.51 . . . . 0.0 114.335 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 m -74.7 -31.01 61.75 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.775 1.23 . . . . 0.0 112.242 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -90.76 -37.88 13.38 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.768 1.227 . . . . 0.0 113.027 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.39 166.82 23.72 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -176.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.6 m -125.9 142.5 51.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.086 1.754 . . . . 0.0 108.51 167.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.1 t -118.16 138.18 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.489 0.716 . . . . 0.0 110.782 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.12 152.36 46.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.303 1.441 . . . . 0.0 112.639 -175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -106.85 135.05 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.552 1.541 . . . . 0.0 110.498 170.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.42 121.34 43.26 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -94.61 114.54 26.52 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.6 m -69.52 -16.2 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -168.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -80.46 -24.14 39.74 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.831 0.852 . . . . 0.0 112.726 169.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.8 p -86.9 -30.96 20.99 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -148.18 106.4 3.61 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 124.683 1.193 . . . . 0.0 110.987 163.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.2 -10.95 29.37 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 121.775 1.65 . . . . 0.0 112.465 161.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -60.77 -51.45 69.27 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.335 1.454 . . . . 0.0 112.194 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.56 -30.46 64.45 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.509 0.724 . . . . 0.0 112.05 176.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.09 -43.43 98.86 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.499 -0.751 . . . . 0.0 111.944 173.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.3 ptt-85 -77.26 -24.62 51.06 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -59.86 -44.59 94.04 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.289 0.95 . . . . 0.0 112.092 172.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.51 15.05 24.38 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.233 1.413 . . . . 0.0 113.704 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 50.99 46.15 26.77 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.223 2.209 . . . . 0.0 113.836 173.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 73.0 t -63.96 121.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.357 1.063 . . . . 0.0 109.54 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.7 p -115.22 -29.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.054 1.342 . . . . 0.0 112.907 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.5 m -125.7 155.9 40.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.215 1.806 . . . . 0.0 110.201 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.0 mt -122.31 123.08 27.25 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.82 159.01 98.22 Favored 'Cis proline' 0 CA--C 1.542 0.876 0 CA-C-N 120.015 1.041 . . . . 0.0 113.321 0.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.2 m -127.07 129.98 49.03 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.492 1.117 . . . . 0.0 108.874 161.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.76 144.26 38.42 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.057 1.343 . . . . 0.0 110.367 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.7 tp -140.72 126.78 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.005 1.322 . . . . 0.0 109.508 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 tp -94.76 133.19 38.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.686 1.194 . . . . 0.0 110.789 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -118.95 149.65 41.25 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.84 1.656 . . . . 0.0 111.633 173.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -146.49 136.44 23.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.596 1.159 . . . . 0.0 110.75 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 55.33 30.02 14.04 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.324 1.05 . . . . 0.0 112.665 -171.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.58 5.12 49.15 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.613 2.054 . . . . 0.0 114.895 -172.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -95.26 131.75 29.26 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 118.527 1.163 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.66 132.49 23.59 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.55 2.167 . . . . 0.0 110.812 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.2 t -106.72 -47.47 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.547 1.139 . . . . 0.0 111.832 -172.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -158.45 131.83 7.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.682 1.193 . . . . 0.0 111.254 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -112.28 136.55 51.58 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.379 1.471 . . . . 0.0 110.73 174.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.42 122.98 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.893 1.277 . . . . 0.0 109.524 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.09 41.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.014 1.325 . . . . 0.0 112.883 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -169.76 -178.77 41.07 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.154 0.883 . . . . 0.0 114.067 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.18 157.23 34.23 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.684 1.193 . . . . 0.0 113.871 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -129.98 160.7 32.82 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.6 1.96 . . . . 0.0 112.645 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.35 164.02 12.12 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.3 1.428 . . . . 0.0 110.85 159.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -52.57 -40.8 62.97 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.546 1.139 . . . . 0.0 113.253 -176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.45 -44.96 77.38 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.17 0.588 . . . . 0.0 111.794 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -40.32 68.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.524 0.73 . . . . 0.0 112.242 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.445 HD11 HD21 ' A' ' 29' ' ' LEU . 15.3 tp -62.29 -44.67 95.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.921 0.888 . . . . 0.0 111.452 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.0 tp -68.12 -30.04 69.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.459 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -60.57 -47.69 85.08 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.604 1.093 . . . . 0.0 110.933 168.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -59.61 -40.5 87.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.475 1.034 . . . . 0.0 111.815 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.48 -30.52 69.39 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.8 m -75.63 -26.19 57.56 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.656 1.183 . . . . 0.0 112.386 171.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -85.7 11.15 11.55 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.342 1.857 . . . . 0.0 113.498 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 p -73.45 147.27 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 120.881 -1.137 . . . . 0.0 113.319 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.8 142.23 10.86 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 126.513 1.925 . . . . 0.0 109.893 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.43 107.72 2.05 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 121.987 1.791 . . . . 0.0 109.772 171.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.97 -17.24 64.54 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -165.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.4 tp -73.02 -21.49 60.81 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.676 1.19 . . . . 0.0 113.383 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.9 m120 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.295 1.438 . . . . 0.0 113.11 -177.674 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 ttp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 t -98.55 163.29 12.73 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.163 0.985 . . . . 0.0 112.802 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -63.96 -24.74 67.84 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.73 1.212 . . . . 0.0 113.976 -171.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.0 m -91.79 -0.19 57.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.154 1.382 . . . . 0.0 114.049 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -92.33 -14.21 29.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.983 1.313 . . . . 0.0 113.589 -173.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.67 178.69 4.21 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.829 2.052 . . . . 0.0 111.932 174.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 m -60.94 119.24 7.89 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.459 1.104 . . . . 0.0 112.323 -176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.77 61.94 4.61 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.792 0.837 . . . . 0.0 111.392 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -111.08 139.46 46.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.043 1.337 . . . . 0.0 112.708 -174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.0 pt -137.34 167.58 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.766 1.626 . . . . 0.0 111.132 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -127.71 148.41 50.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.704 0.802 . . . . 0.0 112.203 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.14 159.58 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.677 1.591 . . . . 0.0 112.446 -170.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.9 p -142.6 168.42 19.77 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.829 2.452 . . . . 0.0 110.501 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -56.03 -25.97 46.99 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.26 -16.68 39.37 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.1 p -119.64 -25.28 5.99 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.676 1.591 . . . . 0.0 114.71 -171.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -50.53 -39.44 48.93 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.36 1.864 . . . . 0.0 112.932 -175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.35 71.85 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.2 m -87.33 -30.77 20.57 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.448 -0.782 . . . . 0.0 112.043 176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -87.31 -43.92 11.8 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.0 t -98.62 -52.87 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.89 1.276 . . . . 0.0 111.344 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -79.81 -13.77 59.17 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.4 m -110.4 18.18 20.08 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 0.0 113.343 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.0 p -62.25 -36.89 83.43 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -167.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.295 0.5 OUTLIER 48.01 21.6 0.33 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.916 1.687 . . . . 0.0 115.185 -161.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.22 168.1 11.85 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 126.177 1.791 . . . . 0.0 111.928 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -62.75 139.31 74.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.708 2.272 . . . . 0.0 112.901 169.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.74 124.77 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.69 1.196 . . . . 0.0 111.388 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.5 99.01 10.69 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.702 1.601 . . . . 0.0 109.171 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.2 t -99.28 121.05 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.282 -0.887 . . . . 0.0 110.655 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -102.34 118.4 36.8 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.6 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -91.97 112.82 24.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.614 1.566 . . . . 0.0 108.552 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.1 172.62 13.98 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.378 1.071 . . . . 0.0 113.02 -169.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -115.54 175.08 5.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.591 1.156 . . . . 0.0 111.09 168.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.5 p -74.93 -18.54 60.38 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.0 -1.062 . . . . 0.0 113.726 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 p-90 -116.95 -5.25 11.47 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.572 1.693 . . . . 0.0 115.572 -163.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.75 134.39 39.18 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 119.457 1.026 . . . . 0.0 113.699 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.49 -62.99 5.54 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.454 1.026 . . . . 0.0 114.094 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.17 -25.01 65.47 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.335 2.023 . . . . 0.0 113.363 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -74.55 -33.42 62.71 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.091 0.859 . . . . 0.0 112.088 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -64.01 -40.75 97.03 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.453 -0.779 . . . . 0.0 112.023 165.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -62.7 -29.82 70.94 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.43 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.76 -45.16 99.64 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-N 120.343 1.429 . . . . 0.0 113.517 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.82 -41.69 36.33 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.869 1.713 . . . . 0.0 112.163 172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.0 t -64.14 -47.04 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.57 1.148 . . . . 0.0 111.77 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 pp -69.74 -38.21 76.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.112 0.965 . . . . 0.0 111.243 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -68.08 -41.05 82.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.612 1.096 . . . . 0.0 112.314 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -67.03 -47.97 69.76 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 121.013 -1.054 . . . . 0.0 111.614 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.1 mm -59.14 -40.5 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.286 1.403 . . . . 0.0 111.233 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.52 -33.73 75.48 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.714 0.688 . . . . 0.0 112.564 174.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.4 m -78.19 -40.42 37.7 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.284 -0.885 . . . . 0.0 111.463 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -85.17 -21.7 29.09 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -170.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -128.66 25.67 5.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.622 1.569 . . . . 0.0 113.146 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -34.11 21.07 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.499 1.52 . . . . 0.0 114.459 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -78.17 -18.56 55.38 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.465 1.506 . . . . 0.0 113.701 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -97.61 -38.25 9.61 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.135 1.374 . . . . 0.0 112.49 176.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 160.42 43.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.4 m -109.08 138.01 46.09 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.099 1.359 . . . . 0.0 109.508 166.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.74 133.5 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.33 147.34 49.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.209 1.404 . . . . 0.0 111.873 -176.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.55 135.19 53.56 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.533 1.133 . . . . 0.0 111.705 173.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.31 124.93 52.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.039 1.336 . . . . 0.0 109.26 164.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -91.29 96.61 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.928 0.891 . . . . 0.0 109.926 -176.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -65.73 -22.72 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 121.044 -1.035 . . . . 0.0 112.493 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.31 -27.48 63.42 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.527 1.531 . . . . 0.0 113.015 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.1 p -123.51 -21.24 5.33 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.069 1.348 . . . . 0.0 114.254 -175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -128.73 63.84 67.1 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.385 1.474 . . . . 0.0 111.929 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.25 -13.26 38.89 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.322 2.681 . . . . 0.0 113.784 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -61.9 -37.36 84.3 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.218 -0.926 . . . . 0.0 112.199 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -77.5 -32.29 54.07 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.648 -0.657 . . . . 0.0 112.096 171.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.43 -40.24 95.92 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.059 -1.025 . . . . 0.0 111.657 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -75.7 -25.55 56.78 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -56.34 -42.74 78.22 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.224 0.92 . . . . 0.0 111.977 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -104.52 9.87 35.31 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.431 1.492 . . . . 0.0 113.795 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.9 mm-40 49.55 48.55 21.25 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 113.675 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.6 t -82.1 130.69 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.617 1.167 . . . . 0.0 110.297 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -123.04 -17.01 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -172.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 68.9 m -128.66 158.81 37.49 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.66 1.584 . . . . 0.0 111.079 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 19.4 pt -135.54 142.54 41.5 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.189 0.996 . . . . 0.0 112.07 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.39 139.55 57.12 Favored 'Cis proline' 0 CA--C 1.538 0.711 0 CA-C-N 119.495 0.855 . . . . 0.0 111.501 -8.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.0 m -122.46 118.18 27.73 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.857 0.863 . . . . 0.0 108.858 168.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.05 141.62 32.63 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.333 1.053 . . . . 0.0 109.822 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 tp -137.77 121.47 21.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 125.065 1.346 . . . . 0.0 108.443 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.1 tp -95.88 114.99 26.77 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.237 1.415 . . . . 0.0 109.706 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -95.55 148.74 22.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.207 1.403 . . . . 0.0 110.44 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -129.73 119.16 23.01 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.38 1.472 . . . . 0.0 108.877 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 49.87 35.22 8.95 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 124.684 1.194 . . . . 0.0 113.814 -174.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.5 76.85 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.745 1.458 . . . . 0.0 116.745 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -122.23 141.55 34.79 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 119.465 1.632 . . . . 0.0 111.843 165.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.07 142.56 38.53 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.31 2.673 . . . . 0.0 112.277 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 t -120.85 -43.49 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.384 1.074 . . . . 0.0 113.118 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.62 133.16 19.77 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.492 1.117 . . . . 0.0 112.144 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -111.59 141.3 45.36 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.394 1.477 . . . . 0.0 111.668 171.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.6 147.46 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 127.301 2.24 . . . . 0.0 110.665 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -132.28 141.85 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 0.0 111.035 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.82 171.03 44.61 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.193 1.377 . . . . 0.0 113.597 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.41 145.44 39.34 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -138.97 158.95 43.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.905 2.082 . . . . 0.0 111.044 -176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.42 169.35 32.92 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.519 1.057 . . . . 0.0 111.863 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -57.58 -38.05 74.19 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 122.099 -0.648 . . . . 0.0 112.568 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.72 -42.84 81.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.333 0.653 . . . . 0.0 111.677 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.22 -45.25 77.37 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.37 0.668 . . . . 0.0 111.594 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.65 -40.17 96.18 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.107 0.963 . . . . 0.0 112.103 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.8 tp -67.07 -33.15 74.88 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.846 0.858 . . . . 0.0 112.401 172.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -68.21 -38.93 82.44 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.49 1.041 . . . . 0.0 112.403 172.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -61.49 -38.71 88.3 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.016 0.826 . . . . 0.0 111.537 170.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.2 tp -67.2 -43.56 81.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.72 0.408 . . . . 0.0 111.814 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 80.2 p -71.82 -15.37 62.14 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.37 -16.99 64.56 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 166.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.8 t -122.55 -27.17 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.562 1.945 . . . . 0.0 111.873 -173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.3 t -125.98 86.93 56.94 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.174 1.79 . . . . 0.0 109.738 -174.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.3 161.05 88.24 Favored 'Cis proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.513 0.862 . . . . 0.0 113.056 -7.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -85.86 -17.38 35.78 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 tt 63.06 -41.33 0.19 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 128.951 2.9 . . . . 0.0 115.828 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 127.204 2.202 . . . . 0.0 111.96 178.574 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 p -145.59 178.64 7.98 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 126.682 1.993 . . . . 0.0 109.783 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.1 -9.86 8.62 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.7 m -133.33 25.55 4.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.997 1.719 . . . . 0.0 113.097 171.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -139.7 84.26 1.97 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.619 1.568 . . . . 0.0 107.943 171.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? 52.45 86.86 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.24 1.816 . . . . 0.0 110.859 -153.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.1 p -66.08 162.04 20.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 130.278 3.431 . . . . 0.0 117.937 17.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.18 27.8 0.66 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.672 1.189 . . . . 0.0 113.543 172.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -76.8 174.02 11.0 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.138 -0.976 . . . . 0.0 111.742 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 pt -112.47 163.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.448 1.099 . . . . 0.0 111.227 160.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -126.46 130.72 51.23 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.683 1.593 . . . . 0.0 109.611 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -126.31 156.23 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.09 0.956 . . . . 0.0 113.368 -168.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 42.3 p -138.96 163.47 32.27 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 127.44 2.296 . . . . 0.0 110.406 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -61.04 -32.66 72.28 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -166.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.28 -20.59 57.21 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -109.38 -18.87 13.46 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.561 1.545 . . . . 0.0 113.88 -174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -52.93 -41.39 64.42 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.8 1.64 . . . . 0.0 112.927 -174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.47 -31.44 72.18 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.5 m -85.52 -22.14 28.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 112.57 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -96.45 -42.38 8.13 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 -54.36 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.871 1.268 . . . . 0.0 111.623 -174.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 mt -75.66 -11.73 60.06 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.3 p -78.35 -14.34 59.45 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.311 1.844 . . . . 0.0 114.098 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.9 t -69.31 148.92 49.07 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -161.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -107.01 21.37 17.67 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 126.9 2.08 . . . . 0.0 112.386 167.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -138.76 156.23 72.95 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 128.31 2.644 . . . . 0.0 108.977 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -56.31 141.35 88.91 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 121.711 1.607 . . . . 0.0 112.559 160.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 123.09 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.418 1.087 . . . . 0.0 110.55 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.46 131.25 34.96 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.492 1.117 . . . . 0.0 108.531 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.0 t -119.63 127.9 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 119.089 0.859 . . . . 0.0 109.837 169.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -102.13 125.12 48.74 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.617 0.767 . . . . 0.0 111.172 169.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -96.16 112.24 24.04 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.412 1.485 . . . . 0.0 109.115 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.88 171.68 16.39 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -166.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.83 174.72 7.74 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.168 1.387 . . . . 0.0 111.954 174.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.6 p -75.11 -18.73 60.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 17.0 p-90 -115.11 -7.0 12.49 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -165.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.05 128.02 33.25 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.37 -60.69 8.5 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.467 1.032 . . . . 0.0 114.102 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.42 -27.1 54.91 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.192 1.928 . . . . 0.0 113.501 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.61 -33.18 64.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.048 0.84 . . . . 0.0 112.015 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.82 67.32 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.172 -0.955 . . . . 0.0 112.722 167.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 73.8 mtm -65.89 -30.34 70.92 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.835 1.198 . . . . 0.0 113.79 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -87.64 -6.57 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 172.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.94 -53.89 53.05 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 119.469 1.031 . . . . 0.0 113.496 175.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.0 -33.85 91.6 Favored 'Trans proline' 0 C--N 1.354 0.834 0 CA-C-N 121.646 1.624 . . . . 0.0 112.409 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.91 -50.02 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.988 0.915 . . . . 0.0 112.08 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 pp -67.78 -37.68 82.36 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.36 0.664 . . . . 0.0 111.31 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -69.1 -37.37 78.36 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.143 0.577 . . . . 0.0 112.338 176.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.39 -48.59 66.93 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.781 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mm -59.67 -38.84 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 120.734 1.606 . . . . 0.0 111.185 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.66 90.51 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.802 0.728 . . . . 0.0 112.884 174.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.3 m -74.52 -39.5 62.35 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.041 0.536 . . . . 0.0 111.909 176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -91.27 -34.67 14.85 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -167.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -117.01 20.48 13.79 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.216 1.406 . . . . 0.0 113.619 -168.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.8 -27.8 19.71 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -81.16 -18.79 45.1 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.48 1.512 . . . . 0.0 113.936 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -94.56 -42.59 8.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.829 1.252 . . . . 0.0 112.068 175.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.62 155.94 38.31 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.007 1.323 . . . . 0.0 112.64 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.82 137.85 37.72 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.159 171.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.11 133.0 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 118.829 0.741 . . . . 0.0 109.821 173.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.63 153.87 44.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.625 1.97 . . . . 0.0 111.705 -176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -123.12 131.48 53.71 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.103 0.961 . . . . 0.0 112.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.91 121.96 45.55 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.384 1.474 . . . . 0.0 108.729 170.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.22 95.05 7.14 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.184 0.994 . . . . 0.0 109.772 -171.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.5 -20.73 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.327 1.051 . . . . 0.0 113.323 -170.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -74.44 -33.12 62.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.876 1.27 . . . . 0.0 112.827 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.5 p -107.35 -20.83 13.15 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.343 1.457 . . . . 0.0 113.349 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.05 81.91 69.78 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 126.734 2.013 . . . . 0.0 109.449 173.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -74.99 -11.22 21.49 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.202 2.601 . . . . 0.0 114.356 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.8 -40.28 61.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.161 0.984 . . . . 0.0 112.772 -172.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 m -73.74 -29.59 62.32 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.025 -1.047 . . . . 0.0 112.472 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.14 94.18 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.371 0.669 . . . . 0.0 111.97 174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -81.66 -23.24 37.02 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -59.42 -44.79 92.8 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.692 1.197 . . . . 0.0 111.575 171.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.43 4.77 50.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.144 1.378 . . . . 0.0 114.49 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 48.73 61.15 3.23 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.667 1.587 . . . . 0.0 112.763 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.2 t -68.25 134.17 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.604 1.562 . . . . 0.0 110.767 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.19 -14.14 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.0 t -146.71 167.55 23.53 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.025 1.33 . . . . 0.0 111.95 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 96.3 mt -133.28 121.91 16.84 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.709 1.204 . . . . 0.0 108.36 173.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.65 157.32 94.66 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 119.882 0.994 . . . . 0.0 112.59 -5.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.9 m -130.33 120.81 24.92 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.216 1.006 . . . . 0.0 109.559 165.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.4 126.99 50.86 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.644 1.577 . . . . 0.0 109.006 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.39 133.27 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.287 1.035 . . . . 0.0 110.501 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 48.2 tp -104.18 118.39 36.54 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.825 1.25 . . . . 0.0 110.539 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.86 151.34 19.65 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.602 1.561 . . . . 0.0 110.43 167.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -124.7 124.39 42.06 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.964 1.705 . . . . 0.0 108.834 166.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 50.26 36.25 12.27 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.458 1.103 . . . . 0.0 113.5 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.97 18.26 78.94 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.073 1.321 . . . . 0.0 116.094 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -126.3 140.29 36.76 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.565 1.682 . . . . 0.0 111.469 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.05 140.06 33.9 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.128 2.552 . . . . 0.0 112.53 -174.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 t -114.53 -48.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.713 1.205 . . . . 0.0 112.605 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -153.92 141.14 19.52 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.488 1.115 . . . . 0.0 111.269 -167.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.7 ttp180 -129.36 136.34 49.87 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.91 1.284 . . . . 0.0 112.416 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 40.7 mm -129.83 142.62 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.964 2.106 . . . . 0.0 109.868 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -113.42 148.99 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.332 1.453 . . . . 0.0 112.363 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.31 175.41 42.78 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.158 0.885 . . . . 0.0 114.239 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.74 148.42 38.56 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -154.19 163.87 39.44 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.601 1.961 . . . . 0.0 112.092 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.48 166.79 32.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.688 1.137 . . . . 0.0 112.642 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -60.88 -32.09 71.55 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.637 1.175 . . . . 0.0 114.131 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.57 -39.6 91.83 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.225 0.61 . . . . 0.0 111.691 177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.23 60.78 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.082 0.953 . . . . 0.0 112.773 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.58 -44.0 65.29 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.266 -0.896 . . . . 0.0 111.295 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.7 tp -67.38 -30.32 70.07 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.398 -0.813 . . . . 0.0 112.127 172.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -68.46 -42.81 78.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.585 1.084 . . . . 0.0 112.505 172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.04 -29.45 69.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.445 1.02 . . . . 0.0 112.186 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.77 -44.21 81.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.228 0.467 . . . . 0.0 111.87 168.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.1 m -66.25 -18.96 65.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.819 1.248 . . . . 0.0 112.641 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.06 -18.82 65.62 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 172.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.47 148.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.87 1.268 . . . . 0.0 110.888 175.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.5 t -128.66 133.81 25.59 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.712 1.605 . . . . 0.0 110.14 -175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.95 165.85 30.48 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.528 2.819 . . . . 0.0 113.009 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -146.31 158.44 43.89 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.45 1.5 . . . . 0.0 110.681 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -73.77 -10.42 59.66 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.735 1.384 . . . . 0.0 114.735 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 127.361 2.264 . . . . 0.0 110.486 176.7 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tmm? . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.2 p -72.07 -30.6 65.29 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.448 1.099 . . . . 0.0 113.938 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 60.76 16.45 6.75 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.372 1.869 . . . . 0.0 113.934 -161.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.5 m -79.06 -31.35 44.44 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.013 -1.055 . . . . 0.0 112.707 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -126.85 103.25 7.41 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.078 0.942 . . . . 0.0 110.863 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.72 -173.34 4.49 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 128.805 2.842 . . . . 0.0 108.435 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.6 m -60.79 113.61 2.58 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.237 1.38 . . . . 0.0 111.443 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -125.5 50.45 1.81 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 130.308 3.443 . . . . 0.0 111.404 -13.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -94.88 152.47 18.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.566 1.546 . . . . 0.0 112.973 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.34 141.96 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.65 1.58 . . . . 0.0 111.431 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -97.95 134.76 40.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.553 1.141 . . . . 0.0 110.995 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.21 162.25 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.735 1.214 . . . . 0.0 112.833 -175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.2 p -123.03 169.77 10.84 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.478 1.911 . . . . 0.0 111.238 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.65 -25.86 60.79 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.096 -1.003 . . . . 0.0 113.264 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.44 -50.67 7.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.54 1.136 . . . . 0.0 113.574 171.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.7 p -80.33 -16.1 55.37 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -171.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -49.28 -42.96 42.62 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.815 1.246 . . . . 0.0 111.632 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.16 -45.2 94.46 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.507 -0.746 . . . . 0.0 112.281 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 m -72.32 -30.21 64.55 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -94.93 -34.14 12.51 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.93 -49.65 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.667 1.187 . . . . 0.0 111.562 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.1 mt -88.91 -34.83 16.8 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.8 m -83.94 3.54 33.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.556 1.142 . . . . 0.0 113.866 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -62.03 151.71 34.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.355 1.062 . . . . 0.0 113.139 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.5 p-10 -81.21 -7.31 59.54 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.179 1.392 . . . . 0.0 114.022 174.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -142.76 167.08 17.17 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 126.402 1.881 . . . . 0.0 110.64 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -60.98 149.75 87.39 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.69 2.26 . . . . 0.0 112.207 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.1 t -129.66 130.01 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.723 0.809 . . . . 0.0 112.062 -173.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.4 132.34 36.84 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.385 1.474 . . . . 0.0 108.627 168.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -120.29 129.92 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 119.15 0.886 . . . . 0.0 110.345 169.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -105.71 114.17 28.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.934 0.894 . . . . 0.0 111.128 171.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -91.9 117.2 29.58 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.529 1.531 . . . . 0.0 109.135 173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.39 168.52 23.18 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -168.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.99 51.7 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 155.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.4 p -65.69 -12.29 52.34 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -167.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -105.41 -10.69 16.81 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.487 1.915 . . . . 0.0 114.452 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 145.11 45.76 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.311 0.96 . . . . 0.0 112.294 -173.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.52 -64.33 4.42 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.306 -0.872 . . . . 0.0 113.873 -172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -59.21 -28.2 87.08 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.15 2.566 . . . . 0.0 114.05 173.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 59.1 m -63.7 -49.67 72.19 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.537 0.735 . . . . 0.0 110.461 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.9 -29.27 67.51 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.054 -1.029 . . . . 0.0 112.202 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 49.0 tpp -62.15 -31.71 72.22 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.27 -12.97 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.371 0.987 . . . . 0.0 113.647 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.5 -50.09 73.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 120.415 1.461 . . . . 0.0 114.176 176.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.72 -26.55 38.97 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.453 2.102 . . . . 0.0 113.493 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.2 t -69.35 -40.54 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 120.907 -1.121 . . . . 0.0 110.829 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.54 -40.41 35.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.0 1.32 . . . . 0.0 111.096 -174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.59 -43.16 46.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.535 1.134 . . . . 0.0 111.481 162.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -77.05 -51.71 10.6 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.984 -0.447 . . . . 0.0 111.442 -172.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.8 mm -62.0 -38.2 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 O-C-N 121.542 -0.723 . . . . 0.0 111.111 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.79 85.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.391 0.996 . . . . 0.0 112.43 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -75.53 -36.43 60.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.693 0.678 . . . . 0.0 111.689 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.95 -34.2 11.88 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -114.28 22.51 13.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.533 1.533 . . . . 0.0 113.444 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.37 -26.55 41.87 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.4 t -78.97 -22.76 45.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.443 1.097 . . . . 0.0 113.012 175.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -90.63 -46.76 8.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.264 1.426 . . . . 0.0 111.872 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.84 156.72 38.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.326 1.451 . . . . 0.0 112.272 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.6 m -106.0 143.5 34.05 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.618 1.167 . . . . 0.0 109.794 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.81 128.6 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.899 0.88 . . . . 0.0 110.587 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.29 160.36 25.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.496 1.918 . . . . 0.0 112.297 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -124.75 137.37 54.33 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.94 1.696 . . . . 0.0 111.458 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -125.77 122.64 36.81 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.977 0.911 . . . . 0.0 110.351 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -93.47 111.82 23.58 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.64 0.776 . . . . 0.0 110.55 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.09 -16.75 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -170.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.91 -42.85 23.29 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.061 0.944 . . . . 0.0 112.764 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.9 p -87.38 -25.5 23.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.02 0.928 . . . . 0.0 113.342 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -127.96 60.5 46.37 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 125.147 1.379 . . . . 0.0 112.222 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -65.43 -17.35 57.46 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.746 2.297 . . . . 0.0 112.553 172.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -60.44 -46.29 90.58 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.416 1.086 . . . . 0.0 111.533 174.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.73 -29.94 67.44 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 120.198 -1.564 . . . . 0.0 111.714 175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.0 -34.72 78.36 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 121.255 -0.903 . . . . 0.0 112.752 174.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.75 -26.11 54.22 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.806 1.184 . . . . 0.0 113.273 168.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -57.28 -44.86 84.38 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.906 0.882 . . . . 0.0 111.441 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -107.35 9.05 29.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.646 1.351 . . . . 0.0 114.646 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 47.44 60.04 3.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.943 1.697 . . . . 0.0 112.003 -178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 66.5 t -84.5 117.1 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.045 1.338 . . . . 0.0 110.741 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.446 ' H ' ' NH2' ' A' ' 94' ' ' ARG . 51.6 t -147.99 129.46 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.978 2.111 . . . . 0.0 107.114 174.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -121.98 157.37 31.44 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 129.881 3.272 . . . . 0.0 110.826 -9.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.8 pt -69.28 145.66 96.08 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -171.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.46 138.96 56.12 Favored 'Cis proline' 0 CA--C 1.538 0.713 0 CA-C-N 118.756 0.592 . . . . 0.0 110.937 -11.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.5 m -112.35 113.87 26.31 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.955 0.902 . . . . 0.0 108.957 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.23 124.78 46.08 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.987 1.315 . . . . 0.0 108.457 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -128.76 138.82 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.088 0.955 . . . . 0.0 111.367 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.57 129.89 52.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.099 1.36 . . . . 0.0 111.983 175.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -109.87 139.67 44.68 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.816 2.047 . . . . 0.0 111.114 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -124.02 122.31 37.57 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.365 1.866 . . . . 0.0 108.982 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 49.01 32.65 4.03 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.128 1.371 . . . . 0.0 114.38 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.79 18.87 69.22 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.605 1.402 . . . . 0.0 116.605 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.61 147.06 59.12 Favored Pre-proline 0 N--CA 1.476 0.848 0 CA-C-N 119.519 1.659 . . . . 0.0 112.385 161.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.68 146.49 48.94 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.331 2.687 . . . . 0.0 112.016 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.97 -45.42 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -147.63 133.85 19.45 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.94 0.896 . . . . 0.0 112.112 -175.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' NH2' ' H ' ' A' ' 78' ' ' VAL . 52.3 ttt180 -117.8 131.94 56.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.255 2.222 . . . . 0.0 110.002 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.57 140.58 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.268 1.827 . . . . 0.0 109.603 -177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.27 146.92 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.929 1.292 . . . . 0.0 112.012 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.83 172.2 45.51 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.247 0.927 . . . . 0.0 113.712 -176.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.09 143.88 47.23 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.46 156.64 43.05 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.86 2.064 . . . . 0.0 111.321 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.95 174.92 39.54 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 125.257 1.408 . . . . 0.0 112.932 -174.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -58.76 -39.97 82.55 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.29 78.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.476 0.711 . . . . 0.0 111.321 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.13 -40.42 74.85 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.778 0.831 . . . . 0.0 112.049 176.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.66 -42.94 81.41 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.353 -0.842 . . . . 0.0 111.895 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.9 tp -66.73 -31.28 71.82 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.676 -0.64 . . . . 0.0 111.928 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.24 -44.78 96.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.127 -0.939 . . . . 0.0 111.685 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -60.58 -38.05 83.34 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 120.005 1.275 . . . . 0.0 111.862 174.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.37 -46.85 78.51 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.491 0.316 . . . . 0.0 111.54 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.3 m -67.71 -24.34 65.38 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.204 176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.99 -10.59 59.99 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.6 t -124.82 -40.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.012 1.725 . . . . 0.0 112.102 -167.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.9 p -149.65 131.16 7.42 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 123.841 0.856 . . . . 0.0 111.887 -174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.56 144.56 97.83 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.023 2.482 . . . . 0.0 112.597 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -146.22 177.94 8.61 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.546 1.139 . . . . 0.0 111.566 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.4 mt -81.73 48.72 1.23 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.114 1.766 . . . . 0.0 111.42 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 . . . . . 0 C--O 1.254 1.341 0 C-N-CA 125.83 1.652 . . . . 0.0 114.529 -158.151 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.479 0.18 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.3 p -79.72 -17.37 53.72 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.651 1.18 . . . . 0.0 113.967 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -145.63 165.84 27.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.105 1.762 . . . . 0.0 111.012 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.3 p -140.52 -172.26 3.4 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.818 1.647 . . . . 0.0 112.613 -173.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.5 -10.33 24.9 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.284 1.434 . . . . 0.0 113.991 170.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mttm 62.79 169.57 0.14 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.131 2.573 . . . . 0.0 114.747 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 m -67.16 152.05 46.46 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.922 1.289 . . . . 0.0 112.365 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.37 14.48 29.56 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -168.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -82.22 151.86 26.66 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.085 -1.01 . . . . 0.0 111.319 173.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.7 pt -126.84 171.58 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.135 1.374 . . . . 0.0 112.414 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -125.95 145.42 50.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.466 1.506 . . . . 0.0 111.493 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.24 159.41 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.537 1.535 . . . . 0.0 112.272 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 76.7 p -140.19 166.97 23.22 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 128.257 2.623 . . . . 0.0 109.935 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -58.16 -28.06 64.38 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.623 -1.298 . . . . 0.0 114.392 -171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.08 -24.28 35.3 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.5 p -102.51 -27.08 12.99 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.49 1.516 . . . . 0.0 114.172 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -51.07 -40.72 58.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.682 1.993 . . . . 0.0 112.457 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.33 -31.4 71.64 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -83.07 -34.94 26.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.777 0.831 . . . . 0.0 111.798 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -86.74 -32.94 20.15 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -109.9 -52.92 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.288 1.435 . . . . 0.0 111.366 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.4 mt -82.37 -13.38 56.95 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -171.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.5 t -89.1 1.69 55.22 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.575 1.15 . . . . 0.0 113.009 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -67.15 154.01 42.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.458 1.503 . . . . 0.0 114.946 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -121.06 22.59 10.94 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 126.718 2.007 . . . . 0.0 111.9 168.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -146.13 168.72 11.03 Favored Pre-proline 0 N--CA 1.479 0.99 0 C-N-CA 127.956 2.503 . . . . 0.0 111.14 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.19 137.63 52.76 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.492 2.128 . . . . 0.0 112.209 167.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.7 t -133.71 116.42 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.118 1.367 . . . . 0.0 110.219 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 28.6 tp -92.03 133.81 35.39 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.754 1.222 . . . . 0.0 109.072 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.9 129.5 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 119.503 1.047 . . . . 0.0 110.763 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -103.69 128.09 51.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.9 1.28 . . . . 0.0 111.706 174.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -99.53 116.66 32.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.235 1.414 . . . . 0.0 108.894 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -144.4 167.94 21.28 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.7 176.76 6.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 111.519 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.3 p -68.19 -24.71 64.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -112.88 -13.33 13.18 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -162.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 p -78.19 124.62 28.28 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -164.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.72 -59.59 10.52 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.795 1.188 . . . . 0.0 114.085 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.27 -27.0 41.37 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 120.128 1.964 . . . . 0.0 113.225 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.1 p -72.03 -39.58 69.02 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.305 0.957 . . . . 0.0 111.686 176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -68.93 -29.34 67.56 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.293 -0.879 . . . . 0.0 112.434 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.5 ttp -68.66 -35.93 77.89 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.703 0.801 . . . . 0.0 113.156 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -82.73 -24.32 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.566 1.075 . . . . 0.0 113.511 174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -45.94 -47.66 41.59 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -64.17 -27.62 64.72 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 121.96 1.773 . . . . 0.0 113.039 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 t -68.24 -35.87 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 119.889 1.222 . . . . 0.0 111.229 173.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.3 mt -67.98 -48.99 64.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.24 1.016 . . . . 0.0 110.341 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -55.65 -40.61 72.43 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.661 0.784 . . . . 0.0 110.866 172.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -75.16 -51.97 12.11 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.645 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.2 mm -59.5 -39.71 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 119.972 1.26 . . . . 0.0 111.361 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.45 96.89 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.745 0.702 . . . . 0.0 111.604 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.5 m -76.79 -32.48 57.7 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -85.06 -22.83 28.82 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -130.18 27.24 5.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.983 1.313 . . . . 0.0 113.504 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.62 -32.61 29.67 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.424 1.49 . . . . 0.0 114.517 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 p -78.11 -18.29 55.86 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.14 1.376 . . . . 0.0 113.737 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -102.01 -40.55 6.81 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.858 1.263 . . . . 0.0 112.687 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.06 172.79 12.57 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.635 1.174 . . . . 0.0 113.674 -175.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.4 m -126.19 143.89 50.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.438 1.495 . . . . 0.0 109.779 170.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.8 127.83 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 121.568 0.699 . . . . 0.0 110.408 168.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.74 164.51 16.47 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.74 2.416 . . . . 0.0 111.722 -173.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -132.36 137.96 47.57 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.498 1.119 . . . . 0.0 111.909 -177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -120.17 122.34 40.76 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.24 1.416 . . . . 0.0 110.175 175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.84 108.63 19.63 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.803 0.841 . . . . 0.0 110.507 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -72.09 -16.65 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -173.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.3 -41.14 11.1 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.541 1.137 . . . . 0.0 112.522 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.7 p -89.43 -22.25 22.61 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -131.26 72.5 81.15 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.782 1.233 . . . . 0.0 111.793 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.53 -14.59 45.64 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.891 2.394 . . . . 0.0 113.141 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -62.56 -42.87 99.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.978 0.911 . . . . 0.0 112.546 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.0 m -74.18 -31.71 62.79 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 119.34 0.973 . . . . 0.0 111.711 172.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.29 94.38 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.658 0.783 . . . . 0.0 111.856 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -77.53 -24.51 49.95 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 168.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -61.28 -46.47 90.21 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.175 0.898 . . . . 0.0 111.474 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -101.11 4.25 41.98 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 48.85 62.78 2.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.768 1.627 . . . . 0.0 112.59 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.4 p -67.6 141.92 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 O-C-N 121.527 -0.733 . . . . 0.0 110.652 170.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -125.48 -45.03 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.599 1.16 . . . . 0.0 111.951 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -121.67 158.04 29.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.577 1.551 . . . . 0.0 111.287 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 54.6 mt -128.58 130.46 23.51 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 123.998 0.919 . . . . 0.0 110.079 -172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.09 150.5 95.79 Favored 'Cis proline' 0 CA--C 1.541 0.851 0 CA-C-N 119.944 1.016 . . . . 0.0 113.317 -5.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 m -121.1 134.98 55.27 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.127 1.371 . . . . 0.0 109.12 164.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.5 mt -110.73 139.75 45.74 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.156 1.782 . . . . 0.0 110.145 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.3 tp -135.03 126.2 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.71 1.204 . . . . 0.0 108.235 174.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.7 tp -107.06 126.4 52.3 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.978 1.311 . . . . 0.0 109.681 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -107.85 152.37 24.5 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.969 1.708 . . . . 0.0 110.275 173.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -131.7 122.84 26.58 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.202 1.801 . . . . 0.0 108.07 172.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 52.43 32.08 10.72 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.8 16.83 79.55 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 125.524 1.535 . . . . 0.0 116.841 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.62 144.14 43.59 Favored Pre-proline 0 N--CA 1.476 0.84 0 CA-C-N 119.543 1.671 . . . . 0.0 111.776 166.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -70.45 140.29 39.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.839 2.359 . . . . 0.0 112.2 -177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.0 m -117.15 -31.8 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 125.124 1.37 . . . . 0.0 114.226 176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -158.17 142.12 15.66 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.183 0.993 . . . . 0.0 112.257 -170.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -125.76 136.68 53.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.106 1.763 . . . . 0.0 110.73 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.47 151.89 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.021 1.728 . . . . 0.0 110.295 -176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.6 p -134.56 147.14 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.492 1.117 . . . . 0.0 111.693 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.07 171.96 48.42 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.478 1.037 . . . . 0.0 113.753 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.36 146.8 38.52 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 -173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -139.47 152.0 46.65 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.718 2.007 . . . . 0.0 111.341 -176.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -91.39 169.16 32.76 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.419 1.009 . . . . 0.0 112.022 171.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.43 -34.46 72.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.93 -42.76 84.78 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.14 0.576 . . . . 0.0 111.388 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.83 -44.83 72.64 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.582 0.753 . . . . 0.0 111.853 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.36 -43.48 97.56 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.731 0.813 . . . . 0.0 111.62 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -63.37 -35.75 81.44 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.406 0.682 . . . . 0.0 111.955 172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 51.2 tpt85 -68.32 -38.25 81.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.201 0.909 . . . . 0.0 112.774 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.83 -39.48 91.96 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.444 1.02 . . . . 0.0 111.467 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -42.92 78.96 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.948 0.499 . . . . 0.0 111.867 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.0 m -66.16 -20.16 66.05 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.061 1.344 . . . . 0.0 112.631 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.78 -19.83 66.03 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.31 146.28 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.099 1.359 . . . . 0.0 110.359 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.6 m -124.15 146.5 51.65 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 126.194 1.798 . . . . 0.0 109.794 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -64.3 -27.6 63.71 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.8 2.333 . . . . 0.0 114.187 -166.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -88.0 -6.62 57.89 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.417 1.487 . . . . 0.0 114.551 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.7 tp 52.61 34.97 16.9 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.496 1.918 . . . . 0.0 113.564 -170.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.254 1.329 0 C-N-CA 127.702 2.401 . . . . 0.0 113.869 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 ttp . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.4 m -73.65 -33.05 64.32 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.108 0.963 . . . . 0.0 112.706 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -143.9 147.99 34.79 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.22 1.808 . . . . 0.0 109.946 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -59.05 120.85 9.9 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.344 1.058 . . . . 0.0 113.559 -168.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -141.11 33.66 1.73 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.548 1.539 . . . . 0.0 111.404 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -69.5 -20.32 63.72 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -173.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.2 m -127.99 140.78 51.77 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.502 1.921 . . . . 0.0 110.481 173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -90.56 22.11 3.64 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -82.58 155.42 24.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.005 1.322 . . . . 0.0 112.415 174.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.4 pt -130.75 157.68 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.2 1.4 . . . . 0.0 111.703 177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -103.09 141.74 35.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.85 1.26 . . . . 0.0 110.605 168.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -125.88 159.44 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.734 1.613 . . . . 0.0 111.359 174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 67.5 p -141.39 168.28 20.16 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 127.927 2.491 . . . . 0.0 109.787 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -54.23 -27.4 34.36 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 120.636 -1.29 . . . . 0.0 113.933 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.55 -13.76 57.68 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.8 p -126.72 -22.1 3.96 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -172.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -51.18 -41.55 60.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.134 1.773 . . . . 0.0 112.625 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.26 -31.38 71.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.3 m -86.07 -29.52 23.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.826 0.85 . . . . 0.0 112.15 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -91.84 -35.48 14.05 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.77 -55.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.823 1.249 . . . . 0.0 111.282 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.1 mt -80.01 -20.84 44.45 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.6 m -92.96 0.78 57.48 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.735 1.214 . . . . 0.0 113.318 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 t -65.82 143.72 57.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.863 0.865 . . . . 0.0 112.697 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -91.6 3.63 54.56 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.293 1.437 . . . . 0.0 113.044 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -141.62 168.85 12.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.642 1.977 . . . . 0.0 111.294 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -54.55 144.52 62.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.749 2.299 . . . . 0.0 114.092 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.43 129.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.704 1.202 . . . . 0.0 109.956 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.81 135.66 34.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 164.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.3 t -119.88 125.13 73.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 118.542 0.61 . . . . 0.0 110.078 168.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -107.34 113.73 27.3 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.535 1.134 . . . . 0.0 112.245 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -86.21 115.04 23.51 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.798 2.039 . . . . 0.0 109.102 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.54 172.03 15.66 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -167.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.75 146.39 50.6 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.611 1.165 . . . . 0.0 110.438 159.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.0 p -72.38 -14.96 61.84 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -173.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -93.66 -9.63 37.25 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.909 1.684 . . . . 0.0 114.032 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.87 135.22 36.39 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.373 1.069 . . . . 0.0 111.504 -177.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.23 -65.24 3.66 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.831 1.205 . . . . 0.0 114.643 -174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.06 -25.87 65.94 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.376 2.05 . . . . 0.0 112.634 177.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.6 m -63.36 -45.7 89.96 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.833 0.853 . . . . 0.0 111.672 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -69.06 -32.83 72.58 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.0 tpt -66.65 -35.19 79.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.345 1.058 . . . . 0.0 113.561 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.2 m -77.84 -25.19 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 119.646 1.112 . . . . 0.0 113.684 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.92 -43.48 75.4 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 -169.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.24 -36.48 87.96 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.541 2.161 . . . . 0.0 112.954 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.64 -37.03 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.137 0.975 . . . . 0.0 110.926 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.67 -49.69 51.15 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.521 1.128 . . . . 0.0 110.278 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.88 -40.8 76.89 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.36 0.664 . . . . 0.0 110.859 173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -76.42 -48.82 18.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.81 -0.614 . . . . 0.0 112.074 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.0 mm -63.49 -39.82 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 110.825 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.07 96.62 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.388 0.994 . . . . 0.0 111.628 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 m -77.82 -33.63 52.31 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -85.29 -30.51 23.69 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 121.235 -0.915 . . . . 0.0 113.054 -174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -118.45 26.52 9.54 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.248 1.819 . . . . 0.0 112.174 -175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.25 -31.68 33.57 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.352 1.461 . . . . 0.0 114.195 -176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.7 p -76.89 -18.18 58.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.235 1.414 . . . . 0.0 113.671 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -101.4 -39.54 7.52 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.477 1.511 . . . . 0.0 112.663 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.03 167.24 29.07 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -120.03 138.87 53.25 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.313 1.445 . . . . 0.0 109.737 166.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.3 t -101.43 127.6 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.177 0.591 . . . . 0.0 109.768 169.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.93 158.76 22.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.482 1.913 . . . . 0.0 111.585 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.21 131.41 54.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.196 1.398 . . . . 0.0 110.599 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -111.7 120.63 42.68 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.261 0.553 . . . . 0.0 109.582 164.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -94.67 97.25 9.96 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.091 0.957 . . . . 0.0 109.619 -172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -64.55 -19.41 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 121.186 -0.946 . . . . 0.0 112.37 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.93 -23.26 60.66 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.262 1.425 . . . . 0.0 114.056 175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.0 p -127.2 -22.92 3.65 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -144.66 76.23 14.29 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.897 1.279 . . . . 0.0 111.134 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -70.6 -3.81 13.33 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.401 2.734 . . . . 0.0 113.9 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -60.25 -42.58 95.6 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.426 1.09 . . . . 0.0 113.051 -174.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -27.17 52.7 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.27 -39.9 94.46 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 111.796 172.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -76.75 -28.59 55.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 171.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -58.43 -44.29 89.05 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.327 0.967 . . . . 0.0 112.069 172.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -96.68 7.36 46.75 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.939 1.296 . . . . 0.0 113.718 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 50.9 49.02 21.95 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.087 1.755 . . . . 0.0 113.246 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.04 123.32 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.504 1.121 . . . . 0.0 109.985 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.64 -23.92 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -170.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.6 t -135.5 165.69 24.92 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.256 1.422 . . . . 0.0 111.877 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.65 143.5 46.8 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.968 1.307 . . . . 0.0 111.745 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.7 147.37 86.49 Favored 'Cis proline' 0 CA--C 1.54 0.806 0 CA-C-N 119.431 0.833 . . . . 0.0 111.523 -8.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.2 m -133.04 122.22 23.86 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.216 1.006 . . . . 0.0 109.842 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.71 137.42 44.77 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.934 1.294 . . . . 0.0 109.75 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.34 132.83 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.114 0.966 . . . . 0.0 109.767 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -114.09 119.79 38.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.105 1.362 . . . . 0.0 111.307 -169.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -101.55 146.68 27.35 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.874 2.07 . . . . 0.0 110.357 173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -98.99 -41.17 7.69 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.696 0.798 . . . . 0.0 113.094 178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -149.92 53.82 0.93 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.272 1.429 . . . . 0.0 110.422 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.96 15.96 63.38 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.491 1.043 . . . . 0.0 113.667 -168.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -129.68 126.81 22.8 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.969 2.108 . . . . 0.0 109.161 -175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.74 143.64 27.02 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.567 2.844 . . . . 0.0 112.754 -170.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.35 -46.6 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.45 1.1 . . . . 0.0 112.418 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -151.05 156.29 40.79 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -121.71 137.55 54.71 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.741 2.016 . . . . 0.0 110.126 169.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.56 127.85 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.352 1.461 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.2 157.71 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.525 1.13 . . . . 0.0 112.126 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.15 177.72 40.68 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.655 1.121 . . . . 0.0 113.818 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -67.33 155.71 38.25 Favored 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.24 151.85 50.12 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.606 1.962 . . . . 0.0 111.288 167.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.52 170.98 37.58 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.7 1.143 . . . . 0.0 111.332 161.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -55.28 -39.13 69.48 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.881 0.841 . . . . 0.0 113.028 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.65 85.01 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.398 0.679 . . . . 0.0 112.09 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.82 78.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.353 0.661 . . . . 0.0 111.696 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 104' ' ' LEU . 14.0 tp -66.2 -39.07 89.39 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.201 -0.937 . . . . 0.0 111.782 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.02 -30.63 69.05 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.328 1.051 . . . . 0.0 112.657 172.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -62.06 -47.6 83.98 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.691 1.132 . . . . 0.0 111.143 168.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -59.17 -41.58 88.78 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.121 0.873 . . . . 0.0 111.903 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.0 -41.95 97.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.137 0.575 . . . . 0.0 112.471 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.2 m -67.4 -25.1 65.78 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.352 1.061 . . . . 0.0 112.465 176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -75.96 0.05 19.8 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.15 0.98 . . . . 0.0 113.392 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 79.6 t -125.59 -39.42 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.92 1.688 . . . . 0.0 112.523 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.7 m -132.9 140.78 38.73 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 124.733 1.213 . . . . 0.0 111.707 172.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.71 158.05 84.71 Favored 'Cis proline' 0 CA--C 1.541 0.831 0 CA-C-N 120.188 1.103 . . . . 0.0 113.823 0.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -67.85 -16.74 64.23 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -161.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -76.82 -4.6 44.39 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.201 0 C-N-CA 125.3 1.44 . . . . 0.0 111.705 173.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.4 m -63.89 142.06 58.54 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.407 1.083 . . . . 0.0 111.578 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -59.39 144.58 46.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.304 1.041 . . . . 0.0 112.942 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.1 p 53.92 19.72 2.09 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.387 1.875 . . . . 0.0 115.506 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 56.27 27.59 12.03 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.872 1.669 . . . . 0.0 113.752 -171.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -65.64 156.53 32.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.289 1.436 . . . . 0.0 111.562 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.6 m -59.96 145.05 47.49 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.649 0.779 . . . . 0.0 110.862 165.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.06 29.89 0.27 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -172.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.3 p -94.15 159.12 15.29 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.93 1.292 . . . . 0.0 112.862 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.1 pt -113.73 164.08 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.197 1.399 . . . . 0.0 110.941 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -120.95 143.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.753 1.221 . . . . 0.0 110.923 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.51 156.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.661 1.584 . . . . 0.0 112.283 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.3 p -117.72 174.33 6.23 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.333 2.253 . . . . 0.0 110.332 175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -54.07 -29.77 45.62 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.94 -47.45 11.0 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.036 0.934 . . . . 0.0 113.262 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.79 -12.35 55.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.99 -46.24 43.51 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.714 1.205 . . . . 0.0 112.666 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.47 -31.32 69.53 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.3 m -89.31 -19.94 24.67 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.88 1.272 . . . . 0.0 113.223 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -122.01 -21.92 5.84 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.92 -37.23 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-N 120.511 1.505 . . . . 0.0 114.406 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.8 mt -75.33 -11.42 60.05 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 120.059 1.3 . . . . 0.0 113.389 171.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 79.9 p -76.9 -7.56 55.75 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.453 1.501 . . . . 0.0 114.111 174.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 84.1 p -67.69 160.13 28.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.001 1.721 . . . . 0.0 114.883 -171.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -131.12 16.03 5.11 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.117 1.767 . . . . 0.0 112.536 172.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -142.43 173.03 5.03 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 128.282 2.633 . . . . 0.0 109.533 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -61.06 140.12 88.02 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.141 1.894 . . . . 0.0 113.383 174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.7 t -134.02 114.93 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 125.078 1.351 . . . . 0.0 110.75 174.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.84 117.01 23.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.3 t -105.76 124.01 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 118.849 0.75 . . . . 0.0 109.873 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -101.64 117.06 34.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.869 1.268 . . . . 0.0 110.531 177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.19 115.0 26.74 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.099 1.759 . . . . 0.0 109.351 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -148.1 168.04 23.44 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.6 170.41 7.95 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.183 0.993 . . . . 0.0 111.107 166.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.9 p -76.64 -6.17 50.93 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -129.41 -2.72 4.93 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -165.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.1 p -80.5 136.6 36.33 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 119.709 1.141 . . . . 0.0 113.981 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.39 -62.93 5.32 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.805 1.193 . . . . 0.0 114.458 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.71 -23.18 42.53 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.37 2.046 . . . . 0.0 112.873 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.43 -40.06 58.13 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -68.29 -32.58 72.83 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.093 -1.004 . . . . 0.0 112.05 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.7 -32.3 71.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.791 0.836 . . . . 0.0 113.025 174.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.2 m -88.37 -5.5 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -53.52 52.3 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 120.269 1.395 . . . . 0.0 113.461 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.26 -33.48 48.56 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.627 1.551 . . . . 0.0 112.31 175.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.38 -52.01 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.1 0.864 . . . . 0.0 111.317 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -67.81 -36.7 80.88 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.738 0.815 . . . . 0.0 110.902 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -70.8 -34.19 71.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -66.61 -46.02 77.23 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.261 -0.9 . . . . 0.0 111.321 171.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mm -56.7 -43.73 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.674 1.579 . . . . 0.0 110.973 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB2' ' HB ' ' A' ' 60' ' ' VAL . . . -57.81 -45.58 85.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.729 0.412 . . . . 0.0 111.761 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.6 m -79.08 -29.85 43.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.389 1.076 . . . . 0.0 112.262 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -87.2 -23.05 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.9 mmt-85 -129.4 24.96 5.48 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.34 -30.63 29.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.254 1.422 . . . . 0.0 114.712 -177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -77.5 -18.45 57.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.245 1.418 . . . . 0.0 113.933 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -104.3 -37.88 7.08 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.144 1.378 . . . . 0.0 112.726 177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.61 173.79 12.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.092 1.357 . . . . 0.0 113.017 -177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.8 m -122.21 153.78 38.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.43 1.492 . . . . 0.0 109.939 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 51' ' ' ALA . 59.1 t -124.19 138.03 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.68 0.792 . . . . 0.0 109.58 168.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.38 160.36 38.68 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.097 1.759 . . . . 0.0 112.007 -170.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -125.83 138.26 53.81 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.218 1.007 . . . . 0.0 112.697 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -119.39 125.59 49.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.934 1.694 . . . . 0.0 109.37 172.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.14 93.17 7.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.024 0.93 . . . . 0.0 110.519 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 m -66.02 -23.34 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.364 1.065 . . . . 0.0 113.152 -173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.09 -27.89 69.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.806 1.242 . . . . 0.0 112.368 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.7 p -119.46 -11.17 9.53 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.836 1.654 . . . . 0.0 113.844 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -127.07 56.82 19.59 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.839 1.656 . . . . 0.0 112.594 179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -70.39 -13.37 33.02 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.178 2.586 . . . . 0.0 113.874 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -75.31 -30.7 60.41 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.378 1.071 . . . . 0.0 112.437 175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -33.94 58.07 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.189 0.996 . . . . 0.0 112.559 165.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.66 -40.07 95.89 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.838 0.744 . . . . 0.0 112.324 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -76.31 -23.43 54.31 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -63.3 -43.06 98.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.537 0.735 . . . . 0.0 111.851 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.41 11.98 35.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.479 1.512 . . . . 0.0 114.061 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.8 tp60 52.54 60.23 3.95 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.235 1.814 . . . . 0.0 113.056 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.5 t -66.11 126.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.915 0.886 . . . . 0.0 109.373 167.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.9 m -129.21 -30.55 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.002 1.321 . . . . 0.0 112.704 -177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.2 m -131.23 147.72 52.62 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.474 1.91 . . . . 0.0 109.358 167.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 pt -111.73 129.88 23.73 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.301 1.04 . . . . 0.0 110.145 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.63 143.39 77.38 Favored 'Cis proline' 0 CA--C 1.54 0.805 0 CA-C-N 119.649 0.91 . . . . 0.0 112.711 1.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.58 133.23 46.57 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.556 1.142 . . . . 0.0 108.036 161.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.39 126.15 51.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.7 1.2 . . . . 0.0 108.621 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.68 126.86 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 O-C-N 121.478 -0.764 . . . . 0.0 109.954 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.24 117.55 35.2 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.923 1.289 . . . . 0.0 110.399 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -94.14 158.33 15.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.868 168.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -142.54 135.39 28.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.749 1.619 . . . . 0.0 108.63 158.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.56 37.48 23.25 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.803 0.841 . . . . 0.0 113.093 -176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.19 16.65 67.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.508 2.004 . . . . 0.0 115.223 -176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -123.52 138.22 29.84 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.947 1.299 . . . . 0.0 110.973 -177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.42 139.85 32.39 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.914 2.409 . . . . 0.0 112.62 -173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -116.07 -42.83 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.664 1.586 . . . . 0.0 112.304 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -150.76 147.23 27.06 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.777 1.231 . . . . 0.0 112.597 -170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -125.21 137.11 54.12 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.854 2.062 . . . . 0.0 111.092 174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.64 159.78 24.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 127.103 2.161 . . . . 0.0 110.874 175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.6 153.54 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.618 1.567 . . . . 0.0 111.527 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.45 169.36 25.89 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.637 1.113 . . . . 0.0 113.414 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.06 154.92 38.26 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -136.57 156.39 48.64 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.665 1.986 . . . . 0.0 110.923 168.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.99 162.63 42.85 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 161.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -57.33 -34.41 68.73 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.248 1.019 . . . . 0.0 113.645 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.36 77.79 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.856 0.463 . . . . 0.0 111.584 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.44 -50.09 64.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.685 0.794 . . . . 0.0 111.736 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.3 tp -61.61 -40.64 95.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.689 -0.632 . . . . 0.0 111.673 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.19 -40.22 95.34 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.106 0.866 . . . . 0.0 111.871 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -49.85 76.0 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 119.359 0.982 . . . . 0.0 110.662 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -63.19 -30.05 71.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -39.73 26.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.532 1.133 . . . . 0.0 112.13 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.1 m -67.52 -18.11 64.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.8 1.64 . . . . 0.0 112.835 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.89 -16.02 15.49 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.09 1.356 . . . . 0.0 113.57 167.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.8 t -117.83 147.9 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 127.004 2.122 . . . . 0.0 109.913 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 19.5 m -74.66 148.1 85.01 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 124.321 1.048 . . . . 0.0 112.227 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.96 142.04 65.88 Favored 'Cis proline' 0 CA--C 1.541 0.84 0 CA-C-N 120.171 1.097 . . . . 0.0 113.468 0.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -151.67 139.0 19.38 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.896 1.679 . . . . 0.0 109.492 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 tp -81.01 -24.63 37.81 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.029 1.332 . . . . 0.0 113.568 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 . . . . . 0 C--O 1.252 1.235 0 C-N-CA 124.646 1.179 . . . . 0.0 113.454 -174.111 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.575 0.226 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.6 p -76.27 158.45 31.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.659 1.184 . . . . 0.0 112.6 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -145.9 139.42 26.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.141 1.376 . . . . 0.0 111.369 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.0 p -158.28 -47.12 0.06 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.732 1.213 . . . . 0.0 112.742 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -144.81 143.79 30.81 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.777 2.031 . . . . 0.0 110.097 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -91.66 156.64 17.46 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.724 1.609 . . . . 0.0 111.918 177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.5 p -71.77 159.64 33.98 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.797 1.239 . . . . 0.0 112.586 172.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.4 19.71 20.12 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -171.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 t -87.71 151.96 22.51 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.107 0.963 . . . . 0.0 111.83 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.0 pt -128.36 170.98 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.398 1.479 . . . . 0.0 112.08 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -128.69 149.6 50.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.21 1.004 . . . . 0.0 112.274 165.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.33 156.56 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.643 1.577 . . . . 0.0 112.209 -173.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.5 p -139.07 159.56 41.86 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.644 1.978 . . . . 0.0 110.166 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.9 -27.94 68.53 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 -164.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.98 -23.08 60.6 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.8 m -111.46 -19.87 12.42 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.791 1.636 . . . . 0.0 113.46 -177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -49.36 -39.46 31.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.846 2.058 . . . . 0.0 112.966 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.09 71.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.5 m -84.7 -33.87 23.06 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.613 -0.679 . . . . 0.0 111.751 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -80.85 -42.37 21.67 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.63 -52.48 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.538 1.535 . . . . 0.0 110.956 -174.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.4 mt -80.3 -12.37 59.61 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.6 t -98.81 5.2 47.59 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.605 1.162 . . . . 0.0 113.353 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.1 p -67.11 152.11 46.36 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.497 1.519 . . . . 0.0 114.598 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.83 28.5 8.74 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.993 1.717 . . . . 0.0 111.022 171.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -153.06 169.33 9.88 Favored Pre-proline 0 N--CA 1.474 0.765 0 C-N-CA 128.267 2.627 . . . . 0.0 110.236 -175.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -64.23 144.84 87.66 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.073 1.848 . . . . 0.0 111.484 161.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.1 t -132.8 118.66 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.274 1.029 . . . . 0.0 109.597 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -101.25 112.72 25.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.948 1.299 . . . . 0.0 108.753 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.1 124.24 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 119.377 0.99 . . . . 0.0 110.667 -175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -97.54 112.7 24.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.319 1.048 . . . . 0.0 111.429 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -85.55 111.14 19.75 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.747 1.619 . . . . 0.0 108.188 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.85 178.92 8.46 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -162.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.13 144.47 45.09 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.525 0.73 . . . . 0.0 110.364 159.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.9 p -67.37 -23.26 65.57 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -173.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.1 p-90 -85.23 -9.58 57.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.361 1.464 . . . . 0.0 114.245 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 135.38 36.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.011 0.924 . . . . 0.0 111.48 -178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -62.95 5.63 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.742 1.163 . . . . 0.0 114.546 -174.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.4 -21.02 61.3 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.342 2.028 . . . . 0.0 113.149 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.4 m -68.03 -49.63 60.25 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.937 0.789 . . . . 0.0 110.991 171.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.85 -32.97 74.66 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.108 -0.995 . . . . 0.0 112.03 175.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.6 ttt -59.51 -35.22 73.74 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.212 1.005 . . . . 0.0 113.108 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.63 -7.54 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.28 -52.76 63.22 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 120.406 1.457 . . . . 0.0 114.15 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.23 -35.81 30.96 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.496 1.464 . . . . 0.0 112.012 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.8 t -64.83 -48.94 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.917 0.887 . . . . 0.0 111.469 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.17 -39.11 82.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.344 0.657 . . . . 0.0 110.756 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -61.8 -45.38 94.09 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.399 0.545 . . . . 0.0 112.075 173.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.92 -47.53 68.5 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.345 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.4 mm -62.05 -35.21 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 120.999 1.727 . . . . 0.0 111.949 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.15 -43.95 92.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.547 1.067 . . . . 0.0 111.606 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.0 m -81.1 -30.09 34.73 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.889 0.876 . . . . 0.0 112.604 -174.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -79.75 -15.57 57.24 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.365 1.066 . . . . 0.0 113.733 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.2 mmt-85 -136.64 24.22 3.14 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.359 1.464 . . . . 0.0 114.122 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.41 -29.57 49.47 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.7 p -82.41 -17.99 43.5 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.289 1.436 . . . . 0.0 113.688 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -101.66 -41.41 6.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.081 1.352 . . . . 0.0 112.698 178.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 176.46 10.4 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.911 1.684 . . . . 0.0 112.864 -177.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -129.36 142.64 50.76 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.981 1.312 . . . . 0.0 110.407 173.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.16 132.27 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.533 0.733 . . . . 0.0 109.84 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.05 162.65 30.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.204 2.202 . . . . 0.0 112.214 -164.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -127.59 139.65 52.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.234 1.413 . . . . 0.0 112.676 -176.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.55 124.27 39.6 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.616 1.566 . . . . 0.0 109.766 170.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -89.62 97.46 11.21 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.157 0.983 . . . . 0.0 110.149 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.5 -25.15 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.984 -1.073 . . . . 0.0 112.559 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.18 -21.09 43.4 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.707 1.603 . . . . 0.0 113.845 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 81.0 p -125.89 -17.08 5.47 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -131.01 79.0 72.34 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.226 1.01 . . . . 0.0 111.542 163.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.27 -13.47 36.01 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 123.436 2.757 . . . . 0.0 114.496 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -58.09 -40.57 81.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.77 1.228 . . . . 0.0 112.821 -177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -81.52 -30.66 33.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.85 -1.156 . . . . 0.0 112.07 172.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.0 87.57 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.361 -0.837 . . . . 0.0 111.958 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.08 -23.1 54.99 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.055 0.942 . . . . 0.0 113.5 169.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -64.36 -44.57 91.01 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.982 0.81 . . . . 0.0 111.084 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.78 4.27 37.73 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.973 1.309 . . . . 0.0 114.481 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 50.59 49.54 20.63 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.97 1.708 . . . . 0.0 113.093 178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.72 134.63 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.807 0.843 . . . . 0.0 111.598 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.09 -40.04 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.353 1.061 . . . . 0.0 112.768 -170.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.5 t -142.27 168.39 19.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.227 1.411 . . . . 0.0 111.717 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.0 pt -130.76 146.18 60.85 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.822 1.249 . . . . 0.0 112.697 -177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.18 143.03 75.88 Favored 'Cis proline' 0 CA--C 1.54 0.79 0 CA-C-N 118.976 0.67 . . . . 0.0 111.423 -8.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.1 m -121.99 118.26 28.39 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.203 1.001 . . . . 0.0 108.665 169.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mp -105.65 129.5 53.88 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.142 0.977 . . . . 0.0 109.53 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.59 126.7 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 124.547 1.139 . . . . 0.0 109.833 -176.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -105.19 119.75 39.83 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.127 1.371 . . . . 0.0 111.042 -173.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -97.08 154.73 17.16 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.158 1.783 . . . . 0.0 110.927 171.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -130.89 109.16 10.35 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.333 1.853 . . . . 0.0 109.386 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 52.97 37.74 25.36 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.211 1.004 . . . . 0.0 112.906 -174.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.06 11.65 82.16 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.307 1.432 . . . . 0.0 116.5 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -113.7 138.09 22.51 Favored Pre-proline 0 N--CA 1.475 0.782 0 CA-C-N 119.601 1.701 . . . . 0.0 111.507 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.57 139.55 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.593 2.195 . . . . 0.0 111.724 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.74 -43.13 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.403 1.081 . . . . 0.0 112.661 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -149.46 141.12 23.51 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.835 1.254 . . . . 0.0 111.463 -165.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -129.17 138.28 51.65 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.284 1.434 . . . . 0.0 111.662 169.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.4 151.67 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.655 1.982 . . . . 0.0 111.665 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.4 147.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.049 1.339 . . . . 0.0 111.225 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.23 168.11 42.65 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.819 1.676 . . . . 0.0 113.389 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.52 156.39 35.04 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.971 1.101 . . . . 0.0 113.971 -172.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.97 158.07 45.09 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.724 2.01 . . . . 0.0 111.197 169.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.82 170.27 41.62 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.026 0.822 . . . . 0.0 111.179 162.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.6 mtmt -55.77 -39.81 71.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.55 -46.75 78.28 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.09 0.556 . . . . 0.0 111.575 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.31 76.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.324 0.65 . . . . 0.0 111.818 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.92 -40.04 95.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.203 0.601 . . . . 0.0 112.113 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.97 -30.12 68.48 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.64 -0.663 . . . . 0.0 112.269 174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -36.8 70.96 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.864 1.211 . . . . 0.0 112.47 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -61.9 -35.89 79.69 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.508 -0.745 . . . . 0.0 111.847 168.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -67.59 -38.2 83.67 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -68.31 -21.11 64.79 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.412 1.085 . . . . 0.0 112.572 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -68.51 -10.66 57.05 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t -121.74 -38.09 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.93 1.692 . . . . 0.0 112.704 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -127.02 152.15 75.23 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 125.866 1.666 . . . . 0.0 112.417 175.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.76 39.96 0.81 Allowed 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 124.086 3.191 . . . . 0.0 115.166 -169.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -56.21 -32.26 64.25 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 120.512 -1.367 . . . . 0.0 112.823 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -77.43 -2.89 37.51 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 125.676 1.59 . . . . 0.0 111.772 -176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.4 ttm . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.8 p -74.19 156.79 36.93 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.676 1.19 . . . . 0.0 113.01 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -74.04 153.87 39.49 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.255 1.022 . . . . 0.0 112.605 177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 83.1 p -149.13 170.02 19.36 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.02 1.328 . . . . 0.0 112.446 177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -84.43 5.03 28.86 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.66 1.184 . . . . 0.0 113.571 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -69.8 148.37 49.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.978 1.311 . . . . 0.0 112.451 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.8 m -66.39 146.17 54.87 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.665 1.186 . . . . 0.0 112.7 178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.14 22.05 14.73 Favored 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -169.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 p -94.22 160.84 14.51 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.204 -0.935 . . . . 0.0 112.143 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.2 pt -119.45 173.44 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.942 1.297 . . . . 0.0 111.46 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -127.81 139.4 52.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.771 1.628 . . . . 0.0 109.654 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.88 160.33 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.787 1.235 . . . . 0.0 112.795 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.8 p -124.47 166.61 15.72 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 128.296 2.638 . . . . 0.0 110.136 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.86 -25.83 63.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.1 -42.15 17.74 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.572 1.149 . . . . 0.0 113.07 174.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -80.34 -18.35 49.35 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -47.92 -41.72 25.39 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.917 2.087 . . . . 0.0 112.98 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -31.25 71.35 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.057 -1.027 . . . . 0.0 113.626 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -92.47 -19.0 22.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.378 1.471 . . . . 0.0 113.071 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -116.13 -25.47 7.61 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.6 t -109.11 -54.93 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.511 1.124 . . . . 0.0 111.422 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.8 mt -71.66 -16.94 62.27 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 80.4 p -75.33 -16.91 60.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.763 1.625 . . . . 0.0 114.505 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -72.0 149.14 45.24 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -165.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -89.62 -0.03 57.25 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.508 1.523 . . . . 0.0 113.796 172.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.94 167.25 20.91 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 127.019 2.127 . . . . 0.0 110.978 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -51.06 147.12 20.5 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.802 2.334 . . . . 0.0 114.311 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.3 t -133.5 125.58 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.797 0.839 . . . . 0.0 111.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.46 129.09 35.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.054 . . . . 0.0 108.802 172.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -116.49 127.8 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.321 1.048 . . . . 0.0 109.287 166.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -104.23 123.86 48.1 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.379 0.672 . . . . 0.0 111.409 170.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -87.1 112.81 22.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.258 1.023 . . . . 0.0 109.317 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.34 174.12 12.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -168.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.77 174.72 8.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.396 1.478 . . . . 0.0 111.206 171.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.1 p -75.93 -10.49 59.46 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -124.39 -5.05 7.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -164.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -81.55 132.39 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 119.597 1.089 . . . . 0.0 113.886 -173.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -58.99 11.32 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.719 1.152 . . . . 0.0 114.284 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.87 -23.89 40.75 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 119.982 1.891 . . . . 0.0 113.041 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.9 -34.71 59.96 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.024 -1.047 . . . . 0.0 111.788 175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -67.12 -32.32 73.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.821 0.848 . . . . 0.0 112.131 166.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.0 ttt -64.42 -35.37 80.7 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 174.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -86.42 -11.45 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.65 85.4 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.14 -30.99 37.35 Favored 'Trans proline' 0 C--N 1.354 0.836 0 CA-C-N 121.467 1.56 . . . . 0.0 112.643 174.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.6 -47.82 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.253 0.933 . . . . 0.0 111.682 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.14 -35.27 73.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.258 1.023 . . . . 0.0 111.47 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -63.87 -45.26 90.23 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 119.061 0.846 . . . . 0.0 112.324 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -66.14 -45.87 79.52 Favored 'General case' 0 C--O 1.224 -0.266 0 O-C-N 121.933 -0.479 . . . . 0.0 110.756 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.3 mm -61.28 -38.38 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.659 1.118 . . . . 0.0 111.881 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.69 -40.63 92.89 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.619 1.1 . . . . 0.0 112.264 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.5 m -79.02 -33.27 45.03 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.064 0.946 . . . . 0.0 111.859 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -90.92 -33.42 15.61 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -113.27 26.4 10.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.622 1.569 . . . . 0.0 113.101 -170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.57 -25.88 53.67 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -73.2 -29.9 63.15 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.593 1.157 . . . . 0.0 112.153 173.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -90.71 -38.22 13.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.271 1.428 . . . . 0.0 113.008 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.11 173.05 13.82 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.3 m -110.9 146.87 35.77 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.782 1.633 . . . . 0.0 109.363 157.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.58 129.57 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 121.387 -0.821 . . . . 0.0 110.251 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.84 161.14 29.72 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.261 2.225 . . . . 0.0 111.295 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -131.76 142.95 49.9 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.433 0.693 . . . . 0.0 111.614 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -113.21 127.52 56.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.297 1.839 . . . . 0.0 109.599 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -96.04 97.25 9.44 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.485 1.114 . . . . 0.0 111.825 -169.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.94 -16.0 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -72.2 -25.2 61.57 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.623 0.769 . . . . 0.0 112.538 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.8 p -126.67 -23.16 3.77 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -146.74 67.58 11.37 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 125.035 1.334 . . . . 0.0 111.977 -177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.34 2.86 5.21 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.014 3.143 . . . . 0.0 114.75 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -61.79 -39.73 92.71 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 120.842 -1.161 . . . . 0.0 113.59 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.34 -28.66 53.14 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 120.993 -1.067 . . . . 0.0 113.863 170.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.79 -37.64 88.29 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 119.873 1.215 . . . . 0.0 112.117 173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -75.51 -27.26 58.69 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.097 -1.002 . . . . 0.0 113.328 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -59.73 -41.82 91.75 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.21 0.914 . . . . 0.0 111.938 171.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -96.65 19.17 12.79 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.506 1.522 . . . . 0.0 113.597 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 52.59 42.52 31.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.451 2.301 . . . . 0.0 114.637 169.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 70.6 t -64.85 124.07 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.668 1.187 . . . . 0.0 110.59 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.88 -40.04 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.072 0.949 . . . . 0.0 111.418 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -147.88 161.74 40.68 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.615 1.566 . . . . 0.0 111.026 175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.5 pt -109.01 142.39 25.42 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.746 1.218 . . . . 0.0 111.688 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.87 154.03 99.42 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 119.545 0.873 . . . . 0.0 112.535 -0.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -133.88 120.92 21.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.823 0.849 . . . . 0.0 108.868 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.12 134.16 38.15 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.963 1.305 . . . . 0.0 109.0 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.6 131.19 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.411 1.084 . . . . 0.0 109.111 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.7 tp -108.18 116.4 31.9 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.845 1.258 . . . . 0.0 110.476 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -93.87 157.37 16.16 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.233 1.813 . . . . 0.0 111.514 173.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -144.75 131.56 20.16 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.493 1.917 . . . . 0.0 109.45 169.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.6 t70 50.0 32.99 6.19 Favored 'General case' 0 CA--C 1.554 1.122 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.27 16.21 80.73 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 124.876 1.227 . . . . 0.0 115.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -117.1 152.22 48.61 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 119.209 1.504 . . . . 0.0 111.638 164.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -68.1 150.43 77.31 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.293 1.996 . . . . 0.0 111.301 168.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.02 -42.94 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.258 1.023 . . . . 0.0 112.37 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -142.19 146.08 34.86 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.808 1.243 . . . . 0.0 112.32 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -129.44 130.35 45.81 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.533 1.533 . . . . 0.0 110.557 166.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 36.0 mm -129.81 123.88 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.83 1.652 . . . . 0.0 109.777 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 148.06 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.687 1.195 . . . . 0.0 111.873 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.92 172.62 39.53 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.495 1.045 . . . . 0.0 114.333 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 149.8 42.0 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -151.48 162.02 41.68 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.308 1.843 . . . . 0.0 112.513 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.94 166.67 31.32 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.797 1.189 . . . . 0.0 112.547 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -59.89 -31.64 69.99 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.72 -40.9 97.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.216 0.606 . . . . 0.0 111.868 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.65 -30.72 56.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.954 0.902 . . . . 0.0 113.199 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 tp -69.65 -42.88 73.64 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 121.33 -0.856 . . . . 0.0 110.793 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.1 tp -67.88 -33.47 74.78 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.473 -0.767 . . . . 0.0 112.391 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.57 -50.11 70.75 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.566 1.075 . . . . 0.0 111.32 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -64.28 -29.34 70.43 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 120.553 -0.459 . . . . 0.0 112.164 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 41.9 tp -67.74 -47.18 70.02 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.764 0.826 . . . . 0.0 113.194 171.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.8 m -68.89 -20.43 64.25 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.446 0.698 . . . . 0.0 112.385 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -74.75 -9.19 58.32 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.6 -42.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.588 1.555 . . . . 0.0 112.79 -166.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.33 142.07 97.58 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 118.99 0.814 . . . . 0.0 112.517 -175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.26 155.81 43.92 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.12 2.547 . . . . 0.0 114.04 175.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -144.6 136.14 25.57 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.465 1.506 . . . . 0.0 110.488 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.3 tp -86.67 -19.34 29.38 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.26 1.424 . . . . 0.0 113.354 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.256 1.403 0 C-N-CA 125.655 1.582 . . . . 0.0 112.016 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 111.409 0.152 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 p -78.66 -22.56 46.62 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.8 t70 52.09 -102.31 0.13 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.77 2.028 . . . . 0.0 113.963 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.1 t -154.02 166.44 33.01 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.652 1.581 . . . . 0.0 111.615 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -78.84 69.55 5.03 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.481 1.512 . . . . 0.0 111.679 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -73.8 162.48 29.08 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.636 1.574 . . . . 0.0 112.805 176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.4 p -68.79 134.66 50.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.361 1.464 . . . . 0.0 112.674 177.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.45 69.38 8.96 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.914 0.886 . . . . 0.0 111.148 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -124.87 152.33 44.14 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.202 1.401 . . . . 0.0 112.585 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -132.3 166.85 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.027 1.731 . . . . 0.0 111.905 -174.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -116.42 139.36 50.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.795 1.638 . . . . 0.0 109.837 168.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -124.64 158.54 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.559 1.544 . . . . 0.0 112.041 -176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.2 p -143.53 162.71 35.15 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.028 1.731 . . . . 0.0 111.748 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.14 -28.15 62.49 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -170.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.59 -18.15 49.15 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.401 1.08 . . . . 0.0 113.835 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -124.06 -10.0 7.65 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 114.351 -171.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -53.16 -41.07 64.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.714 1.606 . . . . 0.0 112.959 -174.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.75 -31.47 72.13 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 m -84.58 -26.67 27.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.136 1.375 . . . . 0.0 112.437 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -92.86 -44.78 8.3 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 41.8 t -98.96 -55.18 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.009 1.324 . . . . 0.0 111.083 -175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 40.2 mt -78.14 -11.99 59.96 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.9 p -71.56 -17.24 62.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.23 1.412 . . . . 0.0 113.627 172.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -83.08 123.29 29.35 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.565 1.546 . . . . 0.0 111.833 -171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 p-10 -78.7 -24.43 45.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.231 1.012 . . . . 0.0 112.701 171.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -82.51 166.73 34.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 125.589 1.556 . . . . 0.0 110.479 171.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.87 144.94 99.38 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.297 1.998 . . . . 0.0 112.722 175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.6 t -132.17 124.99 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.074 0.949 . . . . 0.0 110.412 169.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.98 132.03 36.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 169.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.1 127.72 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.079 0.854 . . . . 0.0 110.418 170.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.73 118.34 36.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.031 1.333 . . . . 0.0 111.559 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.2 112.56 24.26 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.631 1.573 . . . . 0.0 109.203 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -149.22 170.19 19.02 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -163.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -129.88 -167.54 1.82 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.907 1.683 . . . . 0.0 109.672 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -98.83 -20.16 17.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 175.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -86.44 -22.36 26.56 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -171.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.98 132.81 35.41 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.247 1.019 . . . . 0.0 113.018 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.16 -59.02 11.4 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.39 0.995 . . . . 0.0 114.213 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.33 -25.06 36.58 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.269 1.979 . . . . 0.0 113.406 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.2 p -77.51 -32.91 54.43 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.359 -0.838 . . . . 0.0 112.088 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -70.51 -36.57 73.85 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.318 1.047 . . . . 0.0 111.589 169.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 28.1 ttt -60.49 -31.94 70.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.671 1.188 . . . . 0.0 113.762 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.91 -5.91 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.01 -52.73 70.28 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 119.811 1.187 . . . . 0.0 113.963 178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.02 -33.32 74.49 Favored 'Trans proline' 0 C--N 1.353 0.805 0 CA-C-N 121.421 1.543 . . . . 0.0 112.423 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -68.31 -49.64 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.811 0.844 . . . . 0.0 111.792 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.51 -37.03 84.17 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.386 0.539 . . . . 0.0 111.176 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -67.92 -38.53 83.01 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.028 0.831 . . . . 0.0 112.25 175.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.05 -48.03 69.52 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.295 -0.878 . . . . 0.0 111.819 176.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mm -59.49 -41.6 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 120.545 1.52 . . . . 0.0 111.001 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.52 71.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.356 0.662 . . . . 0.0 112.684 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.3 m -76.73 -42.95 39.33 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.088 -1.007 . . . . 0.0 111.2 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -87.43 -36.06 17.93 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -166.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -114.75 21.64 14.23 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.926 1.29 . . . . 0.0 113.601 -171.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.2 41.76 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.353 1.461 . . . . 0.0 114.589 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.6 p -80.95 -18.28 47.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.479 1.512 . . . . 0.0 113.657 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -101.75 -39.54 7.38 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.071 1.348 . . . . 0.0 112.784 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.9 169.21 21.68 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.891 1.276 . . . . 0.0 113.676 -176.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.8 m -110.54 142.26 42.58 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.465 1.506 . . . . 0.0 110.09 171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.2 t -117.28 119.31 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.735 0.814 . . . . 0.0 109.531 169.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.77 163.33 16.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.838 2.055 . . . . 0.0 111.535 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -132.75 137.92 47.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.594 0.758 . . . . 0.0 112.049 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.61 123.44 46.18 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.845 1.258 . . . . 0.0 109.443 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -91.49 108.74 20.1 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.998 0.919 . . . . 0.0 109.447 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 m -70.86 -16.23 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -172.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -87.95 -41.24 13.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.271 1.028 . . . . 0.0 112.671 175.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.2 p -87.35 -22.29 25.17 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -139.99 69.6 35.58 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 124.568 1.147 . . . . 0.0 112.644 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -65.43 -14.83 46.96 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.249 2.632 . . . . 0.0 113.829 176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -64.98 -34.9 79.55 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.059 -1.026 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -80.2 -30.31 38.69 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.476 -0.765 . . . . 0.0 112.051 169.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.93 -35.51 80.91 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.627 -1.296 . . . . 0.0 112.308 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -76.75 -23.2 53.01 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 168.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -60.6 -43.5 97.33 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.004 0.922 . . . . 0.0 111.683 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -102.43 7.76 40.26 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.18 1.392 . . . . 0.0 114.039 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 48.67 67.05 0.92 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.762 1.625 . . . . 0.0 112.331 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.03 81.44 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 123.055 1.407 . . . . 0.0 110.249 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.8 m -87.43 -22.97 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.306 1.842 . . . . 0.0 112.868 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.0 m -122.07 133.14 54.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.221 1.808 . . . . 0.0 109.73 173.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.6 tt -118.23 135.08 23.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.384 1.074 . . . . 0.0 111.517 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.82 157.23 92.44 Favored 'Cis proline' 0 CA--C 1.54 0.788 0 CA-C-N 118.847 0.624 . . . . 0.0 112.7 -9.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.4 m -107.42 124.21 49.51 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.673 1.189 . . . . 0.0 108.39 163.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -111.13 122.78 48.77 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.38 1.472 . . . . 0.0 108.283 174.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.0 tp -130.37 129.83 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.486 1.114 . . . . 0.0 109.986 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.2 tp -100.14 132.34 45.56 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.151 1.38 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -118.36 151.76 37.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.875 1.67 . . . . 0.0 111.576 175.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -143.59 130.0 19.98 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.14 1.776 . . . . 0.0 109.832 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 t70 49.63 35.91 9.6 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.952 1.301 . . . . 0.0 114.381 179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.87 16.41 80.8 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.847 1.213 . . . . 0.0 116.012 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -125.21 144.35 47.15 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 118.745 1.273 . . . . 0.0 111.494 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.46 144.96 51.77 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.009 2.473 . . . . 0.0 111.673 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.13 -54.7 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.832 1.253 . . . . 0.0 112.17 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -156.05 152.72 28.4 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -117.97 141.6 48.28 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.587 1.955 . . . . 0.0 111.571 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.79 146.71 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.952 . . . . 0.0 109.706 171.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -128.05 151.61 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.719 1.207 . . . . 0.0 111.267 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.16 -171.15 55.11 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.748 0.689 . . . . 0.0 111.959 -170.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -83.08 155.79 23.67 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -135.17 149.92 50.04 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.214 2.205 . . . . 0.0 110.139 -173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.46 160.62 29.33 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 162.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -58.03 -34.53 70.15 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.75 73.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.313 0.645 . . . . 0.0 111.655 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.38 -47.36 73.61 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.565 0.746 . . . . 0.0 111.598 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.8 tp -62.62 -40.58 97.43 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.764 -0.585 . . . . 0.0 111.565 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 43.8 tp -68.32 -33.4 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -61.58 -48.68 79.84 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 119.625 1.102 . . . . 0.0 110.555 170.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.66 -33.97 74.91 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 mt -71.2 -35.33 71.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.268 1.027 . . . . 0.0 113.623 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.0 t -69.69 -26.41 64.35 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.634 1.174 . . . . 0.0 112.008 172.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -76.38 5.44 7.16 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.412 1.485 . . . . 0.0 114.451 178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 p -64.59 162.98 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 125.005 1.322 . . . . 0.0 112.984 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.83 128.94 89.6 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 123.958 0.903 . . . . 0.0 109.899 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -59.53 148.31 87.78 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.998 2.465 . . . . 0.0 113.369 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -71.55 -12.36 61.33 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -172.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.2 mt -110.37 9.18 23.52 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.241 1.816 . . . . 0.0 113.289 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.273 0 C-N-CA 125.536 1.534 . . . . 0.0 111.82 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.584 0.231 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.4 p -76.38 157.33 32.45 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.769 1.228 . . . . 0.0 112.484 176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -121.23 168.31 11.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 129.482 3.113 . . . . 0.0 112.86 0.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.8 m -78.29 44.72 0.51 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.903 1.681 . . . . 0.0 113.652 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 54.18 52.75 12.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.758 2.023 . . . . 0.0 113.236 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -65.5 -23.39 66.88 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.6 m -82.66 124.95 30.67 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.085 1.354 . . . . 0.0 112.127 -161.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.04 12.75 1.26 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 128.378 2.671 . . . . 0.0 115.023 -11.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -77.33 143.95 38.41 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 120.776 -1.203 . . . . 0.0 110.901 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 pt -108.3 134.4 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.813 0.845 . . . . 0.0 112.752 -170.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -83.08 129.51 35.03 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.836 1.255 . . . . 0.0 109.415 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.4 m -123.48 155.72 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.568 1.147 . . . . 0.0 111.544 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.7 p -121.47 172.7 7.88 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.385 1.874 . . . . 0.0 110.891 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.09 -24.78 42.32 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 174.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.58 -51.14 7.56 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.23 1.012 . . . . 0.0 113.167 172.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -80.65 -23.23 39.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -50.76 -41.63 56.95 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.087 1.355 . . . . 0.0 112.018 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.86 -31.48 72.11 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.765 -1.209 . . . . 0.0 113.654 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -84.44 -30.63 25.14 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 121.365 -0.834 . . . . 0.0 112.421 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -92.56 -30.02 15.87 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.21 -54.39 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.216 1.406 . . . . 0.0 111.288 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.25 -22.46 35.81 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -172.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.0 m -88.31 3.75 48.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.348 1.059 . . . . 0.0 113.201 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -68.29 154.79 41.05 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.563 1.545 . . . . 0.0 114.237 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -112.91 9.45 18.85 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.562 1.945 . . . . 0.0 113.315 168.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -138.49 170.4 10.4 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 127.631 2.372 . . . . 0.0 111.288 -173.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -66.88 138.97 50.18 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.104 1.869 . . . . 0.0 112.379 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.46 113.46 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.961 1.304 . . . . 0.0 110.323 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -86.64 128.71 35.01 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.375 1.07 . . . . 0.0 108.181 170.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -120.06 124.48 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.899 0.772 . . . . 0.0 110.028 169.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.53 124.11 41.65 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.04 0.936 . . . . 0.0 111.119 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CD2' HD12 ' A' ' 63' ' ' LEU . 9.8 m-85 -95.01 118.36 31.69 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.421 1.488 . . . . 0.0 109.325 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -145.03 165.32 28.54 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -171.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.17 177.62 4.66 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.261 1.824 . . . . 0.0 111.748 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.1 p -68.52 -23.43 64.54 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -117.71 -13.95 10.18 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -161.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -74.98 129.06 37.0 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -165.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.74 -62.98 5.51 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.198 0.904 . . . . 0.0 112.897 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -60.33 -30.44 91.03 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.415 2.077 . . . . 0.0 113.952 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.06 -33.56 70.38 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 118.931 0.787 . . . . 0.0 112.161 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -73.11 -32.24 64.82 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.912 0.885 . . . . 0.0 112.597 168.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -68.64 -31.01 69.85 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -83.17 -17.61 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 119.715 1.143 . . . . 0.0 113.161 174.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.51 -50.24 67.01 Favored Pre-proline 0 CA--C 1.553 1.068 0 CA-C-N 120.255 1.389 . . . . 0.0 114.345 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.1 -33.23 51.0 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.021 1.814 . . . . 0.0 113.092 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.61 -42.88 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.261 1.391 . . . . 0.0 111.06 175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.1 mt -70.72 -48.2 55.79 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.304 1.442 . . . . 0.0 111.01 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -55.04 -37.31 66.52 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.386 1.074 . . . . 0.0 111.648 169.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.98 -43.8 23.71 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.894 -0.574 . . . . 0.0 111.788 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.3 mm -65.53 -34.31 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.463 1.029 . . . . 0.0 111.543 173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 -39.64 86.9 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.513 0.597 . . . . 0.0 112.022 169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 87.6 m -76.16 -34.33 59.37 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.241 0.473 . . . . 0.0 111.741 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -79.83 -35.99 37.52 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -170.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -131.2 30.53 4.51 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.257 1.023 . . . . 0.0 113.444 -173.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.14 -34.04 20.95 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.624 1.57 . . . . 0.0 114.562 -176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.4 p -76.33 -18.2 59.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.001 1.32 . . . . 0.0 114.069 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -105.8 -37.96 6.53 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.681 1.193 . . . . 0.0 112.848 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.31 165.2 29.11 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -121.49 144.38 48.73 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.886 1.675 . . . . 0.0 110.719 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.95 139.02 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.034 173.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -141.67 164.45 30.17 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.937 1.695 . . . . 0.0 114.113 -167.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -118.44 132.23 56.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.846 2.058 . . . . 0.0 111.806 174.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 32' ' ' PHE . 3.0 tm? -114.36 125.25 53.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.893 1.277 . . . . 0.0 109.477 164.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.59 113.12 25.07 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.279 0.631 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.98 -20.53 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -171.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.69 -38.27 33.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.754 0.822 . . . . 0.0 111.963 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 t -95.9 -8.64 33.42 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -128.37 61.5 54.13 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 124.995 1.318 . . . . 0.0 113.358 171.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.22 -29.61 88.14 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.183 1.922 . . . . 0.0 113.486 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -66.07 -38.49 88.45 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.986 0.914 . . . . 0.0 112.428 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -35.2 57.71 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.603 -0.685 . . . . 0.0 111.31 173.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.55 93.17 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.585 -0.697 . . . . 0.0 111.667 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -71.93 -23.84 61.53 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.08 -39.17 77.9 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.951 0.9 . . . . 0.0 112.161 175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -110.01 21.5 16.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.854 1.662 . . . . 0.0 113.366 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 52.98 35.8 20.29 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.743 2.017 . . . . 0.0 114.241 175.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.0 t -81.72 125.5 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.253 1.021 . . . . 0.0 110.09 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.21 -48.49 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.328 1.451 . . . . 0.0 110.099 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.5 m -85.94 143.8 27.98 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.481 1.112 . . . . 0.0 110.752 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.05 145.7 58.91 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.906 1.282 . . . . 0.0 111.147 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.16 146.51 85.17 Favored 'Cis proline' 0 CA--C 1.537 0.638 0 CA-C-N 119.715 0.934 . . . . 0.0 113.103 0.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.1 m -129.73 120.84 25.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.82 0.848 . . . . 0.0 109.258 165.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mp -94.48 132.59 38.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.29 1.436 . . . . 0.0 108.566 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.9 tp -127.2 126.4 67.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.841 1.256 . . . . 0.0 107.972 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.9 tp -108.22 128.44 54.72 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.285 1.434 . . . . 0.0 109.638 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -110.0 151.93 26.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.942 1.697 . . . . 0.0 110.156 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -123.06 117.34 25.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.604 1.561 . . . . 0.0 108.021 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.309 4.0 p30 48.57 38.84 11.96 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 4.39 90.24 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.981 1.753 . . . . 0.0 116.124 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -106.96 133.6 20.21 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 119.236 1.518 . . . . 0.0 110.635 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.66 138.55 41.83 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.426 2.084 . . . . 0.0 111.656 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 m -122.22 -31.99 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.879 1.271 . . . . 0.0 114.205 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -159.52 141.55 13.39 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 119.485 1.038 . . . . 0.0 112.493 -172.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -133.79 130.93 38.69 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.596 1.559 . . . . 0.0 111.533 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.3 mm -129.6 123.7 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 125.463 1.505 . . . . 0.0 110.075 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.93 36.41 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 125.142 1.377 . . . . 0.0 113.572 -172.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -168.06 -172.74 35.37 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.319 -0.863 . . . . 0.0 114.257 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.96 154.14 41.86 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.331 1.052 . . . . 0.0 113.545 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -136.22 153.52 51.2 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.427 1.891 . . . . 0.0 110.773 173.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -104.35 163.54 14.9 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.61 1.1 . . . . 0.0 110.792 165.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -52.31 -43.04 64.31 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.444 1.122 . . . . 0.0 113.205 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.88 72.79 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.131 0.572 . . . . 0.0 111.7 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.97 -40.06 63.27 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.132 0.973 . . . . 0.0 111.969 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.0 tp -63.98 -46.0 86.56 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.399 -0.813 . . . . 0.0 111.34 175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.3 tp -71.59 -24.67 61.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.389 -0.815 . . . . 0.0 112.328 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -60.6 -47.2 87.26 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 120.322 1.419 . . . . 0.0 111.388 162.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -59.78 -36.08 75.95 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.086 0.857 . . . . 0.0 112.339 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.57 -36.38 68.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.918 0.887 . . . . 0.0 113.103 174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.8 m -69.82 -22.76 63.27 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.376 1.07 . . . . 0.0 112.329 175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -73.0 -10.43 59.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.75 1.22 . . . . 0.0 113.275 169.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.59 -30.75 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.423 1.889 . . . . 0.0 112.558 -173.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.2 140.71 31.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 125.332 1.453 . . . . 0.0 110.52 169.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -56.85 117.78 4.52 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.619 2.213 . . . . 0.0 112.179 176.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 116' ' ' ASN . 22.3 t30 -156.94 153.19 27.69 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.532 1.533 . . . . 0.0 110.755 -171.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.83 -4.67 59.22 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -172.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.408 ' H ' ' ND2' ' A' ' 114' ' ' ASN . 41.2 t-20 . . . . . 0 C--O 1.254 1.303 0 C-N-CA 127.149 2.18 . . . . 0.0 112.954 -166.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 119.461 -0.304 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.6 p -74.2 159.33 32.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.476 1.11 . . . . 0.0 112.623 175.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -145.5 148.1 32.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.334 1.454 . . . . 0.0 111.654 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -105.55 16.77 24.93 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.339 1.456 . . . . 0.0 113.967 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 61.22 8.54 2.09 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 127.151 2.181 . . . . 0.0 115.553 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 52.77 26.44 4.53 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 127.512 2.325 . . . . 0.0 115.677 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.6 p -75.7 152.91 37.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.18 0.992 . . . . 0.0 112.998 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.96 12.55 28.6 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -163.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.38 151.85 41.05 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 120.828 -1.17 . . . . 0.0 111.542 169.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.44 166.77 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.357 1.463 . . . . 0.0 111.403 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -124.7 143.45 50.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.529 1.132 . . . . 0.0 111.9 173.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.56 165.92 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.242 1.417 . . . . 0.0 112.658 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.9 p -132.17 175.41 9.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.351 2.66 . . . . 0.0 110.755 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -56.48 -29.46 61.78 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 120.89 -1.131 . . . . 0.0 113.08 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.96 -49.56 8.85 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.98 0.912 . . . . 0.0 112.849 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.5 p -80.14 -20.84 44.02 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -51.02 -41.23 59.68 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.144 1.378 . . . . 0.0 112.805 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -31.43 71.91 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.099 -1.001 . . . . 0.0 113.516 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -89.28 -19.35 25.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.703 1.601 . . . . 0.0 113.198 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -112.98 -27.05 8.21 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.36 -54.06 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.539 1.136 . . . . 0.0 111.631 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.0 mt -73.53 -12.34 60.74 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 84.5 p -76.83 -14.04 59.94 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.889 1.676 . . . . 0.0 113.97 173.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 95.9 p -69.98 155.83 40.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -165.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -114.25 17.49 17.58 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.787 2.035 . . . . 0.0 112.595 172.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -142.62 169.44 10.83 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 127.58 2.352 . . . . 0.0 111.297 -170.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.67 135.32 69.84 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.03 2.487 . . . . 0.0 112.644 159.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -137.6 123.49 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.511 1.124 . . . . 0.0 110.963 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.7 tp -93.92 133.69 37.09 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.313 1.445 . . . . 0.0 109.637 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.5 t -123.12 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.155 0.889 . . . . 0.0 110.295 172.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -107.01 122.49 46.56 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.509 1.524 . . . . 0.0 111.626 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -89.11 116.57 27.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.298 1.439 . . . . 0.0 110.687 173.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -147.11 169.77 18.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.166 0.986 . . . . 0.0 113.613 -172.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.19 39.11 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.128 1.371 . . . . 0.0 111.21 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 m -58.09 -28.4 64.55 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.978 1.311 . . . . 0.0 113.117 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -88.9 -2.78 58.76 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.585 1.554 . . . . 0.0 114.515 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.4 t -84.43 105.19 15.06 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.905 -1.122 . . . . 0.0 112.859 -175.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.45 -56.78 22.73 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 125.38 1.467 . . . . 0.0 114.79 176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -66.51 -29.36 44.72 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 120.613 2.207 . . . . 0.0 112.509 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.36 -47.41 79.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.162 0.892 . . . . 0.0 111.467 173.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -63.69 -32.44 73.92 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 18.6 tmm? -66.0 -42.71 89.42 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.736 0.814 . . . . 0.0 112.31 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.6 m -84.08 -17.78 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -42.02 -48.94 11.3 Favored Pre-proline 0 CA--C 1.557 1.225 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -64.4 -27.29 62.91 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.106 1.871 . . . . 0.0 113.66 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.4 -38.74 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.092 1.315 . . . . 0.0 111.084 173.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 47' ' ' LEU . 2.9 mt -69.26 -48.72 60.98 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.751 1.22 . . . . 0.0 109.777 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -55.75 -40.56 72.7 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.18 171.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -71.74 -50.08 33.37 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.539 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.3 mm -58.15 -41.7 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 119.82 1.191 . . . . 0.0 111.436 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.48 -44.35 97.24 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.818 0.735 . . . . 0.0 111.762 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.2 m -76.77 -31.67 57.19 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.519 0.727 . . . . 0.0 112.198 -175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -85.04 -31.65 23.32 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -122.34 30.33 6.59 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.414 1.485 . . . . 0.0 113.372 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.8 29.48 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.937 1.295 . . . . 0.0 114.356 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.2 m -72.82 -27.43 61.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.946 1.299 . . . . 0.0 112.568 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -99.66 -33.93 10.41 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.207 1.403 . . . . 0.0 113.451 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 176.95 9.81 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.9 m -129.57 149.26 51.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.984 1.714 . . . . 0.0 108.784 162.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.65 135.12 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.902 0.774 . . . . 0.0 110.721 171.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.0 152.25 44.46 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.749 1.62 . . . . 0.0 112.859 -175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 4.8 mmmm -107.45 134.03 51.08 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.14 1.376 . . . . 0.0 111.302 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 tp -130.76 110.83 11.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.5 1.12 . . . . 0.0 109.962 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.65 111.78 20.99 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.727 -0.608 . . . . 0.0 111.955 -170.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -72.89 -20.41 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -80.13 -31.37 39.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.251 1.02 . . . . 0.0 112.124 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 t -104.71 -22.82 13.16 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.062 0.945 . . . . 0.0 113.233 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -128.9 67.54 78.03 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.7 1.6 . . . . 0.0 110.781 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.15 -15.5 31.96 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.337 2.692 . . . . 0.0 113.958 -176.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -63.22 -35.06 79.05 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.223 -0.923 . . . . 0.0 112.527 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.7 p -77.18 -33.29 56.45 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.882 0.873 . . . . 0.0 112.699 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.65 -38.58 91.49 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.497 0.719 . . . . 0.0 111.845 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -76.77 -25.7 53.69 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 171.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -65.01 -44.57 88.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.958 0.799 . . . . 0.0 112.027 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.25 10.18 41.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.299 1.439 . . . . 0.0 114.071 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 51.22 58.11 5.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.242 1.817 . . . . 0.0 113.124 176.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 54.1 t -70.81 121.55 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.207 1.003 . . . . 0.0 109.256 173.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 15.8 m -137.19 -29.69 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.207 1.403 . . . . 0.0 112.724 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 61.8 p -121.21 152.59 38.64 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.468 1.907 . . . . 0.0 109.359 161.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.8 tt -134.2 135.45 24.2 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.534 0.734 . . . . 0.0 111.941 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.14 147.42 66.22 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.15 0.732 . . . . 0.0 113.76 -6.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -99.89 136.89 39.13 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 154.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 mt -110.93 140.48 45.39 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.586 1.555 . . . . 0.0 108.994 168.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.4 tp -130.63 131.61 64.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.31 125.56 51.27 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.226 1.01 . . . . 0.0 109.489 -173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -108.96 158.17 17.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.858 2.063 . . . . 0.0 110.242 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -138.93 134.14 32.78 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.781 1.232 . . . . 0.0 108.995 160.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 t70 54.08 39.82 31.02 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.019 0.927 . . . . 0.0 112.858 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.68 17.53 69.16 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 126.115 1.817 . . . . 0.0 114.982 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -125.9 134.11 25.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.835 1.254 . . . . 0.0 110.854 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.27 139.67 39.0 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.712 2.275 . . . . 0.0 111.764 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.4 m -124.51 -36.63 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -154.29 149.52 27.03 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 119.856 1.207 . . . . 0.0 113.672 170.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -101.59 145.6 28.83 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.154 1.782 . . . . 0.0 110.25 167.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.86 147.9 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.512 1.525 . . . . 0.0 109.623 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.31 147.98 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.386 1.074 . . . . 0.0 111.594 177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.74 175.07 43.23 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 122.182 0.879 . . . . 0.0 113.592 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.31 149.84 44.09 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.14 145.83 46.26 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.282 1.833 . . . . 0.0 111.542 168.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -85.01 173.72 48.97 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.624 1.107 . . . . 0.0 111.167 166.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -59.52 -35.12 73.57 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -169.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.0 -43.54 74.6 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.946 0.498 . . . . 0.0 111.523 177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.49 -42.45 71.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.483 0.713 . . . . 0.0 111.921 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.8 tp -63.39 -40.75 98.09 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.996 0.918 . . . . 0.0 111.39 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 tp -66.14 -30.74 71.28 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 118.519 -0.753 . . . . 0.0 112.354 171.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -68.34 -42.15 79.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.127 1.331 . . . . 0.0 112.551 171.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -56.25 -41.73 76.22 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 118.776 0.716 . . . . 0.0 110.565 170.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.5 -39.33 85.18 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -70.16 -20.25 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.392 1.077 . . . . 0.0 112.394 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -69.72 -11.13 60.61 Favored 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 168.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.1 t -125.61 -40.92 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.83 1.652 . . . . 0.0 113.702 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.16 -38.72 49.59 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 125.79 1.636 . . . . 0.0 114.68 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -60.48 156.69 40.17 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.988 2.458 . . . . 0.0 114.901 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -147.47 162.54 38.83 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.67 1.588 . . . . 0.0 110.795 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.1 -21.87 65.84 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.941 1.296 . . . . 0.0 113.416 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.141 0 C-N-CA 127.051 2.14 . . . . 0.0 110.575 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 mmt . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.3 p -136.5 158.08 45.28 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.615 1.566 . . . . 0.0 111.97 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.9 t0 53.6 37.4 25.87 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.593 1.557 . . . . 0.0 114.05 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.7 p -143.52 166.47 24.72 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.952 1.701 . . . . 0.0 112.502 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -77.42 98.05 5.15 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.098 0.959 . . . . 0.0 110.804 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -69.67 168.03 15.74 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.958 1.303 . . . . 0.0 113.319 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m 53.22 50.51 17.51 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.184 1.794 . . . . 0.0 112.627 -175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.58 55.46 1.99 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.269 1.428 . . . . 0.0 114.001 -166.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.5 p -117.47 161.61 19.3 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.666 1.186 . . . . 0.0 113.515 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.5 pt -133.39 161.06 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.916 1.686 . . . . 0.0 111.467 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -106.42 143.31 34.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 110.738 164.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.89 160.89 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.7 1.6 . . . . 0.0 111.625 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.6 p -136.24 170.01 16.73 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.663 1.985 . . . . 0.0 109.706 173.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.93 -27.49 13.25 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.76 -1.213 . . . . 0.0 113.912 173.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.04 -20.08 53.09 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 176.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.8 p -121.0 -16.02 8.14 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -53.4 -41.3 65.82 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.862 1.665 . . . . 0.0 112.933 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.22 -31.63 70.34 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.7 m -81.26 -31.66 33.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 112.194 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.56 -39.91 7.68 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -175.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -96.83 -54.3 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.309 1.044 . . . . 0.0 111.53 -177.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.3 mt -77.57 -15.07 59.47 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.5 t -66.61 -37.87 85.79 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.905 0.882 . . . . 0.0 112.209 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.402 ' CB ' ' HA ' ' A' ' 25' ' ' ASN 0.299 3.5 t 52.89 -138.9 1.07 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 125.537 1.535 . . . . 0.0 111.249 168.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HA ' ' CB ' ' A' ' 24' ' ' SER . 51.1 p-10 -84.31 -8.31 59.05 Favored 'General case' 0 CA--C 1.548 0.903 3 C-N-CA 133.582 4.753 . . . . 0.0 113.999 -1.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.14 156.49 76.6 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 124.078 0.951 . . . . 0.0 110.995 170.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -57.5 146.03 85.74 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.877 1.718 . . . . 0.0 114.634 -177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.5 t -129.12 124.24 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.131 0.972 . . . . 0.0 109.719 173.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.53 130.43 44.6 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.088 1.355 . . . . 0.0 108.837 175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 t -120.05 131.51 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.788 0.835 . . . . 0.0 110.619 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -98.42 119.62 37.44 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.74 0.816 . . . . 0.0 111.384 167.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -90.41 112.09 23.58 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.505 1.122 . . . . 0.0 108.399 172.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.54 174.4 13.46 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -160.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.54 156.96 47.86 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.839 1.256 . . . . 0.0 111.174 167.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.5 p -74.03 -27.51 60.98 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -84.23 -8.93 58.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.426 1.49 . . . . 0.0 113.894 176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 t -80.41 122.09 26.54 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 111.97 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.49 -57.34 20.31 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.065 1.317 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -67.53 -22.65 44.4 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 CA-C-N 120.238 2.019 . . . . 0.0 112.959 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.7 m -67.69 -42.4 82.1 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.235 -0.916 . . . . 0.0 111.331 172.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -66.67 -32.36 73.63 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.781 0.832 . . . . 0.0 112.562 170.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -64.24 -38.0 89.48 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.978 0.808 . . . . 0.0 112.987 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.5 m -83.93 -10.95 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 176.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.29 -44.96 99.92 Favored Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 119.791 1.178 . . . . 0.0 113.717 -178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.11 -38.2 47.1 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 122.247 1.965 . . . . 0.0 112.461 171.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.7 t -64.91 -49.18 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.693 0.797 . . . . 0.0 111.258 -177.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.83 -37.13 81.54 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.168 0.587 . . . . 0.0 112.124 176.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -64.11 -41.85 97.1 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.951 0.796 . . . . 0.0 112.203 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -72.74 -43.55 62.78 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.733 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mm -61.44 -40.87 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.654 1.115 . . . . 0.0 110.909 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.11 -39.41 92.43 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 100.0 m -70.3 -38.16 74.94 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.404 0.682 . . . . 0.0 111.32 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -83.2 -32.33 26.6 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -172.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -122.94 27.41 7.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -172.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.58 10.47 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -75.59 -33.52 60.58 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.89 1.276 . . . . 0.0 113.486 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -90.51 -38.2 13.37 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.28 0.945 . . . . 0.0 112.888 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.07 167.93 22.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -172.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -114.18 145.21 41.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.98 1.712 . . . . 0.0 109.705 168.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.69 135.67 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.418 0.687 . . . . 0.0 110.595 172.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.27 165.5 24.67 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.535 1.934 . . . . 0.0 111.825 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -127.69 147.97 50.39 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 168.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -114.29 124.61 52.43 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.695 1.598 . . . . 0.0 109.205 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.08 97.91 11.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.526 1.131 . . . . 0.0 109.927 -174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.56 -20.95 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.292 -0.88 . . . . 0.0 112.455 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.29 -25.88 63.54 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.439 1.496 . . . . 0.0 113.292 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.7 p -125.57 -22.81 4.19 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -142.17 72.57 22.33 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.407 1.083 . . . . 0.0 111.961 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -72.25 -0.95 9.39 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.605 2.87 . . . . 0.0 114.505 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -63.33 -40.35 97.08 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.742 -1.224 . . . . 0.0 113.269 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.46 -27.72 52.17 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.208 -0.932 . . . . 0.0 113.411 168.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.08 -40.04 94.47 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.633 1.106 . . . . 0.0 112.006 174.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -75.5 -27.44 58.79 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 171.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -61.32 -42.16 98.22 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.153 0.888 . . . . 0.0 112.076 173.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -96.6 14.68 23.98 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.218 1.407 . . . . 0.0 113.478 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 50.55 41.18 25.11 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.474 2.31 . . . . 0.0 114.025 173.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.73 121.8 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.639 1.175 . . . . 0.0 110.421 -175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.4 p -101.78 -27.63 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.838 1.255 . . . . 0.0 113.571 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 70.9 m -133.85 160.4 37.77 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.987 1.715 . . . . 0.0 111.41 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.3 pt -127.97 144.34 51.12 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 123.946 0.898 . . . . 0.0 111.7 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -68.14 153.67 88.18 Favored 'Cis proline' 0 CA--C 1.537 0.659 0 CA-C-N 119.462 0.843 . . . . 0.0 111.773 -6.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.3 m -133.34 119.62 19.94 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.972 0.909 . . . . 0.0 109.27 168.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.0 mt -103.13 119.77 39.46 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 109.193 -174.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.35 135.09 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.615 1.166 . . . . 0.0 110.372 -174.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 tp -118.73 123.72 45.54 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.114 0.965 . . . . 0.0 111.722 -170.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -104.55 152.44 22.4 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.305 1.842 . . . . 0.0 111.315 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -142.51 135.28 28.19 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.15 1.78 . . . . 0.0 109.754 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 t70 52.01 31.6 8.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.667 1.187 . . . . 0.0 113.329 -168.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.46 7.41 60.71 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.06 1.791 . . . . 0.0 114.662 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -100.56 129.89 26.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 118.771 1.285 . . . . 0.0 110.096 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -68.95 135.93 33.77 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.352 2.034 . . . . 0.0 110.789 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.38 -44.88 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 123.953 0.901 . . . . 0.0 112.214 -175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 9.6 ptpt -153.37 150.55 28.98 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.609 1.164 . . . . 0.0 113.087 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -125.81 127.87 46.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.512 2.325 . . . . 0.0 109.879 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 22.9 mm -122.59 126.06 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.807 1.243 . . . . 0.0 109.985 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -90.06 147.6 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.371 1.069 . . . . 0.0 111.345 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.04 173.44 49.66 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.42 1.009 . . . . 0.0 114.19 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.27 151.56 38.35 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -138.44 155.11 48.77 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.519 1.928 . . . . 0.0 111.731 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.38 167.5 27.53 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.642 1.115 . . . . 0.0 111.942 169.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -56.29 -37.48 69.92 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.914 0.886 . . . . 0.0 112.789 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.96 78.57 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.23 0.612 . . . . 0.0 111.724 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.08 78.05 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.402 0.681 . . . . 0.0 111.957 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.1 tp -67.98 -39.99 83.2 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.417 -0.802 . . . . 0.0 111.875 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.1 tp -69.47 -28.5 66.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.256 0.622 . . . . 0.0 112.264 172.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -61.95 -48.57 79.8 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.615 1.098 . . . . 0.0 110.875 167.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -58.45 -38.08 76.78 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.293 0.951 . . . . 0.0 111.875 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.0 mt -66.51 -43.47 85.2 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.6 m -70.0 -23.57 63.16 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.007 0.923 . . . . 0.0 112.458 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.9 -10.53 59.5 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.112 1.365 . . . . 0.0 112.667 173.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 44.8 t -113.93 -42.03 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.117 1.767 . . . . 0.0 112.8 -176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.1 p -134.76 142.69 43.36 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.628 1.171 . . . . 0.0 111.897 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.1 164.9 20.85 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.811 2.341 . . . . 0.0 113.306 169.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -138.53 136.24 35.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.423 1.489 . . . . 0.0 110.162 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 tp -135.27 22.65 3.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.588 1.555 . . . . 0.0 111.252 175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.727 1.611 . . . . 0.0 112.447 -172.949 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 t -148.62 169.1 21.1 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.805 1.242 . . . . 0.0 112.17 173.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -79.38 156.75 27.82 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.13 1.372 . . . . 0.0 113.679 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -59.21 -21.96 60.3 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.425 1.49 . . . . 0.0 114.093 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 44.3 mt-10 -90.92 88.53 7.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 157.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 97.7 mttt -123.61 11.06 9.14 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 129.933 3.293 . . . . 0.0 115.126 19.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.9 t -62.34 104.79 0.53 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.797 1.18 . . . . 0.0 112.588 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.24 55.65 2.9 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.155 0.982 . . . . 0.0 112.719 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.2 p -94.45 151.21 19.55 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.945 0.898 . . . . 0.0 112.558 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.8 pt -136.5 165.63 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.674 1.59 . . . . 0.0 111.189 171.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -126.23 138.84 53.67 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.011 1.324 . . . . 0.0 110.707 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.06 156.08 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.521 1.129 . . . . 0.0 112.918 -172.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.3 p -142.39 161.82 37.06 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.007 2.123 . . . . 0.0 110.107 172.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -55.1 -35.61 64.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -166.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.08 59.68 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.5 m -113.27 -21.59 10.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.504 1.522 . . . . 0.0 113.79 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -44.83 -41.98 7.51 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.888 2.475 . . . . 0.0 113.114 178.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.91 -31.61 71.5 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.1 m -89.93 -25.96 20.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.856 1.262 . . . . 0.0 112.096 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -84.37 -50.01 8.2 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.931 0.892 . . . . 0.0 113.295 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.53 -33.65 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -169.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.2 mt -77.73 -11.68 59.9 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 120.052 1.296 . . . . 0.0 113.585 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.0 m -88.96 -0.87 57.78 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -66.24 153.03 43.6 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.824 1.25 . . . . 0.0 113.653 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -121.53 28.02 7.94 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.37 1.468 . . . . 0.0 112.173 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -140.77 171.16 8.06 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 128.459 2.703 . . . . 0.0 109.823 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.76 139.51 80.86 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 121.853 1.702 . . . . 0.0 111.572 161.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.62 123.97 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.589 0.756 . . . . 0.0 111.928 170.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.49 125.5 31.81 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.313 1.445 . . . . 0.0 107.875 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -113.75 121.06 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-N 119.3 0.955 . . . . 0.0 109.266 169.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -107.36 115.98 31.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.264 1.026 . . . . 0.0 111.634 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD2' HD12 ' A' ' 63' ' ' LEU . 8.5 m-85 -92.35 123.91 36.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.969 1.708 . . . . 0.0 109.288 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.476 ' CE2' ' HE2' ' A' ' 62' ' ' LYS . 0.2 OUTLIER -149.82 168.1 24.67 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -176.315 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.03 174.75 5.75 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.998 1.319 . . . . 0.0 111.951 170.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.6 p -71.66 -22.66 61.64 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -116.06 -12.75 11.26 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -163.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -74.94 130.15 38.88 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -164.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.17 -59.57 10.61 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 124.82 1.2 . . . . 0.0 114.179 176.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.75 -23.73 48.16 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.36 2.04 . . . . 0.0 113.301 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.3 p -77.76 -35.08 52.08 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 121.344 -0.848 . . . . 0.0 112.405 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -75.41 -27.88 59.2 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.934 -1.104 . . . . 0.0 112.359 170.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 ttt -58.91 -31.34 68.55 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.245 1.018 . . . . 0.0 113.262 171.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.7 m -87.62 -5.85 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.29 -48.6 95.84 Favored Pre-proline 0 CA--C 1.554 1.122 0 CA-C-N 119.983 1.265 . . . . 0.0 114.39 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -66.01 -32.09 45.05 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.383 1.53 . . . . 0.0 112.589 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -69.52 -48.15 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 O-C-N 121.352 -0.843 . . . . 0.0 111.664 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.0 -37.38 84.09 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.626 0.77 . . . . 0.0 110.977 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -63.01 -45.81 90.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.684 0.675 . . . . 0.0 111.97 172.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.51 -46.15 77.18 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.575 -0.703 . . . . 0.0 111.465 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.98 -42.79 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 120.025 1.284 . . . . 0.0 111.249 174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.53 -31.62 72.83 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.4 0.545 . . . . 0.0 112.359 177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.4 m -78.6 -40.07 35.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.413 0.685 . . . . 0.0 111.745 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -89.84 -22.11 22.23 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -168.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 mmt-85 -128.36 22.93 6.0 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.794 1.238 . . . . 0.0 113.877 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.37 -28.63 44.53 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.351 1.461 . . . . 0.0 114.682 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -80.17 -18.34 49.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.394 1.478 . . . . 0.0 113.643 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -101.7 -38.22 7.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.101 1.361 . . . . 0.0 112.88 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.58 177.76 9.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.264 1.426 . . . . 0.0 112.873 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.99 153.95 40.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.781 1.632 . . . . 0.0 109.326 167.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.08 136.14 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.605 0.762 . . . . 0.0 110.361 172.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.84 152.79 49.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.416 1.887 . . . . 0.0 112.092 -170.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.476 ' HE2' ' CE2' ' A' ' 33' ' ' TRP . 17.2 mmmt -115.98 135.26 54.13 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.935 1.294 . . . . 0.0 112.61 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.436 HD12 ' CD2' ' A' ' 32' ' ' PHE . 3.4 tm? -121.78 127.09 50.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.618 1.167 . . . . 0.0 110.484 167.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.37 104.29 16.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.399 1.08 . . . . 0.0 110.054 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.5 m -69.88 -20.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.294 -0.879 . . . . 0.0 112.973 -173.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.62 -33.39 47.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.468 1.107 . . . . 0.0 112.952 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -106.83 -22.47 12.7 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.539 1.136 . . . . 0.0 113.601 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -131.59 68.07 80.58 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 124.923 1.289 . . . . 0.0 111.743 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -63.52 -14.64 43.68 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.094 2.529 . . . . 0.0 113.058 173.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -58.31 -41.12 83.78 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.467 1.107 . . . . 0.0 112.605 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -75.63 -32.9 60.44 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.083 0.856 . . . . 0.0 111.71 173.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.66 92.04 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.149 -0.969 . . . . 0.0 111.81 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -76.98 -23.15 52.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 169.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -61.03 -47.72 85.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.799 0.84 . . . . 0.0 111.234 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.51 6.53 44.31 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 50.9 53.83 12.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 112.795 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 85.9 t -88.16 121.52 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.649 1.18 . . . . 0.0 109.443 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -110.71 -29.44 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.511 1.124 . . . . 0.0 112.701 -171.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.2 t -121.8 160.75 23.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.518 1.527 . . . . 0.0 111.686 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.68 147.02 64.36 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.679 1.192 . . . . 0.0 112.888 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.35 154.29 89.01 Favored 'Cis proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.126 0.723 . . . . 0.0 111.829 -11.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.6 m -130.94 120.54 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.726 0.811 . . . . 0.0 109.638 168.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.49 122.82 37.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.85 126.83 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 124.316 1.047 . . . . 0.0 108.9 177.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.4 tp -112.12 128.3 56.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.623 1.569 . . . . 0.0 110.034 -166.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -108.24 157.35 18.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.686 1.594 . . . . 0.0 110.159 174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.1 127.51 26.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.167 1.787 . . . . 0.0 108.528 167.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 t70 52.01 40.36 28.15 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.763 0.792 . . . . 0.0 112.727 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.23 17.35 72.05 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 126.03 1.776 . . . . 0.0 115.409 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -124.08 133.04 24.37 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 124.71 1.204 . . . . 0.0 110.843 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -70.48 139.15 37.11 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.831 2.354 . . . . 0.0 112.073 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.5 -26.35 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -174.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.17 149.61 32.29 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 120.056 1.298 . . . . 0.0 111.86 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -143.68 127.87 17.66 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.702 1.201 . . . . 0.0 111.098 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mm -132.09 137.59 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.392 1.077 . . . . 0.0 110.618 172.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.1 m -96.93 157.51 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.079 1.352 . . . . 0.0 112.401 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.12 173.81 36.35 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.745 1.164 . . . . 0.0 113.913 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -66.39 156.63 34.04 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.53 152.41 50.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.351 1.86 . . . . 0.0 111.732 171.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.2 166.92 44.71 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 159.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -57.25 -34.43 68.6 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.15 -39.41 82.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.582 0.753 . . . . 0.0 112.372 177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.29 -39.83 65.03 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.634 0.774 . . . . 0.0 112.253 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.91 -48.11 80.39 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 122.079 -0.388 . . . . 0.0 110.203 172.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.48 -32.25 72.25 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 121.477 -0.764 . . . . 0.0 112.37 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.9 tpt85 -69.24 -43.17 74.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.078 175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.98 -27.3 65.58 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.253 1.388 . . . . 0.0 112.505 172.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.27 -41.36 81.19 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.453 0.701 . . . . 0.0 111.871 169.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 t -65.71 -25.74 67.45 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.545 1.138 . . . . 0.0 111.705 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.97 1.09 6.07 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 170.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.7 t -127.26 -35.56 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.777 2.031 . . . . 0.0 111.714 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.8 76.4 75.13 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 125.961 1.705 . . . . 0.0 111.119 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.49 169.52 17.01 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.55 2.833 . . . . 0.0 112.43 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -62.0 -22.74 65.93 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -171.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -95.36 6.33 49.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.503 1.521 . . . . 0.0 115.015 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.278 0 C-N-CA 125.609 1.563 . . . . 0.0 112.279 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m 51.6 38.72 23.27 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.108 1.763 . . . . 0.0 113.672 -174.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -81.77 60.16 4.56 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 120.644 -1.285 . . . . 0.0 110.777 174.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.2 m 57.71 16.04 3.26 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 126.018 1.727 . . . . 0.0 114.35 -159.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.94 -12.8 61.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.232 1.413 . . . . 0.0 114.36 -173.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -87.47 -7.28 57.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.484 1.514 . . . . 0.0 113.934 173.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 t -75.3 145.46 41.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.28 1.032 . . . . 0.0 112.397 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.91 12.38 30.49 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.846 1.259 . . . . 0.0 113.257 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.1 p -80.73 157.44 25.85 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.076 0.951 . . . . 0.0 113.21 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 pt -124.1 165.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 126.019 1.728 . . . . 0.0 111.695 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -109.89 143.23 40.09 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.176 1.79 . . . . 0.0 110.376 170.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.73 156.21 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.801 1.241 . . . . 0.0 111.697 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.1 p -114.7 168.81 9.56 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.15 2.18 . . . . 0.0 110.532 176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.85 -27.84 67.0 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 120.819 -1.176 . . . . 0.0 113.221 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.34 -47.3 14.69 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.193 0.997 . . . . 0.0 112.894 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.0 p -77.79 -26.56 49.79 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -49.76 -39.89 39.24 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.2 1.8 . . . . 0.0 112.605 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.31 -30.16 70.51 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.9 m -95.33 -20.66 18.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.694 1.198 . . . . 0.0 112.531 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -91.39 -58.29 2.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.417 1.087 . . . . 0.0 112.347 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -88.09 -51.88 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 125.213 1.405 . . . . 0.0 111.349 -172.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 49.5 mt -71.15 -15.01 62.47 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -77.43 -18.05 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 m -85.89 118.72 25.55 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -166.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 p-10 -75.42 -24.51 57.12 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.718 1.207 . . . . 0.0 112.113 160.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -65.26 146.35 98.96 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 127.17 2.188 . . . . 0.0 110.087 167.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -62.02 140.12 82.67 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.062 1.841 . . . . 0.0 111.4 170.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.62 130.97 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.984 0.914 . . . . 0.0 110.554 176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.6 mp -104.5 124.66 49.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.898 1.679 . . . . 0.0 108.769 173.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 t -120.1 117.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.107 0.963 . . . . 0.0 110.311 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -98.45 117.58 33.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.606 0.763 . . . . 0.0 112.638 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -90.19 112.68 24.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.854 1.661 . . . . 0.0 108.442 175.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.26 170.28 19.88 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -164.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.69 155.78 48.74 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.989 1.316 . . . . 0.0 111.881 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -78.61 -19.52 52.52 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -86.05 -5.45 59.21 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.707 1.203 . . . . 0.0 113.822 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.48 120.11 31.31 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.184 1.394 . . . . 0.0 112.215 -171.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.91 -55.17 31.64 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.018 1.294 . . . . 0.0 114.726 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.03 -23.93 53.21 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 CA-C-N 120.201 2.0 . . . . 0.0 112.638 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.3 m -67.16 -39.19 86.45 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.065 -1.022 . . . . 0.0 111.588 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -67.9 -31.89 71.99 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.438 -0.789 . . . . 0.0 112.711 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ttt -65.34 -34.7 78.94 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.1 m -86.0 -12.15 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.341 0.973 . . . . 0.0 113.589 174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.76 -49.14 85.03 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -29.27 49.08 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 121.763 1.642 . . . . 0.0 112.718 173.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.8 t -71.5 -48.06 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 O-C-N 121.147 -0.97 . . . . 0.0 111.517 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.6 -36.79 79.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.297 0.639 . . . . 0.0 112.021 175.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.33 -46.91 87.3 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.777 0.717 . . . . 0.0 111.424 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -69.05 -47.77 64.51 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.715 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.2 mm -59.44 -40.8 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-N 121.061 1.755 . . . . 0.0 110.95 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.54 -38.54 90.41 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.093 0.86 . . . . 0.0 112.546 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.1 m -77.09 -36.12 55.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.651 0.78 . . . . 0.0 111.325 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -92.64 -34.66 13.89 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -116.82 13.74 15.09 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.932 1.293 . . . . 0.0 113.583 -163.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.14 -31.03 29.26 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -69.72 -29.94 67.44 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.27 -0.894 . . . . 0.0 112.671 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -90.53 -41.12 11.57 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.772 1.229 . . . . 0.0 112.76 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.3 162.52 41.03 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -176.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.0 m -106.48 136.36 46.37 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.734 1.214 . . . . 0.0 110.482 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.2 t -110.91 122.15 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.083 0.953 . . . . 0.0 110.47 176.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.5 164.38 18.2 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.637 1.975 . . . . 0.0 111.739 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -129.75 143.52 50.86 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 111.42 -174.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -126.43 120.91 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.362 1.465 . . . . 0.0 109.721 170.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -96.29 85.22 3.91 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.228 1.811 . . . . 0.0 111.153 -169.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -60.81 -22.44 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -166.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.04 -28.32 61.36 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.217 1.407 . . . . 0.0 113.459 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -127.17 -9.88 5.88 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.949 1.7 . . . . 0.0 114.585 -171.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -142.51 59.51 8.74 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 126.897 2.079 . . . . 0.0 110.318 -174.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.85 -6.17 14.13 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.534 2.822 . . . . 0.0 114.565 -167.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.2 -39.18 92.49 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.119 -0.988 . . . . 0.0 112.374 -174.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -30.4 54.77 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.391 -0.818 . . . . 0.0 112.065 172.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.34 99.04 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.313 -0.867 . . . . 0.0 111.65 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -74.16 -23.25 59.23 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 172.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -61.75 -44.03 97.7 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.882 0.873 . . . . 0.0 111.282 172.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.55 5.57 50.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.142 1.377 . . . . 0.0 114.162 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 50.51 41.23 24.99 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.408 1.883 . . . . 0.0 113.666 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.59 128.96 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.94 1.296 . . . . 0.0 110.128 178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.94 -45.66 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.869 1.268 . . . . 0.0 111.348 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 p -86.26 152.4 22.81 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.717 1.207 . . . . 0.0 111.674 170.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 pt -145.43 155.54 53.62 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 125.834 1.654 . . . . 0.0 111.098 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.35 138.67 57.02 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 119.795 0.963 . . . . 0.0 111.6 -4.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.3 m -125.29 108.08 11.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.624 0.77 . . . . 0.0 109.9 -174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.29 126.1 43.65 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.754 1.222 . . . . 0.0 110.136 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.1 tt -120.9 132.85 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 122.199 1.0 . . . . 0.0 110.634 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.89 130.67 44.15 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.197 2.199 . . . . 0.0 109.565 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -120.07 148.5 43.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.287 1.835 . . . . 0.0 111.319 174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -144.81 135.13 24.24 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.971 1.708 . . . . 0.0 109.701 174.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 t70 51.34 33.68 10.39 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.63 19.92 71.53 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.335 1.445 . . . . 0.0 115.401 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -126.15 150.25 69.1 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 118.8 1.3 . . . . 0.0 112.104 169.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.37 145.93 44.01 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.905 2.403 . . . . 0.0 112.399 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.45 -46.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.97 1.308 . . . . 0.0 111.678 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -159.54 146.38 16.62 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.887 1.275 . . . . 0.0 111.94 -171.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -129.0 137.21 51.21 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.159 1.384 . . . . 0.0 112.156 173.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.8 116.55 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 126.234 1.814 . . . . 0.0 110.224 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.7 m -100.17 159.4 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 126.054 1.742 . . . . 0.0 112.407 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.1 -171.69 50.67 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.067 0.841 . . . . 0.0 111.958 -174.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.18 147.02 45.14 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.153 -1.204 . . . . 0.0 112.93 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.69 153.15 47.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.077 1.751 . . . . 0.0 111.707 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.37 163.9 24.23 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.565 1.079 . . . . 0.0 112.092 174.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -59.88 -33.97 72.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.244 1.018 . . . . 0.0 113.53 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.13 -42.37 80.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.968 0.507 . . . . 0.0 111.522 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.5 -48.72 71.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.311 0.645 . . . . 0.0 111.214 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.2 tp -62.53 -40.32 96.41 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.219 -0.926 . . . . 0.0 112.344 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.4 tp -70.17 -30.81 68.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.844 0.858 . . . . 0.0 112.686 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -62.6 -44.93 95.06 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.729 1.149 . . . . 0.0 111.413 167.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.1 -36.03 80.47 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 119.32 0.964 . . . . 0.0 111.789 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -68.58 -39.2 81.07 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 174.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -65.34 -26.06 67.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.468 1.107 . . . . 0.0 112.211 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -75.95 -5.08 44.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.9 1.28 . . . . 0.0 114.089 177.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.22 151.37 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.055 1.342 . . . . 0.0 111.755 172.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -101.04 132.97 21.32 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.969 1.708 . . . . 0.0 109.891 171.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.6 -33.27 36.57 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.377 2.052 . . . . 0.0 113.899 -171.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -139.32 139.22 37.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.603 1.561 . . . . 0.0 111.519 176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.43 -15.5 45.94 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.17 1.388 . . . . 0.0 113.149 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.3 t30 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 126.975 2.11 . . . . 0.0 110.889 -179.842 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.1 p -100.56 -35.22 9.6 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.556 1.143 . . . . 0.0 113.92 -174.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.7 -21.71 54.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.027 0.931 . . . . 0.0 113.353 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.9 m -154.22 154.38 33.38 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.949 2.1 . . . . 0.0 109.726 170.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.15 43.07 0.77 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.47 1.108 . . . . 0.0 113.397 -173.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -80.77 -20.25 43.05 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -174.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.9 p -149.23 147.24 28.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.655 1.582 . . . . 0.0 111.877 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.11 39.79 3.52 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.959 1.303 . . . . 0.0 112.843 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p -94.83 163.81 13.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.957 1.303 . . . . 0.0 113.217 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.2 pt -117.93 157.47 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.466 1.506 . . . . 0.0 111.192 170.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -109.25 137.59 46.89 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.886 1.674 . . . . 0.0 110.007 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.4 m -126.35 156.34 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.821 1.248 . . . . 0.0 112.475 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.2 p -143.29 161.55 38.02 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.548 1.939 . . . . 0.0 110.793 175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -53.83 -35.62 61.65 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -168.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.95 -18.87 60.32 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.6 m -119.26 -11.6 9.54 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.703 1.601 . . . . 0.0 113.646 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -51.9 -40.09 60.14 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.16 1.784 . . . . 0.0 113.08 -175.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 -31.5 72.04 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -83.2 -32.25 26.65 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.158 0.983 . . . . 0.0 111.953 176.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.56 -37.81 15.4 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.42 -54.48 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.155 1.382 . . . . 0.0 110.986 -174.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 45.8 mt -77.95 -12.03 59.95 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.5 m -78.74 -11.5 59.98 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.5 m -80.73 121.31 25.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.273 1.429 . . . . 0.0 112.641 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.35 -26.98 60.46 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.006 0.523 . . . . 0.0 111.857 164.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -69.75 153.54 95.49 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.253 1.021 . . . . 0.0 110.701 169.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.06 145.75 85.69 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.755 1.637 . . . . 0.0 111.675 173.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -139.0 132.3 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.564 1.145 . . . . 0.0 111.915 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.5 134.22 35.98 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.769 1.628 . . . . 0.0 109.169 170.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -122.27 129.8 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.316 0.647 . . . . 0.0 110.457 167.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -103.52 136.73 42.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.406 1.482 . . . . 0.0 113.076 178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -100.26 120.17 39.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.126 1.37 . . . . 0.0 111.097 172.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -75.03 168.1 20.64 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.261 1.024 . . . . 0.0 113.344 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.69 144.79 32.86 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.044 0.938 . . . . 0.0 109.244 142.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.9 p -67.94 -31.42 71.16 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -165.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -96.33 -8.28 33.04 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.644 1.978 . . . . 0.0 113.777 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.5 t -82.41 110.44 17.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.52 1.128 . . . . 0.0 113.24 -160.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.57 -57.07 12.87 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.277 1.418 . . . . 0.0 114.364 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.17 -24.42 65.91 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 CA-C-N 120.481 2.14 . . . . 0.0 113.349 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.84 -42.03 82.05 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.213 0.915 . . . . 0.0 111.217 171.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -66.3 -32.23 73.51 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 121.463 -0.773 . . . . 0.0 112.462 171.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -68.55 -31.93 71.49 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.3 m -83.65 -14.52 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.781 1.173 . . . . 0.0 113.691 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.41 -54.37 46.1 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.21 -32.0 52.72 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.674 1.583 . . . . 0.0 112.327 176.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.43 -51.22 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 119.352 0.978 . . . . 0.0 111.734 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.06 -35.28 74.12 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.743 0.817 . . . . 0.0 111.298 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -71.43 -34.9 70.69 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 173.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -66.18 -47.6 73.45 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 120.806 -1.184 . . . . 0.0 111.222 171.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -56.38 -40.75 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 120.609 1.549 . . . . 0.0 111.08 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.19 -38.02 85.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.9 0.773 . . . . 0.0 112.581 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.5 m -77.19 -34.92 56.16 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.036 0.934 . . . . 0.0 111.663 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -88.52 -39.58 14.07 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -113.64 17.25 18.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.231 1.412 . . . . 0.0 113.457 -162.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.89 34.62 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.328 1.451 . . . . 0.0 114.626 -173.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.7 p -78.23 -18.52 55.28 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.216 1.407 . . . . 0.0 113.825 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -98.18 -41.41 7.91 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.838 1.255 . . . . 0.0 112.48 176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.32 164.08 35.9 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.598 1.159 . . . . 0.0 113.3 -178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.6 m -107.15 144.45 33.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.883 1.273 . . . . 0.0 110.359 171.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -118.84 128.76 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 123.422 0.689 . . . . 0.0 110.286 170.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.49 162.31 23.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.644 1.978 . . . . 0.0 111.429 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -136.28 144.75 44.92 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.91 122.69 46.64 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.765 1.626 . . . . 0.0 110.448 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -87.15 84.08 7.33 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.823 1.249 . . . . 0.0 110.797 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.6 p -62.92 -24.06 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.66 -26.57 61.69 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.08 0.952 . . . . 0.0 113.383 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 74.1 p -110.06 -22.66 11.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.416 1.086 . . . . 0.0 113.479 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.03 77.39 26.0 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.464 1.506 . . . . 0.0 111.548 176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -69.67 -15.21 37.3 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.718 2.278 . . . . 0.0 112.851 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.81 -38.24 75.21 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.666 1.187 . . . . 0.0 112.966 -176.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.1 m -72.2 -34.0 68.05 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.119 0.872 . . . . 0.0 112.331 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.22 -32.0 73.41 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.906 -1.122 . . . . 0.0 111.454 173.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -74.99 -39.52 61.2 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.284 1.033 . . . . 0.0 111.768 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -52.84 -45.41 67.34 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.993 1.317 . . . . 0.0 111.622 176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -98.18 15.72 23.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.305 1.442 . . . . 0.0 114.512 177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.272 7.6 pt20 47.46 42.53 14.57 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.773 2.029 . . . . 0.0 115.13 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.95 126.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.454 1.502 . . . . 0.0 110.429 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.1 m -130.91 -9.84 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.431 1.492 . . . . 0.0 113.799 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 151.19 41.13 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.37 1.868 . . . . 0.0 110.197 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.23 141.48 29.54 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.879 0.872 . . . . 0.0 112.579 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.17 154.49 88.45 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.261 0.772 . . . . 0.0 111.951 -7.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -132.55 135.56 46.02 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.831 1.252 . . . . 0.0 108.73 171.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.2 mp -117.6 142.83 46.75 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.318 1.047 . . . . 0.0 110.386 169.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.5 tp -122.34 137.6 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.827 1.651 . . . . 0.0 109.117 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 65.8 tp -108.8 125.57 52.1 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.612 1.565 . . . . 0.0 109.694 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -116.08 155.6 27.88 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.574 1.149 . . . . 0.0 111.391 172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -143.54 136.12 27.27 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.66 1.584 . . . . 0.0 109.646 164.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t70 53.78 32.2 14.44 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.11 1.364 . . . . 0.0 114.256 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.59 17.31 80.18 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.853 1.216 . . . . 0.0 115.63 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -126.09 143.62 46.22 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 118.776 1.288 . . . . 0.0 111.503 172.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 144.09 42.13 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.893 2.395 . . . . 0.0 111.628 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.4 t -111.34 -45.18 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.12 1.368 . . . . 0.0 111.388 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -158.37 146.15 18.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.443 1.097 . . . . 0.0 111.529 -163.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.34 142.14 51.67 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.38 1.472 . . . . 0.0 110.826 172.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.45 132.4 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.998 1.719 . . . . 0.0 110.098 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.81 143.89 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.403 1.481 . . . . 0.0 110.647 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.29 176.02 46.07 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.708 0.671 . . . . 0.0 112.719 -168.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.23 152.06 44.65 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -128.33 149.17 50.63 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.097 2.159 . . . . 0.0 109.851 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.24 166.42 32.1 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 161.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -57.53 -38.99 75.58 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.073 0.949 . . . . 0.0 113.183 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.59 -38.42 77.33 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.404 0.681 . . . . 0.0 111.593 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.68 -45.56 64.81 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.524 0.73 . . . . 0.0 111.82 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.2 tp -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.349 0.977 . . . . 0.0 111.355 176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.54 -37.58 87.84 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.762 -0.586 . . . . 0.0 111.926 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.8 ttp85 -61.76 -43.03 99.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.771 -1.206 . . . . 0.0 112.29 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.88 -31.96 73.32 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.937 0.789 . . . . 0.0 112.372 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -69.7 -40.27 76.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.668 0.387 . . . . 0.0 111.815 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.5 m -64.78 -25.48 67.94 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.234 -0.916 . . . . 0.0 112.695 170.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -68.56 -10.78 57.94 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.168 1.387 . . . . 0.0 114.41 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 p -63.78 157.8 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.131 1.373 . . . . 0.0 114.162 -173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.3 t -80.9 142.29 52.05 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 125.677 1.591 . . . . 0.0 110.386 176.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -61.78 162.08 23.01 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.563 2.842 . . . . 0.0 114.964 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -72.9 -17.69 61.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.946 0.898 . . . . 0.0 113.016 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.7 tp 59.38 15.03 4.1 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.195 2.198 . . . . 0.0 114.654 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 127.418 2.287 . . . . 0.0 110.824 176.191 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpt . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.388 0.614 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.1 m -82.53 84.86 7.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.664 1.186 . . . . 0.0 110.12 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.4 t70 61.3 -53.13 0.11 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 128.65 2.78 . . . . 0.0 115.458 -170.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.2 t -154.92 129.54 9.21 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.486 1.515 . . . . 0.0 110.902 171.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -140.8 135.83 31.85 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.965 1.706 . . . . 0.0 109.646 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -106.29 152.02 24.08 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.522 1.529 . . . . 0.0 112.183 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.6 m -126.88 150.83 49.07 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.123 1.769 . . . . 0.0 110.708 172.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.86 36.83 0.77 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.4 p -99.09 153.59 18.77 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.733 1.613 . . . . 0.0 112.196 177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.6 pt -130.76 164.08 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.711 1.204 . . . . 0.0 112.7 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -109.46 142.73 40.05 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.882 1.673 . . . . 0.0 110.141 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.81 154.01 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.439 1.096 . . . . 0.0 112.638 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.2 p -145.45 160.93 40.84 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.973 2.109 . . . . 0.0 110.159 172.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -51.81 -34.53 40.55 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -171.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.99 -20.48 62.41 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -120.88 -14.2 8.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.59 1.556 . . . . 0.0 113.693 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -51.17 -41.65 60.32 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 126.397 1.879 . . . . 0.0 113.34 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.89 -31.25 71.72 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.5 m -82.19 -33.71 29.33 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.593 0.757 . . . . 0.0 111.793 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -81.08 -43.25 19.76 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.97 -54.42 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.001 1.32 . . . . 0.0 111.194 -173.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.6 mt -80.06 -17.07 53.67 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -171.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.6 m -101.45 7.27 42.57 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.843 1.257 . . . . 0.0 113.119 175.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.3 t -66.01 144.63 56.62 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.979 0.912 . . . . 0.0 112.994 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -84.23 1.68 43.47 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.988 1.315 . . . . 0.0 113.213 174.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 pttt -142.73 166.69 19.27 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 126.825 2.05 . . . . 0.0 111.651 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_exo -47.45 147.12 6.54 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 124.024 3.149 . . . . 0.0 114.822 163.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.2 t -138.1 130.78 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.477 1.111 . . . . 0.0 110.789 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.4 129.04 39.68 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.909 1.284 . . . . 0.0 107.931 169.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.2 t -112.37 123.89 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 119.445 1.021 . . . . 0.0 109.801 170.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -113.08 121.9 45.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.403 1.081 . . . . 0.0 112.458 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -93.69 120.11 33.55 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.354 1.862 . . . . 0.0 110.598 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -148.72 171.17 16.65 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.416 1.636 . . . . 0.0 115.416 -178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -116.97 176.92 4.9 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.86 1.664 . . . . 0.0 111.541 170.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -71.43 -29.58 65.05 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.841 -1.162 . . . . 0.0 113.118 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -100.23 -14.86 18.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -163.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.2 p -76.47 127.67 33.29 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -163.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.23 -63.54 5.22 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.739 1.162 . . . . 0.0 113.948 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.0 -24.42 60.17 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.43 2.086 . . . . 0.0 113.149 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.5 p -74.89 -36.33 62.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.93 0.786 . . . . 0.0 111.789 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -75.48 -28.01 59.05 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.987 -1.071 . . . . 0.0 112.629 171.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.3 mmm -63.93 -29.71 70.85 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.1 m -83.48 -8.57 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-N 119.664 1.12 . . . . 0.0 113.928 172.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.4 -50.69 83.66 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 120.708 1.595 . . . . 0.0 113.905 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.24 -37.05 33.39 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.538 1.492 . . . . 0.0 112.359 174.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.3 t -62.91 -49.23 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.374 1.069 . . . . 0.0 111.694 179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 pp -70.36 -39.87 74.36 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.614 1.166 . . . . 0.0 110.858 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -62.03 -44.16 97.3 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.75 0.705 . . . . 0.0 111.962 173.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -64.61 -54.29 34.28 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.449 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.3 mm -65.48 -33.9 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 119.742 1.155 . . . . 0.0 111.502 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.47 -45.17 89.19 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.482 1.037 . . . . 0.0 111.364 172.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.2 m -82.38 -30.82 30.01 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.415 0.686 . . . . 0.0 112.74 -175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -80.1 -28.32 39.06 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.044 -1.035 . . . . 0.0 113.203 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -120.27 29.42 7.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.798 1.639 . . . . 0.0 112.621 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.04 -25.84 33.29 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.842 1.257 . . . . 0.0 114.293 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.1 p -80.71 -18.5 47.65 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.433 1.493 . . . . 0.0 113.884 175.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -103.5 -36.49 7.94 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.404 1.482 . . . . 0.0 112.945 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.43 160.28 43.81 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.8 m -111.03 139.62 46.23 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.297 1.439 . . . . 0.0 109.872 166.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -100.03 127.93 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.57 0.7 . . . . 0.0 110.153 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.68 145.55 42.63 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.541 2.337 . . . . 0.0 110.608 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -122.5 137.94 54.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.5 129.23 54.61 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.798 1.639 . . . . 0.0 109.637 177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -99.35 105.65 17.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.392 1.077 . . . . 0.0 109.433 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.97 -22.1 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 -164.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.52 -29.91 41.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.551 1.141 . . . . 0.0 113.233 178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.1 p -106.08 -19.18 13.8 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.451 1.1 . . . . 0.0 113.81 -176.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -133.03 78.68 64.74 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.687 0.795 . . . . 0.0 112.068 164.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.25 -22.57 75.01 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.125 2.55 . . . . 0.0 114.11 175.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -65.21 -43.28 92.01 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.834 0.854 . . . . 0.0 113.096 -174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.5 m -76.93 -30.49 56.11 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.137 0.88 . . . . 0.0 111.679 172.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.58 98.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.252 -0.905 . . . . 0.0 111.969 176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -76.68 -24.47 53.19 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -56.8 -40.01 75.17 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.37 0.986 . . . . 0.0 112.125 174.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -107.65 13.65 26.41 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.652 1.581 . . . . 0.0 113.807 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 51.45 53.25 13.14 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.591 1.956 . . . . 0.0 114.141 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -65.54 137.05 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.278 -0.889 . . . . 0.0 110.219 172.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.0 t -134.55 -61.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.353 1.061 . . . . 0.0 109.788 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 66.8 m -86.86 151.33 23.43 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.237 1.015 . . . . 0.0 110.621 166.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.5 133.62 25.29 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.364 1.065 . . . . 0.0 109.515 -171.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -75.74 159.94 96.57 Favored 'Cis proline' 0 C--N 1.351 0.676 0 CA-C-N 120.365 1.166 . . . . 0.0 113.246 -0.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -126.98 136.11 51.8 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.426 1.09 . . . . 0.0 109.197 163.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.26 141.87 44.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.027 2.131 . . . . 0.0 109.128 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.72 129.38 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.901 0.88 . . . . 0.0 108.954 166.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.8 tp -109.44 125.21 52.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.892 1.277 . . . . 0.0 110.821 -173.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -104.83 148.45 26.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.249 1.819 . . . . 0.0 111.196 175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -112.71 116.92 30.89 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.859 1.664 . . . . 0.0 108.264 164.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 51.16 37.37 18.1 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.644 1.178 . . . . 0.0 113.934 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.07 9.83 85.68 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.19 1.376 . . . . 0.0 115.944 -177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -113.93 131.39 23.16 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-N 119.27 1.535 . . . . 0.0 110.665 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.75 139.93 37.86 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.79 2.327 . . . . 0.0 112.526 -173.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.2 t -112.61 -48.66 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.966 1.306 . . . . 0.0 112.02 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -157.6 158.5 35.66 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.312 1.045 . . . . 0.0 113.436 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -118.51 140.36 50.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.021 1.728 . . . . 0.0 110.532 168.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.6 139.09 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.772 1.629 . . . . 0.0 109.522 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.48 142.89 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.657 1.183 . . . . 0.0 111.059 178.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.82 175.86 51.17 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 124.213 0.911 . . . . 0.0 113.228 -170.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.32 156.68 38.38 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -118.16 158.02 25.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.131 2.172 . . . . 0.0 110.086 172.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.5 166.65 25.48 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 155.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -51.17 -45.68 61.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.972 0.886 . . . . 0.0 112.169 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.18 -36.67 84.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.298 1.039 . . . . 0.0 112.651 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.2 -42.92 62.14 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.451 0.7 . . . . 0.0 111.864 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -63.32 -40.13 96.47 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 121.366 -0.834 . . . . 0.0 111.364 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.3 tp -67.02 -30.87 71.08 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.695 1.198 . . . . 0.0 112.854 171.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -64.7 -42.64 95.15 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.342 0.974 . . . . 0.0 111.47 169.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.44 -39.2 92.56 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.537 1.062 . . . . 0.0 111.776 173.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.3 -40.73 96.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.167 0.587 . . . . 0.0 112.104 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -65.92 -28.3 68.83 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.336 -0.852 . . . . 0.0 111.899 173.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -79.6 -18.79 50.81 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 0.0 113.339 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.3 t -77.42 -23.89 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.491 1.516 . . . . 0.0 112.228 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.2 t 54.58 63.31 7.34 Favored Pre-proline 0 N--CA 1.478 0.939 0 C-N-CA 125.868 1.667 . . . . 0.0 111.734 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -61.49 -21.85 73.0 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.502 2.801 . . . . 0.0 113.578 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -76.18 -4.15 40.16 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.123 1.769 . . . . 0.0 114.738 175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 tp -65.52 -25.97 67.69 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.885 1.274 . . . . 0.0 113.559 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.1 m120 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.67 1.588 . . . . 0.0 112.653 -171.922 . . . . . . . . 0 0 . 1 stop_ save_